{"meta":{"query_hash":"641073d730bc","filters":{"venue":"The Lancet Neurology"},"cohort_total":552,"direct_labels_cover":3,"predictions_cover":552,"exported":552,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/641073d730bc","api":"https://metacan.xera.ac/api/v1/cohort?venue=The+Lancet+Neurology"},"results":[{"id":"W1534323731","doi":"10.1016/s1474-4422(15)00053-8","title":"Unfreezing of gait in patients with Parkinson's disease","year":2015,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Gait; Parkinson's disease; Physical medicine and rehabilitation; Disease; Medicine; Psychology; Internal medicine","score_opus":0.02508292718449368,"score_gpt":0.24765676133489462,"score_spread":0.22257383415040094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1534323731","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.044229057,0.026739283,0.00041652145,0.87793386,0.016090145,0.000053697167,0.00039079136,0.00011110289,0.03403556],"genre_scores_gemma":[0.39034903,0.018248737,0.0008254622,0.48934156,0.091885805,0.00006815924,0.00033682643,0.00005219998,0.00889219],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990139,0.00023350542,0.00023439832,0.00011851323,0.00021105519,0.00018868773],"domain_scores_gemma":[0.99600595,0.0020201015,0.0006137311,0.00012880376,0.00068349025,0.00054789777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067768653,0.0005838873,0.0014870394,0.0009835066,0.0017116658,0.0015098664,0.00096633256,0.015779465,0.0029398508],"category_scores_gemma":[0.013847849,0.00038762152,0.0010433636,0.0013005517,0.0016140384,0.0013948692,0.0006259164,0.010108235,0.0010640697],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001345248,0.00045109307,0.11938665,0.0012720333,0.0005194194,0.24255669,0.0011366877,0.0004831625,0.0011560738,0.00847633,0.49681923,0.12639733],"study_design_scores_gemma":[0.001793733,0.0016325943,0.24454254,0.0060105026,0.0010369091,0.49078012,0.002914686,0.0038580073,0.00077361637,0.036377028,0.20987616,0.0004041451],"about_ca_topic_score_codex":0.007897631,"about_ca_topic_score_gemma":0.017468376,"teacher_disagreement_score":0.015779465,"about_ca_system_score_codex":0.0022933392,"about_ca_system_score_gemma":0.0017792408,"threshold_uncertainty_score":0.016639352},"labels":[],"label_agreement":null},{"id":"W1858544150","doi":"10.1016/s1474-4422(15)00186-6","title":"Insights from late-onset familial parkinsonism on the pathogenesis of idiopathic Parkinson's disease","year":2015,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Parkinson Canada; Canada Excellence Research Chairs, Government of Canada; University of British Columbia; Canada Research Chairs; Parkinson Society Canada; Genome British Columbia","keywords":"Pathogenesis; Disease; Parkinsonism; Neuroscience; Parkinson's disease; Neuroprotection; Medicine; Bioinformatics; Biology; Immunology; Pathology","score_opus":0.07415295265725902,"score_gpt":0.3091093832398649,"score_spread":0.2349564305826059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1858544150","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000036938258,0.99946994,0.000020033116,0.00018865473,0.000070800386,0.0000011123401,0.000004821957,0.0000012599525,0.00020644382],"genre_scores_gemma":[0.0003165409,0.999281,0.00004272357,0.00013208155,0.00009820233,0.0000013066243,0.0000073906945,2.6354203e-7,0.00012052765],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978024,0.00004373951,0.00003167581,0.000029555751,0.00009076566,0.000024017087],"domain_scores_gemma":[0.99942905,0.00033647416,0.00008349633,0.000010707851,0.000101940714,0.00003826665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009152775,0.0009770938,0.0021480445,0.0020560992,0.00024510178,0.0011270274,0.00095594407,0.001334634,0.0032707774],"category_scores_gemma":[0.0010197491,0.00028575133,0.0007417766,0.0018466709,0.00058548606,0.0012491269,0.0009241765,0.001937316,0.0009472521],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013295663,0.00006585855,0.00020649322,0.030007392,0.0002419583,0.00034179137,0.000083790816,0.00030565227,0.0009896666,0.004345017,0.030801766,0.93247765],"study_design_scores_gemma":[0.000067828194,0.00012301723,0.0014988888,0.013542062,0.00046991484,0.0015442513,0.00012084259,0.00013332957,0.00021259057,0.0051173,0.9771417,0.000028303648],"about_ca_topic_score_codex":0.0020417639,"about_ca_topic_score_gemma":0.0054855742,"teacher_disagreement_score":0.0032707774,"about_ca_system_score_codex":0.0007537244,"about_ca_system_score_gemma":0.0012366399,"threshold_uncertainty_score":0.010941803},"labels":[],"label_agreement":null},{"id":"W1879121056","doi":"10.1016/s1474-4422(15)00278-1","title":"Characterisation of mutations of the phosphoinositide-3-kinase regulatory subunit, PIK3R2, in perisylvian polymicrogyria: a next-generation sequencing study","year":2015,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Connective tissue disorders research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; Seventh Framework Programme; National Institutes of Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Agence Nationale de la Recherche; Institut de France","keywords":"Polymicrogyria; Exome sequencing; Genetics; Biology; Global developmental delay; Mutation; Epilepsy; Medicine; Phenotype; Gene; Neuroscience","score_opus":0.11260719112443497,"score_gpt":0.31069702919601583,"score_spread":0.19808983807158087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1879121056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99700963,0.00029562903,0.0013404508,0.00016002805,0.00001964404,0.00003435473,0.0003516358,0.000034647925,0.0007540532],"genre_scores_gemma":[0.99826175,0.00013803416,0.00091248925,0.00013522615,0.000015114561,0.000010876275,0.00021822072,0.00001849693,0.00028981763],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99973696,0.00002469948,0.000037307163,0.00007750856,0.00007764439,0.000045948764],"domain_scores_gemma":[0.9995271,0.00018940862,0.00007911238,0.000025586165,0.00008468308,0.000094129966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034832602,0.0008976768,0.00042270025,0.0011506606,0.00037824683,0.0006098077,0.0004411602,0.0013733787,0.0010120904],"category_scores_gemma":[0.0011381794,0.00028100985,0.0008789976,0.0004992157,0.00042092137,0.00025175526,0.00041399317,0.0005077636,0.00038480107],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018512112,0.0003267264,0.17179675,0.00020548365,0.00045140085,0.13499159,0.0013173242,0.0024757348,0.6511084,0.0006349717,0.0014857022,0.033354804],"study_design_scores_gemma":[0.0003192736,0.0011666409,0.689024,0.00021539071,0.0012089193,0.17154492,0.0010512037,0.016757961,0.11185889,0.0009748216,0.005747898,0.00013012778],"about_ca_topic_score_codex":0.002729144,"about_ca_topic_score_gemma":0.0028453479,"teacher_disagreement_score":0.002729144,"about_ca_system_score_codex":0.0004486296,"about_ca_system_score_gemma":0.00031252793,"threshold_uncertainty_score":0.0054264665},"labels":[],"label_agreement":null},{"id":"W1932494896","doi":"10.1016/s1474-4422(15)00140-4","title":"Endovascular stent thrombectomy: the new standard of care for large vessel ischaemic stroke","year":2015,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":315,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"Merck Sharp and Dohme; Universität Duisburg-Essen; Bundesministerium für Bildung und Forschung; Deutsche Forschungsgemeinschaft; H. Lundbeck A/S; National Heart Foundation of Australia; AstraZeneca; Alberta Health Services; Alberta Innovates - Health Solutions; National Health and Medical Research Council; Hotchkiss Brain Institute; GlaxoSmithKline Australia; European Commission; Cilag; University of Calgary; Boehringer Ingelheim; Heart and Stroke Foundation of Canada; National Institutes of Health; Royal Australasian College of Physicians; Medtronic; Covidien; Novartis","keywords":"Medicine; Thrombolysis; Stroke (engine); Clinical trial; Ischaemic stroke; Standard of care; Occlusion; Randomized controlled trial; Stent; Surgery; Internal medicine; Ischemia","score_opus":0.0543302941966797,"score_gpt":0.34080891167440397,"score_spread":0.2864786174777243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1932494896","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021464208,0.9991953,0.000037344424,0.00037000768,0.00016834015,0.0000017924363,0.000011253419,0.0000027548485,0.0001918331],"genre_scores_gemma":[0.00030302972,0.9988955,0.0000757601,0.000395314,0.00021810306,0.0000023763264,0.00001352745,6.9968144e-7,0.00009559226],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993687,0.00013077402,0.00010960791,0.00008201553,0.00026771997,0.000041228395],"domain_scores_gemma":[0.99865866,0.00074031437,0.000261042,0.000023416875,0.0002460459,0.000070431786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00152659,0.0010169549,0.0033712634,0.0030257544,0.00033287168,0.0015760425,0.001255411,0.0017689184,0.0039100815],"category_scores_gemma":[0.002442578,0.00029859974,0.0010801083,0.0034188936,0.000653505,0.0019541392,0.0010598338,0.002794617,0.001367135],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000118007825,0.000035499143,0.00016398646,0.05082276,0.00037634588,0.0000974627,0.00003872272,0.00025601388,0.00046452487,0.003531239,0.050524354,0.893571],"study_design_scores_gemma":[0.00012586016,0.00015511404,0.0018698615,0.04487745,0.0013294275,0.000997795,0.00013474551,0.00016429528,0.00020207431,0.005221241,0.9448724,0.000049799004],"about_ca_topic_score_codex":0.0023740476,"about_ca_topic_score_gemma":0.0051942714,"teacher_disagreement_score":0.0039100815,"about_ca_system_score_codex":0.0011560186,"about_ca_system_score_gemma":0.0020552676,"threshold_uncertainty_score":0.013080597},"labels":[],"label_agreement":null},{"id":"W1965462309","doi":"10.1016/s1474-4422(13)70058-9","title":"Cooling of children with severe traumatic brain injury","year":2013,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Traumatic Brain Injury and Neurovascular Disturbances","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; Traumatic brain injury; Hypothermia; Intracranial pressure; Randomized controlled trial; Anesthesia; Neurology; Pediatrics; Surgery","score_opus":0.03141899171558501,"score_gpt":0.2641467374076269,"score_spread":0.23272774569204188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965462309","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.085112125,0.0139337685,0.00035595408,0.8676719,0.016035313,0.000050178976,0.00014452076,0.00007372027,0.016622502],"genre_scores_gemma":[0.48108053,0.012298495,0.00055706745,0.45151696,0.04851473,0.00009885892,0.00011178363,0.00006132315,0.0057602837],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.999503,0.00012336353,0.000078377685,0.000056869732,0.00007169181,0.00016657116],"domain_scores_gemma":[0.99826294,0.0007619113,0.00031373126,0.00006417606,0.00017935394,0.00041792277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004881993,0.0005322136,0.00095246255,0.00041277116,0.0017006464,0.00086735806,0.0008559749,0.01064719,0.0022497901],"category_scores_gemma":[0.009170467,0.0003316879,0.0008034234,0.00043999663,0.0016930036,0.0011875887,0.0007277462,0.009405736,0.00051493547],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007076765,0.00022780627,0.06565203,0.0006512406,0.00018025754,0.4236339,0.0015533328,0.0007542645,0.002271235,0.0047874,0.44922882,0.050352037],"study_design_scores_gemma":[0.0014456775,0.0017222576,0.18483031,0.0026993258,0.00052181905,0.5059162,0.0062592705,0.0020455406,0.0029611567,0.014115233,0.27722222,0.0002610483],"about_ca_topic_score_codex":0.008938618,"about_ca_topic_score_gemma":0.014577064,"teacher_disagreement_score":0.01064719,"about_ca_system_score_codex":0.0026937951,"about_ca_system_score_gemma":0.0017505876,"threshold_uncertainty_score":0.019545019},"labels":[],"label_agreement":null},{"id":"W1965784059","doi":"10.1016/s1474-4422(12)70162-x","title":"Imaging neural correlates of mild cognitive impairment in Parkinson's disease","year":2012,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Innovation Council; Institut Universitaire de Gériatrie de Montréal; Vancouver Coastal Health; Université de Montréal","funders":"","keywords":"Dementia; Cognition; Parkinson's disease; Disease; Medicine; Cognitive decline; Psychology; Cognitive impairment; Scopus; Psychiatry; Internal medicine; MEDLINE","score_opus":0.025868127157557312,"score_gpt":0.27550290528344556,"score_spread":0.24963477812588825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965784059","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08000857,0.03123011,0.000799996,0.84890795,0.014162585,0.00007747696,0.0005513888,0.00017573764,0.02408605],"genre_scores_gemma":[0.4865204,0.017527599,0.0015150453,0.35478938,0.1291684,0.00012955847,0.00028202328,0.0000636742,0.010003925],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99956053,0.00010750524,0.00008531432,0.00005058863,0.000102077785,0.00009395849],"domain_scores_gemma":[0.9974897,0.0015314047,0.0001914054,0.00009033611,0.00047155627,0.00022554402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006652422,0.00049785845,0.0013066591,0.0007811651,0.0007956419,0.0012400687,0.001060702,0.013035279,0.0022301513],"category_scores_gemma":[0.0074661896,0.0004003996,0.0006213179,0.0007413992,0.0011690096,0.0014212285,0.00037206546,0.006472747,0.000984626],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035164168,0.0005398347,0.067161106,0.001108303,0.0004887115,0.14478251,0.0005195477,0.0005229691,0.0067660385,0.0041640075,0.58806634,0.18236426],"study_design_scores_gemma":[0.0042826016,0.0022187089,0.27383888,0.0024808368,0.0019089867,0.31899405,0.0021515582,0.0067823622,0.0076638903,0.048879348,0.33028892,0.00050985115],"about_ca_topic_score_codex":0.005769252,"about_ca_topic_score_gemma":0.012462716,"teacher_disagreement_score":0.013035279,"about_ca_system_score_codex":0.0015051628,"about_ca_system_score_gemma":0.0009182483,"threshold_uncertainty_score":0.011471331},"labels":[],"label_agreement":null},{"id":"W1966125392","doi":"10.1016/s1474-4422(14)70144-9","title":"Restoring function after spinal cord injury: towards clinical translation of experimental strategies","year":2014,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":348,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; International Collaboration On Repair Discoveries; Vancouver General Hospital","funders":"Medical Research Council; University of British Columbia; Canadian Institutes of Health Research; Rosetrees Trust; International Spinal Research Trust","keywords":"Spinal cord injury; Medicine; Spinal cord; Neuroprotection; Regeneration (biology); Rehabilitation; Physical medicine and rehabilitation; Neuroplasticity; Neuroscience; Physical therapy; Psychology; Pharmacology; Biology","score_opus":0.32377037219308685,"score_gpt":0.5378649540911873,"score_spread":0.21409458189810043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966125392","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002610315,0.99914575,0.00006061927,0.00034830446,0.00016493104,0.000003957788,0.000008908897,0.000002790218,0.00023856875],"genre_scores_gemma":[0.00028655157,0.9990067,0.00013782753,0.00032661366,0.00013351964,0.000006544422,0.000011712423,7.8701873e-7,0.00008984471],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99923825,0.00020765263,0.0001182482,0.00010701035,0.00025925777,0.00006959161],"domain_scores_gemma":[0.9967092,0.0025523112,0.00021361191,0.00007496553,0.0003655841,0.00008426206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034341784,0.0016588325,0.004373273,0.0027318683,0.0003904793,0.002502387,0.0021964514,0.0032231875,0.0043021548],"category_scores_gemma":[0.004347176,0.00049233227,0.001285382,0.0026930675,0.001750491,0.0027906585,0.0015599316,0.0038303758,0.0015220925],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023279779,0.00012515983,0.00015346578,0.07493174,0.00036112248,0.00014310858,0.000089800014,0.00046729154,0.0012188342,0.0094524855,0.027515903,0.8853082],"study_design_scores_gemma":[0.00015035238,0.00022749996,0.0010438629,0.04044941,0.0006992872,0.00059851434,0.00022625779,0.0001340202,0.00046907327,0.011111507,0.9448332,0.00005698515],"about_ca_topic_score_codex":0.0025570954,"about_ca_topic_score_gemma":0.0045602224,"teacher_disagreement_score":0.004373273,"about_ca_system_score_codex":0.0015192891,"about_ca_system_score_gemma":0.004048016,"threshold_uncertainty_score":0.018161893},"labels":[],"label_agreement":null},{"id":"W1966167492","doi":"10.1016/s1474-4422(12)70322-8","title":"Somnambulism: clinical aspects and pathophysiological hypotheses","year":2013,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Neuroscience of respiration and sleep","field":"Neuroscience","cited_by":223,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Sleep & Circadian Network; Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Sleepwalking; Psychology; Arousal; Wakefulness; Psychiatry; Sleep disorder; Medicine; Neuroscience; Insomnia","score_opus":0.32569637882314134,"score_gpt":0.4160232156464159,"score_spread":0.09032683682327458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966167492","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000060959064,0.99924123,0.000046188903,0.00026234164,0.000109104934,0.0000015210342,0.0000073366723,0.0000020378625,0.0002692856],"genre_scores_gemma":[0.000739246,0.99837315,0.00008789328,0.00020184582,0.0004226494,0.0000028284815,0.000013538646,6.995143e-7,0.00015805197],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997584,0.000039740487,0.0000493219,0.00005492871,0.000070406,0.000027086939],"domain_scores_gemma":[0.99942446,0.00032561636,0.00009825606,0.00001242006,0.00009365257,0.000045570414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008205477,0.001341206,0.0024674854,0.002669176,0.0003644,0.0015578149,0.001062852,0.0017038406,0.002545432],"category_scores_gemma":[0.0010384371,0.00032771268,0.00065694575,0.002524675,0.0014467749,0.0018604377,0.000951382,0.0024804154,0.001092713],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014434138,0.000073979914,0.0006092396,0.017035823,0.0001610137,0.0009277227,0.00008886272,0.00043149575,0.0007982581,0.0041278847,0.028687567,0.9469138],"study_design_scores_gemma":[0.0001297441,0.00018839061,0.005307807,0.015743658,0.00056141603,0.015666204,0.0004864743,0.0004660676,0.000536127,0.01381684,0.9469733,0.00012404614],"about_ca_topic_score_codex":0.0015423754,"about_ca_topic_score_gemma":0.0036810734,"teacher_disagreement_score":0.002669176,"about_ca_system_score_codex":0.0008356937,"about_ca_system_score_gemma":0.0016100515,"threshold_uncertainty_score":0.008515358},"labels":[],"label_agreement":null},{"id":"W1969296692","doi":"10.1016/s1474-4422(13)70289-8","title":"Pain: what poisons are revealing about its mechanisms","year":2013,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biology; Zoology; Ecology","score_opus":0.11708875224955267,"score_gpt":0.3517071274211989,"score_spread":0.23461837517164624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969296692","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018332346,0.9982533,0.00003816503,0.0008342228,0.00040577562,0.0000013018694,0.000007430923,0.0000031462498,0.00043823474],"genre_scores_gemma":[0.0003019778,0.99754435,0.00009207387,0.0009147518,0.0008074446,0.000002675459,0.000008452079,0.0000012275514,0.00032710677],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99956197,0.00010449007,0.00005978808,0.00005832027,0.00017302629,0.000042366388],"domain_scores_gemma":[0.9987764,0.00070081075,0.00015491463,0.000039535735,0.00025526763,0.00007304576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012081855,0.0012854426,0.0027827623,0.00247034,0.0004592155,0.0020671121,0.0012229774,0.0027140006,0.0051694717],"category_scores_gemma":[0.0018296666,0.00047310104,0.0007783793,0.003243969,0.0018477489,0.0035486089,0.0012405083,0.004063714,0.0027242],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015120099,0.000058070673,0.00018947697,0.031119442,0.00020140482,0.00024273356,0.00011968182,0.0002677418,0.0010294025,0.008121048,0.098304,0.8601957],"study_design_scores_gemma":[0.00004050432,0.000054861594,0.0005042246,0.008391535,0.0001677254,0.0006888664,0.00013493189,0.000057328172,0.00012812663,0.0054377974,0.9843656,0.000028587006],"about_ca_topic_score_codex":0.0021506196,"about_ca_topic_score_gemma":0.0041849953,"teacher_disagreement_score":0.0051694717,"about_ca_system_score_codex":0.0012037324,"about_ca_system_score_gemma":0.0021650202,"threshold_uncertainty_score":0.017293632},"labels":[],"label_agreement":null},{"id":"W1970178389","doi":"10.1016/s1474-4422(15)70019-0","title":"Frontotemporal dementia: a peek under its invisibility cloak","year":2015,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Engineering and Physical Sciences Research Council; Medical Research Council","keywords":"Frontotemporal dementia; Peek; Invisibility; Dementia; Medicine; Psychology; Composite material; Materials science; Physics; Pathology; Optics; Disease","score_opus":0.15586861381432504,"score_gpt":0.35026147992163775,"score_spread":0.1943928661073127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970178389","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00090348074,0.48807073,0.001014335,0.44135678,0.05034572,0.000016680731,0.00040307708,0.00025690524,0.017632358],"genre_scores_gemma":[0.019695159,0.6130926,0.0031054968,0.21036215,0.11420451,0.000055810087,0.00067058735,0.0005447975,0.038268782],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960454,0.0010742373,0.000561558,0.00029970042,0.0016734123,0.0003458009],"domain_scores_gemma":[0.9842987,0.006042736,0.0009916434,0.0009335692,0.0059909644,0.0017423962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0063369125,0.0009807779,0.0022472185,0.0068370304,0.0029336112,0.009649183,0.0017918693,0.005003607,0.016628798],"category_scores_gemma":[0.019292895,0.0004951917,0.0010458526,0.0050860923,0.0073310495,0.015873583,0.004999295,0.009278212,0.011299729],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055217453,0.000013749942,0.00044673984,0.0012801453,0.00003254308,0.00055135705,0.0008261834,0.000027757005,0.00020643794,0.010250787,0.79430914,0.192],"study_design_scores_gemma":[0.000011119847,0.000026302498,0.0008892468,0.00543425,0.00003570214,0.0028047317,0.0016187818,0.000032025328,0.000073971336,0.014087033,0.9749517,0.000035242378],"about_ca_topic_score_codex":0.0075771557,"about_ca_topic_score_gemma":0.01711388,"teacher_disagreement_score":0.016628798,"about_ca_system_score_codex":0.0028047971,"about_ca_system_score_gemma":0.0052872463,"threshold_uncertainty_score":0.055628896},"labels":[],"label_agreement":null},{"id":"W1970396709","doi":"10.1016/s1474-4422(10)70136-8","title":"Effect modification and ischaemic stroke treatment","year":2010,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Hemispatial neglect; Ischaemic stroke; Stroke (engine); Intervention (counseling); Neglect; Physical therapy; Internal medicine; Ischemia; Psychiatry","score_opus":0.025602015908522,"score_gpt":0.28824172223050903,"score_spread":0.262639706321987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970396709","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044139216,0.014142631,0.00011114257,0.9615903,0.01430172,0.000013894776,0.00006239857,0.000022285634,0.009314324],"genre_scores_gemma":[0.01013994,0.009648421,0.00028719622,0.88640153,0.0867647,0.00007934239,0.000055338907,0.000019260444,0.006604389],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99227047,0.0035305659,0.0008148889,0.00057099195,0.0021293163,0.0006838273],"domain_scores_gemma":[0.9758183,0.018406585,0.0016043115,0.00062179245,0.0015725372,0.0019765783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070313876,0.00089854404,0.003080403,0.0013060072,0.001904177,0.0036707805,0.0017807573,0.041085243,0.014780469],"category_scores_gemma":[0.03970998,0.0007028831,0.0020619251,0.0011358941,0.0034107426,0.0033042748,0.0016239956,0.03704028,0.005916488],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067044655,0.00016220515,0.0010735947,0.0006597577,0.00022599797,0.0013479576,0.00010145583,0.00019373462,0.00013714607,0.013596815,0.90783954,0.07399143],"study_design_scores_gemma":[0.005015818,0.00038875843,0.0053285896,0.0029598335,0.00053200615,0.0024122281,0.00026728303,0.0011994696,0.00028245986,0.090385154,0.89108855,0.0001397943],"about_ca_topic_score_codex":0.004656312,"about_ca_topic_score_gemma":0.0136554865,"teacher_disagreement_score":0.041085243,"about_ca_system_score_codex":0.0051194066,"about_ca_system_score_gemma":0.004593089,"threshold_uncertainty_score":0.04944557},"labels":[],"label_agreement":null},{"id":"W1971827552","doi":"10.1016/s1474-4422(14)70197-8","title":"Embolic strokes of undetermined source: support for a new clinical construct–Authors' reply","year":2014,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Cerebrovascular and Carotid Artery Diseases","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Boehringer Ingelheim; Bayer","keywords":"Medicine; Clinical trial; Family medicine; Internal medicine","score_opus":0.054786776178900286,"score_gpt":0.3336448511822183,"score_spread":0.27885807500331805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971827552","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019254634,0.0010404768,0.000051369323,0.9859907,0.012025906,0.000003088951,0.000025234964,0.000008357278,0.0006623192],"genre_scores_gemma":[0.003383861,0.0007802801,0.00011825519,0.9369812,0.05760108,0.000015010808,0.00002045063,0.000010925179,0.0010889563],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953935,0.001564544,0.0006854234,0.00083318347,0.00095829536,0.00056507485],"domain_scores_gemma":[0.97048193,0.01833008,0.0021946866,0.001101385,0.005365452,0.002526465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053343275,0.000772554,0.0025924423,0.0010969286,0.0031458626,0.0051363837,0.0032406652,0.09123265,0.0073628244],"category_scores_gemma":[0.04777659,0.00089516985,0.0012629902,0.0010371949,0.0064568175,0.0066900905,0.0029654528,0.06629027,0.00680957],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007059062,0.000021529067,0.0009512125,0.00008032754,0.00004026404,0.0014772608,0.00019533327,0.000043322838,0.000097221084,0.0028400014,0.9891065,0.005076361],"study_design_scores_gemma":[0.00050005375,0.00011405934,0.00330163,0.0013579143,0.00017144947,0.0059063295,0.0017073702,0.00064018875,0.00040030174,0.029158644,0.9564159,0.0003261828],"about_ca_topic_score_codex":0.003432601,"about_ca_topic_score_gemma":0.0054195183,"teacher_disagreement_score":0.09123265,"about_ca_system_score_codex":0.0033063171,"about_ca_system_score_gemma":0.0037350815,"threshold_uncertainty_score":0.028210998},"labels":[],"label_agreement":null},{"id":"W1971993717","doi":"10.1016/s1474-4422(05)70026-0","title":"Treatment for the progression of Parkinson's disease","year":2005,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"","keywords":"Ropinirole; Levodopa; Parkinson's disease; Medicine; Pramipexole; Neuroprotection; Disease; Dopamine; Selegiline; Neuroscience; Internal medicine; Psychology","score_opus":0.047313656029269166,"score_gpt":0.3210345851313552,"score_spread":0.273720929102086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971993717","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00082296197,0.031369194,0.00021314865,0.9328416,0.025717076,0.000015199824,0.00007257968,0.000046479487,0.008901758],"genre_scores_gemma":[0.016293513,0.024791984,0.00067899394,0.8375946,0.103258885,0.00007270127,0.00009994413,0.000023804783,0.017185578],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985372,0.00054865255,0.0001762994,0.00010373601,0.00048793043,0.00014617044],"domain_scores_gemma":[0.9974241,0.0016568226,0.00017847159,0.00005448929,0.00035705572,0.00032902797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001532199,0.00071777357,0.0019153693,0.00087016507,0.0018141753,0.0012526709,0.0011148443,0.02760659,0.005669505],"category_scores_gemma":[0.0087805865,0.000311882,0.0013522736,0.00058823917,0.0015852895,0.0019810295,0.0006810429,0.018253816,0.0035139252],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033838855,0.00011368697,0.0006871886,0.00041739963,0.00006399596,0.003261042,0.00007090939,0.00013916128,0.00027733308,0.006119495,0.93110573,0.057405632],"study_design_scores_gemma":[0.0010863282,0.0004253893,0.0024117394,0.0010843775,0.00011743992,0.006802832,0.00017176008,0.00067357766,0.0002904302,0.015971798,0.9709066,0.000057741625],"about_ca_topic_score_codex":0.00287952,"about_ca_topic_score_gemma":0.009528002,"teacher_disagreement_score":0.02760659,"about_ca_system_score_codex":0.002563891,"about_ca_system_score_gemma":0.0015127027,"threshold_uncertainty_score":0.018966377},"labels":[],"label_agreement":null},{"id":"W1976010346","doi":"10.1016/s1474-4422(13)70299-0","title":"Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies","year":2014,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":615,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; McMaster University","funders":"National Institute of Neurological Disorders and Stroke; National Institute of Mental Health; National Institutes of Health","keywords":"Status epilepticus; Antibody; GABAA receptor; Medicine; Encephalitis; Antigen; Limbic encephalitis; Immunology; Receptor; Epilepsy; Internal medicine; Autoantibody; Psychiatry; Virus","score_opus":0.00977226858090144,"score_gpt":0.2403765939662419,"score_spread":0.23060432538534045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976010346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97703856,0.0076988623,0.0015781757,0.0014382347,0.00030294945,0.00016078555,0.00018494432,0.00008886979,0.011508593],"genre_scores_gemma":[0.9947142,0.0021139113,0.00043314355,0.00067067106,0.0008824902,0.00002320429,0.00008490027,0.00003119038,0.0010462285],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99878174,0.00016468129,0.00021293506,0.00026242164,0.000157399,0.00042092922],"domain_scores_gemma":[0.99732226,0.0010142432,0.00050623994,0.0003638081,0.00019269406,0.0006007175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006333982,0.0036931494,0.001741714,0.0036757435,0.003385876,0.0022041637,0.0016434306,0.006644964,0.0031340239],"category_scores_gemma":[0.004898874,0.002239264,0.0022242619,0.0023520377,0.003553868,0.0036028856,0.002149574,0.003551505,0.0018366753],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060547893,0.000093760886,0.008535951,0.000034157238,0.000019037709,0.98937607,0.00018643182,0.00005249657,0.00038744698,0.00007060778,0.00015824572,0.0010252049],"study_design_scores_gemma":[0.000015769658,0.00006617062,0.0054590427,0.00000891012,0.000026409536,0.993733,0.00012401349,0.00007725129,0.00022729898,0.00008207382,0.00016565349,0.000014374371],"about_ca_topic_score_codex":0.0037463354,"about_ca_topic_score_gemma":0.0042963885,"teacher_disagreement_score":0.006644964,"about_ca_system_score_codex":0.0017414794,"about_ca_system_score_gemma":0.0011373075,"threshold_uncertainty_score":0.01263541},"labels":[],"label_agreement":null},{"id":"W1976567755","doi":"10.1016/s1474-4422(06)70573-7","title":"Optical coherence tomography in multiple sclerosis","year":2006,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Optical coherence tomography; Multiple sclerosis; Tomography; Coherence (philosophical gambling strategy); Medicine; Physics; Optics; Quantum mechanics; Psychiatry","score_opus":0.23649061048902195,"score_gpt":0.3749529070592325,"score_spread":0.13846229657021056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976567755","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000024659716,0.9996669,0.000012583221,0.00009561255,0.000075600336,0.0000038905014,0.0000068562777,9.572541e-7,0.000112883245],"genre_scores_gemma":[0.000558642,0.99892104,0.00008661394,0.00021346983,0.00010228222,0.000008977281,0.000008056874,3.9521666e-7,0.0001005722],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991209,0.00027458047,0.0002302893,0.00008212384,0.00024885987,0.000043202286],"domain_scores_gemma":[0.99681,0.0021271277,0.0006358236,0.00005167792,0.0002989162,0.00007627319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024078842,0.0012029123,0.0041648755,0.0058696666,0.00030029495,0.0012199177,0.0009525661,0.0016354324,0.0053280466],"category_scores_gemma":[0.00441708,0.0005092208,0.0012209993,0.0058068824,0.00080492266,0.0014443926,0.0010378145,0.001182705,0.0007776724],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028179865,0.000045365457,0.0002597933,0.156695,0.0011407856,0.00022861526,0.00006318959,0.00014837626,0.00047446165,0.0012820443,0.028799718,0.81058085],"study_design_scores_gemma":[0.0007469423,0.00048278357,0.005369948,0.15109427,0.009308666,0.0025963287,0.00036585794,0.0001504773,0.0005861735,0.0030818703,0.8261455,0.00007116183],"about_ca_topic_score_codex":0.0043780655,"about_ca_topic_score_gemma":0.014362558,"teacher_disagreement_score":0.0058696666,"about_ca_system_score_codex":0.0013299304,"about_ca_system_score_gemma":0.0027115366,"threshold_uncertainty_score":0.017824113},"labels":[],"label_agreement":null},{"id":"W1977863028","doi":"10.1016/s1474-4422(15)70015-3","title":"The systematic search for risk factors in multiple sclerosis","year":2015,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Scopus; Medicine; MEDLINE; Biology; Psychiatry","score_opus":0.2482884064964362,"score_gpt":0.3471756921986402,"score_spread":0.09888728570220401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977863028","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012306332,0.08409317,0.00027730502,0.8914182,0.01986493,0.00006401854,0.0009849372,0.000036793794,0.0020301393],"genre_scores_gemma":[0.021648021,0.045669332,0.0010517411,0.8607564,0.068289995,0.00036847507,0.00046214042,0.000043175754,0.0017107843],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.943449,0.03279972,0.013664647,0.0018059969,0.006786198,0.001494455],"domain_scores_gemma":[0.7355632,0.20932752,0.02598695,0.005714744,0.018746987,0.004660579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.041344255,0.0009275516,0.0049456903,0.0041827327,0.0020339398,0.002943567,0.0024317538,0.022810277,0.0052759508],"category_scores_gemma":[0.24323615,0.0013450992,0.0029006177,0.0036488096,0.0023280215,0.0034655868,0.0026784102,0.0095216,0.0024091937],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087067805,0.00003322186,0.0058331457,0.013099701,0.0030045083,0.0009705337,0.0002864694,0.00010711974,0.0001699081,0.0028801786,0.938516,0.03422843],"study_design_scores_gemma":[0.010923538,0.00078074157,0.03168146,0.12155096,0.024311837,0.004522565,0.0011679392,0.0018695118,0.0008644065,0.036893066,0.7650185,0.0004153767],"about_ca_topic_score_codex":0.014489397,"about_ca_topic_score_gemma":0.036054224,"teacher_disagreement_score":0.041344255,"about_ca_system_score_codex":0.006440757,"about_ca_system_score_gemma":0.012200504,"threshold_uncertainty_score":0.21865195},"labels":[],"label_agreement":null},{"id":"W1982312358","doi":"10.1016/s1474-4422(14)70070-5","title":"Genome-wide association study in FTD: divide to conquer","year":2014,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital; Université de Montréal; McGill University and Génome Québec Innovation Centre","funders":"","keywords":"Frontotemporal dementia; C9orf72; Genetics; Dementia; Biology; Neuroscience; Psychology; Medicine; Disease; Pathology","score_opus":0.060788913709494116,"score_gpt":0.3225025713915464,"score_spread":0.2617136576820523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982312358","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008359412,0.0038074919,0.00017562907,0.9851638,0.008665671,0.000003926152,0.00007579821,0.00002809433,0.0012436918],"genre_scores_gemma":[0.018008614,0.0038180524,0.00071410683,0.83844906,0.13610947,0.000030436362,0.00009613451,0.000036007525,0.0027381692],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.991606,0.003873599,0.0011923215,0.0008185298,0.0020293354,0.0004802298],"domain_scores_gemma":[0.9597396,0.030807639,0.0015560981,0.001405146,0.0037733628,0.002718099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010011769,0.0006703962,0.003001756,0.0013413739,0.002799023,0.0028096095,0.0025147866,0.039735373,0.0043697325],"category_scores_gemma":[0.049028106,0.0007598968,0.0014212588,0.0013452612,0.0031614315,0.0033621679,0.0014999027,0.027847437,0.0037676394],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065302284,0.00015638028,0.014762609,0.0003353731,0.00044600887,0.0071886247,0.00022638697,0.00018369744,0.00071710674,0.004627286,0.91444206,0.056261458],"study_design_scores_gemma":[0.0029583217,0.0007452772,0.046647426,0.0030557793,0.0014673595,0.018698256,0.0017117616,0.004476216,0.0014856753,0.09273148,0.8255304,0.0004920573],"about_ca_topic_score_codex":0.0043188054,"about_ca_topic_score_gemma":0.008634046,"teacher_disagreement_score":0.039735373,"about_ca_system_score_codex":0.002308635,"about_ca_system_score_gemma":0.0028689355,"threshold_uncertainty_score":0.05294788},"labels":[],"label_agreement":null},{"id":"W1985168631","doi":"10.1016/s1474-4422(07)70298-3","title":"Alzheimer's disease: advances in trafficking","year":2008,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute on Aging; Wellcome Trust","keywords":"Disease; Alzheimer's disease; Neuroscience; Medicine; Biology; Pathology","score_opus":0.09853042202914944,"score_gpt":0.3963080417442891,"score_spread":0.2977776197151396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985168631","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000027142956,0.99846005,0.00008235868,0.0004897547,0.00035369841,0.0000032882576,0.000010402066,0.00000608456,0.00056719664],"genre_scores_gemma":[0.00023362342,0.9984364,0.0001487684,0.00045444854,0.00031424125,0.000005278937,0.000013028105,0.0000012001258,0.0003930954],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995894,0.00008520002,0.00006163219,0.00006436524,0.00015042491,0.000049085807],"domain_scores_gemma":[0.99917346,0.00041933465,0.00012333885,0.000030616644,0.00018949842,0.00006375922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015353425,0.0018311186,0.003916343,0.0033041728,0.0005029327,0.0025305492,0.0012446494,0.0028144552,0.005933234],"category_scores_gemma":[0.0017519856,0.00048580347,0.0009093457,0.004128934,0.0012289932,0.003718584,0.001431524,0.0035929214,0.0029860497],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014524533,0.00007619676,0.00014632351,0.017931849,0.000117821306,0.00017838633,0.00006637879,0.00032176322,0.0007588353,0.007686527,0.08132619,0.8912444],"study_design_scores_gemma":[0.00004386937,0.00005869178,0.00031458063,0.0045578317,0.00013650856,0.000570313,0.000057407637,0.00006370501,0.00012737642,0.0032551584,0.9907996,0.000014992239],"about_ca_topic_score_codex":0.0025868497,"about_ca_topic_score_gemma":0.0054165632,"teacher_disagreement_score":0.005933234,"about_ca_system_score_codex":0.0015663533,"about_ca_system_score_gemma":0.0030433235,"threshold_uncertainty_score":0.019848645},"labels":[],"label_agreement":null},{"id":"W1985174354","doi":"10.1016/s1474-4422(02)00101-1","title":"Deep brain stimulation for Parkinson's disease: disrupting the disruption","year":2002,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":355,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"National Institutes of Health; Canadian Institutes of Health Research; Medtronic","keywords":"Deep brain stimulation; Parkinson's disease; Neuroscience; Stimulation; Disease; Brain stimulation; Medicine; Psychology; Internal medicine","score_opus":0.10308562307370644,"score_gpt":0.37284407488753535,"score_spread":0.2697584518138289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985174354","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008505667,0.99866354,0.00010290111,0.00022359283,0.00019454373,0.0000041803605,0.0000065555523,0.000003887924,0.00071576866],"genre_scores_gemma":[0.00064355566,0.99811757,0.00020289021,0.0003106955,0.00018311013,0.0000068460554,0.000010786434,0.0000011054854,0.0005233161],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997814,0.000047126803,0.000031074116,0.00003944289,0.000082303945,0.000018491695],"domain_scores_gemma":[0.99967146,0.00020292797,0.000048849517,0.000007642216,0.000048325823,0.00002075548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073744403,0.0012795341,0.002677194,0.001547312,0.0003080293,0.0010927535,0.0010921791,0.0019143561,0.0032373508],"category_scores_gemma":[0.00068499503,0.00026845493,0.00061448984,0.001921248,0.00079339946,0.0013010721,0.00054469774,0.0022470485,0.0018611797],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017500391,0.00009666459,0.000105520274,0.01581113,0.00016357334,0.00034461857,0.000049096714,0.00035241418,0.0016314134,0.0032639254,0.021708058,0.9562986],"study_design_scores_gemma":[0.00020173984,0.00030331098,0.0017086313,0.007270306,0.00035395304,0.0044442,0.00016422305,0.00020221756,0.0006510702,0.005174378,0.9794844,0.00004170242],"about_ca_topic_score_codex":0.002269973,"about_ca_topic_score_gemma":0.0060590007,"teacher_disagreement_score":0.0032373508,"about_ca_system_score_codex":0.0007190192,"about_ca_system_score_gemma":0.000997084,"threshold_uncertainty_score":0.010829985},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W1988362126","doi":"10.1016/s1474-4422(06)70522-1","title":"Neurological aspects of spinal-cord repair: promises and challenges","year":2006,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":189,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Collaboration On Repair Discoveries; University of British Columbia","funders":"American Academy of Neurology","keywords":"Spinal cord injury; Spinal cord; Quadrupedalism; Medicine; Neuroscience; Animal studies; Lesion; Physical medicine and rehabilitation; Regeneration (biology); Clinical trial; Psychology; Anatomy; Biology; Surgery; Pathology; Internal medicine","score_opus":0.28635321140864695,"score_gpt":0.4446790292119111,"score_spread":0.15832581780326416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988362126","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018852166,0.9985436,0.000037996626,0.00081424625,0.00028798214,0.0000010894051,0.0000050177246,0.0000026374507,0.00028851244],"genre_scores_gemma":[0.0001892893,0.99850404,0.00012081494,0.0004948204,0.0005157283,0.000002506339,0.000007205481,7.415234e-7,0.00016497137],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994411,0.00014336278,0.00007557872,0.00006809539,0.00021664417,0.000055272012],"domain_scores_gemma":[0.99709487,0.0020769588,0.00018607336,0.000052723797,0.00045009426,0.00013924108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030395063,0.0015654655,0.004486378,0.0028561347,0.000666104,0.0028316665,0.0020301668,0.0038935721,0.004716023],"category_scores_gemma":[0.0031806717,0.0004959142,0.00097254163,0.0037664282,0.0023816072,0.005577756,0.0014585819,0.005029585,0.002219735],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022592352,0.00009830639,0.00029382305,0.025025992,0.00024698622,0.00036313094,0.00013989393,0.000530178,0.000979383,0.014025785,0.09465317,0.86341745],"study_design_scores_gemma":[0.000072757306,0.00009105546,0.0008833953,0.009835519,0.00018626472,0.0009815119,0.0003361246,0.00011336142,0.00011336315,0.01103622,0.9763071,0.000043294527],"about_ca_topic_score_codex":0.003558843,"about_ca_topic_score_gemma":0.010094655,"teacher_disagreement_score":0.004716023,"about_ca_system_score_codex":0.0017436675,"about_ca_system_score_gemma":0.0038359512,"threshold_uncertainty_score":0.016074657},"labels":[],"label_agreement":null},{"id":"W1993308931","doi":"10.1016/s1474-4422(13)70157-1","title":"Will imaging biomarkers transform spinal cord injury trials?","year":2013,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Toronto Western Hospital","funders":"","keywords":"Medicine; Spinal cord injury; Spinal cord; Clinical trial; Physical medicine and rehabilitation; Gold standard (test); Randomized controlled trial; Physical therapy; Surgery; Pathology; Internal medicine; Psychiatry","score_opus":0.10871551837627524,"score_gpt":0.41141684219207164,"score_spread":0.3027013238157964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993308931","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000067936184,0.0017200736,0.000077723824,0.9878703,0.009458091,0.000005316162,0.00003267837,0.000013140447,0.00075473427],"genre_scores_gemma":[0.0012710219,0.0013522276,0.00024038984,0.9614004,0.034466166,0.000027845726,0.00002016246,0.000014869873,0.0012068353],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9764405,0.010888736,0.0027416863,0.0020303316,0.005923833,0.001974853],"domain_scores_gemma":[0.8963682,0.07358053,0.006194293,0.002304137,0.011974968,0.0095778955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02920598,0.0013574357,0.0033681793,0.0014901806,0.0044719065,0.008709922,0.0040519587,0.104087375,0.011195686],"category_scores_gemma":[0.1525344,0.0013142138,0.0026487089,0.0016403415,0.009166604,0.010337363,0.004107824,0.06693057,0.010061213],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020483788,0.00004149431,0.0006903798,0.00015277232,0.00007463893,0.0003537353,0.00007330362,0.00010305948,0.00010057471,0.0063326145,0.9709524,0.020920267],"study_design_scores_gemma":[0.0011014286,0.00020981258,0.0012614822,0.0013726234,0.00017573433,0.0006740608,0.0003561557,0.0007922376,0.00025538023,0.06480261,0.9288305,0.00016795447],"about_ca_topic_score_codex":0.009338035,"about_ca_topic_score_gemma":0.016539985,"teacher_disagreement_score":0.104087375,"about_ca_system_score_codex":0.008972139,"about_ca_system_score_gemma":0.014085443,"threshold_uncertainty_score":0.15445781},"labels":[],"label_agreement":null},{"id":"W1994116326","doi":"10.1016/s1474-4422(06)70452-5","title":"Demystifying vaccination-associated encephalopathy","year":2006,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Bacterial Infections and Vaccines","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Adverse Event Reporting System; Medicine; Adverse effect; Vaccination; Encephalopathy; Polio vaccine; Smallpox; Poliomyelitis; Family medicine; Pediatrics; Virology; Psychiatry; Internal medicine","score_opus":0.02657351261405221,"score_gpt":0.24982446826823726,"score_spread":0.22325095565418504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994116326","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038375586,0.01633251,0.0011733436,0.8644779,0.04046148,0.00010987566,0.00017719298,0.00022105504,0.03867119],"genre_scores_gemma":[0.33634105,0.012272493,0.0011595038,0.50209755,0.13000001,0.000076267184,0.0001553364,0.00007237861,0.017825507],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993135,0.00021282543,0.000080941056,0.00007160306,0.00010659011,0.00021456913],"domain_scores_gemma":[0.99747187,0.0013733725,0.00022761391,0.00013128447,0.00029555915,0.0005002841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013100897,0.0009642357,0.0013443724,0.00067992974,0.002008639,0.001277253,0.0013108847,0.026039852,0.0021515437],"category_scores_gemma":[0.009543998,0.00044210593,0.0009679497,0.00055476086,0.0020473385,0.0021921105,0.0007807111,0.011590695,0.0010353063],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090421713,0.00016630391,0.008144534,0.00030737047,0.00009996851,0.6901859,0.00038854455,0.00022991496,0.000882105,0.0044878754,0.2725447,0.02165851],"study_design_scores_gemma":[0.0016568433,0.0010827514,0.02962315,0.0013651229,0.00042763347,0.6312765,0.0015690516,0.0037044736,0.0025809482,0.029158698,0.2973818,0.00017308201],"about_ca_topic_score_codex":0.004310511,"about_ca_topic_score_gemma":0.007198151,"teacher_disagreement_score":0.026039852,"about_ca_system_score_codex":0.0023156484,"about_ca_system_score_gemma":0.0012920013,"threshold_uncertainty_score":0.016801357},"labels":[],"label_agreement":null},{"id":"W1994839162","doi":"10.1016/s1474-4422(11)70057-6","title":"New lexicon and criteria for the diagnosis of Alzheimer's disease – Authors' reply","year":2011,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Lexicon; Medicine; Disease; Psychology; Linguistics; Philosophy; Pathology","score_opus":0.1205511326542484,"score_gpt":0.3728987558983313,"score_spread":0.25234762324408294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994839162","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025867924,0.0020145278,0.00014398011,0.89399815,0.10289309,0.000011408054,0.00019101717,0.000021001842,0.00046816978],"genre_scores_gemma":[0.002071425,0.001698034,0.00031154635,0.8916655,0.10213335,0.000055493845,0.00016784,0.000020225116,0.001876605],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949675,0.0009676793,0.0016792893,0.00060920545,0.0012394655,0.0005368521],"domain_scores_gemma":[0.9733401,0.013001055,0.001751737,0.00091122,0.008742808,0.002253064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006744159,0.000926218,0.0024141956,0.0018755221,0.0019425257,0.0027269195,0.002906623,0.033421487,0.004803152],"category_scores_gemma":[0.04002793,0.0009646308,0.0021298768,0.0012458593,0.0029842332,0.0047091255,0.002395861,0.040506948,0.004421492],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000786393,0.000022528477,0.00055847014,0.0001195245,0.000026362228,0.00048956345,0.00012105192,0.00003275293,0.0001251196,0.0010890715,0.99105185,0.006284947],"study_design_scores_gemma":[0.00038855014,0.000095822084,0.005823069,0.000839824,0.00015841736,0.0035505607,0.0010462898,0.00034938927,0.0004753602,0.007601423,0.9794667,0.00020468535],"about_ca_topic_score_codex":0.0075131124,"about_ca_topic_score_gemma":0.009011099,"teacher_disagreement_score":0.033421487,"about_ca_system_score_codex":0.002573726,"about_ca_system_score_gemma":0.004325185,"threshold_uncertainty_score":0.035666943},"labels":[],"label_agreement":null},{"id":"W1996879495","doi":"10.1016/s1474-4422(08)70272-2","title":"Multiple sclerosis: following clues from cause to cure","year":2008,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Multiple sclerosis; Medicine; Psychiatry","score_opus":0.29795396172939187,"score_gpt":0.4012550063500703,"score_spread":0.1033010446206784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996879495","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014498399,0.99858725,0.000025143781,0.0007951953,0.00042159404,0.000004043213,0.000012466997,0.000002639131,0.00013716752],"genre_scores_gemma":[0.00031095825,0.99746704,0.00014692186,0.0014699517,0.00038211475,0.000008358707,0.000015067067,0.0000015144694,0.00019811322],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979894,0.00068575196,0.0005354503,0.00020615394,0.00049760035,0.000085530075],"domain_scores_gemma":[0.9917448,0.0060134,0.00110819,0.00015124593,0.0007936348,0.0001886545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039016397,0.0018088863,0.0071604424,0.0065955743,0.00046919557,0.0035388612,0.0019823196,0.004070097,0.0064706714],"category_scores_gemma":[0.010521632,0.0007876825,0.0015029287,0.006944387,0.0016353887,0.0045701056,0.0016664435,0.0036052486,0.0024663813],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031904085,0.000051706753,0.0003564149,0.22158189,0.0016067454,0.00045752467,0.00029341428,0.00023414576,0.0005063255,0.0059642373,0.14987172,0.61875683],"study_design_scores_gemma":[0.00024956113,0.000106059735,0.001128839,0.14997046,0.0021918572,0.0011196593,0.0003828166,0.000085027285,0.00012545814,0.0057764845,0.8388089,0.000054992062],"about_ca_topic_score_codex":0.0039997045,"about_ca_topic_score_gemma":0.01064604,"teacher_disagreement_score":0.0071604424,"about_ca_system_score_codex":0.0018029414,"about_ca_system_score_gemma":0.0042914506,"threshold_uncertainty_score":0.02164656},"labels":[],"label_agreement":null},{"id":"W1997880566","doi":"10.1016/s1474-4422(14)70068-7","title":"Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study","year":2014,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":395,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"IC Design Education Center; Biogen","keywords":"Medicine; Placebo; Multiple sclerosis; Internal medicine; Clinical endpoint; Expanded Disability Status Scale; Relapsing remitting; Adverse effect; Gastroenterology; Dosing; Pegylated interferon; Randomized controlled trial; Immunology; Ribavirin; Pathology","score_opus":0.1893065369257501,"score_gpt":0.385908890795452,"score_spread":0.19660235386970187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997880566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830184,0.005028054,0.0012381615,0.00046787015,0.0005437963,0.006671732,0.0012440844,0.00018923522,0.0015987384],"genre_scores_gemma":[0.96782804,0.004977164,0.0049801054,0.0019184046,0.0010734114,0.012612513,0.0019957207,0.000067120396,0.0045474856],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9985794,0.00071394205,0.00011382727,0.00019677005,0.00015120735,0.0002449511],"domain_scores_gemma":[0.998315,0.0005329044,0.00034400972,0.00023126535,0.00010567067,0.00047111564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004124814,0.0025070952,0.005488447,0.00084509,0.00071163516,0.0009304273,0.0011280086,0.0032432217,0.006545107],"category_scores_gemma":[0.0024272131,0.0012372284,0.003129922,0.0007723575,0.0018703119,0.0019559816,0.0007529889,0.0028707585,0.0012397723],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9896321,0.00275332,0.00016692786,0.000261624,0.00036711438,0.000019009232,0.000031310512,0.00013433922,0.0011355252,0.00004984308,0.0002096006,0.005239296],"study_design_scores_gemma":[0.9796412,0.019320121,0.0005413932,0.000009137604,0.0001289273,0.000011260891,0.0000055707833,0.0000745679,0.00009006158,0.00005050248,0.00012083852,0.0000064626224],"about_ca_topic_score_codex":0.0014420775,"about_ca_topic_score_gemma":0.0018954636,"teacher_disagreement_score":0.006545107,"about_ca_system_score_codex":0.000834994,"about_ca_system_score_gemma":0.0015676073,"threshold_uncertainty_score":0.021895528},"labels":[],"label_agreement":null},{"id":"W1999747499","doi":"10.1016/s1474-4422(12)70068-6","title":"Donation after cardiac death: enter the neurologist","year":2012,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Organ Donation and Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Organ donation; Medicine; Donation; Declaration; Brain dead; Transplantation; Cause of death; Intensive care medicine; Internal medicine; Disease","score_opus":0.03718148793823956,"score_gpt":0.27322626606944334,"score_spread":0.23604477813120378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999747499","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000366415,0.0020663363,0.000041339554,0.9842019,0.010623901,0.0000044849344,0.000012720681,0.000009440217,0.002673472],"genre_scores_gemma":[0.005193135,0.0018752132,0.00009881387,0.9501153,0.036895912,0.000016222157,0.000013135598,0.00001655764,0.0057756696],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971956,0.0010157037,0.00032238063,0.000295979,0.0005639909,0.0006063543],"domain_scores_gemma":[0.99247897,0.0029130888,0.0006668823,0.00019150498,0.0009822833,0.002767223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029932829,0.0009165402,0.001419564,0.0006256439,0.0064213937,0.005354878,0.0018292649,0.09194569,0.007881157],"category_scores_gemma":[0.020575041,0.0008054275,0.0011313409,0.0006908443,0.0035172997,0.0054955203,0.0023795802,0.06544954,0.0048060655],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007130365,0.000045674387,0.0011408088,0.000083328785,0.000022904207,0.0065952674,0.00029196547,0.000050293507,0.00015696028,0.002410648,0.9826279,0.0065030656],"study_design_scores_gemma":[0.00024215595,0.00014010716,0.003331298,0.0015432681,0.000078235906,0.0135456985,0.0028698444,0.0005402568,0.00023522436,0.018435506,0.95889574,0.00014254973],"about_ca_topic_score_codex":0.008557647,"about_ca_topic_score_gemma":0.02661427,"teacher_disagreement_score":0.09194569,"about_ca_system_score_codex":0.0048780115,"about_ca_system_score_gemma":0.0070459847,"threshold_uncertainty_score":0.035392642},"labels":[],"label_agreement":null},{"id":"W2000900321","doi":"10.1016/s1474-4422(14)70231-5","title":"Treatment of progressive multiple sclerosis: what works, what does not, and what is needed","year":2015,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":277,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Multiple sclerosis; Spasticity; Medicine; Disease; Physical medicine and rehabilitation; Psychological intervention; Depression (economics); Clinical trial; Physical therapy; Psychiatry; Internal medicine","score_opus":0.22004555104698492,"score_gpt":0.3919833442980172,"score_spread":0.17193779325103226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000900321","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000026783948,0.9994703,0.000011531923,0.0003373152,0.00008744345,0.000003289611,0.000008926523,8.1618646e-7,0.00005355638],"genre_scores_gemma":[0.0005862638,0.99867,0.00008206987,0.00046656097,0.00014452738,0.000007800663,0.00000999036,6.669548e-7,0.000032045373],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99732083,0.0011113149,0.00063789356,0.00026158188,0.00054921524,0.00011912166],"domain_scores_gemma":[0.98898506,0.008822753,0.0011826642,0.0001422417,0.00069140154,0.00017600121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006639122,0.0014083191,0.00935479,0.003302752,0.00048163734,0.0026966275,0.002243553,0.003418387,0.004458189],"category_scores_gemma":[0.013846488,0.0006769455,0.0038571367,0.0040504485,0.0013707066,0.0028533249,0.0011059416,0.002949149,0.0007081955],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006324027,0.000081120226,0.0003925762,0.3723042,0.0050382554,0.00011598567,0.0001364503,0.0002365611,0.0003817883,0.0025416894,0.016015276,0.6021237],"study_design_scores_gemma":[0.0010335677,0.0005066388,0.0037389975,0.5806381,0.023382843,0.00094147585,0.0006876951,0.0002024464,0.00042395128,0.0068308176,0.3814989,0.000114568466],"about_ca_topic_score_codex":0.0044947187,"about_ca_topic_score_gemma":0.011343374,"teacher_disagreement_score":0.00935479,"about_ca_system_score_codex":0.001728305,"about_ca_system_score_gemma":0.0042981775,"threshold_uncertainty_score":0.035111487},"labels":[],"label_agreement":null},{"id":"W2002257186","doi":"10.1016/s1474-4422(11)70188-0","title":"Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy","year":2011,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":565,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"National Institute of Biomedical Imaging and Bioengineering; National Heart, Lung, and Blood Institute; National Institute on Aging; National Institutes of Health","keywords":"Type 2 diabetes; Open label; Medicine; Brain function; Diabetes mellitus; Physical medicine and rehabilitation; Psychology; Internal medicine; Randomized controlled trial; Neuroscience; Endocrinology","score_opus":0.02454118800188835,"score_gpt":0.2835870044925701,"score_spread":0.25904581649068176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002257186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99405044,0.0025053,0.0002826775,0.00020649181,0.000220619,0.0011119609,0.00073799124,0.000045354696,0.000839132],"genre_scores_gemma":[0.99125004,0.0021433062,0.00077903434,0.00067820365,0.000855037,0.002190351,0.0009811731,0.000015104775,0.001107831],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998771,0.00067040714,0.00013480635,0.00015423865,0.000089628506,0.0001799127],"domain_scores_gemma":[0.99794585,0.0008015534,0.00040727344,0.0002958911,0.00012232731,0.000427229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026904,0.0021369734,0.005200393,0.000816183,0.00077974563,0.0011760925,0.0010075335,0.0028720172,0.0051549994],"category_scores_gemma":[0.0029799459,0.0011783066,0.003522501,0.00090792077,0.0015835486,0.0015232771,0.0008433878,0.0034952397,0.0006987755],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98652494,0.0044296035,0.0015298498,0.00035869898,0.0017234767,0.000027077604,0.0000726881,0.00012632014,0.0006481206,0.000022751887,0.0001760288,0.004360498],"study_design_scores_gemma":[0.9016498,0.08106064,0.0129404515,0.00006163387,0.003265803,0.000032013984,0.00006059153,0.00019687886,0.00024434694,0.00014580078,0.00030738232,0.00003459946],"about_ca_topic_score_codex":0.0048033088,"about_ca_topic_score_gemma":0.006702054,"teacher_disagreement_score":0.005200393,"about_ca_system_score_codex":0.000946451,"about_ca_system_score_gemma":0.00070393184,"threshold_uncertainty_score":0.017245173},"labels":[],"label_agreement":null},{"id":"W2002633239","doi":"10.1016/s1474-4422(03)00665-3","title":"Lending a helping eye: artists in residence at a memory clinic","year":2004,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Art Therapy and Mental Health","field":"Arts and Humanities","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Residence; Scholarship; Resource (disambiguation); Medicine; Memory clinic; Psychology; Disease; Visual arts; Medical education; Gerontology; Sociology; Dementia; Art; Political science; Computer science; Pathology","score_opus":0.0998726891562505,"score_gpt":0.3327016116305048,"score_spread":0.23282892247425432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002633239","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1737164,0.011411786,0.0004310987,0.710197,0.015450817,0.00014616581,0.00019637142,0.00020224757,0.0882481],"genre_scores_gemma":[0.70646703,0.016820062,0.0012574709,0.19006036,0.015997116,0.00019912026,0.00015972502,0.0003985538,0.068640515],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.99681866,0.00088397105,0.00008678789,0.00015865196,0.00023083326,0.0018210287],"domain_scores_gemma":[0.9841322,0.0015386298,0.0010730637,0.0002247936,0.00055517594,0.012476113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023020664,0.00077322166,0.00071032566,0.0011483075,0.03341338,0.008871523,0.0029990573,0.015320223,0.04448111],"category_scores_gemma":[0.016034465,0.0009761168,0.00071302644,0.0015957465,0.0075305053,0.0046491968,0.0077608554,0.02162591,0.0041435864],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039289184,0.0010505351,0.027336918,0.00042715453,0.000070409515,0.059820946,0.07824089,0.00018062642,0.0008577447,0.0072392444,0.7368561,0.08752652],"study_design_scores_gemma":[0.0002638272,0.00048687632,0.021090705,0.0012389099,0.00009527072,0.047230158,0.6016988,0.00028642244,0.0002858603,0.012539295,0.3145883,0.00019560888],"about_ca_topic_score_codex":0.014228444,"about_ca_topic_score_gemma":0.07563391,"teacher_disagreement_score":0.04448111,"about_ca_system_score_codex":0.0036784706,"about_ca_system_score_gemma":0.009253632,"threshold_uncertainty_score":0.14880413},"labels":[],"label_agreement":null},{"id":"W2006940176","doi":"10.1016/s1474-4422(12)70096-0","title":"Reducing the risk of recurrent stroke in patients with AF","year":2012,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Stroke (engine); MEDLINE; Internal medicine; Cardiology; Intensive care medicine; Political science","score_opus":0.0488304321000626,"score_gpt":0.2895876386232984,"score_spread":0.2407572065232358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006940176","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005204921,0.0062583517,0.00016152211,0.96966124,0.010328793,0.000015869471,0.00010814896,0.000038014612,0.00822313],"genre_scores_gemma":[0.07328272,0.010954664,0.0007987108,0.7836693,0.12655634,0.000074625634,0.0001668368,0.00003084714,0.0044660494],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978569,0.0007491562,0.00032976962,0.00015208099,0.0006468495,0.00026520915],"domain_scores_gemma":[0.9936336,0.003604689,0.0005086731,0.0001626203,0.000992666,0.0010978351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019312229,0.00044316586,0.0018614243,0.00060795917,0.0012772401,0.0020235404,0.00097431015,0.016830942,0.004847643],"category_scores_gemma":[0.025617212,0.00036836395,0.0012697725,0.00080578757,0.00086237723,0.0015630741,0.00066449895,0.014410799,0.002379082],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015179471,0.0008068779,0.020533875,0.00066214165,0.0005591409,0.003449143,0.00043254314,0.0004727138,0.0008271358,0.004272772,0.78418785,0.18227783],"study_design_scores_gemma":[0.009646879,0.0035254825,0.11004604,0.0036381185,0.00245825,0.013126324,0.002152369,0.0051589035,0.0016815166,0.06797634,0.78024346,0.00034631195],"about_ca_topic_score_codex":0.0051709507,"about_ca_topic_score_gemma":0.011536472,"teacher_disagreement_score":0.016830942,"about_ca_system_score_codex":0.0016540105,"about_ca_system_score_gemma":0.0022235403,"threshold_uncertainty_score":0.016216993},"labels":[],"label_agreement":null},{"id":"W2007390314","doi":"10.1016/s1474-4422(11)70012-6","title":"Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial","year":2011,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":195,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"ACADIA Pharmaceuticals; Ministero dell’Istruzione, dell’Università e della Ricerca; National Parkinson Foundation; Novartis; Genzyme; National Institute of Mental Health; Schering-Plough","keywords":"Parkinson's disease; Double blind; Physical medicine and rehabilitation; Medicine; Phase (matter); Physical therapy; Disease; Internal medicine; Physics; Alternative medicine; Placebo; Pathology","score_opus":0.032107413351436014,"score_gpt":0.2631726952557821,"score_spread":0.23106528190434605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007390314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96365166,0.017014174,0.0025564241,0.0019763124,0.002779825,0.0059447424,0.0022779761,0.00043769894,0.0033611413],"genre_scores_gemma":[0.9689015,0.008714767,0.0031672625,0.0026778323,0.0011509374,0.007108774,0.0018452337,0.00007490938,0.006358745],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99919146,0.00039404712,0.00005998782,0.00017647987,0.00004395517,0.00013403788],"domain_scores_gemma":[0.9990885,0.00030830427,0.00016600819,0.00007206108,0.00005894857,0.00030615777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017310781,0.00284626,0.006095034,0.0005949172,0.00062055804,0.001431749,0.0013502667,0.003220088,0.008960683],"category_scores_gemma":[0.0020781206,0.0010621429,0.002618443,0.0005888254,0.0017978213,0.00205064,0.0006070553,0.004156074,0.0016693335],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99221146,0.00089840195,0.00010938676,0.00060662755,0.0006015314,0.000029746501,0.00002442432,0.00012580749,0.00074565347,0.00009749355,0.00040102054,0.004148418],"study_design_scores_gemma":[0.9879133,0.011153394,0.00023491336,0.000021864875,0.00018204378,0.0000147239125,0.000010131745,0.00010394178,0.00006130805,0.000105876476,0.00018976841,0.000008700905],"about_ca_topic_score_codex":0.0013793894,"about_ca_topic_score_gemma":0.0024880632,"teacher_disagreement_score":0.008960683,"about_ca_system_score_codex":0.0008456091,"about_ca_system_score_gemma":0.0011811194,"threshold_uncertainty_score":0.029976487},"labels":[],"label_agreement":null},{"id":"W2009817157","doi":"10.1016/s1474-4422(06)70680-9","title":"Diagnosis of brain death in children","year":2006,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Organ Donation and Transplantation","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal Children's Hospital","funders":"","keywords":"Organ donation; Medicine; Intensive care medicine; Psychology; Transplantation; Surgery","score_opus":0.05068286903627244,"score_gpt":0.3421830113135532,"score_spread":0.29150014227728077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009817157","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010992268,0.99874085,0.000073437375,0.00036624106,0.00021606564,0.000002841679,0.000022721304,0.000004803437,0.00046320286],"genre_scores_gemma":[0.0014566785,0.99774736,0.00012319158,0.0002190766,0.0003101993,0.0000033404965,0.000044573186,0.0000010160171,0.00009460138],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99959344,0.00009339127,0.00009068425,0.000064454696,0.00012515821,0.000032881893],"domain_scores_gemma":[0.9981055,0.001184751,0.00036090837,0.000025822836,0.00026029997,0.00006263711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010048805,0.00090093585,0.0025979646,0.003263543,0.00021704574,0.0011604589,0.0013895949,0.0014275109,0.002112036],"category_scores_gemma":[0.0040599005,0.0003398915,0.0009591166,0.002349838,0.0006742265,0.0012381002,0.00065100606,0.0019264888,0.00079929945],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012524572,0.000031368818,0.0019512434,0.029661821,0.00037028178,0.0014243418,0.00005726625,0.000328261,0.00018396537,0.0016408042,0.056825783,0.9073996],"study_design_scores_gemma":[0.00037884217,0.00029371635,0.019734396,0.12996405,0.0033576412,0.03169875,0.00070008286,0.0005660295,0.00067475083,0.0058013815,0.8066802,0.0001500477],"about_ca_topic_score_codex":0.005176775,"about_ca_topic_score_gemma":0.008817037,"teacher_disagreement_score":0.005176775,"about_ca_system_score_codex":0.0011189252,"about_ca_system_score_gemma":0.0019467664,"threshold_uncertainty_score":0.010293305},"labels":[],"label_agreement":null},{"id":"W2013284164","doi":"10.1016/s1474-4422(10)70068-5","title":"Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial","year":2010,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; ALS Society of Canada; University of Rochester; Massachusetts General Hospital; National Institutes of Health; ALS Association","keywords":"Riluzole; Placebo; Interim analysis; Amyotrophic lateral sclerosis; Medicine; Hazard ratio; Clinical endpoint; Lithium (medication); Internal medicine; Randomized controlled trial; Physical therapy; Confidence interval","score_opus":0.05036810347857466,"score_gpt":0.31367217133490827,"score_spread":0.2633040678563336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013284164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95901006,0.02585346,0.0013159508,0.001368653,0.0026384534,0.004916693,0.0014299573,0.00035386585,0.0031129313],"genre_scores_gemma":[0.977452,0.0076116584,0.0015019645,0.0013734448,0.0017522139,0.0054880558,0.0010774101,0.000056402067,0.0036869687],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998092,0.0010031814,0.00021253772,0.0003363828,0.0001386636,0.00021728514],"domain_scores_gemma":[0.9983444,0.0005721072,0.0003796245,0.0001571473,0.00013257534,0.0004140647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026019563,0.0032351497,0.010029617,0.0010332518,0.0009495482,0.001845236,0.0021249086,0.005067573,0.0074793953],"category_scores_gemma":[0.0038073305,0.001388321,0.0035555537,0.00093013834,0.0028453548,0.0023511392,0.0006982244,0.00426327,0.0018789896],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9933988,0.0011650953,0.00010037741,0.00057935674,0.0007017845,0.000019374664,0.00001901749,0.000054044354,0.0007078319,0.00003215965,0.00017950371,0.0030426548],"study_design_scores_gemma":[0.97541237,0.023299597,0.00028617305,0.000028914747,0.00048234282,0.000012973374,0.000008868993,0.00013008242,0.00011729339,0.000047337293,0.00016134027,0.000012633374],"about_ca_topic_score_codex":0.0016088369,"about_ca_topic_score_gemma":0.002226444,"teacher_disagreement_score":0.010029617,"about_ca_system_score_codex":0.001459854,"about_ca_system_score_gemma":0.0014750417,"threshold_uncertainty_score":0.025021076},"labels":[],"label_agreement":null},{"id":"W2016998239","doi":"10.1016/s1474-4422(05)70120-4","title":"In pursuit of evidence-based treatments for paediatric stroke: the UK and Chest guidelines","year":2005,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation","funders":"","keywords":"Stroke (engine); Medicine; Intensive care medicine; Physical medicine and rehabilitation; Engineering","score_opus":0.4074890849185079,"score_gpt":0.44581723924379035,"score_spread":0.03832815432528247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016998239","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000117151365,0.9745779,0.0004793148,0.018911615,0.0036378882,0.00011007997,0.00032084278,0.000030424957,0.0018148021],"genre_scores_gemma":[0.0014415829,0.9788902,0.004096,0.011467202,0.0016774102,0.00025152313,0.00036798685,0.000016382593,0.0017918014],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9966306,0.00078088895,0.0013383409,0.0002462613,0.00085576414,0.00014811265],"domain_scores_gemma":[0.9868407,0.0069129076,0.0022311797,0.00019636862,0.0031567682,0.00066209346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074150283,0.0015149832,0.005989223,0.00519154,0.00075641874,0.0032945825,0.0029112895,0.0075647295,0.0071903523],"category_scores_gemma":[0.016570589,0.000827751,0.0031951761,0.005366186,0.0011068154,0.0030749473,0.0017630064,0.008520543,0.0030975242],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047951294,0.00009586387,0.0003236168,0.06519795,0.0008897994,0.00038723196,0.00013153943,0.0006325163,0.00043833308,0.004699684,0.39659193,0.5301321],"study_design_scores_gemma":[0.0007975673,0.000118697964,0.0020309677,0.12149165,0.002352854,0.0006153194,0.00015647123,0.0002511722,0.0002373243,0.003787119,0.86810094,0.000059865055],"about_ca_topic_score_codex":0.014636644,"about_ca_topic_score_gemma":0.03898643,"teacher_disagreement_score":0.014636644,"about_ca_system_score_codex":0.0038180542,"about_ca_system_score_gemma":0.010965921,"threshold_uncertainty_score":0.03921485},"labels":[],"label_agreement":null},{"id":"W2018721445","doi":"10.1016/s1474-4422(11)70307-6","title":"Cerebral microinfarcts: the invisible lesions","year":2012,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":457,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; University of Calgary","funders":"National Institute on Aging; National Institutes of Health; Canadian Institutes of Health Research; Alberta Innovates; Scottish Funding Council","keywords":"Arteriolosclerosis; Cerebral amyloid angiopathy; Hyperintensity; Pathological; Pathology; Medicine; Leukoaraiosis; Neuropathology; White matter; Cognitive decline; Population; Magnetic resonance imaging; Dementia; Radiology; Disease","score_opus":0.11116417455629904,"score_gpt":0.3467213179548559,"score_spread":0.23555714339855685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018721445","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020227835,0.999406,0.000020365538,0.0001890704,0.00017314323,0.0000016153413,0.000006581807,0.0000016946527,0.00018134009],"genre_scores_gemma":[0.0002777364,0.99891245,0.00005286753,0.0003288515,0.00027387234,0.0000026389937,0.000011956834,7.3172566e-7,0.00013892894],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994875,0.00010591814,0.00009710339,0.00007241315,0.00018720578,0.000049790237],"domain_scores_gemma":[0.99888784,0.0006642712,0.00021939061,0.000022876706,0.00014433918,0.00006131929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011562185,0.001352289,0.0035319251,0.0034705934,0.00031755178,0.0020449143,0.001296079,0.0021803011,0.0039813113],"category_scores_gemma":[0.0021381646,0.00043646042,0.000893822,0.0038504351,0.0009694365,0.0027153522,0.0012486088,0.0023963044,0.0012990073],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012863478,0.00004550561,0.00021497534,0.05011848,0.00029154393,0.00023918459,0.000075925076,0.00019804758,0.00043542698,0.002622631,0.05803454,0.887595],"study_design_scores_gemma":[0.00014287829,0.00009516829,0.0016456658,0.04922478,0.000954036,0.0021114289,0.00021109376,0.000108713895,0.00015603706,0.0037660906,0.9415353,0.00004880308],"about_ca_topic_score_codex":0.0025602898,"about_ca_topic_score_gemma":0.005711348,"teacher_disagreement_score":0.0039813113,"about_ca_system_score_codex":0.00095882104,"about_ca_system_score_gemma":0.0018922267,"threshold_uncertainty_score":0.013318837},"labels":[],"label_agreement":null},{"id":"W2021494469","doi":"10.1016/s1474-4422(03)00317-x","title":"Predictive testing for Huntington's disease: a universal model?","year":2003,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Predictive testing; Disease; Ambiguity; Genetic testing; Huntingtin; Huntington's disease; Psychology; Genetics; Medicine; Biology; Internal medicine; Computer science","score_opus":0.06449346784460598,"score_gpt":0.2795405484587411,"score_spread":0.21504708061413513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021494469","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14288245,0.05486268,0.46171114,0.3024155,0.0033439398,0.00024794642,0.0020875162,0.001292265,0.031156655],"genre_scores_gemma":[0.9302982,0.010199592,0.035700828,0.01829967,0.0034976557,0.0002011457,0.00052011316,0.00014508153,0.0011377544],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9796101,0.012708962,0.001140132,0.0029411174,0.0027457848,0.000853853],"domain_scores_gemma":[0.84638953,0.13236955,0.0045203706,0.009410342,0.005224309,0.0020858939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.049526405,0.0017962919,0.00449797,0.0032113835,0.0011799088,0.004288149,0.0057558105,0.0049337745,0.004373246],"category_scores_gemma":[0.17691745,0.00086856016,0.002215058,0.0020910057,0.008634364,0.013954766,0.0036320554,0.006819587,0.00062817754],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018626156,0.0005189043,0.17344885,0.001367108,0.002856294,0.0016269287,0.0012438291,0.036180366,0.0009472841,0.30326077,0.032456424,0.4442306],"study_design_scores_gemma":[0.000243403,0.00040008812,0.013717278,0.0010119315,0.00086030253,0.0013033177,0.00036969106,0.07603465,0.00043760674,0.89972514,0.0058049853,0.000091540525],"about_ca_topic_score_codex":0.005220017,"about_ca_topic_score_gemma":0.004091121,"teacher_disagreement_score":0.049526405,"about_ca_system_score_codex":0.0024962504,"about_ca_system_score_gemma":0.003751849,"threshold_uncertainty_score":0.2619238},"labels":[],"label_agreement":null},{"id":"W2021588219","doi":"10.1016/s1474-4422(07)70221-1","title":"Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C→T (Arg493X) mutation: an international initiative","year":2007,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":218,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Western University; Vancouver General Hospital","funders":"National Institute of Neurological Disorders and Stroke; National Institute on Aging; National Institutes of Health","keywords":"Frontotemporal lobar degeneration; Haplotype; Neuropathology; Frontotemporal dementia; Genetics; Biology; Dementia; Tau protein; Single-nucleotide polymorphism; Pathology; Alzheimer's disease; Genotype; Medicine; Disease; Gene","score_opus":0.03325448820968048,"score_gpt":0.3045975118611807,"score_spread":0.27134302365150026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021588219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989581,0.00010980387,0.00013537546,0.00007584365,0.000008297593,0.0000061156247,0.000093177245,0.000006611804,0.0006066133],"genre_scores_gemma":[0.99948883,0.00006443368,0.00014289813,0.00005280187,0.00001988163,0.0000046975697,0.00012565458,0.0000073239826,0.00009346792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995473,0.00011348539,0.000076678065,0.00011617419,0.00008787353,0.000058421563],"domain_scores_gemma":[0.9987801,0.0005214938,0.00032509406,0.00006420294,0.0001355857,0.00017351731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055930193,0.00068580237,0.0004947046,0.0013844887,0.0005210879,0.0005026181,0.0003900366,0.00058126973,0.0015011616],"category_scores_gemma":[0.0024845554,0.00014490535,0.00031932624,0.0008179129,0.0005256014,0.00031324773,0.00045965062,0.00040392354,0.0002391682],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001437465,0.00013145767,0.92483044,0.000032206364,0.00016817027,0.024949567,0.00076944457,0.00026071724,0.030846918,0.00016012555,0.00072418206,0.015689237],"study_design_scores_gemma":[0.00003965531,0.00025065127,0.9595366,0.0000111263535,0.000070200986,0.03752001,0.0003644029,0.00038223818,0.0013025231,0.00015891634,0.000343444,0.000020022224],"about_ca_topic_score_codex":0.0011679305,"about_ca_topic_score_gemma":0.0010687989,"teacher_disagreement_score":0.0015011616,"about_ca_system_score_codex":0.00020612038,"about_ca_system_score_gemma":0.00017793592,"threshold_uncertainty_score":0.0050219297},"labels":[],"label_agreement":null},{"id":"W2023750497","doi":"10.1016/s1474-4422(12)70184-9","title":"The burden of serogroup B meningococcal disease","year":2012,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Bacterial Infections and Vaccines","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Neisseria meningitidis; Meningitis; Meningococcal disease; Medicine; Scopus; Disease; Pediatrics; MEDLINE; Internal medicine; Biology","score_opus":0.025284717542966188,"score_gpt":0.25291371432708804,"score_spread":0.22762899678412185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023750497","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00075637584,0.0033849746,0.000060029754,0.97177255,0.020675804,0.0000049009464,0.00006290998,0.000022802442,0.0032596304],"genre_scores_gemma":[0.012370668,0.0054190196,0.00024182751,0.8619626,0.11015076,0.000022462656,0.00007210928,0.000024496258,0.0097361505],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9983708,0.0005243405,0.00015202661,0.00013615366,0.00051547785,0.00030127546],"domain_scores_gemma":[0.9964844,0.0014421246,0.00027172395,0.00011523778,0.00078060204,0.00090602215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018232499,0.0008188878,0.0012520369,0.0005609219,0.0019948217,0.002320612,0.0009741891,0.028607996,0.006475256],"category_scores_gemma":[0.013176228,0.0005361793,0.00080715003,0.0005046687,0.0016530526,0.0032162045,0.0011009822,0.01975208,0.0044552605],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010380819,0.000034786844,0.0010401441,0.0000753967,0.000018846897,0.00149351,0.00007357489,0.000044488217,0.00022943823,0.0010899693,0.9824635,0.013332644],"study_design_scores_gemma":[0.0002683734,0.00017010425,0.0057043904,0.0005568623,0.000085457636,0.0048414106,0.0006134973,0.00057398196,0.00032398885,0.010700711,0.9760799,0.000081252365],"about_ca_topic_score_codex":0.009251678,"about_ca_topic_score_gemma":0.017442314,"teacher_disagreement_score":0.028607996,"about_ca_system_score_codex":0.0027882564,"about_ca_system_score_gemma":0.0029230176,"threshold_uncertainty_score":0.021661937},"labels":[],"label_agreement":null},{"id":"W2029860252","doi":"10.1016/s1474-4422(05)70053-3","title":"Results from the FOOD trial","year":2005,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Clinical Nutrition and Gastroenterology","field":"Nursing","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; Western University","funders":"","keywords":"Randomized controlled trial; Medicine; Clinical trial; Set (abstract data type); Stroke (engine); Internal medicine; Computer science; Engineering","score_opus":0.1946621598789967,"score_gpt":0.4007452731975626,"score_spread":0.20608311331856588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029860252","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001905805,0.98896676,0.00016281466,0.0034596415,0.0018885256,0.000106786945,0.0008366722,0.000016937141,0.0026560545],"genre_scores_gemma":[0.035388563,0.943433,0.0006652746,0.0147706065,0.0015212909,0.00031258637,0.0011001924,0.0000296019,0.0027790067],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99701595,0.0016645956,0.00038101827,0.0003209897,0.00043787586,0.00017955169],"domain_scores_gemma":[0.99355423,0.00477328,0.0008271461,0.0002391422,0.00038302824,0.00022319348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072242566,0.001408523,0.0052095433,0.0009069865,0.00025484455,0.001452064,0.0012510754,0.0019721857,0.013808566],"category_scores_gemma":[0.016468894,0.00038182936,0.004795964,0.0013388845,0.00064281723,0.0011202685,0.0009114371,0.003910122,0.0013366764],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059309974,0.00020197801,0.0012229737,0.21978325,0.033145364,0.00041110764,0.00015516,0.00060784863,0.0008514498,0.0035261905,0.12469875,0.556086],"study_design_scores_gemma":[0.11446483,0.0075126854,0.018846462,0.13987921,0.13788398,0.001496005,0.0003872517,0.00023827258,0.0013428223,0.011696742,0.5660448,0.0002069021],"about_ca_topic_score_codex":0.002859646,"about_ca_topic_score_gemma":0.0070060543,"teacher_disagreement_score":0.013808566,"about_ca_system_score_codex":0.0014638759,"about_ca_system_score_gemma":0.0021657415,"threshold_uncertainty_score":0.046194315},"labels":[],"label_agreement":null},{"id":"W2030066012","doi":"10.1016/s1474-4422(12)70248-x","title":"The adverse effects of antiepileptic drugs differ in patients with migraine – Authors' reply","year":2012,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Migraine; Topiramate; Adverse effect; Lamotrigine; Medicine; Epilepsy; Tolerability; Psychiatry; Depression (economics); Scopus; MEDLINE; Intensive care medicine; Pharmacology","score_opus":0.008299874735476236,"score_gpt":0.24323191882725678,"score_spread":0.23493204409178053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030066012","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0043118927,0.014965511,0.00009166257,0.9162117,0.061900385,0.000025794474,0.0008226291,0.00001785205,0.001652639],"genre_scores_gemma":[0.021510825,0.00523604,0.0002059344,0.90454924,0.06547969,0.00007165091,0.0002334032,0.00002209776,0.00269111],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958626,0.0017139917,0.00093744416,0.00050886604,0.00072084775,0.00025615664],"domain_scores_gemma":[0.94786453,0.03787707,0.0038368613,0.0020893565,0.0068617216,0.0014705374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008300079,0.00048090014,0.0014932717,0.00076971203,0.0008957364,0.0017017267,0.0014255797,0.01352877,0.007992697],"category_scores_gemma":[0.04969703,0.0005382536,0.0015559375,0.0009449044,0.0016731668,0.0029143766,0.0012429387,0.014182575,0.002467619],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019236899,0.0000785093,0.011398177,0.0012879546,0.000952802,0.0012243254,0.0007133994,0.00010368279,0.00035664302,0.0015620417,0.95998716,0.020411612],"study_design_scores_gemma":[0.0041919965,0.00079381594,0.067606114,0.0026583332,0.0022604787,0.006338838,0.0045027286,0.0003680742,0.001007698,0.011297312,0.8984566,0.0005180639],"about_ca_topic_score_codex":0.0034300408,"about_ca_topic_score_gemma":0.004540188,"teacher_disagreement_score":0.01352877,"about_ca_system_score_codex":0.0008999595,"about_ca_system_score_gemma":0.0014963534,"threshold_uncertainty_score":0.043895543},"labels":[],"label_agreement":null},{"id":"W2031656722","doi":"10.1016/s1474-4422(07)70132-1","title":"Autoimmune disease in families with multiple sclerosis: a population-based study","year":2007,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Medical Research Council; Multiple Sclerosis Society of Canada; Michael Smith Health Research BC","keywords":"Medicine; Rheumatoid arthritis; Autoimmune disease; Multiple sclerosis; Vitiligo; Internal medicine; First-degree relatives; Population; Odds ratio; Disease; Ulcerative colitis; Type 1 diabetes; Psoriasis; Immunology; Inflammatory bowel disease; Autoimmune thyroiditis; Thyroiditis; Gastroenterology; Diabetes mellitus; Family history; Endocrinology","score_opus":0.0718953325507682,"score_gpt":0.3182357302146931,"score_spread":0.2463403976639249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031656722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990575,0.00032116237,0.00006027468,0.000077754885,0.0000064461274,0.0000093040835,0.00015289578,0.0000021819378,0.00031254845],"genre_scores_gemma":[0.9992531,0.00027892253,0.0000714529,0.00007406699,0.000015206382,0.000019199948,0.00013959479,0.0000023896373,0.00014587627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99713385,0.0014130728,0.00021508528,0.0006821727,0.00029114974,0.00026472472],"domain_scores_gemma":[0.99614537,0.0011374519,0.0011485758,0.00041114294,0.0004459209,0.00071156496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019447828,0.0010561077,0.001160999,0.0020672863,0.0030163643,0.001674578,0.0010407834,0.002061208,0.0028501982],"category_scores_gemma":[0.0065077925,0.0010553875,0.0011701459,0.0041672555,0.0012625549,0.0019244483,0.0013939975,0.0016574851,0.0004236333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040723788,0.00024101736,0.99568945,0.000024833,0.00043370345,0.0007254599,0.0010517588,0.000026001344,0.00039891773,0.000049126553,0.00015221025,0.0008003102],"study_design_scores_gemma":[0.0000767974,0.00047179393,0.9947531,0.000030025889,0.00040573685,0.0018308769,0.0020056404,0.00008229421,0.00005016808,0.00007413633,0.00020136496,0.000018055533],"about_ca_topic_score_codex":0.019136406,"about_ca_topic_score_gemma":0.016314404,"teacher_disagreement_score":0.019136406,"about_ca_system_score_codex":0.0007896112,"about_ca_system_score_gemma":0.0008019991,"threshold_uncertainty_score":0.038049996},"labels":[],"label_agreement":null},{"id":"W2032120877","doi":"10.1016/s1474-4422(11)70263-0","title":"Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data","year":2011,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":540,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute for Health and Care Research","keywords":"Huntington's disease; Observational study; Medicine; Atrophy; Clinical trial; White matter; Biomarker; Internal medicine; Psychology; Disease; Magnetic resonance imaging; Biology","score_opus":0.5240058223250217,"score_gpt":0.4476743832643977,"score_spread":0.076331439060624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032120877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96207255,0.023860337,0.0026054033,0.00080519804,0.00027956293,0.0011643291,0.007337396,0.0000690458,0.0018060753],"genre_scores_gemma":[0.98820215,0.0019601241,0.0011364344,0.00044178125,0.00024219205,0.0013996931,0.0059902365,0.000025341878,0.00060191756],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9873028,0.009419282,0.0011601293,0.0008798817,0.000725963,0.000511969],"domain_scores_gemma":[0.96876067,0.018544162,0.0071451953,0.002518207,0.001277716,0.0017540037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022571016,0.0013882125,0.004721391,0.00083451835,0.0008682151,0.0028916989,0.0010541982,0.002763461,0.0021952833],"category_scores_gemma":[0.027155757,0.00044624138,0.0056216274,0.0018011925,0.0007811837,0.0024705245,0.0011735159,0.003027642,0.0003317201],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8538119,0.0008021504,0.11255373,0.0010590808,0.013959997,0.0001749392,0.00012543004,0.0012302566,0.0013541685,0.000525112,0.0015542841,0.012848924],"study_design_scores_gemma":[0.20896696,0.06289034,0.6734425,0.0006261219,0.034853064,0.00039240788,0.00034937446,0.0058910185,0.001724587,0.004763357,0.005875527,0.00022475861],"about_ca_topic_score_codex":0.00089541933,"about_ca_topic_score_gemma":0.0016596066,"teacher_disagreement_score":0.022571016,"about_ca_system_score_codex":0.00093884836,"about_ca_system_score_gemma":0.0013713215,"threshold_uncertainty_score":0.119368374},"labels":[],"label_agreement":null},{"id":"W2037692131","doi":"10.1016/s1474-4422(12)70292-2","title":"Paediatric neurology: improved care of the developing brain","year":2012,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Neonatal and fetal brain pathology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; SickKids Foundation","funders":"","keywords":"Neurology; Medicine; Pediatric Neurology; Intensive care medicine; Pediatrics; Psychiatry","score_opus":0.05385730554700774,"score_gpt":0.31264109443499477,"score_spread":0.25878378888798703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037692131","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021054093,0.9984848,0.000039711595,0.0006251981,0.0003469747,0.0000014004701,0.0000072323082,0.0000034234204,0.00047021624],"genre_scores_gemma":[0.00021167287,0.9987484,0.00006958636,0.00037212437,0.00044012553,0.0000019050475,0.000010684795,8.267864e-7,0.0001446809],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995005,0.000106229985,0.000069051566,0.00007278798,0.00018562224,0.00006569001],"domain_scores_gemma":[0.9980749,0.0010368387,0.00027695068,0.00003480964,0.00041483415,0.00016159429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001464935,0.0016572049,0.002191961,0.003137637,0.00045158324,0.0015458063,0.0015826434,0.0027788668,0.004921306],"category_scores_gemma":[0.002863773,0.00037814278,0.0006380347,0.0045238277,0.0011285014,0.0023728646,0.0016009954,0.0032801789,0.0018960744],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063979416,0.00004228354,0.00021335039,0.026684968,0.000109535096,0.00024128318,0.000054559303,0.00048518696,0.00038889004,0.0040471912,0.093350306,0.8743184],"study_design_scores_gemma":[0.00003390913,0.00005034294,0.0014841569,0.021792851,0.0001867494,0.0014754622,0.00013957651,0.00009221863,0.00012182533,0.0026647535,0.9719306,0.000027363463],"about_ca_topic_score_codex":0.0059983963,"about_ca_topic_score_gemma":0.012591729,"teacher_disagreement_score":0.0059983963,"about_ca_system_score_codex":0.0023126372,"about_ca_system_score_gemma":0.004242151,"threshold_uncertainty_score":0.016779363},"labels":[],"label_agreement":null},{"id":"W2041090550","doi":"10.1016/s1474-4422(12)70153-9","title":"Adverse effects of antiepileptic drugs","year":2012,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":675,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University","funders":"National Institute of Neurological Disorders and Stroke; American Academy of Neurology","keywords":"Adverse effect; Medicine; Tolerability; Epilepsy; Antiepileptic drug; Drug; Intensive care medicine; Pharmacology; Pharmacogenomics; Quality of life (healthcare); Psychiatry","score_opus":0.07586693431871296,"score_gpt":0.374603989534631,"score_spread":0.29873705521591803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041090550","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016634108,0.999288,0.00003555833,0.00006797636,0.000058998365,0.000007458331,0.000045132587,0.0000022818517,0.0003282356],"genre_scores_gemma":[0.0015876832,0.9978509,0.00011767707,0.00017303976,0.0000732925,0.000007914291,0.00003576886,7.429773e-7,0.00015288788],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989028,0.00026908042,0.00032575664,0.00009426587,0.0003722284,0.000035856625],"domain_scores_gemma":[0.9968978,0.0018712225,0.00088176446,0.000052426705,0.00024943944,0.000047344347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001811542,0.0010858834,0.0025999078,0.0024816676,0.00016181821,0.0008611078,0.0009717705,0.0008148658,0.0046216804],"category_scores_gemma":[0.0034710385,0.00030622704,0.0019488957,0.002848739,0.00033731648,0.00064583815,0.0006551045,0.0009116243,0.0004383409],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005051924,0.000055430028,0.00052464806,0.17337714,0.002952166,0.00019805516,0.00005287894,0.0002920571,0.0007247542,0.00065736426,0.009909754,0.8107506],"study_design_scores_gemma":[0.00094703806,0.00095512776,0.013737074,0.1580197,0.02840769,0.0034242186,0.0003026995,0.00023528656,0.0018518019,0.0034588003,0.7885587,0.00010180385],"about_ca_topic_score_codex":0.0018724129,"about_ca_topic_score_gemma":0.0053271498,"teacher_disagreement_score":0.0046216804,"about_ca_system_score_codex":0.00060750736,"about_ca_system_score_gemma":0.0009692227,"threshold_uncertainty_score":0.015461087},"labels":[],"label_agreement":null},{"id":"W2042912471","doi":"10.1016/s1474-4422(10)70231-3","title":"Would riluzole be efficacious in the new ALS trial design? – Authors' reply","year":2010,"lang":"nl","type":"article","venue":"The Lancet Neurology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Riluzole; Amyotrophic lateral sclerosis; Medicine; Placebo; Clinical trial; Internal medicine; Physical therapy; Disease; Alternative medicine; Pathology","score_opus":0.11106108771836715,"score_gpt":0.36281689868471534,"score_spread":0.2517558109663482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042912471","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000549314,0.0017368586,0.00025005895,0.95930445,0.037433986,0.000029876024,0.00021356739,0.00003782465,0.00044408528],"genre_scores_gemma":[0.0033691276,0.0006807922,0.00040816632,0.96130466,0.033004664,0.00010056645,0.000049416416,0.000026565142,0.0010559858],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98947245,0.0054749036,0.0019499833,0.0012186337,0.0014017022,0.0004823632],"domain_scores_gemma":[0.89651686,0.083715424,0.0043741725,0.002695334,0.009557862,0.0031403045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023516838,0.00078799174,0.0025563026,0.0008531339,0.0013965373,0.0025069343,0.0027932609,0.029148817,0.0069747916],"category_scores_gemma":[0.11440698,0.0010167767,0.0016532614,0.00096998806,0.0037673942,0.0035752945,0.0015591489,0.03498554,0.0038208973],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010688559,0.000052559823,0.0012830148,0.0005614086,0.00028273932,0.00044685605,0.00021718188,0.0001727568,0.00029138688,0.0025932519,0.98046196,0.01256811],"study_design_scores_gemma":[0.005045938,0.0006787335,0.006646057,0.0017818325,0.0011643927,0.0020354977,0.0009086175,0.0017067265,0.00156353,0.02811698,0.94980204,0.0005496379],"about_ca_topic_score_codex":0.0020292085,"about_ca_topic_score_gemma":0.0026616848,"teacher_disagreement_score":0.029148817,"about_ca_system_score_codex":0.0021234187,"about_ca_system_score_gemma":0.0032332712,"threshold_uncertainty_score":0.124370396},"labels":[],"label_agreement":null},{"id":"W2046340393","doi":"10.1016/s1474-4422(06)70658-5","title":"Stroke: the dashed hopes of neuroprotection","year":2006,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Neuroprotection; Stroke (engine); Medicine; Internal medicine; Physics","score_opus":0.016016620537980232,"score_gpt":0.24647814083143602,"score_spread":0.2304615202934558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046340393","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00066280103,0.11787055,0.0013780197,0.8577485,0.011534415,0.000008488721,0.00009505643,0.000050866453,0.010651325],"genre_scores_gemma":[0.08168732,0.2065286,0.0045882766,0.5774368,0.1150337,0.0001045519,0.00020493612,0.0001853664,0.01423045],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9920827,0.0030663065,0.000627503,0.0006890477,0.0028788175,0.000655583],"domain_scores_gemma":[0.96385264,0.021384623,0.002004708,0.0021180403,0.00533787,0.00530218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020336267,0.0013251492,0.0030804803,0.0020637303,0.0033884193,0.011531476,0.0022419868,0.023542412,0.01518338],"category_scores_gemma":[0.03607881,0.0008116335,0.0010100949,0.0012746765,0.021804897,0.023805927,0.0074657043,0.03230665,0.0060186586],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005986555,0.00016706038,0.00090345764,0.001148596,0.00020945218,0.00031531198,0.0005289335,0.0005758112,0.00053309795,0.32214054,0.53567094,0.13720816],"study_design_scores_gemma":[0.00035914016,0.00015621784,0.0011641458,0.0017013,0.00009420095,0.000364125,0.001246227,0.00040522258,0.0001679347,0.45686433,0.5373781,0.0000990282],"about_ca_topic_score_codex":0.0025187514,"about_ca_topic_score_gemma":0.0060323984,"teacher_disagreement_score":0.023542412,"about_ca_system_score_codex":0.004021101,"about_ca_system_score_gemma":0.008312228,"threshold_uncertainty_score":0.10754979},"labels":[],"label_agreement":null},{"id":"W2048769411","doi":"10.1016/s1474-4422(14)70097-3","title":"Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise? – Authors' reply","year":2014,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Intracerebral and Subarachnoid Hemorrhage Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; University of Calgary","funders":"National Institute of Neurological Disorders and Stroke; National Institute on Aging","keywords":"Cerebral amyloid angiopathy; Angiopathy; Medicine; Amyloid (mycology); Clinical trial; Pathology; Disease; Neuroscience; Psychology; Dementia; Endocrinology","score_opus":0.09078863861565359,"score_gpt":0.34127387032821743,"score_spread":0.25048523171256387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048769411","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010510427,0.0009170126,0.00004712561,0.9846751,0.013797804,0.000006100738,0.000053152267,0.000014389724,0.00038414836],"genre_scores_gemma":[0.001123773,0.00048533644,0.00012524518,0.9691787,0.028042365,0.0000296225,0.000022912947,0.0000118133285,0.0009802653],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98833257,0.0049864417,0.001554095,0.001383018,0.0027327393,0.0010111087],"domain_scores_gemma":[0.9414455,0.0404024,0.0034423983,0.001510297,0.008149567,0.005049879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013873319,0.0010329492,0.0036354167,0.0014556478,0.0030903514,0.0056644105,0.0032158175,0.07693804,0.0063249464],"category_scores_gemma":[0.083641894,0.0013841618,0.0016792789,0.0012973198,0.005968063,0.005707552,0.0029306447,0.062030368,0.0070294635],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000118812095,0.000021774555,0.00061223184,0.0000921029,0.000053769076,0.00035861434,0.00008370348,0.0000553781,0.00008669538,0.0012884454,0.991577,0.005651559],"study_design_scores_gemma":[0.0011795108,0.00020739346,0.0025290127,0.0009871634,0.00022788405,0.001461781,0.0006175429,0.0008018773,0.00046127802,0.024525736,0.9667089,0.00029201794],"about_ca_topic_score_codex":0.0041142195,"about_ca_topic_score_gemma":0.005762615,"teacher_disagreement_score":0.07693804,"about_ca_system_score_codex":0.004071595,"about_ca_system_score_gemma":0.0055506723,"threshold_uncertainty_score":0.07337004},"labels":[],"label_agreement":null},{"id":"W2050265501","doi":"10.1016/s1474-4422(15)70027-x","title":"Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis","year":2015,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":697,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; London Health Sciences Centre; Institute for Clinical Evaluative Sciences; Western University","funders":"","keywords":"Atrial fibrillation; Medicine; Stroke (engine); Ambulatory; Internal medicine; Cardiology; Cardiac monitoring; Emergency medicine","score_opus":0.23946783632828766,"score_gpt":0.4121820447442527,"score_spread":0.17271420841596502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050265501","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004155069,0.99451053,0.00039326746,0.00013335435,0.0001769231,0.00012055423,0.00031642627,0.000020114898,0.00017375793],"genre_scores_gemma":[0.18128783,0.81300104,0.0024753616,0.0012739681,0.00042156555,0.00049441267,0.00064071454,0.00002933406,0.00037583135],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9939073,0.002219687,0.0021482965,0.00079990237,0.0006741515,0.00025066416],"domain_scores_gemma":[0.9870183,0.009219027,0.0023329451,0.0005245302,0.0007272483,0.00017795696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0079099815,0.0024195116,0.016683586,0.004327502,0.0005420478,0.0024839242,0.0019567236,0.0024565498,0.0039868136],"category_scores_gemma":[0.026509598,0.0018294443,0.028574882,0.005193784,0.0006546863,0.0020659114,0.002000681,0.002349499,0.00038419318],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001556116,0.000030976516,0.005712513,0.25944138,0.72012544,0.0001345488,0.000090221576,0.0002673371,0.00017053957,0.000113473696,0.0007107252,0.011646771],"study_design_scores_gemma":[0.0006535664,0.00011823261,0.0040208558,0.010938547,0.98274857,0.00009884538,0.000037490114,0.00008362108,0.000048150425,0.00015500825,0.0010733572,0.00002366809],"about_ca_topic_score_codex":0.007255998,"about_ca_topic_score_gemma":0.02107117,"teacher_disagreement_score":0.016683586,"about_ca_system_score_codex":0.0017915248,"about_ca_system_score_gemma":0.0024611286,"threshold_uncertainty_score":0.041832507},"labels":[],"label_agreement":null},{"id":"W2051801901","doi":"10.1016/s1474-4422(06)70612-3","title":"Plasma amyloid-β concentrations in Alzheimer's disease: an alternative hypothesis","year":2006,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Dementia; Disease; Confounding; Vascular dementia; Alzheimer's disease; Rotterdam Study; Medicine; Risk factor; Pathological; Amyloid beta; Psychology; Internal medicine","score_opus":0.06961676465553339,"score_gpt":0.3200816677761702,"score_spread":0.2504649031206368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051801901","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005853076,0.014017827,0.0013268939,0.95217246,0.019646179,0.000020922913,0.000116900024,0.00005223129,0.006793502],"genre_scores_gemma":[0.106096685,0.011841059,0.0013936647,0.5749592,0.3012511,0.00009240166,0.000115672374,0.000022827497,0.0042274413],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99770796,0.0009098143,0.0003372702,0.00040224288,0.00046549318,0.00017718649],"domain_scores_gemma":[0.98481965,0.0117112,0.0010006506,0.000511103,0.0013445894,0.0006128825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041410965,0.0012787805,0.0031665736,0.0012981503,0.0013618176,0.002674682,0.0027175471,0.034871753,0.0071827588],"category_scores_gemma":[0.034194943,0.00065934745,0.0015109206,0.0011975243,0.0058378354,0.0073766764,0.0017013653,0.022131873,0.0040812534],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046442603,0.00051022,0.02248459,0.0018973659,0.0009173321,0.084086865,0.0010504154,0.00090221583,0.0017657202,0.09546663,0.66643757,0.11983681],"study_design_scores_gemma":[0.0075786244,0.0013587654,0.010202721,0.0017368436,0.000860411,0.0949067,0.0012470777,0.0049551544,0.0016613175,0.5115458,0.36367905,0.00026756877],"about_ca_topic_score_codex":0.00072123006,"about_ca_topic_score_gemma":0.0006048835,"teacher_disagreement_score":0.034871753,"about_ca_system_score_codex":0.002167425,"about_ca_system_score_gemma":0.0012017832,"threshold_uncertainty_score":0.024028659},"labels":[],"label_agreement":null},{"id":"W2051819887","doi":"10.1016/s1474-4422(14)70124-3","title":"The genetics of common epilepsies: common or distinct?","year":2014,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Epilepsy; Genetics; Medicine; Evolutionary biology; Biology; Neuroscience","score_opus":0.02491913386481528,"score_gpt":0.2731504930413104,"score_spread":0.2482313591764951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051819887","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003382856,0.02122336,0.00034128266,0.96607447,0.0061082644,0.000006405668,0.000045934954,0.000033130924,0.0027842885],"genre_scores_gemma":[0.072551,0.028050335,0.00093626295,0.7059077,0.18931931,0.000029222341,0.00008805444,0.000032543747,0.0030855366],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9982974,0.0006263205,0.00021437874,0.00024102906,0.00037268156,0.00024825576],"domain_scores_gemma":[0.99391043,0.0042866715,0.00047014345,0.00025468742,0.0005432422,0.0005348404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002407946,0.0008663359,0.0024393443,0.0010662803,0.0010919049,0.0021717562,0.001972088,0.025855817,0.0036783586],"category_scores_gemma":[0.01107941,0.0006240612,0.001105206,0.0008410761,0.003856862,0.0047647865,0.0012144112,0.017832696,0.0016011137],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091844006,0.00020721855,0.021262225,0.0006753297,0.00037958723,0.061358627,0.0005753206,0.00046685128,0.0022922056,0.029392175,0.80568933,0.07678272],"study_design_scores_gemma":[0.0025428534,0.00038463774,0.022168402,0.0027327326,0.0007277976,0.15040468,0.002504236,0.004034467,0.0016015237,0.24077514,0.5717387,0.00038486818],"about_ca_topic_score_codex":0.0026684413,"about_ca_topic_score_gemma":0.0038337724,"teacher_disagreement_score":0.025855817,"about_ca_system_score_codex":0.0022176353,"about_ca_system_score_gemma":0.001368248,"threshold_uncertainty_score":0.016090155},"labels":[],"label_agreement":null},{"id":"W2053412248","doi":"10.1016/s1474-4422(05)00974-9","title":"Evidence for use of glatiramer acetate in multiple sclerosis","year":2005,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University","funders":"","keywords":"Glatiramer acetate; Multiple sclerosis; Scopus; Medicine; Placebo; Cochrane Library; Randomized controlled trial; Internal medicine; MEDLINE; Alternative medicine; Psychiatry; Pathology; Chemistry","score_opus":0.49184814377994596,"score_gpt":0.38614582383174634,"score_spread":0.10570231994819962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053412248","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028798955,0.5431295,0.00050379476,0.39089262,0.018786859,0.000099691206,0.0025169963,0.000064691456,0.015206903],"genre_scores_gemma":[0.29156387,0.18932013,0.0022149337,0.46454182,0.046562057,0.0001866113,0.0014641605,0.00007273959,0.004073628],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9637141,0.021506226,0.007520057,0.0015909488,0.004868523,0.0008001467],"domain_scores_gemma":[0.6646875,0.29204437,0.024955297,0.0050371005,0.009842874,0.0034327903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0285781,0.000667853,0.003996888,0.002312601,0.0009824908,0.002692974,0.0030322298,0.013944605,0.00835845],"category_scores_gemma":[0.19503777,0.0006125858,0.0049418807,0.004372658,0.0027163685,0.0026870435,0.001624107,0.0070832837,0.0015666747],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07587222,0.0005922953,0.10545322,0.053063475,0.059585083,0.008281392,0.00137681,0.0007020027,0.0024986959,0.005066528,0.35508928,0.33241898],"study_design_scores_gemma":[0.052066747,0.010275074,0.25186,0.069791965,0.11225479,0.010676408,0.002562613,0.0010504412,0.002587813,0.017039416,0.46939617,0.00043857863],"about_ca_topic_score_codex":0.00578003,"about_ca_topic_score_gemma":0.011675702,"teacher_disagreement_score":0.0285781,"about_ca_system_score_codex":0.0024653347,"about_ca_system_score_gemma":0.0030690301,"threshold_uncertainty_score":0.15113723},"labels":[],"label_agreement":null},{"id":"W2054208549","doi":"10.1016/s1474-4422(14)70230-3","title":"In pursuit of prodromal Parkinson's disease","year":2014,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Parkinson's disease; Disease; Medicine; Psychology; Physical medicine and rehabilitation; Pathology","score_opus":0.03116436793167115,"score_gpt":0.275341439387433,"score_spread":0.24417707145576184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054208549","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.081811495,0.4719159,0.002475778,0.39292443,0.013585191,0.00013205124,0.001758983,0.00018045599,0.035215765],"genre_scores_gemma":[0.55749506,0.20422028,0.0041978974,0.17260502,0.03258496,0.00016660352,0.0019098009,0.00013884155,0.02668162],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99937564,0.00016371501,0.00009176471,0.00011718431,0.00016697712,0.000084748375],"domain_scores_gemma":[0.9983796,0.0005893459,0.00033862563,0.00007592706,0.00033044873,0.00028605835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011100395,0.00045816504,0.0008146189,0.00081272743,0.00058520655,0.0013035695,0.00050688616,0.0023601288,0.008409334],"category_scores_gemma":[0.0041499115,0.00018988698,0.00038343942,0.00095556665,0.0005170309,0.001632981,0.00058671,0.00227881,0.0022020044],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016301897,0.00044155738,0.15467282,0.0022554232,0.000265137,0.013474609,0.0013021503,0.00007963727,0.002521908,0.009393287,0.34741324,0.46655],"study_design_scores_gemma":[0.000966454,0.0014944184,0.24077561,0.0073857764,0.0005999942,0.09197986,0.0042624366,0.00071406923,0.002186044,0.044865716,0.6046033,0.00016638904],"about_ca_topic_score_codex":0.002017915,"about_ca_topic_score_gemma":0.0063906093,"teacher_disagreement_score":0.008409334,"about_ca_system_score_codex":0.0005288969,"about_ca_system_score_gemma":0.0009777457,"threshold_uncertainty_score":0.028131962},"labels":[],"label_agreement":null},{"id":"W2055514366","doi":"10.1016/s1474-4422(11)70250-2","title":"MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study","year":2011,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":190,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba; McGill University; McMaster University; McMaster Children's Hospital; University of British Columbia; Hospital for Sick Children; Montreal Neurological Institute and Hospital; University of Toronto; SickKids Foundation","funders":"Multiple Sclerosis Scientific Research Foundation","keywords":"Multiple sclerosis; Medicine; Prospective cohort study; Cohort; Magnetic resonance imaging; Cohort study; Pediatrics; Pathology; Radiology; Immunology","score_opus":0.10753658154757506,"score_gpt":0.3100234219994051,"score_spread":0.20248684045183002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055514366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992323,0.00019433754,0.000047303893,0.0000437308,0.000009521848,0.00000409357,0.00033731564,0.0000029987555,0.00012839268],"genre_scores_gemma":[0.99921775,0.00014703552,0.000098448814,0.000019608606,0.000011508005,0.000008950971,0.00038199284,0.000004257471,0.00011038232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895966,0.00030479376,0.000111934285,0.00030384847,0.00014667196,0.00017297498],"domain_scores_gemma":[0.996496,0.0007518306,0.0013458404,0.00056420563,0.00036066293,0.00048146208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013900733,0.0008775783,0.0008084055,0.00090492726,0.00080400583,0.0011576269,0.001016153,0.0013581346,0.0010868147],"category_scores_gemma":[0.004250129,0.0010065977,0.0013392008,0.0015861727,0.0006043285,0.0012628777,0.00085002364,0.002122653,0.0002950055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022695615,0.000049782862,0.99884015,0.0000048749234,0.00014207484,0.00009379726,0.0000658335,0.00003376247,0.0001878884,0.000010184699,0.00006440416,0.0002803192],"study_design_scores_gemma":[0.000017358081,0.00009640037,0.99914324,0.000005422482,0.000087787004,0.00024249221,0.00015428258,0.00012367385,0.000047779933,0.0000130698445,0.00006249842,0.000006010205],"about_ca_topic_score_codex":0.016524829,"about_ca_topic_score_gemma":0.013017941,"teacher_disagreement_score":0.016524829,"about_ca_system_score_codex":0.0006242147,"about_ca_system_score_gemma":0.0007455716,"threshold_uncertainty_score":0.0328573},"labels":[],"label_agreement":null},{"id":"W2059839160","doi":"10.1016/s1474-4422(15)00061-7","title":"Desmoteplase for late treatment of stroke: still in the dark","year":2015,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Placebo; Stroke (engine); Ischaemic stroke; Occlusion; Neurology; Clinical trial; Internal medicine; Cardiology; Anesthesia; Ischemia; Pathology; Psychiatry","score_opus":0.05787118454328993,"score_gpt":0.3019548963777793,"score_spread":0.24408371183448935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059839160","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00049383607,0.016547062,0.00006919324,0.96778876,0.011072401,0.0000051326338,0.00004231045,0.000016962062,0.0039643776],"genre_scores_gemma":[0.0130835,0.034394167,0.0004000377,0.77266353,0.171933,0.000031624873,0.000074803735,0.000034420136,0.007384878],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979572,0.00073048973,0.00032415998,0.0001523175,0.00058734464,0.0002483866],"domain_scores_gemma":[0.99409914,0.0030578908,0.00047648264,0.00011941981,0.0011183305,0.0011286979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021053106,0.000519645,0.0018807809,0.00090390054,0.0018215508,0.0029913296,0.001187199,0.019521715,0.008764921],"category_scores_gemma":[0.013665767,0.00035539016,0.0012083753,0.00069852587,0.0018310472,0.0033948245,0.00082566694,0.02174204,0.005545968],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029230292,0.00014231246,0.0016371872,0.0004551307,0.000081037724,0.0038365102,0.00016246333,0.00011652895,0.00042155696,0.0057279174,0.9026233,0.08450385],"study_design_scores_gemma":[0.0009884178,0.00036548518,0.0041130106,0.0045254966,0.00017941503,0.007950674,0.0009361147,0.0005308333,0.00031550904,0.031028505,0.94894594,0.000120519275],"about_ca_topic_score_codex":0.0035862084,"about_ca_topic_score_gemma":0.010915184,"teacher_disagreement_score":0.019521715,"about_ca_system_score_codex":0.0029546055,"about_ca_system_score_gemma":0.003469764,"threshold_uncertainty_score":0.02932161},"labels":[],"label_agreement":null},{"id":"W2060633440","doi":"10.1016/s1474-4422(12)70258-2","title":"Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation","year":2012,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Rivaroxaban; Atrial fibrillation; Medicine; Warfarin; Dabigatran; Apixaban; Stroke (engine); Anticoagulant; Antithrombotic; Cardiology; Internal medicine; Direct thrombin inhibitor","score_opus":0.2077298342774711,"score_gpt":0.42811318551253197,"score_spread":0.22038335123506086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060633440","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008422218,0.9993567,0.000034016375,0.0001254153,0.000115973264,0.000005319448,0.000016674472,0.0000028490663,0.00025876335],"genre_scores_gemma":[0.001307703,0.9979249,0.00014803892,0.00027291803,0.00015827388,0.000008247495,0.000022048975,8.588491e-7,0.00015705175],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99960154,0.000090464884,0.00010268636,0.00004590899,0.00012871344,0.000030631483],"domain_scores_gemma":[0.9990277,0.00060793373,0.00023239452,0.0000131391525,0.00008909055,0.000029764798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000985097,0.00083549944,0.0030995612,0.0024109972,0.00020134983,0.00087741856,0.00078847917,0.0011774853,0.0046264427],"category_scores_gemma":[0.0020210056,0.00030967584,0.0015447595,0.0022975479,0.00025615684,0.00070005906,0.00052650145,0.0015537662,0.0007334844],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003471092,0.000082381375,0.00031973448,0.1253244,0.002425386,0.00021041314,0.0000496074,0.00025596743,0.00069687236,0.0012773928,0.02810385,0.840907],"study_design_scores_gemma":[0.0016772919,0.0009648435,0.008280995,0.1521546,0.025248839,0.0029679167,0.0002290603,0.00048843777,0.0009032551,0.004636395,0.80236,0.00008831111],"about_ca_topic_score_codex":0.0020652863,"about_ca_topic_score_gemma":0.005785167,"teacher_disagreement_score":0.0046264427,"about_ca_system_score_codex":0.00061124767,"about_ca_system_score_gemma":0.0010666578,"threshold_uncertainty_score":0.015477002},"labels":[],"label_agreement":null},{"id":"W2061418826","doi":"10.1016/s1474-4422(11)70049-7","title":"Towards a neuroimaging biomarker for amyotrophic lateral sclerosis","year":2011,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":167,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Medical Research Council","keywords":"Amyotrophic lateral sclerosis; Neuroimaging; Neuroscience; Medicine; Scopus; Neuroprotection; Disease; Psychology; Physical medicine and rehabilitation; MEDLINE; Pathology; Political science","score_opus":0.2114817649417648,"score_gpt":0.3336431162102373,"score_spread":0.1221613512684725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061418826","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13116664,0.3267888,0.16477935,0.33346713,0.01612493,0.0004976728,0.0023984853,0.0013907128,0.023386307],"genre_scores_gemma":[0.5985941,0.06868703,0.22024414,0.08457984,0.017664032,0.0007553984,0.0025609694,0.00028641138,0.0066280942],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99647456,0.001022568,0.000664143,0.00059300277,0.0009571798,0.00028850776],"domain_scores_gemma":[0.9814973,0.008262655,0.002035507,0.0010210174,0.006226599,0.0009569963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014828151,0.0013466219,0.003768028,0.0052316873,0.0012083558,0.0076536313,0.0027422626,0.007946218,0.0024522392],"category_scores_gemma":[0.033539005,0.0011993141,0.0013893149,0.0016215275,0.0041124555,0.010059423,0.0028473523,0.006863274,0.0020631303],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030264815,0.0018481606,0.15430188,0.004098854,0.0019759997,0.0019245746,0.0008125655,0.0040051676,0.071355715,0.07231844,0.07015983,0.6141724],"study_design_scores_gemma":[0.0014833357,0.005723082,0.1289673,0.0073665488,0.0050460333,0.009239938,0.003758036,0.024208846,0.04294066,0.5287144,0.2416902,0.00086166814],"about_ca_topic_score_codex":0.0015532019,"about_ca_topic_score_gemma":0.0016099702,"teacher_disagreement_score":0.014828151,"about_ca_system_score_codex":0.002078918,"about_ca_system_score_gemma":0.0051600905,"threshold_uncertainty_score":0.078419685},"labels":[],"label_agreement":null},{"id":"W2061854453","doi":"10.1016/s1474-4422(09)70241-8","title":"Antithrombotic treatments, outcomes, and prognostic factors in acute childhood-onset arterial ischaemic stroke: a multicentre, observational, cohort study","year":2009,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":197,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Antithrombotic; Observational study; Ischaemic stroke; Stroke (engine); Cardiology; Internal medicine; Cohort; Fibrinolytic agent; Cohort study; Ischemia","score_opus":0.045338278344086554,"score_gpt":0.31017608328688273,"score_spread":0.2648378049427962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061854453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99851507,0.00030328083,0.00008645218,0.00004457784,0.0000115532475,0.000020900448,0.00088244776,0.0000038073508,0.00013189059],"genre_scores_gemma":[0.99791163,0.00031854963,0.0001821808,0.00006164334,0.00003041601,0.000041226784,0.0012688127,0.00000687096,0.00017867089],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971474,0.0009812333,0.0003018133,0.0006605367,0.00034882274,0.0005602065],"domain_scores_gemma":[0.9930004,0.0013613071,0.002781494,0.001407238,0.000561792,0.0008877709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002328921,0.0012788568,0.0017656158,0.0011093831,0.0018524703,0.0018510256,0.0013033045,0.0015188688,0.0013720283],"category_scores_gemma":[0.0054608667,0.0017434576,0.0021109672,0.0038783834,0.0013384217,0.0013340166,0.0013179214,0.002274668,0.0003942906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036696726,0.00049872574,0.99179924,0.000044645432,0.0014584376,0.00030239005,0.00037071464,0.0001187054,0.00047506214,0.000056281566,0.00034185706,0.0008644291],"study_design_scores_gemma":[0.0005225644,0.0007010589,0.9966942,0.000016699436,0.0006760486,0.00048805974,0.00037699626,0.00021539742,0.00007891246,0.000038076145,0.00016446298,0.000027518066],"about_ca_topic_score_codex":0.04091217,"about_ca_topic_score_gemma":0.039895475,"teacher_disagreement_score":0.04091217,"about_ca_system_score_codex":0.002146572,"about_ca_system_score_gemma":0.0018182123,"threshold_uncertainty_score":0.08134812},"labels":[],"label_agreement":null},{"id":"W2063885093","doi":"10.1016/s1474-4422(04)00937-8","title":"The promise of minocycline in neurology","year":2004,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":518,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Multiple Sclerosis Society of Canada; Teva Pharmaceutical Industries","keywords":"Minocycline; Amyotrophic lateral sclerosis; Neurology; Multiple sclerosis; Medicine; Disease; Stroke (engine); Neuroscience; Psychology; Psychiatry; Pathology; Antibiotics; Biology","score_opus":0.12407379812612299,"score_gpt":0.35446376225781084,"score_spread":0.23038996413168786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063885093","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006282062,0.99774534,0.00006926441,0.0007893442,0.0006329622,0.0000020289115,0.000006856476,0.000005213546,0.00068622036],"genre_scores_gemma":[0.0006550194,0.99630016,0.0002261986,0.00065445714,0.0011062564,0.0000052860355,0.000013818707,0.0000019095246,0.001036881],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977416,0.000047727826,0.000036381236,0.000034347635,0.000082015475,0.000025427205],"domain_scores_gemma":[0.9992835,0.0003913472,0.000075698365,0.00002432333,0.00015194574,0.00007316876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010007699,0.0011372068,0.0025963048,0.0016559615,0.00041881186,0.0015528079,0.0013550118,0.0027948616,0.0042079287],"category_scores_gemma":[0.0011230112,0.0002816106,0.00051276595,0.0014873,0.0009193286,0.0026306042,0.0006610457,0.0035943643,0.001973469],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029663893,0.00011218939,0.00014103731,0.009682027,0.000091606664,0.00062861555,0.000064924665,0.00039334418,0.0022922456,0.0044315774,0.07383228,0.90803343],"study_design_scores_gemma":[0.00009342653,0.00014848483,0.0005954411,0.0022017166,0.00008518386,0.0012916584,0.00007807888,0.00010894621,0.0003992023,0.0028726344,0.99210393,0.00002115395],"about_ca_topic_score_codex":0.002247198,"about_ca_topic_score_gemma":0.006575843,"teacher_disagreement_score":0.0042079287,"about_ca_system_score_codex":0.0010223278,"about_ca_system_score_gemma":0.0014885602,"threshold_uncertainty_score":0.014076948},"labels":[],"label_agreement":null},{"id":"W2071356639","doi":"10.1016/s1474-4422(14)70091-2","title":"Unruptured intracranial aneurysms: why we must not perpetuate the impasse for another 25 years","year":2014,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Intracranial Aneurysms: Treatment and Complications","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Université de Montréal; Hôpital Notre-Dame; University of Alberta Hospital","funders":"","keywords":"Natural history; Medicine; Observational study; Clinical trial; Randomized controlled trial; Cohort; Population; Scopus; MEDLINE; Intensive care medicine; Surgery; Internal medicine","score_opus":0.042045513022862385,"score_gpt":0.27869594604582143,"score_spread":0.23665043302295904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071356639","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014583449,0.0033055216,0.0000311757,0.9878824,0.007907935,9.0559405e-7,0.0000051146576,0.0000052723512,0.0007158311],"genre_scores_gemma":[0.0044839545,0.0046823327,0.00013484816,0.92212623,0.06667329,0.0000076155825,0.000009819065,0.000017367427,0.0018644697],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99434316,0.0018834121,0.0005407281,0.000515303,0.0018458198,0.0008714903],"domain_scores_gemma":[0.97609746,0.013130855,0.0016198297,0.0007197232,0.0038479264,0.004584257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062814374,0.00074717414,0.0018801285,0.0010277936,0.0049929232,0.006769914,0.0017018822,0.07007552,0.0064727836],"category_scores_gemma":[0.045839217,0.0007159202,0.0010882864,0.0009160444,0.008381527,0.011488616,0.0032652928,0.07293878,0.006090665],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008779428,0.00006358902,0.0009113886,0.00011337331,0.000050068968,0.0024708882,0.00037943464,0.00008034183,0.00017651646,0.008744267,0.96812016,0.018802207],"study_design_scores_gemma":[0.00026741947,0.00010770505,0.0014379818,0.0011903583,0.00007270979,0.0052980348,0.0015839569,0.0002665052,0.00017517954,0.04871124,0.9407356,0.00015334436],"about_ca_topic_score_codex":0.0039023925,"about_ca_topic_score_gemma":0.008597146,"teacher_disagreement_score":0.07007552,"about_ca_system_score_codex":0.0056750206,"about_ca_system_score_gemma":0.0059524826,"threshold_uncertainty_score":0.041175306},"labels":[],"label_agreement":null},{"id":"W2072683774","doi":"10.1016/s1474-4422(10)70303-3","title":"Movement disorders: new insights into Parkinson's disease","year":2010,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Parkinson's disease; Disease; Psychological intervention; Clinical trial; Movement disorders; Medicine; Neuroscience; Psychology; Intensive care medicine; Psychiatry; Pathology","score_opus":0.016119342867491816,"score_gpt":0.2639410121446049,"score_spread":0.2478216692771131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072683774","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00085331924,0.9469417,0.0007768664,0.042485,0.0030670974,0.0000047123144,0.00005445934,0.000029150593,0.0057876795],"genre_scores_gemma":[0.023499576,0.9412937,0.0012862142,0.0138019,0.016923422,0.000021059457,0.000052528354,0.000011426855,0.0031101713],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99944526,0.00018513978,0.000059192742,0.000071101575,0.00018266377,0.000056570574],"domain_scores_gemma":[0.99797815,0.0012781862,0.00019210165,0.000084892825,0.0002667678,0.00019988674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018742541,0.0010200109,0.0019178176,0.0018700253,0.00048957026,0.002960179,0.0008776184,0.004014859,0.007480708],"category_scores_gemma":[0.0021052014,0.0002889181,0.0007627662,0.0013212344,0.0031274594,0.0050099706,0.001421998,0.003542246,0.0014712667],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068011635,0.00022238398,0.003228158,0.007557977,0.00030166443,0.0011214555,0.0005010005,0.0008769869,0.0028343413,0.11551164,0.14024642,0.7269178],"study_design_scores_gemma":[0.000310879,0.00046122412,0.0063281716,0.0037427286,0.0002517707,0.003746087,0.00090034824,0.0009690591,0.00045387886,0.21483292,0.7679321,0.00007078907],"about_ca_topic_score_codex":0.0011871029,"about_ca_topic_score_gemma":0.0033309874,"teacher_disagreement_score":0.007480708,"about_ca_system_score_codex":0.0019549448,"about_ca_system_score_gemma":0.001821281,"threshold_uncertainty_score":0.025025487},"labels":[],"label_agreement":null},{"id":"W2073048162","doi":"10.1016/s1474-4422(11)70214-9","title":"Advances in imaging in Parkinson's disease","year":2011,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Parkinson's disease; Disease; Neuroimaging; Medicine; Neuroscience; Biomarker; Psychology; Pathology; Biology","score_opus":0.05177587308000588,"score_gpt":0.337000428215412,"score_spread":0.2852245551354061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073048162","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016402433,0.9991792,0.000048789247,0.00024569876,0.00016238535,0.0000016782353,0.000005456188,0.0000030125007,0.00033735659],"genre_scores_gemma":[0.00023235206,0.9986852,0.0001546034,0.00031083426,0.00037305907,0.0000034879076,0.000010911397,0.0000010127038,0.00022861436],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99956673,0.0000929681,0.00006983452,0.000061086655,0.00016799514,0.00004134016],"domain_scores_gemma":[0.9983967,0.0009846835,0.00018962305,0.000031203817,0.00032188516,0.00007581736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016989658,0.0016095387,0.0032632933,0.003486733,0.00034629917,0.0016259003,0.0012769118,0.002580569,0.0045435573],"category_scores_gemma":[0.0020341538,0.00053537136,0.00086591707,0.0037757093,0.0011683918,0.0023438658,0.00090957974,0.0035361452,0.0026328294],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012460825,0.00006936057,0.00014993976,0.018531693,0.00014485848,0.00021012641,0.000036651993,0.00028335987,0.0008559453,0.0029892013,0.05547708,0.92112714],"study_design_scores_gemma":[0.000094671435,0.00012477253,0.0009617848,0.008286333,0.00033893378,0.0016996136,0.000073694195,0.00014921474,0.00030130448,0.0037312757,0.984202,0.000036304682],"about_ca_topic_score_codex":0.0028393636,"about_ca_topic_score_gemma":0.00635278,"teacher_disagreement_score":0.0045435573,"about_ca_system_score_codex":0.0012735837,"about_ca_system_score_gemma":0.00193799,"threshold_uncertainty_score":0.015199661},"labels":[],"label_agreement":null},{"id":"W2073077090","doi":"10.1016/s1474-4422(07)70326-5","title":"Strategies to advance translational research into brain barriers","year":2008,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Cellular transport and secretion","field":"Biochemistry, Genetics and Molecular Biology","cited_by":469,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Cancer Institute","keywords":"Medicine; Blood–brain barrier; Translational research; Intensive care medicine; Lysosomal storage disorders; Neuroscience; Brain disease; Disease; Central nervous system; Pathology; Psychology","score_opus":0.0603782508960553,"score_gpt":0.37470237567884607,"score_spread":0.31432412478279076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073077090","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004582903,0.9873043,0.0008906064,0.006947108,0.0033729686,0.0000080768095,0.00001758968,0.000025442687,0.0013881144],"genre_scores_gemma":[0.00068853877,0.9880177,0.0015885506,0.004363601,0.0040293243,0.00003585115,0.00003267876,0.0000069906387,0.0012367757],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993759,0.00019195012,0.00006957205,0.00009410065,0.0001887082,0.00007983401],"domain_scores_gemma":[0.9967649,0.0021758776,0.00016161693,0.000101099584,0.0005711116,0.00022540205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005422359,0.0023887735,0.0034605924,0.0027768326,0.0006830491,0.002851973,0.0026962121,0.0065757707,0.0061654146],"category_scores_gemma":[0.004549348,0.0006399287,0.0008908534,0.0021583717,0.0040938435,0.0053782254,0.0020729573,0.010680448,0.0033782222],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019756377,0.00012340584,0.000262647,0.012311367,0.0001501526,0.00057821785,0.00014338802,0.0008848851,0.0019195674,0.060009316,0.24304661,0.6803729],"study_design_scores_gemma":[0.00010382094,0.00006690443,0.00026710395,0.0027141243,0.000081888706,0.0008109759,0.00011723608,0.0001586549,0.00034134844,0.029067053,0.96624047,0.000030344368],"about_ca_topic_score_codex":0.0016942387,"about_ca_topic_score_gemma":0.0040537585,"teacher_disagreement_score":0.0065757707,"about_ca_system_score_codex":0.0029959478,"about_ca_system_score_gemma":0.0035121962,"threshold_uncertainty_score":0.02867651},"labels":[],"label_agreement":null},{"id":"W2073624150","doi":"10.1016/s1474-4422(11)70081-3","title":"Primary angiitis of the CNS","year":2011,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":323,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; SickKids Foundation","funders":"","keywords":"Primary (astronomy); Medicine; Physics","score_opus":0.0644460437326814,"score_gpt":0.30344463740087796,"score_spread":0.23899859366819656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073624150","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003694381,0.9993913,0.000015801432,0.000102175996,0.00017134317,0.000001616276,0.000007032678,0.0000017636054,0.0002720142],"genre_scores_gemma":[0.00044372928,0.9988644,0.000036458146,0.000177286,0.00023795475,0.000002008105,0.0000130476565,4.503728e-7,0.00022466859],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996698,0.000058379763,0.000052019896,0.000049354323,0.00012851592,0.00004189598],"domain_scores_gemma":[0.99940884,0.0002997418,0.0001421419,0.000013953114,0.000086135835,0.000049221308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005727193,0.0010570055,0.0030875483,0.0038163173,0.0002914648,0.0011661835,0.00085590035,0.0012085054,0.0046606874],"category_scores_gemma":[0.0010710867,0.0003368656,0.00077186193,0.0037635164,0.0005627879,0.0011081109,0.0008175257,0.0015373417,0.0012716099],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014716008,0.000059116766,0.000271631,0.062846966,0.00037660424,0.0008116283,0.00004633924,0.00027753474,0.0007641598,0.0013712649,0.06411688,0.8689107],"study_design_scores_gemma":[0.00020387577,0.00020618831,0.0033081765,0.040087678,0.0015895838,0.008287171,0.00018770384,0.00013273345,0.00039381388,0.002245342,0.94330525,0.00005244208],"about_ca_topic_score_codex":0.0041491743,"about_ca_topic_score_gemma":0.010168506,"teacher_disagreement_score":0.0046606874,"about_ca_system_score_codex":0.0009021651,"about_ca_system_score_gemma":0.0018663158,"threshold_uncertainty_score":0.015591562},"labels":[],"label_agreement":null},{"id":"W2075849746","doi":"10.1016/s1474-4422(12)70038-8","title":"Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study","year":2012,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Intracerebral and Subarachnoid Hemorrhage Research","field":"Medicine","cited_by":631,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto; Dalhousie University; University of Calgary; Hôpital Charles-Le Moyne; Ottawa Hospital; University of Ottawa; Université de Sherbrooke","funders":"Canadian Stroke Consortium","keywords":"Medicine; Observational study; Prospective cohort study; Radiology; Intracerebral hemorrhage; Angiography; Surgery; Internal medicine; Subarachnoid hemorrhage","score_opus":0.07931985549252715,"score_gpt":0.3029732784693665,"score_spread":0.22365342297683935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075849746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992906,0.00012206836,0.000060796316,0.000035997753,0.0000127987005,0.000013319971,0.00023015427,0.0000022289262,0.0002321371],"genre_scores_gemma":[0.9992281,0.00011106901,0.00007491862,0.000027781529,0.000031354542,0.0000148072095,0.00040312842,0.000002412954,0.000106510786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913186,0.000275183,0.000114291186,0.0001953863,0.00013064544,0.00015257562],"domain_scores_gemma":[0.99463224,0.0012742823,0.002090299,0.0007249416,0.00037586797,0.00090235414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013250003,0.000782013,0.0008689165,0.00076558517,0.000850197,0.0015920958,0.0008874921,0.0018608662,0.0017358128],"category_scores_gemma":[0.0060409987,0.001147137,0.001420332,0.0016518703,0.0010403601,0.0020715324,0.0010445919,0.0026227618,0.00055530947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011166888,0.0001604579,0.99775225,0.00001047443,0.00015310168,0.00011095182,0.000067302106,0.00005460102,0.00011881957,0.000020174635,0.000061629435,0.00037351548],"study_design_scores_gemma":[0.000115806506,0.00089799217,0.9973621,0.000010290495,0.00016224886,0.00038516615,0.00026044116,0.00051916117,0.000060377148,0.00009099826,0.000111708396,0.00002370705],"about_ca_topic_score_codex":0.0052399123,"about_ca_topic_score_gemma":0.0035998966,"teacher_disagreement_score":0.0052399123,"about_ca_system_score_codex":0.0005215997,"about_ca_system_score_gemma":0.00062766403,"threshold_uncertainty_score":0.010418832},"labels":[],"label_agreement":null},{"id":"W2080961987","doi":"10.1016/s1474-4422(12)70094-7","title":"Unmasking the benefits of B vitamins in stroke prevention","year":2012,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Institute for Clinical Evaluative Sciences; Research Canada; University of Toronto","funders":"","keywords":"Medicine; Homocysteine; Stroke (engine); B vitamins; Internal medicine; Scopus; Meta-analysis; Randomized controlled trial; MEDLINE; Biochemistry","score_opus":0.07368608868058459,"score_gpt":0.3278716151854823,"score_spread":0.25418552650489773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080961987","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00053582294,0.006681649,0.00007647336,0.9790781,0.011698756,0.0000054198495,0.000036557147,0.000019470204,0.0018677086],"genre_scores_gemma":[0.012080911,0.009668987,0.0003065517,0.83442366,0.14005038,0.000032047712,0.00003351903,0.0000208882,0.0033830365],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961804,0.001438259,0.00047014104,0.00035545637,0.0011641225,0.00039155615],"domain_scores_gemma":[0.9797127,0.014690567,0.000934097,0.00039051916,0.0024272748,0.0018447929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043497956,0.0008936925,0.0028062875,0.0008942573,0.00237933,0.0030522135,0.0019370118,0.044446703,0.0076258234],"category_scores_gemma":[0.03625738,0.0006703984,0.0012084639,0.00081236893,0.0037205648,0.0043163043,0.0015659947,0.034867708,0.0048773703],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010592783,0.00015483805,0.0014766435,0.00051789056,0.0001620901,0.0025249915,0.00013614591,0.0001459602,0.00080624264,0.005628395,0.9126105,0.07477701],"study_design_scores_gemma":[0.0022271457,0.0005037832,0.005254217,0.0015393979,0.0004672061,0.0034871374,0.00055173266,0.0008546975,0.0013778164,0.05187472,0.9317037,0.00015842132],"about_ca_topic_score_codex":0.006142754,"about_ca_topic_score_gemma":0.0114456015,"teacher_disagreement_score":0.044446703,"about_ca_system_score_codex":0.0039315904,"about_ca_system_score_gemma":0.003801371,"threshold_uncertainty_score":0.028525889},"labels":[],"label_agreement":null},{"id":"W2086595819","doi":"10.1016/s1474-4422(11)70217-4","title":"Clazosentan for patients with subarachnoid haemorrhage: lessons learned – Authors' reply","year":2011,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Intracranial Aneurysms: Treatment and Complications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Subarachnoid hemorrhage; Medicine; Transcranial Doppler; Stroke (engine); Randomized controlled trial; Vasospasm; Population; Placebo; Infarction; Anesthesia; Cardiology; Internal medicine; Myocardial infarction","score_opus":0.07374280901028556,"score_gpt":0.30286647104380976,"score_spread":0.2291236620335242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086595819","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001012166,0.01144797,0.00009153118,0.95107347,0.03517117,0.000008045781,0.00011347198,0.000019234123,0.0010628486],"genre_scores_gemma":[0.012775672,0.0122600775,0.00026806322,0.8532265,0.11931707,0.000034825778,0.00010345486,0.00002773044,0.001986606],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99862254,0.00043749093,0.0003516817,0.00018725026,0.00024255822,0.00015842605],"domain_scores_gemma":[0.98642063,0.008591401,0.0008155948,0.00044336266,0.0025675972,0.0011614392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029729782,0.0006096979,0.0019951616,0.00067856064,0.0010732342,0.002423195,0.0019554044,0.026787406,0.004833546],"category_scores_gemma":[0.023329692,0.00047571235,0.0012849761,0.00080436136,0.0016058,0.0037718227,0.0011561402,0.024381109,0.0025972393],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006175633,0.000076195865,0.0022799443,0.0005305465,0.00022634014,0.0037240656,0.00025313214,0.00017315037,0.0002399127,0.0016531234,0.963627,0.026599076],"study_design_scores_gemma":[0.0029750492,0.000633778,0.01087234,0.0025612453,0.00080341264,0.009213522,0.0015908328,0.00073172594,0.0009829007,0.0137901865,0.9553865,0.00045845076],"about_ca_topic_score_codex":0.00326255,"about_ca_topic_score_gemma":0.003999583,"teacher_disagreement_score":0.026787406,"about_ca_system_score_codex":0.0015393207,"about_ca_system_score_gemma":0.0020052572,"threshold_uncertainty_score":0.016169846},"labels":[],"label_agreement":null},{"id":"W2087243986","doi":"10.1016/s1474-4422(15)70016-5","title":"Neuroinflammation in Alzheimer's disease","year":2015,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":6102,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Douglas Mental Health University Institute","funders":"National Institute of Neurological Disorders and Stroke; National Institute on Aging; Medical Research Council","keywords":"Neuroinflammation; Microglia; Disease; Inflammation; Immune system; Pathogenesis; Alzheimer's disease; Innate immune system; Neuroscience; Immunology; Medicine; Biology; Pathology","score_opus":0.22155087273989868,"score_gpt":0.37286985681438506,"score_spread":0.15131898407448638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087243986","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003016258,0.9992607,0.00003257554,0.0001852444,0.00019153341,0.000001969584,0.000008954396,0.0000028108518,0.00028597354],"genre_scores_gemma":[0.00029898804,0.99884737,0.00006926418,0.00017382184,0.00029753736,0.0000029013868,0.000012660197,5.274674e-7,0.0002970041],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997775,0.000033974015,0.000039828214,0.000032239997,0.00008882829,0.000027643553],"domain_scores_gemma":[0.9995679,0.00017216794,0.00008349997,0.000010901271,0.000114988994,0.000050514376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086694077,0.0013428886,0.0022257522,0.002364841,0.00030761812,0.0014815093,0.00095019524,0.0018127951,0.003837721],"category_scores_gemma":[0.0009782764,0.00038337146,0.00055836496,0.0024258513,0.0006234011,0.0016397748,0.0011086784,0.0022574821,0.002037786],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014428487,0.00007546303,0.0002014016,0.023963422,0.00015266125,0.00022946953,0.00006664857,0.00036835755,0.0011561794,0.002470623,0.059486054,0.9116856],"study_design_scores_gemma":[0.00007082998,0.00011727331,0.0012376736,0.008656379,0.00036051995,0.001112795,0.000104847575,0.00012050171,0.00026156148,0.0034977086,0.98442614,0.00003377162],"about_ca_topic_score_codex":0.0018739233,"about_ca_topic_score_gemma":0.0042735916,"teacher_disagreement_score":0.003837721,"about_ca_system_score_codex":0.0006773624,"about_ca_system_score_gemma":0.0016813154,"threshold_uncertainty_score":0.012838483},"labels":[],"label_agreement":null},{"id":"W2089346722","doi":"10.1016/s1474-4422(08)70040-1","title":"Vascular cognitive impairment: current concepts and clinical developments","year":2008,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Neurological Disorders and Treatments","field":"Neuroscience","cited_by":356,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"H. Lundbeck A/S; Dalhousie Medical Research Foundation","keywords":"Cognitive impairment; Current (fluid); Cognition; Medicine; Intensive care medicine; Psychology; Psychiatry; Engineering; Electrical engineering","score_opus":0.18683348276917547,"score_gpt":0.43232363393948636,"score_spread":0.2454901511703109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089346722","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000030204745,0.99915755,0.00005198818,0.00029688334,0.0001910226,0.0000018926979,0.000007566288,0.000003899493,0.0002590473],"genre_scores_gemma":[0.00031318812,0.99873537,0.00013502645,0.00027662038,0.0003542705,0.000004147055,0.000011460972,7.436983e-7,0.00016909515],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996557,0.000059018443,0.00005934976,0.000063370826,0.00012464737,0.00003787612],"domain_scores_gemma":[0.99890184,0.0006315751,0.0001413077,0.000019032617,0.00022328219,0.00008291964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015071586,0.0019132338,0.00386638,0.0029211822,0.00036906663,0.002361573,0.0015448668,0.002407519,0.0036745786],"category_scores_gemma":[0.0016771659,0.00040154665,0.0007615646,0.0035777027,0.0010905053,0.0023593383,0.0010247837,0.0029759903,0.0018504858],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017074587,0.0000736879,0.00022647978,0.015315199,0.00011002525,0.00026195607,0.0000512394,0.0003449913,0.00043655245,0.002770582,0.045148097,0.93509036],"study_design_scores_gemma":[0.0001300413,0.00017637429,0.0017034918,0.011823139,0.00045724364,0.0025955746,0.00022180892,0.00027591825,0.00023267555,0.0056066257,0.97671974,0.000057375357],"about_ca_topic_score_codex":0.0024094586,"about_ca_topic_score_gemma":0.0057327407,"teacher_disagreement_score":0.00386638,"about_ca_system_score_codex":0.0012247027,"about_ca_system_score_gemma":0.002863796,"threshold_uncertainty_score":0.0122926235},"labels":[],"label_agreement":null},{"id":"W2091767899","doi":"10.1016/s1474-4422(11)70161-2","title":"CSF α-synuclein, tau, and amyloid β in Parkinson's disease – Authors' reply","year":2011,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"Volkswagen Foundation; Deutsche Forschungsgemeinschaft; European Commission; Bayer Schering; Novartis; GlaxoSmithKline; Horizon Pharma; Boehringer Ingelheim","keywords":"Parkinson's disease; Amyloid (mycology); Neuroscience; Disease; Philosophy; Medicine; Psychology; Pathology","score_opus":0.04110259158526825,"score_gpt":0.26557487045213257,"score_spread":0.22447227886686433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091767899","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005551057,0.0058029406,0.0000698029,0.93946755,0.053558026,0.0000069990842,0.000076608674,0.000012199975,0.0004507341],"genre_scores_gemma":[0.007279943,0.0055491906,0.0002146234,0.8469661,0.1369688,0.000044899174,0.000066437286,0.000017825047,0.0028920441],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99803966,0.0005515754,0.00045680397,0.00030927802,0.00045295354,0.00018985357],"domain_scores_gemma":[0.9831146,0.0109823905,0.0008622656,0.00049189955,0.0034998674,0.0010490575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040688505,0.00067811547,0.002016979,0.0008979133,0.0016305355,0.0020199853,0.00211548,0.029433887,0.0042237546],"category_scores_gemma":[0.02687685,0.0006839285,0.0012405957,0.000698077,0.0025620137,0.0041234945,0.0017579192,0.027853157,0.0023421615],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021908864,0.000034692937,0.0012242179,0.00021656882,0.00006068192,0.0015516041,0.00019570383,0.00005563374,0.00016470111,0.001134218,0.98468417,0.01045887],"study_design_scores_gemma":[0.0006712614,0.00019812345,0.005684751,0.000758601,0.00024841054,0.0064742314,0.0015864213,0.00046959418,0.0006803156,0.012738418,0.97024757,0.00024237536],"about_ca_topic_score_codex":0.0029081882,"about_ca_topic_score_gemma":0.0036009983,"teacher_disagreement_score":0.029433887,"about_ca_system_score_codex":0.001442118,"about_ca_system_score_gemma":0.0023175615,"threshold_uncertainty_score":0.02151841},"labels":[],"label_agreement":null},{"id":"W2093409635","doi":"10.1016/s1474-4422(08)70044-9","title":"Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial","year":2008,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":1040,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"GlaxoSmithKline; Pfizer","keywords":"Medicine; Placebo; Clinical endpoint; Stroke (engine); Modified Rankin Scale; Randomized controlled trial; Internal medicine; Thrombolysis; Anesthesia; Ischemia; Ischemic stroke; Myocardial infarction; Pathology","score_opus":0.018069931644105777,"score_gpt":0.27951054915734264,"score_spread":0.2614406175132369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093409635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97370267,0.015102481,0.0008559227,0.0014313147,0.0021545738,0.0019017891,0.0012253302,0.00014690876,0.0034790554],"genre_scores_gemma":[0.9807999,0.005758373,0.0010114922,0.0015610951,0.0015227206,0.0028272716,0.0011035155,0.000033847657,0.005381702],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99936455,0.0003043644,0.00004653046,0.00012899723,0.000034023975,0.0001213936],"domain_scores_gemma":[0.9992532,0.00029315168,0.0001463128,0.000068037356,0.00004298857,0.00019630716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013825821,0.0022395104,0.0048729703,0.0003430685,0.00060930464,0.0012226613,0.0009270408,0.0028394244,0.008373315],"category_scores_gemma":[0.0018954048,0.0007245078,0.0024422747,0.00036093654,0.0012656117,0.0017022727,0.0004808128,0.0040446147,0.001232064],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99448204,0.0008775908,0.00011985209,0.00036771258,0.00055436196,0.000026821412,0.000017290455,0.00006519949,0.00057898794,0.00006135671,0.0002598799,0.0025888954],"study_design_scores_gemma":[0.9806043,0.01692491,0.001092824,0.000040781793,0.0006486254,0.00001466657,0.000014438813,0.000109694636,0.000116191026,0.00012202208,0.00029791007,0.000013489101],"about_ca_topic_score_codex":0.0012843057,"about_ca_topic_score_gemma":0.0021680552,"teacher_disagreement_score":0.008373315,"about_ca_system_score_codex":0.0006339351,"about_ca_system_score_gemma":0.0007855978,"threshold_uncertainty_score":0.02801156},"labels":[],"label_agreement":null},{"id":"W2093774639","doi":"10.1016/s1474-4422(14)70095-x","title":"Are statins to be STASHed in subarachnoid haemorrhage?","year":2014,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Simvastatin; Subarachnoid hemorrhage; Modified Rankin Scale; Subarachnoid haemorrhage; Neurology; Neurovascular bundle; Randomized controlled trial; Statin; Clinical trial; Aneurysm; Ischemia; Anesthesia; Surgery; Internal medicine; Ischemic stroke","score_opus":0.052902818737815244,"score_gpt":0.2939375126166353,"score_spread":0.24103469387882007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093774639","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008259141,0.009751109,0.0000545612,0.9739768,0.013095094,0.000006164598,0.000058278336,0.000014236314,0.0022177608],"genre_scores_gemma":[0.010711694,0.0077883205,0.00020847039,0.8812659,0.09745022,0.000023059893,0.000053959076,0.000019554744,0.002478807],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969529,0.0007933458,0.0006980814,0.0002366637,0.00082123035,0.00049779227],"domain_scores_gemma":[0.9902845,0.0048129726,0.0012984216,0.00031527402,0.0012601464,0.0020285964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034270447,0.0006489887,0.0030788118,0.0011962474,0.0028402102,0.003253156,0.0016116665,0.050031975,0.0063467235],"category_scores_gemma":[0.03631764,0.0008124939,0.001983993,0.0011353911,0.0028056763,0.0048092436,0.0014066517,0.044929553,0.004770282],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010259696,0.00019488308,0.008213975,0.0005997366,0.0003970579,0.008756744,0.00029251343,0.00015880067,0.00050289655,0.0060262363,0.9072212,0.06660999],"study_design_scores_gemma":[0.0030292824,0.00067711144,0.016245605,0.0040044077,0.000990193,0.013564376,0.001594357,0.0009382718,0.0006590822,0.04936351,0.90861374,0.00031996594],"about_ca_topic_score_codex":0.008294877,"about_ca_topic_score_gemma":0.015692208,"teacher_disagreement_score":0.050031975,"about_ca_system_score_codex":0.0040208814,"about_ca_system_score_gemma":0.0053120716,"threshold_uncertainty_score":0.029173672},"labels":[],"label_agreement":null},{"id":"W2094293045","doi":"10.1016/s1474-4422(08)70124-8","title":"EPITHET—where next? – Authors' reply","year":2008,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Penumbra; Epithet; Clinical trial; Thrombolysis; Stroke (engine); Placebo; Internal medicine; Alternative medicine; Pathology; Myocardial infarction; Ischemia; History","score_opus":0.045589593384481576,"score_gpt":0.27860096486159003,"score_spread":0.23301137147710846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094293045","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000096636984,0.0009734602,0.000040303923,0.9364102,0.062026616,0.0000046125,0.000027402288,0.000012196206,0.00040860256],"genre_scores_gemma":[0.0009549183,0.0003919257,0.000056249773,0.9550788,0.041571874,0.000014927907,0.00001280246,0.000015507387,0.0019030304],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99283546,0.0020563619,0.0011489084,0.001243474,0.0016775664,0.0010382844],"domain_scores_gemma":[0.96184236,0.024112375,0.002443649,0.0011180167,0.006872275,0.0036112762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0087144645,0.0011529926,0.002571153,0.0014693491,0.0049804593,0.0069859135,0.0043911003,0.095352285,0.012469009],"category_scores_gemma":[0.06206561,0.0017302361,0.0020875223,0.0012126243,0.0066568917,0.0074531683,0.0046705483,0.08760015,0.010117047],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003450027,0.0000076060733,0.00017831677,0.000046000867,0.00002080461,0.00029734612,0.00017666101,0.000019533778,0.000051979518,0.0009335964,0.99672616,0.0015073894],"study_design_scores_gemma":[0.00019178772,0.00004842512,0.00097036775,0.0004890832,0.000093026574,0.0009549114,0.001881281,0.00020271761,0.0002133186,0.0060226,0.9887832,0.00014936998],"about_ca_topic_score_codex":0.0048870104,"about_ca_topic_score_gemma":0.0069626975,"teacher_disagreement_score":0.095352285,"about_ca_system_score_codex":0.0040916335,"about_ca_system_score_gemma":0.0050155595,"threshold_uncertainty_score":0.046087086},"labels":[],"label_agreement":null},{"id":"W2094509101","doi":"10.1016/s1474-4422(11)70231-9","title":"Stroke on awakening and the tissue window for thrombolysis","year":2011,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Thrombolysis; Stroke (engine); Window (computing); Cardiology; Medicine; Physical medicine and rehabilitation; Internal medicine; Computer science; Myocardial infarction; Engineering; World Wide Web","score_opus":0.037530318699334556,"score_gpt":0.27608180302999763,"score_spread":0.2385514843306631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094509101","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010446033,0.002474797,0.00008770474,0.97376853,0.01491546,0.000009512377,0.000039092687,0.000016445965,0.007643816],"genre_scores_gemma":[0.015118381,0.005020457,0.00029330936,0.8271078,0.14229268,0.000033557313,0.00005524999,0.000030332008,0.010048252],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998185,0.00056833075,0.00021913632,0.00018838883,0.0004849892,0.00035413302],"domain_scores_gemma":[0.99602294,0.0022365963,0.00032629623,0.00012341348,0.0005244325,0.0007663039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015640678,0.00083622657,0.001545868,0.0007550631,0.0028999131,0.0035267735,0.0012990017,0.04754644,0.0063430886],"category_scores_gemma":[0.01727639,0.0006935113,0.0012612477,0.00072659657,0.0027387035,0.0040190713,0.0010037629,0.04080208,0.00450277],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018391077,0.00009079194,0.001690063,0.00010405794,0.000037554677,0.008571548,0.00016407654,0.00013210741,0.00025199045,0.00463038,0.96823925,0.015904255],"study_design_scores_gemma":[0.00072159217,0.00027993042,0.006192605,0.001365036,0.00020345126,0.021009617,0.001481866,0.0017541221,0.0005666586,0.048536256,0.91770226,0.0001866073],"about_ca_topic_score_codex":0.0062969094,"about_ca_topic_score_gemma":0.016872916,"teacher_disagreement_score":0.04754644,"about_ca_system_score_codex":0.0043732044,"about_ca_system_score_gemma":0.003747811,"threshold_uncertainty_score":0.031729996},"labels":[],"label_agreement":null},{"id":"W2094701432","doi":"10.1016/s1474-4422(10)70240-4","title":"Addition of brain and carotid imaging to the ABCD2 score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational study","year":2010,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":295,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"National Institute of Neurological Disorders and Stroke; Canadian Institutes of Health Research; U.S. Public Health Service","keywords":"Medicine; Logistic regression; Internal medicine; Stroke (engine); Population; Ischaemic stroke; Cardiology; Dyslipidemia; Ischemia","score_opus":0.03078137869999676,"score_gpt":0.301428065150259,"score_spread":0.27064668645026224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094701432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99874336,0.00042487125,0.00012095135,0.000083113424,0.00003404417,0.000032870976,0.00035563446,0.0000047418084,0.00020041427],"genre_scores_gemma":[0.99833304,0.00020153976,0.00022815743,0.000121944286,0.0001051775,0.000051890023,0.0007920585,0.000007719872,0.00015854937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99649423,0.0015239556,0.00036652217,0.000816264,0.00037702848,0.0004219874],"domain_scores_gemma":[0.989248,0.0037068413,0.0027662872,0.00196119,0.001015308,0.0013022821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040977607,0.0019172272,0.0029744739,0.00084788806,0.001082341,0.0026120897,0.0017524952,0.0034366813,0.0015425297],"category_scores_gemma":[0.012673508,0.002412695,0.0040503447,0.002296691,0.0012552512,0.0025512523,0.0013751502,0.003907118,0.00054501684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023046067,0.0010237399,0.9689255,0.0000976955,0.003204134,0.0003784704,0.00031605532,0.00019974598,0.00085074914,0.000045570618,0.00039672738,0.0015156238],"study_design_scores_gemma":[0.001948478,0.0022731957,0.9923194,0.000024589419,0.00165525,0.00035544232,0.00020594517,0.00078286324,0.00011532684,0.00010237846,0.00016726849,0.0000498336],"about_ca_topic_score_codex":0.010595433,"about_ca_topic_score_gemma":0.009304525,"teacher_disagreement_score":0.010595433,"about_ca_system_score_codex":0.0011194407,"about_ca_system_score_gemma":0.0012066661,"threshold_uncertainty_score":0.021671295},"labels":[],"label_agreement":null},{"id":"W2094745518","doi":"10.1016/s1474-4422(13)70047-4","title":"Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities","year":2013,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Toronto Western Hospital; Montreal General Hospital; University of Toronto","funders":"UCB Pharma; Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; H. Lundbeck A/S; Janssen Pharmaceuticals; Eberhard Karls Universität Tübingen; Robert Bosch Stiftung; GlaxoSmithKline; Parkinson Society Canada; European Parkinson’s Disease Association; UCB; European Commission; Meso Scale Diagnostics; Helmholtz Association; Edwin S. Webster Foundation; Novartis; Bundesministerium für Bildung und Forschung; Teva Pharmaceutical Industries; Michael J. Fox Foundation for Parkinson's Research; Boehringer Ingelheim; Medtronic","keywords":"Parkinson's disease; Disease; Medicine; Computer science; Management science; Psychology; Data science; Engineering; Pathology","score_opus":0.19553185397725578,"score_gpt":0.37066502445331717,"score_spread":0.1751331704760614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094745518","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014557935,0.116038285,0.0050500515,0.85751384,0.017319355,0.0001148599,0.00013941963,0.00008009915,0.0022882794],"genre_scores_gemma":[0.063152514,0.18629964,0.080644704,0.56158066,0.104164675,0.00084217003,0.0011376757,0.00032447482,0.0018534864],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.81087625,0.07793617,0.050520007,0.011583141,0.04258562,0.006498892],"domain_scores_gemma":[0.28195956,0.43247783,0.029029286,0.021117361,0.20528749,0.030128542],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.40736917,0.0026064594,0.012985566,0.008642748,0.005825113,0.01615191,0.020626232,0.028425103,0.005299803],"category_scores_gemma":[0.41939116,0.0020653186,0.004376027,0.005544327,0.025962569,0.029388767,0.012727698,0.042886857,0.0030513462],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010874026,0.0011360556,0.012382931,0.009652707,0.0006375622,0.0008166626,0.0034713442,0.0009410205,0.0017463681,0.10378007,0.3209764,0.5433715],"study_design_scores_gemma":[0.0011356778,0.0012149721,0.019479273,0.035598904,0.0007974763,0.0039835656,0.012942331,0.004257088,0.0010013016,0.34355062,0.57495946,0.0010793966],"about_ca_topic_score_codex":0.02671116,"about_ca_topic_score_gemma":0.03379614,"teacher_disagreement_score":0.59263086,"about_ca_system_score_codex":0.016766645,"about_ca_system_score_gemma":0.04786257,"threshold_uncertainty_score":0.73081934},"labels":[],"label_agreement":null},{"id":"W2096479500","doi":"10.1016/s1474-4422(14)70191-7","title":"Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial","year":2014,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":298,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Teriflunomide; Placebo; Multiple sclerosis; Double blind; Medicine; Clinical trial; Physical therapy; Internal medicine; Alternative medicine; Psychiatry; Fingolimod; Pathology","score_opus":0.14263836272772237,"score_gpt":0.377089253445585,"score_spread":0.23445089071786265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096479500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9647915,0.020386733,0.0009724171,0.0016518389,0.0017300824,0.0058686803,0.0015911848,0.0002167824,0.0027907698],"genre_scores_gemma":[0.97208756,0.009574475,0.0017888438,0.002246153,0.0011607399,0.007522509,0.0013656656,0.000036660924,0.0042173215],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995103,0.00021421265,0.000037670627,0.000092645205,0.00003828513,0.000107005806],"domain_scores_gemma":[0.99921846,0.0002594579,0.00016702412,0.000055941484,0.000053738968,0.00024544212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015397063,0.0019963204,0.0048707607,0.0005598467,0.00066743436,0.0011814096,0.00090519595,0.0033460748,0.006861747],"category_scores_gemma":[0.0019243117,0.000814839,0.002967636,0.00057190383,0.0011690486,0.0012901023,0.00042443888,0.0031764898,0.0013006936],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9863392,0.0018391546,0.00028481145,0.000977797,0.0008007229,0.00005115044,0.0000502366,0.000102582584,0.0017154656,0.000066198765,0.0005800041,0.00719262],"study_design_scores_gemma":[0.98248094,0.015993644,0.00071211986,0.000030334066,0.00027667102,0.000021672742,0.00001281645,0.00006551983,0.00007373579,0.000059114103,0.00026533913,0.000008092382],"about_ca_topic_score_codex":0.0013891939,"about_ca_topic_score_gemma":0.0026442131,"teacher_disagreement_score":0.006861747,"about_ca_system_score_codex":0.00065229414,"about_ca_system_score_gemma":0.00090677396,"threshold_uncertainty_score":0.022954822},"labels":[],"label_agreement":null},{"id":"W2097034088","doi":"10.1016/s1474-4422(15)70038-4","title":"Sulfonylureas—a novel treatment to reduce tissue damage after acute spinal cord injury? – Authors' reply","year":2015,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Collaboration On Repair Discoveries; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Spinal cord injury; Spinal cord; Physical medicine and rehabilitation; Psychiatry","score_opus":0.1050948146386015,"score_gpt":0.4239398597848487,"score_spread":0.31884504514624723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097034088","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019569926,0.002297404,0.00004142327,0.97230184,0.024425426,0.0000045082725,0.000037192684,0.000012112791,0.00068437535],"genre_scores_gemma":[0.002363054,0.0014810647,0.000079634505,0.94292766,0.05060841,0.00002258763,0.00002183507,0.000011006233,0.002484738],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997063,0.0009573149,0.000412515,0.0003789138,0.0007781794,0.00041009014],"domain_scores_gemma":[0.990569,0.0058894753,0.0009083562,0.0002505741,0.0013105476,0.0010720848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032896148,0.0008333514,0.0022407894,0.00082139444,0.0025101558,0.0037668755,0.0018612205,0.064602494,0.005753833],"category_scores_gemma":[0.02736438,0.00084514474,0.0014525031,0.00066383305,0.0034655388,0.004463063,0.0023328685,0.045659877,0.004720235],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112057016,0.000031436142,0.0004198447,0.00009364813,0.000037508493,0.0010428122,0.00012832301,0.00006414006,0.000114198614,0.0019909234,0.98893857,0.0070267287],"study_design_scores_gemma":[0.00043151042,0.00017014264,0.0011553039,0.00055168394,0.000097504744,0.002006414,0.000603549,0.00040387566,0.00028576364,0.010878242,0.98327166,0.00014442229],"about_ca_topic_score_codex":0.0027834359,"about_ca_topic_score_gemma":0.0038661484,"teacher_disagreement_score":0.064602494,"about_ca_system_score_codex":0.0027351636,"about_ca_system_score_gemma":0.002957907,"threshold_uncertainty_score":0.019845128},"labels":[],"label_agreement":null},{"id":"W2097693778","doi":"10.1016/s1474-4422(08)70165-0","title":"NMDA receptors in clinical neurology: excitatory times ahead","year":2008,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":412,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Medicine; Neurology; Amyotrophic lateral sclerosis; Neuroscience; Neurodegeneration; NMDA receptor; Clinical trial; Epilepsy; Schizophrenia (object-oriented programming); Memantine; Stroke (engine); Neuropathic pain; Psychiatry; Receptor; Psychology; Pharmacology; Internal medicine; Disease","score_opus":0.26816718604340684,"score_gpt":0.47284160464603936,"score_spread":0.20467441860263252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097693778","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018636068,0.99558926,0.00007919531,0.0025341802,0.0012752281,0.0000011849924,0.000005074979,0.000004999764,0.000492226],"genre_scores_gemma":[0.0003688341,0.9930791,0.00021622331,0.0027946734,0.002884047,0.0000045422153,0.00001215314,0.000002437764,0.00063805166],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99952805,0.00013003942,0.000068235895,0.000065408756,0.00015973597,0.00004840883],"domain_scores_gemma":[0.9973695,0.0015438369,0.0001849118,0.00006550715,0.0006358766,0.0002003844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024542734,0.0016491824,0.003035833,0.001574966,0.00049595843,0.0018576611,0.001755231,0.004535044,0.003953058],"category_scores_gemma":[0.0029543808,0.00043183236,0.0006012128,0.0023900808,0.0016723132,0.004891548,0.0011474595,0.006342157,0.0037617683],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017265171,0.000059671955,0.00017818205,0.009587875,0.00008510303,0.00031540962,0.00007790495,0.00033172782,0.0007479548,0.012087658,0.2659671,0.71038884],"study_design_scores_gemma":[0.00005127968,0.00005530154,0.00041048517,0.0042332723,0.000065546315,0.0007730767,0.00011432047,0.00008333228,0.00007895348,0.0078075975,0.98630536,0.00002158464],"about_ca_topic_score_codex":0.0017377498,"about_ca_topic_score_gemma":0.0053979815,"teacher_disagreement_score":0.004535044,"about_ca_system_score_codex":0.0014868502,"about_ca_system_score_gemma":0.0023078015,"threshold_uncertainty_score":0.013224363},"labels":[],"label_agreement":null},{"id":"W2098778388","doi":"10.1016/s1474-4422(10)70243-x","title":"Treatment of small vessel primary CNS vasculitis in children: an open-label cohort study","year":2010,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Azathioprine; Cohort; Pediatrics; Maintenance therapy; Regimen; Cyclophosphamide; Surgery; Internal medicine; Disease; Chemotherapy","score_opus":0.029790226226991706,"score_gpt":0.2934814562194283,"score_spread":0.26369122999243655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098778388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997537,0.0010129999,0.00011797001,0.00008290323,0.000039554216,0.0001450901,0.00084479066,0.0000051119905,0.00021452499],"genre_scores_gemma":[0.99615896,0.0011874789,0.00026055926,0.00018856004,0.00009023634,0.0002977744,0.0014754558,0.00000847592,0.0003324918],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975279,0.0010359425,0.0001889375,0.0004586886,0.00027580472,0.0005128126],"domain_scores_gemma":[0.99352705,0.0019988795,0.0021961457,0.0008703101,0.0003881242,0.0010194917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022811606,0.0014744118,0.0031254785,0.00057011517,0.001139046,0.0015291534,0.001139236,0.0018450588,0.0024931985],"category_scores_gemma":[0.0049572866,0.0010868536,0.0035190114,0.0013416096,0.0016185512,0.0017299248,0.0006875589,0.0026412834,0.00048573792],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29799554,0.012126072,0.6568062,0.00090404286,0.010056601,0.0012802817,0.0010438538,0.00078854576,0.003131554,0.00025501975,0.0020737192,0.013538663],"study_design_scores_gemma":[0.08029018,0.05767014,0.8498948,0.00023712884,0.0059268787,0.0012314683,0.0011559079,0.0008322462,0.00059361896,0.00022721596,0.001758201,0.00018224002],"about_ca_topic_score_codex":0.010305591,"about_ca_topic_score_gemma":0.010216709,"teacher_disagreement_score":0.010305591,"about_ca_system_score_codex":0.0022663018,"about_ca_system_score_gemma":0.0022130958,"threshold_uncertainty_score":0.020491183},"labels":[],"label_agreement":null},{"id":"W2098900970","doi":"10.1016/s1474-4422(10)70250-7","title":"Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies","year":2010,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Renin-Angiotensin System Studies","field":"Medicine","cited_by":211,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute","funders":"","keywords":"Medicine; Ramipril; Telmisartan; Internal medicine; Dementia; Placebo; Cardiology; Cognitive decline; Odds ratio; Blood pressure; Diabetes mellitus; Disease; Endocrinology; Pathology","score_opus":0.03705181982819089,"score_gpt":0.2662082510387253,"score_spread":0.22915643121053442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098900970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898037,0.008574801,0.00016950643,0.00006890871,0.000037556558,0.000015238332,0.0008881778,0.000007859387,0.00043432563],"genre_scores_gemma":[0.9971138,0.0013864065,0.00014995538,0.000065549524,0.000063249616,0.000014090893,0.001044569,0.000006323583,0.00015610896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980605,0.0010794178,0.00020638284,0.00028238987,0.00022025814,0.00015099336],"domain_scores_gemma":[0.992562,0.0042555206,0.0014201468,0.001038238,0.00034956954,0.0003746523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004165445,0.0012883653,0.002542164,0.0008062169,0.00030090797,0.0011287717,0.00063941354,0.00068536005,0.00097035913],"category_scores_gemma":[0.00445203,0.000466536,0.0035698982,0.0014643742,0.0005184762,0.00077042315,0.00082544197,0.0013694116,0.0001051294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22467835,0.00076090975,0.6424428,0.0020197588,0.09995494,0.0008931781,0.00039227548,0.0011557303,0.0042860075,0.0003504114,0.0013156146,0.021750044],"study_design_scores_gemma":[0.007387033,0.0057499367,0.9360404,0.00012642227,0.047078565,0.00050019956,0.0002662465,0.0005481094,0.00071347196,0.0002950941,0.0012239158,0.00007067785],"about_ca_topic_score_codex":0.002567731,"about_ca_topic_score_gemma":0.005247168,"teacher_disagreement_score":0.004165445,"about_ca_system_score_codex":0.00027237058,"about_ca_system_score_gemma":0.0003092631,"threshold_uncertainty_score":0.022029221},"labels":[],"label_agreement":null},{"id":"W2100830657","doi":"10.1016/s1474-4422(09)70043-2","title":"Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis","year":2009,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":616,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; University of Calgary","funders":"","keywords":"Multiple sclerosis; AMPA receptor; Neuroscience; Neuroprotection; Glutamate receptor; Ionotropic effect; Medicine; Biology; Receptor; Internal medicine; Immunology","score_opus":0.18727851789675085,"score_gpt":0.36036164906498097,"score_spread":0.17308313116823013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100830657","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000050393064,0.9997899,0.00001063504,0.000039051083,0.00003486477,0.0000018453401,0.0000060358834,7.8921994e-7,0.00006662544],"genre_scores_gemma":[0.00060344936,0.99918514,0.00004271324,0.00006285916,0.000042031144,0.0000026152582,0.000008435067,2.5794643e-7,0.00005247283],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996271,0.00008786781,0.00009808581,0.00005339963,0.00011307074,0.000020386544],"domain_scores_gemma":[0.9986946,0.00089060346,0.00024642347,0.000018264995,0.000118492295,0.000031615233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012629277,0.00087411236,0.0034928867,0.002886387,0.00020858813,0.001070671,0.0010684849,0.0012953059,0.0029979283],"category_scores_gemma":[0.0022841569,0.0003678409,0.0009822522,0.0037485214,0.0006356509,0.0011431767,0.00072402734,0.0008791743,0.00060806173],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033886833,0.000057077235,0.00039423016,0.18922962,0.0014457616,0.00029988433,0.00008967316,0.00025168966,0.0006892092,0.0012475492,0.014945017,0.7910114],"study_design_scores_gemma":[0.0007270461,0.0005921241,0.010958288,0.15443712,0.012388944,0.0049156016,0.00064008584,0.00020064184,0.0010125934,0.0056013917,0.8083813,0.00014480055],"about_ca_topic_score_codex":0.0033667616,"about_ca_topic_score_gemma":0.006506584,"teacher_disagreement_score":0.0034928867,"about_ca_system_score_codex":0.00067089184,"about_ca_system_score_gemma":0.0014416628,"threshold_uncertainty_score":0.0100290775},"labels":[],"label_agreement":null},{"id":"W2101232950","doi":"10.1016/s1474-4422(12)70064-9","title":"Sham neurosurgical procedures in clinical trials for neurodegenerative diseases: scientific and ethical considerations","year":2012,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Pain Management and Placebo Effect","field":"Neuroscience","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"National Institutes of Health; Wellcome Trust","keywords":"Clinical trial; Medicine; Intensive care medicine; Engineering ethics; Psychology; Pathology; Engineering","score_opus":0.32331714409539436,"score_gpt":0.45818066825380704,"score_spread":0.13486352415841268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101232950","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0421804,0.13491815,0.1598302,0.51429087,0.06383521,0.022287952,0.0012229896,0.00062965276,0.060804583],"genre_scores_gemma":[0.40941384,0.017536398,0.26405776,0.20101236,0.047992017,0.047984168,0.00030536775,0.00028495849,0.011413167],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.5177339,0.41130117,0.029781763,0.00868635,0.030387731,0.002109144],"domain_scores_gemma":[0.2926501,0.606629,0.023337264,0.05423564,0.019242523,0.0039055177],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.51923674,0.0016478945,0.0075822882,0.0024789046,0.003579852,0.0084165465,0.0052368343,0.03283864,0.005905865],"category_scores_gemma":[0.5163652,0.0020488054,0.0037923995,0.0027980236,0.02787831,0.0069544637,0.0038242494,0.019976983,0.0019720758],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04538117,0.0019654224,0.004573223,0.015262276,0.003925183,0.0020087087,0.009356559,0.0020642376,0.007880971,0.53140813,0.094258286,0.28191584],"study_design_scores_gemma":[0.034677103,0.0071663675,0.012229463,0.023792388,0.0027940443,0.0042850957,0.002735607,0.012003909,0.005983577,0.6084507,0.2853687,0.0005129085],"about_ca_topic_score_codex":0.00066260906,"about_ca_topic_score_gemma":0.0019032655,"teacher_disagreement_score":0.48076326,"about_ca_system_score_codex":0.0032010223,"about_ca_system_score_gemma":0.008021022,"threshold_uncertainty_score":0.5928667},"labels":[],"label_agreement":null},{"id":"W2102182787","doi":"10.1016/s1474-4422(11)70108-9","title":"Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)","year":2011,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Intracranial Aneurysms: Treatment and Complications","field":"Medicine","cited_by":638,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Actelion Pharmaceuticals","keywords":"Endothelin receptor antagonist; Medicine; Glasgow Outcome Scale; Subarachnoid hemorrhage; Placebo; Endovascular coiling; Clinical endpoint; Vasospasm; Anesthesia; Randomized controlled trial; Internal medicine; Aneurysm; Antagonist; Surgery; Endovascular treatment","score_opus":0.0542099779558352,"score_gpt":0.29810048771351166,"score_spread":0.24389050975767645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102182787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832118,0.008572094,0.0006687219,0.0010467401,0.0011961143,0.001755393,0.001154701,0.00018456152,0.0022098878],"genre_scores_gemma":[0.9799004,0.007213235,0.0014809894,0.002102553,0.0011633636,0.002831937,0.0014865207,0.00003693095,0.0037839927],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995726,0.00017857105,0.000033904398,0.00007980115,0.000037620375,0.00009745957],"domain_scores_gemma":[0.99942195,0.0001651953,0.00010551005,0.00004839723,0.000041609364,0.00021732622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010165282,0.0017507608,0.004192305,0.00044841008,0.00045788492,0.0010794917,0.00081923587,0.0019802444,0.005657507],"category_scores_gemma":[0.0016201447,0.0007639821,0.0019653048,0.0005303457,0.0011276051,0.0011426149,0.00033951292,0.0033316824,0.0009183887],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9867719,0.0015875708,0.00029329766,0.00071064226,0.00077127246,0.000038534785,0.000035960587,0.00011308862,0.002181845,0.000058483583,0.0005399681,0.006897454],"study_design_scores_gemma":[0.98398906,0.014129377,0.0010612707,0.00001619052,0.00029957935,0.000017629955,0.000012571248,0.00010109622,0.00013481971,0.00004561721,0.00018247632,0.000010331718],"about_ca_topic_score_codex":0.0016183147,"about_ca_topic_score_gemma":0.0033772495,"teacher_disagreement_score":0.005657507,"about_ca_system_score_codex":0.00055245834,"about_ca_system_score_gemma":0.0010400049,"threshold_uncertainty_score":0.018926203},"labels":[],"label_agreement":null},{"id":"W2102491127","doi":"10.1016/s1474-4422(04)00740-9","title":"Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough","year":2004,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":340,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital","funders":"National Institutes of Health","keywords":"Dopaminergic; Parkinson's disease; Levodopa; Dopamine; Medicine; Disease; Neuroscience; Deep brain stimulation; Adverse effect; Neurodegeneration; Psychology; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.11057767373493171,"score_gpt":0.3266734137085842,"score_spread":0.2160957399736525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102491127","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047132587,0.99751544,0.0000795758,0.0013694649,0.00034711175,0.0000015835412,0.000005455472,0.000006161249,0.0006281481],"genre_scores_gemma":[0.00045663465,0.9973724,0.00019238918,0.0009596736,0.00037911834,0.0000038158687,0.000011637793,0.000001498277,0.00062282395],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997174,0.000061242994,0.000031456537,0.000038401642,0.00012471605,0.000026859081],"domain_scores_gemma":[0.99926513,0.0003964043,0.00007927333,0.000022171214,0.0001669811,0.000070066904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013350078,0.0011234157,0.0030323046,0.0016764547,0.0004703294,0.0016098858,0.0013468202,0.002879357,0.0034998565],"category_scores_gemma":[0.0010755925,0.0003252894,0.000636718,0.00204673,0.0011831608,0.002694952,0.0007922212,0.0035705958,0.0026359316],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014650013,0.00009279093,0.00013849483,0.009963244,0.00014840369,0.0003419146,0.00008481988,0.00038894042,0.0015033751,0.0069060847,0.09732353,0.8829619],"study_design_scores_gemma":[0.0000401797,0.000079612655,0.0003736074,0.0026791757,0.00008019935,0.000791697,0.000110203575,0.000058737805,0.00014928513,0.003914889,0.9917042,0.000018216126],"about_ca_topic_score_codex":0.0024963643,"about_ca_topic_score_gemma":0.007367454,"teacher_disagreement_score":0.0034998565,"about_ca_system_score_codex":0.001060263,"about_ca_system_score_gemma":0.0018770152,"threshold_uncertainty_score":0.0117082},"labels":[],"label_agreement":null},{"id":"W2102496376","doi":"10.1016/s1474-4422(07)70106-0","title":"Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study","year":2007,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":296,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"National Institute of Mental Health; National Institutes of Health","keywords":"Entorhinal cortex; Allele; Apolipoprotein E; Genotype; Cerebral cortex; Internal medicine; Biology; Neuroscience; Pathology; Psychology; Genetics; Disease; Medicine; Hippocampus; Gene","score_opus":0.059048335468524595,"score_gpt":0.33682650351554816,"score_spread":0.27777816804702354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102496376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99938726,0.00012416832,0.000032166525,0.000019083607,0.0000032274118,0.00000829917,0.00027233598,0.0000024995604,0.00015090252],"genre_scores_gemma":[0.99908257,0.00016985566,0.000056753186,0.000038213642,0.000008341322,0.000019158102,0.00049949286,0.0000048713746,0.00012074575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989115,0.0002488775,0.00013842096,0.00032584427,0.0001842153,0.00019118568],"domain_scores_gemma":[0.9971444,0.00052794744,0.0012342556,0.00031951914,0.0003309255,0.00044293754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008553548,0.001346992,0.0017982131,0.0016887633,0.0013093275,0.001738415,0.0010394359,0.001599079,0.0017195017],"category_scores_gemma":[0.0037130273,0.0013888844,0.0015343634,0.003634541,0.0012783051,0.001482486,0.0009812186,0.001922232,0.00047429965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002924864,0.00014296989,0.9976407,0.000016544269,0.00018779689,0.0005427795,0.0002934875,0.000023998191,0.00026573014,0.000021800939,0.00008648759,0.0004852472],"study_design_scores_gemma":[0.00003588774,0.00017504347,0.9980063,0.000007057044,0.00010333181,0.0010346202,0.0004408008,0.00003739729,0.00004725635,0.000024979245,0.00007884623,0.000008494344],"about_ca_topic_score_codex":0.017725453,"about_ca_topic_score_gemma":0.01620948,"teacher_disagreement_score":0.017725453,"about_ca_system_score_codex":0.00087616866,"about_ca_system_score_gemma":0.0008576792,"threshold_uncertainty_score":0.035244584},"labels":[],"label_agreement":null},{"id":"W2104818454","doi":"10.1016/s1474-4422(14)70251-0","title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","year":2015,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":3882,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Merck Sharp and Dohme; U.S. Food and Drug Administration; National Institutes of Health; Innovative Medicines Initiative; Medtronic; Bayer Schering; Advanced Scientific Computing Research; Eisai; Bundesministerium für Bildung und Forschung; National Centre for the Replacement Refinement and Reduction of Animals in Research; National Institute of Neurological Disorders and Stroke; National Centre for the Replacement, Refinement and Reduction of Animals in Research; National Institute of Academic Anaesthesia; Boehringer Ingelheim; Novartis; Biogen Idec; AbbVie; Deutsche Forschungsgemeinschaft; Merck; Dunhill Medical Trust; Wellcome Trust; Sanofi Pasteur; Astellas Pharma US; Westminster Medical School Research Trust; Pfizer; International Fibrodysplasia Ossificans Progressiva Association; Allergan; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Pharmacotherapy; Neuropathic pain; Medicine; Meta-analysis; Anesthesia; Psychiatry; Internal medicine","score_opus":0.17169158448866484,"score_gpt":0.4132279130049627,"score_spread":0.24153632851629786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104818454","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022078296,0.9968742,0.00023784646,0.000084535684,0.00009973923,0.00016348786,0.00019370297,0.000014795181,0.00012374028],"genre_scores_gemma":[0.077119626,0.9189888,0.0018790461,0.0008686707,0.0001790233,0.00041352634,0.00028579342,0.000017910772,0.00024754315],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9948881,0.0018787086,0.0017655265,0.00058820995,0.0006336615,0.00024583918],"domain_scores_gemma":[0.99190724,0.0052403375,0.0019652192,0.0002686078,0.00047808504,0.00014049992],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0072329105,0.0028927138,0.02024421,0.0048919567,0.0005563065,0.002711712,0.0020807795,0.002526006,0.0051297504],"category_scores_gemma":[0.018662976,0.0016551442,0.028507337,0.0058786017,0.00071675784,0.0021627871,0.0019643838,0.0022180248,0.00034276367],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023550144,0.000057767527,0.001791175,0.4779755,0.4973912,0.00012305337,0.000087542874,0.00030593257,0.00022193893,0.00009740255,0.0006540085,0.018939534],"study_design_scores_gemma":[0.0013709877,0.00024922256,0.002689864,0.029340424,0.9641065,0.000109288405,0.000056139583,0.00011269996,0.00007162764,0.00014337769,0.0017196038,0.000030191057],"about_ca_topic_score_codex":0.0069562877,"about_ca_topic_score_gemma":0.024875069,"teacher_disagreement_score":0.9927671,"about_ca_system_score_codex":0.0022134485,"about_ca_system_score_gemma":0.0029392918,"threshold_uncertainty_score":0.038251698},"labels":[],"label_agreement":null},{"id":"W2105053272","doi":"10.1016/s1474-4422(09)70021-3","title":"Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study","year":2009,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":473,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"IC Design Education Center; Ministerstvo Školství, Mládeže a Tělovýchovy; Biogen","keywords":"Natalizumab; Multiple sclerosis; Medicine; Placebo; Internal medicine; Radiological weapon; Post-hoc analysis; Clinical trial; Disease; Gastroenterology; Surgery; Pathology; Immunology","score_opus":0.09742600106346866,"score_gpt":0.3579958020875762,"score_spread":0.26056980102410754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105053272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963881,0.0027743084,0.0000981984,0.000035430232,0.000017594353,0.000017018216,0.00043062738,0.0000037687794,0.00023508722],"genre_scores_gemma":[0.9988691,0.000362405,0.000068666115,0.00003387117,0.000024974583,0.00001251338,0.0005354865,0.0000033444758,0.00008958603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968166,0.0016490057,0.00043881466,0.00051901233,0.00040115693,0.00017548175],"domain_scores_gemma":[0.9937378,0.0016574675,0.0028264131,0.0009223669,0.00043641386,0.00041946862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041939192,0.0006501123,0.0015341268,0.00052924687,0.00038816102,0.0009665029,0.0006061508,0.00076012244,0.00062114914],"category_scores_gemma":[0.0050472263,0.0005955356,0.0019829858,0.0010100978,0.0006549225,0.0008105862,0.00048762307,0.0008307224,0.00020472679],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07808153,0.0002610839,0.9029095,0.00026211797,0.009224508,0.00025375857,0.00015891151,0.00032959826,0.002485108,0.000110307556,0.0003442732,0.0055793594],"study_design_scores_gemma":[0.0021495624,0.0031819062,0.98851925,0.000028646264,0.004096758,0.00037248124,0.00009366825,0.00036608952,0.00050505495,0.00007323722,0.0005808669,0.00003258304],"about_ca_topic_score_codex":0.0013924722,"about_ca_topic_score_gemma":0.0015226238,"teacher_disagreement_score":0.0041939192,"about_ca_system_score_codex":0.0005297609,"about_ca_system_score_gemma":0.00042588782,"threshold_uncertainty_score":0.022179842},"labels":[],"label_agreement":null},{"id":"W2105089616","doi":"10.1016/s1474-4422(11)70121-1","title":"Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases","year":2011,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":302,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Fondazione Cassa di Risparmio di Genova e Imperia; Ministero della Salute; Ministero dell’Istruzione, dell’Università e della Ricerca; Fondazione Italiana Sclerosi Multipla","keywords":"Experimental autoimmune encephalomyelitis; Mesenchymal stem cell; Multiple sclerosis; Medicine; Immune system; Neuroprotection; Progenitor cell; Immunology; Encephalomyelitis; Stem cell; Pathology; Biology; Pharmacology","score_opus":0.3421804346162982,"score_gpt":0.374036884940287,"score_spread":0.03185645032398876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105089616","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000040985204,0.9987519,0.00008965149,0.00030373313,0.00033882944,0.0000029246412,0.00001102819,0.000004740262,0.00045611465],"genre_scores_gemma":[0.00036038525,0.9983551,0.00018059864,0.00028892845,0.00028963553,0.0000044587046,0.000020756914,0.0000013009197,0.000498812],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974173,0.00004439551,0.000033223634,0.00003364079,0.00012498353,0.000021945787],"domain_scores_gemma":[0.9993767,0.0003574353,0.000062071515,0.000015309239,0.0001381787,0.000050327966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011211273,0.0011317407,0.0021498739,0.0022857469,0.00032287423,0.0010727916,0.0011918134,0.0016480302,0.0036679823],"category_scores_gemma":[0.0010425796,0.0002896926,0.0005791169,0.002348414,0.00078956306,0.001472139,0.00087118306,0.0029386603,0.0022304475],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014196399,0.00007609728,0.00007129275,0.011514421,0.00012483292,0.00016631275,0.000036021996,0.00033326514,0.0017699276,0.004207629,0.05695126,0.9246069],"study_design_scores_gemma":[0.00008297113,0.00010653683,0.0004213778,0.0030421515,0.00015904853,0.00076293654,0.000044183962,0.000094196475,0.00041612796,0.002341423,0.9925081,0.000020968862],"about_ca_topic_score_codex":0.0019165446,"about_ca_topic_score_gemma":0.00481612,"teacher_disagreement_score":0.0036679823,"about_ca_system_score_codex":0.0007074667,"about_ca_system_score_gemma":0.0011129625,"threshold_uncertainty_score":0.012270629},"labels":[],"label_agreement":null},{"id":"W2105213416","doi":"10.1016/s1474-4422(14)70103-6","title":"Pain assessment in elderly adults with dementia","year":2014,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":312,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Northern British Columbia; University of Regina","funders":"","keywords":"Dementia; Observational study; Context (archaeology); Pain assessment; Neuroimaging; Medicine; Population; Psychiatry; Psychology; Physical medicine and rehabilitation; Clinical psychology; Physical therapy; Pain management; Disease","score_opus":0.031670922220938556,"score_gpt":0.3257785895571063,"score_spread":0.2941076673361678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105213416","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017923916,0.9993647,0.000025160094,0.00011091704,0.000073930656,0.0000069502275,0.000016401678,0.0000017296624,0.00022094615],"genre_scores_gemma":[0.003735931,0.9952342,0.00020569852,0.0004606438,0.00015568471,0.000020905432,0.000028303395,7.9377014e-7,0.00015788864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992568,0.00021413012,0.00022099205,0.00007794072,0.00018260199,0.000047564852],"domain_scores_gemma":[0.9980983,0.00121499,0.00039716656,0.000017891125,0.00022566163,0.000045901455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013028235,0.0009729689,0.0031535896,0.0026733468,0.00026629376,0.0010970702,0.0006979057,0.0010761705,0.0029357192],"category_scores_gemma":[0.004922749,0.00034362875,0.0017255092,0.002249379,0.00036254965,0.0008580675,0.0008537951,0.0012317766,0.00031261522],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004289899,0.0000745947,0.0012765593,0.13769533,0.0018753653,0.00017857208,0.00009367727,0.0001646323,0.00027100806,0.00030930073,0.011366109,0.84626585],"study_design_scores_gemma":[0.0023546738,0.0015350705,0.0464724,0.44562936,0.027870642,0.0066224635,0.0011488367,0.0006697655,0.0007610623,0.0025833894,0.46412715,0.00022516072],"about_ca_topic_score_codex":0.005394467,"about_ca_topic_score_gemma":0.017684493,"teacher_disagreement_score":0.005394467,"about_ca_system_score_codex":0.0009549942,"about_ca_system_score_gemma":0.0018037269,"threshold_uncertainty_score":0.010726094},"labels":[],"label_agreement":null},{"id":"W2106654138","doi":"10.1016/s1474-4422(11)70262-9","title":"Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial","year":2011,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":214,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Merck KGaA","keywords":"Interferon beta-1a; Medicine; Multiple sclerosis; Placebo; Clinical endpoint; Dosing; Interferon beta-1b; Internal medicine; Clinical trial; Phases of clinical research; Neurology; Subcutaneous injection; Gastroenterology; Interferon beta; Immunology; Pathology","score_opus":0.20573489367515593,"score_gpt":0.4105453321222841,"score_spread":0.20481043844712818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106654138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98086584,0.008112906,0.0014217126,0.00092532014,0.0017407113,0.0042791488,0.00072608155,0.00019291094,0.0017353948],"genre_scores_gemma":[0.98415357,0.0031265907,0.0019986208,0.001119064,0.0010083782,0.005336801,0.0006687011,0.000048203397,0.0025401495],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965984,0.0018213036,0.00033689605,0.000587598,0.00022676597,0.00042899532],"domain_scores_gemma":[0.995477,0.0022745254,0.0008731146,0.00039686952,0.00022131878,0.00075727154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004578919,0.0036845293,0.008614851,0.0010504789,0.0009258192,0.0025342265,0.0025787274,0.005439747,0.010006784],"category_scores_gemma":[0.0061521437,0.001987674,0.0060449,0.0010625416,0.0029182215,0.0031386765,0.0009744231,0.006097267,0.001766771],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99514365,0.001567622,0.00008489659,0.00020121248,0.0004582733,0.000012016291,0.00002673309,0.00006865995,0.00033158858,0.000029975923,0.0000641,0.0020113178],"study_design_scores_gemma":[0.9747478,0.024425356,0.00027011457,0.000017323251,0.00025074818,0.000006622015,0.000010572931,0.00009924203,0.000046299734,0.000059004888,0.00005728475,0.000009708136],"about_ca_topic_score_codex":0.002391285,"about_ca_topic_score_gemma":0.0024295938,"teacher_disagreement_score":0.010006784,"about_ca_system_score_codex":0.0018091885,"about_ca_system_score_gemma":0.0019207451,"threshold_uncertainty_score":0.033476055},"labels":[],"label_agreement":null},{"id":"W2106786486","doi":"10.1016/s1474-4422(14)70324-2","title":"Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis","year":2015,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":544,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Université Laval; Toronto Western Hospital; University Health Network; University of Toronto; Hôpital de l'Enfant-Jésus; Baycrest Hospital; Occupational Cancer Research Centre; Health Sciences Centre; Mount Sinai Hospital; Sunnybrook Health Science Centre","funders":"Medical Research Council; Ministero della Salute; Engineering and Physical Sciences Research Council; Canadian Institutes of Health Research; National Institute for Health and Care Research; University College London; Brain Research Trust; Swedish Brain Power; Wellcome Trust","keywords":"C9orf72; Frontotemporal dementia; Dementia; Neuropsychology; Medicine; Neuroimaging; Psychology; Psychiatry; Oncology; Clinical psychology; Cognition; Disease; Internal medicine","score_opus":0.1045529669607354,"score_gpt":0.3641213004163914,"score_spread":0.259568333455656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106786486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988656,0.00018613822,0.000041074203,0.000020083191,0.000005394138,0.000024297095,0.0005514413,0.000002366912,0.0003036788],"genre_scores_gemma":[0.9985672,0.0000861727,0.00012740771,0.000045768506,0.000012089663,0.000037993614,0.0009343273,0.000003000397,0.0001858861],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993338,0.0001813303,0.00006865012,0.00020936197,0.000097283744,0.00010957941],"domain_scores_gemma":[0.99855,0.00024073668,0.00051544496,0.0001476217,0.00023425909,0.0003119809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001763098,0.00047857477,0.00041736334,0.001210133,0.00079481106,0.00075526384,0.00068235624,0.0010591304,0.0015059314],"category_scores_gemma":[0.0022883485,0.0006019048,0.0006436755,0.001246898,0.00036260995,0.0005326795,0.0006542587,0.0006420561,0.00032644573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018729817,0.000058176407,0.9988294,0.000007752225,0.00010208097,0.00012788751,0.00013196674,0.000013615612,0.000107271,0.000007919536,0.00008749854,0.00033912048],"study_design_scores_gemma":[0.000013540223,0.00007799488,0.9994211,0.000004151846,0.00005061767,0.00019429123,0.00011408859,0.000035605386,0.000012703061,0.000006245225,0.00006731541,0.0000023492964],"about_ca_topic_score_codex":0.018849358,"about_ca_topic_score_gemma":0.029741889,"teacher_disagreement_score":0.018849358,"about_ca_system_score_codex":0.0005922867,"about_ca_system_score_gemma":0.00040425654,"threshold_uncertainty_score":0.03747934},"labels":[],"label_agreement":null},{"id":"W2106931873","doi":"10.1016/s1474-4422(07)70178-3","title":"Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria","year":2007,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":4384,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Douglas Mental Health University Institute; University of British Columbia; Vancouver Coastal Health","funders":"Cilag","keywords":"Psychology; Disease; Gerontology; Medicine; Linguistics; History; Philosophy; Pathology","score_opus":0.3535341884481704,"score_gpt":0.5392693002928292,"score_spread":0.18573511184465874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106931873","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026514006,0.9922909,0.0011350086,0.0024760412,0.0014033916,0.00030651517,0.0006551574,0.000031904874,0.001435944],"genre_scores_gemma":[0.0031488992,0.9812821,0.0081113335,0.002834001,0.00080049544,0.0005855187,0.00239856,0.000013202331,0.00082585745],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952242,0.0012075412,0.0015997726,0.00025924252,0.0015133087,0.00019602496],"domain_scores_gemma":[0.9927625,0.0029528842,0.0014216398,0.00015744007,0.0024558394,0.00024968135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010417772,0.002679665,0.009179654,0.009225604,0.00064284937,0.0013593833,0.0050937175,0.0020466712,0.002750506],"category_scores_gemma":[0.009391956,0.0006505651,0.0045808973,0.0061342246,0.0011397586,0.0015238421,0.0012900112,0.003888187,0.0014626147],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039500167,0.0001621501,0.0021439178,0.071099915,0.0017675315,0.00040469214,0.00014112236,0.0005413061,0.0007605699,0.0052710655,0.1747406,0.7425721],"study_design_scores_gemma":[0.0009775031,0.00029794,0.019796096,0.08597059,0.0063637164,0.0037640184,0.00039369753,0.0009230777,0.0007807618,0.011459717,0.86901945,0.00025354297],"about_ca_topic_score_codex":0.022430433,"about_ca_topic_score_gemma":0.029706484,"teacher_disagreement_score":0.022430433,"about_ca_system_score_codex":0.0036467265,"about_ca_system_score_gemma":0.011056179,"threshold_uncertainty_score":0.055095136},"labels":[],"label_agreement":null},{"id":"W2107571592","doi":"10.1016/s1474-4422(03)00533-7","title":"The treatment of Alzheimer's disease: success short of cure","year":2003,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Dalhousie University","funders":"","keywords":"Metaphor; Disease; Point (geometry); Path (computing); Medicine; Psychology; Cognitive psychology; Psychotherapist; Intensive care medicine; Computer science; Pathology; Philosophy","score_opus":0.103231729179475,"score_gpt":0.41816185193307226,"score_spread":0.3149301227535973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107571592","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000032013693,0.99875844,0.000034993842,0.000545942,0.00031282761,0.0000025103461,0.0000072251614,0.000003969254,0.00030201505],"genre_scores_gemma":[0.0003526475,0.99838984,0.00011724234,0.00061435724,0.0003014154,0.0000044125477,0.000007765547,0.000001093509,0.00021125872],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992648,0.00020083162,0.0001061467,0.00009561802,0.00028255756,0.00005002471],"domain_scores_gemma":[0.99753296,0.0016925073,0.00025033407,0.000049789454,0.0003283341,0.00014611901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002347995,0.0015841903,0.0055437675,0.0025641543,0.0005380487,0.0018533724,0.0016148168,0.0032044079,0.0043790466],"category_scores_gemma":[0.0035125846,0.00040080873,0.0010752999,0.0036596064,0.0015123752,0.002822017,0.0010101113,0.0045427443,0.0020154286],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003626761,0.00007296144,0.00016507067,0.048815686,0.00050450675,0.00022357758,0.00011341288,0.00034450795,0.00072435406,0.008381162,0.085967265,0.85432476],"study_design_scores_gemma":[0.00018952458,0.0001741818,0.00093258003,0.019360242,0.0005860831,0.0007689979,0.00017264277,0.0000880788,0.00010969971,0.0050453492,0.9725441,0.000028543614],"about_ca_topic_score_codex":0.003697498,"about_ca_topic_score_gemma":0.009113878,"teacher_disagreement_score":0.0055437675,"about_ca_system_score_codex":0.0014058502,"about_ca_system_score_gemma":0.0028050789,"threshold_uncertainty_score":0.014649332},"labels":[],"label_agreement":null},{"id":"W2107715463","doi":"10.1016/s1474-4422(12)70159-x","title":"Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomised controlled trial","year":2012,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Cerebrovascular and Carotid Artery Diseases","field":"Medicine","cited_by":402,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Medicine; Amaurosis fugax; Restenosis; Cardiology; Endarterectomy; Clinical endpoint; Internal medicine; Stroke (engine); Carotid endarterectomy; Stenosis; Myocardial infarction; Carotid stenting; Stent; Asymptomatic; Surgery; Randomized controlled trial","score_opus":0.016601459344027448,"score_gpt":0.2570381747151309,"score_spread":0.24043671537110345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107715463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9239308,0.034398,0.003283912,0.0016524803,0.0024552876,0.016991254,0.008989119,0.0003731985,0.007925999],"genre_scores_gemma":[0.9565075,0.0077388296,0.0032151008,0.00161552,0.0016484456,0.019743357,0.0056071077,0.000068048364,0.0038560776],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99285614,0.004556646,0.0006956227,0.00080648175,0.00060025015,0.00048491434],"domain_scores_gemma":[0.99329376,0.0023144456,0.001995253,0.0006737572,0.0009342451,0.0007885979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006537546,0.002662851,0.006692664,0.0009908194,0.00062862225,0.002245342,0.0010457913,0.002628968,0.008919077],"category_scores_gemma":[0.013420759,0.00075396505,0.0068783523,0.0012857408,0.001236004,0.0012302621,0.0009606805,0.0028495344,0.00085448235],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98045117,0.0004656709,0.0008504673,0.0040947534,0.008352599,0.00007698261,0.000048354228,0.00017711987,0.00047454736,0.00019380946,0.0010216617,0.0037928289],"study_design_scores_gemma":[0.97056836,0.0116759995,0.004108623,0.00025623597,0.011543702,0.000068054345,0.000029233348,0.0003438714,0.00012467406,0.0003045531,0.000948307,0.000028233457],"about_ca_topic_score_codex":0.0020751662,"about_ca_topic_score_gemma":0.0037097812,"teacher_disagreement_score":0.008919077,"about_ca_system_score_codex":0.0008571314,"about_ca_system_score_gemma":0.0022533166,"threshold_uncertainty_score":0.03457421},"labels":[],"label_agreement":null},{"id":"W2107831538","doi":"10.1016/s1474-4422(11)70195-8","title":"Collateral blood vessels in acute ischaemic stroke: a potential therapeutic target","year":2011,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":501,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Ischaemic stroke; Medicine; Stroke (engine); Collateral; Collateral circulation; Cardiology; Collateral damage; Acute stroke; Internal medicine; Ischemia; Tissue plasminogen activator; Psychology; Business","score_opus":0.04402276417070911,"score_gpt":0.3107969153267856,"score_spread":0.2667741511560765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107831538","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003237352,0.99934536,0.000034306428,0.00020675853,0.00013076449,0.0000017642257,0.000006666416,0.0000023261343,0.00023961798],"genre_scores_gemma":[0.00040903882,0.99889743,0.000067646026,0.00019065588,0.00023687826,0.0000034813138,0.000011083108,6.495963e-7,0.00018310138],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997558,0.000052058516,0.00003931071,0.00003988291,0.00008616212,0.000026759632],"domain_scores_gemma":[0.9994543,0.0003134312,0.000099888806,0.00001073745,0.00008596282,0.00003559404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008501804,0.001033945,0.0032343888,0.0020216,0.00027349003,0.0014881769,0.0009407139,0.0019894065,0.0047622686],"category_scores_gemma":[0.0010797766,0.00037352703,0.0006746652,0.002187012,0.00068137725,0.0016480349,0.0007839093,0.0025084228,0.0018740774],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021146976,0.00008575824,0.00018756384,0.030894484,0.00025411946,0.00033397734,0.000053004907,0.00035182413,0.0009776929,0.002657812,0.056954566,0.90703773],"study_design_scores_gemma":[0.0002637926,0.0002735423,0.0015446792,0.01603605,0.00085727253,0.001985082,0.00014247802,0.00020890213,0.00031221044,0.0034141256,0.9749156,0.000046215144],"about_ca_topic_score_codex":0.0014244927,"about_ca_topic_score_gemma":0.0033747726,"teacher_disagreement_score":0.0047622686,"about_ca_system_score_codex":0.0006439031,"about_ca_system_score_gemma":0.0012022234,"threshold_uncertainty_score":0.015931368},"labels":[],"label_agreement":null},{"id":"W2108191354","doi":"10.1016/s1474-4422(10)70195-2","title":"TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia","year":2010,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":973,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"National Institute on Aging; Canadian Institutes of Health Research; Stiftung Synapsis - Alzheimer Forschung Schweiz AFS; Bundesministerium für Bildung und Forschung; National Institutes of Health; ALS Association","keywords":"Amyotrophic lateral sclerosis; Frontotemporal lobar degeneration; Frontotemporal dementia; Neurodegeneration; C9orf72; Ubiquitin; Biomarker; Neuroscience; Biology; TARDBP; Dementia; Medicine; Pathology; Genetics; Disease; Gene","score_opus":0.10899890664241928,"score_gpt":0.3477609651691984,"score_spread":0.23876205852677912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108191354","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000057684156,0.9993094,0.00001971438,0.00013053563,0.00012785796,0.0000021563103,0.00001210188,0.0000026175746,0.00033791256],"genre_scores_gemma":[0.0008711361,0.998038,0.00009841589,0.0002604892,0.00016246275,0.000006798848,0.000029346733,7.5573234e-7,0.0005326057],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976593,0.000038093243,0.000049142353,0.000029106553,0.00009451448,0.000023259918],"domain_scores_gemma":[0.99961627,0.00018681985,0.00009647019,0.000007922132,0.000064724365,0.0000277942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087232766,0.0012011811,0.0027899807,0.0032884798,0.00027847558,0.0010387473,0.0009534686,0.0017064194,0.0048684888],"category_scores_gemma":[0.0011146219,0.00037244894,0.000704166,0.0035479257,0.0004961118,0.0013109802,0.0008416356,0.0011790763,0.0013473551],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026115423,0.000053566182,0.00021174605,0.030751456,0.00042041394,0.00049704575,0.00005676676,0.00029957248,0.0008246344,0.0016073427,0.052579418,0.9124369],"study_design_scores_gemma":[0.00019552368,0.00015824585,0.0018517505,0.014239771,0.001524453,0.0028360072,0.00015635257,0.00012833424,0.00029728765,0.002577169,0.976,0.00003506807],"about_ca_topic_score_codex":0.004202944,"about_ca_topic_score_gemma":0.010858625,"teacher_disagreement_score":0.0048684888,"about_ca_system_score_codex":0.0010212974,"about_ca_system_score_gemma":0.001998651,"threshold_uncertainty_score":0.016286671},"labels":[],"label_agreement":null},{"id":"W2108299953","doi":"10.1016/s1474-4422(14)70148-6","title":"Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial","year":2014,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":134,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Levodopa; Parkinson's disease; Placebo; Medicine; Clinical trial; Internal medicine; Randomized controlled trial; Physical therapy; Disease","score_opus":0.022445304079248492,"score_gpt":0.2731337439507725,"score_spread":0.250688439871524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108299953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749296,0.012705453,0.0010727063,0.0015708054,0.0015005379,0.0034266433,0.0015747442,0.00027355718,0.0029459894],"genre_scores_gemma":[0.9771428,0.007939675,0.001483797,0.0023609176,0.00067479385,0.0036345369,0.0016120995,0.000042568838,0.005108819],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99952877,0.0002158288,0.00003598021,0.00008735604,0.0000307834,0.00010130415],"domain_scores_gemma":[0.99948066,0.00014639355,0.000104144834,0.00003147591,0.00003605212,0.00020122973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012774951,0.0026129722,0.0040405346,0.0005987358,0.00047016426,0.0014363069,0.0010637343,0.0028070281,0.0074673267],"category_scores_gemma":[0.0014390793,0.0008405961,0.0026631763,0.0005444994,0.0012280535,0.0015017714,0.00045481574,0.003137437,0.0013480869],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.982872,0.0015509864,0.00039992208,0.0009877783,0.001260187,0.000056963294,0.000052509236,0.00023992463,0.0017964531,0.00015506528,0.0008963303,0.009732024],"study_design_scores_gemma":[0.98322994,0.015081503,0.00061723654,0.000030843603,0.00031559757,0.000024086603,0.000019753874,0.00014067054,0.000087821005,0.000105291874,0.00033663143,0.000010538575],"about_ca_topic_score_codex":0.0018480143,"about_ca_topic_score_gemma":0.00381699,"teacher_disagreement_score":0.0074673267,"about_ca_system_score_codex":0.0008531071,"about_ca_system_score_gemma":0.0009230096,"threshold_uncertainty_score":0.024980724},"labels":[],"label_agreement":null},{"id":"W2109448373","doi":"10.1016/s1474-4422(10)70135-6","title":"Emerging effects of comorbidities on multiple sclerosis","year":2010,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Manitoba Health; Manitoba Beekeepers' Association","funders":"","keywords":"Comorbidity; Medicine; Quality of life (healthcare); Affect (linguistics); Multiple sclerosis; Disease; Obesity; Socioeconomic status; Population; Psychiatry; Gerontology; Psychology; Environmental health; Internal medicine","score_opus":0.17495959689562401,"score_gpt":0.3794406598067833,"score_spread":0.2044810629111593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109448373","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007063548,0.9996917,0.000010587205,0.00008860865,0.00004877184,0.0000015067319,0.000015536929,8.0332904e-7,0.00007178047],"genre_scores_gemma":[0.00077945227,0.9989429,0.00004788429,0.00013414645,0.000054557324,0.0000024505966,0.000013500692,3.395812e-7,0.000024783216],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989567,0.00032605234,0.00024908656,0.00011312429,0.00030131717,0.000053720945],"domain_scores_gemma":[0.99374044,0.0049304413,0.0007720794,0.000062670704,0.0003927093,0.00010169568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028504815,0.0010832482,0.004040681,0.0035616152,0.0002606413,0.0015188052,0.0009725508,0.0014312385,0.003717669],"category_scores_gemma":[0.0072937096,0.00038037574,0.0020672677,0.005907559,0.00050297467,0.0012221042,0.0010719437,0.0012813502,0.00035450258],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005608173,0.00004363582,0.0014121876,0.2607716,0.0058502723,0.00026960144,0.00011297986,0.00030145535,0.00040278523,0.0013005756,0.014890412,0.71408373],"study_design_scores_gemma":[0.0007909194,0.00050666725,0.030240998,0.34902537,0.05068921,0.0025319038,0.0006976082,0.0002809962,0.00066277356,0.0055864253,0.558864,0.00012317486],"about_ca_topic_score_codex":0.0058942754,"about_ca_topic_score_gemma":0.016391642,"teacher_disagreement_score":0.0058942754,"about_ca_system_score_codex":0.001014712,"about_ca_system_score_gemma":0.0025447262,"threshold_uncertainty_score":0.015075028},"labels":[],"label_agreement":null},{"id":"W2109574134","doi":"10.1016/s1474-4422(06)70581-6","title":"Sex ratio of multiple sclerosis in Canada: a longitudinal study","year":2006,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Demographic Trends and Gender Preferences","field":"Social Sciences","cited_by":932,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"Medical Research Council; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada","keywords":"Multiple sclerosis; Incidence (geometry); Sex ratio; Demography; Longitudinal study; Population; Medicine; Disease; Immunology; Internal medicine; Pathology","score_opus":0.11499177823155599,"score_gpt":0.28746835087401673,"score_spread":0.17247657264246075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109574134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900181,0.0015737806,0.000104732404,0.0007017036,0.000034458844,0.00003754958,0.0060885814,0.000020433408,0.0014205412],"genre_scores_gemma":[0.99611783,0.00072713307,0.00013959009,0.00018940253,0.0000128567535,0.000019838777,0.001601142,0.000010573479,0.0011816849],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998524,0.000140023,0.00010103923,0.000221536,0.00043241485,0.00058096345],"domain_scores_gemma":[0.9943509,0.00022023679,0.00092040846,0.00024257072,0.00301578,0.0012499827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009915819,0.00048582803,0.00077694084,0.002628582,0.0038718344,0.0017264861,0.0023045924,0.0014397914,0.0023044432],"category_scores_gemma":[0.004294671,0.00065860135,0.0010421472,0.006984362,0.00097551075,0.0010250517,0.0010669114,0.0018599675,0.00040328348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013546889,0.000055470693,0.9959174,0.000014875302,0.00007596442,0.0000785544,0.0005475173,0.00006054275,0.00010001288,0.000083802515,0.00080256147,0.0021278565],"study_design_scores_gemma":[0.000006580199,0.000025410129,0.99841595,0.000013164837,0.000028557579,0.000079772995,0.00074053975,0.00016281003,0.000026384783,0.000025070707,0.00046229674,0.000013454764],"about_ca_topic_score_codex":0.9901299,"about_ca_topic_score_gemma":0.9896638,"teacher_disagreement_score":0.02263863,"about_ca_system_score_codex":0.02263863,"about_ca_system_score_gemma":0.028485436,"threshold_uncertainty_score":0.16425556},"labels":[],"label_agreement":null},{"id":"W2109891655","doi":"10.1016/s1474-4422(08)70090-5","title":"Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial","year":2008,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":295,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Institute for Health and Care Research","keywords":"Medicine; Clinical Dementia Rating; Placebo; Internal medicine; Dementia; Rating scale; Clinical endpoint; Activities of daily living; Clinical trial; Alzheimer's disease; Disease; Physical therapy; Psychology; Pathology","score_opus":0.07448811469319558,"score_gpt":0.3552938017609166,"score_spread":0.280805687067721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109891655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97602737,0.01100511,0.00080621446,0.001661745,0.0011259622,0.0038981244,0.0020250762,0.00016406631,0.0032863417],"genre_scores_gemma":[0.98171544,0.0046532247,0.0010693796,0.001937588,0.0007995569,0.0036736114,0.0017845794,0.00003118393,0.0043355003],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989423,0.0005278833,0.00007267244,0.00018613691,0.00008187248,0.0001891464],"domain_scores_gemma":[0.9987841,0.0004396456,0.00023110476,0.00012222369,0.00007782158,0.00034507093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026909346,0.0027957521,0.004978229,0.00060031435,0.0006417649,0.0013497351,0.0014478265,0.0035279286,0.008067278],"category_scores_gemma":[0.002561208,0.0008823793,0.0028680123,0.0004983805,0.0018459493,0.0020138302,0.0005197716,0.0034763834,0.0014544174],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98918706,0.0021339017,0.00028253553,0.0003949799,0.0006140739,0.00003643081,0.00003563236,0.00010295887,0.0009915609,0.00008385638,0.0005478131,0.005589077],"study_design_scores_gemma":[0.975609,0.022596892,0.0007330242,0.00001946764,0.00035452144,0.000021577092,0.000013950655,0.000107293636,0.0001282553,0.00012109362,0.00028284395,0.000012061616],"about_ca_topic_score_codex":0.0015490118,"about_ca_topic_score_gemma":0.0023604196,"teacher_disagreement_score":0.008067278,"about_ca_system_score_codex":0.0011564582,"about_ca_system_score_gemma":0.0011582258,"threshold_uncertainty_score":0.026987731},"labels":[],"label_agreement":null},{"id":"W2110222797","doi":"10.1016/s1474-4422(12)70017-0","title":"Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial","year":2012,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; University of Toronto; McMaster University; Population Health Research Institute","funders":"Javna Agencija za Raziskovalno Dejavnost RS; Pfizer; Bristol-Myers Squibb","keywords":"Atrial fibrillation; Apixaban; Medicine; Aspirin; Stroke (engine); Cardiology; Subgroup analysis; Internal medicine; Randomized controlled trial; Anesthesia; Warfarin; Rivaroxaban; Meta-analysis","score_opus":0.0618546420996147,"score_gpt":0.3109023196980213,"score_spread":0.2490476775984066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110222797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9065696,0.0712601,0.0036433914,0.002764932,0.0039535915,0.0033147936,0.004097088,0.00029934983,0.004097104],"genre_scores_gemma":[0.97768676,0.009915759,0.0018334204,0.0018122123,0.0015038706,0.002872023,0.0019678697,0.00006298528,0.0023452016],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9966898,0.0017113712,0.00058074633,0.0004852095,0.00021079744,0.0003220414],"domain_scores_gemma":[0.9975938,0.0011801444,0.00047525537,0.00034972222,0.00013469587,0.0002662859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046329913,0.0039318125,0.010729447,0.0007918687,0.0005610545,0.0024680956,0.0013255443,0.0025689136,0.00666553],"category_scores_gemma":[0.008089391,0.001218368,0.013206767,0.00080102833,0.00087905786,0.0019781224,0.0013905016,0.0047647166,0.00078339584],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95234704,0.0002694028,0.0015076408,0.0033367276,0.034247283,0.00010723138,0.000075664444,0.000397207,0.0008914048,0.00018293875,0.00070333143,0.0059340936],"study_design_scores_gemma":[0.9456467,0.0062328596,0.004301362,0.00025296918,0.040838093,0.00007997657,0.00010211273,0.00071015605,0.00019518456,0.0008453281,0.00073161133,0.000063724154],"about_ca_topic_score_codex":0.0015346812,"about_ca_topic_score_gemma":0.0036210848,"teacher_disagreement_score":0.010729447,"about_ca_system_score_codex":0.00091029715,"about_ca_system_score_gemma":0.0010662281,"threshold_uncertainty_score":0.02450192},"labels":[],"label_agreement":null},{"id":"W2110304206","doi":"10.1016/s1474-4422(06)70409-4","title":"Pneumococcal meningitis in adults: new approaches to management and prevention","year":2006,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Meningitis; Medicine; Vaccination; Intensive care medicine; Streptococcus pneumoniae; Antibiotics; Haemophilus influenzae; Pediatrics; Dexamethasone; Incidence (geometry); Disease; Immunology; Internal medicine; Biology; Microbiology","score_opus":0.17594824841377635,"score_gpt":0.33936359285769685,"score_spread":0.1634153444439205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110304206","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023782357,0.998679,0.000051486717,0.00057399477,0.00039487268,0.0000028505574,0.000009563669,0.000004953689,0.0002594799],"genre_scores_gemma":[0.00021891585,0.9987425,0.00010713939,0.0003761768,0.00039933235,0.000004346857,0.000011438015,7.2749066e-7,0.00013930633],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99920684,0.00015495716,0.00014911836,0.000096028816,0.0003343524,0.000058699672],"domain_scores_gemma":[0.9982311,0.0009165149,0.0002871511,0.000035457502,0.00040348622,0.00012627705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019579588,0.0018672798,0.0049736015,0.003100727,0.00036744802,0.0017206772,0.0016822922,0.0027383205,0.0044607394],"category_scores_gemma":[0.0034762116,0.00047305707,0.0010318378,0.0038288787,0.0009836311,0.0024255419,0.0010666598,0.0030517217,0.0019068124],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014983404,0.00007555123,0.00024396078,0.029408762,0.0002556153,0.00019861147,0.000063565814,0.00043732734,0.00032834866,0.0022006205,0.08218595,0.8844519],"study_design_scores_gemma":[0.00016610004,0.00021604524,0.0019499549,0.023388516,0.0007261029,0.0013470313,0.00018607113,0.00020527527,0.00013770045,0.002864229,0.96876824,0.000044642682],"about_ca_topic_score_codex":0.0050132377,"about_ca_topic_score_gemma":0.011096972,"teacher_disagreement_score":0.0050132377,"about_ca_system_score_codex":0.0017181861,"about_ca_system_score_gemma":0.003355642,"threshold_uncertainty_score":0.0149226785},"labels":[],"label_agreement":null},{"id":"W2112185768","doi":"10.1016/s1474-4422(05)70075-2","title":"Anthropological contributions to the understanding of age-related cognitive impairment","year":2005,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Aging and Gerontology Research","field":"Psychology","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Eisai; National Institute on Aging; Pfizer","keywords":"Biomedicine; Sociocultural evolution; Cognition; Meaning (existential); Criticism; Perspective (graphical); Cognitive impairment; Sociology; Identification (biology); Dementia; Psychology; Epistemology; Anthropology; Medicine; Disease; Psychotherapist; Political science; Psychiatry","score_opus":0.24845993333742883,"score_gpt":0.5016234955343909,"score_spread":0.25316356219696207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112185768","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006674582,0.99860436,0.00008332596,0.0006602272,0.00018969487,0.0000015125626,0.0000058288374,0.0000014271762,0.00038690554],"genre_scores_gemma":[0.00048083905,0.9987587,0.00011000381,0.00024448227,0.00030030284,0.000002512912,0.0000061998976,5.119767e-7,0.00009644923],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99950004,0.0001419977,0.00006768542,0.00009858008,0.00016237816,0.000029346285],"domain_scores_gemma":[0.9971601,0.0021024577,0.0001869286,0.00006933114,0.0004092455,0.00007188056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025726918,0.0015066147,0.0032527975,0.0045153834,0.00051178696,0.0018147789,0.001790316,0.0025094443,0.0030264477],"category_scores_gemma":[0.0042027347,0.0004579312,0.0008528457,0.0050160233,0.0036473053,0.002777395,0.0018399215,0.003476494,0.0008379986],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010009769,0.00010679586,0.0012350145,0.02261343,0.0003744562,0.0003314772,0.00036779678,0.00047849165,0.0005229964,0.013141134,0.018001664,0.94272655],"study_design_scores_gemma":[0.00005614953,0.00015424556,0.012661948,0.019371731,0.0005518817,0.0026321574,0.00097387546,0.00019570693,0.00033676066,0.03690302,0.9260611,0.000101327125],"about_ca_topic_score_codex":0.006038045,"about_ca_topic_score_gemma":0.009596423,"teacher_disagreement_score":0.006038045,"about_ca_system_score_codex":0.0017527379,"about_ca_system_score_gemma":0.0027814987,"threshold_uncertainty_score":0.013605833},"labels":[],"label_agreement":null},{"id":"W2113154361","doi":"10.1016/s1474-4422(10)70143-5","title":"Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment","year":2010,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":1793,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bundesministerium für Bildung und Forschung; Dairy Farmers of Nova Scotia","keywords":"Neuropathic pain; Medicine; Postherpetic neuralgia; Neuralgia; Trigeminal neuralgia; Pathophysiology; Somatosensory system; Neuroscience; Anesthesia; Physical medicine and rehabilitation; Psychology; Pathology","score_opus":0.07790560977728415,"score_gpt":0.3275212017813624,"score_spread":0.24961559200407824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113154361","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000030304529,0.99911505,0.00005763318,0.00024740386,0.00016499567,0.0000039117,0.000007857964,0.0000030918784,0.00036971818],"genre_scores_gemma":[0.00021807135,0.99909127,0.00011402983,0.00015929416,0.00019896585,0.0000043387486,0.000009804693,4.5433129e-7,0.00020382603],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999637,0.000066547,0.000049008628,0.00004767743,0.00016957868,0.000030159354],"domain_scores_gemma":[0.9993599,0.00031509547,0.00011366827,0.000015425916,0.00014507964,0.000050780116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009957606,0.0016261727,0.0032136845,0.002970603,0.0003465761,0.0012941147,0.0014999221,0.0016339374,0.0037278065],"category_scores_gemma":[0.0012773813,0.0004001235,0.0007415144,0.0029238975,0.00087519,0.0016181252,0.00089421176,0.002888996,0.0021693192],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013492613,0.00010109288,0.00012993465,0.018593585,0.00013686062,0.00016072414,0.000033215794,0.00037677612,0.0008336268,0.0022931974,0.039093107,0.938113],"study_design_scores_gemma":[0.00014221133,0.00016688634,0.0017289614,0.01548711,0.0004694919,0.002288866,0.00015871266,0.00025032475,0.00031869096,0.0057841637,0.9731529,0.00005165674],"about_ca_topic_score_codex":0.0032063443,"about_ca_topic_score_gemma":0.0075617447,"teacher_disagreement_score":0.0037278065,"about_ca_system_score_codex":0.0011401925,"about_ca_system_score_gemma":0.0021431055,"threshold_uncertainty_score":0.012470722},"labels":[],"label_agreement":null},{"id":"W2113661629","doi":"10.1016/s1474-4422(13)70088-7","title":"Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data","year":2013,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":839,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Academy of Medical Sciences; National Institute for Health and Care Research; CHDI Foundation","keywords":"Huntington's disease; Observational study; Medicine; Internal medicine; Disease; Longitudinal study; Pathology","score_opus":0.07709197160351793,"score_gpt":0.31954456733465064,"score_spread":0.2424525957311327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113661629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99835,0.00027989296,0.00005084039,0.000031628504,0.000007385232,0.0000051310108,0.0011546102,0.0000032626137,0.00011724326],"genre_scores_gemma":[0.9973621,0.00012754701,0.00005623842,0.000014009133,0.000013394675,0.000009520956,0.0023069638,0.000003896266,0.00010641899],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988312,0.00034682988,0.00016864062,0.0003502275,0.00012078285,0.00018241095],"domain_scores_gemma":[0.99592775,0.0008120257,0.0017017567,0.000541392,0.00034893764,0.00066814624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021002237,0.00052767526,0.0010296917,0.0010515022,0.00064576743,0.0011921534,0.00087283936,0.001258742,0.0010220483],"category_scores_gemma":[0.0040900954,0.0005449236,0.0015241433,0.0021323499,0.00042200251,0.0013739583,0.0011499599,0.001393061,0.00022053822],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060353,0.000027999939,0.99853873,0.0000059387194,0.00018104663,0.000058319107,0.000050852617,0.000046317025,0.00009885121,0.00001120218,0.00007880738,0.00029841144],"study_design_scores_gemma":[0.000020144917,0.00006790382,0.9994543,0.0000031633804,0.00006172909,0.00007679058,0.00009687088,0.0001307447,0.00001637739,0.000018423938,0.00004858109,0.0000048744146],"about_ca_topic_score_codex":0.015338952,"about_ca_topic_score_gemma":0.016788466,"teacher_disagreement_score":0.015338952,"about_ca_system_score_codex":0.0004601756,"about_ca_system_score_gemma":0.0005180965,"threshold_uncertainty_score":0.03049934},"labels":[],"label_agreement":null},{"id":"W2115138492","doi":"10.1016/s1474-4422(09)70150-4","title":"Motor recovery after stroke: a systematic review","year":2009,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Stroke Rehabilitation and Recovery","field":"Medicine","cited_by":2298,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Heart and Stroke Foundation of Canada","keywords":"Physical medicine and rehabilitation; Motor imagery; Psychological intervention; Motor learning; Functional movement; Biofeedback; Rehabilitation; Task (project management); Stroke (engine); Physical therapy; Balance (ability); Medicine; Psychology; Brain–computer interface; Neuroscience","score_opus":0.038995104271769616,"score_gpt":0.33386816392061475,"score_spread":0.29487305964884514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115138492","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007798239,0.99768364,0.00010508504,0.00026708102,0.0002011336,0.0003081642,0.00032332467,0.00000987732,0.0003218268],"genre_scores_gemma":[0.014462408,0.9834067,0.00053511775,0.00067585445,0.000107625434,0.0003837805,0.00016071816,0.000006046236,0.00026162923],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9957573,0.0013779793,0.0015433439,0.00034456069,0.0007230183,0.0002537169],"domain_scores_gemma":[0.99064726,0.005913958,0.0023855136,0.0001677675,0.00067824544,0.00020728042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00564566,0.0018044834,0.010683783,0.0077183,0.0005886553,0.0020168216,0.0016707162,0.0022449018,0.0073842565],"category_scores_gemma":[0.021589924,0.0013017582,0.006244696,0.008468206,0.0008479329,0.0022448301,0.0018982196,0.0015733863,0.0005082846],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044513063,0.000025168345,0.00043053136,0.9434878,0.016106889,0.00016842021,0.00013547046,0.00009387845,0.00012898356,0.00014969835,0.0033974028,0.03543057],"study_design_scores_gemma":[0.0020630597,0.0005067538,0.0064351265,0.74895656,0.2075425,0.00088653405,0.0004599322,0.000101882935,0.0002283553,0.00054002344,0.032212317,0.000066931956],"about_ca_topic_score_codex":0.010267522,"about_ca_topic_score_gemma":0.047066957,"teacher_disagreement_score":0.010683783,"about_ca_system_score_codex":0.0034035132,"about_ca_system_score_gemma":0.009271048,"threshold_uncertainty_score":0.029857457},"labels":[],"label_agreement":null},{"id":"W2115836576","doi":"10.1016/s1474-4422(08)70198-4","title":"Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study","year":2008,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":357,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Boehringer Ingelheim (Canada); Population Health Research Institute","funders":"National Institute of Neurological Disorders and Stroke; Boehringer Ingelheim","keywords":"Telmisartan; Medicine; Dipyridamole; Clopidogrel; Stroke (engine); Aspirin; Placebo; Regimen; Internal medicine; Modified Rankin Scale; Anesthesia; Ischemic stroke; Ischemia; Blood pressure","score_opus":0.028055784430528148,"score_gpt":0.29889982807892246,"score_spread":0.2708440436483943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115836576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99135065,0.004153033,0.0003668826,0.00044066616,0.0005489257,0.0008819511,0.0007282862,0.00010607184,0.001423549],"genre_scores_gemma":[0.9870591,0.0037798812,0.0012251897,0.000981815,0.001436337,0.0013402287,0.0009840223,0.000026214539,0.0031671263],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99936146,0.00030789655,0.000055098673,0.00012368328,0.00005087394,0.0001010195],"domain_scores_gemma":[0.9988863,0.00039226844,0.00020456854,0.00010367968,0.00005803747,0.00035523114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015529852,0.002394783,0.0058320095,0.00050513557,0.000511546,0.0013823687,0.0012146935,0.0022233592,0.004675982],"category_scores_gemma":[0.001988726,0.0010642264,0.0028559542,0.00043675012,0.0010629907,0.0015297367,0.00050576887,0.003315103,0.0008994923],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98840487,0.0030143175,0.0003110828,0.00037291367,0.0010673575,0.000027824357,0.00003104357,0.00014003292,0.0008535998,0.000044615732,0.00024122001,0.005491022],"study_design_scores_gemma":[0.9470377,0.048450835,0.002578048,0.000023021461,0.0010986613,0.00002284699,0.00001963731,0.00029652994,0.00019172802,0.000083910796,0.00017796556,0.000019075982],"about_ca_topic_score_codex":0.0012624749,"about_ca_topic_score_gemma":0.0022247445,"teacher_disagreement_score":0.0058320095,"about_ca_system_score_codex":0.0005128173,"about_ca_system_score_gemma":0.00072574266,"threshold_uncertainty_score":0.015642703},"labels":[],"label_agreement":null},{"id":"W2115989506","doi":"10.1016/s1474-4422(09)70226-1","title":"250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study","year":2009,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":403,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Glatiramer acetate; Multiple sclerosis; Relapsing remitting; Medicine; Interferon beta-1b; Internal medicine; Interferon beta; Immunology","score_opus":0.12544643758172822,"score_gpt":0.3452588528123868,"score_spread":0.21981241523065856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115989506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99054927,0.0049522594,0.0004254523,0.0003873052,0.0006924092,0.0015393784,0.00048165573,0.000074414034,0.00089784944],"genre_scores_gemma":[0.9904626,0.0028441246,0.0010038824,0.00065126154,0.00068536017,0.0017735461,0.0005075674,0.000028629043,0.0020429604],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973097,0.0015879022,0.00020155699,0.00038125316,0.00015755766,0.0003621057],"domain_scores_gemma":[0.9972459,0.0011922527,0.0005367128,0.00034367346,0.00012064119,0.0005607761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045073805,0.0033890975,0.0070046443,0.0009321465,0.00073621277,0.0016934526,0.0019216841,0.0036903485,0.006409409],"category_scores_gemma":[0.004280673,0.0018793377,0.0040671406,0.0011358708,0.0028004276,0.0023159303,0.00086950447,0.0039210576,0.0016192541],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9934801,0.0023599693,0.00020521815,0.00020903294,0.00044473688,0.00001558179,0.000025955404,0.000084019106,0.0006944536,0.000023925539,0.00008245338,0.0023745692],"study_design_scores_gemma":[0.9474189,0.05013124,0.0013291516,0.00002341524,0.00064083707,0.000015516178,0.00002088241,0.0001152633,0.00012584937,0.00007095974,0.000093924835,0.000014159272],"about_ca_topic_score_codex":0.0025733465,"about_ca_topic_score_gemma":0.00272262,"teacher_disagreement_score":0.0070046443,"about_ca_system_score_codex":0.0014276345,"about_ca_system_score_gemma":0.0014073565,"threshold_uncertainty_score":0.023837566},"labels":[],"label_agreement":null},{"id":"W2116427214","doi":"10.1016/s1474-4422(13)70310-7","title":"Embolic strokes of undetermined source: the case for a new clinical construct","year":2014,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Cerebrovascular and Carotid Artery Diseases","field":"Medicine","cited_by":1662,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McMaster University; Population Health Research Institute","funders":"Cilag; National Institutes of Health; H. Lundbeck A/S; European Commission; Novartis; Bundesministerium für Bildung und Forschung; Deutsche Forschungsgemeinschaft; GlaxoSmithKline; Bristol-Myers Squibb; AstraZeneca; Bayer; Boehringer Ingelheim","keywords":"Medicine; Thrombus; Embolic stroke; Ischaemic stroke; Cardiology; Embolism; Stroke (engine); Internal medicine; Paradoxical embolism; Stenosis; Radiology; Ischemia; Ischemic stroke; Patent foramen ovale","score_opus":0.043528069267954966,"score_gpt":0.32994949311018984,"score_spread":0.2864214238422349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116427214","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019802848,0.033760488,0.017397426,0.8942068,0.008746348,0.00006552552,0.0001769719,0.000087049775,0.025756506],"genre_scores_gemma":[0.66025805,0.04595776,0.028936537,0.1669966,0.09321169,0.00023263786,0.00039959478,0.00024214192,0.0037648862],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99313146,0.0021240988,0.0010248292,0.0014021334,0.001577348,0.0007401488],"domain_scores_gemma":[0.9519607,0.02761587,0.0048203096,0.0059956145,0.0057689515,0.0038385475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017705323,0.00097629457,0.002133113,0.0042427555,0.0043712696,0.009902668,0.004048689,0.019134818,0.0059017316],"category_scores_gemma":[0.06005426,0.001159439,0.0013039253,0.0025206245,0.04573016,0.04341115,0.007818533,0.029858999,0.00202168],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052067137,0.00019976372,0.03365127,0.0009061142,0.00017597305,0.017250538,0.004744804,0.0006485536,0.0011964523,0.7640653,0.06904859,0.10759203],"study_design_scores_gemma":[0.00017366256,0.00012809776,0.007894961,0.001990659,0.00010625725,0.04585536,0.0075878445,0.0021015226,0.00021082483,0.8410951,0.09259524,0.00026047518],"about_ca_topic_score_codex":0.0020085184,"about_ca_topic_score_gemma":0.0033433535,"teacher_disagreement_score":0.019134818,"about_ca_system_score_codex":0.00432053,"about_ca_system_score_gemma":0.004954211,"threshold_uncertainty_score":0.0936358},"labels":[],"label_agreement":null},{"id":"W2116453337","doi":"10.1016/s1474-4422(14)70319-9","title":"Orbital compartment syndrome after head trauma","year":2015,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Facial Trauma and Fracture Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Toronto","funders":"","keywords":"Compartment (ship); Head (geology); Medicine; Head trauma; Anatomy; Physical medicine and rehabilitation; Geology; Surgery; Paleontology; Oceanography","score_opus":0.0693883526812586,"score_gpt":0.3028909000004384,"score_spread":0.2335025473191798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116453337","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020594796,0.01424112,0.00043194188,0.88397574,0.035295274,0.000054689674,0.00014587141,0.000106870604,0.045153704],"genre_scores_gemma":[0.2992823,0.012304436,0.0009613745,0.50002027,0.16700464,0.00007513755,0.00019190193,0.000087104236,0.020072866],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99884844,0.00022343724,0.00016411343,0.000114932525,0.0002852061,0.0003639488],"domain_scores_gemma":[0.9958055,0.0019057322,0.00080869463,0.00017157503,0.00049510854,0.00081338576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009431469,0.0008621143,0.0012347884,0.0015525084,0.0043254886,0.003386325,0.0016688909,0.032934044,0.0063297944],"category_scores_gemma":[0.016704531,0.0008625186,0.0014594079,0.0014173479,0.0033338491,0.0027284045,0.0017842402,0.021987062,0.0028013438],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014582691,0.0000968646,0.009900039,0.00023850516,0.000097962955,0.6521349,0.00057745917,0.00030241912,0.00043164482,0.0041392106,0.31763682,0.014298361],"study_design_scores_gemma":[0.00054183154,0.0003144505,0.01829847,0.0026795557,0.00026178785,0.7701469,0.0036163277,0.0026090352,0.0007870731,0.020740934,0.17983148,0.00017219395],"about_ca_topic_score_codex":0.007705904,"about_ca_topic_score_gemma":0.013956551,"teacher_disagreement_score":0.032934044,"about_ca_system_score_codex":0.0053137727,"about_ca_system_score_gemma":0.003841509,"threshold_uncertainty_score":0.03855425},"labels":[],"label_agreement":null},{"id":"W2116709840","doi":"10.1016/s1474-4422(14)70090-0","title":"Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria","year":2014,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":3296,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; Douglas Mental Health University Institute; University of British Columbia; Vancouver Coastal Health","funders":"Economic and Social Research Council; National Institute for Health and Care Research","keywords":"Disease; Biomarker; Medicine; Diagnostic biomarker; Alzheimer's disease; Pathology; Diagnostic accuracy; Internal medicine; Biology","score_opus":0.08703608064542438,"score_gpt":0.43363649699029205,"score_spread":0.34660041634486766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116709840","genre_codex":"other","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17636523,0.23767403,0.07747295,0.1082,0.022652602,0.015832633,0.08266212,0.0024727795,0.27666774],"genre_scores_gemma":[0.46710882,0.07755955,0.20486014,0.041269127,0.010455506,0.020191282,0.14359762,0.0007743993,0.034183614],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9946397,0.0009350606,0.0014074811,0.00031287648,0.0020557675,0.0006492244],"domain_scores_gemma":[0.9917046,0.0014252326,0.002155904,0.00030853122,0.0033264048,0.0010794544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066534053,0.003343309,0.0039944425,0.008661336,0.001997258,0.0024971531,0.0033532032,0.004823414,0.004370473],"category_scores_gemma":[0.01468313,0.000819611,0.003560338,0.0053138053,0.001054381,0.0024085464,0.0031072015,0.0045653856,0.0030913122],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029655157,0.0006424285,0.20417568,0.0031030122,0.0013144551,0.007000246,0.0011849597,0.0023792677,0.0048244493,0.029019468,0.5232109,0.22017959],"study_design_scores_gemma":[0.0021959275,0.00071440893,0.5776485,0.009876411,0.0021422498,0.027309494,0.0012925823,0.008457453,0.0039304993,0.04876113,0.3170474,0.00062394654],"about_ca_topic_score_codex":0.023133676,"about_ca_topic_score_gemma":0.030134255,"teacher_disagreement_score":0.023133676,"about_ca_system_score_codex":0.0025484532,"about_ca_system_score_gemma":0.008577307,"threshold_uncertainty_score":0.045998037},"labels":[],"label_agreement":null},{"id":"W2116939568","doi":"10.1016/s1474-4422(08)70214-x","title":"Non-dopaminergic treatments in development for Parkinson's disease","year":2008,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; Centre for Movement Disorders","funders":"","keywords":"Dopaminergic; Pars compacta; Substantia nigra; Parkinson's disease; Neuroscience; Disease; Medicine; Levodopa; Pathological; Dopamine; Motor symptoms; Psychology; Internal medicine","score_opus":0.07138775560080683,"score_gpt":0.33440739809662345,"score_spread":0.2630196424958166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116939568","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013723153,0.99775463,0.00011573579,0.0002498525,0.00023599385,0.000010982978,0.000034552046,0.000010253912,0.0014507498],"genre_scores_gemma":[0.0014102764,0.99607915,0.00036793257,0.00041317087,0.00021594322,0.000019555833,0.000048879396,0.0000020118832,0.0014429658],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.999785,0.000038107155,0.00003934565,0.000026838286,0.00009026507,0.000020560228],"domain_scores_gemma":[0.99951553,0.00025342577,0.00011984054,0.000011784286,0.00006838793,0.00003096425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008079589,0.0010661087,0.00236872,0.002294259,0.00027390048,0.00084482715,0.0009914302,0.0014355965,0.008104897],"category_scores_gemma":[0.000824697,0.00033049632,0.0006577025,0.0017117171,0.0004672516,0.0009947384,0.0005395498,0.0017109099,0.0024358311],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019471045,0.000095481264,0.000109784705,0.021655716,0.00018690954,0.00022683256,0.000036009435,0.00020563991,0.0011193219,0.0018365494,0.035000775,0.93933237],"study_design_scores_gemma":[0.00020102547,0.0003405386,0.0012448938,0.0070260977,0.0006706814,0.0016147407,0.00006312686,0.00010532605,0.0005273502,0.0016979215,0.9864893,0.000018896242],"about_ca_topic_score_codex":0.0011745072,"about_ca_topic_score_gemma":0.0050145243,"teacher_disagreement_score":0.008104897,"about_ca_system_score_codex":0.0006321107,"about_ca_system_score_gemma":0.001091321,"threshold_uncertainty_score":0.027113557},"labels":[],"label_agreement":null},{"id":"W2117658318","doi":"10.1016/s1474-4422(10)70038-7","title":"Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events","year":2010,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Rivaroxaban; Edoxaban; Aspirin; Dabigatran; Cilostazol; Apixaban; Stroke (engine); Clopidogrel; Antithrombotic; Dipyridamole; Cardiology; Atrial fibrillation; Warfarin; Internal medicine; Vitamin K antagonist; Discovery and development of direct thrombin inhibitors; Platelet; Thrombin","score_opus":0.06682636904744327,"score_gpt":0.35888551006044567,"score_spread":0.2920591410130024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117658318","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002749263,0.998216,0.000059517803,0.00039576268,0.00025035167,0.000012125979,0.000033297427,0.000005504951,0.0007524752],"genre_scores_gemma":[0.0041308203,0.9941906,0.00020062712,0.0006662471,0.0003327811,0.00002274645,0.000046810826,0.0000015456155,0.00040775875],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99964845,0.00009376293,0.00009065465,0.000032765936,0.00010544152,0.000028895933],"domain_scores_gemma":[0.9991487,0.0004789612,0.00025164962,0.000011659354,0.000073933785,0.00003503336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082942995,0.0007049886,0.0027479487,0.0018185654,0.00016176084,0.0005979218,0.00065489067,0.0010667575,0.0044956664],"category_scores_gemma":[0.0022244523,0.0002381824,0.0012973839,0.0013945883,0.00021261918,0.00051580154,0.00040580388,0.0012545282,0.0007400556],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005673035,0.00010323189,0.00045735782,0.07118259,0.0021962777,0.00029451368,0.00005261935,0.00023508412,0.0005604066,0.0011671203,0.04260266,0.88058096],"study_design_scores_gemma":[0.004176405,0.0017580176,0.014479253,0.10411563,0.024359295,0.004623978,0.00024256995,0.0006150218,0.0009901499,0.004051463,0.84050417,0.00008411294],"about_ca_topic_score_codex":0.0020881412,"about_ca_topic_score_gemma":0.0065382025,"teacher_disagreement_score":0.0044956664,"about_ca_system_score_codex":0.00065199763,"about_ca_system_score_gemma":0.0011352056,"threshold_uncertainty_score":0.015039563},"labels":[],"label_agreement":null},{"id":"W2118416292","doi":"10.1016/s1474-4422(05)70248-9","title":"Cholesterol in Alzheimer's disease","year":2005,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":328,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pathogenesis; Disease; Alzheimer's disease; Dementia; Cholesterol; Amyloid beta; Medicine; Amyloid (mycology); Lipid metabolism; Amyloid precursor protein; Biochemistry of Alzheimer's disease; Neuroscience; Bioinformatics; Biology; Internal medicine; Pathology","score_opus":0.09434395617123283,"score_gpt":0.3676350615179319,"score_spread":0.2732911053466991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118416292","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000046573543,0.9985123,0.00002856889,0.0003927522,0.0005107599,0.0000057033253,0.00001710344,0.000004217602,0.00048193158],"genre_scores_gemma":[0.00047616946,0.99804664,0.000085547385,0.00047859395,0.0003736982,0.000007795862,0.00002022413,6.708341e-7,0.00051067944],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996226,0.00007302994,0.00007899825,0.000040004365,0.00014760137,0.00003776752],"domain_scores_gemma":[0.9992711,0.00030827947,0.00017616921,0.000016906413,0.0001573521,0.00007022426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013090444,0.0012937967,0.0035415695,0.0046140463,0.00034095373,0.001468354,0.00089334516,0.00196536,0.0055670757],"category_scores_gemma":[0.0018996033,0.00040660155,0.0007947925,0.005123547,0.00058426696,0.0014598033,0.0010227213,0.0016947808,0.0018624887],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025047627,0.00007348428,0.00024707906,0.046029605,0.0005114395,0.0002439005,0.000063329164,0.00021320643,0.0004110802,0.0018728431,0.1073233,0.8427603],"study_design_scores_gemma":[0.00026543584,0.00017326797,0.0018388965,0.026359929,0.0016535498,0.00092372973,0.0001259255,0.000089060835,0.0001505008,0.0021223186,0.96627265,0.000024770105],"about_ca_topic_score_codex":0.0053957263,"about_ca_topic_score_gemma":0.017062798,"teacher_disagreement_score":0.0055670757,"about_ca_system_score_codex":0.0013980756,"about_ca_system_score_gemma":0.0031043387,"threshold_uncertainty_score":0.01862371},"labels":[],"label_agreement":null},{"id":"W2119077291","doi":"10.1016/s1474-4422(09)70017-1","title":"Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study","year":2009,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":278,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Northwestern University","keywords":"Medicine; Filgrastim; Alemtuzumab; Transplantation; Internal medicine; Stem cell; Cyclophosphamide; Gastroenterology; Autologous stem-cell transplantation; Surgery; Granulocyte colony-stimulating factor; Immunology; Chemotherapy","score_opus":0.08445012853253087,"score_gpt":0.33251057259845607,"score_spread":0.2480604440659252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119077291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954638,0.0020659834,0.00024257718,0.00018028164,0.00008614452,0.00097212,0.00034189658,0.000022038646,0.0006251988],"genre_scores_gemma":[0.9912204,0.0028432757,0.00086802006,0.0006312614,0.0003161775,0.0017052756,0.00094317674,0.00001715659,0.0014553503],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99888176,0.00065640424,0.000063913176,0.0001325076,0.00009893545,0.00016641938],"domain_scores_gemma":[0.99861,0.0003497096,0.00022968298,0.00024085013,0.00009638476,0.00047338384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003211144,0.0020366372,0.0031859782,0.0006402297,0.0006947993,0.0011071897,0.0013006323,0.0016767262,0.0022988557],"category_scores_gemma":[0.0013593511,0.0006090231,0.0017486779,0.00081247,0.0022996387,0.00092664745,0.0004177112,0.0027444072,0.0007103819],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8589023,0.07386131,0.0041408166,0.00065406354,0.0017240284,0.00028354113,0.00022738606,0.0009501071,0.018352157,0.00019645675,0.0009732743,0.039734695],"study_design_scores_gemma":[0.6207738,0.36891848,0.006899703,0.000031431566,0.00067973824,0.0001342025,0.000054897046,0.00021390156,0.0014678019,0.00015772843,0.00065072475,0.000017629225],"about_ca_topic_score_codex":0.0014277053,"about_ca_topic_score_gemma":0.0018783504,"teacher_disagreement_score":0.003211144,"about_ca_system_score_codex":0.0006914051,"about_ca_system_score_gemma":0.0015403859,"threshold_uncertainty_score":0.016982317},"labels":[],"label_agreement":null},{"id":"W2119792797","doi":"10.1016/s1474-4422(15)00019-8","title":"Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment","year":2015,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":549,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital","funders":"","keywords":"Apathy; Parkinson's disease; Disease; Psychology; Neuroscience; Prefrontal cortex; Cognition; Medicine; Psychiatry; Pathology","score_opus":0.13837476308249938,"score_gpt":0.3952970066393838,"score_spread":0.2569222435568844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119792797","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000395002,0.99970466,0.000016427235,0.00008186802,0.000035174817,0.0000015450801,0.00000670072,0.0000014174518,0.00011264156],"genre_scores_gemma":[0.00046547723,0.99919397,0.000061472834,0.00008558229,0.000087224566,0.000002521244,0.000012101774,3.4010608e-7,0.0000914048],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997192,0.00004514018,0.00005609477,0.000041435957,0.00011525552,0.000022885484],"domain_scores_gemma":[0.9994504,0.00029284623,0.00012208126,0.000011174768,0.00009179153,0.0000316714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089415075,0.0010739359,0.0031192254,0.0026347972,0.00027741693,0.0013032481,0.001188279,0.0014047895,0.0024953398],"category_scores_gemma":[0.0010480194,0.00038977398,0.00094491837,0.002212885,0.0006193288,0.0010380207,0.00080471404,0.0019665547,0.0009591111],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017568108,0.0000906037,0.00036049582,0.030908648,0.00033765283,0.00025921327,0.000051120307,0.00035511813,0.0005832321,0.0016755902,0.01921151,0.94599116],"study_design_scores_gemma":[0.00029578706,0.0003158137,0.0052550104,0.02930604,0.0015498762,0.0048889397,0.00022028833,0.00033567223,0.00033819655,0.0064492105,0.9509635,0.000081691745],"about_ca_topic_score_codex":0.0023456851,"about_ca_topic_score_gemma":0.006318983,"teacher_disagreement_score":0.0031192254,"about_ca_system_score_codex":0.0006638175,"about_ca_system_score_gemma":0.0013216515,"threshold_uncertainty_score":0.00834775},"labels":[],"label_agreement":null},{"id":"W2120753166","doi":"10.1016/s1474-4422(11)70014-x","title":"α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study","year":2011,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":629,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Dementia with Lewy bodies; Parkinsonism; Dementia; Medicine; Atrophy; Cohort; Synucleinopathies; Neurology; Pathology; Cerebrospinal fluid; Parkinson's disease; Internal medicine; Autopsy; Lewy body; Alpha-synuclein; Disease; Psychiatry","score_opus":0.029908710193315338,"score_gpt":0.2568633075790492,"score_spread":0.22695459738573384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120753166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99954396,0.0000913116,0.000040267303,0.000018727,0.000008633068,0.00000907542,0.0001626767,0.0000020978673,0.0001233348],"genre_scores_gemma":[0.99914765,0.00011830447,0.000062631574,0.00003855651,0.000021564765,0.000016375892,0.00036248498,0.000004212023,0.00022816118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989812,0.00019379903,0.00012437855,0.0003934971,0.00013382972,0.00017337095],"domain_scores_gemma":[0.9981129,0.00033006005,0.00052609266,0.0003410111,0.00025485174,0.00043505811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008030361,0.0011466924,0.0012174322,0.0013337459,0.0018990301,0.0018836135,0.00088730134,0.0014515816,0.0017575535],"category_scores_gemma":[0.0034898426,0.0014217895,0.001574302,0.0018670585,0.0008571036,0.0021969122,0.0010896672,0.001711529,0.0006473421],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007712611,0.00020854498,0.9965436,0.000009159559,0.00023663332,0.00056059175,0.00031957097,0.000018525683,0.0006540732,0.000013885646,0.0000747743,0.0005894456],"study_design_scores_gemma":[0.00007772022,0.00062001625,0.99602133,0.00000658764,0.00021770791,0.0017835966,0.0008138197,0.00011260316,0.00012464152,0.000044464643,0.00015587146,0.000021573382],"about_ca_topic_score_codex":0.008408138,"about_ca_topic_score_gemma":0.0069496403,"teacher_disagreement_score":0.008408138,"about_ca_system_score_codex":0.00076446205,"about_ca_system_score_gemma":0.0007400777,"threshold_uncertainty_score":0.016718388},"labels":[],"label_agreement":null},{"id":"W2121846783","doi":"10.1016/s1474-4422(14)70221-2","title":"End-of-life management in patients with amyotrophic lateral sclerosis","year":2015,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":184,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"","keywords":"Palliative care; Psychosocial; Psychological intervention; End-of-life care; Quality of life (healthcare); Autonomy; Health care; Distress; Amyotrophic lateral sclerosis; Medicine; Nursing; Advance care planning; Psychology; Compassion; Disease; Psychiatry; Clinical psychology","score_opus":0.13087792117151328,"score_gpt":0.34558483274141377,"score_spread":0.2147069115699005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121846783","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000053268468,0.9996407,0.000016377053,0.00009532562,0.000058593807,0.0000018668263,0.000008053664,0.0000011814238,0.00012450709],"genre_scores_gemma":[0.0010966709,0.9983871,0.00008269801,0.0002606064,0.000087198605,0.0000051026836,0.000019777612,4.6496027e-7,0.0000602809],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99959356,0.00011743688,0.0000914009,0.000052121843,0.000112045695,0.000033464054],"domain_scores_gemma":[0.99905914,0.00064347323,0.00016730434,0.000009572219,0.000087880384,0.000032595817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009864155,0.00083874195,0.0023895395,0.0015201276,0.00018245843,0.0009228034,0.00096987066,0.0012154053,0.0024485502],"category_scores_gemma":[0.0026858144,0.00023217224,0.0011778874,0.0016151528,0.00031265276,0.0009482255,0.00065239856,0.0016408181,0.0004034073],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029180228,0.00006480393,0.00046623868,0.08790416,0.0010042597,0.00017884444,0.00007460437,0.0002670213,0.00029946776,0.0009050783,0.021020105,0.88752365],"study_design_scores_gemma":[0.0008747227,0.0006820896,0.010773778,0.21199569,0.008709795,0.0035061694,0.0005015226,0.00035857697,0.00039809145,0.004704023,0.7573631,0.00013241624],"about_ca_topic_score_codex":0.0018568054,"about_ca_topic_score_gemma":0.00487058,"teacher_disagreement_score":0.0024485502,"about_ca_system_score_codex":0.0006513747,"about_ca_system_score_gemma":0.0010210931,"threshold_uncertainty_score":0.008191228},"labels":[],"label_agreement":null},{"id":"W2122804887","doi":"10.1016/s1474-4422(04)00878-6","title":"Dietary factors and Alzheimer's disease","year":2004,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":431,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Institute on Aging","keywords":"Disease; Medicine; Homocysteine; Alcohol intake; Vitamin B12; Epidemiology; Alzheimer's disease; Dementia; Vitamin E; Oxidative stress; B vitamins; Environmental health; Physiology; Alcohol; Biology; Internal medicine; Antioxidant; Biochemistry","score_opus":0.17423354022315363,"score_gpt":0.4006527160570799,"score_spread":0.2264191758339263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122804887","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003979719,0.9992409,0.0000150784235,0.00022959347,0.00022407334,0.0000027207236,0.000016008615,0.0000017038441,0.00023012352],"genre_scores_gemma":[0.0003986841,0.99885476,0.00006327768,0.00023614775,0.00014042597,0.0000054870243,0.000015972162,3.5479346e-7,0.0002848988],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996604,0.00007516979,0.00008480689,0.000044466004,0.00010637573,0.000028787932],"domain_scores_gemma":[0.9992187,0.00040474333,0.00018758696,0.000017364493,0.000134458,0.00003704503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012839541,0.0013560803,0.0033996226,0.0038424195,0.00031098415,0.0011582125,0.0008211922,0.0021038824,0.0065450664],"category_scores_gemma":[0.0021757756,0.00047187618,0.0009889939,0.005285188,0.00048328302,0.001152003,0.0008366008,0.0011517139,0.0012501528],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004407554,0.00006586639,0.00043256485,0.097079106,0.0012560814,0.00026662406,0.00007339515,0.00023113508,0.00054942264,0.0015454296,0.06935401,0.82870567],"study_design_scores_gemma":[0.00034392948,0.00020991071,0.0029893653,0.051198695,0.004395927,0.0011580808,0.00019185233,0.000069792535,0.0002604823,0.0021095206,0.93704104,0.000031354208],"about_ca_topic_score_codex":0.008236464,"about_ca_topic_score_gemma":0.02261246,"teacher_disagreement_score":0.008236464,"about_ca_system_score_codex":0.001408,"about_ca_system_score_gemma":0.002765687,"threshold_uncertainty_score":0.021895409},"labels":[],"label_agreement":null},{"id":"W2122843800","doi":"10.1016/s1474-4422(12)70015-7","title":"Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis","year":2012,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Intracerebral and Subarachnoid Hemorrhage Research","field":"Medicine","cited_by":510,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute on Aging; Elan; National Institute for Health and Care Research","keywords":"Medicine; Disease; Amyloid (mycology); Pathology; Retrospective cohort study; Alzheimer's disease","score_opus":0.012352979005167608,"score_gpt":0.252053976470106,"score_spread":0.23970099746493842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122843800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989557,0.0005533103,0.000054242548,0.000018608802,0.0000051700604,0.000004656577,0.00015368684,0.0000019568654,0.00025265032],"genre_scores_gemma":[0.9994512,0.00019330421,0.000036932426,0.000023241819,0.000013422028,0.000004166139,0.00021854785,0.000001670619,0.0000573839],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999172,0.00014935256,0.0001539848,0.00025675702,0.0001440128,0.00012387524],"domain_scores_gemma":[0.99805874,0.00041179676,0.0008678402,0.00024066484,0.00020622095,0.00021478788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059173006,0.00035295525,0.0006601655,0.0011348838,0.0005458281,0.0009728947,0.0004075403,0.0006289579,0.0010784803],"category_scores_gemma":[0.002259314,0.000492321,0.00073547574,0.001980365,0.0005152281,0.0008648414,0.00047296737,0.0005250576,0.00022829979],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027183775,0.000026776179,0.9982488,0.0000072288203,0.00011666869,0.0004230946,0.000047585163,0.000015453254,0.00020322985,0.000011178078,0.000027391296,0.00060077925],"study_design_scores_gemma":[0.000025487612,0.000158839,0.9967212,0.0000059381737,0.00014627966,0.0022972743,0.0002064671,0.000092623464,0.00011268357,0.000027635742,0.00019776092,0.000007777264],"about_ca_topic_score_codex":0.0023630226,"about_ca_topic_score_gemma":0.0020271423,"teacher_disagreement_score":0.0023630226,"about_ca_system_score_codex":0.00039221038,"about_ca_system_score_gemma":0.00040266846,"threshold_uncertainty_score":0.004698515},"labels":[],"label_agreement":null},{"id":"W2123166047","doi":"10.1016/s1474-4422(08)70162-5","title":"Biomarkers for cognitive impairment and dementia in elderly people","year":2008,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Research Resources; National Institute on Aging; Canadian Stroke Network; National Institute of Neurological Disorders and Stroke; Nancy and Buster Alvord Endowment","keywords":"Dementia; Neuroimaging; Disease; Medicine; Cognition; Cognitive impairment; Alzheimer's disease; Psychology; Psychiatry; Pathology","score_opus":0.0690160343192147,"score_gpt":0.37409535392278837,"score_spread":0.30507931960357365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123166047","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007744835,0.99919754,0.00006169753,0.0002183351,0.00022409545,0.0000056224926,0.000030649662,0.000004125805,0.00018042793],"genre_scores_gemma":[0.0013583989,0.997332,0.00028413913,0.00044492108,0.0002850592,0.00002038959,0.00005664089,0.0000010146617,0.00021748834],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.999342,0.00013454913,0.00015520043,0.00009338461,0.00023431524,0.000040433468],"domain_scores_gemma":[0.9981133,0.0010299665,0.00045347016,0.000032842563,0.0003046514,0.00006585144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021623117,0.001973438,0.00548877,0.0038985687,0.0002164493,0.0011683356,0.0012859874,0.0017237697,0.0021569005],"category_scores_gemma":[0.0040650186,0.0004700466,0.0015566724,0.0033530868,0.00056798983,0.0013622248,0.0008662653,0.0017356302,0.0007867242],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034789476,0.00007015105,0.0012237144,0.030831287,0.0012962973,0.00018364798,0.000036389585,0.00018107877,0.00032785628,0.0012865806,0.035884872,0.9283302],"study_design_scores_gemma":[0.0009440299,0.0007079954,0.02103175,0.070262715,0.011844429,0.0033324277,0.00030107886,0.00046251446,0.0010116422,0.011781825,0.8781496,0.00016993104],"about_ca_topic_score_codex":0.004356912,"about_ca_topic_score_gemma":0.007223604,"teacher_disagreement_score":0.00548877,"about_ca_system_score_codex":0.00093989645,"about_ca_system_score_gemma":0.0017992955,"threshold_uncertainty_score":0.011435509},"labels":[],"label_agreement":null},{"id":"W2123472957","doi":"10.1016/s1474-4422(14)70066-3","title":"Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial","year":2014,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":420,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Neurological Disorders and Stroke; Genentech; National Institutes of Health","keywords":"Medicine; Thrombolysis; Modified Rankin Scale; Stroke (engine); Tissue plasminogen activator; Reperfusion therapy; Internal medicine; Clinical trial; Logistic regression; Cardiology; Surgery; Myocardial infarction; Ischemia; Ischemic stroke","score_opus":0.06438256283684524,"score_gpt":0.38482525594582023,"score_spread":0.320442693108975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123472957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930254,0.0037932317,0.00025542927,0.00036208562,0.00009342408,0.00012724033,0.0015394782,0.0000276811,0.00077594974],"genre_scores_gemma":[0.99352384,0.0013392451,0.00042151872,0.0003836182,0.00022985516,0.00025097045,0.0033683022,0.000035036373,0.00044759992],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9979621,0.0012742192,0.00013769156,0.00028341444,0.00013899665,0.00020360868],"domain_scores_gemma":[0.99486107,0.0021453337,0.0015907281,0.00060546375,0.00018361327,0.00061384286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052031567,0.0016681126,0.0030913136,0.00035652,0.0004852305,0.0019634622,0.0011566497,0.0013601047,0.002288378],"category_scores_gemma":[0.0065723574,0.0006069113,0.00370214,0.0009781655,0.0009122876,0.0012978171,0.00071863044,0.0030224333,0.0004141272],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90267456,0.0019756765,0.061468337,0.00062358467,0.017602464,0.0001330619,0.00014917839,0.0011032019,0.0016287243,0.0002553635,0.0027569018,0.009628953],"study_design_scores_gemma":[0.40740988,0.040296208,0.5057187,0.00030870386,0.037233155,0.00040519287,0.00028429585,0.0028501037,0.0010775322,0.0016827212,0.0025578884,0.0001755929],"about_ca_topic_score_codex":0.0018072838,"about_ca_topic_score_gemma":0.0030350764,"teacher_disagreement_score":0.0052031567,"about_ca_system_score_codex":0.0007299206,"about_ca_system_score_gemma":0.0011112135,"threshold_uncertainty_score":0.02751726},"labels":[],"label_agreement":null},{"id":"W2124413251","doi":"10.1016/s1474-4422(07)70196-5","title":"Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study","year":2007,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":346,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; University of Ottawa; McGill University; University of Calgary; University of British Columbia; Hospital for Sick Children; Montreal Neurological Institute and Hospital; Dalhousie University; University of Toronto; SickKids Foundation; London Health Sciences Centre","funders":"Hospital for Sick Children; Multiple Sclerosis Society of Canada","keywords":"Observational study; Multiple sclerosis; Medicine; Multinational corporation; Virology; Internal medicine; Immunology; Political science","score_opus":0.20876294150318533,"score_gpt":0.396533831851344,"score_spread":0.18777089034815866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124413251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992299,0.00019185767,0.000029507892,0.000044091088,0.000003816099,0.0000056366443,0.0003826802,0.0000018158621,0.000110809466],"genre_scores_gemma":[0.99912375,0.00015173104,0.00006994597,0.000043384738,0.000010130217,0.000017468692,0.0005209809,0.0000035403461,0.000059091257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974721,0.0010714757,0.00030875418,0.00048615795,0.00031786473,0.00034354627],"domain_scores_gemma":[0.99156874,0.0015305451,0.0044088424,0.00077810447,0.0005745771,0.0011391762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020435709,0.0009101094,0.0011835351,0.0011873738,0.0010726848,0.001287742,0.0010942067,0.0011942743,0.001081403],"category_scores_gemma":[0.006186355,0.0009086499,0.0012545257,0.0036541738,0.0010977178,0.0016069709,0.0013029426,0.0018588797,0.00027189008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119519194,0.0000335814,0.9992654,0.0000069057874,0.00007391048,0.00009592232,0.00009967744,0.000012144019,0.00009783577,0.0000062810723,0.00004283971,0.0001459209],"study_design_scores_gemma":[0.000019479972,0.000114529794,0.99885535,0.000007695868,0.00005471688,0.0004599203,0.00034608578,0.00003556674,0.000030509093,0.000009082367,0.00006231778,0.0000047232256],"about_ca_topic_score_codex":0.01736601,"about_ca_topic_score_gemma":0.014473289,"teacher_disagreement_score":0.01736601,"about_ca_system_score_codex":0.0010387177,"about_ca_system_score_gemma":0.0011248876,"threshold_uncertainty_score":0.034529865},"labels":[],"label_agreement":null},{"id":"W2124660038","doi":"10.1016/s1474-4422(09)70170-x","title":"Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data","year":2009,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":973,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Center for Research Resources; National Institute of Neurological Disorders and Stroke; National Institute for Health and Care Research","keywords":"Huntington's disease; Medicine; Disease; Cohort; Physical medicine and rehabilitation; Cognition; Internal medicine; Psychology; Psychiatry","score_opus":0.23656623745863023,"score_gpt":0.4351373238014206,"score_spread":0.1985710863427904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124660038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979759,0.00021922251,0.0001545176,0.0000274143,0.0000075399685,0.000011669982,0.0014097409,0.000007060909,0.00018684655],"genre_scores_gemma":[0.99730456,0.000089850866,0.00014973083,0.000021720636,0.000008265448,0.000022395554,0.0022075435,0.0000052576124,0.000190618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847955,0.00072523975,0.00014555913,0.00031526375,0.00018201211,0.00015238734],"domain_scores_gemma":[0.99581593,0.00082714943,0.001244279,0.0007758894,0.000677247,0.0006595132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00370131,0.00042530603,0.0006992602,0.000799616,0.00067003816,0.0010790906,0.00058194244,0.0010082225,0.00093121256],"category_scores_gemma":[0.005101212,0.0006768713,0.0007491837,0.0014083735,0.00035580745,0.0011130192,0.0006421137,0.0010143318,0.0002595811],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003383881,0.000047732912,0.9987465,0.0000035472644,0.00015359018,0.00003143582,0.000058489608,0.000040762097,0.00019248568,0.000011053422,0.00006874824,0.00030728747],"study_design_scores_gemma":[0.0000132414925,0.000098400684,0.99952006,0.0000017414039,0.00005089434,0.00007066707,0.000061013012,0.00009242936,0.000028553113,0.000010619401,0.00004927014,0.0000030787758],"about_ca_topic_score_codex":0.014886378,"about_ca_topic_score_gemma":0.016554372,"teacher_disagreement_score":0.014886378,"about_ca_system_score_codex":0.00056904054,"about_ca_system_score_gemma":0.0006052162,"threshold_uncertainty_score":0.029599488},"labels":[],"label_agreement":null},{"id":"W2125469441","doi":"10.1016/s1474-4422(14)70003-1","title":"Outcome markers for clinical trials in cerebral amyloid angiopathy","year":2014,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Intracerebral and Subarachnoid Hemorrhage Research","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; University of Calgary","funders":"National Institute of Neurological Disorders and Stroke; National Institute on Aging; National Institutes of Health; ZonMw","keywords":"Cerebral amyloid angiopathy; Medicine; Clinical trial; Stroke (engine); Surrogate endpoint; Intensive care medicine; Neuroimaging; Internal medicine; Dementia; Psychiatry; Disease","score_opus":0.43508856000363455,"score_gpt":0.5460612398467405,"score_spread":0.11097267984310594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125469441","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001264268,0.9992157,0.000055730143,0.00025869402,0.00014634803,0.000024505238,0.000035774396,0.0000045843476,0.00013223046],"genre_scores_gemma":[0.0064276285,0.99073875,0.0005912372,0.0014800769,0.00040601497,0.00014104378,0.00008998051,0.0000041012954,0.000121127516],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99533457,0.0022198567,0.0012487654,0.00036335652,0.00066854217,0.00016486949],"domain_scores_gemma":[0.96913314,0.025978126,0.0035583726,0.00025063692,0.0008010665,0.0002786426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010408948,0.0013609456,0.010536387,0.002669364,0.0002597497,0.0024965662,0.0018101713,0.0026579963,0.0069002686],"category_scores_gemma":[0.02626886,0.0005904028,0.004309134,0.002650966,0.0011512203,0.0018477988,0.0012685951,0.0033691493,0.00050609437],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039135604,0.00014672885,0.0008302875,0.3155522,0.008586468,0.00015467887,0.00008893319,0.00047717543,0.0004126871,0.0027420286,0.017128201,0.649967],"study_design_scores_gemma":[0.021263987,0.003876281,0.012367915,0.53655773,0.08359491,0.001075844,0.00043279282,0.00093855313,0.0009051993,0.018396858,0.3203422,0.0002477563],"about_ca_topic_score_codex":0.0012609859,"about_ca_topic_score_gemma":0.0028318954,"teacher_disagreement_score":0.010536387,"about_ca_system_score_codex":0.0016605415,"about_ca_system_score_gemma":0.002578709,"threshold_uncertainty_score":0.055048466},"labels":[],"label_agreement":null},{"id":"W2125766898","doi":"10.1016/s1474-4422(12)70327-7","title":"The natural history of multiple system atrophy: a prospective European cohort study","year":2013,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":535,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Allergan; National Institutes of Health; Deutsche Parkinson Vereinigung; Ipsen; H. Lundbeck A/S; Uniklinikum Giessen und Marburg; Valeant Pharmaceuticals International; Alzheimer Forschung Initiative; Eli Lilly and Company; AstraZeneca; CSL Behring; Merz Pharmaceuticals; Teva Pharmaceutical Industries; Austrian Science Fund; International Parkinson and Movement Disorder Society; CSL Behring Foundation for Research and Advancement of Patient Health; Oesterreichische Nationalbank; GlaxoSmithKline","keywords":"Natural history; Prospective cohort study; Atrophy; Medicine; Natural (archaeology); Cohort; Cohort study; Natural history study; Geography; Pathology; Internal medicine; Archaeology","score_opus":0.022750472778426668,"score_gpt":0.23312361958576786,"score_spread":0.21037314680734118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125766898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989028,0.00027364958,0.000094559226,0.000027535316,0.0000047938356,0.000014935055,0.00047783335,0.0000027837036,0.00020108577],"genre_scores_gemma":[0.99883837,0.00019254303,0.000103339284,0.00003846859,0.000010179709,0.000022171891,0.00068510394,0.0000027582591,0.000107163774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99919194,0.00027502378,0.00006883362,0.0002721997,0.000093606046,0.0000983423],"domain_scores_gemma":[0.99847466,0.00027582387,0.00045810838,0.00025753735,0.00017130932,0.00036260305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019189076,0.0005123568,0.0007050803,0.0007314368,0.0006030478,0.0008015461,0.00048468387,0.00071612967,0.0014321833],"category_scores_gemma":[0.0018830406,0.0004217055,0.0008238927,0.0013532464,0.00032105984,0.0008495168,0.0006659983,0.0007061074,0.00027155175],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004570823,0.000064545755,0.99790704,0.000010078223,0.00018542231,0.00023932972,0.00008776548,0.000045503268,0.00020357939,0.000022612814,0.00009791899,0.000679205],"study_design_scores_gemma":[0.000039471684,0.00021026714,0.9988048,0.0000080753825,0.00008450302,0.0004086839,0.00011277911,0.00012866336,0.000022857752,0.000021957927,0.00015145885,0.0000065806976],"about_ca_topic_score_codex":0.0040394566,"about_ca_topic_score_gemma":0.0038156556,"teacher_disagreement_score":0.0040394566,"about_ca_system_score_codex":0.00029249562,"about_ca_system_score_gemma":0.0003165066,"threshold_uncertainty_score":0.010148287},"labels":[],"label_agreement":null},{"id":"W2125872628","doi":"10.1016/s1474-4422(13)70223-0","title":"High-dose albumin treatment for acute ischaemic stroke (ALIAS) part 2: a randomised, double-blind, phase 3, placebo-controlled trial","year":2013,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":198,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"Baxter Healthcare Corporation; National Institutes of Health; National Institute of Neurological Disorders and Stroke; University of Michigan","keywords":"Medicine; Modified Rankin Scale; Placebo; Clinical trial; Ischaemic stroke; Internal medicine; Albumin; Randomized controlled trial; Clinical endpoint; Stroke (engine); Physical therapy; Surgery; Ischemia; Ischemic stroke","score_opus":0.05118472457038524,"score_gpt":0.33489479170821285,"score_spread":0.2837100671378276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125872628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9566899,0.016944168,0.002772973,0.0022176336,0.0022263248,0.010393954,0.0035708097,0.0008113898,0.004372881],"genre_scores_gemma":[0.9543076,0.010671023,0.0041813445,0.0036479624,0.0017363476,0.014282016,0.0027080982,0.00011074827,0.008354781],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993825,0.0002647631,0.000044803193,0.0001373235,0.000049506427,0.00012100417],"domain_scores_gemma":[0.9992224,0.00019580338,0.00021354768,0.0000815865,0.00005779956,0.00022885777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017134087,0.003000836,0.006101392,0.0007648807,0.0006683714,0.0017661704,0.0013977388,0.0031944867,0.011686317],"category_scores_gemma":[0.0019492946,0.00091427297,0.0033410487,0.0006788824,0.0014814482,0.0015948511,0.00053503364,0.0031938215,0.0021869629],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9885311,0.002067621,0.00012411388,0.00088836753,0.0010578433,0.000027134585,0.00002825002,0.0001272717,0.0012442505,0.0000778501,0.000675516,0.005150561],"study_design_scores_gemma":[0.99115646,0.007679498,0.00036769547,0.000020871285,0.0003137171,0.000009325292,0.0000056189087,0.00008757958,0.00007668761,0.00005557455,0.0002191613,0.000007923259],"about_ca_topic_score_codex":0.0013677302,"about_ca_topic_score_gemma":0.0022911995,"teacher_disagreement_score":0.011686317,"about_ca_system_score_codex":0.00088485423,"about_ca_system_score_gemma":0.0012307492,"threshold_uncertainty_score":0.039094627},"labels":[],"label_agreement":null},{"id":"W2126036317","doi":"10.1016/s1474-4422(14)70227-3","title":"Paediatric stroke: pressing issues and promising directions","year":2014,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Medicine; Stroke (engine); Intensive care medicine; Psychological intervention; Clinical trial; Rehabilitation; Antithrombotic; Translational research; Quality of life (healthcare); Pediatric stroke; Physical therapy; Ischemic stroke; Psychiatry; Nursing; Ischemia; Pathology","score_opus":0.07996882619763297,"score_gpt":0.365071760698278,"score_spread":0.28510293450064506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126036317","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023043338,0.99801,0.000028544471,0.0012122918,0.00042351795,0.0000014910531,0.0000114994455,0.000003550498,0.0002860512],"genre_scores_gemma":[0.0002580992,0.99796367,0.00008804343,0.0009172306,0.00056204305,0.000003033201,0.000014371187,9.814145e-7,0.00019266817],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99947435,0.00012696465,0.00009101817,0.000068366535,0.00017482264,0.00006448661],"domain_scores_gemma":[0.9978397,0.001338815,0.00023050891,0.00003234676,0.00039664275,0.00016197891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021094498,0.0011303972,0.0033055253,0.0026309944,0.00042861394,0.0027006844,0.0012488746,0.0030228484,0.0072580343],"category_scores_gemma":[0.0030438632,0.00044826177,0.00092247414,0.0034502496,0.0011742846,0.0035117436,0.0015503302,0.003926123,0.0021545917],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020237993,0.000070117414,0.0002823602,0.03691202,0.00024039975,0.00036045315,0.00011985675,0.00037086662,0.000464405,0.0070511545,0.14206843,0.81185746],"study_design_scores_gemma":[0.000083389066,0.0000714037,0.00084165373,0.019453743,0.00037218147,0.00081009814,0.0002611515,0.00011303681,0.00007606873,0.0050215255,0.9728599,0.00003592061],"about_ca_topic_score_codex":0.00227953,"about_ca_topic_score_gemma":0.007779895,"teacher_disagreement_score":0.0072580343,"about_ca_system_score_codex":0.0014462294,"about_ca_system_score_gemma":0.004298998,"threshold_uncertainty_score":0.024280548},"labels":[],"label_agreement":null},{"id":"W2127776176","doi":"10.1016/s1474-4422(07)70329-0","title":"Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial","year":2008,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":669,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Polyradiculoneuropathy; Placebo; Medicine; Clinical endpoint; Internal medicine; Randomized controlled trial; Crossover study; Clinical trial; Physical therapy; Pediatrics; Guillain-Barre syndrome","score_opus":0.021903432616871346,"score_gpt":0.2595174740789908,"score_spread":0.23761404146211945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127776176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9680586,0.020582834,0.0011008693,0.00079515495,0.001552228,0.0033935122,0.001396904,0.0001840022,0.0029359607],"genre_scores_gemma":[0.97368085,0.011772822,0.0013921676,0.0016829848,0.0014553071,0.0039063883,0.0014433898,0.000040590596,0.0046255304],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993105,0.0003093386,0.00004351601,0.00013958164,0.000046217356,0.00015089494],"domain_scores_gemma":[0.99907565,0.0003600589,0.0001676796,0.00007937146,0.000058374448,0.0002588127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016021804,0.0021719465,0.0059839906,0.0006604925,0.00049461616,0.0013887845,0.0013460758,0.003235116,0.0062398748],"category_scores_gemma":[0.0018205504,0.0007852606,0.0023054476,0.00074653677,0.0018289638,0.0012121894,0.00043516097,0.0032576153,0.0010905161],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98969764,0.0018231146,0.00018614024,0.00080818054,0.00071451307,0.00003239096,0.00002570219,0.00010959383,0.0010983332,0.00006875271,0.00031193768,0.0051237387],"study_design_scores_gemma":[0.9840874,0.014521622,0.0005421593,0.000037796675,0.00032747487,0.000012795581,0.000010551408,0.00006794855,0.000116455834,0.000040072566,0.00022972084,0.000006002793],"about_ca_topic_score_codex":0.0019681763,"about_ca_topic_score_gemma":0.0028380393,"teacher_disagreement_score":0.0062398748,"about_ca_system_score_codex":0.00087953045,"about_ca_system_score_gemma":0.0011212331,"threshold_uncertainty_score":0.02087444},"labels":[],"label_agreement":null},{"id":"W2127927152","doi":"10.1016/s1474-4422(11)70178-8","title":"Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis","year":2011,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Intensive Care Unit Cognitive Disorders","field":"Medicine","cited_by":682,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Critical illness polyneuropathy; Medicine; Muscle weakness; Myopathy; Muscle biopsy; Weakness; Intensive care unit; Paralysis; Intensive care medicine; Polyneuropathy; Critical illness; Physical medicine and rehabilitation; Internal medicine; Critically ill; Biopsy; Surgery","score_opus":0.05766988369434998,"score_gpt":0.33930369707237606,"score_spread":0.28163381337802607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127927152","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006222147,0.999052,0.000039723014,0.00023331954,0.00021596195,0.0000021408684,0.000011017131,0.0000035839055,0.00038000348],"genre_scores_gemma":[0.0004963997,0.9985006,0.00008220924,0.00027609026,0.00030485826,0.000002739895,0.000022076194,7.2036113e-7,0.0003142468],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996747,0.00003269806,0.000048485566,0.00004902768,0.0001607876,0.000034299213],"domain_scores_gemma":[0.99936277,0.00025308973,0.0001545906,0.000011680005,0.00015597121,0.00006184023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006242067,0.0012432301,0.0031429613,0.0026013858,0.00030335117,0.0012185397,0.0011663252,0.0017927575,0.003541046],"category_scores_gemma":[0.0010407298,0.00033106428,0.0006541961,0.0033348459,0.00053608656,0.001228377,0.0008417696,0.0017549001,0.0022182823],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008489277,0.00005538014,0.00043274488,0.02273731,0.00022254669,0.00055457855,0.000038301485,0.00019057206,0.0008638623,0.0010429171,0.057046246,0.91673064],"study_design_scores_gemma":[0.000121711535,0.00016810327,0.0053035305,0.016181959,0.0006708173,0.0074641667,0.00016761133,0.00012907608,0.00029373393,0.0022867625,0.9671661,0.00004631304],"about_ca_topic_score_codex":0.0026846996,"about_ca_topic_score_gemma":0.0060031805,"teacher_disagreement_score":0.003541046,"about_ca_system_score_codex":0.00070243713,"about_ca_system_score_gemma":0.0016911542,"threshold_uncertainty_score":0.011846006},"labels":[],"label_agreement":null},{"id":"W2127951002","doi":"10.1016/s1474-4422(13)70083-8","title":"Anticoagulant therapy in acute brain ischaemia","year":2013,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Heparin; Antithrombotic; Ischaemic stroke; Stroke (engine); Anticoagulant; Low molecular weight heparin; Intensive care medicine; Thrombosis; Fibrinolytic agent; Acute stroke; Fondaparinux; Internal medicine; Ischemia; Tissue plasminogen activator; Venous thromboembolism","score_opus":0.03374676658701921,"score_gpt":0.2854186372548925,"score_spread":0.25167187066787333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127951002","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008219403,0.0047104233,0.00010072919,0.9630935,0.021246647,0.000012948044,0.000038555652,0.000023149512,0.009952031],"genre_scores_gemma":[0.012826521,0.0057991357,0.00031175296,0.8292474,0.14294054,0.00004567875,0.000051825016,0.00002695835,0.008750098],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99778783,0.0007114222,0.0003453063,0.0001627031,0.00063722074,0.00035554983],"domain_scores_gemma":[0.9951697,0.0024369173,0.0005320478,0.0001183749,0.00077183166,0.00097110413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016267999,0.0007018436,0.0015713823,0.0010981822,0.002770814,0.0032824352,0.0012512649,0.047008123,0.0054213046],"category_scores_gemma":[0.021745615,0.00055391126,0.0010810575,0.0011743434,0.0022310428,0.002533313,0.0010814159,0.029308105,0.0045018937],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011267283,0.000065289685,0.0014656219,0.00012585743,0.000036772555,0.007080066,0.000108947344,0.00012703995,0.00016090322,0.0028216646,0.96765983,0.020235488],"study_design_scores_gemma":[0.00088096777,0.00022494057,0.005791752,0.0022289578,0.00019285084,0.016959136,0.0006203379,0.0019055235,0.00044046057,0.031126257,0.93950194,0.00012681744],"about_ca_topic_score_codex":0.0064824168,"about_ca_topic_score_gemma":0.016286679,"teacher_disagreement_score":0.047008123,"about_ca_system_score_codex":0.0044171703,"about_ca_system_score_gemma":0.0040289233,"threshold_uncertainty_score":0.03204894},"labels":[],"label_agreement":null},{"id":"W2128361812","doi":"10.1016/s1474-4422(14)70005-5","title":"Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial","year":2014,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":246,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"EMD Serono; Merck KGaA","keywords":"Multiple sclerosis; Cladribine; Medicine; Internal medicine; Pediatrics; Immunology","score_opus":0.046205167456945154,"score_gpt":0.3307759744024873,"score_spread":0.28457080694554215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128361812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902878,0.0044736974,0.00043906065,0.0007169078,0.00052168,0.0011709713,0.0009445052,0.00006782147,0.0013775405],"genre_scores_gemma":[0.99316746,0.0018092026,0.0005887793,0.0005805457,0.0002610157,0.0011663908,0.00065937766,0.000014908658,0.0017523649],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99934167,0.00032646305,0.00003785664,0.000116469295,0.00003728896,0.00014020718],"domain_scores_gemma":[0.9985083,0.0005282364,0.0002617345,0.0001268239,0.00006980529,0.000505197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013174998,0.0017540366,0.0034611744,0.0003305634,0.0005012672,0.0011078248,0.0009763197,0.0021235633,0.0053036404],"category_scores_gemma":[0.0019913912,0.00065655616,0.002551876,0.0004125648,0.0014897876,0.0010165966,0.0004486296,0.0035152764,0.0008942419],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9921714,0.0012404359,0.00021647173,0.00023962907,0.00037262507,0.00001670735,0.00002478437,0.00019468926,0.0007968432,0.00003923789,0.00022103745,0.0044661504],"study_design_scores_gemma":[0.9544734,0.043201316,0.001285642,0.00003061706,0.0002977629,0.000016946295,0.000016262316,0.00021173107,0.00014997652,0.000077045515,0.00022697606,0.00001237985],"about_ca_topic_score_codex":0.002561118,"about_ca_topic_score_gemma":0.0036459295,"teacher_disagreement_score":0.0053036404,"about_ca_system_score_codex":0.001237569,"about_ca_system_score_gemma":0.0011901084,"threshold_uncertainty_score":0.017742455},"labels":[],"label_agreement":null},{"id":"W2129250133","doi":"10.1016/s1474-4422(10)70276-3","title":"Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis","year":2010,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":600,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Cardiff University; National Institute for Health and Care Research","keywords":"Medicine; Huntington's disease; Demographics; Atrophy; Observational study; Internal medicine; Disease; Longitudinal study; Demography; Pathology","score_opus":0.10441596822652043,"score_gpt":0.3500308996249813,"score_spread":0.24561493139846086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129250133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986885,0.00032812188,0.00005411314,0.000049532853,0.00000956844,0.00000803191,0.0006340949,0.0000038202593,0.00022422365],"genre_scores_gemma":[0.99782145,0.00014996194,0.0000676326,0.000032744905,0.000015787147,0.000018852192,0.0013931617,0.000004134478,0.00049630366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994862,0.00014357612,0.000055872006,0.0001285112,0.00007033752,0.00011550273],"domain_scores_gemma":[0.9983516,0.00017220329,0.0005730691,0.00022275985,0.00029149224,0.0003889182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002020318,0.0005951838,0.00067375886,0.0011365798,0.0011537826,0.0011046533,0.00065554766,0.0013252313,0.0007947789],"category_scores_gemma":[0.003003763,0.0006154707,0.0009846794,0.0012500195,0.00042208075,0.0013534648,0.0010743217,0.0012303852,0.00029969576],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010348747,0.00010614285,0.9966304,0.000006405269,0.00018730994,0.00012825377,0.00020267873,0.00004328035,0.00033010956,0.00001678218,0.00015204508,0.0011617031],"study_design_scores_gemma":[0.000013010446,0.00012942143,0.9994574,0.0000022868182,0.00005147533,0.00008601672,0.000102455786,0.000041773146,0.000026280497,0.000014304451,0.00007144148,0.000003995427],"about_ca_topic_score_codex":0.02499863,"about_ca_topic_score_gemma":0.029135343,"teacher_disagreement_score":0.02499863,"about_ca_system_score_codex":0.0006413348,"about_ca_system_score_gemma":0.00057954603,"threshold_uncertainty_score":0.04970628},"labels":[],"label_agreement":null},{"id":"W2129669150","doi":"10.1016/s1474-4422(14)70088-2","title":"Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial","year":2014,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Biological Activity of Diterpenoids and Biflavonoids","field":"Biochemistry, Genetics and Molecular Biology","cited_by":289,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Paladin Labs (Canada); Arbutus Biopharma (Canada); University of Toronto","funders":"National Institute on Aging; Allos Therapeutics","keywords":"Progressive supranuclear palsy; Placebo; Double blind; Physical medicine and rehabilitation; Medicine; Physical therapy; Internal medicine; Disease; Pathology; Alternative medicine","score_opus":0.018145724500165727,"score_gpt":0.27144536367235084,"score_spread":0.2532996391721851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129669150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9648028,0.02191513,0.0012649321,0.0012656712,0.0018651825,0.00370187,0.0014205009,0.0003012242,0.0034627637],"genre_scores_gemma":[0.97181904,0.012379364,0.0017622272,0.0019527193,0.00081006455,0.004383076,0.001383471,0.000043397482,0.0054667103],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995479,0.00017632745,0.00003388074,0.00009666768,0.00003580373,0.00010943765],"domain_scores_gemma":[0.99938655,0.00021576454,0.000104757266,0.000041793373,0.000046338053,0.00020482544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014417369,0.0020107047,0.0051300502,0.00049932033,0.0005084038,0.0011509263,0.0011279328,0.0027854154,0.007147531],"category_scores_gemma":[0.00137092,0.0007309773,0.0022329523,0.0005108353,0.0013577932,0.0014448012,0.00037318107,0.003465493,0.0012095902],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98053384,0.0019751075,0.00026300596,0.0010971867,0.0009666221,0.000074227755,0.000046245448,0.00018018785,0.002252056,0.00011968133,0.00065825303,0.011833508],"study_design_scores_gemma":[0.97971594,0.018698722,0.000565932,0.00003915271,0.00027866685,0.000032066207,0.00002056206,0.00010520141,0.00012502406,0.00010766375,0.00030043986,0.000010674438],"about_ca_topic_score_codex":0.0013950891,"about_ca_topic_score_gemma":0.0025031418,"teacher_disagreement_score":0.007147531,"about_ca_system_score_codex":0.0006358299,"about_ca_system_score_gemma":0.001051402,"threshold_uncertainty_score":0.02391082},"labels":[],"label_agreement":null},{"id":"W2130190017","doi":"10.1016/s1474-4422(12)70225-9","title":"Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial","year":2012,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Intracranial Aneurysms: Treatment and Complications","field":"Medicine","cited_by":399,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McMaster University; Queen Elizabeth II Health Sciences Centre; London Health Sciences Centre; University of Toronto; Royal University Hospital; Western University; St. Michael's Hospital; University of Saskatchewan; Université Laval; Toronto Western Hospital; Ottawa Hospital; University of Alberta Hospital; University Health Network; Dalhousie University; Hotchkiss Brain Institute; University of Calgary","funders":"","keywords":"Medicine; Aneurysm; Adverse effect; Placebo; Stroke (engine); Clinical trial; Population; Randomized controlled trial; Double blind; Anesthesia; Internal medicine; Surgery; Pathology","score_opus":0.016730066322979086,"score_gpt":0.26655451615901976,"score_spread":0.24982444983604069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130190017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974133,0.01835005,0.00078032847,0.0009030271,0.0011389902,0.0015600021,0.0007814403,0.00010419978,0.0022489645],"genre_scores_gemma":[0.9817405,0.008671272,0.0013940594,0.0013017996,0.001103656,0.0020419997,0.0010421366,0.000024577866,0.0026801815],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994343,0.00028170756,0.00005961443,0.00010595907,0.000045729943,0.000072640025],"domain_scores_gemma":[0.9989826,0.00033376575,0.00028609906,0.00008194851,0.00007563675,0.00024004231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014288954,0.001489589,0.0041524856,0.0003995809,0.00052905874,0.00143338,0.0010707653,0.002448824,0.004110351],"category_scores_gemma":[0.0022241063,0.0007965842,0.0020623116,0.00041330507,0.0013663677,0.0016334824,0.00039748734,0.0032277792,0.00076471234],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98603976,0.0020175406,0.00052440603,0.0008848838,0.0011679342,0.000034998546,0.000050455426,0.00013286846,0.0010464323,0.00008215915,0.00040524354,0.0076134223],"study_design_scores_gemma":[0.96222067,0.03386894,0.0017638775,0.000058950984,0.00081928435,0.000041166393,0.000026409105,0.00025336727,0.00026358242,0.00014469402,0.0005207194,0.00001846475],"about_ca_topic_score_codex":0.0007020105,"about_ca_topic_score_gemma":0.0012537385,"teacher_disagreement_score":0.0041524856,"about_ca_system_score_codex":0.0004938323,"about_ca_system_score_gemma":0.00097065925,"threshold_uncertainty_score":0.013750553},"labels":[],"label_agreement":null},{"id":"W2131979090","doi":"10.1016/s1474-4422(13)70048-6","title":"MR-guided focused ultrasound thalamotomy for essential tremor: a proof-of-concept study","year":2013,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":604,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Sunnybrook Health Science Centre; Health Sciences Centre; Toronto Western Hospital; University of Toronto","funders":"","keywords":"Essential tremor; Thalamotomy; Medicine; Deep brain stimulation; Adverse effect; Movement disorders; Focused ultrasound; Ultrasound; Physical medicine and rehabilitation; Surgery; Radiology; Internal medicine; Parkinson's disease","score_opus":0.04696123147440019,"score_gpt":0.31118570125762873,"score_spread":0.26422446978322855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131979090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9504277,0.018867845,0.015385669,0.0020573891,0.00087263517,0.0075557204,0.0009406694,0.00021288943,0.0036794292],"genre_scores_gemma":[0.9634482,0.013314592,0.015727034,0.001923315,0.00050131994,0.0026678266,0.0007526895,0.00004889618,0.001616066],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99886465,0.0005953146,0.000055955603,0.00013323242,0.00018118173,0.00016962536],"domain_scores_gemma":[0.99865544,0.00061333855,0.00022809359,0.00014083485,0.000117796655,0.0002445869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042483634,0.0014855879,0.0015354925,0.00038242096,0.0003106653,0.0013354542,0.001630367,0.002553684,0.0033132525],"category_scores_gemma":[0.0027021256,0.00045903015,0.0018342921,0.0001953738,0.0015878637,0.0011458724,0.00041859533,0.002082065,0.0006910836],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21044521,0.09283848,0.0032241878,0.0073346416,0.006229979,0.0040122354,0.0009971806,0.0041519646,0.3462186,0.002311809,0.0113218725,0.31091383],"study_design_scores_gemma":[0.1868897,0.74518234,0.007399768,0.000543199,0.0039735413,0.002705018,0.00033119714,0.0039500254,0.034252938,0.0008090377,0.013810308,0.00015291166],"about_ca_topic_score_codex":0.0011959085,"about_ca_topic_score_gemma":0.0013615808,"teacher_disagreement_score":0.0042483634,"about_ca_system_score_codex":0.0007649357,"about_ca_system_score_gemma":0.0016781058,"threshold_uncertainty_score":0.022467792},"labels":[],"label_agreement":null},{"id":"W2132247347","doi":"10.1016/s1474-4422(07)70250-8","title":"Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial","year":2007,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":558,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research; Sanofi","keywords":"Medicine; Stroke (engine); Clopidogrel; Placebo; Aspirin; Internal medicine; Relative risk; Randomized controlled trial; Absolute risk reduction; Surgery; Anesthesia; Confidence interval","score_opus":0.03280484385702336,"score_gpt":0.3193459786047938,"score_spread":0.28654113474777043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132247347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97842693,0.008756979,0.0014285373,0.0013666721,0.0018397003,0.004236028,0.0017614671,0.00018386524,0.0019997552],"genre_scores_gemma":[0.971901,0.0058670305,0.003682863,0.0017548245,0.0018404097,0.009605692,0.0017359208,0.000055898927,0.003556332],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99823964,0.0009058328,0.0001393834,0.00028909542,0.00011748827,0.0003086272],"domain_scores_gemma":[0.99600166,0.0017027368,0.0006759929,0.00046552168,0.00023426906,0.0009198042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004377895,0.0026183473,0.009101124,0.000767296,0.0007907731,0.0017055407,0.0013542778,0.003553995,0.010124388],"category_scores_gemma":[0.0048562326,0.001317936,0.004419851,0.0007982974,0.0017961604,0.0029185142,0.0011879066,0.0050162016,0.0010204829],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9926064,0.0017814975,0.00027365182,0.0004053361,0.0010163827,0.000032289223,0.0000386276,0.00012217139,0.00025344815,0.00010433063,0.000352507,0.0030133023],"study_design_scores_gemma":[0.9804951,0.017500145,0.00094973884,0.00002793014,0.00062252145,0.000018142817,0.000017852715,0.00010315135,0.000033560307,0.0000997774,0.00012067737,0.000011340478],"about_ca_topic_score_codex":0.002991937,"about_ca_topic_score_gemma":0.002382167,"teacher_disagreement_score":0.010124388,"about_ca_system_score_codex":0.000788572,"about_ca_system_score_gemma":0.0015627191,"threshold_uncertainty_score":0.033869445},"labels":[],"label_agreement":null},{"id":"W2132968358","doi":"10.1016/s1474-4422(10)70300-8","title":"Very early hypothermia induction in patients with severe brain injury (the National Acute Brain Injury Study: Hypothermia II): a randomised trial","year":2010,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Thermal Regulation in Medicine","field":"Medicine","cited_by":522,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Hypothermia; Medicine; Randomized controlled trial; Anesthesia; Glasgow Outcome Scale; Traumatic brain injury; Clinical trial; Glasgow Coma Scale; Surgery; Internal medicine; Psychiatry","score_opus":0.019249284805236744,"score_gpt":0.2903634861182294,"score_spread":0.27111420131299263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132968358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97812986,0.012619308,0.0012934384,0.001310266,0.0017660963,0.0020135897,0.0009362374,0.000106034626,0.0018251401],"genre_scores_gemma":[0.98762053,0.003905995,0.0010954267,0.0013525762,0.00086359214,0.002561105,0.0007928838,0.000022067114,0.0017857249],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982578,0.000979615,0.00013711874,0.00024603234,0.00007693703,0.00030245414],"domain_scores_gemma":[0.998692,0.00038300548,0.00031254767,0.00017231722,0.000055910194,0.00038424626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022354203,0.0019682841,0.006031561,0.00035215094,0.00053542596,0.0015379309,0.0012166458,0.002755951,0.005122976],"category_scores_gemma":[0.002568277,0.0008115074,0.0040068226,0.0006015254,0.0014795258,0.0015882077,0.00093677134,0.0041696485,0.00081283785],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9915666,0.0009849671,0.00048332207,0.00054396794,0.0015712953,0.000024439752,0.00003129576,0.00011350749,0.0005818349,0.000093676244,0.0004059916,0.0035991909],"study_design_scores_gemma":[0.97934955,0.017203221,0.0017720405,0.000064261854,0.00089279097,0.000021215514,0.000023050778,0.00010417804,0.00010098091,0.00019387512,0.0002592372,0.000015671007],"about_ca_topic_score_codex":0.0014332721,"about_ca_topic_score_gemma":0.0021217028,"teacher_disagreement_score":0.006031561,"about_ca_system_score_codex":0.0009506381,"about_ca_system_score_gemma":0.0011106499,"threshold_uncertainty_score":0.017138124},"labels":[],"label_agreement":null},{"id":"W2133329597","doi":"10.1016/s1474-4422(13)70308-9","title":"Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial","year":2014,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":570,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; University of Toronto","funders":"Serono Symposia International Foundation; Universitätsspital Basel; Universität Basel","keywords":"Teriflunomide; Double blind; Multiple sclerosis; Medicine; Placebo; Internal medicine; Physical therapy; Alternative medicine; Psychiatry; Pathology; Fingolimod","score_opus":0.10906965169014442,"score_gpt":0.3401949859973124,"score_spread":0.23112533430716797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133329597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96914375,0.016469503,0.0011265213,0.001415275,0.0015121332,0.005089923,0.0020272455,0.00029758833,0.0029179808],"genre_scores_gemma":[0.9704874,0.008328025,0.0025927103,0.0028945075,0.0010448652,0.007484269,0.0019497591,0.000047062134,0.0051713088],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995296,0.00021065545,0.000039053466,0.00008738377,0.000035095884,0.000098121614],"domain_scores_gemma":[0.9992343,0.00020543605,0.00017483534,0.00006128769,0.00004758751,0.00027659634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015360533,0.002112787,0.0042243283,0.000512315,0.00076898106,0.0009572292,0.0010650358,0.0028521898,0.00748347],"category_scores_gemma":[0.0017068427,0.0007478676,0.0029550088,0.0004994151,0.0011875966,0.0014219602,0.00042663774,0.003058865,0.0014741388],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.984983,0.0019394595,0.00027615702,0.0008640844,0.0008811437,0.00005263376,0.000047103316,0.00014915595,0.0017320114,0.00007263203,0.00076834095,0.0082342485],"study_design_scores_gemma":[0.98313314,0.015525722,0.00060661725,0.000027037679,0.00023331966,0.000020171758,0.000012503019,0.000071922885,0.00007561637,0.000052939376,0.00023213314,0.000008930325],"about_ca_topic_score_codex":0.0016783478,"about_ca_topic_score_gemma":0.0043497793,"teacher_disagreement_score":0.00748347,"about_ca_system_score_codex":0.0008142138,"about_ca_system_score_gemma":0.00108736,"threshold_uncertainty_score":0.025034726},"labels":[],"label_agreement":null},{"id":"W2133940094","doi":"10.1016/s1474-4422(14)70011-0","title":"Distinct neurological disorders with ATP1A3 mutations","year":2014,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Ion Transport and Channel Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":248,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; Canadian Institutes of Health Research; Lundbeckfonden","keywords":"Mutation; Parkinsonism; Dystonia; Disease; Gene; Medicine; Genetics; Neuroscience; Bioinformatics; Coding region; Biology; Internal medicine","score_opus":0.0249528679960982,"score_gpt":0.2825473030158987,"score_spread":0.2575944350198005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133940094","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002476619,0.99715245,0.0003467337,0.00065222284,0.00039691298,0.0000026284642,0.000022085887,0.00001394218,0.0011654296],"genre_scores_gemma":[0.0025962905,0.99364215,0.00061628915,0.0009867941,0.0010000146,0.000007234585,0.000083244595,0.0000065224035,0.0010615092],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974996,0.00003347369,0.000045216188,0.00005710773,0.000080256104,0.00003402444],"domain_scores_gemma":[0.9996649,0.00018967228,0.000043517,0.000011382301,0.000057326808,0.000033237997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000632857,0.0014291961,0.0023998215,0.002128888,0.0002541128,0.0012051762,0.0012486712,0.0019524391,0.0024431811],"category_scores_gemma":[0.0008018708,0.00027660377,0.00054970523,0.0020059242,0.0010380405,0.0013443744,0.0009374303,0.0023216037,0.0012165746],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016771865,0.00004952117,0.0005624474,0.007756841,0.00016526652,0.0045704674,0.00006796315,0.0004984521,0.0023495695,0.0073992442,0.055486083,0.9209265],"study_design_scores_gemma":[0.00008102844,0.00005112052,0.0017716873,0.004136685,0.00036853488,0.03053975,0.00011589456,0.00020507773,0.00090941135,0.008724635,0.9530483,0.000047892754],"about_ca_topic_score_codex":0.0008946732,"about_ca_topic_score_gemma":0.0019064168,"teacher_disagreement_score":0.0024431811,"about_ca_system_score_codex":0.00081998366,"about_ca_system_score_gemma":0.0008689571,"threshold_uncertainty_score":0.008173287},"labels":[],"label_agreement":null},{"id":"W2134033939","doi":"10.1016/s1474-4422(12)70056-x","title":"Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study","year":2012,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of British Columbia Hospital","funders":"Schweizerische Multiple Sklerose Gesellschaft; National Research Foundation; Multiple Sclerosis Society; Novartis Foundation","keywords":"Fingolimod; Placebo; Multiple sclerosis; Medicine; Double blind; Subgroup analysis; Physical therapy; Internal medicine; Alternative medicine; Psychiatry; Meta-analysis; Pathology","score_opus":0.10341334741099334,"score_gpt":0.331713505969883,"score_spread":0.2283001585588897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134033939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95640737,0.0373269,0.0009893661,0.0005045767,0.0006654921,0.0009411333,0.0021928695,0.0000822188,0.0008900428],"genre_scores_gemma":[0.9925373,0.0034507397,0.0005785049,0.0003485318,0.00039119367,0.00074318284,0.0012274205,0.000023822819,0.0006992561],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9944834,0.0033572116,0.0008633857,0.0005409921,0.00040040846,0.00035453305],"domain_scores_gemma":[0.9958526,0.001864131,0.00097464403,0.0007821442,0.00026099684,0.00026543025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068707736,0.0028469842,0.010185543,0.0011009533,0.0006238712,0.0014448122,0.001275062,0.00222648,0.002491213],"category_scores_gemma":[0.009259177,0.0010990718,0.015087048,0.0010388393,0.00080540916,0.0011138237,0.0012755989,0.0025561263,0.00032322996],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9146707,0.00031780102,0.006355014,0.0019994369,0.068222106,0.00007640427,0.0001143996,0.00035083795,0.0014538161,0.000091393806,0.00040010895,0.005947926],"study_design_scores_gemma":[0.73876,0.019252049,0.06820354,0.000391282,0.16828443,0.0001747415,0.0002594418,0.0011881986,0.00097192323,0.0010714112,0.0012849406,0.00015802486],"about_ca_topic_score_codex":0.0023004506,"about_ca_topic_score_gemma":0.0037787703,"teacher_disagreement_score":0.010185543,"about_ca_system_score_codex":0.00090652,"about_ca_system_score_gemma":0.00090332323,"threshold_uncertainty_score":0.0363366},"labels":[],"label_agreement":null},{"id":"W2134829539","doi":"10.1016/s1474-4422(08)70117-0","title":"Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study","year":2008,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":1563,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute on Aging; National Institute of Neurological Disorders and Stroke; Medical Research Council; National Institutes of Health; Fondazione Grigioni per il Morbo di Parkinson; Agence Nationale de la Recherche; Volkswagen Foundation; Brain Research Trust; Mayo Clinic; Parkinson's UK; Michael J. Fox Foundation for Parkinson's Research","keywords":"LRRK2; Penetrance; Disease; Dyskinesia; Mutation; Medicine; Genotype; Parkinson's disease; Internal medicine; Mutation frequency; Genetics; Phenotype; Biology; Gene","score_opus":0.02268382312665334,"score_gpt":0.25598681058861955,"score_spread":0.2333029874619662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134829539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987814,0.00025030028,0.0002831247,0.000019936873,0.000006055335,0.000033196782,0.00012299708,0.00000775532,0.00049519725],"genre_scores_gemma":[0.99924785,0.00012941539,0.00018116899,0.000021867274,0.000013436841,0.00002684913,0.00022696261,0.0000058812157,0.00014646459],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837804,0.00040546324,0.00015939189,0.00063302787,0.0002678533,0.00015615029],"domain_scores_gemma":[0.99806815,0.00054777437,0.00043314276,0.00041840482,0.00025198018,0.00028064853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017714419,0.0010830407,0.0008928605,0.0022189652,0.0014616109,0.0010036477,0.0007461677,0.001117617,0.0028288173],"category_scores_gemma":[0.0041009514,0.0008994747,0.00083644455,0.0016618471,0.0008853632,0.0006051675,0.0008616676,0.0006918648,0.00041504623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036313746,0.00033810112,0.99058,0.000026724709,0.0002739114,0.0039760466,0.00071222545,0.00006505284,0.0008175698,0.00008649942,0.00020979036,0.0025509398],"study_design_scores_gemma":[0.00013970603,0.00064708764,0.98024565,0.000021756025,0.00022327024,0.016911918,0.0004991527,0.0003616055,0.00022511774,0.000081176666,0.00062052166,0.000022949069],"about_ca_topic_score_codex":0.007244425,"about_ca_topic_score_gemma":0.0054773963,"teacher_disagreement_score":0.007244425,"about_ca_system_score_codex":0.0006303669,"about_ca_system_score_gemma":0.00035475785,"threshold_uncertainty_score":0.014404535},"labels":[],"label_agreement":null},{"id":"W2135907949","doi":"10.1016/s1474-4422(08)70065-6","title":"Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial","year":2008,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":587,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Neurturin; Tolerability; Medicine; Adverse effect; Adeno-associated virus; Dyskinesia; Internal medicine; Parkinson's disease; Neurotrophic factors; Clinical trial; Disease; Oncology; Glial cell line-derived neurotrophic factor; Vector (molecular biology); Biology","score_opus":0.037403649097922556,"score_gpt":0.3094398217889936,"score_spread":0.27203617269107105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135907949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99180365,0.003847017,0.0007378081,0.00043698802,0.00026259193,0.00066208316,0.0005781735,0.00012405042,0.001547612],"genre_scores_gemma":[0.99414647,0.0017643129,0.00044641565,0.0004264207,0.00022705681,0.0006431163,0.00058065983,0.000026829295,0.0017387861],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99948126,0.00023765772,0.000023594941,0.00010427846,0.000038100483,0.000115086856],"domain_scores_gemma":[0.9993005,0.0002183268,0.00015320024,0.000062519226,0.00003599523,0.00022951719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001183157,0.0021858208,0.0027270853,0.00042217673,0.00042547917,0.001357371,0.00095026765,0.0025403993,0.0039250543],"category_scores_gemma":[0.0013497422,0.00071380084,0.0022816467,0.00041320463,0.0016155796,0.0016533211,0.00022797327,0.004254607,0.0009948038],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9271706,0.014663582,0.00081948383,0.0005729174,0.0010536695,0.00012798575,0.00015254867,0.0010003981,0.014243409,0.00023288309,0.0009927046,0.038969837],"study_design_scores_gemma":[0.6670769,0.32505256,0.002531763,0.000040789757,0.0006061148,0.00012435578,0.00006195376,0.0010580694,0.0023127426,0.00027605088,0.00081956433,0.00003911282],"about_ca_topic_score_codex":0.0006993258,"about_ca_topic_score_gemma":0.0010244529,"teacher_disagreement_score":0.0039250543,"about_ca_system_score_codex":0.0008201329,"about_ca_system_score_gemma":0.00073932705,"threshold_uncertainty_score":0.013130605},"labels":[],"label_agreement":null},{"id":"W2136049238","doi":"10.1016/s1474-4422(15)00047-2","title":"Safety and efficacy of desmoteplase given 3–9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial","year":2015,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute for Health and Care Research","keywords":"Medicine; Modified Rankin Scale; Placebo; Clinical endpoint; Stroke (engine); Randomized controlled trial; Clinical trial; Stenosis; Internal medicine; Adverse effect; Surgery; Ischemia; Ischemic stroke; Pathology","score_opus":0.024507304619910335,"score_gpt":0.27555588114447527,"score_spread":0.2510485765245649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136049238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903137,0.004309283,0.00039013097,0.000557097,0.00054879993,0.0014994387,0.0009197613,0.000098586104,0.0013630999],"genre_scores_gemma":[0.9882053,0.0028429667,0.0007331363,0.0010117993,0.0006584771,0.0020265835,0.0011218155,0.000028399192,0.0033714813],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994686,0.00022485253,0.0000389093,0.00011676124,0.000037280006,0.00011356578],"domain_scores_gemma":[0.9992269,0.00020620042,0.0001857827,0.0000638208,0.000048841117,0.00026843662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013000148,0.0021846988,0.0040683234,0.00041830514,0.00057161116,0.0011760909,0.0011396577,0.0030423803,0.006334574],"category_scores_gemma":[0.0015395574,0.000879843,0.002967601,0.0003853714,0.0015988764,0.0011455636,0.00043448448,0.0034392981,0.0016655045],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9899741,0.0024338379,0.0002845579,0.00039237097,0.0007061354,0.000028467259,0.000042385804,0.000102696446,0.00176982,0.000039953575,0.0003001466,0.003925452],"study_design_scores_gemma":[0.9559151,0.0412445,0.0016889217,0.000025361709,0.00042814238,0.00001733706,0.000021106378,0.00013667696,0.0001934743,0.0000916703,0.00022148751,0.00001623411],"about_ca_topic_score_codex":0.0016107582,"about_ca_topic_score_gemma":0.0029171424,"teacher_disagreement_score":0.006334574,"about_ca_system_score_codex":0.0006859191,"about_ca_system_score_gemma":0.0010480498,"threshold_uncertainty_score":0.02119124},"labels":[],"label_agreement":null},{"id":"W2136148158","doi":"10.1016/s1474-4422(06)70441-0","title":"Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases","year":2006,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":374,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; Institut Universitaire de Gériatrie de Montréal; Hôpital du Sacré-Cœur de Montréal; Université de Montréal","funders":"Government of Canada; ALS Association","keywords":"Dementia with Lewy bodies; Progressive supranuclear palsy; REM sleep behavior disorder; Rapid eye movement sleep; Dementia; Neuroscience; Eye movement; Atrophy; Disease; Non-rapid eye movement sleep; Psychology; Medicine; Movement disorders; Cognition; Parkinson's disease; Pathology","score_opus":0.04056336725521668,"score_gpt":0.3225323198171877,"score_spread":0.281968952561971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136148158","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000059475915,0.9980977,0.00006947287,0.00027628537,0.00034592682,0.0000060309794,0.000015971738,0.000006945946,0.0011222318],"genre_scores_gemma":[0.00064219354,0.99710363,0.00021784806,0.00028948442,0.00044435597,0.000011850425,0.000028273202,0.0000011897674,0.0012611995],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997918,0.000037255802,0.000035082132,0.00002528761,0.00009221146,0.000018399534],"domain_scores_gemma":[0.99961674,0.00017854097,0.00008178466,0.000010761709,0.000077686826,0.00003454394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007203371,0.0012715892,0.002980877,0.0026393612,0.0003336854,0.0010136319,0.0009984309,0.001550587,0.0076721665],"category_scores_gemma":[0.00085790193,0.000346401,0.00052639627,0.0028702142,0.000555767,0.0014997519,0.0006480977,0.0016673806,0.0035804794],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013641047,0.00008621263,0.00013779261,0.013395372,0.00013556257,0.00026508802,0.000037583995,0.00019782015,0.0006247474,0.001540918,0.0592326,0.92420983],"study_design_scores_gemma":[0.00011121604,0.000167957,0.0012761669,0.0044831308,0.00029092137,0.0019134218,0.00007645917,0.0000864749,0.00016954378,0.0020506924,0.9893554,0.000018661549],"about_ca_topic_score_codex":0.0019970844,"about_ca_topic_score_gemma":0.007268353,"teacher_disagreement_score":0.0076721665,"about_ca_system_score_codex":0.0007283197,"about_ca_system_score_gemma":0.001240871,"threshold_uncertainty_score":0.025665939},"labels":[],"label_agreement":null},{"id":"W2137414549","doi":"10.1016/s1474-4422(11)70070-9","title":"Development of biomarkers for Huntington's disease","year":2011,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":161,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institutes of Health","keywords":"Disease; Huntington's disease; Medicine; Clinical trial; Population; Intervention (counseling); Genetic testing; Biomarker; Bioinformatics; Pathology; Internal medicine; Psychiatry; Biology; Genetics","score_opus":0.1657449139360142,"score_gpt":0.35201388097367914,"score_spread":0.18626896703766493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137414549","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007400445,0.9982969,0.00024932163,0.0005448364,0.00039004485,0.0000056775793,0.00002177865,0.00000915516,0.00040823602],"genre_scores_gemma":[0.00083944085,0.99706715,0.00053281424,0.0006167105,0.0004500337,0.000012725217,0.000060360042,0.000002626969,0.00041813252],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99949324,0.0000855405,0.00008736626,0.000095614356,0.0001849138,0.000053324493],"domain_scores_gemma":[0.99837685,0.00086182734,0.00022453559,0.000043519078,0.00041407993,0.00007916352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023299905,0.002220787,0.0036100121,0.0023704458,0.0003265958,0.0016228689,0.0018566931,0.0028983336,0.0019911625],"category_scores_gemma":[0.0026701526,0.0005692673,0.00089107663,0.0018562963,0.001074791,0.002237029,0.0010435351,0.0036696608,0.0015238023],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018167472,0.00009212043,0.00036261708,0.009120497,0.00017848187,0.000299916,0.000031029376,0.00037557597,0.0017785091,0.0035709229,0.04102402,0.9429846],"study_design_scores_gemma":[0.00016740759,0.00032692528,0.0017089185,0.0057106214,0.00056590687,0.0016351626,0.00008465562,0.00032441356,0.00170664,0.0058747777,0.9818372,0.000057362093],"about_ca_topic_score_codex":0.0023232675,"about_ca_topic_score_gemma":0.003639765,"teacher_disagreement_score":0.0036100121,"about_ca_system_score_codex":0.0013549455,"about_ca_system_score_gemma":0.0021043129,"threshold_uncertainty_score":0.012322307},"labels":[],"label_agreement":null},{"id":"W2137728866","doi":"10.1016/s1474-4422(08)70292-8","title":"Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology","year":2008,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":478,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"Johnson and Johnson; National Institutes of Health; Shire; GlaxoSmithKline; AstraZeneca; Novartis; Pfizer; National Institute of Neurological Disorders and Stroke; Eisai; Abbott Laboratories","keywords":"Lennox–Gastaut syndrome; Pathognomonic; Pediatrics; Epilepsy syndromes; Medicine; Intensive care medicine; Epilepsy; Psychiatry; Psychology; Disease; Internal medicine","score_opus":0.31409085596979097,"score_gpt":0.4571949109034185,"score_spread":0.14310405493362754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137728866","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00051595294,0.955162,0.012772808,0.025953557,0.0023904154,0.0018234451,0.0002922703,0.000056805424,0.0010328564],"genre_scores_gemma":[0.02724122,0.8435066,0.09493557,0.020010605,0.0030316866,0.009755709,0.0007609113,0.00009368035,0.00066396984],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.8707784,0.082438245,0.029625911,0.005119952,0.011027363,0.0010100794],"domain_scores_gemma":[0.6989422,0.25876325,0.01763229,0.005520738,0.017266335,0.0018751553],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.20863523,0.0021445611,0.016764719,0.0046693357,0.0013588753,0.0068285614,0.009760592,0.008307104,0.002477061],"category_scores_gemma":[0.3096135,0.0013426419,0.0070071723,0.0043103164,0.002847474,0.0057490226,0.0046211975,0.0073783663,0.0008466299],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012909529,0.000078050085,0.00149507,0.17223524,0.008964738,0.00013366995,0.0005647889,0.0015253416,0.00035546737,0.019525446,0.0276581,0.76617306],"study_design_scores_gemma":[0.0062613576,0.0006111266,0.004586931,0.58049315,0.03972727,0.00096566696,0.00091191125,0.005722146,0.0013666159,0.112266004,0.24674456,0.0003433148],"about_ca_topic_score_codex":0.0040667662,"about_ca_topic_score_gemma":0.005264797,"teacher_disagreement_score":0.20863523,"about_ca_system_score_codex":0.008450468,"about_ca_system_score_gemma":0.024107749,"threshold_uncertainty_score":0.9758937},"labels":[],"label_agreement":null},{"id":"W2137753851","doi":"10.1016/s1474-4422(09)70106-1","title":"Use of alteplase in childhood arterial ischaemic stroke: a multicentre, observational, cohort study","year":2009,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary; Health Sciences Centre; Hospital for Sick Children; McMaster University; University of Toronto","funders":"National Institutes of Health; Canadian Stroke Network; Child Neurology Foundation; Thrasher Research Fund; Heart and Stroke Foundation of Canada; National Center for Research Resources; National Institute of Neurological Disorders and Stroke; American Heart Association","keywords":"Medicine; Observational study; Stroke (engine); Ischaemic stroke; Cohort; Cohort study; Internal medicine; Cardiology; Ischemia","score_opus":0.08293647866208709,"score_gpt":0.30978894655289935,"score_spread":0.22685246789081226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137753851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986002,0.00045437377,0.000085672575,0.00005547402,0.0000126202785,0.000012481053,0.0006095951,0.000003887232,0.00016573665],"genre_scores_gemma":[0.99874663,0.0003636106,0.00012652385,0.000046749672,0.000019558747,0.00001583662,0.00055195455,0.0000038676,0.00012522166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981711,0.0006182892,0.00022506701,0.00046083593,0.000247953,0.0002768174],"domain_scores_gemma":[0.99437165,0.0011893795,0.002289515,0.0010412991,0.0004887077,0.0006193374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017459309,0.0007600895,0.0012374116,0.0008600824,0.00089130295,0.0013756682,0.00094812346,0.0014108099,0.0011315483],"category_scores_gemma":[0.0049281004,0.0013142669,0.0017838727,0.0025679413,0.0007809559,0.0012216589,0.00073731894,0.0018458668,0.00027282932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021545507,0.000203409,0.99411607,0.0000344179,0.0013407094,0.0002834442,0.00017126663,0.00007455915,0.0005569695,0.000040911695,0.00019002668,0.00083368015],"study_design_scores_gemma":[0.00020431846,0.00052140723,0.9976043,0.00001309548,0.00059517135,0.00042763402,0.00020092378,0.00019996589,0.00008204909,0.00002835976,0.00010596395,0.000016712262],"about_ca_topic_score_codex":0.02359306,"about_ca_topic_score_gemma":0.019533088,"teacher_disagreement_score":0.02359306,"about_ca_system_score_codex":0.0010488379,"about_ca_system_score_gemma":0.0009934471,"threshold_uncertainty_score":0.046911478},"labels":[],"label_agreement":null},{"id":"W2138065855","doi":"10.1016/s1474-4422(02)00038-8","title":"The placebo effect in neurological disorders","year":2002,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Pain Management and Placebo Effect","field":"Neuroscience","cited_by":187,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Placebo; Addiction; Depression (economics); Medicine; Dopaminergic; Psychiatry; Disease; Mechanism (biology); Psychology; Neuroscience; Dopamine; Internal medicine; Alternative medicine","score_opus":0.07176536497795155,"score_gpt":0.3273430061556772,"score_spread":0.25557764117772563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138065855","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006271799,0.9990569,0.00007928191,0.00026643722,0.0002245313,0.000004787457,0.0000063903867,0.0000030147266,0.00029600083],"genre_scores_gemma":[0.0030798474,0.9947314,0.00028622276,0.0007909732,0.00066230533,0.000021479034,0.000010747094,0.000002081991,0.0004149127],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989973,0.00042507105,0.00018051139,0.000119226344,0.00023448833,0.000043464843],"domain_scores_gemma":[0.9966221,0.002832067,0.00032069677,0.000048053505,0.00012767379,0.00004943437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027426446,0.0013105351,0.005116289,0.002148886,0.000312167,0.0013692016,0.0011043724,0.0028720472,0.005406464],"category_scores_gemma":[0.0051502865,0.00047550924,0.0013218913,0.0017023748,0.0014581485,0.0016457841,0.0006742162,0.0030188004,0.0006711128],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016015028,0.00009393184,0.00011867441,0.0873117,0.0009601716,0.00042976823,0.000086772234,0.0003126456,0.0010950543,0.0055333264,0.017666854,0.8847896],"study_design_scores_gemma":[0.004920654,0.00181712,0.0039632283,0.072895326,0.0065258294,0.0054718084,0.0003067915,0.00061033585,0.0017188746,0.033327833,0.8683177,0.00012454549],"about_ca_topic_score_codex":0.0010019959,"about_ca_topic_score_gemma":0.002165315,"teacher_disagreement_score":0.005406464,"about_ca_system_score_codex":0.00080511445,"about_ca_system_score_gemma":0.0010743953,"threshold_uncertainty_score":0.018086433},"labels":[],"label_agreement":null},{"id":"W2138115784","doi":"10.1016/s1474-4422(07)70242-9","title":"Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions","year":2007,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":391,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; SickKids Foundation; Montreal Neurological Institute and Hospital; Hospital for Sick Children; University of Toronto","funders":"National Institutes of Health; Multiple Sclerosis Society of Canada; Immune Tolerance Network","keywords":"Multiple sclerosis; Acute disseminated encephalomyelitis; Medicine; Disease; Pathological; Pediatrics; Encephalomyelitis; Demyelinating disease; Intensive care medicine; Pathology; Immunology","score_opus":0.2695491440954591,"score_gpt":0.43693271457469574,"score_spread":0.16738357047923663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138115784","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019929652,0.9996848,0.000010889951,0.00017508556,0.000043524466,0.000001311199,0.000005559942,9.3881044e-7,0.000057976224],"genre_scores_gemma":[0.0001752082,0.99959356,0.000049677226,0.0000995871,0.000049691676,0.0000024383753,0.0000053194253,1.8827441e-7,0.000024436333],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99923825,0.00021779891,0.0001749573,0.000097307005,0.00022793283,0.000043853015],"domain_scores_gemma":[0.9963342,0.0024821311,0.00056875474,0.000043276523,0.00045674545,0.00011473379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029032752,0.0012799333,0.0053342846,0.0041098357,0.00031642153,0.0017959311,0.0015721029,0.0017497261,0.003354885],"category_scores_gemma":[0.0045934147,0.00043107185,0.0011084218,0.0056374082,0.0008897146,0.0018733178,0.00083934795,0.001763661,0.00087724003],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002201822,0.000053679225,0.0006100456,0.08809042,0.00072006014,0.00026336833,0.000089378176,0.0002960195,0.00036014424,0.0025063886,0.028225297,0.8785651],"study_design_scores_gemma":[0.00033966752,0.00024988776,0.0061405418,0.14688927,0.0042481064,0.0032421271,0.0006794892,0.00022311763,0.0003339674,0.00577779,0.8317905,0.0000855062],"about_ca_topic_score_codex":0.0047165737,"about_ca_topic_score_gemma":0.012489041,"teacher_disagreement_score":0.0053342846,"about_ca_system_score_codex":0.0017313887,"about_ca_system_score_gemma":0.004174799,"threshold_uncertainty_score":0.0153541565},"labels":[],"label_agreement":null},{"id":"W2138282259","doi":"10.1016/s1474-4422(13)70258-8","title":"Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study","year":2013,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":438,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"National Center for Research Resources","keywords":"ADAR; SAMHD1; Interferon; Genetics; Virology; Biology; Medicine; Polymerase chain reaction; Gene; RNA; Reverse transcriptase","score_opus":0.012359994245116693,"score_gpt":0.2552329367692237,"score_spread":0.24287294252410702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138282259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99937856,0.00022428189,0.00013517386,0.000016132362,0.0000046859823,0.000013832432,0.000045340483,0.0000038380003,0.0001782827],"genre_scores_gemma":[0.99960655,0.00008581005,0.00013475312,0.000020352925,0.000011914869,0.000008899755,0.000051027735,0.000002340603,0.000078417965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991155,0.00023595251,0.00012513167,0.00028689372,0.00014318261,0.00009325977],"domain_scores_gemma":[0.9985684,0.0006012416,0.00037279926,0.000121746314,0.00014473405,0.00019095931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009907368,0.0012058056,0.00094933924,0.002000578,0.0010494926,0.0008440928,0.0007043956,0.0016377143,0.0015749196],"category_scores_gemma":[0.0028159223,0.00071301963,0.00077423954,0.00096850685,0.0010435063,0.00057650043,0.00045077104,0.00067511987,0.00019337794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017692741,0.00043649858,0.9678187,0.00005311468,0.00031913942,0.01877812,0.00064707425,0.00013295731,0.0064785006,0.00014330244,0.00014081111,0.0032826043],"study_design_scores_gemma":[0.00022604123,0.0010998215,0.95490897,0.000033275774,0.00036892353,0.040433165,0.00046805953,0.0009945477,0.000935763,0.00016178799,0.00033177336,0.000037757127],"about_ca_topic_score_codex":0.0027365491,"about_ca_topic_score_gemma":0.0016983738,"teacher_disagreement_score":0.0027365491,"about_ca_system_score_codex":0.0005974003,"about_ca_system_score_gemma":0.00028796136,"threshold_uncertainty_score":0.005441308},"labels":[],"label_agreement":null},{"id":"W2138447230","doi":"10.1016/s1474-4422(11)70024-2","title":"Emerging targets and treatments in amyotrophic lateral sclerosis","year":2011,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Amyotrophic lateral sclerosis; Riluzole; Motor neuron; Disease; Neuroscience; Medicine; Physical medicine and rehabilitation; Psychology; Pathology","score_opus":0.15991016190396656,"score_gpt":0.36591931673222283,"score_spread":0.20600915482825627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138447230","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020462036,0.999318,0.000030638508,0.00018146564,0.00016792338,0.0000024811432,0.000008945802,0.000002624839,0.0002675073],"genre_scores_gemma":[0.00027500666,0.998923,0.000104754516,0.0002682524,0.00017744237,0.000005155416,0.000015334734,7.1638107e-7,0.00023032911],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99958223,0.00008159409,0.00007231359,0.00004956791,0.00017150474,0.000042771306],"domain_scores_gemma":[0.9992213,0.00047346973,0.00011825702,0.00001571554,0.00012961624,0.00004160062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014020263,0.0014515705,0.0034181676,0.0027534056,0.0003349485,0.00175609,0.0012480601,0.0020959326,0.0041327337],"category_scores_gemma":[0.0016408961,0.00046317678,0.00095252023,0.002845317,0.00075640867,0.0020150237,0.000915182,0.0033387584,0.0020200557],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026636472,0.00008261256,0.00012432497,0.031164715,0.00030167424,0.0002214868,0.000053809184,0.0004900342,0.00096135685,0.0035792843,0.05803954,0.9047148],"study_design_scores_gemma":[0.00018358632,0.00016873087,0.0007439864,0.012209204,0.000652141,0.0007761271,0.00009610328,0.00013703835,0.00022935079,0.0037905856,0.9809807,0.000032405376],"about_ca_topic_score_codex":0.0021947923,"about_ca_topic_score_gemma":0.005245294,"teacher_disagreement_score":0.0041327337,"about_ca_system_score_codex":0.0010951114,"about_ca_system_score_gemma":0.0017924766,"threshold_uncertainty_score":0.013825417},"labels":[],"label_agreement":null},{"id":"W2139535317","doi":"10.1016/s1474-4422(14)70093-6","title":"Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research","year":2014,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"National Institute of Neurological Disorders and Stroke; Multiple Sclerosis Society of Canada; Philadelphia Foundation","keywords":"Multiple sclerosis; Medicine; Clinical trial; Neuroimaging; Disease; Clinically isolated syndrome; Pediatrics; Intensive care medicine; Pathology; Immunology; Psychiatry","score_opus":0.4587530122105508,"score_gpt":0.5035618582042498,"score_spread":0.044808845993699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139535317","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000026799784,0.9995272,0.000019436568,0.00023441948,0.000091078815,0.0000023204595,0.000021356424,0.000001771757,0.00007573416],"genre_scores_gemma":[0.0002030592,0.99923575,0.00009479546,0.00029186418,0.000114818424,0.000003805839,0.000021801208,5.595472e-7,0.000033543503],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986112,0.00034532722,0.00043021998,0.00015090386,0.0003869381,0.000075393276],"domain_scores_gemma":[0.9933995,0.0047581163,0.00086579623,0.00008103714,0.00076171977,0.00013390384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039099013,0.0012444598,0.0046069124,0.006229417,0.0003325875,0.0022401742,0.0014957543,0.0019174946,0.0034153797],"category_scores_gemma":[0.0068247044,0.000575673,0.002014811,0.0072868243,0.0007768036,0.0025930898,0.0012108064,0.0021534846,0.00071622315],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021005362,0.0000583027,0.00068454933,0.14023128,0.00091278245,0.0001845312,0.00012533033,0.00023941336,0.00045333436,0.0020088225,0.047055077,0.8078366],"study_design_scores_gemma":[0.00021787136,0.00017498093,0.004233869,0.15196212,0.0045687794,0.0015110483,0.00031216268,0.000143827,0.00025072845,0.0026325858,0.8339158,0.00007615405],"about_ca_topic_score_codex":0.00558164,"about_ca_topic_score_gemma":0.014360574,"teacher_disagreement_score":0.006229417,"about_ca_system_score_codex":0.0018630399,"about_ca_system_score_gemma":0.006199873,"threshold_uncertainty_score":0.020677805},"labels":[],"label_agreement":null},{"id":"W2139560421","doi":"10.1016/s1474-4422(14)70222-4","title":"Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial","year":2014,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":239,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Ceftriaxone; Placebo; Medicine; Amyotrophic lateral sclerosis; Internal medicine; Clinical trial; Antibiotics; Disease; Pathology","score_opus":0.12024339115993969,"score_gpt":0.35106407164419545,"score_spread":0.23082068048425575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139560421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96784794,0.01815585,0.0015062205,0.001136284,0.001592044,0.0062545952,0.0013027964,0.00015844488,0.0020457052],"genre_scores_gemma":[0.97804356,0.0064758323,0.0019119243,0.0013785554,0.0009920815,0.0066587166,0.0010201326,0.000033441233,0.0034856952],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99822694,0.00086598145,0.00018574357,0.00036047425,0.00014869052,0.00021215272],"domain_scores_gemma":[0.99764144,0.0010214954,0.00052293355,0.00019549081,0.00020024911,0.0004183464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030893937,0.0025501251,0.006668015,0.0007226208,0.00064485107,0.0015238618,0.0013570279,0.005126936,0.0060554235],"category_scores_gemma":[0.004874217,0.0010856072,0.0034955232,0.0005951781,0.0021986752,0.0020751513,0.00052838045,0.0031239486,0.0012347038],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9934324,0.0009957313,0.00016134902,0.00059753173,0.0005340789,0.000019331172,0.000023222552,0.000059173864,0.0009407919,0.000035509653,0.0001498628,0.003050968],"study_design_scores_gemma":[0.98123837,0.017275551,0.00060429476,0.000037062822,0.00035719093,0.0000123409745,0.000008565569,0.000109554734,0.00012483963,0.000049696955,0.00017123007,0.000011249806],"about_ca_topic_score_codex":0.0010824729,"about_ca_topic_score_gemma":0.001373159,"teacher_disagreement_score":0.006668015,"about_ca_system_score_codex":0.001060308,"about_ca_system_score_gemma":0.0011553103,"threshold_uncertainty_score":0.020257354},"labels":[],"label_agreement":null},{"id":"W2139560482","doi":"10.1016/s1474-4422(13)70102-9","title":"Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study","year":2013,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":233,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Placebo; Tolerability; Multiple sclerosis; Dose-ranging study; Internal medicine; Cohort; Clinical endpoint; Adverse effect; Interim analysis; Randomized controlled trial; Double blind; Pathology; Immunology","score_opus":0.030383427956818237,"score_gpt":0.25372460308156963,"score_spread":0.2233411751247514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139560482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930733,0.0021794802,0.00058110466,0.00045884564,0.00025303906,0.0013173859,0.000640082,0.00012439211,0.0013723621],"genre_scores_gemma":[0.98449796,0.0033738143,0.0023973952,0.0014073936,0.00037598042,0.0031955778,0.001198513,0.000047285666,0.0035059892],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997342,0.00011465495,0.00001328163,0.000042193882,0.000022479015,0.00007312467],"domain_scores_gemma":[0.9995347,0.00012711651,0.00007512767,0.000053344713,0.000026759122,0.00018286942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010123648,0.0019711824,0.002848276,0.00045133752,0.00032775485,0.00081737764,0.0007661752,0.0015172007,0.0043906164],"category_scores_gemma":[0.0009282398,0.0005389898,0.0015284431,0.00041552607,0.00097459287,0.0010582851,0.00039719115,0.002617477,0.00089615304],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.940597,0.008672401,0.0008259341,0.000777137,0.0012474706,0.00007987539,0.00009334461,0.0012311147,0.008584826,0.00020819668,0.0010050471,0.036677685],"study_design_scores_gemma":[0.9213672,0.07435353,0.0021509484,0.000029497141,0.00033657078,0.000040027262,0.00002619228,0.00044703792,0.00043323194,0.00020020753,0.0005955602,0.000020057952],"about_ca_topic_score_codex":0.00070869917,"about_ca_topic_score_gemma":0.0014836575,"teacher_disagreement_score":0.0043906164,"about_ca_system_score_codex":0.00047414668,"about_ca_system_score_gemma":0.0008107851,"threshold_uncertainty_score":0.014688134},"labels":[],"label_agreement":null},{"id":"W2140052686","doi":"10.1016/s1474-4422(03)00442-3","title":"Neural transplantation for the treatment of Parkinson's disease","year":2003,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Nerve injury and regeneration","field":"Neuroscience","cited_by":357,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Medical Research Council","keywords":"Dopaminergic; Parkinson's disease; Striatum; Transplantation; Dopamine; Neuroscience; Disease; Medicine; Degenerative disease; Internal medicine; Psychology","score_opus":0.1372065685097453,"score_gpt":0.3628622315507211,"score_spread":0.2256556630409758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140052686","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000105981555,0.99797755,0.00016758095,0.00024036155,0.00038017193,0.0000049126706,0.000010022574,0.000007579901,0.0011058513],"genre_scores_gemma":[0.0006755722,0.99770445,0.00028118564,0.00022989833,0.00025766896,0.000007383075,0.000018236396,0.0000020425869,0.0008236392],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998318,0.00003069604,0.000021795622,0.000027954871,0.00007164313,0.000016066459],"domain_scores_gemma":[0.9996019,0.00021774608,0.00004475538,0.000012963736,0.00008675451,0.00003584738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009842761,0.0011938512,0.0022204649,0.0020097701,0.00034949087,0.0010363375,0.0013195166,0.0016131934,0.003974223],"category_scores_gemma":[0.0007215611,0.00023298053,0.0005514459,0.0020271982,0.000805335,0.0012505917,0.00057399535,0.0024765392,0.0024110258],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016027167,0.00012089959,0.00009620579,0.008743313,0.000100342324,0.00035054388,0.000038433955,0.00038087068,0.0015170607,0.0031226152,0.034585856,0.9507836],"study_design_scores_gemma":[0.00013403119,0.00020479107,0.0008176232,0.003345604,0.00016748851,0.002170997,0.00007094683,0.0001289927,0.00057712133,0.002653881,0.98970467,0.000023995934],"about_ca_topic_score_codex":0.0020767832,"about_ca_topic_score_gemma":0.0060192235,"teacher_disagreement_score":0.003974223,"about_ca_system_score_codex":0.0006582801,"about_ca_system_score_gemma":0.0008442163,"threshold_uncertainty_score":0.013295114},"labels":[],"label_agreement":null},{"id":"W2140646485","doi":"10.1016/s1474-4422(06)70536-1","title":"Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study","year":2006,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Institute for Clinical Evaluative Sciences; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Atrial fibrillation; Warfarin; Antithrombotic; Stroke (engine); Internal medicine; Modified Rankin Scale; Odds ratio; Cardiology; Ischemic stroke; Ischemia","score_opus":0.08951200398208381,"score_gpt":0.3376258250827998,"score_spread":0.248113821100716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140646485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973911,0.00070250843,0.00016049118,0.000114501585,0.000040537296,0.00003650314,0.0012124451,0.000005548159,0.0003363492],"genre_scores_gemma":[0.9966281,0.0004186603,0.00021436467,0.0001807209,0.000115557836,0.00007106254,0.0021066496,0.0000062705267,0.00025855418],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99681014,0.0011860615,0.0005354458,0.0006667488,0.00037513312,0.0004264228],"domain_scores_gemma":[0.9861996,0.0034954855,0.004934742,0.0023157794,0.0010037997,0.0020506466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003002293,0.0011320146,0.0026163205,0.0010831702,0.0015792788,0.0026373283,0.001802202,0.0027180975,0.002153906],"category_scores_gemma":[0.009742506,0.002266206,0.0039060144,0.0041641183,0.0009722266,0.0024274532,0.001389841,0.004515319,0.000489588],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004383537,0.00056797656,0.9911742,0.000078605146,0.0022211273,0.00020009936,0.00016784202,0.000072126495,0.00021267378,0.00005230422,0.00028596396,0.0005836041],"study_design_scores_gemma":[0.000981542,0.0012219951,0.99469286,0.000028748793,0.0014426343,0.0005285461,0.00031790574,0.00033657576,0.00006277637,0.00009603525,0.0002521592,0.000038174367],"about_ca_topic_score_codex":0.014137679,"about_ca_topic_score_gemma":0.015749132,"teacher_disagreement_score":0.014137679,"about_ca_system_score_codex":0.0010927625,"about_ca_system_score_gemma":0.0016862096,"threshold_uncertainty_score":0.028110802},"labels":[],"label_agreement":null},{"id":"W2141031417","doi":"10.1016/s1474-4422(14)70224-8","title":"Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial","year":2014,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital; McMaster University; Population Health Research Institute","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke","keywords":"Medicine; Lacunar stroke; Term (time); Stroke (engine); Cognition; Internal medicine; Dual (grammatical number); Blood pressure; Cardiology; Physical therapy; Physical medicine and rehabilitation; Ischemic stroke; Psychiatry; Ischemia","score_opus":0.008169124620431725,"score_gpt":0.22389109605125,"score_spread":0.21572197143081825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141031417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98035115,0.011608535,0.0005727727,0.0009609946,0.0009304349,0.000535963,0.0027324178,0.00007786488,0.0022298263],"genre_scores_gemma":[0.99029094,0.0027970634,0.00051175995,0.0008738631,0.00080722605,0.0006189527,0.0025208995,0.000023604025,0.0015556426],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9985833,0.00072237506,0.000160216,0.00023067584,0.00011032561,0.00019310227],"domain_scores_gemma":[0.998237,0.0006396675,0.00039941355,0.00020515666,0.00015034093,0.00036849832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025123667,0.0023107699,0.00535815,0.0003991305,0.0005020428,0.0016474694,0.001006147,0.0019272417,0.0062603108],"category_scores_gemma":[0.0031095978,0.0007642567,0.009207695,0.00075093773,0.0011957621,0.0014196986,0.0009155313,0.0043847007,0.0008512877],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9855468,0.000374592,0.0013327771,0.0007709054,0.0078197345,0.00004466228,0.000028045197,0.00018945363,0.0005486249,0.000080338155,0.0005835733,0.0026804106],"study_design_scores_gemma":[0.9490277,0.017143134,0.016050642,0.00014457038,0.015433457,0.00008975774,0.000066180306,0.00045536034,0.0002227612,0.0005682597,0.00075412734,0.000043956992],"about_ca_topic_score_codex":0.003134703,"about_ca_topic_score_gemma":0.0053671133,"teacher_disagreement_score":0.0062603108,"about_ca_system_score_codex":0.0009629013,"about_ca_system_score_gemma":0.0013089492,"threshold_uncertainty_score":0.020942807},"labels":[],"label_agreement":null},{"id":"W2144100180","doi":"10.1016/s1474-4422(11)70291-5","title":"Cardiovascular and neurological causes of sudden death after ischaemic stroke","year":2012,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Heart Rate Variability and Autonomic Control","field":"Medicine","cited_by":268,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Stroke (engine); Sudden cardiac death; Cardiology; Sudden death; Internal medicine; Cause of death; Disease","score_opus":0.09099102919488906,"score_gpt":0.31479144615674753,"score_spread":0.22380041696185848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144100180","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000088873174,0.9989672,0.000043463286,0.00021007002,0.00030187026,0.0000037770865,0.000027968279,0.000003744981,0.00035314364],"genre_scores_gemma":[0.0010253934,0.9979571,0.000060282815,0.00023790234,0.00052080356,0.0000054760835,0.000035515375,7.67206e-7,0.00015673706],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996464,0.00006302538,0.000094900024,0.000056918485,0.00010959174,0.000029147013],"domain_scores_gemma":[0.9990007,0.00051874097,0.00024386012,0.000022337574,0.00015791228,0.000056443583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087493856,0.0011291321,0.0031688141,0.0031498575,0.0002370155,0.0009091032,0.0008406234,0.0013371119,0.003839001],"category_scores_gemma":[0.0022279741,0.00035986546,0.0013252099,0.002609152,0.00040299297,0.0009134084,0.00084246084,0.0014213814,0.0009200422],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002710127,0.000060690756,0.0008249816,0.050590146,0.0013818799,0.00017614674,0.000044653065,0.0002561034,0.00026690873,0.00090380304,0.034196828,0.9110269],"study_design_scores_gemma":[0.0005976963,0.0006344175,0.023944816,0.059743132,0.011946991,0.0029520623,0.0003352836,0.00048782126,0.00046854245,0.0050779595,0.8936486,0.00016267526],"about_ca_topic_score_codex":0.0034294217,"about_ca_topic_score_gemma":0.008261004,"teacher_disagreement_score":0.003839001,"about_ca_system_score_codex":0.0005680848,"about_ca_system_score_gemma":0.0016393743,"threshold_uncertainty_score":0.012842715},"labels":[],"label_agreement":null},{"id":"W2144781915","doi":"10.1016/s1474-4422(11)70045-x","title":"Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study","year":2011,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":318,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Hôpital Charles-Le Moyne; The Scarborough Hospital; Windsor Regional Hospital; Trillium Health Centre; Janeway Children's Health and Rehabilitation Centre; Children's Hospital of Western Ontario; University of Manitoba; Children's Hospital of Eastern Ontario; Centre Hospitalier Universitaire Sainte-Justine; McMaster Children's Hospital; Montreal Neurological Institute and Hospital; Queen's University; Alberta Children's Hospital; Children's Hospital of Winnipeg; Mount Sinai Hospital; University of Calgary; McGill University; BC Children's Hospital; Izaak Walton Killam Health Centre; Royal University Hospital; Montreal Children's Hospital; Sudbury Regional Hospital; University of Toronto; University of British Columbia; Saint John Regional Hospital; SickKids Foundation; Stollery Children's Hospital; Hospital for Sick Children; Victoria General Hospital; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Multiple sclerosis; Medicine; Prospective cohort study; Cohort; Cohort study; Pediatrics; Environmental health; Internal medicine; Immunology","score_opus":0.09899395451931238,"score_gpt":0.33737005061147385,"score_spread":0.23837609609216148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144781915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99897015,0.00019808412,0.000059660324,0.0000596296,0.000008862998,0.0000077966415,0.00051296025,0.000002480303,0.00018052077],"genre_scores_gemma":[0.9988411,0.00022472892,0.0001515707,0.000038969294,0.000011198351,0.000020490417,0.00051361544,0.000004747572,0.0001935589],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983901,0.000496269,0.00018776166,0.0004377778,0.00023213748,0.00025597587],"domain_scores_gemma":[0.9971481,0.00046942534,0.00089369825,0.000569975,0.00038429713,0.00053456385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017266325,0.0008478351,0.0007795016,0.0009141963,0.0015897356,0.0011688637,0.0010986034,0.0013137927,0.0012701747],"category_scores_gemma":[0.0034558843,0.0011322766,0.0012751926,0.0022228782,0.0007428787,0.0012085807,0.001212198,0.001873743,0.00033594883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025190267,0.000091798654,0.9980506,0.000008156107,0.00021369774,0.00023220885,0.00024360705,0.000039673585,0.00037840055,0.000032771703,0.00010703229,0.00035001818],"study_design_scores_gemma":[0.000028134917,0.000112826696,0.9986327,0.000007998997,0.00010876193,0.00046538553,0.0003792289,0.00006888853,0.0000478014,0.000022045513,0.00011875918,0.0000073544393],"about_ca_topic_score_codex":0.03165972,"about_ca_topic_score_gemma":0.030091172,"teacher_disagreement_score":0.03165972,"about_ca_system_score_codex":0.0007686602,"about_ca_system_score_gemma":0.0010713107,"threshold_uncertainty_score":0.06295091},"labels":[],"label_agreement":null},{"id":"W2145036730","doi":"10.1016/s1474-4422(07)70174-6","title":"Deciphering the role of heterozygous mutations in genes associated with parkinsonism","year":2007,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":311,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Occupational Cancer Research Centre; Toronto Western Hospital","funders":"National Institutes of Health; Volkswagen Foundation; Michael J. Fox Foundation for Parkinson's Research","keywords":"LRRK2; Parkin; Parkinsonism; PINK1; Genetics; Mutation; Loss of heterozygosity; Parkinson's disease; Biology; Disease; Compound heterozygosity; Gene; Medicine; Allele; Internal medicine","score_opus":0.06353779093659583,"score_gpt":0.3335439101097914,"score_spread":0.27000611917319556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145036730","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000109302666,0.9986873,0.00012104923,0.00033329375,0.000156829,0.0000024178637,0.000011272417,0.0000058124133,0.0005728093],"genre_scores_gemma":[0.0005680923,0.9982724,0.00023621881,0.00032664946,0.00021296291,0.000003398211,0.000023276036,0.0000011944335,0.00035568041],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974877,0.000042733172,0.000036834368,0.00003999713,0.000111323745,0.000020417627],"domain_scores_gemma":[0.9995172,0.0002828951,0.00006714953,0.000013106184,0.0000910133,0.000028520888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079453015,0.0011241891,0.0026521147,0.0018621235,0.00019986992,0.0010308694,0.0014247877,0.0017482784,0.002512301],"category_scores_gemma":[0.00090458983,0.00030067997,0.0005424106,0.0016204078,0.0006778005,0.001290954,0.00062524446,0.0021202092,0.001824071],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010692212,0.000048465554,0.0002511677,0.008632087,0.00014068648,0.0006989144,0.00003793852,0.00032509948,0.0023751624,0.0032495968,0.026525985,0.9576079],"study_design_scores_gemma":[0.00007018262,0.00009614607,0.0015215789,0.003329225,0.00026816374,0.004172636,0.00008140938,0.00012908867,0.00083133444,0.005206865,0.9842631,0.000030148343],"about_ca_topic_score_codex":0.0011230129,"about_ca_topic_score_gemma":0.002275195,"teacher_disagreement_score":0.0026521147,"about_ca_system_score_codex":0.00057213334,"about_ca_system_score_gemma":0.00084086653,"threshold_uncertainty_score":0.008404493},"labels":[],"label_agreement":null},{"id":"W2145341368","doi":"10.1016/s1474-4422(03)00352-1","title":"Long-term prognosis after lacunar infarction","year":2003,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":266,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Heart and Stroke Foundation of Canada","keywords":"Medicine; Stroke (engine); Cardiology; Dementia; Disease; Lacunar stroke; Internal medicine; Risk factor; Infarction; Cognitive decline; Ischemia; Myocardial infarction; Ischemic stroke","score_opus":0.0561596027771974,"score_gpt":0.3338353877482948,"score_spread":0.2776757849710974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145341368","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003289913,0.99889404,0.00001890351,0.00023099929,0.00017655747,0.0000022155805,0.000039911367,0.000002088346,0.00030628566],"genre_scores_gemma":[0.0030700713,0.99627775,0.00004242328,0.00020544679,0.00016788175,0.0000049037094,0.000055759083,5.439386e-7,0.00017528005],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99975497,0.00005016278,0.000061982835,0.000036276186,0.00007305077,0.000023566137],"domain_scores_gemma":[0.99935704,0.00032661605,0.00017408775,0.000012410436,0.000092323375,0.00003755961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088018854,0.00068692456,0.0027113417,0.0013975551,0.00018903379,0.00073813734,0.00068516115,0.0008985629,0.002374014],"category_scores_gemma":[0.0021764133,0.00017797001,0.0008104792,0.002128994,0.00028078436,0.00071988825,0.00042276332,0.0008707071,0.00058486505],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006547969,0.00007566232,0.0030471408,0.043262552,0.0016072739,0.00043903288,0.000076926786,0.00026939446,0.00027439283,0.0008338749,0.040825754,0.9086332],"study_design_scores_gemma":[0.0010890274,0.0012406579,0.061822385,0.113940135,0.015402778,0.0061484855,0.00067178695,0.00037117454,0.0005175786,0.0054417783,0.7932075,0.00014665553],"about_ca_topic_score_codex":0.0038410255,"about_ca_topic_score_gemma":0.01084234,"teacher_disagreement_score":0.0038410255,"about_ca_system_score_codex":0.0006983089,"about_ca_system_score_gemma":0.0014224951,"threshold_uncertainty_score":0.007941902},"labels":[],"label_agreement":null},{"id":"W2145599246","doi":"10.1016/s1474-4422(15)00068-x","title":"Sleep-wake disturbances after traumatic brain injury","year":2015,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Neuroscience of respiration and sleep","field":"Neuroscience","cited_by":227,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut Universitaire en Santé Mentale de Québec; Université Laval; Centre for Interdisciplinary Research in Rehabilitation","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research","keywords":"Traumatic brain injury; Insomnia; Anxiety; Depression (economics); Sleep disorder; Medicine; Psychology; Sleep (system call); Physical medicine and rehabilitation; Psychiatry","score_opus":0.15777674785162052,"score_gpt":0.3805228107298047,"score_spread":0.2227460628781842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145599246","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004313759,0.99951684,0.000021341057,0.00009824227,0.00011613652,0.0000015296957,0.000008525483,0.0000013319321,0.00019290639],"genre_scores_gemma":[0.00058703386,0.9987141,0.000046052322,0.00016734851,0.0002913176,0.0000035498804,0.00002031382,5.35449e-7,0.00016978572],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983156,0.000027857779,0.000042582684,0.000031745178,0.000044530745,0.00002172444],"domain_scores_gemma":[0.9995999,0.00022437627,0.00008907122,0.000008363904,0.000054010616,0.00002444124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050483446,0.0009877209,0.0015848926,0.0018207141,0.0002549065,0.00090190425,0.00086756016,0.0011462113,0.0025808709],"category_scores_gemma":[0.0012108657,0.0002268588,0.00058958796,0.0019308232,0.0005314476,0.001080291,0.00097449863,0.0013038843,0.00085124554],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014842457,0.00004549172,0.00032747324,0.027401669,0.0002540254,0.00027366294,0.000042697953,0.0002170481,0.0004050594,0.001094469,0.02435338,0.94543654],"study_design_scores_gemma":[0.00015267928,0.00028380784,0.008394727,0.032202993,0.0011316115,0.0048495703,0.00028669962,0.00021888534,0.0004574374,0.0049807075,0.94695836,0.00008250769],"about_ca_topic_score_codex":0.0021871992,"about_ca_topic_score_gemma":0.0060910545,"teacher_disagreement_score":0.0025808709,"about_ca_system_score_codex":0.0005173055,"about_ca_system_score_gemma":0.0011508595,"threshold_uncertainty_score":0.008633912},"labels":[],"label_agreement":null},{"id":"W2145751373","doi":"10.1016/s1474-4422(05)70170-8","title":"Multiple sclerosis and birth order: a longitudinal cohort study","year":2005,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Multiple Sclerosis Society of Canada","keywords":"Birth order; Sibling; Demography; Context (archaeology); Multiple sclerosis; Epidemiology; Cohort; Cohort study; Longitudinal study; Population; Medicine; Offspring; Pregnancy; Pediatrics; Biology; Psychology; Genetics; Developmental psychology; Immunology; Internal medicine","score_opus":0.09816487826702526,"score_gpt":0.3232258371230358,"score_spread":0.22506095885601057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145751373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99722457,0.0007084266,0.00017487434,0.00029222723,0.000044327127,0.000011124009,0.0013157526,0.0000093573535,0.0002192878],"genre_scores_gemma":[0.9968092,0.00060943357,0.0003212327,0.00011063351,0.000040320803,0.00003686108,0.0010854334,0.000012649953,0.00097423664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980324,0.0008593543,0.000167428,0.0003907044,0.00016602244,0.00038418735],"domain_scores_gemma":[0.987723,0.0023434872,0.0036889187,0.0031978895,0.0010789775,0.0019676804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039877645,0.0008332907,0.000981914,0.0016800353,0.0023662343,0.0019649803,0.0016351637,0.0018345027,0.0025325322],"category_scores_gemma":[0.009419163,0.0015680343,0.001814152,0.0040184245,0.00090294937,0.0018778774,0.0016834812,0.0028320274,0.0005785644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011589105,0.0002195488,0.9944659,0.00001834972,0.0009411278,0.0003355579,0.00058778824,0.00006668649,0.00039568942,0.0001567368,0.0004759208,0.0011778506],"study_design_scores_gemma":[0.00013690013,0.00040197675,0.9960334,0.000034151504,0.0007350556,0.0005222642,0.0009722218,0.00028786616,0.00009954311,0.000193328,0.0005481888,0.000035062254],"about_ca_topic_score_codex":0.058949538,"about_ca_topic_score_gemma":0.054745853,"teacher_disagreement_score":0.058949538,"about_ca_system_score_codex":0.0010283823,"about_ca_system_score_gemma":0.0021646195,"threshold_uncertainty_score":0.11721283},"labels":[],"label_agreement":null},{"id":"W2147407414","doi":"10.1016/s1474-4422(05)70097-1","title":"Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis","year":2005,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":274,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McGill University; Royal Victoria Hospital","funders":"","keywords":"Medicine; Cochrane Library; Meta-analysis; Vitamin; beta-Carotene; Observational study; Relative risk; Internal medicine; Parkinson's disease; Carotenoid; Vitamin C; Randomized controlled trial; Cohort study; Vitamin E; Disease; Physiology; Endocrinology; Confidence interval; Food science; Antioxidant; Biochemistry; Biology","score_opus":0.06165552565509721,"score_gpt":0.32064497450689183,"score_spread":0.25898944885179465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147407414","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009433677,0.9888343,0.00074720563,0.00015749258,0.00019680569,0.00009395473,0.00031748303,0.000031091018,0.0001879748],"genre_scores_gemma":[0.16894759,0.8263358,0.0025944314,0.00047149623,0.00021970524,0.00025675196,0.00058986817,0.00002170573,0.000562667],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9975018,0.0012652781,0.0005038821,0.0003311575,0.00029329216,0.00010473155],"domain_scores_gemma":[0.99533194,0.0035044951,0.00053042173,0.00019522023,0.00034212033,0.00009582049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061325035,0.0028332274,0.013814756,0.0023779157,0.0004166053,0.0016548951,0.0018513278,0.0016766111,0.0022992415],"category_scores_gemma":[0.010615647,0.0013866329,0.023032285,0.0036589894,0.00032845678,0.00080142,0.00092041004,0.0013483012,0.00024592833],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010667399,0.00006266482,0.0048625525,0.0859868,0.8730079,0.00020185186,0.00005002344,0.0009475031,0.0005261131,0.00011832268,0.0009500383,0.022618808],"study_design_scores_gemma":[0.0014977602,0.00030658202,0.003580728,0.002730186,0.9896746,0.00013179617,0.000023901497,0.0001969919,0.00015132036,0.00020380176,0.0014810133,0.000021237156],"about_ca_topic_score_codex":0.0073459726,"about_ca_topic_score_gemma":0.015494683,"teacher_disagreement_score":0.013814756,"about_ca_system_score_codex":0.0014608818,"about_ca_system_score_gemma":0.0017251151,"threshold_uncertainty_score":0.03243214},"labels":[],"label_agreement":null},{"id":"W2148207944","doi":"10.1016/s1474-4422(08)70267-9","title":"Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study","year":2008,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":569,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"National Center for Research Resources; National Institute of Biomedical Imaging and Bioengineering; National Institute of Neurological Disorders and Stroke","keywords":"Medicine; Modified Rankin Scale; Placebo; Clinical endpoint; Magnetic resonance imaging; Stroke (engine); Perfusion scanning; Perfusion; Tissue plasminogen activator; Fluid-attenuated inversion recovery; Randomized controlled trial; Internal medicine; Nuclear medicine; Radiology; Surgery; Ischemia; Ischemic stroke; Pathology","score_opus":0.010323969048258422,"score_gpt":0.24080042261620485,"score_spread":0.23047645356794644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148207944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991507,0.0048392974,0.00035992576,0.00033709797,0.00044317835,0.0010867843,0.00044322634,0.000057135876,0.00092642073],"genre_scores_gemma":[0.98942786,0.004519686,0.00065372983,0.0006106221,0.00092433963,0.0013417548,0.000691348,0.000012634321,0.0018179755],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999395,0.00023732806,0.00006261393,0.00011677447,0.000058580634,0.0001295383],"domain_scores_gemma":[0.99939215,0.00018517816,0.00011858501,0.000048747737,0.000044148237,0.00021121324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009943453,0.002154403,0.00463052,0.0006135818,0.0004469244,0.0009528193,0.00085187115,0.0026897627,0.004076622],"category_scores_gemma":[0.0014052745,0.001202129,0.0020092356,0.00067042815,0.0015862603,0.0011047776,0.00046615436,0.002270311,0.00095564855],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98197997,0.0047872528,0.000781669,0.0007177507,0.00089451636,0.00006912399,0.000057855475,0.000108778004,0.0038748041,0.000042502314,0.00019734738,0.006488389],"study_design_scores_gemma":[0.9118104,0.083206,0.0032589918,0.00002966709,0.0007322641,0.00003130554,0.000037260652,0.00014821427,0.00037387156,0.000059523732,0.00029408146,0.00001835196],"about_ca_topic_score_codex":0.0011469945,"about_ca_topic_score_gemma":0.001771006,"teacher_disagreement_score":0.00463052,"about_ca_system_score_codex":0.00044165712,"about_ca_system_score_gemma":0.00078689173,"threshold_uncertainty_score":0.013637662},"labels":[],"label_agreement":null},{"id":"W2148333046","doi":"10.1016/s1474-4422(12)70003-0","title":"Association between pathological and MRI findings in multiple sclerosis","year":2012,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":484,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cameco (Canada); University of Saskatchewan","funders":"Biogen","keywords":"Multiple sclerosis; Pathological; Association (psychology); Medicine; Pathology; Psychology; Psychiatry; Psychotherapist","score_opus":0.3285362247754656,"score_gpt":0.38232185859510587,"score_spread":0.053785633819640244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148333046","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000077533805,0.99971455,0.00001601475,0.00005061655,0.00004313456,0.0000033514268,0.000021955912,0.0000011505082,0.000071784714],"genre_scores_gemma":[0.0011373251,0.99849486,0.00010583706,0.00012482207,0.000055602002,0.0000057991406,0.000028291734,5.935177e-7,0.000046801717],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99884546,0.00025464044,0.0004241444,0.00016675077,0.00026698335,0.000042033647],"domain_scores_gemma":[0.9953745,0.0033339781,0.0008401776,0.00006733074,0.00032409836,0.00005994474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024321147,0.00104417,0.004292569,0.005233514,0.0002338411,0.0013081614,0.0014034249,0.0013571118,0.003260106],"category_scores_gemma":[0.008011258,0.0005696445,0.0019287915,0.006312079,0.00078164233,0.001310403,0.0010842279,0.0010719892,0.0004617352],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041327218,0.000045690973,0.0017533373,0.46723863,0.005805345,0.00030816538,0.000119199925,0.00017794636,0.00062418845,0.0009047655,0.010852289,0.5117572],"study_design_scores_gemma":[0.00073780824,0.0005822112,0.030494342,0.44137084,0.07768872,0.0048282193,0.00076816883,0.00019225423,0.0008904357,0.0037958766,0.4384466,0.00020444191],"about_ca_topic_score_codex":0.0042312075,"about_ca_topic_score_gemma":0.0103311455,"teacher_disagreement_score":0.005233514,"about_ca_system_score_codex":0.0009042666,"about_ca_system_score_gemma":0.00199114,"threshold_uncertainty_score":0.012862384},"labels":[],"label_agreement":null},{"id":"W2149731696","doi":"10.1016/s1474-4422(10)70254-4","title":"Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial","year":2010,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":680,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"UCB Pharma; U.S. Food and Drug Administration; Schering-Plough; National Institutes of Health; H. Lundbeck A/S; Teva Pharmaceutical Industries; Pfizer; Michael J. Fox Foundation for Parkinson's Research","keywords":"Neurturin; Medicine; Clinical endpoint; Consolidated Standards of Reporting Trials; Adverse effect; Randomized controlled trial; Clinical trial; Internal medicine; Surgery; Neurotrophic factors; Glial cell line-derived neurotrophic factor","score_opus":0.03476311458167437,"score_gpt":0.3135376124543153,"score_spread":0.2787744978726409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149731696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88475275,0.053920906,0.0076641026,0.003271079,0.009059995,0.02982276,0.0043320376,0.000909676,0.006266603],"genre_scores_gemma":[0.92330223,0.018422365,0.0066260872,0.00378986,0.0024230713,0.032558735,0.0017349721,0.00013334787,0.011009261],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99747723,0.001281252,0.00024602993,0.0004584895,0.0002130865,0.0003238641],"domain_scores_gemma":[0.9982527,0.00074484834,0.0003783182,0.00015499444,0.00014271241,0.00032646052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044818423,0.0038552189,0.010458486,0.001029871,0.0008326029,0.002251798,0.001782803,0.005530778,0.010432028],"category_scores_gemma":[0.0041278633,0.0012527131,0.00439924,0.0011783936,0.0028877393,0.0021622858,0.00070571585,0.0039185984,0.0016439595],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9910159,0.0009520004,0.00006166068,0.0014754485,0.0012230842,0.000018719755,0.000025718955,0.00008633017,0.0009962341,0.00009475223,0.0003315888,0.0037184895],"study_design_scores_gemma":[0.98856574,0.010258303,0.0001557901,0.000047963094,0.0004611242,0.0000060014136,0.000007726226,0.0000892559,0.000098413504,0.00008752444,0.0002132788,0.000008941261],"about_ca_topic_score_codex":0.0019754958,"about_ca_topic_score_gemma":0.0024780899,"teacher_disagreement_score":0.010458486,"about_ca_system_score_codex":0.0013055116,"about_ca_system_score_gemma":0.0015789173,"threshold_uncertainty_score":0.03489864},"labels":[],"label_agreement":null},{"id":"W2150352511","doi":"10.1016/s1474-4422(07)70219-3","title":"Homocysteine-lowering therapy: a role in stroke prevention?","year":2007,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":223,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Medicine; Homocysteine; Stroke (engine); Vitamin B12; Myocardial infarction; Clinical trial; Thrombosis; Internal medicine; Cardiology; Intensive care medicine","score_opus":0.14688908506356937,"score_gpt":0.43247951635063003,"score_spread":0.28559043128706063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150352511","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002950604,0.9981748,0.000029791392,0.0011245111,0.00038603274,0.0000012120097,0.000010086283,0.0000031832565,0.00024093305],"genre_scores_gemma":[0.00052381516,0.99740666,0.00010730245,0.0010826729,0.0006556577,0.0000036840236,0.000012811783,0.00000133683,0.00020601095],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993262,0.00020028031,0.00012890511,0.00010366403,0.00018616157,0.000054795844],"domain_scores_gemma":[0.9981146,0.0012085458,0.00027181546,0.00004237389,0.00027092156,0.00009183257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026738462,0.0012889304,0.006584205,0.0018564147,0.00040516167,0.002010438,0.0018490605,0.0041423137,0.0075004725],"category_scores_gemma":[0.0036322796,0.0005078026,0.0011083696,0.0028340372,0.0011761031,0.0021646998,0.0007745148,0.004437444,0.0029948915],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009445654,0.00008468851,0.00029047005,0.037358165,0.0010447702,0.00034579544,0.00005848661,0.00026855932,0.00057359017,0.0044745565,0.11863051,0.8359259],"study_design_scores_gemma":[0.0007732025,0.0002978641,0.0015661675,0.025790013,0.002521148,0.0011971415,0.00015277966,0.0001879487,0.00024749537,0.0051346268,0.9620855,0.000046159683],"about_ca_topic_score_codex":0.0035979797,"about_ca_topic_score_gemma":0.008014007,"teacher_disagreement_score":0.0075004725,"about_ca_system_score_codex":0.0013452754,"about_ca_system_score_gemma":0.0022339448,"threshold_uncertainty_score":0.025091588},"labels":[],"label_agreement":null},{"id":"W2151384687","doi":"10.1016/s1474-4422(12)70142-4","title":"Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study","year":2012,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Autopsy Techniques and Outcomes","field":"Medicine","cited_by":848,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University","funders":"Avid Radiopharmaceuticals; National Center for Theoretical Sciences","keywords":"Neuropathology; Senile plaques; Medicine; Autopsy; Pathology; Amyloid (mycology); Prospective cohort study; Neuroscience; Alzheimer's disease; Psychology; Disease","score_opus":0.020761478191384214,"score_gpt":0.28359985413099964,"score_spread":0.26283837593961545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151384687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993506,0.00022799218,0.00005646906,0.000020682419,0.00001408863,0.000012463981,0.00017891267,0.0000032920132,0.00013543795],"genre_scores_gemma":[0.9991636,0.00017668579,0.00008528328,0.000029520908,0.000029173085,0.000020941925,0.00027611872,0.0000079566225,0.00021067614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862766,0.00039310096,0.00010114681,0.0005210916,0.00012710934,0.00022981741],"domain_scores_gemma":[0.99647814,0.00077502645,0.0010472275,0.00085756765,0.00039062774,0.00045141624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022234514,0.0018760274,0.0011876577,0.0010351938,0.0012120826,0.0018032625,0.0012309479,0.0021755842,0.0016610364],"category_scores_gemma":[0.0045950064,0.0023816752,0.0022508865,0.0013786703,0.0011021276,0.0019735394,0.00096569746,0.0024830962,0.00059529813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01167053,0.0007856866,0.9816669,0.000029812922,0.0020213993,0.00056440564,0.00032697487,0.00009770574,0.0015875847,0.00003968914,0.00015397255,0.0010552247],"study_design_scores_gemma":[0.0006925671,0.0023350692,0.9935987,0.000012519727,0.0012423405,0.0007028646,0.00048752467,0.0003824159,0.0002724204,0.00009103852,0.00013965384,0.00004285478],"about_ca_topic_score_codex":0.01049015,"about_ca_topic_score_gemma":0.007979422,"teacher_disagreement_score":0.01049015,"about_ca_system_score_codex":0.0007505464,"about_ca_system_score_gemma":0.00057549746,"threshold_uncertainty_score":0.020858169},"labels":[],"label_agreement":null},{"id":"W2151491950","doi":"10.1016/s1474-4422(10)70103-4","title":"Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis","year":2010,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":199,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"Sixth Framework Programme; European Commission","keywords":"Multiple sclerosis; Interferon beta; Medicine; Interferon; Antibody; Immunology; Interferon beta-1b; BETA (programming language); Disease; Virology; Internal medicine","score_opus":0.6690279598419704,"score_gpt":0.49234210691360064,"score_spread":0.17668585292836975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151491950","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0069225775,0.11992349,0.03923145,0.6641183,0.06833652,0.027730241,0.01406584,0.0023813648,0.057290293],"genre_scores_gemma":[0.05061281,0.042094875,0.43093646,0.37229174,0.024756888,0.049089957,0.008942806,0.001378615,0.019895896],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.43206826,0.36514196,0.13841666,0.00823919,0.050520215,0.0056137224],"domain_scores_gemma":[0.1312252,0.56367445,0.055084165,0.02201006,0.21444502,0.013560991],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.363314,0.004611728,0.016062506,0.01766935,0.0048485724,0.014529509,0.015368963,0.042011473,0.020138336],"category_scores_gemma":[0.6289305,0.0051815906,0.018331483,0.020393854,0.0069322046,0.013394419,0.00740457,0.026492627,0.010347627],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009129039,0.0007284216,0.010923214,0.06700209,0.007214514,0.0010395997,0.0035422635,0.0016233317,0.0024322704,0.009864529,0.56750023,0.31900054],"study_design_scores_gemma":[0.021331144,0.0016724456,0.033703547,0.18785709,0.014265153,0.001140064,0.0052504544,0.0039795483,0.0026402404,0.025236454,0.70169395,0.0012299645],"about_ca_topic_score_codex":0.018956222,"about_ca_topic_score_gemma":0.020804785,"teacher_disagreement_score":0.363314,"about_ca_system_score_codex":0.0075881784,"about_ca_system_score_gemma":0.029624658,"threshold_uncertainty_score":0.7851472},"labels":[],"label_agreement":null},{"id":"W2151492920","doi":"10.1016/s1474-4422(14)70028-6","title":"Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial","year":2014,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":330,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"EMD Serono; Bayer HealthCare; Merck KGaA","keywords":"Medicine; Clinical endpoint; Placebo; Internal medicine; Population; Clinical trial; Double blind; Multiple sclerosis; Adverse effect; Phases of clinical research; Immunology; Pathology","score_opus":0.1721700253737474,"score_gpt":0.36591812658642453,"score_spread":0.19374810121267713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151492920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9391706,0.03288336,0.00244153,0.0025879508,0.004098904,0.010705797,0.0035022418,0.00063825806,0.0039713196],"genre_scores_gemma":[0.93536764,0.018016698,0.0064820647,0.004639073,0.0026440376,0.020679787,0.0029015616,0.00012141805,0.009147727],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990012,0.00047297575,0.000093169714,0.00021703345,0.00009023604,0.00012542857],"domain_scores_gemma":[0.9987509,0.00041673132,0.00026466142,0.00010457399,0.00009928968,0.0003637637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031983305,0.0034680679,0.006732539,0.00086804637,0.00090637396,0.0015965991,0.0015719346,0.0040341406,0.009787082],"category_scores_gemma":[0.002999448,0.0011244987,0.003154852,0.0008215115,0.0015883113,0.0025348389,0.0005694968,0.0045475774,0.0019522886],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98440903,0.0022951404,0.00017279269,0.0011055158,0.0010906565,0.000034287084,0.00004179255,0.00015021411,0.0013678755,0.000121674944,0.001059969,0.008151096],"study_design_scores_gemma":[0.98914987,0.009853038,0.00023153987,0.000021714812,0.00025901402,0.0000139246495,0.000006354689,0.000085080595,0.00006843862,0.00006340642,0.00024059557,0.0000070280857],"about_ca_topic_score_codex":0.0011574742,"about_ca_topic_score_gemma":0.002196771,"teacher_disagreement_score":0.009787082,"about_ca_system_score_codex":0.0009196649,"about_ca_system_score_gemma":0.0015557775,"threshold_uncertainty_score":0.03274107},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W2152748843","doi":"10.1016/s1474-4422(14)70065-1","title":"Frontotemporal dementia and its subtypes: a genome-wide association study","year":2014,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":402,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; University of Toronto; University of British Columbia","funders":"Pacific Alzheimer Research Foundation; National Institute on Aging; Medical Research Council; National Institute of Neurological Disorders and Stroke; National Institute for Health and Care Research; U.S. Bureau of Land Management; Háskólinn í Reykjavík; National Health and Medical Research Council; Miyuki Giken; Novo Nordisk Fonden; National Institutes of Health; Fondazione Cariplo; Canadian Institutes of Health Research; Hersenstichting; Rothamsted Research; Wellcome Trust","keywords":"Frontotemporal dementia; Genome-wide association study; Association (psychology); Dementia; Psychology; Medicine; Genetics; Biology; Disease; Single-nucleotide polymorphism; Internal medicine; Gene; Genotype; Psychotherapist","score_opus":0.035425602854769284,"score_gpt":0.2932006996329686,"score_spread":0.2577750967781993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152748843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99611914,0.001980156,0.00020079139,0.00022326638,0.0000327433,0.000011015473,0.0007655415,0.00001118811,0.00065606437],"genre_scores_gemma":[0.99821305,0.00051164726,0.00026146107,0.00007686179,0.00004221905,0.0000124384005,0.00050245546,0.000009164236,0.00037063533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986291,0.0003690298,0.00017426815,0.0004754073,0.00017263863,0.00017960292],"domain_scores_gemma":[0.9984692,0.0004975486,0.0004293651,0.0002434869,0.00016135548,0.00019899294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020071685,0.0010126801,0.0013052853,0.0015535472,0.0015263088,0.0017355046,0.0012073134,0.0017897844,0.002306763],"category_scores_gemma":[0.0027534843,0.0009535204,0.0021664742,0.003660375,0.00072672195,0.000968558,0.001113358,0.0015115731,0.0002993188],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036022835,0.00025704017,0.97782034,0.00011478655,0.005940793,0.0014023882,0.00061175774,0.00017844769,0.0033082163,0.00025607686,0.0009037293,0.005604171],"study_design_scores_gemma":[0.000153175,0.00012917623,0.9957475,0.000022448961,0.0021893638,0.00058541435,0.0002986164,0.00020352025,0.00008381915,0.00018981953,0.00038012365,0.000017056685],"about_ca_topic_score_codex":0.018375782,"about_ca_topic_score_gemma":0.02487097,"teacher_disagreement_score":0.018375782,"about_ca_system_score_codex":0.0005353706,"about_ca_system_score_gemma":0.0005085092,"threshold_uncertainty_score":0.036537647},"labels":[],"label_agreement":null},{"id":"W2153108747","doi":"10.1016/s1474-4422(15)00009-5","title":"Epidemiology, pathophysiology, diagnosis, and management of intracranial artery dissection","year":2015,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Intracranial Aneurysms: Treatment and Complications","field":"Medicine","cited_by":465,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network","funders":"Biocenter Finland; Sigrid Juséliuksen Säätiö; Schweizerische Herzstiftung; Biomedicum Helsinki-säätiö; Suomalainen Tiedeakatemia; National Institutes of Health; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; European Commission; University of Bern; Helsingin ja Uudenmaan Sairaanhoitopiiri; African Studies Association; Agence Nationale de la Recherche; American Stroke Association; Hartstichting; National Science Foundation; American Heart Association; Schering-Plough; Bayer; Emil Aaltosen Säätiö; Pfizer; Maud Kuistilan Muistosäätiö","keywords":"Medicine; Carotid artery dissection; Dissection (medical); Subarachnoid hemorrhage; Stroke (engine); Radiology; Cervical Artery; Epidemiology; Vertebral artery dissection; Surgery; Internal medicine","score_opus":0.10804400000498805,"score_gpt":0.36894996716122075,"score_spread":0.2609059671562327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153108747","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006372301,0.9995703,0.000028187018,0.00017087643,0.000055746146,0.0000015352801,0.000010666271,0.0000012965594,0.00009759049],"genre_scores_gemma":[0.00047360687,0.9991339,0.000072744486,0.00010289805,0.00016468421,0.0000018508774,0.000015681739,3.225232e-7,0.00003421537],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99941456,0.0000876605,0.00017194463,0.000093538634,0.00019404145,0.00003825354],"domain_scores_gemma":[0.99781287,0.0011812036,0.00058083487,0.000031644366,0.00030980544,0.00008353081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012804747,0.00090570794,0.0026021714,0.003859044,0.00029760244,0.0014066263,0.0012426694,0.0013432078,0.0015122613],"category_scores_gemma":[0.0033646757,0.00041152295,0.0009919533,0.0039272085,0.0008092492,0.0016474945,0.00082605926,0.001766232,0.0004893025],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013794613,0.00006455646,0.0025688852,0.046171974,0.00049662765,0.00032794653,0.00008586673,0.00045909808,0.00039767587,0.0018937121,0.025031894,0.9223639],"study_design_scores_gemma":[0.00013258163,0.00033543073,0.02409678,0.080599904,0.0036595983,0.011716506,0.00057602505,0.0005799773,0.0005014475,0.0073542716,0.8702632,0.00018429989],"about_ca_topic_score_codex":0.0038956034,"about_ca_topic_score_gemma":0.0065354556,"teacher_disagreement_score":0.0038956034,"about_ca_system_score_codex":0.0010835263,"about_ca_system_score_gemma":0.0027921784,"threshold_uncertainty_score":0.007861555},"labels":[],"label_agreement":null},{"id":"W2153558039","doi":"10.1016/s1474-4422(10)70105-8","title":"Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers","year":2010,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":275,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Glioma; Molecular pathology; Medicine; Molecular biomarkers; Molecular diagnostics; Pathology; Oncology; Bioinformatics; Internal medicine; Biology; Cancer research; Gene","score_opus":0.019402205459236724,"score_gpt":0.2936583496286476,"score_spread":0.2742561441694109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153558039","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005200828,0.9994199,0.000072985276,0.00020969093,0.00006869815,0.0000015288197,0.000010576457,0.0000032193523,0.00016141134],"genre_scores_gemma":[0.0005066153,0.9988739,0.00015069977,0.00015838433,0.00017028123,0.0000024059623,0.000019679685,6.714023e-7,0.000117362295],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996295,0.00006229956,0.000058445596,0.000069410424,0.00015060262,0.000029706991],"domain_scores_gemma":[0.998744,0.00069036137,0.00019317535,0.000029242652,0.0002817789,0.000061344675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013975524,0.0013354352,0.0030774039,0.0024570555,0.00020334688,0.0013428713,0.0013386576,0.001419022,0.0013560221],"category_scores_gemma":[0.001677051,0.00039979978,0.0007077543,0.0024937964,0.00076503964,0.0014698755,0.000661869,0.001991809,0.001057491],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012362035,0.000046619785,0.000600909,0.010929849,0.000187017,0.00022850037,0.000029263336,0.00046237075,0.00095184846,0.001552856,0.025845723,0.9590415],"study_design_scores_gemma":[0.000085260785,0.00018209829,0.0047337073,0.009918936,0.00085614366,0.0038602154,0.00013049447,0.0003789641,0.00091252645,0.0045155757,0.97435355,0.00007264974],"about_ca_topic_score_codex":0.0020340357,"about_ca_topic_score_gemma":0.0038316536,"teacher_disagreement_score":0.0030774039,"about_ca_system_score_codex":0.0010372966,"about_ca_system_score_gemma":0.0014815313,"threshold_uncertainty_score":0.0075261593},"labels":[],"label_agreement":null},{"id":"W2153982124","doi":"10.1016/s1474-4422(12)70154-0","title":"Disorders of consciousness: responding to requests for novel diagnostic and therapeutic interventions","year":2012,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Traumatic Brain Injury Research","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Persistent vegetative state; Consciousness; Medicine; Consciousness Disorders; Psychological intervention; Intensive care medicine; Level of consciousness; Minimally conscious state; Psychology; Psychiatry; Neuroscience","score_opus":0.14459115978805248,"score_gpt":0.4140461349148147,"score_spread":0.2694549751267622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153982124","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.058494486,0.03502941,0.009671755,0.8325919,0.00746435,0.0002736456,0.0002783961,0.0004174207,0.055778634],"genre_scores_gemma":[0.67645735,0.082372785,0.026391461,0.17705165,0.02766182,0.00044133232,0.00046775452,0.0001942315,0.008961526],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965661,0.001684911,0.0003217258,0.00032600312,0.00069740944,0.00040395962],"domain_scores_gemma":[0.98366827,0.009200197,0.002394402,0.00078545965,0.002212636,0.001739015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055012647,0.0004841489,0.0007452271,0.0016924042,0.0017291576,0.0036484562,0.0011144504,0.0062858234,0.006689248],"category_scores_gemma":[0.034192093,0.0002403748,0.000593211,0.00075050886,0.0016483394,0.003364471,0.0019108488,0.006050191,0.0022279795],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006606442,0.00094615674,0.05432535,0.001101427,0.00019910885,0.0058790715,0.0035897233,0.0008599119,0.004148772,0.018314842,0.20007032,0.7099047],"study_design_scores_gemma":[0.00086370285,0.0013352532,0.12561865,0.0069394414,0.0005538837,0.018365057,0.040194765,0.0053726817,0.0056973654,0.317072,0.47743058,0.0005566097],"about_ca_topic_score_codex":0.0008687091,"about_ca_topic_score_gemma":0.0022037695,"teacher_disagreement_score":0.006689248,"about_ca_system_score_codex":0.0015473297,"about_ca_system_score_gemma":0.0051595205,"threshold_uncertainty_score":0.029093862},"labels":[],"label_agreement":null},{"id":"W2155039139","doi":"10.1016/s1474-4422(03)00502-7","title":"Treatment of Alzheimer's disease; current status and new perspectives","year":2003,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":725,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"American Academy of Neurology; Pfizer","keywords":"Rivastigmine; Memantine; Galantamine; Donepezil; Medicine; Disease; Tacrine; Dementia; Alzheimer's disease; Pharmacology; Acetylcholinesterase; Bioinformatics; Internal medicine; Biology","score_opus":0.08731596543438518,"score_gpt":0.3504418202794293,"score_spread":0.2631258548450441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155039139","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000589422,0.9843241,0.0003647494,0.011721129,0.0011800025,0.000010006989,0.000041109495,0.000022698274,0.0017468244],"genre_scores_gemma":[0.0076678973,0.97552615,0.001252092,0.007564559,0.006643652,0.00005171299,0.000110454734,0.000014360068,0.001169062],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99861443,0.0004119384,0.00024204141,0.00021029425,0.00035793002,0.00016333746],"domain_scores_gemma":[0.9929301,0.004521251,0.00059145555,0.0001386813,0.0011945635,0.00062395196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008353989,0.0013995044,0.0049170363,0.0015224237,0.00088673126,0.0046358705,0.002257165,0.0056925802,0.010886409],"category_scores_gemma":[0.004647463,0.0004957523,0.0017347902,0.0022968396,0.003068003,0.007358009,0.001115085,0.0075843013,0.002743401],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006257371,0.00089558825,0.0013834436,0.012282391,0.0005543607,0.0006711133,0.00021074856,0.0008877857,0.001993782,0.010620845,0.059485707,0.90475684],"study_design_scores_gemma":[0.0035533155,0.004756562,0.0053045047,0.008887572,0.0015255606,0.0019957323,0.0010333604,0.0012553383,0.0008564535,0.024649179,0.9460204,0.00016210148],"about_ca_topic_score_codex":0.0020274383,"about_ca_topic_score_gemma":0.006837134,"teacher_disagreement_score":0.010886409,"about_ca_system_score_codex":0.0016037318,"about_ca_system_score_gemma":0.0030748304,"threshold_uncertainty_score":0.04418069},"labels":[],"label_agreement":null},{"id":"W2155177857","doi":"10.1016/s1474-4422(12)70091-1","title":"Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial","year":2012,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; McMaster University","funders":"National Medical Research Council; Medical Research Council","keywords":"Medicine; Placebo; Post-hoc analysis; Stroke (engine); Internal medicine; Homocysteine; Proportional hazards model; Myocardial infarction; Clinical trial; Randomized controlled trial","score_opus":0.0154470342999406,"score_gpt":0.27486921231318684,"score_spread":0.25942217801324624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155177857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9495432,0.032704115,0.0016113069,0.0010716211,0.0019805147,0.007063474,0.0025945723,0.00019177492,0.0032393883],"genre_scores_gemma":[0.97993773,0.006726405,0.0015889363,0.00089732016,0.00090246595,0.0052059875,0.0015680444,0.000043989538,0.0031291933],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9966618,0.002108792,0.0003300381,0.00043092482,0.00020513318,0.0002632995],"domain_scores_gemma":[0.99593264,0.0018529466,0.00085146696,0.00053535216,0.00042617647,0.00040133932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004925957,0.0018215437,0.005110072,0.0005252938,0.00047820815,0.0019216476,0.000979305,0.0018286931,0.0063241734],"category_scores_gemma":[0.008230705,0.0006802794,0.0060921283,0.0005768272,0.000993342,0.0010249414,0.0007827556,0.0022954228,0.0008093952],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9808529,0.0005244812,0.0006095488,0.0021607613,0.010263703,0.00003307432,0.000044075947,0.0001342783,0.00089905027,0.00008250334,0.0004324437,0.003963194],"study_design_scores_gemma":[0.9606723,0.02197535,0.0034556305,0.000151418,0.011989693,0.000039577117,0.000035014862,0.00023559968,0.000268213,0.0002495173,0.0009088073,0.000018859439],"about_ca_topic_score_codex":0.00090731017,"about_ca_topic_score_gemma":0.0017062601,"teacher_disagreement_score":0.0063241734,"about_ca_system_score_codex":0.0008782663,"about_ca_system_score_gemma":0.0014456421,"threshold_uncertainty_score":0.026051223},"labels":[],"label_agreement":null},{"id":"W2155505990","doi":"10.1016/s1474-4422(08)70096-6","title":"Contralesional repetitive transcranial magnetic stimulation for chronic hemiparesis in subcortical paediatric stroke: a randomised trial","year":2008,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Transcranial Magnetic Stimulation Studies","field":"Neuroscience","cited_by":217,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; University of Calgary; SickKids Foundation; Alberta Children's Hospital","funders":"","keywords":"Transcranial magnetic stimulation; Weakness; Hemiparesis; Medicine; Stroke (engine); Grip strength; Physical medicine and rehabilitation; Physical therapy; Dyskinesia; Stimulation; Internal medicine; Lesion; Surgery; Parkinson's disease","score_opus":0.061712840189200965,"score_gpt":0.29296328346262623,"score_spread":0.23125044327342525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155505990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95911986,0.02260026,0.0016938584,0.0022965109,0.0028290295,0.00620704,0.0020060458,0.00020413856,0.003043308],"genre_scores_gemma":[0.97219986,0.009941667,0.0017978089,0.0015275293,0.0011624044,0.009102842,0.00089255115,0.000033110948,0.003342198],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99776447,0.0012360353,0.00028294112,0.00032232067,0.00012155598,0.0002726187],"domain_scores_gemma":[0.99838257,0.00064167817,0.0004010062,0.00015625752,0.00008653655,0.0003320121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002431925,0.002443288,0.0053733783,0.0006504569,0.0006212324,0.0013592279,0.0012573927,0.003908969,0.009709137],"category_scores_gemma":[0.0041913134,0.0009169727,0.003730593,0.001062357,0.0021424755,0.0016694028,0.0006874422,0.0036178106,0.0012403782],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98448443,0.0011554013,0.00032080116,0.0018316706,0.0019288524,0.00009180727,0.00006325335,0.00016708657,0.0008899873,0.0002168367,0.0006556425,0.008194309],"study_design_scores_gemma":[0.9850969,0.012725208,0.00062770606,0.00009016431,0.00083138107,0.00003136708,0.00001781239,0.00006745631,0.00008205022,0.00012668906,0.0002926823,0.000010642758],"about_ca_topic_score_codex":0.0028659047,"about_ca_topic_score_gemma":0.0041429745,"teacher_disagreement_score":0.009709137,"about_ca_system_score_codex":0.0012595424,"about_ca_system_score_gemma":0.0019368044,"threshold_uncertainty_score":0.03248036},"labels":[],"label_agreement":null},{"id":"W2155620154","doi":"10.1016/s1474-4422(07)70078-9","title":"Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring","year":2007,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":421,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"IC Design Education Center; Multiple Sclerosis Society; Biogen","keywords":"Natalizumab; Multiple sclerosis; Medicine; Fingolimod; Progressive multifocal leukoencephalopathy; Incidence (geometry); Internal medicine; Pediatrics; Immunology","score_opus":0.2664732229267374,"score_gpt":0.40594196091339824,"score_spread":0.13946873798666082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155620154","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039556192,0.98628575,0.0015004161,0.008746068,0.0010253317,0.000066039756,0.00013619765,0.000058997008,0.0017855731],"genre_scores_gemma":[0.0047875578,0.97872716,0.007545146,0.005773647,0.0012840626,0.00016455559,0.00037130257,0.000012666627,0.0013339692],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99901116,0.00030655653,0.00025779317,0.000104901526,0.00026506203,0.000054453867],"domain_scores_gemma":[0.99779105,0.0010399452,0.0005350091,0.000046563386,0.00046771648,0.000119733755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002488927,0.0012066925,0.0039098975,0.0018720753,0.0003307075,0.0011432469,0.0018345357,0.0022311488,0.002755386],"category_scores_gemma":[0.0040294915,0.00036384322,0.0013367172,0.0016316002,0.00047672194,0.0012157683,0.0005361777,0.003271799,0.0016489626],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003034349,0.00010253863,0.0007653792,0.007255188,0.000250123,0.00027290932,0.000028539822,0.00046495438,0.00043230446,0.0014006965,0.095224425,0.89349955],"study_design_scores_gemma":[0.0012972972,0.0004155072,0.0074179126,0.041713987,0.0026109521,0.0036834758,0.00017705717,0.0016643826,0.0008028543,0.007514047,0.9326042,0.000098151155],"about_ca_topic_score_codex":0.003152332,"about_ca_topic_score_gemma":0.0067349756,"teacher_disagreement_score":0.0039098975,"about_ca_system_score_codex":0.0013646855,"about_ca_system_score_gemma":0.0024738312,"threshold_uncertainty_score":0.013162851},"labels":[],"label_agreement":null},{"id":"W2156947103","doi":"10.1016/s1474-4422(11)70186-7","title":"Suboccipital steroid injections for transitional treatment of patients with more than two cluster headache attacks per day: a randomised, double-blind, placebo-controlled trial","year":2011,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":200,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cluster headache; Medicine; Placebo; Anesthesia; Double blind; Cluster randomised controlled trial; Randomized controlled trial; Surgery; Migraine; Alternative medicine","score_opus":0.06881334136679801,"score_gpt":0.321460691210468,"score_spread":0.25264734984367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156947103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9513118,0.033323746,0.0013827933,0.0010373023,0.002754375,0.0055676503,0.0012011006,0.00019459928,0.0032265077],"genre_scores_gemma":[0.9722955,0.013662249,0.0015566987,0.0015323444,0.0015405322,0.0053516016,0.0006701078,0.000028290711,0.0033626456],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989845,0.00043839222,0.0001204016,0.00017633094,0.000090989095,0.00018931049],"domain_scores_gemma":[0.99874336,0.00050898484,0.0002542245,0.00009879861,0.00008568977,0.00030898207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00170721,0.002124111,0.0069839354,0.00083858205,0.0007761761,0.0013760319,0.00129336,0.0035462575,0.008396232],"category_scores_gemma":[0.002402572,0.0010341667,0.003582707,0.0009461706,0.0019349137,0.001275966,0.0006223281,0.003492273,0.0013206424],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98891675,0.0014031312,0.00019047981,0.0012868324,0.0011178908,0.000036663303,0.000038310045,0.000061603416,0.0007152503,0.000048245933,0.00026489905,0.0059199003],"study_design_scores_gemma":[0.9841925,0.014325705,0.0005610637,0.00005157539,0.00047639475,0.000017437107,0.00001602232,0.000061880906,0.000056558656,0.000045113695,0.00018772636,0.000008134669],"about_ca_topic_score_codex":0.002226011,"about_ca_topic_score_gemma":0.0036192103,"teacher_disagreement_score":0.008396232,"about_ca_system_score_codex":0.0007902066,"about_ca_system_score_gemma":0.0011849948,"threshold_uncertainty_score":0.028088212},"labels":[],"label_agreement":null},{"id":"W2157110881","doi":"10.1016/s1474-4422(10)70223-4","title":"Revising the definition of Alzheimer's disease: a new lexicon","year":2010,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":1850,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Douglas Mental Health University Institute; University of British Columbia","funders":"Eisai; National Institute for Health and Care Research","keywords":"Lexicon; Dementia; Disease; Alzheimer's disease; Medicine; Cornerstone; Psychology; Intensive care medicine; Pathology; Computer science; Artificial intelligence; History","score_opus":0.07853089368687088,"score_gpt":0.33989545481126077,"score_spread":0.2613645611243899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157110881","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028308951,0.558944,0.033530064,0.35131842,0.033937283,0.000052977208,0.00040566523,0.0001836342,0.01879713],"genre_scores_gemma":[0.122255586,0.54547244,0.053071123,0.17815353,0.09406397,0.00039943572,0.0012166039,0.00056130195,0.0048059877],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9871837,0.005535343,0.003276939,0.0013312496,0.00222475,0.00044802405],"domain_scores_gemma":[0.96012354,0.027742933,0.002212352,0.0017334985,0.00628028,0.0019074467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017795276,0.0019855837,0.005897268,0.01298135,0.003091972,0.016110523,0.006338741,0.008528281,0.002727377],"category_scores_gemma":[0.03355683,0.00081849186,0.002330516,0.011124415,0.02758197,0.024360046,0.005338952,0.023817105,0.0013005103],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016658,0.000089307665,0.0014122464,0.0033457722,0.000119589866,0.0004607029,0.0074042757,0.0005422891,0.0008481182,0.7113904,0.14455844,0.12966226],"study_design_scores_gemma":[0.00006684766,0.00007181083,0.0012505776,0.004785752,0.00012374026,0.0022577725,0.004520038,0.0009591502,0.00014498399,0.41173288,0.5739791,0.00010736273],"about_ca_topic_score_codex":0.010638826,"about_ca_topic_score_gemma":0.008622217,"teacher_disagreement_score":0.017795276,"about_ca_system_score_codex":0.009275722,"about_ca_system_score_gemma":0.013217217,"threshold_uncertainty_score":0.09411156},"labels":[],"label_agreement":null},{"id":"W2157459435","doi":"10.1016/s1474-4422(10)70274-x","title":"Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial","year":2010,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":454,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Population Health Research Institute; McMaster University","funders":"Boehringer Ingelheim","keywords":"Medicine; Dabigatran; Warfarin; Atrial fibrillation; Stroke (engine); Subgroup analysis; Internal medicine; Embolism; Anesthesia; Cardiology; Confidence interval","score_opus":0.050252197674510925,"score_gpt":0.30723225755821637,"score_spread":0.2569800598837054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157459435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97443175,0.020370102,0.0005369068,0.00087568344,0.0007724155,0.00037467055,0.0013306915,0.00005628938,0.001251414],"genre_scores_gemma":[0.9929806,0.0030734518,0.00037406667,0.00059549743,0.0006085214,0.00032926252,0.0010142527,0.000023122551,0.0010011537],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9981305,0.0009317871,0.00026337386,0.00029827154,0.00012901032,0.00024718334],"domain_scores_gemma":[0.99815863,0.0007325042,0.00045283692,0.00034279499,0.00009829149,0.00021493358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025378112,0.002620162,0.0078102998,0.0005904847,0.00045394685,0.001888786,0.000977709,0.0017843753,0.0031256238],"category_scores_gemma":[0.004678293,0.0008159516,0.009655414,0.0008112368,0.00058371865,0.0011203933,0.0007842821,0.0031536508,0.00053913164],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8931799,0.00061068323,0.020622406,0.0019207721,0.068013154,0.0003869695,0.00015533538,0.00071725453,0.002721157,0.00023187695,0.0014516547,0.009988792],"study_design_scores_gemma":[0.728641,0.024430556,0.0950749,0.00045245577,0.14222904,0.00053347944,0.0005811622,0.0026073074,0.0011521733,0.0016600204,0.0024308697,0.00020704852],"about_ca_topic_score_codex":0.00215676,"about_ca_topic_score_gemma":0.00448254,"teacher_disagreement_score":0.0078102998,"about_ca_system_score_codex":0.0006681513,"about_ca_system_score_gemma":0.0008779496,"threshold_uncertainty_score":0.013421416},"labels":[],"label_agreement":null},{"id":"W2157970257","doi":"10.1016/s1474-4422(12)70019-4","title":"Prevention of stroke in atrial fibrillation: cautious optimism","year":2012,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Hospital Edmonton; University of Alberta Hospital","funders":"","keywords":"Atrial fibrillation; Medicine; Stroke (engine); Internal medicine; Vitamin K antagonist; Aspirin; Cardiology; Randomized controlled trial; Dabigatran; Antithrombotic; Warfarin","score_opus":0.0884891012681867,"score_gpt":0.3386650888394166,"score_spread":0.2501759875712299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157970257","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008694438,0.0053519434,0.000139834,0.97893596,0.014846647,0.000002386675,0.000014349771,0.000015198846,0.0006066849],"genre_scores_gemma":[0.003006477,0.008955034,0.0006529415,0.83091503,0.15547292,0.00002306892,0.00002511857,0.000023257524,0.00092611834],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9853334,0.004722183,0.0024353808,0.0016795205,0.0047657285,0.0010637094],"domain_scores_gemma":[0.9239894,0.047061756,0.003093249,0.0019570023,0.015011578,0.008887028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017661953,0.0017048742,0.0058077555,0.0017966229,0.0046297708,0.010974437,0.0042977678,0.07799214,0.008757914],"category_scores_gemma":[0.0756414,0.0012229297,0.0033454832,0.0014376411,0.008257579,0.01635686,0.0040735663,0.116773754,0.0064733545],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023676902,0.00021806589,0.00081630255,0.0006171049,0.0002453776,0.0009705007,0.00038115188,0.0003146,0.00028258335,0.0103060305,0.9501517,0.035459828],"study_design_scores_gemma":[0.0010328453,0.0002738982,0.0019931942,0.004072916,0.00043854793,0.0021051003,0.0014547129,0.0013722148,0.00025596452,0.08961332,0.8970647,0.00032256264],"about_ca_topic_score_codex":0.004762377,"about_ca_topic_score_gemma":0.00878872,"teacher_disagreement_score":0.07799214,"about_ca_system_score_codex":0.0064245067,"about_ca_system_score_gemma":0.008574433,"threshold_uncertainty_score":0.0934065},"labels":[],"label_agreement":null},{"id":"W2158042792","doi":"10.1016/s1474-4422(13)70130-3","title":"Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial","year":2013,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Chest Heart and Stroke Scotland; Schweizerische Herzstiftung; Stockholms Läns Landsting; National Health and Medical Research Council; Norges Forskningsråd; Scottish Funding Council; Dalhousie University; National Institute for Social Care and Health Research; Health Foundation; Karolinska Institutet; Ministry of Education and Science; National Institute for Health and Care Research; University of Edinburgh; Marcus och Amalia Wallenbergs minnesfond; Stroke Association; Novartis; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Boehringer Ingelheim","keywords":"Medicine; Thrombolysis; Randomized controlled trial; Stroke (engine); Quality of life (healthcare); Ischaemic stroke; Physical therapy; Clinical trial; Fibrinolytic agent; Odds ratio; Visual analogue scale; Internal medicine; Pediatrics; Tissue plasminogen activator; Myocardial infarction; Ischemia","score_opus":0.017824464959882647,"score_gpt":0.29337110976612374,"score_spread":0.2755466448062411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158042792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95270276,0.025763873,0.0013880968,0.0011787305,0.0017830079,0.0113942055,0.0025189035,0.00012896398,0.003141521],"genre_scores_gemma":[0.96584857,0.007592426,0.002290316,0.0012818618,0.0013382247,0.016260153,0.0031539302,0.000044193705,0.002190363],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9922661,0.005533668,0.00075963634,0.0006054654,0.00042156564,0.00041352693],"domain_scores_gemma":[0.9916352,0.0032805777,0.0024335978,0.0009566772,0.0006528502,0.001041079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0112809185,0.0017588858,0.005231625,0.00071711617,0.0007568193,0.0017580914,0.001136915,0.0032468878,0.0052389014],"category_scores_gemma":[0.011697765,0.00056012184,0.006010537,0.0011210717,0.0015308282,0.0014258153,0.0007588555,0.002865221,0.00087253714],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9898684,0.0013453409,0.00073697086,0.00095684145,0.0022480523,0.00002611503,0.00003321004,0.00010909589,0.00034485865,0.000056689383,0.0003102892,0.003964232],"study_design_scores_gemma":[0.96356654,0.03001884,0.0028534436,0.00015539498,0.002476722,0.00002445745,0.000018085117,0.00019814984,0.0001708652,0.00013007074,0.00036900426,0.000018427607],"about_ca_topic_score_codex":0.0012737166,"about_ca_topic_score_gemma":0.0015813909,"teacher_disagreement_score":0.0112809185,"about_ca_system_score_codex":0.0010838856,"about_ca_system_score_gemma":0.0015560174,"threshold_uncertainty_score":0.059659958},"labels":[],"label_agreement":null},{"id":"W2158742097","doi":"10.1016/s1474-4422(13)70124-8","title":"Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration","year":2013,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":5401,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Sunnybrook Health Science Centre; Health Sciences Centre; University of British Columbia; University of Calgary","funders":"National Institute of Neurological Disorders and Stroke; National Institute on Aging; Canadian Institutes of Health Research; Medical Research Council; National Institute for Health and Care Research","keywords":"Neuroimaging; Hyperintensity; Cognitive decline; Medicine; Neurodegeneration; Disease; Terminology; Neuroscience; Stroke (engine); Psychology; Magnetic resonance imaging; Dementia; Pathology; Radiology","score_opus":0.056470069106267846,"score_gpt":0.3529866884464827,"score_spread":0.29651661934021484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158742097","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018200867,0.18535988,0.13798238,0.5454936,0.036065202,0.001963342,0.0034096402,0.001424315,0.0701008],"genre_scores_gemma":[0.2906079,0.06793188,0.38584003,0.19066028,0.035046577,0.011009849,0.0077056508,0.0014213541,0.009776574],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.8413348,0.061305877,0.04705143,0.008214272,0.038932446,0.0031610858],"domain_scores_gemma":[0.46823865,0.25521177,0.035761006,0.052919757,0.17698477,0.010883987],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.22118506,0.0014636995,0.0046014884,0.009515265,0.005798556,0.014201556,0.01034171,0.016163364,0.0038527567],"category_scores_gemma":[0.3700778,0.0017953158,0.0030436995,0.005231913,0.0151269,0.011848223,0.011941256,0.020305708,0.0022541895],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009844254,0.00043313456,0.020929301,0.009662067,0.00070618925,0.0004710962,0.003865915,0.0014837272,0.004496953,0.3476134,0.24589106,0.3634628],"study_design_scores_gemma":[0.00065297686,0.0009117117,0.06945113,0.03085756,0.0009716753,0.002637494,0.003580911,0.0030283316,0.0059789033,0.43615985,0.44530413,0.0004652981],"about_ca_topic_score_codex":0.012092629,"about_ca_topic_score_gemma":0.010786771,"teacher_disagreement_score":0.7788149,"about_ca_system_score_codex":0.008025986,"about_ca_system_score_gemma":0.031224946,"threshold_uncertainty_score":0.9604175},"labels":[],"label_agreement":null},{"id":"W2160936210","doi":"10.1016/s1474-4422(15)00018-6","title":"Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparator","year":2015,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Health Technology Assessment Programme; National Institute for Health and Care Research; Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada; Medical Research Council; National Multiple Sclerosis Society","keywords":"Medicine; Glatiramer acetate; Cohort; Expanded Disability Status Scale; Multiple sclerosis; Cost effectiveness; Cohort study; Internal medicine; Physical therapy; Disease; Immunology","score_opus":0.1926002724072926,"score_gpt":0.3796467563979554,"score_spread":0.18704648399066282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160936210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974589,0.0014776454,0.000046603225,0.00011002013,0.00002932621,0.00006482285,0.000573931,0.000003353647,0.00023527726],"genre_scores_gemma":[0.99883157,0.00022509226,0.000064999906,0.000043594366,0.00001923845,0.000053964162,0.0005771656,0.0000016727388,0.00018259775],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9935148,0.00406774,0.0004932547,0.0007435905,0.00048139793,0.0006991181],"domain_scores_gemma":[0.99039686,0.004007384,0.0032365262,0.0010896365,0.0004902878,0.00077926955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058795023,0.00094329246,0.001693438,0.0010697555,0.0005696171,0.0017201157,0.0013134292,0.0020374795,0.0026824817],"category_scores_gemma":[0.01963078,0.0006645125,0.004488894,0.001358702,0.0009079328,0.0020005943,0.0015600459,0.0016740392,0.00031900706],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48689276,0.0041674445,0.46035123,0.00087148644,0.01204311,0.00043702277,0.00095722324,0.00435646,0.0009455071,0.000741407,0.0013026122,0.026933786],"study_design_scores_gemma":[0.039884172,0.04935257,0.8908734,0.0004460232,0.010565497,0.00052744977,0.0009852565,0.0048646526,0.0005098634,0.00078988436,0.0009935561,0.00020782338],"about_ca_topic_score_codex":0.018084211,"about_ca_topic_score_gemma":0.010401833,"teacher_disagreement_score":0.018084211,"about_ca_system_score_codex":0.0035543041,"about_ca_system_score_gemma":0.0011856152,"threshold_uncertainty_score":0.035957873},"labels":[],"label_agreement":null},{"id":"W2161929126","doi":"10.1016/s1474-4422(03)00663-x","title":"Genetics of multiple sclerosis","year":2004,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":560,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biology; Multiple sclerosis; Genetic epidemiology; Locus (genetics); Genetics; Statistical genetics; Human leukocyte antigen; Genome-wide association study; Molecular genetics; Computational biology; Gene; Genome; Evolutionary biology; Human genome; Immunology; Single-nucleotide polymorphism","score_opus":0.2990294704657776,"score_gpt":0.39533197987978147,"score_spread":0.09630250941400387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161929126","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000030025725,0.9986486,0.00003434229,0.00054979144,0.00038869388,0.0000032962894,0.000014054332,0.000002648491,0.00032856438],"genre_scores_gemma":[0.00050330954,0.99748874,0.00012416941,0.0009913287,0.00048605065,0.000010060769,0.000028004873,8.623352e-7,0.0003673743],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989838,0.0003935762,0.00018383656,0.0001142323,0.00027110887,0.000053341555],"domain_scores_gemma":[0.99787116,0.0013950301,0.0003663473,0.00005961959,0.00022440366,0.00008343219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021893908,0.0016150168,0.0037728676,0.0057066977,0.00034196334,0.0015583801,0.0011031732,0.002479573,0.005006608],"category_scores_gemma":[0.0042850818,0.00050341955,0.00086047093,0.005391902,0.0010356115,0.0016738956,0.0013254244,0.0017112592,0.0014533645],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023638464,0.000055275177,0.00060388236,0.044113148,0.00084177346,0.00087799167,0.00013324042,0.00031281164,0.00068473263,0.004589007,0.115593836,0.8319579],"study_design_scores_gemma":[0.0002173628,0.000113737624,0.0025572379,0.036082897,0.0018005392,0.0033749938,0.00016992704,0.00005872852,0.00020476854,0.0049067605,0.95048404,0.000029081655],"about_ca_topic_score_codex":0.004731545,"about_ca_topic_score_gemma":0.0113126505,"teacher_disagreement_score":0.0057066977,"about_ca_system_score_codex":0.0016849827,"about_ca_system_score_gemma":0.0037051435,"threshold_uncertainty_score":0.016748786},"labels":[],"label_agreement":null},{"id":"W2162310837","doi":"10.1016/s1474-4422(11)70073-4","title":"A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes","year":2011,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":212,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"H. Lundbeck A/S; Teva Pharmaceutical Industries","keywords":"Rasagiline; Post-hoc analysis; Post hoc; Parkinson's disease; Medicine; Double blind; Physical medicine and rehabilitation; Disease; Physical therapy; Internal medicine; Placebo; Pathology; Alternative medicine","score_opus":0.11218302916818466,"score_gpt":0.33520598983309574,"score_spread":0.22302296066491106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162310837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98872966,0.0034827068,0.00083973026,0.00042146703,0.00075017876,0.0014299693,0.001594583,0.00024215408,0.0025094505],"genre_scores_gemma":[0.9874741,0.0016678774,0.0015687158,0.000831295,0.0007351154,0.0025025369,0.0018914242,0.00008727184,0.0032416286],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991289,0.0004110151,0.000047581445,0.00018952358,0.000060974246,0.00016210685],"domain_scores_gemma":[0.99838006,0.0004905301,0.00023876636,0.00022805593,0.00009867474,0.00056395953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024564106,0.003950528,0.0078814365,0.00061610335,0.0006697458,0.0013568269,0.001452914,0.002732254,0.0050824475],"category_scores_gemma":[0.0019295528,0.001033048,0.0027853781,0.00052794017,0.0018579299,0.0017640399,0.0005548264,0.004552041,0.00184974],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99336714,0.0019558987,0.00021288083,0.00013094948,0.00039471884,0.000015059713,0.000017537413,0.00011321564,0.00096879434,0.000040216804,0.00023181387,0.0025518625],"study_design_scores_gemma":[0.9575825,0.039907467,0.0012263191,0.000010580275,0.0004076384,0.000023835788,0.00001343273,0.0002506138,0.0002942049,0.00008067328,0.00018946863,0.00001333992],"about_ca_topic_score_codex":0.0011164034,"about_ca_topic_score_gemma":0.0026195429,"teacher_disagreement_score":0.0078814365,"about_ca_system_score_codex":0.0008448364,"about_ca_system_score_gemma":0.0010849021,"threshold_uncertainty_score":0.017002523},"labels":[],"label_agreement":null},{"id":"W2162633791","doi":"10.1016/s1474-4422(08)70086-3","title":"Recent developments in childhood arterial ischaemic stroke","year":2008,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"Thrasher Research Fund; National Institute of Neurological Disorders and Stroke; American Heart Association","keywords":"Medicine; Stroke (engine); Pediatrics; Pediatric stroke; Incidence (geometry); Arterial Ischemic Stroke; Population; Ischemic stroke; Cardiology; Ischemia","score_opus":0.08865325858185599,"score_gpt":0.3339845068473686,"score_spread":0.24533124826551259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162633791","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038733655,0.99857664,0.000035172674,0.00043967817,0.00047492984,0.000002151965,0.000009364743,0.000003916675,0.00041947383],"genre_scores_gemma":[0.00035429967,0.9980854,0.000082418665,0.0004761918,0.00066052406,0.000003490387,0.00001483217,7.839583e-7,0.00032215912],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966896,0.000065185006,0.0000764471,0.00004607754,0.000106582476,0.000036806003],"domain_scores_gemma":[0.99889225,0.00061907765,0.000183464,0.000023693477,0.00019836129,0.00008311995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013040601,0.0013679275,0.003107869,0.00335606,0.00032943493,0.0016588547,0.0008673204,0.002039504,0.004750429],"category_scores_gemma":[0.0018667609,0.00040483233,0.00070782716,0.00408061,0.000775251,0.0020109573,0.0010047815,0.0022810204,0.0020799707],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001886845,0.00006426012,0.0003252651,0.028870841,0.00023101973,0.0005975362,0.00008299494,0.00035908358,0.00052407366,0.0025417178,0.0915187,0.8746958],"study_design_scores_gemma":[0.00009261236,0.000107297055,0.0012549772,0.00811399,0.0004603613,0.0016295968,0.00010904829,0.0000862383,0.00014088325,0.0015961203,0.98638594,0.000022922291],"about_ca_topic_score_codex":0.002324446,"about_ca_topic_score_gemma":0.00719234,"teacher_disagreement_score":0.004750429,"about_ca_system_score_codex":0.0011144064,"about_ca_system_score_gemma":0.001969073,"threshold_uncertainty_score":0.01589179},"labels":[],"label_agreement":null},{"id":"W2163022996","doi":"10.1016/s1474-4422(12)70310-1","title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","year":2013,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":3094,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; National Institute of Neurological Disorders and Stroke; National Institute of Mental Health; National Institute on Aging","keywords":"Medicine; Rituximab; Modified Rankin Scale; Immunotherapy; Internal medicine; Encephalitis; Anti-NMDA receptor encephalitis; Plasmapheresis; Cohort; Pediatrics; Immunology; Antibody; Lymphoma","score_opus":0.07752290966520627,"score_gpt":0.315517209904196,"score_spread":0.23799430023898976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163022996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99869245,0.0003414384,0.000086399115,0.000074589094,0.000020790716,0.000008776769,0.00059551664,0.0000029574696,0.0001770058],"genre_scores_gemma":[0.99854493,0.00018973569,0.00006482317,0.00005212301,0.000032038854,0.000015353071,0.00094174524,0.0000037450802,0.00015554497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988925,0.00024058741,0.00013492371,0.00034552958,0.00010340107,0.00028314433],"domain_scores_gemma":[0.9968047,0.0004837065,0.0012534529,0.00059177924,0.0002447187,0.0006216977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013094704,0.0006590478,0.0010694121,0.00071350054,0.0011409834,0.0014582305,0.0009986226,0.0013115786,0.0017607673],"category_scores_gemma":[0.0032075408,0.00092126866,0.0020385126,0.0019671286,0.0006297772,0.0016185273,0.00094946893,0.0023006967,0.0003433167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012015859,0.00015667434,0.9967733,0.000012805564,0.0006047626,0.00017084202,0.00009155361,0.00006078317,0.00024752005,0.000037472648,0.00020365513,0.0004390673],"study_design_scores_gemma":[0.00012473503,0.00027844612,0.9979603,0.000010381156,0.0003067889,0.000354478,0.00032966668,0.00032157454,0.000041843723,0.00009026271,0.00016188854,0.000019587722],"about_ca_topic_score_codex":0.011623698,"about_ca_topic_score_gemma":0.010761492,"teacher_disagreement_score":0.011623698,"about_ca_system_score_codex":0.00077462924,"about_ca_system_score_gemma":0.0009650546,"threshold_uncertainty_score":0.023112118},"labels":[],"label_agreement":null},{"id":"W2163331125","doi":"10.1016/s1474-4422(12)70234-x","title":"Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE Collaboration): a meta-analysis of genome-wide association studies","year":2012,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":487,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Center for Research Resources; National Institute of Neurological Disorders and Stroke; National Institute of Diabetes and Digestive and Kidney Diseases; National Human Genome Research Institute; National Center for Advancing Translational Sciences; Medical Research Council; Fonds Wetenschappelijk Onderzoek; STROKE-Riksförbundet; Canadian Institutes of Health Research; Directorate for Biological Sciences; National Institutes of Health; National Institute on Aging; National Institute for Health and Care Research; Centre for Cognitive Ageing and Cognitive Epidemiology; Office of Research on Women's Health; National Heart, Lung, and Blood Institute; Deutsche Migräne- und Kopfschmerzgesellschaft e.V.; Vlaamse regering; Wellcome Trust; Biotechnology and Biological Sciences Research Council; Austrian Science Fund; Lunds Universitet; Economic and Social Research Council; Skånes universitetssjukhus; University of Edinburgh; Bundesministerium für Bildung und Forschung; Heart and Stroke Foundation of Canada; National Heart Foundation of Australia; Engineering and Physical Sciences Research Council; AstraZeneca; Vetenskapsrådet; Canadian Stroke Network","keywords":"Genome-wide association study; Meta-analysis; Ischaemic stroke; Stroke (engine); Genetic association; Medicine; Computational biology; Biology; Genetics; Internal medicine; Genotype; Gene; Single-nucleotide polymorphism; Ischemia; Engineering","score_opus":0.11760224250365024,"score_gpt":0.35338435241189237,"score_spread":0.2357821099082421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163331125","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4392327,0.5080776,0.02298031,0.002513459,0.00085642684,0.00059426547,0.023376985,0.0009807358,0.0013874696],"genre_scores_gemma":[0.93983984,0.034317326,0.014018188,0.0007689722,0.00038069297,0.0008422692,0.008870365,0.0002949072,0.0006675488],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98739594,0.007343299,0.0014549748,0.0025217799,0.00089021947,0.00039380175],"domain_scores_gemma":[0.9844556,0.0092585115,0.001703973,0.0030406474,0.0011216664,0.00041952965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014420915,0.0023377659,0.009881101,0.004755202,0.00092357124,0.0022681453,0.0018782878,0.0016058611,0.0024716612],"category_scores_gemma":[0.024948152,0.0014233523,0.026845913,0.0059500146,0.00039897856,0.0008053496,0.0024134389,0.0014388573,0.00028289072],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048917583,0.000025424159,0.08575655,0.007412041,0.88892025,0.00034963957,0.0001222714,0.0015475485,0.0012042571,0.00019961105,0.002136283,0.0074344203],"study_design_scores_gemma":[0.0018772102,0.00032271844,0.087024145,0.0011114575,0.9038435,0.0006323708,0.00009114988,0.0017415758,0.00041043255,0.000629655,0.0022552102,0.000060487735],"about_ca_topic_score_codex":0.010652893,"about_ca_topic_score_gemma":0.017443597,"teacher_disagreement_score":0.014420915,"about_ca_system_score_codex":0.00095660734,"about_ca_system_score_gemma":0.0015110464,"threshold_uncertainty_score":0.07626599},"labels":[],"label_agreement":null},{"id":"W2163394083","doi":"10.1016/s1474-4422(09)70237-6","title":"Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial","year":2009,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":370,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Bayer Schering","keywords":"Medicine; Expanded Disability Status Scale; Multiple sclerosis; Clinically isolated syndrome; Hazard ratio; Internal medicine; Clinical endpoint; Placebo; Interferon beta-1b; Interferon beta-1a; McDonald criteria; Clinical trial; Interferon beta; Physical therapy; Confidence interval; Immunology; Pathology","score_opus":0.09622116179535428,"score_gpt":0.375427040034515,"score_spread":0.2792058782391607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163394083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923499,0.0042106044,0.00025988667,0.0006719689,0.0003566704,0.00036407035,0.0005639028,0.000045988887,0.0011769984],"genre_scores_gemma":[0.9943568,0.0012647844,0.00039583904,0.000948208,0.00042866849,0.0005893877,0.0007916906,0.000013843673,0.0012108546],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984999,0.00078074104,0.00006707459,0.00018971121,0.0000915438,0.00037097276],"domain_scores_gemma":[0.99733895,0.0009155443,0.0005480127,0.0002748753,0.000118553304,0.00080414605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037933183,0.0023757843,0.0046473723,0.0004859459,0.00084318843,0.0016273453,0.0012187556,0.0035222718,0.0036946028],"category_scores_gemma":[0.002983592,0.000674971,0.0044215824,0.00044760076,0.001602037,0.0015890064,0.00078061887,0.0049466337,0.00089697517],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98521996,0.004746724,0.00077332073,0.00012555328,0.0007469746,0.00004256149,0.00003988228,0.00019527771,0.0010410829,0.000041494077,0.0002693106,0.0067578885],"study_design_scores_gemma":[0.8895671,0.09781314,0.009747441,0.000062401166,0.0012694008,0.000055438217,0.000030031544,0.000361862,0.000395426,0.00023130649,0.0004361302,0.000030343937],"about_ca_topic_score_codex":0.0020463236,"about_ca_topic_score_gemma":0.0022842428,"teacher_disagreement_score":0.0046473723,"about_ca_system_score_codex":0.0010807583,"about_ca_system_score_gemma":0.0014835924,"threshold_uncertainty_score":0.020061195},"labels":[],"label_agreement":null},{"id":"W2164632177","doi":"10.1016/s1474-4422(04)00883-x","title":"Comparison studies of cholinesterase inhibitors for Alzheimer's disease","year":2004,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; McMaster University; Toronto Rehabilitation Institute; University of Toronto; University of Calgary","funders":"Pfizer","keywords":"Checklist; Cholinesterase; Medicine; Disease; Alzheimer's disease; Clinical trial; Consolidated Standards of Reporting Trials; Psychology; Pharmacology; Internal medicine","score_opus":0.43499645769402145,"score_gpt":0.4622165648417724,"score_spread":0.02722010714775097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164632177","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010690897,0.99815255,0.000093305214,0.00017619217,0.00006133261,0.000026096408,0.00009665313,0.0000020658088,0.00032275802],"genre_scores_gemma":[0.026968373,0.9717001,0.0005296861,0.00027127351,0.00013226515,0.000057055502,0.00013910678,0.0000031247516,0.00019903335],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9945056,0.0032482608,0.0009673565,0.00035145847,0.0007828473,0.00014442614],"domain_scores_gemma":[0.9820133,0.014756455,0.0020383142,0.0002002873,0.0008107568,0.00018087633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010236681,0.0011346996,0.0063082343,0.0029048314,0.0001655574,0.0013447566,0.0013179227,0.0014287335,0.005371134],"category_scores_gemma":[0.02687105,0.00041774605,0.004082552,0.0046457336,0.00043727813,0.0010106422,0.0007465482,0.0010897643,0.0002969735],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020624047,0.00020901773,0.0023201457,0.28178543,0.07230731,0.00027120503,0.00011124014,0.001219973,0.00085109466,0.0028539954,0.0066636857,0.6107829],"study_design_scores_gemma":[0.030614356,0.009860425,0.044837862,0.17640647,0.45421767,0.0027326813,0.00055922143,0.0009514814,0.003197657,0.013002977,0.2634619,0.00015727436],"about_ca_topic_score_codex":0.003254463,"about_ca_topic_score_gemma":0.00603565,"teacher_disagreement_score":0.010236681,"about_ca_system_score_codex":0.0017217762,"about_ca_system_score_gemma":0.0020896292,"threshold_uncertainty_score":0.05413741},"labels":[],"label_agreement":null},{"id":"W2165232112","doi":"10.1016/s1474-4422(10)70059-4","title":"Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders","year":2010,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Ion channel regulation and function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":452,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Lamotrigine; Epilepsy; Sodium channel; Carbamazepine; Medicine; Neuroscience; Neuropathic pain; Pregabalin; Sodium channel blocker; Anticonvulsant; Multiple sclerosis; Pharmacology; Anesthesia; Psychology; Chemistry; Psychiatry; Sodium","score_opus":0.03484041263737192,"score_gpt":0.2993903944893765,"score_spread":0.26454998185200457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165232112","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011678492,0.99725646,0.0002809361,0.0005206839,0.0006189525,0.000004888005,0.000017069327,0.000014576809,0.001169776],"genre_scores_gemma":[0.00096804876,0.9963355,0.00040310045,0.00042587097,0.0006396377,0.000009298693,0.00003374333,0.0000036259546,0.0011812552],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982506,0.000031779746,0.000019498586,0.000024666675,0.00007679496,0.000022167036],"domain_scores_gemma":[0.9997408,0.000117904216,0.000036017682,0.000008953752,0.000066265995,0.000030113479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084035314,0.001336574,0.0020062441,0.0012982072,0.00022245305,0.00089537376,0.0011094856,0.001330175,0.0033203017],"category_scores_gemma":[0.0007029025,0.0002612466,0.00037326416,0.0014891217,0.00064882665,0.0015550901,0.0006368637,0.0022376815,0.0020599323],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020493711,0.000095396266,0.0001018114,0.007308007,0.00010310016,0.00032509933,0.000033379216,0.00060741475,0.003133608,0.005849119,0.08224967,0.8999885],"study_design_scores_gemma":[0.00008149328,0.00009438639,0.00037313727,0.0010532722,0.00011055259,0.0010544069,0.000037278227,0.00017215428,0.00047009008,0.0033719563,0.9931652,0.000015999287],"about_ca_topic_score_codex":0.0007420053,"about_ca_topic_score_gemma":0.0021267405,"teacher_disagreement_score":0.0033203017,"about_ca_system_score_codex":0.0007000016,"about_ca_system_score_gemma":0.00078117143,"threshold_uncertainty_score":0.011107504},"labels":[],"label_agreement":null},{"id":"W2166502714","doi":"10.1016/s1474-4422(06)70446-x","title":"De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: a retrospective study","year":2006,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":294,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Health and Medical Research Council","keywords":"Encephalopathy; Gene; Sodium channel; Retrospective cohort study; Medicine; Genetics; Virology; Biology; Sodium; Internal medicine; Chemistry","score_opus":0.021688070471572493,"score_gpt":0.2935890257503717,"score_spread":0.2719009552787992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166502714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99925965,0.00018451708,0.000105905805,0.00001939924,0.0000039102442,0.0000042671168,0.00004863666,0.000002066637,0.000371683],"genre_scores_gemma":[0.9997185,0.00008414323,0.000027769198,0.00001934434,0.000005998973,0.0000015395636,0.00006682119,0.0000019458753,0.00007387288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99950147,0.00008107364,0.000075930075,0.000180885,0.00007021621,0.000090455396],"domain_scores_gemma":[0.99805695,0.00052055495,0.00052357983,0.00036159117,0.00023531193,0.00030191636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047295785,0.0003525875,0.00035735287,0.0007938887,0.0006599435,0.0004991852,0.00037151735,0.0006931283,0.0018974094],"category_scores_gemma":[0.0023529932,0.00050579925,0.00042316853,0.00069008325,0.0007362082,0.0007703974,0.00044357838,0.00056775415,0.00045669146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002955466,0.000074667616,0.9875058,0.000009648355,0.0000563105,0.009268286,0.00022943514,0.000053244607,0.001191517,0.000053279706,0.0000562418,0.0012059078],"study_design_scores_gemma":[0.000041046453,0.00094363093,0.9129747,0.000020468351,0.0002073145,0.08194604,0.0011529166,0.00043530413,0.0010908211,0.00018739703,0.0009675538,0.00003283391],"about_ca_topic_score_codex":0.0019687684,"about_ca_topic_score_gemma":0.0011590238,"teacher_disagreement_score":0.0019687684,"about_ca_system_score_codex":0.00029820227,"about_ca_system_score_gemma":0.0003304481,"threshold_uncertainty_score":0.006347418},"labels":[],"label_agreement":null},{"id":"W2167037478","doi":"10.1016/s1474-4422(13)70265-5","title":"The genetic basis of DOORS syndrome: an exome-sequencing study","year":2013,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":227,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"Wellcome Trust; National Human Genome Research Institute; National Institute for Health and Care Research; National Institute of General Medical Sciences; National Institute of Mental Health; Intellectual and Developmental Disabilities Research Center; Action Medical Research; National Institutes of Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development; University College London Hospitals NHS Foundation Trust; National Institute of Child Health and Human Development; Canadian Institutes of Health Research","keywords":"Sanger sequencing; Exome sequencing; Genetics; Exome; Medicine; DNA sequencing; Exon; Intellectual disability; Biology; Mutation; Gene","score_opus":0.01648942293955836,"score_gpt":0.24148683377871932,"score_spread":0.22499741083916097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167037478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99821705,0.0003150345,0.000476152,0.00005121951,0.000005230177,0.000030738167,0.00053185533,0.000008865865,0.0003637312],"genre_scores_gemma":[0.996977,0.00036987255,0.00137466,0.00010218553,0.000012556317,0.000025106277,0.000872043,0.000012159327,0.00025442385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99953437,0.000080144055,0.0000659535,0.00016517483,0.00009551467,0.000058744343],"domain_scores_gemma":[0.9993086,0.00029170152,0.00014865403,0.000052826443,0.00007224762,0.00012600039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005359928,0.0005856516,0.0004953284,0.0012864817,0.00049172,0.00042441583,0.0003971872,0.0006837001,0.0027138663],"category_scores_gemma":[0.0012874202,0.00020397545,0.00036908666,0.0008844188,0.00032978406,0.00023740473,0.0006418194,0.00036069524,0.0003402718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020479436,0.0005808608,0.5550191,0.00058158586,0.00071924075,0.23318447,0.0030430288,0.0012372992,0.16307464,0.0008118385,0.0018393118,0.037860725],"study_design_scores_gemma":[0.00032998467,0.001189823,0.7135502,0.00024202224,0.00062512,0.25117144,0.0015233227,0.002382714,0.020265449,0.0006202269,0.008028641,0.000071106035],"about_ca_topic_score_codex":0.00097364676,"about_ca_topic_score_gemma":0.0014878891,"teacher_disagreement_score":0.0027138663,"about_ca_system_score_codex":0.0002194678,"about_ca_system_score_gemma":0.0002908857,"threshold_uncertainty_score":0.009078741},"labels":[],"label_agreement":null},{"id":"W2167544064","doi":"10.1016/s1474-4422(11)70080-1","title":"Influence of sex on outcomes of stenting versus endarterectomy: a subgroup analysis of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST)","year":2011,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Cerebrovascular and Carotid Artery Diseases","field":"Medicine","cited_by":209,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôpital de l'Enfant-Jésus","funders":"National Institute of Neurological Disorders and Stroke; Abbott Vascular; National Institutes of Health","keywords":"Medicine; Carotid endarterectomy; Carotid stenting; Clinical endpoint; Stroke (engine); Endarterectomy; Hazard ratio; Asymptomatic; Cardiology; Internal medicine; Revascularization; Stent; Stenosis; Myocardial infarction; Surgery; Randomized controlled trial; Confidence interval","score_opus":0.046582576050134133,"score_gpt":0.28258618683882397,"score_spread":0.23600361078868984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167544064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904935,0.006519584,0.00036984633,0.0005353108,0.00041208806,0.00009850428,0.00067664566,0.000022812716,0.0008717542],"genre_scores_gemma":[0.9967818,0.0009730786,0.00023867258,0.00037036024,0.00039171072,0.000110375346,0.00067009806,0.000022339033,0.00044142685],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9965823,0.0018934807,0.00032668194,0.00059082743,0.00022225082,0.0003844327],"domain_scores_gemma":[0.9964826,0.0017521556,0.0005998009,0.0005813074,0.00016638802,0.00041771727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043042796,0.001750066,0.005074268,0.00037030116,0.0005567834,0.0019395154,0.0011015759,0.0023194728,0.0023938252],"category_scores_gemma":[0.008820013,0.0008075174,0.011090727,0.0007232571,0.00079636293,0.0012347655,0.0009793222,0.0033738439,0.00029951837],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8175898,0.00072575663,0.08485416,0.0011292808,0.07841858,0.00046808526,0.00029674245,0.0008171754,0.003373019,0.00036449995,0.0019308112,0.010031984],"study_design_scores_gemma":[0.2658442,0.03574631,0.46643487,0.00047551485,0.21601883,0.0007129806,0.0009879639,0.0054368963,0.0018868912,0.003205258,0.0029279464,0.00032242446],"about_ca_topic_score_codex":0.0034167268,"about_ca_topic_score_gemma":0.0051537594,"teacher_disagreement_score":0.005074268,"about_ca_system_score_codex":0.00048129773,"about_ca_system_score_gemma":0.0009783999,"threshold_uncertainty_score":0.022763431},"labels":[],"label_agreement":null},{"id":"W2167552109","doi":"10.1016/s1474-4422(11)70175-2","title":"Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study","year":2011,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":344,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Environmental Health Sciences; National Institute of Neurological Disorders and Stroke; Yonsei University College of Medicine; Medical Research Council; Instituut Born-Bunge; Centre hospitalier régional universitaire de Lille; Vlaamse regering; Skånes universitetssjukhus; Śląski Uniwersytet Medyczny w Katowicach; Centralsjukhuset Kristianstad; Svenska Läkaresällskapet; Universiteit Antwerpen; Bijzonder Onderzoeksfonds UGent; Association France Parkinson; Kungliga Fysiografiska Sällskapet i Lund; Svenska Sällskapet för Medicinsk Forskning; Vetenskapsrådet; Parkinsonfonden; Universitair Ziekenhuis Antwerpen; Ministero della Salute; Università degli Studi di Milano-Bicocca; Belgian Federal Science Policy Office; AFA Försäkring; Karolinska Institutet; University of Thessaly; Institut National de la Santé et de la Recherche Médicale; Uniwersytet Śląski w Katowicach; Yonsei University; Fondation de France; Bundesministerium für Bildung und Forschung; Griffith University; Hermann und Lilly Schilling-Stiftung für Medizinische Forschung; Canada Excellence Research Chairs, Government of Canada; Agence Nationale de la Recherche; South African Medical Research Council; Eli Lilly and Company; Fonds Wetenschappelijk Onderzoek; Genome British Columbia; Lunds Universitet; National Institutes of Health; Volkswagen Foundation; Michael J. Fox Foundation for Parkinson's Research","keywords":"LRRK2; Odds ratio; Parkinson's disease; Genetics; Genotyping; Haplotype; Minor allele frequency; Parkinsonism; Allele; Case-control study; Disease; Allele frequency; Genetic association; Single-nucleotide polymorphism; Medicine; Biology; Genotype; Internal medicine; Gene","score_opus":0.03163789674805586,"score_gpt":0.2696509180333877,"score_spread":0.23801302128533183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167552109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986166,0.00042663922,0.00030049583,0.000030000607,0.000017982271,0.000035400157,0.00018500569,0.000008256361,0.00037962224],"genre_scores_gemma":[0.99873763,0.00015435503,0.00027250152,0.00005218271,0.00002887996,0.000044352695,0.00025913183,0.000009769625,0.00044123133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997512,0.0006797002,0.0003101921,0.0010155978,0.0002735653,0.00020884999],"domain_scores_gemma":[0.99748564,0.000940148,0.0005767305,0.00049168424,0.00024409873,0.00026171168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017911079,0.0012585705,0.0014605708,0.0012810944,0.0015214535,0.0012178064,0.0011550488,0.0018760758,0.0039666067],"category_scores_gemma":[0.0037901755,0.0015105961,0.0015714361,0.0017030021,0.0012011182,0.00079855986,0.00059105316,0.0012113053,0.0005963831],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011569024,0.0015885463,0.95945257,0.00019168644,0.0035925943,0.00644082,0.0011320206,0.00016218646,0.011047544,0.00027170216,0.00047575127,0.004075569],"study_design_scores_gemma":[0.0010585685,0.0023629908,0.9875706,0.000023630279,0.0015252978,0.005361491,0.0003628259,0.00046034114,0.00049645564,0.00012557603,0.0006094038,0.00004289211],"about_ca_topic_score_codex":0.004793654,"about_ca_topic_score_gemma":0.0037780006,"teacher_disagreement_score":0.004793654,"about_ca_system_score_codex":0.00055624,"about_ca_system_score_gemma":0.00030629477,"threshold_uncertainty_score":0.013269603},"labels":[],"label_agreement":null},{"id":"W2167567290","doi":"10.1016/s1474-4422(14)70198-x","title":"Safety and efficacy of idalopirdine, a 5-HT 6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial","year":2014,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":162,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Donepezil; Placebo; Medicine; Clinical endpoint; Montreal Cognitive Assessment; Internal medicine; Alzheimer's disease; Clinical trial; Randomized controlled trial; Disease; Dementia; Pathology","score_opus":0.025504398557987557,"score_gpt":0.31421976302027416,"score_spread":0.28871536446228663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167567290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98119044,0.009936348,0.00067715684,0.00077481236,0.0005829429,0.002432123,0.001662473,0.00016672471,0.002577005],"genre_scores_gemma":[0.9834135,0.005494518,0.0013468312,0.0014855848,0.0005017807,0.002743511,0.0019039973,0.000026682266,0.0030834975],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994665,0.00023179034,0.00004594737,0.00010939179,0.000046365454,0.00010003112],"domain_scores_gemma":[0.999243,0.00020527333,0.00016863018,0.00006283637,0.000051879055,0.00026825443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016783662,0.0018544791,0.0037046454,0.0004729574,0.00045455332,0.0010880372,0.00090637186,0.002155894,0.005456068],"category_scores_gemma":[0.0018931752,0.0008866489,0.0021088559,0.00037379566,0.0010731723,0.0011942476,0.00045914788,0.002820461,0.0010022656],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9871393,0.0022045018,0.00042982685,0.00054857304,0.00071767083,0.00003295622,0.000043376476,0.0001049419,0.0019522626,0.000051388226,0.0004371212,0.0063381027],"study_design_scores_gemma":[0.9692314,0.02813133,0.0015906021,0.000021769334,0.00038262596,0.000020440842,0.000012107449,0.00011174022,0.00014580137,0.00006233858,0.00027827805,0.000011454436],"about_ca_topic_score_codex":0.0012646304,"about_ca_topic_score_gemma":0.0026407398,"teacher_disagreement_score":0.005456068,"about_ca_system_score_codex":0.00078558165,"about_ca_system_score_gemma":0.0008905126,"threshold_uncertainty_score":0.018252313},"labels":[],"label_agreement":null},{"id":"W2167592761","doi":"10.1016/s1474-4422(07)70131-x","title":"Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study","year":2007,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Cerebral Venous Sinus Thrombosis","field":"Medicine","cited_by":219,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Health Service Executive; Wellcome Trust","keywords":"Medicine; Venous thrombosis; Hazard ratio; Cohort; Internal medicine; Warfarin; Pediatrics; Heparin; Low molecular weight heparin; Thrombosis; Proportional hazards model; Cohort study; Surgery; Confidence interval; Atrial fibrillation","score_opus":0.03551953363602561,"score_gpt":0.3125393860367467,"score_spread":0.2770198524007211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167592761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956528,0.00051203364,0.000113039016,0.000059292946,0.00001067073,0.000035910896,0.0033717717,0.0000065378836,0.00023792866],"genre_scores_gemma":[0.99406356,0.00051662663,0.00022795214,0.00006074513,0.000021957647,0.00007695714,0.0049503683,0.000008471395,0.00007350469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971585,0.0008521638,0.00036436328,0.0008235734,0.000501834,0.00029956046],"domain_scores_gemma":[0.9935768,0.00107272,0.003185225,0.0009534657,0.0005320505,0.00067976775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002459433,0.0005727248,0.001279079,0.0015741265,0.0005927713,0.0012456296,0.0012181399,0.0009019674,0.0011256846],"category_scores_gemma":[0.007205308,0.0006953027,0.0010464919,0.0039263167,0.00048967527,0.0010329251,0.00113843,0.0011578172,0.0002027243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017200134,0.000022522927,0.9984816,0.000020736432,0.0001770964,0.00018247025,0.00008885777,0.000050992767,0.0000611386,0.000027209322,0.00027389027,0.00044141235],"study_design_scores_gemma":[0.000041912575,0.000060356295,0.99872005,0.000017922326,0.00008548282,0.0005787637,0.00011234843,0.00016006551,0.000026491824,0.0000119862325,0.00017747807,0.0000070107494],"about_ca_topic_score_codex":0.021574005,"about_ca_topic_score_gemma":0.015130706,"teacher_disagreement_score":0.021574005,"about_ca_system_score_codex":0.000920318,"about_ca_system_score_gemma":0.0011395089,"threshold_uncertainty_score":0.042896867},"labels":[],"label_agreement":null},{"id":"W2169545979","doi":"10.1016/s1474-4422(07)70328-9","title":"Recurrent reversible coma in an adolescent","year":2008,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Acupuncture Treatment Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Toronto Western Hospital; Hospital for Sick Children; University of Calgary; Alberta Children's Hospital","funders":"","keywords":"Glasgow Coma Scale; Medicine; Anesthesia; Blood pressure; Coma (optics); Neurological examination; Pediatrics; Surgery; Internal medicine","score_opus":0.11178918626285554,"score_gpt":0.3571200989783832,"score_spread":0.24533091271552765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169545979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99779725,0.0010652678,0.000015675882,0.0003188085,0.0000128644615,0.00001693503,0.000041659514,0.0000011628474,0.0007304611],"genre_scores_gemma":[0.9986078,0.0010551453,0.000026320282,0.00012832921,0.000023426359,0.000008072827,0.000035397177,6.70787e-7,0.0001148368],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9996406,0.00016597562,0.000033888602,0.00003728845,0.00003428081,0.000087923814],"domain_scores_gemma":[0.998692,0.00051258295,0.00050226785,0.00006640677,0.000068956564,0.00015782088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045916188,0.0001678615,0.00041994802,0.00039675614,0.00070173724,0.00039179242,0.0002836069,0.00052155025,0.0012420801],"category_scores_gemma":[0.0025907415,0.00012298908,0.0002844249,0.00052314275,0.00052645575,0.00037963782,0.00029181404,0.0006739461,0.00015723133],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018327306,0.0019911164,0.9178322,0.00069777016,0.00032094136,0.047853533,0.0035381496,0.000076558616,0.0021749244,0.0011491296,0.0012869673,0.021246046],"study_design_scores_gemma":[0.00047199926,0.0039957752,0.94982517,0.00025437452,0.00037250083,0.03648309,0.005915124,0.00017609994,0.00048851717,0.0003733412,0.0016243346,0.00001964875],"about_ca_topic_score_codex":0.006156685,"about_ca_topic_score_gemma":0.00841482,"teacher_disagreement_score":0.006156685,"about_ca_system_score_codex":0.00053105847,"about_ca_system_score_gemma":0.00065248,"threshold_uncertainty_score":0.012241721},"labels":[],"label_agreement":null},{"id":"W2171539930","doi":"10.1016/s1474-4422(07)70109-6","title":"Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study","year":2007,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":337,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University of British Columbia Hospital","funders":"Novartis Pharma; National Institutes of Health; Novartis","keywords":"Rivastigmine; Medicine; Placebo; Adverse effect; Internal medicine; Dementia; Clinical trial; Clinical Dementia Rating; Clinical endpoint; Cognitive decline; Donepezil; Disease","score_opus":0.030301042478959272,"score_gpt":0.3574221665960678,"score_spread":0.32712112411710853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171539930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99294585,0.00413016,0.00008645673,0.00038631362,0.00020165136,0.000079413454,0.0008421007,0.00002970607,0.0012982485],"genre_scores_gemma":[0.9956643,0.0017897026,0.00015615906,0.00033497822,0.00020463375,0.00009468456,0.000840704,0.000014534534,0.0009002477],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9993012,0.00028976853,0.00006840797,0.00014130825,0.00007859657,0.000120761695],"domain_scores_gemma":[0.9976057,0.0008082146,0.00064064824,0.00029799307,0.00010854941,0.00053883257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018180929,0.0018818572,0.0032552797,0.0003387139,0.00044606847,0.001411937,0.0010860204,0.0017557725,0.0015167327],"category_scores_gemma":[0.0040228525,0.00065864786,0.0025485961,0.00038626036,0.0009778156,0.001371731,0.0005951753,0.0029854565,0.0005271982],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95520085,0.0036324111,0.021447456,0.00036631286,0.003914788,0.00021121696,0.00011383526,0.00043180236,0.0021351078,0.00010428303,0.001136196,0.011305743],"study_design_scores_gemma":[0.54663426,0.17555298,0.2527285,0.0001763384,0.013960321,0.0008960158,0.0003196304,0.001710757,0.0026083419,0.0009599188,0.0042557037,0.00019722483],"about_ca_topic_score_codex":0.0019535571,"about_ca_topic_score_gemma":0.0020441583,"teacher_disagreement_score":0.0032552797,"about_ca_system_score_codex":0.0009271151,"about_ca_system_score_gemma":0.00083758304,"threshold_uncertainty_score":0.009615123},"labels":[],"label_agreement":null},{"id":"W2171872873","doi":"10.1016/s1474-4422(13)70193-5","title":"Combination pharmacotherapy for management of chronic pain: from bench to bedside","year":2013,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":241,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research; Wellcome Trust","keywords":"Medicine; Tolerability; Pharmacotherapy; Fibromyalgia; Chronic pain; Clinical trial; Intensive care medicine; Combination therapy; Neuropathic pain; Drug; Limiting; Pharmacology; Physical therapy; Adverse effect; Internal medicine","score_opus":0.09613484451347305,"score_gpt":0.39100753140103656,"score_spread":0.2948726868875635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171872873","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000055333338,0.9990683,0.000077129436,0.00023438671,0.00014072575,0.0000034919121,0.000008931165,0.0000045050065,0.00040719006],"genre_scores_gemma":[0.00061603956,0.9982779,0.00023711455,0.00036538852,0.00021490228,0.000005987473,0.000015951648,0.000001406439,0.00026535217],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997056,0.0000619279,0.00004038335,0.0000461617,0.00011898046,0.000026901293],"domain_scores_gemma":[0.99932265,0.00042663055,0.00009291748,0.000014106198,0.00010538714,0.00003829642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080383196,0.0010051209,0.0027656816,0.0020098304,0.00026584827,0.0011805176,0.0011797155,0.0013302851,0.005505612],"category_scores_gemma":[0.0010584666,0.00032014778,0.000997255,0.0019950154,0.00056345563,0.0013463469,0.0007393686,0.002803072,0.0016096943],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015898564,0.00009765506,0.000103903614,0.020790478,0.0003102217,0.00012144285,0.000029657182,0.00023297433,0.0007370541,0.001849676,0.025973981,0.949594],"study_design_scores_gemma":[0.00032004763,0.00036835676,0.0017882125,0.01984545,0.0010620028,0.001954634,0.00012148971,0.00032285723,0.0005168823,0.0043646195,0.969277,0.00005855533],"about_ca_topic_score_codex":0.0014260454,"about_ca_topic_score_gemma":0.0044266083,"teacher_disagreement_score":0.005505612,"about_ca_system_score_codex":0.0006624032,"about_ca_system_score_gemma":0.0010088562,"threshold_uncertainty_score":0.018418133},"labels":[],"label_agreement":null},{"id":"W2175470508","doi":"10.1016/s1474-4422(15)00322-1","title":"Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial","year":2015,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":201,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Center for Research Resources; EMD Serono; National Institutes of Health; Acorda Therapeutics; Genentech; Multiple Sclerosis Society; Alexion Pharmaceuticals; Teva Pharmaceutical Industries; Sun Pharma; Skirball Foundation; Biogen; Questcor Pharmaceuticals; Sanofi","keywords":"Medicine; Placebo; Estriol; Glatiramer acetate; Internal medicine; Multiple sclerosis; Clinical endpoint; Expanded Disability Status Scale; Randomized controlled trial; Hormone; Immunology","score_opus":0.11273012838627847,"score_gpt":0.3285492548460533,"score_spread":0.21581912645977483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2175470508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94181174,0.028544156,0.0011567203,0.003036431,0.002254606,0.016713046,0.0025415637,0.0003447281,0.0035970274],"genre_scores_gemma":[0.9353354,0.01620716,0.0036549566,0.0042165415,0.0019783936,0.028725002,0.0016049254,0.000056914003,0.008220721],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990464,0.0005575084,0.00006111242,0.00016099503,0.00006864759,0.000105396706],"domain_scores_gemma":[0.999278,0.00023136857,0.00020085784,0.000062475745,0.00004641351,0.00018081663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002197734,0.0019485812,0.0038228033,0.0008050466,0.0004757806,0.0009775087,0.0009891,0.0030840586,0.010970933],"category_scores_gemma":[0.0028149155,0.00084776327,0.0018264184,0.0006603553,0.0012231987,0.0012631738,0.0004945669,0.0019507182,0.0014553893],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97950065,0.0044006035,0.00022794862,0.0015175721,0.00062286557,0.000052479303,0.000048187074,0.00012616535,0.0017063139,0.000078428144,0.00067622855,0.011042635],"study_design_scores_gemma":[0.9752554,0.023608822,0.0003700649,0.00003600191,0.00014512564,0.000016853557,0.000009136524,0.000056856414,0.00006922094,0.00004903891,0.00037847564,0.0000050068275],"about_ca_topic_score_codex":0.0006879259,"about_ca_topic_score_gemma":0.0013907142,"teacher_disagreement_score":0.010970933,"about_ca_system_score_codex":0.0006776203,"about_ca_system_score_gemma":0.0011188239,"threshold_uncertainty_score":0.03670138},"labels":[],"label_agreement":null},{"id":"W2187555794","doi":"10.1016/s1474-4422(15)00303-8","title":"Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data","year":2015,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Vascular Malformations Diagnosis and Treatment","field":"Medicine","cited_by":349,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"Medical Research Council; Scottish Government","keywords":"Medicine; Hazard ratio; Meta-analysis; Proportional hazards model; Confidence interval; Study heterogeneity; Presentation (obstetrics); MEDLINE; Pediatrics; Survival analysis; Internal medicine; Surgery","score_opus":0.4971588775329501,"score_gpt":0.47457807081523046,"score_spread":0.02258080671771967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2187555794","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08134553,0.9038621,0.006892656,0.00083335984,0.0005985822,0.00036954085,0.0048818463,0.00016461876,0.0010516968],"genre_scores_gemma":[0.89085823,0.09853756,0.0046861186,0.0011148148,0.00032428154,0.00075551256,0.00324888,0.0001248119,0.00034982787],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97942483,0.012788483,0.0032465716,0.00284845,0.0012008524,0.0004908798],"domain_scores_gemma":[0.9504684,0.03853891,0.0050097094,0.004183664,0.0014080507,0.00039115408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025593309,0.002300455,0.010856106,0.003794218,0.0005749067,0.0031691347,0.0024801902,0.0020775315,0.0023193085],"category_scores_gemma":[0.04995574,0.0014841846,0.05547897,0.0052086883,0.000728295,0.0015003198,0.0014460641,0.0021684347,0.00029522608],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026714327,0.0000145515905,0.022003772,0.019534664,0.950711,0.00010253053,0.000044318538,0.001056019,0.00015061571,0.000090858586,0.0003989696,0.0032212643],"study_design_scores_gemma":[0.00054675236,0.00018135103,0.013357873,0.0018821502,0.98202294,0.00013454443,0.000025854095,0.00052316807,0.00010871784,0.0003705769,0.0008233216,0.000022767817],"about_ca_topic_score_codex":0.0047483062,"about_ca_topic_score_gemma":0.006703292,"teacher_disagreement_score":0.025593309,"about_ca_system_score_codex":0.0012354272,"about_ca_system_score_gemma":0.0011995084,"threshold_uncertainty_score":0.13535196},"labels":[],"label_agreement":null},{"id":"W2194645238","doi":"10.1016/s1474-4422(15)00342-7","title":"Multiple sclerosis and related disorders: evolving pathophysiologic insights","year":2015,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Multiple sclerosis; Pathophysiology; Neuroscience; Medicine; Psychology; Pathology; Psychiatry","score_opus":0.1754010476663399,"score_gpt":0.35186690344528787,"score_spread":0.17646585577894797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2194645238","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001941262,0.99946266,0.000020282492,0.00028555325,0.000104793624,0.0000020662546,0.000012539158,0.0000013901818,0.00009141378],"genre_scores_gemma":[0.00026268818,0.9990337,0.000088377456,0.00037854703,0.00016751848,0.0000043327013,0.00001408658,5.51624e-7,0.000050251998],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99863786,0.0003795626,0.0003516197,0.00016884804,0.00038106675,0.00008103489],"domain_scores_gemma":[0.9919369,0.0062053073,0.00089453364,0.000106275256,0.0007019293,0.0001550114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044051353,0.0013532734,0.004718602,0.0061707874,0.00042949474,0.0030634853,0.0018277107,0.0026873348,0.0051591876],"category_scores_gemma":[0.0081250165,0.0005792279,0.0015894172,0.007408836,0.0012625933,0.0031143688,0.0018451895,0.0026708003,0.0009436889],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024221215,0.000064888634,0.00055726094,0.18824269,0.0014404119,0.00023189076,0.00019737528,0.00028233463,0.0005369409,0.005419119,0.037195507,0.76558936],"study_design_scores_gemma":[0.00020816941,0.00013758344,0.0030520947,0.14067115,0.0043402663,0.0011031508,0.00047183715,0.00014609566,0.00020590298,0.00707161,0.84251124,0.000080861704],"about_ca_topic_score_codex":0.0033809543,"about_ca_topic_score_gemma":0.009216417,"teacher_disagreement_score":0.0061707874,"about_ca_system_score_codex":0.0017827919,"about_ca_system_score_gemma":0.0046224133,"threshold_uncertainty_score":0.023296893},"labels":[],"label_agreement":null},{"id":"W2213019825","doi":"10.1016/s1474-4422(15)00012-5","title":"Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial","year":2015,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":204,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; National Health and Medical Research Council; Scottish Funding Council; Norges Forskningsråd; Dalhousie University; Schweizerische Herzstiftung; National Research Foundation; Karolinska Institutet; National Institute for Health and Care Research; University of Edinburgh; Chest Heart and Stroke Scotland; Stockholms Läns Landsting; National Institute for Social Care and Health Research","keywords":"Medicine; Randomized controlled trial; Stroke (engine); Odds ratio; Leukoaraiosis; Fibrinolytic agent; Internal medicine; Surgery; Cardiology; Pediatrics; Tissue plasminogen activator; Magnetic resonance imaging; Radiology; Hyperintensity","score_opus":0.01624108133024547,"score_gpt":0.28665982640659965,"score_spread":0.27041874507635416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2213019825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98485434,0.006389656,0.000794179,0.00037606363,0.0004417988,0.003489702,0.0021578781,0.00008719053,0.0014092883],"genre_scores_gemma":[0.9862612,0.0015739115,0.0011217451,0.00041007609,0.00061713223,0.0066340026,0.0023167091,0.000027641478,0.0010376207],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9949469,0.003357891,0.0005003274,0.0005275142,0.00029602836,0.00037139462],"domain_scores_gemma":[0.9923636,0.0028784545,0.0024822787,0.0008157044,0.00061546505,0.0008444626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008587982,0.0025083213,0.0061258287,0.000631063,0.00052532664,0.0017282327,0.0013027888,0.0021871314,0.004675656],"category_scores_gemma":[0.00831255,0.00056190114,0.007147836,0.0011782342,0.0012977899,0.0012642624,0.0006749787,0.0026142234,0.00052299345],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9896011,0.0007772209,0.0018897917,0.0007520034,0.004150475,0.000032000335,0.000024824985,0.00021179765,0.00042116095,0.000061058665,0.00028182074,0.0017966406],"study_design_scores_gemma":[0.9231126,0.046948746,0.015807109,0.0001559797,0.01115119,0.00007137778,0.000034055276,0.0012045995,0.0004671998,0.0004654873,0.00053379,0.000047992762],"about_ca_topic_score_codex":0.0010211519,"about_ca_topic_score_gemma":0.0014775089,"teacher_disagreement_score":0.008587982,"about_ca_system_score_codex":0.0010353891,"about_ca_system_score_gemma":0.0014351507,"threshold_uncertainty_score":0.045418143},"labels":[],"label_agreement":null},{"id":"W2264705762","doi":"10.1016/s1474-4422(16)00018-1","title":"Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trial","year":2016,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"","keywords":"Sphingosine-1-phosphate receptor; Placebo; Medicine; Sphingosine-1-phosphate; Internal medicine; Pharmacology; Receptor; Sphingosine; Pathology; Alternative medicine","score_opus":0.04882834581778473,"score_gpt":0.3012512679795377,"score_spread":0.252422922161753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2264705762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98688275,0.007969175,0.00037783768,0.00067734584,0.0004363213,0.0014498364,0.00081726146,0.00007840399,0.001311051],"genre_scores_gemma":[0.98542154,0.00526528,0.0010474586,0.0011674395,0.00065668544,0.0023431808,0.0013277231,0.000028571589,0.0027421897],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99920005,0.0004120719,0.000054502874,0.00014095331,0.00006026541,0.00013212237],"domain_scores_gemma":[0.999129,0.00027912945,0.00021583549,0.00007730129,0.000061182785,0.00023753183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022408916,0.0022993193,0.0035973198,0.00048355048,0.0004631699,0.0011270135,0.0010397066,0.0030554363,0.0060558855],"category_scores_gemma":[0.0018862815,0.00079921953,0.0023829173,0.00042629946,0.0016324595,0.001461231,0.0004906925,0.0031816592,0.0011934242],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98634535,0.0021199007,0.0002823277,0.0005043745,0.00060974725,0.00002606535,0.000035958725,0.00010425415,0.0023764607,0.00006093461,0.00032365756,0.007210917],"study_design_scores_gemma":[0.95170903,0.046090752,0.00096063793,0.00002602527,0.00039786514,0.00002446268,0.000016749069,0.00009519793,0.0002634389,0.00008148506,0.000323148,0.000011242681],"about_ca_topic_score_codex":0.0007451164,"about_ca_topic_score_gemma":0.0012440569,"teacher_disagreement_score":0.0060558855,"about_ca_system_score_codex":0.00075681496,"about_ca_system_score_gemma":0.00090835255,"threshold_uncertainty_score":0.020258963},"labels":[],"label_agreement":null},{"id":"W2280334572","doi":"10.1016/s1474-4422(15)00393-2","title":"MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines","year":2016,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":863,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Chugai Pharmaceutical; European Commission; Sanofi; Bayer HealthCare; McGill University; Eli Lilly and Company; CSL Behring; Medical Research Council; Biogen; Pfizer; Teva Pharmaceutical Industries; National Institutes of Health; Siemens; National Research Foundation","keywords":"Multiple sclerosis; Medicine; Magnetic resonance imaging; Spinal cord; Medical physics; Disease; Clinically isolated syndrome; Expert opinion; Radiology; Pathology; Intensive care medicine; Psychiatry","score_opus":0.4538873705448648,"score_gpt":0.4632092373291845,"score_spread":0.009321866784319732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2280334572","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000101887876,0.9965779,0.0003184754,0.0015142794,0.00054105994,0.00009278996,0.00032293,0.000015407963,0.00051522657],"genre_scores_gemma":[0.002134459,0.9900864,0.0031988367,0.0022425232,0.0005136169,0.0002715602,0.0009947498,0.000011609158,0.0005462998],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956779,0.00089047285,0.001791093,0.0003411227,0.0011196473,0.00017982825],"domain_scores_gemma":[0.99312145,0.003234308,0.0015196132,0.00011783983,0.0017986044,0.00020812756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074969837,0.0027365177,0.008418584,0.011625298,0.000784263,0.0022620643,0.006289816,0.0036241934,0.004903867],"category_scores_gemma":[0.015569601,0.0010364203,0.006857563,0.0069984016,0.0011701627,0.00262286,0.0021350097,0.0029943918,0.0018152567],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007057829,0.0001123039,0.0016875076,0.22421561,0.0039662863,0.00041843177,0.00019945801,0.00065078726,0.0009421555,0.003129925,0.13543448,0.6285373],"study_design_scores_gemma":[0.0011296249,0.00022800778,0.012497316,0.40630138,0.018628744,0.0028482033,0.0004639609,0.0005631172,0.00074536615,0.0073905876,0.5489708,0.00023281766],"about_ca_topic_score_codex":0.016178831,"about_ca_topic_score_gemma":0.02704004,"teacher_disagreement_score":0.016178831,"about_ca_system_score_codex":0.0039038495,"about_ca_system_score_gemma":0.008768658,"threshold_uncertainty_score":0.039648294},"labels":[],"label_agreement":null},{"id":"W2280783985","doi":"10.1016/s1474-4422(15)00401-9","title":"A clinical approach to diagnosis of autoimmune encephalitis","year":2016,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":4396,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster Children's Hospital; Alberta Children's Hospital","funders":"National Institute of Neurological Disorders and Stroke; National Institute on Aging; Erasmus+; National Medical Research Council; National Health and Medical Research Council; Tau Consortium; Wellcome Trust; National Institutes of Health; Fundació la Marató de TV3; CurePSP","keywords":"Autoimmune encephalitis; Medicine; Encephalitis; Differential diagnosis; Autoantibody; Immunology; Immunotherapy; Disease; Diagnostic test; Intensive care medicine; Pediatrics; Antibody; Pathology; Immune system","score_opus":0.1469138029082757,"score_gpt":0.4079038100333693,"score_spread":0.26099000712509357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2280783985","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023514118,0.9984571,0.00011830166,0.0004961481,0.00037277333,0.000003840544,0.000007561481,0.0000042805445,0.0005165511],"genre_scores_gemma":[0.0006127108,0.9967945,0.0003544291,0.0010277777,0.0008667356,0.000006830425,0.000022371893,0.0000012971952,0.00031336778],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99916136,0.00022134531,0.00017553126,0.0000912602,0.00029447748,0.00005607347],"domain_scores_gemma":[0.99832255,0.00097474485,0.00019446803,0.000033941724,0.00040351204,0.0000707316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001636571,0.0015998892,0.0026971174,0.005233271,0.00037435425,0.001804291,0.001695675,0.002292246,0.0030677975],"category_scores_gemma":[0.0026501515,0.00045547175,0.0010059754,0.002765904,0.0012838508,0.002489242,0.0012776825,0.0036667418,0.0016604237],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000103403254,0.000058783822,0.00030538248,0.024715211,0.00019793164,0.00054912997,0.00007777527,0.00032568336,0.0008460238,0.0052720904,0.057673432,0.9098751],"study_design_scores_gemma":[0.000092335395,0.00012110607,0.0015156447,0.024506833,0.0004036003,0.0040286058,0.00016946449,0.00022359076,0.000274068,0.0067338543,0.96187586,0.000055041208],"about_ca_topic_score_codex":0.002433157,"about_ca_topic_score_gemma":0.0047306768,"teacher_disagreement_score":0.005233271,"about_ca_system_score_codex":0.0014005163,"about_ca_system_score_gemma":0.002259573,"threshold_uncertainty_score":0.010262787},"labels":[],"label_agreement":null},{"id":"W2296989255","doi":"10.1016/s1474-4422(16)00068-5","title":"Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study","year":2016,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":333,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"IC Design Education Center; Stichting MS Research; Teva Pharmaceutical Industries; Heidelberg Engineering; Biogen","keywords":"Optical coherence tomography; Multiple sclerosis; Cohort; Retinal; Medicine; Coherence (philosophical gambling strategy); Cohort study; Ophthalmology; Internal medicine; Physics; Psychiatry","score_opus":0.07716175340655962,"score_gpt":0.2982448953279099,"score_spread":0.22108314192135026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2296989255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99887484,0.0004677775,0.00008448783,0.000045138197,0.000019362647,0.0000102932945,0.0002932909,0.000005450995,0.00019917445],"genre_scores_gemma":[0.99899966,0.00028165142,0.000115360985,0.000035828656,0.000035112014,0.000014445827,0.00027774024,0.0000052428454,0.00023500602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987501,0.00032299376,0.00014626967,0.00043000045,0.00013965004,0.00021091095],"domain_scores_gemma":[0.99624157,0.00062449684,0.0011652352,0.0010762342,0.0003410801,0.00055137754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001972653,0.0011610609,0.001065599,0.0010029553,0.0011314637,0.0017277687,0.0011759144,0.0018633016,0.0015152654],"category_scores_gemma":[0.0040045357,0.0016090177,0.0024619796,0.0019414194,0.0007607344,0.0015606781,0.0009656367,0.0025004381,0.0003706167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002346299,0.00029411574,0.9928847,0.00002675949,0.0017890543,0.00030678432,0.00020271711,0.0000682244,0.00079551974,0.00004426168,0.00018211575,0.0010593055],"study_design_scores_gemma":[0.00012550245,0.0005440935,0.99727196,0.000014738995,0.00078205764,0.0004638231,0.00026902647,0.00022354588,0.00009086543,0.000056780307,0.00013467156,0.000022873637],"about_ca_topic_score_codex":0.013543994,"about_ca_topic_score_gemma":0.009327873,"teacher_disagreement_score":0.013543994,"about_ca_system_score_codex":0.00065114663,"about_ca_system_score_gemma":0.00070879346,"threshold_uncertainty_score":0.026930332},"labels":[],"label_agreement":null},{"id":"W2298887234","doi":"10.1016/s1474-4422(16)00062-4","title":"Defeating Alzheimer's disease and other dementias: a priority for European science and society","year":2016,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":1694,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Douglas Mental Health University Institute; University of British Columbia","funders":"National Institute for Health and Care Research","keywords":"Dementia; Disease; Incentive; Medicine; European union; Gerontology; Health care; Alzheimer's disease; Neurology; Political science; Psychology; Psychiatry; Economic growth; Business; Economic policy; Law; Economics","score_opus":0.09232217206322645,"score_gpt":0.39867247923592036,"score_spread":0.3063503071726939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2298887234","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000027277312,0.9980464,0.000015828113,0.0012100852,0.00038772612,0.0000017119224,0.00000800476,0.000002488738,0.00030052222],"genre_scores_gemma":[0.00058018503,0.996793,0.00009897245,0.0017887173,0.00045241576,0.0000047015583,0.000014568589,0.000001248784,0.0002661696],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991566,0.00022756326,0.00013656197,0.00009412712,0.00026662927,0.00011846032],"domain_scores_gemma":[0.9980379,0.0011242968,0.0003298266,0.000037780395,0.00032203746,0.00014816162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025137244,0.0012838502,0.0041537597,0.003064142,0.00062048674,0.0028699315,0.0014144045,0.0049495213,0.008456967],"category_scores_gemma":[0.0034850698,0.0004459573,0.0013346685,0.0033716946,0.0014010445,0.003798811,0.0018650044,0.0043949625,0.0019264459],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020706217,0.00011995068,0.00023356905,0.07031972,0.00049614895,0.00018823332,0.00018792374,0.00024674443,0.0005692492,0.0097273905,0.09372871,0.82397527],"study_design_scores_gemma":[0.00013824539,0.00014322344,0.000890141,0.03891564,0.0005555564,0.0004436555,0.00037742898,0.000051607516,0.00008704223,0.0070034075,0.9513619,0.00003207401],"about_ca_topic_score_codex":0.004777729,"about_ca_topic_score_gemma":0.01310738,"teacher_disagreement_score":0.008456967,"about_ca_system_score_codex":0.0019062789,"about_ca_system_score_gemma":0.0057087564,"threshold_uncertainty_score":0.028291404},"labels":[],"label_agreement":null},{"id":"W2319540158","doi":"10.1016/s1474-4422(16)30008-4","title":"Rapid reversal of haematoma expansion associated with vitamin K antagonists","year":2016,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Population Health Research Institute; McMaster University","funders":"","keywords":"Medicine; Warfarin; Intracranial haemorrhage; Vitamin K antagonist; Intracerebral hemorrhage; Vitamin k; Pediatrics; Internal medicine; Complication; Subarachnoid hemorrhage","score_opus":0.06370717997128844,"score_gpt":0.2981031627027451,"score_spread":0.23439598273145668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319540158","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019007972,0.017049301,0.0016052476,0.91127056,0.02293611,0.00006321782,0.0001592608,0.00027280592,0.027635515],"genre_scores_gemma":[0.26297477,0.013096205,0.0025983609,0.52529955,0.18202238,0.000095313124,0.00020457192,0.000117575066,0.013591297],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9990163,0.00024544817,0.00017433337,0.00009268803,0.00030320857,0.00016804536],"domain_scores_gemma":[0.99504894,0.003054747,0.0006266529,0.00021756259,0.00037204442,0.0006801215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086265994,0.00037240205,0.0013081708,0.00054494257,0.000847691,0.0017081049,0.00080220087,0.009642568,0.0029408073],"category_scores_gemma":[0.014618678,0.00025161103,0.0012557888,0.00040466644,0.0011129944,0.0014167528,0.0005630307,0.013069002,0.0019505407],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016587226,0.00048744827,0.011793397,0.0004944936,0.0002823667,0.20000328,0.0002532308,0.00072426297,0.0022609693,0.011194884,0.6196472,0.15119971],"study_design_scores_gemma":[0.00400728,0.0019794432,0.018211283,0.0017528327,0.00044033988,0.3320535,0.0004191173,0.004808004,0.0030774,0.03380571,0.5992725,0.0001726353],"about_ca_topic_score_codex":0.0013226307,"about_ca_topic_score_gemma":0.0033429768,"teacher_disagreement_score":0.009642568,"about_ca_system_score_codex":0.0018503168,"about_ca_system_score_gemma":0.0015097455,"threshold_uncertainty_score":0.013425112},"labels":[],"label_agreement":null},{"id":"W2322916844","doi":"10.1016/s1474-4422(16)00116-2","title":"The new definition and diagnostic criteria of Parkinson's disease","year":2016,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; McGill University; Montreal General Hospital","funders":"","keywords":"Parkinson's disease; Medicine; Disease; MEDLINE; Pathology; Biology","score_opus":0.03490986941720906,"score_gpt":0.27557276014556686,"score_spread":0.2406628907283578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322916844","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035984642,0.009460875,0.0007154565,0.95470804,0.0323123,0.000015593607,0.00009562368,0.000019486675,0.0023127508],"genre_scores_gemma":[0.008567382,0.013458648,0.0037220882,0.6780325,0.29248786,0.00014955492,0.00032622277,0.000038713817,0.0032171125],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98612297,0.0037068126,0.00472348,0.0012362223,0.003034419,0.00117603],"domain_scores_gemma":[0.96638095,0.01816945,0.0027280648,0.0011722232,0.008616725,0.0029326077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011129431,0.0017649083,0.004630426,0.0030970543,0.0031050046,0.004641185,0.0043478156,0.042472422,0.0028788862],"category_scores_gemma":[0.045816384,0.0012644425,0.0035642039,0.0020984814,0.008583095,0.010215961,0.0035651932,0.071974106,0.0027235758],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013222992,0.000092501716,0.0019219946,0.0005290804,0.00006972295,0.006514379,0.0005388897,0.00022052249,0.0006822955,0.027017655,0.91901,0.04327077],"study_design_scores_gemma":[0.0005848398,0.00022782729,0.0050902334,0.003014906,0.00018044155,0.031012407,0.0008604991,0.0014679276,0.0004572354,0.07749954,0.87933666,0.00026752203],"about_ca_topic_score_codex":0.0057035,"about_ca_topic_score_gemma":0.011448229,"teacher_disagreement_score":0.042472422,"about_ca_system_score_codex":0.0073506334,"about_ca_system_score_gemma":0.007748161,"threshold_uncertainty_score":0.058858752},"labels":[],"label_agreement":null},{"id":"W2341477763","doi":"10.1016/s1474-4422(16)30031-x","title":"Salivary gland biopsy for diagnosis of Parkinson's disease?","year":2016,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver Coastal Health","funders":"","keywords":"Hyposmia; REM sleep behavior disorder; Disease; Parkinson's disease; Substantia nigra; Population; Medicine; Neurology; Pars compacta; Parkinsonism; Neuroscience; Psychology; Pathology; Psychiatry","score_opus":0.03573033160813903,"score_gpt":0.28199667759463276,"score_spread":0.24626634598649372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2341477763","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034569576,0.031603478,0.0004986935,0.9350216,0.018314566,0.00003108517,0.00011200777,0.00006781154,0.010893839],"genre_scores_gemma":[0.07082553,0.02596894,0.0019545134,0.7140544,0.17985617,0.00006243215,0.00019749807,0.000056999885,0.007023587],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984238,0.00044882897,0.00030605684,0.00017006304,0.00042620412,0.00022514719],"domain_scores_gemma":[0.996253,0.0019059132,0.0002627063,0.00017681289,0.00073797524,0.000663551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001769272,0.00087240123,0.0018352764,0.0014387347,0.0017264195,0.0021640994,0.0016390911,0.026394144,0.006020465],"category_scores_gemma":[0.01406167,0.00069325714,0.0022220723,0.00071566337,0.002245953,0.004580021,0.0009248794,0.017980339,0.0054822112],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007503325,0.00030010196,0.018854555,0.0007016503,0.00021751953,0.12779985,0.00032658878,0.00044147045,0.0022348983,0.006458289,0.7359024,0.106012315],"study_design_scores_gemma":[0.0015793104,0.0007059888,0.017915579,0.0073698186,0.00047470583,0.31994656,0.0024636115,0.0030815743,0.0023907947,0.04568074,0.5980948,0.00029640424],"about_ca_topic_score_codex":0.0054053874,"about_ca_topic_score_gemma":0.011019373,"teacher_disagreement_score":0.026394144,"about_ca_system_score_codex":0.0027079761,"about_ca_system_score_gemma":0.0024572976,"threshold_uncertainty_score":0.02014041},"labels":[],"label_agreement":null},{"id":"W2343065118","doi":"10.1016/s1474-4422(16)00111-3","title":"Neural correlates of consciousness in patients who have emerged from a minimally conscious state: a cross-sectional multimodal imaging study","year":2016,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Traumatic Brain Injury Research","field":"Medicine","cited_by":259,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Minimally conscious state; Persistent vegetative state; Wakefulness; Resting state fMRI; Default mode network; Neural correlates of consciousness; Neuroimaging; Coma (optics); Psychology; Medicine; Consciousness; Sedation; Brain mapping; Neurology; Functional magnetic resonance imaging; Neuroscience; Anesthesia; Electroencephalography; Physics","score_opus":0.04007517428464389,"score_gpt":0.33854346349224423,"score_spread":0.2984682892076003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343065118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997769,0.000029634566,0.000024088184,0.000012690374,0.000002150323,0.0000042168144,0.00003082313,5.782705e-7,0.00011897033],"genre_scores_gemma":[0.99965906,0.00004337269,0.0000368423,0.000030742907,0.000010076851,0.0000063963244,0.00012846896,0.000001035832,0.00008400097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999861,0.000022174747,0.000021238624,0.000038551967,0.000018592604,0.000038493035],"domain_scores_gemma":[0.99942255,0.000118991135,0.00018455333,0.00005343679,0.000066174114,0.00015441228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031631443,0.00035951208,0.00043448116,0.0006539408,0.00057988777,0.0008358,0.000263866,0.0007030024,0.0013128452],"category_scores_gemma":[0.0013850459,0.00036702788,0.00031589164,0.00061996246,0.0006746192,0.0010622315,0.0005200528,0.0006742766,0.0002671566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057554094,0.00040686913,0.99253863,0.00001050641,0.00008096421,0.0009409469,0.00054024963,0.00003256673,0.0034810423,0.000043359178,0.00006019338,0.001289128],"study_design_scores_gemma":[0.000013310957,0.00036054075,0.9980393,0.0000019326544,0.000027516498,0.0008474207,0.00045119436,0.000049196347,0.00011934898,0.000029242063,0.000055608234,0.0000055486203],"about_ca_topic_score_codex":0.0017173813,"about_ca_topic_score_gemma":0.002527203,"teacher_disagreement_score":0.0017173813,"about_ca_system_score_codex":0.00021262992,"about_ca_system_score_gemma":0.00023901273,"threshold_uncertainty_score":0.0043919086},"labels":[],"label_agreement":null},{"id":"W2345523668","doi":"10.1016/s1474-4422(16)30041-2","title":"Preventing both stroke and dementia","year":2016,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Western University; University of Toronto; London Health Sciences Centre","funders":"","keywords":"Dementia; Stroke (engine); Scopus; Proclamation; Medicine; Incidence (geometry); Population; Gerontology; Life expectancy; Disease; MEDLINE; Internal medicine; Political science; Environmental health","score_opus":0.0310690037130051,"score_gpt":0.30712804107617975,"score_spread":0.27605903736317466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345523668","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023770347,0.0034881632,0.00004477297,0.9689446,0.02371164,0.000009240703,0.000048780817,0.000018998755,0.0034960713],"genre_scores_gemma":[0.0023118511,0.0025100377,0.00013356702,0.9220403,0.06825038,0.000031010317,0.000037372927,0.0000124268445,0.0046731443],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99367493,0.0016926214,0.0009820367,0.00051534997,0.002065032,0.0010699834],"domain_scores_gemma":[0.9828888,0.007246738,0.0015940109,0.0005665576,0.0024972742,0.0052067055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045588566,0.0013263368,0.0029592686,0.0014544659,0.0044507515,0.0046046497,0.002126902,0.09523746,0.015275022],"category_scores_gemma":[0.04803613,0.0012197259,0.0020873882,0.001080183,0.0034561648,0.005202802,0.0038897088,0.056959413,0.01099687],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093259565,0.000066362285,0.0006623195,0.00021674029,0.00004728933,0.00089149014,0.00010482944,0.00006002507,0.00016078823,0.003584025,0.9717069,0.022405943],"study_design_scores_gemma":[0.0006450432,0.00022527525,0.0024498834,0.0017317283,0.00015222127,0.0020476356,0.00038190384,0.00036917964,0.00025115407,0.018867914,0.9727884,0.00008970313],"about_ca_topic_score_codex":0.0106355585,"about_ca_topic_score_gemma":0.02266732,"teacher_disagreement_score":0.09523746,"about_ca_system_score_codex":0.0048312163,"about_ca_system_score_gemma":0.010560713,"threshold_uncertainty_score":0.051100075},"labels":[],"label_agreement":null},{"id":"W2345730171","doi":"10.1016/s1474-4422(16)00124-1","title":"Effect of baseline Alberta Stroke Program Early CT Score on safety and efficacy of intra-arterial treatment: a subgroup analysis of a randomised phase 3 trial (MR CLEAN)","year":2016,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Randomized controlled trial; Odds ratio; Stroke (engine); Modified Rankin Scale; Subgroup analysis; Logistic regression; Internal medicine; Surgery; Physical therapy; Confidence interval; Ischemic stroke; Ischemia","score_opus":0.016507373532171566,"score_gpt":0.30058475930986683,"score_spread":0.28407738577769526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345730171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96793425,0.020842163,0.0018284828,0.001233558,0.001379725,0.0021601978,0.002166229,0.0001686995,0.0022867213],"genre_scores_gemma":[0.99108547,0.0021155968,0.0010208027,0.0010487587,0.0008205208,0.0014590367,0.0010788824,0.000048716,0.0013221902],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9965334,0.0019418331,0.0004692606,0.000535719,0.00021673655,0.0003030735],"domain_scores_gemma":[0.99618196,0.0018068178,0.0008139555,0.00061653653,0.0001826977,0.00039811525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004809556,0.0026895017,0.006931706,0.00055167696,0.00062892964,0.0021012232,0.0014194133,0.0027214421,0.0065401634],"category_scores_gemma":[0.008022103,0.0009263195,0.012049328,0.0006158122,0.0012739433,0.0017045399,0.0008778714,0.0046867514,0.000757504],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97434705,0.0005207317,0.0010645048,0.0008676047,0.017948685,0.00004282237,0.000046770187,0.00023574485,0.00079440605,0.00007134575,0.00040759423,0.0036526478],"study_design_scores_gemma":[0.940061,0.021816911,0.008142192,0.00013411306,0.027646504,0.000055868215,0.00006718273,0.0005674417,0.00037954064,0.0005677852,0.00049689034,0.00006459655],"about_ca_topic_score_codex":0.0015718888,"about_ca_topic_score_gemma":0.0032718347,"teacher_disagreement_score":0.006931706,"about_ca_system_score_codex":0.00093845127,"about_ca_system_score_gemma":0.0011447781,"threshold_uncertainty_score":0.025435686},"labels":[],"label_agreement":null},{"id":"W2355524658","doi":"10.1016/s1474-4422(16)30030-8","title":"Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study","year":2016,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Intracerebral and Subarachnoid Hemorrhage Research","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Research and Development; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital; University of California, San Diego; Fidelity Biosciences; Genentech; National Institutes of Health; Servier; Centre d'Imagerie BioMédicale; Fujirebio Europe; Eisai; Hartstichting; Alzheimer's Drug Discovery Foundation; ZonMw; Northern California Institute for Research and Education; Pfizer; Biogen; BioClinica; National Center for Research Resources; F. Hoffmann-La Roche; National Institute of Neurological Disorders and Stroke; IXICO; Takeda Pharmaceutical Company; AbbVie; Novartis Pharmaceuticals Corporation; Bristol-Myers Squibb Foundation; Lundbeckfonden; U.S. Department of Defense; Eli Lilly and Company; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; University of Southern California; Roche; Merck; GE Healthcare; Alzheimer's Disease Neuroimaging Initiative; Johnson and Johnson; Meso Scale Diagnostics; Sanofi; Harvard NeuroDiscovery Center; Alzheimer's Association","keywords":"Cerebral amyloid angiopathy; Dementia; Medicine; Neuroimaging; Alzheimer's disease; Pathology; Angiopathy; Atrophy; Disease; Cognitive decline; Amyloid (mycology); Internal medicine; Psychiatry; Endocrinology","score_opus":0.014981660118945457,"score_gpt":0.25856319866878963,"score_spread":0.24358153854984418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2355524658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99873716,0.0005420937,0.00011179361,0.00003249885,0.000016160739,0.000024393961,0.0001296914,0.000006824757,0.00039939804],"genre_scores_gemma":[0.99916697,0.00023913922,0.00009777996,0.00004299433,0.00003688659,0.00002130248,0.00016357377,0.000005698205,0.00022573676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99776447,0.0006735429,0.00028427236,0.00071892346,0.00028103232,0.0002777709],"domain_scores_gemma":[0.9962773,0.0012064826,0.00087019487,0.00065421464,0.00049544225,0.0004963818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001964395,0.0017889173,0.0018056434,0.0028052002,0.0023584936,0.002106068,0.0015587058,0.002318319,0.0037413482],"category_scores_gemma":[0.0058225095,0.0020885693,0.001319009,0.0031121932,0.001966143,0.0016790137,0.0010184544,0.0014459133,0.0005744345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003255394,0.0010374371,0.9850477,0.000089790585,0.0013148197,0.004162762,0.00095652847,0.00005333764,0.0016311414,0.00011665632,0.00027051414,0.0020639214],"study_design_scores_gemma":[0.00029773798,0.0007449077,0.99418086,0.000014444117,0.00047328405,0.0032730915,0.0004908467,0.00015209013,0.00008709372,0.00007730329,0.00018328417,0.00002500117],"about_ca_topic_score_codex":0.013833953,"about_ca_topic_score_gemma":0.011418878,"teacher_disagreement_score":0.013833953,"about_ca_system_score_codex":0.00080792885,"about_ca_system_score_gemma":0.00052722456,"threshold_uncertainty_score":0.027506828},"labels":[],"label_agreement":null},{"id":"W2412702708","doi":"10.1016/s1474-4422(16)30073-4","title":"Global burden of stroke and risk factors in 188 countries, during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013","year":2016,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":1694,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Research Council of New Zealand; School of Medicine, New York University; National Institutes of Health; Brain Research New Zealand; University of Peradeniya; National Research University Higher School of Economics; Wuhan University; Chinese Center for Disease Control and Prevention; Universidade de São Paulo; Ministry of Business, Innovation and Employment; National Institute for Health and Care Research; Gentofte Hospital; King's College London; Institute for Health Metrics and Evaluation; University of Adelaide; Universiti Kebangsaan Malaysia; Monash University; National University of Singapore; University of Miami; York University; Universitat Pompeu Fabra; Rigshospitalet; University of Washington; Murdoch Children's Research Institute; Leonard M. Miller School of Medicine, University of Miami; American Heart Association; Bill and Melinda Gates Foundation; U.S. Department of Health and Human Services; Leonard M. Miller School of Medicine; Yale University; Sichuan University; National Heart, Lung, and Blood Institute; Children’s Hospital of Wisconsin Research Institute","keywords":"Environmental health; Medicine; Stroke (engine); Attributable risk; Risk assessment; Population; Body mass index; Disability-adjusted life year; Risk factor; Disease burden; Disease; Demography; Internal medicine","score_opus":0.01509885565947982,"score_gpt":0.2679971207603209,"score_spread":0.25289826510084107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412702708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.53970104,0.31760034,0.0017714653,0.00089705706,0.0003805627,0.000295981,0.13781916,0.00017191257,0.0013625576],"genre_scores_gemma":[0.9049727,0.0643742,0.0016267049,0.0003734495,0.00014329872,0.00040910023,0.02771398,0.000040752082,0.0003458718],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9981737,0.0003739103,0.0005797506,0.00044218008,0.00028053747,0.00014982917],"domain_scores_gemma":[0.998257,0.00033305452,0.00068747415,0.0001721369,0.00045749338,0.00009289995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027075086,0.0010866962,0.0032057986,0.0036885238,0.00039494367,0.00090187415,0.0007669141,0.0007432753,0.0005386896],"category_scores_gemma":[0.0050810734,0.0010229762,0.008663961,0.0090549,0.00036651967,0.0008528425,0.0014111209,0.00080782303,0.00014014028],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022663015,0.00003406811,0.8791375,0.01696454,0.072684236,0.00024193243,0.00042531345,0.0010766563,0.00039806857,0.00019349038,0.01198642,0.0145914275],"study_design_scores_gemma":[0.00048614148,0.00010330728,0.9419576,0.0031141818,0.047972575,0.00039000885,0.00045845058,0.00042939166,0.00015541779,0.0001594829,0.0047170087,0.000056549605],"about_ca_topic_score_codex":0.10432529,"about_ca_topic_score_gemma":0.18120381,"teacher_disagreement_score":0.10432529,"about_ca_system_score_codex":0.0015402547,"about_ca_system_score_gemma":0.0030995172,"threshold_uncertainty_score":0.20743608},"labels":[],"label_agreement":null},{"id":"W2417234244","doi":"10.1016/s1474-4422(16)30120-x","title":"Stroke is a burdensome but preventable brain disorder","year":2016,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Burden of disease; Scopus; Stroke (engine); Medicine; Disease burden; Disease; Global health; Gerontology; MEDLINE; Public health; Political science; Pathology","score_opus":0.02050680872556385,"score_gpt":0.2661764047630388,"score_spread":0.24566959603747493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2417234244","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027259064,0.002322292,0.000035116293,0.9768744,0.016011534,0.000004773095,0.00002535297,0.000013671763,0.004440341],"genre_scores_gemma":[0.00552143,0.004795711,0.00015951971,0.8570955,0.12381776,0.000017080303,0.000039412644,0.000022585857,0.008531035],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99745065,0.0007246029,0.00033166297,0.0002202006,0.00085443846,0.00041848386],"domain_scores_gemma":[0.99279684,0.0030452863,0.0008608978,0.00022654474,0.0012127494,0.0018576747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018560207,0.0008332799,0.0016208258,0.00077219337,0.0040703425,0.0051116096,0.0012238584,0.049112167,0.0108284755],"category_scores_gemma":[0.022473997,0.000677414,0.0009958096,0.0009017302,0.0031705059,0.0036128638,0.0019951274,0.040660504,0.009308174],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028254512,0.000035110166,0.0007372978,0.00008539458,0.000014999992,0.0019225192,0.00009536517,0.0000392372,0.00010652124,0.0021487183,0.9822187,0.012567937],"study_design_scores_gemma":[0.00021061327,0.000110987414,0.0021675979,0.0010150224,0.00005040869,0.005853009,0.00050684233,0.00033430892,0.00015575154,0.019612422,0.96992,0.00006292541],"about_ca_topic_score_codex":0.003807197,"about_ca_topic_score_gemma":0.010155038,"teacher_disagreement_score":0.049112167,"about_ca_system_score_codex":0.003257236,"about_ca_system_score_gemma":0.004968356,"threshold_uncertainty_score":0.036224842},"labels":[],"label_agreement":null},{"id":"W2418807401","doi":"10.1016/s1474-4422(16)00112-5","title":"Advances in the development of biomarkers for epilepsy","year":2016,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":364,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Epilepsy; Biomarker; Medicine; Intensive care medicine; Molecular biomarkers; Bioinformatics; Psychiatry; Internal medicine; Biology","score_opus":0.10209162914677888,"score_gpt":0.4148418471076693,"score_spread":0.3127502179608904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2418807401","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003180105,0.9989336,0.000108218206,0.0004919063,0.00016954535,0.0000032225273,0.00001761995,0.0000036365054,0.00024047252],"genre_scores_gemma":[0.0004498101,0.998511,0.00023423185,0.00041628748,0.0002426452,0.0000050005638,0.000024503537,9.542141e-7,0.00011557494],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991955,0.00018619742,0.00015974558,0.00011694316,0.00027788954,0.000063762454],"domain_scores_gemma":[0.9958397,0.0029852216,0.00044146072,0.00007200671,0.00055261585,0.000108992244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029122296,0.0014463395,0.0031313016,0.0033029278,0.00027963397,0.0016895102,0.0013335414,0.001974835,0.0036716734],"category_scores_gemma":[0.0055591254,0.00038298388,0.0013576355,0.00290487,0.0008638626,0.0022103828,0.0013127389,0.002955107,0.0012204935],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012316198,0.000045757715,0.00034900903,0.029056212,0.0002821094,0.00013275407,0.00003705866,0.00025429478,0.00069800805,0.004751974,0.021935651,0.942334],"study_design_scores_gemma":[0.00009353599,0.00017298601,0.0017812469,0.024713872,0.0010080644,0.001011825,0.000108170454,0.00022872294,0.0006194979,0.008053425,0.9621551,0.00005349369],"about_ca_topic_score_codex":0.0020307,"about_ca_topic_score_gemma":0.004122028,"teacher_disagreement_score":0.0036716734,"about_ca_system_score_codex":0.0011790685,"about_ca_system_score_gemma":0.002558211,"threshold_uncertainty_score":0.015401483},"labels":[],"label_agreement":null},{"id":"W2460220103","doi":"10.1016/s1474-4422(16)30127-2","title":"Surgical treatment for epilepsy: the potential gap between evidence and practice","year":2016,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Université de Montréal; University of Calgary","funders":"National Institutes of Health; Canada Research Chairs; University College London; Canadian Institutes of Health Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; University of Calgary; American Epilepsy Society","keywords":"Epilepsy surgery; Observational study; Epilepsy; Medicine; Assertion; Drug Resistant Epilepsy; Psychological intervention; Intensive care medicine; Randomized controlled trial; Surgery; General surgery; Psychiatry","score_opus":0.27081974351756816,"score_gpt":0.4712224054644631,"score_spread":0.20040266194689493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2460220103","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000026047603,0.9992242,0.000021140331,0.00046645408,0.00011361068,0.0000021217961,0.000012502891,0.0000012873099,0.00013263687],"genre_scores_gemma":[0.0006665918,0.99852425,0.00013126039,0.0004766491,0.00013468464,0.0000043826417,0.0000130258595,9.144194e-7,0.00004822242],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99824464,0.000528371,0.0004755972,0.00018416677,0.000489756,0.000077330595],"domain_scores_gemma":[0.9907218,0.0075639,0.0009520461,0.00008058736,0.0005664883,0.00011514997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003925651,0.0009831594,0.004342578,0.003383804,0.00033508425,0.0022303986,0.0014519562,0.0022417146,0.0057511926],"category_scores_gemma":[0.010743826,0.00044422748,0.0020510177,0.0043958244,0.0010079641,0.0021126694,0.0011983744,0.0025741078,0.00071782555],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023345335,0.000029041079,0.00027987978,0.27523786,0.0019500672,0.00011743212,0.000099047735,0.0002838963,0.00029852206,0.004094658,0.024162931,0.69321316],"study_design_scores_gemma":[0.00034162123,0.00017415422,0.0028626001,0.4000657,0.0088681625,0.000798879,0.00041888215,0.00021641911,0.00024194144,0.009250144,0.5766916,0.00006986478],"about_ca_topic_score_codex":0.005007069,"about_ca_topic_score_gemma":0.016467279,"teacher_disagreement_score":0.0057511926,"about_ca_system_score_codex":0.0017889488,"about_ca_system_score_gemma":0.0046079336,"threshold_uncertainty_score":0.020761073},"labels":[],"label_agreement":null},{"id":"W2462173540","doi":"10.1016/s1474-4422(16)30121-1","title":"Efficacy and safety of non-immersive virtual reality exercising in stroke rehabilitation (EVREST): a randomised, multicentre, single-blind, controlled trial","year":2016,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Stroke Rehabilitation and Recovery","field":"Medicine","cited_by":395,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Parkwood Institute; McGill University; Jewish Rehabilitation Hospital; Foothills Medical Centre; Providence Health Care; Memorial University of Newfoundland; Riverview Hospital; Toronto Rehabilitation Institute; University of Toronto; Western University; St. Michael's Hospital","funders":"National Institutes of Health","keywords":"Rehabilitation; Virtual Reality Exposure Therapy; Physical therapy; Virtual reality; Stroke (engine); Randomized controlled trial; Medicine; Physical medicine and rehabilitation; Population; Computer science; Surgery","score_opus":0.02432574660126246,"score_gpt":0.2995182555786348,"score_spread":0.27519250897737235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2462173540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803631,0.010478033,0.0012922605,0.0004360793,0.0008698859,0.004162662,0.0007677785,0.00014615084,0.001484068],"genre_scores_gemma":[0.98452026,0.0036419118,0.00198945,0.0006164131,0.000687855,0.00604757,0.0005401605,0.000026484306,0.0019297826],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981931,0.0009560229,0.00022486,0.0003182016,0.0001304444,0.00017738865],"domain_scores_gemma":[0.99816763,0.00080060837,0.0004485065,0.00017367274,0.000113221366,0.00029627656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025267606,0.002079092,0.005173208,0.000474847,0.000541133,0.0012241132,0.0012279599,0.0029056696,0.0059014494],"category_scores_gemma":[0.003777882,0.0008548912,0.0033399388,0.00053857587,0.0015763247,0.0013910645,0.00069596263,0.0027601097,0.0008755403],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9911446,0.0015723133,0.00015365498,0.0008524348,0.0011031694,0.000011296131,0.000030620413,0.00008175074,0.00065260247,0.000043048443,0.0001299073,0.00422462],"study_design_scores_gemma":[0.9571973,0.039303884,0.0013683399,0.0000900519,0.0012604506,0.000016116512,0.000021301932,0.00022228644,0.0002024198,0.000090993664,0.00020607091,0.000020828706],"about_ca_topic_score_codex":0.0012595628,"about_ca_topic_score_gemma":0.0015314806,"teacher_disagreement_score":0.0059014494,"about_ca_system_score_codex":0.000663647,"about_ca_system_score_gemma":0.0008642973,"threshold_uncertainty_score":0.01974231},"labels":[],"label_agreement":null},{"id":"W2464354111","doi":"10.1016/s1474-4422(16)30079-5","title":"Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targets","year":2016,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Cardiovascular Syncope and Autonomic Disorders","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; University Health Network; Health Sciences Centre","funders":"","keywords":"Orthostatic vital signs; Medicine; Supine position; Lightheadedness; Midodrine; Dysautonomia; Anesthesia; Intensive care medicine; Disease; Cardiology; Blood pressure; Internal medicine","score_opus":0.02841008929833991,"score_gpt":0.2666295742017016,"score_spread":0.23821948490336167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2464354111","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000049253533,0.99944717,0.000039910432,0.00019441954,0.00008425165,0.0000028385568,0.00001045377,0.000002470399,0.00016919468],"genre_scores_gemma":[0.0006407519,0.998701,0.00013031017,0.00024847125,0.00014922337,0.0000051012703,0.000019204572,8.045821e-7,0.000105106454],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996495,0.00006867508,0.00008378102,0.000050679475,0.00011306141,0.00003426752],"domain_scores_gemma":[0.9990244,0.0005834463,0.00017795152,0.000016470456,0.00015823697,0.000039487666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013506641,0.0010445615,0.004115558,0.0022217352,0.00026856476,0.001581253,0.0013307781,0.001630139,0.0036213328],"category_scores_gemma":[0.0016319217,0.00037694085,0.0013921062,0.0017107348,0.00045476353,0.0014192687,0.00091393903,0.0026648652,0.0010137806],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002631317,0.00008980576,0.00029043423,0.03898583,0.00061984215,0.0002299806,0.00006198946,0.00039872297,0.00057204673,0.002092918,0.019085983,0.9373094],"study_design_scores_gemma":[0.0005485829,0.0006137494,0.004166886,0.04916527,0.0036997679,0.0023910734,0.00026946125,0.00063277886,0.0005785493,0.0058736065,0.9319495,0.00011079897],"about_ca_topic_score_codex":0.00192343,"about_ca_topic_score_gemma":0.0050592925,"teacher_disagreement_score":0.004115558,"about_ca_system_score_codex":0.0007101548,"about_ca_system_score_gemma":0.00158712,"threshold_uncertainty_score":0.012114584},"labels":[],"label_agreement":null},{"id":"W2512557155","doi":"10.1016/s1474-4422(16)30192-2","title":"Safety and efficacy of amiselimod in relapsing multiple sclerosis (MOMENTUM): a randomised, double-blind, placebo-controlled phase 2 trial","year":2016,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"Mitsubishi Tanabe Pharma Corporation","keywords":"Medicine; Multiple sclerosis; Placebo; Clinical endpoint; Internal medicine; Population; Clinical trial; Randomized controlled trial; Interferon beta-1a; Immunology; Pathology","score_opus":0.11111095557095292,"score_gpt":0.3488235848093346,"score_spread":0.2377126292383817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2512557155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826461,0.008198062,0.00057428767,0.00090658164,0.0008056282,0.0034104784,0.0010726713,0.00015446692,0.0022317872],"genre_scores_gemma":[0.9818749,0.0047815004,0.001437879,0.0015111275,0.0010169481,0.0053988025,0.0011662431,0.00003009436,0.0027825779],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992988,0.00032191924,0.000060501145,0.00014697229,0.00006137635,0.000110430665],"domain_scores_gemma":[0.99899334,0.00032235903,0.00024194675,0.00008776321,0.00006605806,0.0002884701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021381942,0.002352408,0.003815674,0.00065282494,0.00073084945,0.0012652484,0.0008419721,0.0029473423,0.007221316],"category_scores_gemma":[0.002489603,0.0008730619,0.002327128,0.00045980795,0.0016218895,0.0017863706,0.00063135265,0.0026279718,0.0013014135],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9885787,0.002029094,0.00032199096,0.00044653288,0.0005943821,0.000029092163,0.000031308846,0.00008341146,0.0015198915,0.00006036791,0.00031560592,0.0059896423],"study_design_scores_gemma":[0.97577363,0.022609409,0.00086299557,0.000023566878,0.00029007264,0.000013750215,0.000010974447,0.00006582182,0.00009369989,0.000062155144,0.00018567605,0.000008110956],"about_ca_topic_score_codex":0.0008122296,"about_ca_topic_score_gemma":0.0013109078,"teacher_disagreement_score":0.007221316,"about_ca_system_score_codex":0.00062643713,"about_ca_system_score_gemma":0.0010057354,"threshold_uncertainty_score":0.024157703},"labels":[],"label_agreement":null},{"id":"W2516327571","doi":"10.1016/s1474-4422(16)30165-x","title":"Mechanisms of glutamate toxicity in multiple sclerosis: biomarker and therapeutic opportunities","year":2016,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Neurological Disorders and Stroke; National Institute of Mental Health","keywords":"Multiple sclerosis; Glutamatergic; Glutamate receptor; Neuroscience; Oligodendrocyte; Biomarker; Autoimmunity; Medicine; Immune system; Biology; Immunology; Myelin; Central nervous system; Internal medicine; Receptor","score_opus":0.3889803884968951,"score_gpt":0.37840477833110225,"score_spread":0.010575610165792837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2516327571","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000034995384,0.99966204,0.00002483521,0.0001343693,0.000045604076,0.0000017540077,0.00001028208,0.0000010876153,0.00008501012],"genre_scores_gemma":[0.00033051654,0.9993734,0.00006180597,0.000106874286,0.00006476401,0.0000030302,0.000010764056,3.1149773e-7,0.000048624755],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999521,0.00010839478,0.0001227762,0.00006879696,0.00014818381,0.00003080854],"domain_scores_gemma":[0.9984439,0.0009963877,0.00024903755,0.000034555145,0.00023406294,0.000042094278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019956392,0.0012520761,0.0038146283,0.003104845,0.0002486759,0.0018075963,0.0013879586,0.0015792361,0.0024972921],"category_scores_gemma":[0.0025817475,0.00035558536,0.0011934459,0.003766242,0.0008331486,0.0017962251,0.0011386864,0.0017517771,0.0007119919],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003299857,0.00007038032,0.0006424442,0.086162984,0.0009336678,0.00023497098,0.00007580179,0.00038338595,0.000981199,0.0034156663,0.017358558,0.8894109],"study_design_scores_gemma":[0.00029225813,0.00038792347,0.0042360313,0.058135193,0.004011699,0.002387607,0.0003675629,0.00030257675,0.0010469494,0.011496655,0.9172251,0.00011047534],"about_ca_topic_score_codex":0.002514709,"about_ca_topic_score_gemma":0.005680494,"teacher_disagreement_score":0.0038146283,"about_ca_system_score_codex":0.0010322429,"about_ca_system_score_gemma":0.0024649582,"threshold_uncertainty_score":0.010554075},"labels":[],"label_agreement":null},{"id":"W2519246945","doi":"10.1016/s1474-4422(16)30175-2","title":"Calpain 1 in neurodegeneration: a therapeutic target?","year":2016,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Calpain Protease Function and Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Hereditary spastic paraplegia; Ataxia; Genetics; Cerebellar ataxia; Spastic; Neurodegeneration; Medicine; Biology; Gene; Neuroscience; Pathology; Phenotype; Psychiatry; Disease","score_opus":0.01914300322854864,"score_gpt":0.2397566209910078,"score_spread":0.22061361776245916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519246945","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006113708,0.04041347,0.00022384893,0.93709296,0.018599775,0.0000072198845,0.000028193303,0.000030885334,0.002992379],"genre_scores_gemma":[0.024509504,0.07463825,0.0009650983,0.62162584,0.26596817,0.000077415636,0.0000633265,0.00003557716,0.012116826],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99897194,0.00029267563,0.00012417354,0.0001251742,0.0003395129,0.00014652975],"domain_scores_gemma":[0.9977532,0.0012555121,0.00022549175,0.0001029001,0.0003116062,0.00035124389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019441562,0.0009534123,0.0022230388,0.00056928926,0.0011690942,0.0024720938,0.0013475765,0.023125231,0.0042007356],"category_scores_gemma":[0.007367241,0.00040361116,0.0008908101,0.00046726014,0.0032455085,0.003741535,0.001243923,0.022815784,0.0030026753],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048531994,0.00012449388,0.00069572066,0.00042743483,0.000056588153,0.006158764,0.000082231534,0.00022035364,0.0014372056,0.019662866,0.9023191,0.06833001],"study_design_scores_gemma":[0.0006951582,0.0002655358,0.0007678273,0.00061303284,0.00007334163,0.0067894193,0.00017338316,0.00061955675,0.00089608546,0.054894783,0.9341483,0.00006354464],"about_ca_topic_score_codex":0.00068727223,"about_ca_topic_score_gemma":0.0014692366,"teacher_disagreement_score":0.023125231,"about_ca_system_score_codex":0.0026648333,"about_ca_system_score_gemma":0.0016952641,"threshold_uncertainty_score":0.019334793},"labels":[],"label_agreement":null},{"id":"W2524323567","doi":"10.1016/s1474-4422(16)30232-0","title":"Understanding brain development: a major step","year":2016,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Cognitive Abilities and Testing","field":"Psychology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Douglas Mental Health University Institute; McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Primate; Brain development; Non human primate; Neuroscience; Human brain; Cognitive science; Psychology; Biology; Evolutionary biology","score_opus":0.1919043276160423,"score_gpt":0.32480708004129694,"score_spread":0.13290275242525465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524323567","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003234178,0.4761019,0.018410072,0.47989348,0.007093403,0.00007256547,0.0005303798,0.00035879732,0.014305208],"genre_scores_gemma":[0.082952626,0.6543705,0.061031148,0.16302426,0.026429161,0.0002732258,0.0009344059,0.00040667958,0.010578043],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984786,0.0004941879,0.00013628774,0.00027926796,0.00043259357,0.00017908383],"domain_scores_gemma":[0.9785605,0.013834411,0.00083174696,0.0014002312,0.0037391596,0.0016339315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008844157,0.0018424594,0.0030479305,0.0024749625,0.001458327,0.0055317064,0.003008339,0.006317073,0.010507102],"category_scores_gemma":[0.020635882,0.0006935466,0.0012189228,0.00093526597,0.010440085,0.013237184,0.004387539,0.018456386,0.0035038546],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002965844,0.00041851276,0.010246643,0.0061984626,0.0005238696,0.000414974,0.0010919266,0.0012050886,0.0023773783,0.17018673,0.21451607,0.59252375],"study_design_scores_gemma":[0.000064674074,0.00022346809,0.01053924,0.004123717,0.00022429886,0.0007018396,0.0021056011,0.000983411,0.0011622098,0.50919056,0.4705339,0.00014708251],"about_ca_topic_score_codex":0.008330396,"about_ca_topic_score_gemma":0.006936854,"teacher_disagreement_score":0.010507102,"about_ca_system_score_codex":0.0032873985,"about_ca_system_score_gemma":0.012163517,"threshold_uncertainty_score":0.046772897},"labels":[],"label_agreement":null},{"id":"W2525713139","doi":"10.1016/s1474-4422(16)30203-4","title":"DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association study","year":2016,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Medical Research Council; Parkinson's UK","keywords":"LRRK2; Parkinsonism; Genetics; Medicine; Genome-wide association study; Penetrance; Disease; Age of onset; Parkinson's disease; Single-nucleotide polymorphism; Biology; Genotype; Internal medicine; Gene","score_opus":0.02209802777819515,"score_gpt":0.26190771923614237,"score_spread":0.23980969145794723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525713139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99822825,0.00054484594,0.0001957142,0.00011209805,0.0000131076085,0.0000058648193,0.00040859665,0.0000104017445,0.00048117002],"genre_scores_gemma":[0.99906176,0.0001169593,0.00019369954,0.00003410738,0.000013013745,0.000005454293,0.00018006447,0.0000061234496,0.0003888649],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995833,0.00010188734,0.00005311065,0.00013205573,0.00006721324,0.00006235172],"domain_scores_gemma":[0.99942434,0.00016375422,0.0002320409,0.000046521705,0.000046988862,0.00008642509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006246855,0.0008143178,0.0005667214,0.0010738207,0.0007868216,0.0006963355,0.00069123745,0.0012850331,0.0035696642],"category_scores_gemma":[0.0012709167,0.00042194457,0.0012019834,0.0015922558,0.00038342117,0.00037934026,0.00065898814,0.0007584029,0.00031087032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00752168,0.0003072851,0.95269346,0.00008298736,0.001832908,0.0050812466,0.0004900723,0.0004966977,0.022028346,0.00045725287,0.00061241456,0.008395691],"study_design_scores_gemma":[0.00016057435,0.0002310029,0.99329823,0.00002281004,0.000742604,0.00275833,0.00020634894,0.00081663503,0.0008568368,0.00033434664,0.0005503436,0.00002182981],"about_ca_topic_score_codex":0.007260413,"about_ca_topic_score_gemma":0.007963434,"teacher_disagreement_score":0.007260413,"about_ca_system_score_codex":0.00045019883,"about_ca_system_score_gemma":0.000282997,"threshold_uncertainty_score":0.014436305},"labels":[],"label_agreement":null},{"id":"W2530098356","doi":"10.1016/s1474-4422(16)30235-6","title":"Research priorities to reduce the global burden of dementia by 2025","year":2016,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":396,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institutes of Health Research; Institute of Aging","funders":"National Institutes of Health; National Institute for Health and Care Research","keywords":"Dementia; Action plan; Global health; Call to action; Action (physics); Public health; Political science; Public relations; Medicine; Action research; Psychology; Business; Disease; Nursing; Management","score_opus":0.11011109335960229,"score_gpt":0.416812615754786,"score_spread":0.3067015223951837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530098356","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005412855,0.99356395,0.00014375347,0.0040344256,0.0010346998,0.000008573941,0.00008635533,0.000013973562,0.0010601854],"genre_scores_gemma":[0.00062944647,0.9964461,0.00036381348,0.0015292161,0.00052344764,0.000013050422,0.00009595025,0.0000024899707,0.00039645936],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990695,0.00025770502,0.00013748725,0.00010463328,0.00028678201,0.00014399446],"domain_scores_gemma":[0.99715096,0.0015078419,0.00031846287,0.000053474312,0.0007101782,0.00025921708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003760825,0.0017186546,0.0028363748,0.0030531092,0.0004510008,0.0019444302,0.0021457267,0.0036061278,0.013728097],"category_scores_gemma":[0.0051204655,0.00038805982,0.0017697429,0.0031253342,0.00077704235,0.0024422735,0.0016715474,0.0040965197,0.0031457236],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013591269,0.00008949255,0.0003230813,0.04048266,0.00044003004,0.00018831136,0.00009118952,0.0005142403,0.00044490414,0.008084023,0.10439104,0.84481514],"study_design_scores_gemma":[0.000085308064,0.00009751243,0.0015114152,0.040189035,0.000790241,0.0005202382,0.0003057112,0.00013433071,0.00018832616,0.008852432,0.94728065,0.00004487178],"about_ca_topic_score_codex":0.0063608787,"about_ca_topic_score_gemma":0.0112522775,"teacher_disagreement_score":0.013728097,"about_ca_system_score_codex":0.0020716172,"about_ca_system_score_gemma":0.01019726,"threshold_uncertainty_score":0.04592508},"labels":[],"label_agreement":null},{"id":"W2549336896","doi":"10.1016/s1474-4422(16)30328-3","title":"Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study","year":2016,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":435,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; Engineering and Physical Sciences Research Council; Economic and Social Research Council; Medical Research Council","keywords":"Montreal Cognitive Assessment; Dementia; Medicine; Internal medicine; Cognitive decline; Cohort; Parkinson's disease; Logistic regression; Multivariate analysis; Disease; Cognition; Cohort study; Psychiatry","score_opus":0.017353792209539205,"score_gpt":0.27677142118504405,"score_spread":0.25941762897550485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549336896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99925345,0.0002708657,0.000051676252,0.000030840503,0.000016253924,0.000008398438,0.00021801586,0.0000020322009,0.00014850343],"genre_scores_gemma":[0.9992797,0.00015056501,0.00006710714,0.000027142321,0.000023471515,0.000010658634,0.00027788727,0.00000225933,0.00016126422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921227,0.00018242277,0.00008700467,0.00025887354,0.00011280458,0.00014662472],"domain_scores_gemma":[0.99804175,0.0004024728,0.0005814215,0.0003396412,0.00022142351,0.00041331668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012529924,0.00093797833,0.0010116975,0.0008566285,0.0011507549,0.0017115755,0.0008283633,0.001274472,0.0011096902],"category_scores_gemma":[0.0030182248,0.00093342236,0.001808059,0.0015560716,0.0005763887,0.001359175,0.0008554763,0.0019346809,0.00027478064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010757402,0.00014474541,0.9971318,0.000007935975,0.00039214003,0.00017077297,0.00009964253,0.000036622056,0.00024271153,0.000016721593,0.000075431424,0.00060561654],"study_design_scores_gemma":[0.00006612569,0.00030602084,0.9985207,0.0000052649925,0.0002177189,0.0003208086,0.00018229267,0.00020164897,0.000041876803,0.000038082962,0.000088147535,0.000011394607],"about_ca_topic_score_codex":0.010736855,"about_ca_topic_score_gemma":0.011400489,"teacher_disagreement_score":0.010736855,"about_ca_system_score_codex":0.00061287783,"about_ca_system_score_gemma":0.0006978891,"threshold_uncertainty_score":0.021348715},"labels":[],"label_agreement":null},{"id":"W2560609068","doi":"10.1016/s1474-4422(16)30349-0","title":"Placebos in clinical trials: unravelling a complex phenomenon","year":2016,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Pain Management and Placebo Effect","field":"Neuroscience","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Placebo; Nocebo; Clinical trial; Neurology; Medicine; Interpretability; Nocebo Effect; Psychology; Alternative medicine; Psychotherapist; Internal medicine; Psychiatry; Artificial intelligence; Pathology","score_opus":0.41262101449531163,"score_gpt":0.4320573538145831,"score_spread":0.019436339319271467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560609068","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010652856,0.073368825,0.004128708,0.89912945,0.018859442,0.000077022865,0.0001119247,0.000093442235,0.0031658],"genre_scores_gemma":[0.03056543,0.019406615,0.0071248957,0.8170008,0.12437863,0.00027763253,0.000048682625,0.00011786821,0.0010795095],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.8185494,0.119914554,0.020012455,0.012180412,0.027499761,0.0018435117],"domain_scores_gemma":[0.25375563,0.7022225,0.01848112,0.009044696,0.012407723,0.0040882803],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.20062865,0.0016257702,0.008970486,0.0025081208,0.002628037,0.010490591,0.005734437,0.042228475,0.005477238],"category_scores_gemma":[0.46418086,0.0016897757,0.0032769612,0.002922791,0.022052402,0.01974176,0.005005079,0.04983012,0.0029063923],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057198163,0.00031081584,0.0044656564,0.010319987,0.003929759,0.002844476,0.001680366,0.00081777,0.001489338,0.13996215,0.4869257,0.3415341],"study_design_scores_gemma":[0.009512312,0.0013088807,0.0048332806,0.011822083,0.001808227,0.0027607465,0.0007428596,0.0044056675,0.0010940729,0.5155741,0.4457015,0.00043620684],"about_ca_topic_score_codex":0.00092253386,"about_ca_topic_score_gemma":0.0023020238,"teacher_disagreement_score":0.20062865,"about_ca_system_score_codex":0.0068046367,"about_ca_system_score_gemma":0.0046333782,"threshold_uncertainty_score":0.9857672},"labels":[],"label_agreement":null},{"id":"W2562463831","doi":"10.1016/s1474-4422(16)30380-5","title":"Defining early CAA: insights from a rare monogenic disorder","year":2016,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Cerebrovascular and genetic disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Biomarker; Dementia; Disease; Cerebral amyloid angiopathy; Medicine; Population; Pathology; Vascular dementia; Neuropathology; Oncology; Biology; Genetics","score_opus":0.012996994613603579,"score_gpt":0.23257615020824934,"score_spread":0.21957915559464578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562463831","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029536292,0.04491428,0.003009489,0.8940034,0.013080012,0.000035350502,0.00020801605,0.000112820155,0.0151003385],"genre_scores_gemma":[0.29712448,0.043106515,0.0056528156,0.41607723,0.23318318,0.000051372397,0.00020422752,0.00012559639,0.0044744886],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9986526,0.00027029729,0.00029371234,0.00024772625,0.0002829627,0.00025268304],"domain_scores_gemma":[0.9925679,0.00510227,0.0006744833,0.00024560382,0.0007588433,0.00065104396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014861008,0.0011254965,0.0020367836,0.0012066874,0.0016453837,0.0032328102,0.0016228574,0.021618737,0.0016156804],"category_scores_gemma":[0.015129933,0.0006542628,0.001052586,0.00088370277,0.002930288,0.004964228,0.0013675289,0.019477522,0.0010005778],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040864933,0.00015542474,0.029717088,0.0006307935,0.00018278559,0.617325,0.0012871783,0.00061127613,0.0032692836,0.023643583,0.26922983,0.053539127],"study_design_scores_gemma":[0.00024974498,0.00012088759,0.009014779,0.0011427673,0.00019577562,0.8344535,0.0011809062,0.0016029038,0.0009125113,0.049182106,0.10181657,0.00012745804],"about_ca_topic_score_codex":0.0027713794,"about_ca_topic_score_gemma":0.0037209678,"teacher_disagreement_score":0.021618737,"about_ca_system_score_codex":0.0021715,"about_ca_system_score_gemma":0.0013104723,"threshold_uncertainty_score":0.015755415},"labels":[],"label_agreement":null},{"id":"W2575612478","doi":"10.1016/s1474-4422(16)30381-7","title":"Mechanical thrombectomy after intravenous thrombolysis for acute ischaemic stroke","year":2017,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Toronto Western Hospital","funders":"","keywords":"Thrombolysis; Medicine; Stroke (engine); Ischaemic stroke; Acute stroke; Randomized controlled trial; Fibrinolytic agent; Clinical trial; Occlusion; Internal medicine; Ischemia; Tissue plasminogen activator; Myocardial infarction","score_opus":0.027728382930623845,"score_gpt":0.29930127174537785,"score_spread":0.271572888814754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575612478","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022387414,0.0056799594,0.00018123571,0.9494167,0.023181312,0.00002961211,0.00009379564,0.000046498324,0.019132148],"genre_scores_gemma":[0.032018345,0.0071024285,0.00031409896,0.7403118,0.20820777,0.000061515915,0.00016472187,0.000053418542,0.011765885],"study_design_codex":"not_applicable","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99843305,0.00042426697,0.00024343327,0.00013417866,0.0004524921,0.00031261027],"domain_scores_gemma":[0.9951444,0.002765847,0.0005042095,0.00015050365,0.00059082743,0.00084426155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011877408,0.0006032058,0.0013639806,0.001222405,0.002625435,0.0031188636,0.0011204308,0.0316268,0.008444461],"category_scores_gemma":[0.022781719,0.0005242307,0.0011005595,0.0010992634,0.0021068538,0.0019754553,0.00093793677,0.022845767,0.0065423045],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018015521,0.00014154994,0.0032953909,0.00018962659,0.00005595876,0.02084445,0.00018360214,0.00014234349,0.0002665542,0.00412047,0.93899924,0.03158058],"study_design_scores_gemma":[0.0017720803,0.0005034914,0.014464712,0.0029337518,0.0003505217,0.060397916,0.0011071505,0.0024554236,0.00094469404,0.044658948,0.8702329,0.00017842739],"about_ca_topic_score_codex":0.003269803,"about_ca_topic_score_gemma":0.0089469645,"teacher_disagreement_score":0.0316268,"about_ca_system_score_codex":0.003993746,"about_ca_system_score_gemma":0.0038139995,"threshold_uncertainty_score":0.028976798},"labels":[],"label_agreement":null},{"id":"W2582709627","doi":"10.1016/s1474-4422(16)30399-4","title":"Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"Italfarmaco; Baxalta; European Commission; Cytokinetics; Biogen; GlaxoSmithKline","keywords":"Medicine; Placebo; Amyotrophic lateral sclerosis; Internal medicine; Clinical trial; Adverse effect; Clinical endpoint; Physical therapy; Disease; Pathology","score_opus":0.0582750514239321,"score_gpt":0.3281753930159591,"score_spread":0.269900341592027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582709627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779969,0.012797592,0.0007673771,0.0012201437,0.0010158002,0.0027489348,0.0012199703,0.00013302086,0.0021002996],"genre_scores_gemma":[0.9832343,0.0056033893,0.0011146491,0.0015352276,0.00067387166,0.003561702,0.0014304764,0.0000342162,0.0028122244],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99918133,0.0003751656,0.00007187078,0.00017214748,0.00006631385,0.00013319335],"domain_scores_gemma":[0.9991222,0.00028339532,0.00022307494,0.00006160674,0.00006900648,0.00024077062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018852593,0.0027106458,0.0042620013,0.00053845556,0.0005743026,0.0014252199,0.00094490254,0.0031139571,0.0057359603],"category_scores_gemma":[0.002198582,0.00091735413,0.0023972245,0.0004994332,0.0016467927,0.001908048,0.00052562065,0.0030970043,0.0012708991],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99110174,0.0010198905,0.00028504943,0.00058061676,0.0005700848,0.000030049065,0.00003227587,0.00009026991,0.0015028409,0.000046465197,0.00029882416,0.004441866],"study_design_scores_gemma":[0.9813052,0.01673725,0.0009360642,0.000024261892,0.00036401604,0.000020316256,0.00001458008,0.000114003065,0.00013478605,0.00007921774,0.0002598728,0.000010423442],"about_ca_topic_score_codex":0.00090582576,"about_ca_topic_score_gemma":0.0013127038,"teacher_disagreement_score":0.0057359603,"about_ca_system_score_codex":0.0009141637,"about_ca_system_score_gemma":0.0009685908,"threshold_uncertainty_score":0.019188702},"labels":[],"label_agreement":null},{"id":"W2586480138","doi":"10.1016/s1474-4422(17)30007-8","title":"Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study","year":2017,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":162,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Centre Hospitalier de l’Université de Montréal; Université de Montréal; Hôpital Notre-Dame","funders":"NIH Clinical Center; National Health and Medical Research Council; Canadian Institutes of Health Research; Novartis Pharma; EMD Serono; H. Lundbeck A/S; Sanofi Genzyme; Isfahan University of Medical Sciences; Multiple Sclerosis Society; Celgene; Fondazione Italiana Sclerosi Multipla; Biogen; York University; Università degli Studi di Firenze; Multiple Sclerosis Society of Canada; Univerzita Karlova v Praze; Diabetes-Stiftung; NYU Langone Medical Center; Jewish General Hospital; National Institute for Health and Care Research; Medical Research Council; Teva Pharmaceutical Industries; GlaxoSmithKline; Rosetrees Trust; Sanofi","keywords":"Natalizumab; Fingolimod; Multiple sclerosis; Alemtuzumab; Medicine; Relapsing remitting; Cohort; Interferon beta; Interferon beta-1a; Interferon beta-1b; Internal medicine; Oncology; Immunology","score_opus":0.09599620926818118,"score_gpt":0.33482411836152676,"score_spread":0.23882790909334556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586480138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99698997,0.0022201226,0.000047802074,0.00008525038,0.00005037439,0.00003498048,0.0003845045,0.000004883252,0.00018208232],"genre_scores_gemma":[0.9983778,0.00063696876,0.00008493435,0.00009914323,0.00007688254,0.000051607683,0.00042438513,0.0000053499953,0.00024290616],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9968622,0.0014772489,0.00032823224,0.00073636917,0.0002827408,0.0003133164],"domain_scores_gemma":[0.9951315,0.0013592385,0.0018260612,0.00085480534,0.0003022952,0.0005261288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043141902,0.0014368506,0.0021876092,0.00065750483,0.00067390624,0.001518704,0.0012687746,0.001931346,0.001724964],"category_scores_gemma":[0.008406043,0.0009967653,0.0048922123,0.0010686829,0.00063767453,0.0012321562,0.0006462806,0.0018894919,0.0003735363],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5299883,0.004530221,0.391079,0.0005555068,0.053321883,0.00049334415,0.00047668925,0.0007708139,0.0041987896,0.00012930654,0.0010007637,0.013455369],"study_design_scores_gemma":[0.065306686,0.044396013,0.84298706,0.00016532482,0.04184762,0.0006095368,0.0005072645,0.0013252366,0.0011377118,0.0003310524,0.001238766,0.00014777805],"about_ca_topic_score_codex":0.004580573,"about_ca_topic_score_gemma":0.0030788702,"teacher_disagreement_score":0.004580573,"about_ca_system_score_codex":0.00095934834,"about_ca_system_score_gemma":0.00083762937,"threshold_uncertainty_score":0.022815883},"labels":[],"label_agreement":null},{"id":"W2591456311","doi":"10.1016/s1474-4422(17)30038-8","title":"Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":196,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; University of Calgary","funders":"National Institutes of Health; AstraZeneca","keywords":"Medicine; Ticagrelor; Aspirin; Stroke (engine); Internal medicine; Myocardial infarction; Cardiology; Randomized controlled trial; Clinical endpoint; Subgroup analysis; Clopidogrel; Confidence interval","score_opus":0.08448508380058245,"score_gpt":0.3518250801862449,"score_spread":0.26733999638566247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591456311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93074954,0.05631745,0.0018756612,0.0010002754,0.0020207716,0.0022153086,0.0031236731,0.0002178093,0.0024794799],"genre_scores_gemma":[0.9845418,0.00797278,0.00085479824,0.0008849769,0.0011739222,0.0014345107,0.0016116973,0.000048438633,0.0014772096],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968189,0.0016235625,0.0005417907,0.00047053545,0.00024107525,0.000304162],"domain_scores_gemma":[0.99752206,0.0011103773,0.00063394767,0.00033073215,0.00015487759,0.00024801446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004379585,0.003228153,0.010181477,0.0010732234,0.0005400921,0.00220924,0.0011545352,0.002360615,0.00493565],"category_scores_gemma":[0.0061549195,0.0010085606,0.012119747,0.0010067486,0.001042668,0.0013640136,0.00085834105,0.0031864902,0.00074270245],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95743906,0.00024058214,0.0013742959,0.003121265,0.031475242,0.000060781083,0.00005728661,0.0003063299,0.00080342515,0.00009662328,0.00045148277,0.0045736837],"study_design_scores_gemma":[0.9287272,0.0100636585,0.0068257833,0.000264658,0.05157995,0.00008740056,0.00009752264,0.00090314244,0.00034032972,0.00045365302,0.0005820139,0.000074699936],"about_ca_topic_score_codex":0.0017923162,"about_ca_topic_score_gemma":0.0036698338,"teacher_disagreement_score":0.010181477,"about_ca_system_score_codex":0.0010112195,"about_ca_system_score_gemma":0.0011072266,"threshold_uncertainty_score":0.02316171},"labels":[],"label_agreement":null},{"id":"W2599512437","doi":"10.1016/s1474-4422(17)30044-3","title":"Epileptic activity in Alzheimer's disease: causes and clinical relevance","year":2017,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":599,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto","funders":"National Institute on Aging","keywords":"Disease; Epileptogenesis; Subclinical infection; Medicine; Alzheimer's disease; Epilepsy; Cognitive decline; Cognition; Neuroscience; Clinical trial; Dementia; Psychology; Psychiatry; Internal medicine","score_opus":0.26753489383981677,"score_gpt":0.4837905156416938,"score_spread":0.21625562180187702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599512437","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000046732213,0.99959785,0.000014547104,0.00012544617,0.00005805245,0.0000018455999,0.00001128418,0.0000014451341,0.0001428682],"genre_scores_gemma":[0.0005144758,0.999143,0.000043639287,0.00012520567,0.000094320836,0.00000212315,0.000010055008,3.6587102e-7,0.00006678284],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997032,0.00005500976,0.00007145441,0.000051708637,0.00009430264,0.00002426685],"domain_scores_gemma":[0.99913436,0.0005001897,0.00021159175,0.000014459105,0.000102304744,0.00003721029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009843465,0.0010869597,0.0025912984,0.0024211118,0.00022822557,0.0015076423,0.0009385098,0.0013161566,0.004063214],"category_scores_gemma":[0.001582605,0.0003858984,0.0010137912,0.002840637,0.000581026,0.001436133,0.0008944422,0.001730059,0.00095326966],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002003067,0.000054197415,0.000602367,0.07854835,0.0008558409,0.00017048419,0.00010042044,0.00029459133,0.0005775833,0.002468221,0.019963644,0.89616394],"study_design_scores_gemma":[0.00028252057,0.00029083787,0.006563347,0.05745323,0.003765221,0.0021160613,0.00038279133,0.00022972815,0.00034249443,0.0070390934,0.9214528,0.000081798426],"about_ca_topic_score_codex":0.002632673,"about_ca_topic_score_gemma":0.00786953,"teacher_disagreement_score":0.004063214,"about_ca_system_score_codex":0.0007161423,"about_ca_system_score_gemma":0.0018651099,"threshold_uncertainty_score":0.013592839},"labels":[],"label_agreement":null},{"id":"W2601571152","doi":"10.1016/s1474-4422(17)30056-x","title":"Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies","year":2017,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"TRIUMF; Centre for Movement Disorders; University of British Columbia","funders":"National Institute of Biomedical Imaging and Bioengineering; National Institute of Neurological Disorders and Stroke; TRIUMF; Canadian Institutes of Health Research; U.S. Department of Veterans Affairs","keywords":"Dopamine transporter; Dopaminergic; LRRK2; Parkinson's disease; Dopamine; Parkinsonism; Vesicular monoamine transporter; Serotonin transporter; Psychology; Medicine; Neurochemical; Internal medicine; Disease; Neuroscience; Monoamine neurotransmitter; Endocrinology; Serotonin","score_opus":0.10022042023828508,"score_gpt":0.3879061225832022,"score_spread":0.2876857023449171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601571152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983714,0.000821787,0.0001589667,0.000027995353,0.000007058636,0.000010675629,0.0002350729,0.000005318386,0.00036169594],"genre_scores_gemma":[0.9987111,0.000295037,0.00016144969,0.000057041154,0.0000106134585,0.000011034767,0.0003851995,0.0000061554824,0.00036230934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997259,0.00007147212,0.00003311208,0.00011100655,0.000030824496,0.00002759577],"domain_scores_gemma":[0.999175,0.00014877472,0.00035990556,0.00008964269,0.00013562533,0.00009088329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084155705,0.0004159902,0.00043883972,0.00041940695,0.00038029617,0.00060835824,0.00026787329,0.0006831094,0.0012930606],"category_scores_gemma":[0.0014703163,0.00056603155,0.00047555997,0.0005105968,0.00037910222,0.00073264615,0.0002981511,0.0005313739,0.00025287797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085920264,0.00012384093,0.9921354,0.000040837112,0.00075208757,0.0003088749,0.00014810373,0.000042253298,0.002844103,0.000026899355,0.0001060703,0.0026123417],"study_design_scores_gemma":[0.000009081757,0.00015239143,0.9990169,0.0000027772676,0.00012238411,0.00037939288,0.000050626684,0.000037160564,0.00010595048,0.000013127625,0.000107256245,0.0000028191555],"about_ca_topic_score_codex":0.0038033088,"about_ca_topic_score_gemma":0.0080790315,"teacher_disagreement_score":0.0038033088,"about_ca_system_score_codex":0.00034983308,"about_ca_system_score_gemma":0.00013053844,"threshold_uncertainty_score":0.0075623393},"labels":[],"label_agreement":null},{"id":"W2606392388","doi":"10.1016/s1474-4422(17)30078-9","title":"Increasing value and reducing waste in stroke research","year":2017,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"British Heart Foundation; National Institute for Health and Care Research","keywords":"Inefficiency; Stroke (engine); Value (mathematics); Medicine; Business; Actuarial science; Marketing; Engineering; Economics; Computer science","score_opus":0.2658705434733012,"score_gpt":0.4590884570285824,"score_spread":0.19321791355528123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606392388","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000027243766,0.99836594,0.00005572753,0.0009062689,0.00030317047,0.0000063885254,0.000015556003,0.0000038249996,0.00031581524],"genre_scores_gemma":[0.0004946968,0.99799323,0.00022601927,0.0008619696,0.00027306218,0.000009043805,0.000017049437,0.0000021637818,0.0001227872],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953134,0.0016305851,0.00079628965,0.00030333502,0.00163027,0.0003261431],"domain_scores_gemma":[0.9841266,0.012240465,0.0014157486,0.00030040863,0.0015818116,0.00033490005],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.008914172,0.0016868584,0.004218159,0.0071548647,0.00055388093,0.0041698506,0.0019384577,0.0037361337,0.0071131596],"category_scores_gemma":[0.018002497,0.0007178451,0.0021218017,0.008617389,0.0017688595,0.0042538196,0.002732418,0.003751687,0.0015363012],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011619585,0.00005294376,0.0001912719,0.12960932,0.0010762447,0.00009072604,0.0001584362,0.00025492403,0.0002860051,0.008517698,0.038712215,0.820934],"study_design_scores_gemma":[0.00014296807,0.00008297171,0.0011502422,0.15153453,0.0024006679,0.00035894354,0.00027538824,0.00011527273,0.00025204543,0.016130462,0.8275062,0.00005039563],"about_ca_topic_score_codex":0.0040789032,"about_ca_topic_score_gemma":0.009130291,"teacher_disagreement_score":0.9910858,"about_ca_system_score_codex":0.0029013846,"about_ca_system_score_gemma":0.00838952,"threshold_uncertainty_score":0.04714322},"labels":[],"label_agreement":null},{"id":"W2606696949","doi":"10.1016/s1474-4422(17)30076-5","title":"Health-care use before a first demyelinating event suggestive of a multiple sclerosis prodrome: a matched cohort study","year":2017,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Saskatchewan; Saskatchewan Health Quality Council; University of Manitoba; Nova Scotia Health Authority; Vancouver Coastal Health; Manitoba Health; University of British Columbia","funders":"Ministry of Health, British Columbia; National Multiple Sclerosis Society","keywords":"Medicine; Cohort; Medical prescription; Prodrome; Multiple sclerosis; Population; Cohort study; Disease; Health care; Pediatrics; Family medicine; Demography; Environmental health; Internal medicine; Psychiatry","score_opus":0.11041874391683515,"score_gpt":0.3622802377436396,"score_spread":0.25186149382680445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606696949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99810565,0.00057734025,0.00009028249,0.000041152107,0.00003960451,0.000025744792,0.0006975954,0.000004331295,0.00041825022],"genre_scores_gemma":[0.9985979,0.00022078062,0.00007750477,0.000058030728,0.00003633223,0.000023572964,0.0005647205,0.000005112554,0.00041607462],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984983,0.00032237018,0.00014418317,0.00052364776,0.00014085848,0.00037073065],"domain_scores_gemma":[0.99711645,0.00042616515,0.0008992234,0.0006689034,0.00029583753,0.00059341104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012779576,0.0007904284,0.00100497,0.0010962292,0.0014159718,0.0018106627,0.001266348,0.0020412179,0.003595471],"category_scores_gemma":[0.0038560778,0.0013968074,0.0022948126,0.0020981152,0.0005430073,0.0015115588,0.0011010735,0.00201398,0.0007319152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004343369,0.0005879423,0.99019426,0.000048826918,0.0018901691,0.00040796222,0.00024180244,0.000049940834,0.0007878972,0.00006719203,0.00028471622,0.0010959974],"study_design_scores_gemma":[0.0002482468,0.0006023696,0.99735546,0.0000164782,0.00069705886,0.000252799,0.0003099276,0.00015009732,0.00006459386,0.000047780024,0.00023672743,0.000018505783],"about_ca_topic_score_codex":0.025131525,"about_ca_topic_score_gemma":0.021009805,"teacher_disagreement_score":0.025131525,"about_ca_system_score_codex":0.00073993317,"about_ca_system_score_gemma":0.0008242461,"threshold_uncertainty_score":0.049970508},"labels":[],"label_agreement":null},{"id":"W2607217120","doi":"10.1016/s1474-4422(17)30094-7","title":"Rémi W Bouchard, a pioneer in behavioural neurology","year":2017,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Psychology; Mentorship; Medicine; Medical education","score_opus":0.08292234877059794,"score_gpt":0.3413556859146102,"score_spread":0.25843333714401223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607217120","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013189107,0.0065901405,0.000121917765,0.9615324,0.029581182,0.000011492586,0.000030597483,0.000017301612,0.0019830016],"genre_scores_gemma":[0.002913976,0.008309842,0.00026676507,0.91503876,0.061323136,0.00004922226,0.00002943661,0.000037566788,0.012031289],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950315,0.0013038473,0.0004643908,0.0007771562,0.0018946818,0.0005284251],"domain_scores_gemma":[0.9857401,0.0070874123,0.00071900274,0.00031281193,0.002828671,0.003311885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041312953,0.001630104,0.001958446,0.0012167918,0.00376984,0.005283045,0.0018481076,0.036001,0.006525095],"category_scores_gemma":[0.0466689,0.00072456576,0.0010423824,0.00076871034,0.0032709916,0.005019354,0.0019089028,0.04892856,0.0070106173],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036875255,0.000020668225,0.00022112856,0.00008381559,0.00002069128,0.0011113,0.00010036025,0.000032862812,0.00009929163,0.0018592661,0.9899929,0.006420876],"study_design_scores_gemma":[0.00020734967,0.000089561814,0.0008717821,0.00097626395,0.00004913211,0.0042878613,0.00056239375,0.000309952,0.0002548458,0.0104635805,0.9818355,0.000091804446],"about_ca_topic_score_codex":0.006342274,"about_ca_topic_score_gemma":0.009523242,"teacher_disagreement_score":0.036001,"about_ca_system_score_codex":0.004776108,"about_ca_system_score_gemma":0.005218989,"threshold_uncertainty_score":0.034653246},"labels":[],"label_agreement":null},{"id":"W2607237709","doi":"10.1016/s1474-4422(17)30081-9","title":"Optimisation of stroke research","year":2017,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Scopus; Stroke (engine); Burden of disease; Medicine; Disease burden; Global health; Disease; Public health; Gerontology; MEDLINE; Family medicine; Political science; Pathology; Engineering; Law","score_opus":0.127540448697209,"score_gpt":0.375299955235631,"score_spread":0.24775950653842196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607237709","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012926609,0.0075186095,0.0005148094,0.9660705,0.019552283,0.00002082341,0.000036270914,0.000054148855,0.0061033103],"genre_scores_gemma":[0.0082755545,0.008861853,0.0020478307,0.8514584,0.123035505,0.00010103702,0.00011846766,0.00008247958,0.006018837],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.93034786,0.034832638,0.008382377,0.005185914,0.01563332,0.005617892],"domain_scores_gemma":[0.7767067,0.112982474,0.012610654,0.016661512,0.03651811,0.044520553],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0482483,0.0017573569,0.0040451544,0.0036345893,0.0034617584,0.016508246,0.0042521516,0.049389936,0.031304218],"category_scores_gemma":[0.21997765,0.0013428695,0.0031706053,0.0019500729,0.013712804,0.020200333,0.011717425,0.04962869,0.020327048],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020084734,0.00013178901,0.00047767503,0.0007196318,0.00014114217,0.0007182749,0.0001931683,0.00024302574,0.00034180764,0.027807137,0.9079583,0.061067108],"study_design_scores_gemma":[0.00036251041,0.0001427797,0.0008355658,0.0020277854,0.00009371789,0.001040218,0.00043295883,0.00036602633,0.0002323339,0.14876658,0.84562254,0.00007690195],"about_ca_topic_score_codex":0.002778974,"about_ca_topic_score_gemma":0.0044054408,"teacher_disagreement_score":0.9517517,"about_ca_system_score_codex":0.011359411,"about_ca_system_score_gemma":0.029156096,"threshold_uncertainty_score":0.2551645},"labels":[],"label_agreement":null},{"id":"W2623948558","doi":"10.1016/s1474-4422(17)30124-2","title":"Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis","year":2017,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":357,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Medical Research Council; Vetenskapsrådet; National Institutes of Health; Knut och Alice Wallenbergs Stiftelse; Research Councils UK; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research","keywords":"Neurodegeneration; Huntington's disease; Biomarker; Internal medicine; Medicine; Cohort; Oncology; Retrospective cohort study; Disease; Biology; Genetics","score_opus":0.020874872556009394,"score_gpt":0.2780571164582733,"score_spread":0.2571822439022639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623948558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989956,0.00020304408,0.00025658123,0.00000829334,0.0000050384465,0.000018740197,0.00039368763,0.0000040537484,0.00011503653],"genre_scores_gemma":[0.99906546,0.00007819521,0.0001854882,0.000013303033,0.000006469181,0.000020195484,0.00053537264,0.0000037260475,0.000091865884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876106,0.00025613865,0.00013041387,0.00054006616,0.00019554564,0.000116893214],"domain_scores_gemma":[0.9979346,0.00033944543,0.0005956226,0.0005624176,0.00031321618,0.00025472455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017549729,0.00044190368,0.00059495436,0.00086457934,0.0007107496,0.00077910506,0.00049329293,0.0005221417,0.000767371],"category_scores_gemma":[0.002428636,0.00070794654,0.0007499283,0.0011497977,0.00042866304,0.00046484533,0.0005947387,0.00061136443,0.00020128764],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037424665,0.000031065305,0.9982168,0.0000070556453,0.00015339429,0.00013313178,0.00007021275,0.00003595009,0.00043378997,0.000012294203,0.000055423327,0.00047664324],"study_design_scores_gemma":[0.000030510413,0.00033401343,0.9982262,0.0000047971357,0.00016157287,0.00050550496,0.00010622332,0.00027315016,0.00013911114,0.00001661167,0.00019518872,0.0000070972565],"about_ca_topic_score_codex":0.0063103987,"about_ca_topic_score_gemma":0.005875081,"teacher_disagreement_score":0.0063103987,"about_ca_system_score_codex":0.0004362061,"about_ca_system_score_gemma":0.00046157814,"threshold_uncertainty_score":0.012547374},"labels":[],"label_agreement":null},{"id":"W2625168757","doi":"10.1016/s1474-4422(17)30157-6","title":"Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches","year":2017,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":472,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Heart, Lung, and Blood Institute; National Institute on Aging; National Institute of Neurological Disorders and Stroke; Deutsche Forschungsgemeinschaft","keywords":"Progressive supranuclear palsy; Neuropathology; Medicine; Parkinsonism; Chronic traumatic encephalopathy; Corticobasal degeneration; Disease; Movement disorders; Clinical trial; Pathology; Neuroscience; Psychology","score_opus":0.16801051240865172,"score_gpt":0.3883600824385406,"score_spread":0.22034957002988886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625168757","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000036045232,0.9991868,0.000052364696,0.0004071696,0.00010319016,0.000002003777,0.0000106628695,0.000002978963,0.00019879425],"genre_scores_gemma":[0.00046270355,0.9986714,0.00014979283,0.0003614937,0.00021462645,0.0000040366995,0.00001970215,7.228939e-7,0.00011545788],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995333,0.000077745346,0.0000817939,0.00007462677,0.00018892216,0.000043668282],"domain_scores_gemma":[0.99878174,0.0007109935,0.00015775276,0.000023032959,0.00026199402,0.00006447757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017302502,0.0013056975,0.0031984309,0.0027985813,0.00031892557,0.0016897684,0.0014921068,0.001686717,0.0027575963],"category_scores_gemma":[0.0018263254,0.00032092916,0.0010092575,0.002350663,0.0009358337,0.0020628308,0.0012261576,0.0031885887,0.0011934475],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013461546,0.000071893766,0.00034895953,0.021524243,0.00020249632,0.00023060397,0.00005597336,0.00031943113,0.000709269,0.004567997,0.028241297,0.9435932],"study_design_scores_gemma":[0.00010439078,0.00020432254,0.0020618355,0.019776264,0.00074601994,0.002149195,0.00018914089,0.00027408497,0.00048663525,0.009475841,0.9644688,0.000063484295],"about_ca_topic_score_codex":0.002074854,"about_ca_topic_score_gemma":0.0044913045,"teacher_disagreement_score":0.0031984309,"about_ca_system_score_codex":0.0011016552,"about_ca_system_score_gemma":0.0021175435,"threshold_uncertainty_score":0.00922513},"labels":[],"label_agreement":null},{"id":"W2626981951","doi":"10.1016/s1474-4422(17)30122-9","title":"Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohorts","year":2017,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":189,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"National Institute on Aging; Canadian Institutes of Health Research; Avid Radiopharmaceuticals; Sanofi-Aventis Korea Company; Parkinsonfonden; Genentech; Ipsen; Medical Research Council; Physicians' Services Incorporated Foundation; Servier; Rosetrees Trust; H. Lundbeck A/S; Assistance Publique - Hôpitaux de Paris; Prinses Beatrix Spierfonds; University of Toronto; ZonMw; Biogen; Agence Nationale de la Recherche; Ipsen Fund; National Institutes of Health; Voyager Therapeutics; National Institute for Health and Care Research; Fondation Brain Canada; Novartis; Parkinson Study Group; W. Garfield Weston Foundation; Edmond J. Safra Philanthropic Foundation; GlaxoSmithKline; University of Ottawa; Wellcome Trust; Advanced Cardiac Therapeutics; Bristol-Myers Squibb; Cephalon; Teva Pharmaceutical Industries; National Parkinson Foundation; Pfizer; University of Rochester; Parkinson's UK; Brigham and Women's Hospital; Harvard NeuroDiscovery Center; National Institute of Neurological Disorders and Stroke; Stichting ParkinsonFonds; Ontario Brain Institute; Lundbeckfonden; U.S. Department of Defense; Eli Lilly and Company; American Parkinson Disease Association; UCB; Parkinson's Disease Foundation; Parkinson Vereniging; Parkinson Society Canada; Michael J. Fox Foundation for Parkinson's Research; Nederlandse Organisatie voor Wetenschappelijk Onderzoek","keywords":"Cognition; Parkinson's disease; Medicine; Disease; Longitudinal study; Internal medicine; Physical medicine and rehabilitation; Psychology; Psychiatry; Pathology","score_opus":0.07448044597737412,"score_gpt":0.325283804314126,"score_spread":0.2508033583367519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626981951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990907,0.0001926701,0.00013184725,0.000058995658,0.000015242629,0.000005954249,0.0003799064,0.0000040538516,0.00012059816],"genre_scores_gemma":[0.9987765,0.00010018462,0.00016042376,0.00003056965,0.0000117088985,0.000010493536,0.0007355681,0.0000053684594,0.00016932981],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982436,0.00064444094,0.00015398058,0.0005902597,0.00017647514,0.00019130378],"domain_scores_gemma":[0.99678123,0.0005646804,0.0009866143,0.0005869978,0.0005887077,0.0004917951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003287422,0.0009319746,0.0007706621,0.0009060329,0.0014664424,0.0016485912,0.0010348728,0.001328183,0.0009170155],"category_scores_gemma":[0.0043251994,0.00071957486,0.001774328,0.0017054593,0.00086533645,0.0011804147,0.001749702,0.0017697766,0.00023416821],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072298606,0.00007873698,0.9965655,0.0000066676375,0.00084035785,0.00013984049,0.0001798084,0.000097598044,0.00034015527,0.000040643463,0.00013718661,0.0008504194],"study_design_scores_gemma":[0.000043139076,0.00017818602,0.99856997,0.0000063860844,0.0002333883,0.00017685216,0.00018412087,0.00030322376,0.000060390863,0.00007907968,0.00015311672,0.000012210434],"about_ca_topic_score_codex":0.022630714,"about_ca_topic_score_gemma":0.01933223,"teacher_disagreement_score":0.022630714,"about_ca_system_score_codex":0.00078838156,"about_ca_system_score_gemma":0.0007585482,"threshold_uncertainty_score":0.04499799},"labels":[],"label_agreement":null},{"id":"W2647714020","doi":"10.1016/s1474-4422(17)30198-9","title":"Multiple sclerosis tremor: are technical advances enough?","year":2017,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Krembil Foundation; University of Toronto; Toronto Western Hospital","funders":"","keywords":"Deep brain stimulation; Medicine; Essential tremor; Multiple sclerosis; Neurology; Movement disorders; Thalamus; Physical medicine and rehabilitation; Psychology; Neuroscience; Parkinson's disease; Internal medicine; Psychiatry; Disease","score_opus":0.09203530207835575,"score_gpt":0.2986644467774064,"score_spread":0.20662914469905064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2647714020","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011791542,0.0034606706,0.000051910378,0.9844127,0.010672254,0.0000024606757,0.000018867779,0.000012605563,0.0012506567],"genre_scores_gemma":[0.003554624,0.0063353945,0.00022268518,0.85079473,0.13567507,0.000020054744,0.000039933286,0.000019137777,0.0033383656],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963128,0.0012278714,0.0005211306,0.00036021872,0.0011813066,0.000396707],"domain_scores_gemma":[0.9828623,0.010707243,0.0012036072,0.0004947767,0.0026182164,0.0021138373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045272238,0.0009565304,0.0023248042,0.0009448905,0.0023079156,0.0050136824,0.0017231273,0.053921387,0.009499038],"category_scores_gemma":[0.029320417,0.00048412842,0.0013894989,0.00071486615,0.003781428,0.0060074837,0.001921922,0.046261027,0.010750903],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010032078,0.000052482308,0.00058956904,0.0001689777,0.00003536089,0.002290433,0.0000857914,0.00006968489,0.00015919708,0.003971832,0.96904147,0.02343475],"study_design_scores_gemma":[0.00046144536,0.00015450352,0.0011710859,0.001429973,0.00009435663,0.0037524865,0.00051561254,0.00061735616,0.0002472258,0.03304044,0.9584145,0.00010103111],"about_ca_topic_score_codex":0.0019960096,"about_ca_topic_score_gemma":0.004434921,"teacher_disagreement_score":0.053921387,"about_ca_system_score_codex":0.0035122458,"about_ca_system_score_gemma":0.0032948486,"threshold_uncertainty_score":0.03177744},"labels":[],"label_agreement":null},{"id":"W2682695325","doi":"10.1016/s1474-4422(17)30166-7","title":"Safety and efficacy of dual-lead thalamic deep brain stimulation for patients with treatment-refractory multiple sclerosis tremor: a single-centre, randomised, single-blind, pilot trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Deep brain stimulation; Medicine; Essential tremor; Lead (geology); Refractory (planetary science); Randomized controlled trial; Implant; Surgery; Adverse effect; Physical medicine and rehabilitation; Physical therapy; Parkinson's disease; Internal medicine","score_opus":0.08494342183787185,"score_gpt":0.28521438532581145,"score_spread":0.2002709634879396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2682695325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99220544,0.0032265962,0.00082363107,0.00038974837,0.00040234972,0.0012101035,0.00048058058,0.00009758635,0.0011640515],"genre_scores_gemma":[0.9939804,0.0012712643,0.0007924331,0.00041646158,0.00038876024,0.0015619625,0.00051421084,0.000020619123,0.0010540398],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99890244,0.0004988556,0.00010941622,0.00024577737,0.000096591335,0.00014691471],"domain_scores_gemma":[0.9986975,0.00045895716,0.00025581307,0.0001413842,0.00008756511,0.00035869677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001608219,0.00247575,0.0044396184,0.00055291195,0.0004258158,0.0014520101,0.0011966958,0.0030325642,0.0051025646],"category_scores_gemma":[0.0026986664,0.0008033396,0.002417443,0.0005290285,0.002139851,0.0017355888,0.000542896,0.0029745318,0.0011796503],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9842504,0.0023446025,0.00032365558,0.0004115327,0.00072134135,0.000032724296,0.000054341464,0.00017729198,0.0021444291,0.00006437363,0.00020830022,0.009266903],"study_design_scores_gemma":[0.9376281,0.05978809,0.0012372636,0.000025467238,0.0003966554,0.000035863566,0.000021022468,0.00030932648,0.00022848429,0.0001663329,0.00014507496,0.000018366627],"about_ca_topic_score_codex":0.0009472968,"about_ca_topic_score_gemma":0.0014493797,"teacher_disagreement_score":0.0051025646,"about_ca_system_score_codex":0.00090034545,"about_ca_system_score_gemma":0.0008727184,"threshold_uncertainty_score":0.017069817},"labels":[],"label_agreement":null},{"id":"W2722517739","doi":"10.1016/s1474-4422(17)30161-8","title":"Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study","year":2017,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":332,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"UCLH Biomedical Research Centre; Medical Research Council; Seventh Framework Programme; European Commission; Rosetrees Trust; Guarantors of Brain; Research Councils UK; Brain Research Trust; Novartis; National Institute for Health and Care Research; Roche; Wellcome Trust; Agence Nationale de la Recherche; CHDI Foundation","keywords":"Huntington's disease; Disease; Genetic association; Genome-wide association study; Trinucleotide repeat expansion; Genetics; Medicine; Oncology; Biology; Bioinformatics; Internal medicine; Allele; Gene; Genotype; Single-nucleotide polymorphism","score_opus":0.03287868661296017,"score_gpt":0.298027486192952,"score_spread":0.2651487995799918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2722517739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99774194,0.00093052496,0.00027058602,0.00016679798,0.000021345499,0.000011466443,0.00041593393,0.000011412702,0.00043004187],"genre_scores_gemma":[0.9984546,0.00032925137,0.00040255714,0.00008855083,0.000028811264,0.000009568662,0.00038991787,0.000009913964,0.0002868921],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886525,0.00030263324,0.00012743603,0.00044252904,0.0001470037,0.00011515422],"domain_scores_gemma":[0.9985561,0.00061559887,0.00028082886,0.00017909943,0.00015297651,0.00021548226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018633008,0.00086337375,0.00081521255,0.0011687339,0.0012922579,0.0012308541,0.0009764383,0.0017047322,0.0021408214],"category_scores_gemma":[0.002575384,0.0005610548,0.001373231,0.0021376568,0.0009647916,0.0007163781,0.0009926595,0.0015863826,0.00027364705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033989965,0.00038163664,0.96729016,0.00011310901,0.0037755482,0.002667052,0.000654103,0.0002448022,0.013141663,0.00029384394,0.0008152435,0.0072237356],"study_design_scores_gemma":[0.00018038596,0.00028082012,0.99534947,0.000019928488,0.0014763962,0.0011914782,0.00021712952,0.00027532605,0.00030376724,0.00021271167,0.00047285217,0.00001980235],"about_ca_topic_score_codex":0.008417959,"about_ca_topic_score_gemma":0.012740166,"teacher_disagreement_score":0.008417959,"about_ca_system_score_codex":0.00031689217,"about_ca_system_score_gemma":0.00048442013,"threshold_uncertainty_score":0.016737938},"labels":[],"label_agreement":null},{"id":"W2734481583","doi":"10.1016/s1474-4422(17)30196-5","title":"Detection, risk factors, and functional consequences of cerebral microinfarcts","year":2017,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Neurological Disease Mechanisms and Treatments","field":"Neuroscience","cited_by":306,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; University of Calgary","funders":"National Institute of General Medical Sciences; National Institute on Aging; Horizon 2020; Innovate UK; National Medical Research Council; Medical Research Council; Canadian Institutes of Health Research; Horizon 2020 Framework Programme; Partenariat Canadien Contre Le Cancer; Fondation Leducq; National Institute of Neurological Disorders and Stroke; University of Calgary; British Heart Foundation; Heart and Stroke Foundation of Canada; Genentech; Eli Lilly and Company; Age UK; Southern California Clinical and Translational Science Institute; Fondation Brain Canada; Alzheimer's Association; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Hartstichting; Dana Foundation; Wellcome Trust; National Institutes of Health; Hjerteforeningen; ZonMw; Alberta Innovates - Health Solutions; Alzheimer Society; Michael J. Fox Foundation for Parkinson's Research; National Science Foundation","keywords":"Dementia; Cerebral infarction; Cerebral cortex; Pathology; Disease; Medicine; Lesion; Neuroscience; Psychology; Cardiology; Ischemia","score_opus":0.18369830919177133,"score_gpt":0.33889680731404087,"score_spread":0.15519849812226955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2734481583","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000050844934,0.9993272,0.000055579138,0.00030652282,0.0000997261,0.0000013234978,0.0000126135665,0.0000023840623,0.00014388908],"genre_scores_gemma":[0.00050148944,0.9988764,0.00008894497,0.00015965679,0.00028115022,0.0000028036625,0.000018359944,6.086647e-7,0.000070551556],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.999637,0.000060997638,0.000065512904,0.00007488904,0.00012927344,0.0000322673],"domain_scores_gemma":[0.9986712,0.0008284063,0.00022006736,0.000025923558,0.00019793138,0.000056460867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012598375,0.0011566107,0.0025636565,0.0016389044,0.00020441021,0.0013036949,0.0012696716,0.0018093626,0.0017149525],"category_scores_gemma":[0.002964452,0.00028258745,0.0008193084,0.0014241413,0.0007529925,0.0011812077,0.0006866961,0.0022988718,0.00079762476],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013248333,0.000055787856,0.0010762138,0.01716808,0.00035320868,0.00018731812,0.000036451023,0.00031433732,0.00060624204,0.0031587773,0.020117732,0.9567933],"study_design_scores_gemma":[0.00013035379,0.00028278833,0.012738122,0.03374392,0.0022151533,0.0048604594,0.00025221828,0.0004939028,0.0012598089,0.018296652,0.9255907,0.00013595766],"about_ca_topic_score_codex":0.0028388265,"about_ca_topic_score_gemma":0.0043651583,"teacher_disagreement_score":0.0028388265,"about_ca_system_score_codex":0.00072378863,"about_ca_system_score_gemma":0.0020511036,"threshold_uncertainty_score":0.0066627264},"labels":[],"label_agreement":null},{"id":"W2743747991","doi":"10.1016/s1474-4422(17)30180-1","title":"B vitamins in stroke prevention: time to reconsider","year":2017,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; Western University","funders":"","keywords":"Cyanocobalamin; Methylcobalamin; Medicine; Vitamin B12; B vitamins; Stroke (engine); Homocysteine; Internal medicine; Renal function; Cobalamin; Endocrinology; Gastroenterology","score_opus":0.29545967205471985,"score_gpt":0.4733122830771098,"score_spread":0.17785261102238997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2743747991","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023409912,0.9856601,0.000044923436,0.012090149,0.0019036235,0.0000020437724,0.000013076259,0.000005440894,0.0002573886],"genre_scores_gemma":[0.000535767,0.9863912,0.00032739053,0.009344338,0.0029730918,0.000010765416,0.000024631454,0.0000044675508,0.0003884114],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99837166,0.0005839747,0.00029846685,0.00017824325,0.00043617844,0.00013143523],"domain_scores_gemma":[0.9903861,0.0069590244,0.00051447545,0.00017943632,0.0016090797,0.0003517938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066209766,0.0012777604,0.0050794515,0.0023833537,0.0008074978,0.0041377232,0.002635068,0.006395077,0.006455206],"category_scores_gemma":[0.009124559,0.0005469559,0.001759301,0.002739309,0.0022624796,0.006567923,0.0022029474,0.011169454,0.002503112],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035129287,0.00008259533,0.00028447423,0.03366451,0.0006212046,0.00017137195,0.00024422014,0.00023117028,0.00040831833,0.012860661,0.25757247,0.69350773],"study_design_scores_gemma":[0.00015940287,0.000088745524,0.0005233952,0.029139278,0.0005018363,0.00021046239,0.0004730746,0.00008313544,0.00005834072,0.009807499,0.95891494,0.00003995019],"about_ca_topic_score_codex":0.0065655867,"about_ca_topic_score_gemma":0.018730933,"teacher_disagreement_score":0.0066209766,"about_ca_system_score_codex":0.0025241624,"about_ca_system_score_gemma":0.0077659762,"threshold_uncertainty_score":0.035015464},"labels":[],"label_agreement":null},{"id":"W2754252849","doi":"10.1016/s1474-4422(17)30301-0","title":"A new era of multiple sclerosis rehabilitation: lessons from stroke","year":2017,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Multiple sclerosis; Neurodegeneration; Medicine; Stroke (engine); Disease; Neurology; Neuroprotection; Neuroscience; Physical medicine and rehabilitation; Psychology; Internal medicine; Psychiatry","score_opus":0.14314005354573547,"score_gpt":0.34912863487071216,"score_spread":0.2059885813249767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754252849","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016793162,0.015236737,0.00004336034,0.9760808,0.007897184,0.000002799526,0.000025128953,0.000006062469,0.00054002594],"genre_scores_gemma":[0.0049700756,0.022560202,0.0002543668,0.8449629,0.12621023,0.000031805328,0.000031730404,0.00002136981,0.0009573482],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98222107,0.009671789,0.0026748248,0.0011292378,0.003401503,0.0009015975],"domain_scores_gemma":[0.8420564,0.122071244,0.0068328637,0.0039216434,0.015009959,0.010107923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028308159,0.0010212132,0.003701871,0.0023073722,0.004403421,0.008095793,0.0031265544,0.0401778,0.01011486],"category_scores_gemma":[0.11839318,0.00071245275,0.0018547764,0.0024633305,0.008060771,0.017158156,0.005782872,0.041226275,0.003943097],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002449329,0.00008036476,0.0016534462,0.0011574342,0.00017348693,0.0013878895,0.0004918645,0.000070392896,0.00011065394,0.009147448,0.9348876,0.050594624],"study_design_scores_gemma":[0.0009375194,0.00015441117,0.0035769164,0.007218379,0.0003537215,0.0020812338,0.0025235687,0.00026281062,0.00017105164,0.058227066,0.92433816,0.00015524085],"about_ca_topic_score_codex":0.0076853707,"about_ca_topic_score_gemma":0.021485243,"teacher_disagreement_score":0.0401778,"about_ca_system_score_codex":0.006881571,"about_ca_system_score_gemma":0.011529976,"threshold_uncertainty_score":0.14970964},"labels":[],"label_agreement":null},{"id":"W2754321750","doi":"10.1016/s1474-4422(17)30281-8","title":"Exercise in patients with multiple sclerosis","year":2017,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":455,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Scope (computer science); Multiple sclerosis; Quality of life (healthcare); Inclusion (mineral); Rehabilitation; Population; Medicine; Gerontology; Physical activity; Activities of daily living; Psychology; Physical medicine and rehabilitation; Scope of practice; Physical therapy; Health care; Nursing; Psychiatry; Environmental health; Social psychology; Political science; Computer science","score_opus":0.25495670483070043,"score_gpt":0.38026215944615577,"score_spread":0.12530545461545534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754321750","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023046203,0.99932027,0.000009669558,0.00014079614,0.0001046332,0.0000063156076,0.00003813324,9.680931e-7,0.00014880442],"genre_scores_gemma":[0.0047970763,0.9944022,0.00006695138,0.00042680404,0.00014207995,0.000020761823,0.000044340788,7.660955e-7,0.00009901559],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991116,0.00029648832,0.00029006077,0.00010874488,0.0001440916,0.00004906197],"domain_scores_gemma":[0.9976782,0.0016821526,0.00045089523,0.0000293574,0.000111126355,0.00004830957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015531271,0.0010080443,0.0037773633,0.0026158267,0.0002401597,0.0011723406,0.000797965,0.001528641,0.0054673012],"category_scores_gemma":[0.005213059,0.0004178283,0.002298454,0.0033933648,0.0004302535,0.0008173524,0.0010307069,0.0014196424,0.0003353332],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011304374,0.00010152597,0.001828211,0.5183008,0.012929969,0.00014387866,0.00015595675,0.00015050857,0.00023924328,0.00065551035,0.0111929355,0.4531711],"study_design_scores_gemma":[0.003034962,0.0010432733,0.03238002,0.639433,0.090773106,0.0011270957,0.0008014949,0.00018949166,0.00036603972,0.002300893,0.22842135,0.0001292104],"about_ca_topic_score_codex":0.0043798285,"about_ca_topic_score_gemma":0.013402248,"teacher_disagreement_score":0.0054673012,"about_ca_system_score_codex":0.00067565416,"about_ca_system_score_gemma":0.0013502699,"threshold_uncertainty_score":0.018289924},"labels":[],"label_agreement":null},{"id":"W2754967293","doi":"10.1016/s1474-4422(18)30499-x","title":"Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016","year":2019,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":5701,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; Fogarty International Center; National Human Genome Research Institute; National Institute of Mental Health; Faculty of Medicine and Health, University of Sydney; Dipartimento di Medicina e Chirurgia, Università degli Studi di Milano-Bicocca; Institute of Biomedical Sciences, Academia Sinica; Erasmus Universitair Medisch Centrum Rotterdam; Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences; Fundação para a Ciência e a Tecnologia; National Health and Medical Research Council; Biomedical Research Council; Australian Research Council; Medical Research Council; Institute for Physical Activity and Nutrition; Research Institute, Nationwide Children's Hospital; University of California, Irvine; University of California, San Diego; Uniwersytet Opolski; Debre Tabor University; University of Health and Allied Sciences; Alfaisal University; Universitätsklinikum Heidelberg; Moscow Institute of Physics and Technology; Laboratório Associado para a Química Verde; Western Sydney University; Ministry of Health of the Russian Federation; Lomonosov Moscow State University; Ambo University; Bispebjerg Hospital; Universidad Autónoma de Sinaloa; Universidade Federal de Sergipe; Muhimbili University of Health and Allied Sciences; Applied Molecular Biosciences Unit; Wageningen University and Research; Samara University; Kurdistan University Of Medical Sciences; Lorestan University of Medical Sciences; Alborz University of Medical Sciences; University Of Nigeria Nsukka; Charotar University of Science and Technology; Alexandria University; National Center of Neurology and Psychiatry; Mansoura University; International Centre for Diarrhoeal Disease Research, Bangladesh; Nanjing University; The Wellcome Trust DBT India Alliance; Università degli Studi di Messina; University of Peradeniya; University of Gondar; Golestan University of Medical Sciences; Shahid Beheshti University of Medical Sciences; Universitatea de Medicină şi Farmacie \"Carol Davila\" Bucureşti; Universidad Nacional Autónoma de México; National Research University Higher School of Economics; Hjärt-Lungfonden; Centro de Investigación Biomédica en Red de Salud Mental; Generalitat Valenciana; National Taiwan University; Department of Biotechnology, Ministry of Science and Technology, India; Universidad de Chile; NIHR Collaboration for Leadership in Applied Health Research and Care South London; Virginia Commonwealth University; Università di Bologna; Göteborgs Universitet; Taipei Medical University; University of South Africa; University of the Philippines; Universität Bielefeld; Babol University of Medical Sciences; Universidade de São Paulo; Hacettepe Üniversitesi; Universitetet i Oslo; University of New South Wales; Kermanshah University of Medical Sciences; University of Social Welfare and Rehabilitation Sciences; Fujita Health University; Fundação Oswaldo Cruz; Nationwide Children's Hospital; Universidad de Costa Rica; National and Kapodistrian University of Athens; Jazan University; Griffith University; Ahvaz Jundishapur University of Medical Sciences; Umeå Universitet; Ministry of Health and Medical Education; Haramaya University; Inyuvesi Yakwazulu-Natali; University College London; Universiti Kebangsaan Malaysia; Kuwait University; Chinese Center for Disease Control and Prevention; Tampereen Yliopisto; University of Pennsylvania; Tsinghua University; European Regional Development Fund; Karolinska Institutet; Jordan University of Science and Technology; Georg-August-Universität Göttingen; Ministerio de Economía y Competitividad; Ilam University of Medical Sciences; Lunds Universitet; Sistema Nacional de Investigadores; National Institutes of Health; National University of Singapore; Wollega University; Banaras Hindu University; Kyung Hee University; Sun Yat-sen University; Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja; Ministerio de Educación, Cultura y Deporte; King Saud University; Maurice Wilkins Centre for Molecular Biodiscovery; Shiraz University of Medical Sciences; Ain Shams University; Medical School, University of Michigan; Hospital for Sick Children; Academia Sinica; Sanjay Gandhi Postgraduate Institute of Medical Sciences; National Natural Science Foundation of China; Wuhan University; Dezful University of Medical Sciences; Högskolan Dalarna; Rijksuniversiteit Groningen; Ministério da Educação; Eli Lilly and Company; Public Health Agency; Rede de Química e Tecnologia; Tulane University; Tartu Ülikool; Sanofi-Aventis Deutschland; University of Auckland; Universitas Negeri Semarang; Cancer Society of New Zealand; Università degli Studi di Milano; Bayer; Pomorski Uniwersytet Medyczny W Szczecinie; University of Otago; Nanyang Technological University; Ball State University; Addis Ababa University; Università degli Studi di Firenze; Universidad Autónoma Metropolitana; Department of Science and Technology, Ministry of Science and Technology, India; Pacific Institute for Research and Evaluation; Qazvin University of Medical Sciences; Universitair Medisch Centrum Groningen; Australian National University; Uniwersytet Jagielloński Collegium Medicum; Shiraz University; King's College London; Sree Chitra Tirunal Institute for Medical Sciences and Technology; Cochrane South Africa; University of Toronto; High Blood Pressure Research Council of Australia; Public Health England; Imperial College London; Johns Hopkins University; University of Warwick; Jackson State University; University of Southampton; National Research Foundation; National Institute for Health and Care Research; Abbott Diagnostics; Directorate for Biological Sciences; Politechnika Czestochowska; Bundesministerium für Gesundheit; South African Medical Research Council; Mashhad University of Medical Sciences; Saint Paul's Hospital Millennium Medical College; Alexander von Humboldt-Stiftung; Tribhuvan University; NIHR Oxford Biomedical Research Centre; Horizon Pharmaceuticals; Universität Ulm; Bournemouth University; Loma Linda University; University of Embu; Health Research Council of New Zealand; Uniwersytet Łódzki; Maragheh University of Medical Sciences; University of Dhaka; Universiteit Stellenbosch; University of Tabriz; European Commission; Ahmadu Bello University; Universidade do Porto; Australian Government; Ilam University; Wellcome Trust; Korea University; Trường Đại học Duy Tân; Universidade Federal de Santa Catarina; University of West Florida; Sanofi; University of Oxford; McMaster University; Aksum University; University of Hull; Xiamen University; National Institute of Neurological Disorders and Stroke; Technische Universität München; Université de Bourgogne; U.S. Department of Defense; University of Technology Sydney; York University; Yale University; Jimma University; Harvard University; Deutsches Krebsforschungszentrum; Horizon Pharma; Iran University of Medical Sciences; Fudan University; Case Western Reserve University; Novo Nordisk; Danmarks Grundforskningsfond; Durban University of Technology; King Fahd University of Petroleum and Minerals; Hamad Medical Corporation; Medtronic; Deakin University; Bristol-Myers Squibb; BASF; Helsingin Yliopisto; Amgen; Ministério da Educação e Ciência; Birmingham City University; Lee Kong Chian School of Medicine, Nanyang Technological University; School of Medicine, Boston University; Bundesministerium für Bildung und Forschung; Universitat de Barcelona; AbbVie; Student Research Committee, Tabriz University of Medical Sciences; Frankfurt University of Applied Sciences; La Trobe University; Arabian Gulf University; Kaiser Permanente; Astellas Pharma US; Brien Holden Vision Institute; AstraZeneca; Universidade Federal de Minas Gerais; Celgene; University of Cape Town; University of Ottawa; Curtin University of Technology; King Khalid University; Isfahan University of Medical Sciences; Instituto de Salud Carlos III; San Diego State University; Merck Sharp and Dohme; Islamic Azad University; West Virginia University; GlaxoSmithKline; Universidad Nacional de Colombia; Northwestern University; Universiti Sains Malaysia; Háskólinn í Reykjavík; Pfizer; Bill and Melinda Gates Foundation; Australian Catholic University; Universitat de València; Boehringer Ingelheim; Public Health Agency of Canada","keywords":"Burden of disease; Disease; Medicine; Disease burden; Environmental health; Pathology","score_opus":0.025245903556736213,"score_gpt":0.2948064794066499,"score_spread":0.26956057584991366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754967293","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04101899,0.8980621,0.0028993955,0.0017727858,0.00040526703,0.00072669727,0.05387614,0.00012152538,0.0011170924],"genre_scores_gemma":[0.54709536,0.40720493,0.009887512,0.0020123315,0.000466527,0.0032524774,0.029259998,0.00010475422,0.00071608915],"study_design_codex":"meta_analysis","study_design_gemma":"systematic_review","domain_scores_codex":[0.9915456,0.0035468433,0.0023286194,0.0010404163,0.0011912471,0.00034728847],"domain_scores_gemma":[0.9923608,0.0033025385,0.0020863619,0.00057454815,0.0014962571,0.00017961311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012720348,0.0012105255,0.004761948,0.006999207,0.00045369874,0.0012081912,0.0008206809,0.00083683315,0.0021301282],"category_scores_gemma":[0.02455304,0.00087594794,0.019048506,0.010505828,0.00047614565,0.00074539863,0.0016252935,0.001118704,0.00029869823],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030194852,0.000043403445,0.24750343,0.22136512,0.4387163,0.0003437494,0.00065113057,0.002428424,0.0005480097,0.0012214335,0.025599184,0.05856037],"study_design_scores_gemma":[0.0018538394,0.0003581615,0.2625298,0.080770135,0.62433547,0.00066967704,0.0004068942,0.0015182104,0.00029726035,0.0014843139,0.02561328,0.0001630464],"about_ca_topic_score_codex":0.033725526,"about_ca_topic_score_gemma":0.06758447,"teacher_disagreement_score":0.033725526,"about_ca_system_score_codex":0.0019789238,"about_ca_system_score_gemma":0.0058501773,"threshold_uncertainty_score":0.067272425},"labels":[],"label_agreement":null},{"id":"W2755106885","doi":"10.1016/s1474-4422(17)30278-8","title":"Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis","year":2017,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":568,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Optic neuritis; Multiple sclerosis; Retinal; Medicine; Nerve fiber layer; Ophthalmology; Meta-analysis; Optical coherence tomography; Atrophy; Optic nerve; Pathology","score_opus":0.568419215946183,"score_gpt":0.45906680179123455,"score_spread":0.10935241415494851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755106885","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035878266,0.9954318,0.0002880212,0.00009138558,0.00010568208,0.00014776825,0.00020173866,0.000014979846,0.00013095312],"genre_scores_gemma":[0.15779622,0.83676136,0.0026481054,0.0010563111,0.00027801536,0.0005183218,0.00046270402,0.000038823604,0.00044011115],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99337065,0.00259753,0.0022606116,0.00079729134,0.0006723805,0.00030156327],"domain_scores_gemma":[0.9880938,0.008021955,0.0024146906,0.00053920125,0.0007768979,0.00015347038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010171324,0.0031250757,0.017694635,0.004314387,0.00070307235,0.0036043255,0.002396594,0.003094825,0.0051426156],"category_scores_gemma":[0.027031723,0.0019256904,0.028793357,0.0055993795,0.0009446685,0.0024499856,0.0022047174,0.0022627488,0.00047375655],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020867996,0.00003730587,0.0031836864,0.4193794,0.5606613,0.00014207955,0.0001437679,0.00026516258,0.00028223763,0.00012285223,0.0006290367,0.013066308],"study_design_scores_gemma":[0.00077636185,0.00013650222,0.0028444878,0.017371638,0.9771213,0.00008489448,0.00006690717,0.00007955075,0.000069999114,0.00017149156,0.0012491742,0.000027574819],"about_ca_topic_score_codex":0.007158009,"about_ca_topic_score_gemma":0.025718821,"teacher_disagreement_score":0.017694635,"about_ca_system_score_codex":0.0020742924,"about_ca_system_score_gemma":0.0031855558,"threshold_uncertainty_score":0.05379176},"labels":[],"label_agreement":null},{"id":"W2760984499","doi":"10.1016/s1474-4422(17)30334-4","title":"Challenges and unfulfilled promises in Parkinson's disease","year":2017,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; University of British Columbia","funders":"","keywords":"Enthusiasm; Toll; Disease; Parkinson's disease; Medicine; Psychiatry; Intensive care medicine; Gerontology; Psychology; Pathology; Immunology; Social psychology","score_opus":0.06573003395095584,"score_gpt":0.30773207514740325,"score_spread":0.24200204119644741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760984499","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00084715814,0.3902844,0.0005968406,0.5949145,0.008481286,0.0000052220694,0.00007952078,0.000051643205,0.004739443],"genre_scores_gemma":[0.072632894,0.59443414,0.0035385736,0.25112665,0.06976191,0.00007874048,0.00022924326,0.00010155645,0.008096289],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930856,0.0031048385,0.0005543203,0.0005730431,0.0016462103,0.0010359597],"domain_scores_gemma":[0.9688469,0.01835337,0.0012869306,0.0013769649,0.004496966,0.005638808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028130071,0.0012469979,0.0037837839,0.0018231571,0.003897123,0.009308974,0.0024917237,0.017051678,0.012081664],"category_scores_gemma":[0.02495651,0.00074983115,0.0012679633,0.0012420339,0.020396456,0.023934694,0.008614656,0.02107752,0.00432832],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094285846,0.00028926003,0.0012234119,0.0037862146,0.00024136518,0.0007634961,0.0015971722,0.00089494523,0.0010413455,0.2763179,0.407164,0.30573797],"study_design_scores_gemma":[0.00019784544,0.00023307465,0.00090780045,0.0019149593,0.000078528865,0.00049384084,0.0021022048,0.00040666293,0.0002089397,0.3962751,0.5970659,0.00011511642],"about_ca_topic_score_codex":0.0037632,"about_ca_topic_score_gemma":0.008403917,"teacher_disagreement_score":0.028130071,"about_ca_system_score_codex":0.006533861,"about_ca_system_score_gemma":0.012511296,"threshold_uncertainty_score":0.14876783},"labels":[],"label_agreement":null},{"id":"W2764285200","doi":"10.1016/s1474-4422(17)30327-7","title":"Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis","year":2017,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Restless Legs Syndrome Research","field":"Medicine","cited_by":240,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Montreal Neurological Institute and Hospital; Canadian Sleep & Circadian Network; Hôpital du Sacré-Cœur de Montréal; Institut Universitaire en Santé Mentale de Québec; Université de Montréal; Institut Universitaire de Gériatrie de Montréal; McGill University","funders":"UCB Pharma; Helmholtz Zentrum München; National Institutes of Health; Britannia Pharmaceuticals; H. Lundbeck A/S; Servier; NIHR Cambridge Biomedical Research Centre; Else Kröner-Fresenius-Stiftung; Deutsche Forschungsgemeinschaft; University of Thessaly; European Commission; ResMed; Covis Pharma; Eesti Teadusagentuur; National Institute of Neurological Disorders and Stroke; British Heart Foundation; Wellcome Trust; Teva Pharmaceutical Industries; Medical Research Council; Pfizer; Biogen; Vifor Pharma; Restless Legs Syndrome Foundation; University of Oxford; National Institute for Health and Care Research; NHS Blood and Transplant; European Regional Development Fund; Bundesministerium für Bildung und Forschung","keywords":"Genome-wide association study; Meta-analysis; Odds ratio; Genetics; Genetic association; Restless legs syndrome; Biology; Candidate gene; Linkage disequilibrium; Gene; Single-nucleotide polymorphism; Bioinformatics; Medicine; Allele; Haplotype; Neuroscience; Genotype; Internal medicine; Neurology","score_opus":0.5651654138783573,"score_gpt":0.5048769704080062,"score_spread":0.060288443470351116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2764285200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52690786,0.44844744,0.014234266,0.0015264739,0.00073934835,0.0002674579,0.0058599133,0.00043989622,0.0015773155],"genre_scores_gemma":[0.9753194,0.01867307,0.0030495853,0.0004436094,0.00016452916,0.00021023944,0.0017543235,0.00008387212,0.00030131006],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9879291,0.0055279126,0.0020229456,0.0029676983,0.0009070017,0.0006453297],"domain_scores_gemma":[0.9831215,0.011700798,0.0016849374,0.0021483288,0.0008954982,0.00044889902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014789109,0.002598151,0.0077078296,0.0050792373,0.0011735511,0.0036504674,0.002036489,0.002253352,0.0030024871],"category_scores_gemma":[0.019002963,0.0014034563,0.03188153,0.008014984,0.0007482561,0.0011708161,0.0017314473,0.0018069984,0.00030041952],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004380911,0.00005392625,0.2763291,0.0053983703,0.70171106,0.0007284756,0.000119232165,0.0014226041,0.0015421683,0.00018128619,0.00073727005,0.007395535],"study_design_scores_gemma":[0.0006855698,0.0003083585,0.16528212,0.00080819323,0.82793015,0.00056738494,0.00012829958,0.0020699908,0.00050047436,0.0005868213,0.001085382,0.00004727153],"about_ca_topic_score_codex":0.0061143455,"about_ca_topic_score_gemma":0.006858202,"teacher_disagreement_score":0.014789109,"about_ca_system_score_codex":0.0009341816,"about_ca_system_score_gemma":0.0013226754,"threshold_uncertainty_score":0.078213215},"labels":[],"label_agreement":null},{"id":"W2767805413","doi":"10.1016/s1474-4422(17)30378-2","title":"Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":269,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"Sanofi Genzyme; Seventh Framework Programme; Genentech; Grifols; Ono Pharmaceutical; Mitsubishi Tanabe Pharma Corporation; Teijin Pharma; Prinses Beatrix Spierfonds; Ministry of Health, Labour and Welfare; Pfizer Japan; Shionogi; Argenx; Bayer Yakuhin; Celgene; Ministry of Education, Culture, Sports, Science and Technology; Calithera Biosciences; Union Chimique Belge; Neurocrine Biosciences; Kissei; Boehringer Ingelheim Japan; Teva Pharmaceutical Industries; Myasthenia Gravis Foundation of America; Bayer HealthCare; European Commission; Sanofi; Pfizer; Biogen; Japan Society for the Promotion of Science; GlaxoSmithKline; Bristol-Myers Squibb; CSL Behring; AstraZeneca; Eisai","keywords":"Medicine; Chronic inflammatory demyelinating polyneuropathy; Placebo; Internal medicine; Clinical trial; Polyradiculoneuropathy; Randomized controlled trial; Antibody; Polyneuropathy; Intention-to-treat analysis; Physical therapy; Surgery; Pediatrics; Guillain-Barre syndrome; Immunology; Pathology","score_opus":0.041857880497931765,"score_gpt":0.332183446972469,"score_spread":0.2903255664745372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767805413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9660384,0.01965401,0.001636634,0.0010029395,0.0013833307,0.0054314705,0.0016210072,0.00036846517,0.0028637224],"genre_scores_gemma":[0.9718675,0.009252864,0.002555086,0.0019693184,0.0009530083,0.007014402,0.0014880975,0.000048148835,0.0048516756],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994873,0.00021236061,0.00003385401,0.00010315289,0.000047688933,0.00011571564],"domain_scores_gemma":[0.99921703,0.00028607532,0.00015332148,0.0000627448,0.00005070743,0.00023011935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001622489,0.0018032308,0.004290544,0.00057288614,0.00047756944,0.001070362,0.0013531619,0.0029259862,0.008865932],"category_scores_gemma":[0.0014845605,0.0005269477,0.0023066609,0.0006356082,0.0015412486,0.0013943366,0.00045802526,0.0032025916,0.0013744974],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97987366,0.0022556894,0.00021090975,0.0011520225,0.0007883685,0.00004418207,0.000036951464,0.00014943624,0.0013746507,0.00008435976,0.00056341593,0.013466479],"study_design_scores_gemma":[0.9792013,0.019685214,0.0004973147,0.000033118376,0.00015846237,0.000016691141,0.0000081265725,0.00008337982,0.0000672235,0.000058474056,0.00018550384,0.000005178462],"about_ca_topic_score_codex":0.0013158896,"about_ca_topic_score_gemma":0.0021287592,"teacher_disagreement_score":0.008865932,"about_ca_system_score_codex":0.000775657,"about_ca_system_score_gemma":0.0010270228,"threshold_uncertainty_score":0.02965945},"labels":[],"label_agreement":null},{"id":"W2767813783","doi":"10.1016/s1474-4422(17)30371-x","title":"Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research","year":2017,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Trauma and Emergency Care Studies","field":"Medicine","cited_by":2547,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"School of Medicine, University of California, San Diego; School of Medicine, University of California, San Francisco; Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Johns Hopkins Bloomberg School of Public Health; GlaxoSmithKline; University of California, San Francisco; National Institutes of Health; One Mind; Uniformed Services University of the Health Sciences; Turun Yliopistollinen Keskussairaala; Monash University; Università degli Studi di Messina; European Brain Council; ZNS - Hannelore Kohl Stiftung; Universiteit Antwerpen; Turun Yliopisto; Leids Universitair Medisch Centrum; Broad Institute; Stanley Center for Psychiatric Research, Broad Institute; Nanyang Technological University; Johns Hopkins University; Lee Kong Chian School of Medicine, Nanyang Technological University; University of California, San Diego; Helsingin Yliopisto; University of Stirling; Universiteit Leiden; University of Glasgow; Erasmus Medisch Centrum; University of Oxford; École Polytechnique Fédérale de Lausanne; Karolinska Institutet; Hotchkiss Brain Institute; U.S. Department of Defense; La Trobe University; National Institute of Neurological Disorders and Stroke; Ontario Neurotrauma Foundation; Academy of Medical Sciences; European Commission; Université de Liège; National Institute for Health and Care Research; NHS Blood and Transplant; University of Exeter; Ontario Brain Institute; Renji Hospital; University of Cincinnati; Universitätsmedizin Göttingen; Sapienza Università di Roma; Massachusetts General Hospital","keywords":"Traumatic brain injury; Public health; Medicine; Population; Health care; Societal impact of nanotechnology; Occupational safety and health; Years of potential life lost; Injury prevention; Global health; Environmental health; Poison control; Psychiatry; Economic growth; Nursing; Life expectancy","score_opus":0.7210824605081598,"score_gpt":0.5578142090847009,"score_spread":0.1632682514234589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767813783","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000027050652,0.9963883,0.00013787986,0.002398645,0.00040374894,0.000024025276,0.000017692502,0.000009006403,0.0005937454],"genre_scores_gemma":[0.00044185642,0.99765235,0.0005310338,0.0009038769,0.00026993183,0.000032643893,0.000022847758,0.000002188254,0.00014333182],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99492943,0.002266312,0.0008456555,0.00031336845,0.0013697111,0.00027555076],"domain_scores_gemma":[0.9879739,0.008362218,0.0008958461,0.00034779028,0.0019715484,0.00044869498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009935443,0.0019138776,0.003669187,0.007212973,0.00073555287,0.0039401,0.0024682072,0.003256925,0.006296292],"category_scores_gemma":[0.017334249,0.0005720638,0.002513972,0.0068617077,0.0016527694,0.0050263503,0.0032542478,0.0045375917,0.002132424],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059044043,0.00009068762,0.00023425066,0.127976,0.00082077837,0.00009983129,0.0003171319,0.0003523861,0.00023709128,0.01253184,0.061379135,0.79590183],"study_design_scores_gemma":[0.00006598432,0.000089722336,0.0010355929,0.13984895,0.0009681657,0.00042593118,0.000498963,0.00009938416,0.00013522679,0.009728217,0.8470691,0.000034769408],"about_ca_topic_score_codex":0.005338466,"about_ca_topic_score_gemma":0.009080664,"teacher_disagreement_score":0.009935443,"about_ca_system_score_codex":0.0038447585,"about_ca_system_score_gemma":0.014860256,"threshold_uncertainty_score":0.052544236},"labels":[],"label_agreement":null},{"id":"W2768506860","doi":"10.1016/s1474-4422(17)30402-7","title":"Balancing ethics and care in disorders of consciousness","year":2017,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Traumatic Brain Injury Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroDevNet; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Premise; Psychological intervention; Neurosurgery; Psychiatry; Psychology; Medicine; Philosophy","score_opus":0.09033597033680665,"score_gpt":0.3711480879590551,"score_spread":0.28081211762224845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768506860","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026961797,0.00091617845,0.000042912212,0.99194497,0.0047221896,0.0000028489799,0.000004641937,0.000002528793,0.0020941743],"genre_scores_gemma":[0.010481455,0.0012664988,0.00011792852,0.95303106,0.032357074,0.000027792286,0.0000068498566,0.000010890988,0.0027004243],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9909965,0.0041705538,0.00067864923,0.0006364856,0.001804339,0.0017134324],"domain_scores_gemma":[0.97033596,0.021116715,0.0014721308,0.0006221278,0.0024214098,0.00403164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008167949,0.0006555258,0.0015592455,0.0008266128,0.009206877,0.00890137,0.0024953603,0.10125112,0.0052815094],"category_scores_gemma":[0.0671284,0.00074336736,0.001039775,0.0009528193,0.016160656,0.009090838,0.004984161,0.08438165,0.0025515931],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006455063,0.000047575275,0.00088183646,0.00011800309,0.000035985788,0.0040184655,0.0016228964,0.00012471422,0.000114870214,0.052824445,0.92642295,0.013723696],"study_design_scores_gemma":[0.00026760594,0.00005915764,0.0013312545,0.0013359024,0.00005350756,0.0044339425,0.0045811115,0.0006983998,0.00021099615,0.20082654,0.78607917,0.00012243986],"about_ca_topic_score_codex":0.009028275,"about_ca_topic_score_gemma":0.019014923,"teacher_disagreement_score":0.10125112,"about_ca_system_score_codex":0.009103429,"about_ca_system_score_gemma":0.013945641,"threshold_uncertainty_score":0.06605035},"labels":[],"label_agreement":null},{"id":"W2773895341","doi":"10.1016/s1474-4422(17)30407-6","title":"Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data","year":2017,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":319,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Toronto Western Hospital; Foothills Medical Centre; University of Saskatchewan; University of Calgary","funders":"Health Technology Assessment Programme; Canadian Institutes of Health Research; St. Jude Medical; Genentech; Alberta Health Services; Alberta Innovates; Hartstichting; Royal Australasian College of Physicians; Heart and Stroke Foundation of Canada; National Heart Foundation of Australia; National Stroke Foundation; Servier; University of Glasgow; Pfizer; Stroke Association; Daiichi-Sankyo; National Institute for Health and Care Research; Medical Research Council; Penumbra; Faculty of Veterinary Medicine, University of Calgary; National Health and Medical Research Council; AstraZeneca; Alberta Innovates - Health Solutions; Hotchkiss Brain Institute; Stryker; University of Calgary; Boehringer Ingelheim","keywords":"Medicine; Modified Rankin Scale; Sedation; Stroke (engine); Meta-analysis; Randomized controlled trial; Observational study; Clinical trial; Standard of care; Thrombolysis; General anaesthesia; Occlusion; Surgery; Anesthesia; Internal medicine; Ischemic stroke; Myocardial infarction; Ischemia","score_opus":0.1618464740579822,"score_gpt":0.372936745151615,"score_spread":0.21109027109363282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2773895341","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07760227,0.9163702,0.0021831223,0.0004296962,0.00051595963,0.00048779708,0.001533104,0.00008357038,0.0007942318],"genre_scores_gemma":[0.84349996,0.14929293,0.0027188144,0.0010235518,0.00035457034,0.0009589924,0.0016315025,0.000063220665,0.00045638712],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9844922,0.009546835,0.003026536,0.0015850802,0.00094314717,0.00040629008],"domain_scores_gemma":[0.977603,0.016497498,0.003461995,0.0012608531,0.0008629586,0.00031362032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016604362,0.0024059261,0.015693313,0.0038989463,0.00057056797,0.0035824622,0.0018310534,0.002629416,0.0024753555],"category_scores_gemma":[0.035050835,0.0012453437,0.055712055,0.004851877,0.00078651315,0.0014771221,0.0014414164,0.0022712143,0.00029609032],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006800173,0.000030423016,0.005446731,0.03021649,0.9539113,0.00006206135,0.000033229124,0.0005252557,0.00012551103,0.00005605968,0.00016383266,0.0026289283],"study_design_scores_gemma":[0.0012290063,0.0002982472,0.0043376246,0.0015388429,0.9917528,0.00004264564,0.00001893396,0.0002305773,0.00007045387,0.00013644963,0.0003295882,0.000014881007],"about_ca_topic_score_codex":0.005473748,"about_ca_topic_score_gemma":0.00669371,"teacher_disagreement_score":0.016604362,"about_ca_system_score_codex":0.0018391362,"about_ca_system_score_gemma":0.0013185034,"threshold_uncertainty_score":0.08781332},"labels":[],"label_agreement":null},{"id":"W2774903942","doi":"10.1016/s1474-4422(17)30400-3","title":"Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study","year":2017,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":289,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; University of Toronto","funders":"National Center for Advancing Translational Sciences; California Sea Grant, University of California, San Diego; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Neurological Disorders and Stroke; National Human Genome Research Institute; National Institute of Mental Health; NIHR Oxford Biomedical Research Centre; National Health and Medical Research Council; Medical Research Council; Alzheimer's Society; Canadian Institutes of Health Research; National Institutes of Health; Parkinson's Disease Foundation; Samfundet Folkhälsan; Krembil Foundation; University of Toronto; Generalitat de Catalunya; Suomalainen Tiedeakatemia; Parkinson's UK; National Institute on Aging; Folkhälsanin Tutkimussäätiö; National Institute for Health and Care Research; Alzheimer Society; University College London Hospitals NHS Foundation Trust; University of California, San Diego; Johns Hopkins University; Neuroscience Research Australia; UCLH Biomedical Research Centre; Big Lottery Fund; Michael J. Fox Foundation for Parkinson's Research; National Institute on Drug Abuse; Consortium canadien en neurodégénérescence associée au vieillissement; U.S. Department of Veterans Affairs; University of Pennsylvania; Little Family Foundation; National Cancer Institute; BRACE; Helene Morgan Babcock and Alfred Babcock Memorial Scholarship Trust; Autistica; NIH Office of the Director; Wellcome Trust; Memorial University of Newfoundland; University of New South Wales; Common Fund; Alzheimer’s Research UK; Centres de Recerca de Catalunya; National Heart, Lung, and Blood Institute; Helsingin ja Uudenmaan Sairaanhoitopiiri; Agence Nationale de la Recherche; Mayo Clinic; U.S. Department of Health and Human Services","keywords":"Dementia with Lewy bodies; Dementia; Lewy body; Genome-wide association study; Genotyping; Genetic association; Disease; Medicine; Pathology; Single-nucleotide polymorphism; Biology; Genotype; Genetics","score_opus":0.02263238661146419,"score_gpt":0.27514830173910776,"score_spread":0.2525159151276436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774903942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99693155,0.0010808845,0.0011014953,0.00019777058,0.00002310518,0.000041463987,0.0003125459,0.000017099099,0.00029411775],"genre_scores_gemma":[0.9972192,0.0003696489,0.0012566916,0.00011352141,0.00002153043,0.00004597041,0.00046016928,0.000016626245,0.00049670704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953922,0.0020388784,0.00039661324,0.00130431,0.0004050684,0.0004629826],"domain_scores_gemma":[0.9947584,0.002139052,0.00074235396,0.0012064957,0.0006299994,0.0005236674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076795323,0.0017693797,0.0018076607,0.0011635681,0.0023429394,0.0027149108,0.0017764407,0.003165371,0.0012895372],"category_scores_gemma":[0.008790502,0.0018072735,0.004175571,0.002373184,0.0013937796,0.0015213259,0.0025283908,0.002838655,0.00032943368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072313272,0.000631283,0.96552557,0.00015609748,0.007324872,0.0018326725,0.0014855127,0.00039136686,0.008833612,0.0003329165,0.00048246398,0.0057722954],"study_design_scores_gemma":[0.00050939084,0.00066518557,0.9908903,0.000033099845,0.0041031633,0.00081150566,0.00051613786,0.0010542263,0.0005433567,0.00035338404,0.00046678202,0.000053388587],"about_ca_topic_score_codex":0.018721575,"about_ca_topic_score_gemma":0.025120348,"teacher_disagreement_score":0.018721575,"about_ca_system_score_codex":0.00073600025,"about_ca_system_score_gemma":0.0013632604,"threshold_uncertainty_score":0.04061377},"labels":[],"label_agreement":null},{"id":"W2777074421","doi":"10.1016/s1474-4422(17)30470-2","title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","year":2017,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7986,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto; St. Michael's Hospital; University of Manitoba; Ottawa Hospital; University of Ottawa","funders":"National Multiple Sclerosis Society","keywords":"Multiple sclerosis; McDonald criteria; Medicine; Clinically isolated syndrome; Clinical Practice; Presentation (obstetrics); Medical physics; Neuroscience; Pathology; Radiology; Psychology; Physical therapy; Psychiatry","score_opus":0.48326579413160964,"score_gpt":0.46104665010400053,"score_spread":0.022219144027609106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2777074421","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009048592,0.9950748,0.0001506551,0.0022879657,0.0018273952,0.00005593266,0.00021973373,0.000009924593,0.0002830287],"genre_scores_gemma":[0.0016692119,0.99191976,0.0014454576,0.00309033,0.0010858554,0.00012038968,0.00046445243,0.000009059839,0.00019553366],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9870581,0.0029734722,0.005554023,0.00075649505,0.0033177366,0.00034026132],"domain_scores_gemma":[0.97734845,0.012786552,0.0040921937,0.00036111765,0.0049864044,0.00042543074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019606307,0.0021826862,0.008090202,0.011503626,0.00067216065,0.0033431181,0.0040923003,0.002698272,0.0035753609],"category_scores_gemma":[0.03486016,0.0010038773,0.007017326,0.007379669,0.0018086634,0.0032267543,0.0028744654,0.0043261587,0.00093901256],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093481684,0.00006470731,0.0013065522,0.28790727,0.0053921323,0.00020298659,0.00023778566,0.00032861257,0.0005289168,0.004323685,0.11014821,0.58862436],"study_design_scores_gemma":[0.0013034949,0.000280839,0.008361388,0.35987684,0.023820207,0.0015789552,0.00034813726,0.00027727082,0.00038125395,0.004630739,0.5989551,0.00018580197],"about_ca_topic_score_codex":0.0149092125,"about_ca_topic_score_gemma":0.030953044,"teacher_disagreement_score":0.019606307,"about_ca_system_score_codex":0.004999805,"about_ca_system_score_gemma":0.01524812,"threshold_uncertainty_score":0.10368931},"labels":[],"label_agreement":null},{"id":"W2783592187","doi":"10.1016/s1474-4422(17)30404-0","title":"Prediction of late seizures after ischaemic stroke with a novel prognostic model (the SeLECT score): a multivariable prediction model development and validation study","year":2018,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":318,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Centre Hospitalier de l’Université de Montréal","funders":"Epilepsy Research UK; Medical Research Council; National Institute for Health and Care Research","keywords":"Stroke (engine); Medicine; Concordance; Proportional hazards model; Internal medicine; Ischaemic stroke; Epilepsy; Etiology; Cardiology; Ischemia","score_opus":0.05424428430595551,"score_gpt":0.28191314887618,"score_spread":0.2276688645702245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783592187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99446154,0.00009266155,0.0046860906,0.000107478416,0.000019159083,0.00005005504,0.00039160924,0.00004600722,0.00014539139],"genre_scores_gemma":[0.9964695,0.00007501972,0.0024428812,0.000026037229,0.00001943928,0.000057860503,0.0007550965,0.000014864371,0.00013918999],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987393,0.00077200023,0.00006189773,0.00015480255,0.00016592786,0.00010602301],"domain_scores_gemma":[0.99121183,0.0058087287,0.00064771174,0.0008317243,0.001128558,0.00037138513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009644518,0.0012288374,0.00092076097,0.0007051754,0.0003702987,0.00081240607,0.00091082894,0.0004647437,0.000813324],"category_scores_gemma":[0.012728567,0.00033048243,0.0012586478,0.0004758561,0.00040913917,0.0007213981,0.0010263391,0.0016488746,0.00023837869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013363716,0.0029169933,0.8650886,0.000104915554,0.0024923636,0.0001862874,0.0003215869,0.04393451,0.0017925332,0.0006057148,0.0034232438,0.06576964],"study_design_scores_gemma":[0.0017525913,0.007765656,0.37335482,0.000041248728,0.0022418227,0.00034058254,0.00027190225,0.60900843,0.0023476721,0.0017705482,0.0010090752,0.000095606],"about_ca_topic_score_codex":0.0037316156,"about_ca_topic_score_gemma":0.0026770143,"teacher_disagreement_score":0.009644518,"about_ca_system_score_codex":0.00055822206,"about_ca_system_score_gemma":0.0012931857,"threshold_uncertainty_score":0.05100572},"labels":[],"label_agreement":null},{"id":"W2784397775","doi":"10.1016/s1474-4422(18)30026-7","title":"Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan","year":2018,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":454,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"Centers for Disease Control and Prevention; National Institutes of Health; Massachusetts General Hospital","keywords":"Psychosocial; Multidisciplinary approach; Medicine; Duchenne muscular dystrophy; Psychological intervention; Health care; Quality of life (healthcare); MEDLINE; Nursing; Psychiatry","score_opus":0.022104247974925592,"score_gpt":0.30948415524490763,"score_spread":0.287379907269982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2784397775","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004065703,0.99905485,0.00006711277,0.0003630811,0.00016753034,0.0000031623392,0.000010484705,0.0000032288713,0.00028982805],"genre_scores_gemma":[0.0004848752,0.99865156,0.00013849638,0.00026124687,0.0002876342,0.0000045035995,0.000025447509,7.123813e-7,0.00014562892],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995332,0.00008897901,0.00008533916,0.00007241232,0.00017740029,0.000042676154],"domain_scores_gemma":[0.9990453,0.0005230924,0.00015634528,0.000013508825,0.00019232687,0.00006933448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010929321,0.0009906348,0.0021286195,0.002322884,0.00029686026,0.0011577256,0.0013909499,0.0015500276,0.0024802515],"category_scores_gemma":[0.0021407888,0.00027144846,0.00072869286,0.001791953,0.0006027889,0.0011157144,0.0008497804,0.001943864,0.0009793567],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058659454,0.000051301657,0.00042920365,0.015840644,0.00014084305,0.00024129172,0.00004869583,0.00040855346,0.0002613067,0.0018139854,0.032115754,0.9485897],"study_design_scores_gemma":[0.000081141436,0.0001423604,0.006085707,0.03899209,0.0005615416,0.0047529857,0.00023079292,0.000284125,0.0002390832,0.003531967,0.9450386,0.000059503665],"about_ca_topic_score_codex":0.0046138405,"about_ca_topic_score_gemma":0.007859417,"teacher_disagreement_score":0.0046138405,"about_ca_system_score_codex":0.0012893681,"about_ca_system_score_gemma":0.001964713,"threshold_uncertainty_score":0.009355068},"labels":[],"label_agreement":null},{"id":"W2784812244","doi":"10.1016/s1474-4422(18)30025-5","title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management","year":2018,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1135,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Children's Hospital of Eastern Ontario","funders":"National Heart, Lung, and Blood Institute; Centers for Disease Control and Prevention; National Institutes of Health","keywords":"Duchenne muscular dystrophy; Medicine; Multidisciplinary approach; Intensive care medicine; Muscular dystrophy; Osteoporosis; Natural history; Disease; Quality of life (healthcare); Disease management; Physical therapy; Internal medicine; Nursing","score_opus":0.0401157050670317,"score_gpt":0.30783737656877874,"score_spread":0.267721671501747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2784812244","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003489359,0.9988135,0.00010602189,0.0003973062,0.00026839878,0.0000025555676,0.000013639985,0.00000542809,0.00035842703],"genre_scores_gemma":[0.00048045703,0.9979937,0.0002019206,0.00042006737,0.0005910325,0.000003941577,0.000041224786,0.0000014732559,0.00026622906],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99953544,0.00007460301,0.00008858196,0.00007037077,0.00019085773,0.000040225896],"domain_scores_gemma":[0.9990652,0.00047883647,0.0001506868,0.000015759397,0.00021307453,0.00007647936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009461575,0.001139076,0.0024224068,0.0028102773,0.00027620269,0.0010703631,0.0015930042,0.0016011122,0.0030929043],"category_scores_gemma":[0.0019523862,0.00029941875,0.0007573838,0.0016188703,0.00060901407,0.0011267466,0.00085301604,0.0023129662,0.001650255],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058693455,0.000039413233,0.00028292675,0.012836175,0.00012491144,0.00042469785,0.000028742426,0.00042164425,0.0004032506,0.0017064628,0.051732454,0.93194073],"study_design_scores_gemma":[0.000063984124,0.00009326484,0.0025823563,0.018526344,0.00039317264,0.005794457,0.00010387095,0.00020944183,0.00024174084,0.0029092114,0.9690356,0.000046566],"about_ca_topic_score_codex":0.0025429947,"about_ca_topic_score_gemma":0.0049686083,"teacher_disagreement_score":0.0030929043,"about_ca_system_score_codex":0.001071349,"about_ca_system_score_gemma":0.001327021,"threshold_uncertainty_score":0.01034683},"labels":[],"label_agreement":null},{"id":"W2784992484","doi":"10.1016/s1474-4422(18)30024-3","title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management","year":2018,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1326,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"Centers for Disease Control and Prevention; National Institutes of Health","keywords":"Duchenne muscular dystrophy; Medicine; Neuromuscular disease; Rehabilitation; Dysphagia; Multidisciplinary approach; Endocrine system; Intensive care medicine; Muscular dystrophy; Quality of life (healthcare); Disease; Physical therapy; Nursing; Internal medicine; Surgery; Hormone","score_opus":0.024577994046743674,"score_gpt":0.28509501189980246,"score_spread":0.2605170178530588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2784992484","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000036948015,0.998899,0.000116985415,0.0003861228,0.0002342574,0.0000028007407,0.0000128210195,0.000004684748,0.00030629855],"genre_scores_gemma":[0.0004160181,0.9981723,0.0002203553,0.00039985223,0.0004981616,0.000003990221,0.000036803718,0.0000013443905,0.0002510376],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99951756,0.000076545955,0.00010048505,0.00007597027,0.0001946026,0.00003494107],"domain_scores_gemma":[0.99911124,0.00043905014,0.00015839825,0.000016497072,0.00020600851,0.000068689966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010009278,0.0011556465,0.0023123096,0.0029655544,0.00026846083,0.0010856485,0.0015767382,0.0015066492,0.0026522332],"category_scores_gemma":[0.0017683577,0.00031508767,0.0007241937,0.0016997634,0.00068559294,0.0013370425,0.00086836977,0.00231638,0.0014758046],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006313346,0.00004862547,0.0003397638,0.014902015,0.00012667912,0.00043453858,0.000033402717,0.00044070923,0.00055655034,0.0016298593,0.046414502,0.93501025],"study_design_scores_gemma":[0.000061480285,0.00010354689,0.0030473566,0.018334236,0.0003662852,0.0066723307,0.00011644,0.00021276472,0.0003070862,0.0028302507,0.967901,0.000047240956],"about_ca_topic_score_codex":0.0024317561,"about_ca_topic_score_gemma":0.0050529167,"teacher_disagreement_score":0.0029655544,"about_ca_system_score_codex":0.0010816848,"about_ca_system_score_gemma":0.0013727628,"threshold_uncertainty_score":0.008872569},"labels":[],"label_agreement":null},{"id":"W2786632296","doi":"10.1016/s1474-4422(18)30032-2","title":"The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages of Parkinson's disease: a cross-sectional PET study","year":2018,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"TRIUMF; University of British Columbia, Okanagan Campus; University of British Columbia; Vancouver Coastal Health","funders":"Genentech; National Institute of Neurological Disorders and Stroke; TRIUMF","keywords":"Parkinson's disease; LRRK2; Acetylcholinesterase; Medicine; Progressive supranuclear palsy; Disease; Internal medicine; Cholinergic; Neurology; Pathology; Psychology; Oncology; Neuroscience; Psychiatry; Biology","score_opus":0.02196163873862441,"score_gpt":0.30907139724472377,"score_spread":0.2871097585060994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2786632296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99940825,0.00018830443,0.000038206857,0.0000151169625,0.0000034833033,0.0000048403376,0.00012060716,0.0000017468224,0.00021940257],"genre_scores_gemma":[0.99945885,0.000071718794,0.000034677338,0.000021544138,0.0000047277563,0.0000043881746,0.00017165275,0.0000029053176,0.00022951371],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99949527,0.00015626631,0.00005305697,0.00016718131,0.000059790247,0.00006840991],"domain_scores_gemma":[0.9988404,0.0002593548,0.00036042655,0.00016453397,0.00017435673,0.00020098157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009597643,0.0005585909,0.0005049735,0.0005932469,0.0005912146,0.0008931201,0.0004380692,0.001229184,0.001224193],"category_scores_gemma":[0.0020361478,0.0007976917,0.0006017172,0.00063567935,0.0005684846,0.0010525414,0.0004731369,0.00082472333,0.00033124862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010782534,0.00021058523,0.9954443,0.000010187526,0.00024428315,0.00033758723,0.0002193726,0.000038349688,0.0014510882,0.000020247988,0.00004676841,0.0008990014],"study_design_scores_gemma":[0.000010195689,0.00028047938,0.99904305,0.0000016268808,0.00006530062,0.00032499863,0.00010033098,0.00004009542,0.00006847912,0.000012534588,0.000049375623,0.0000035209493],"about_ca_topic_score_codex":0.005929594,"about_ca_topic_score_gemma":0.0071026636,"teacher_disagreement_score":0.005929594,"about_ca_system_score_codex":0.00042141922,"about_ca_system_score_gemma":0.00018989568,"threshold_uncertainty_score":0.011790156},"labels":[],"label_agreement":null},{"id":"W2787297607","doi":"10.1016/s1474-4422(18)30075-9","title":"The SeLECT score is useful to predict post-stroke epilepsy","year":2018,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; National Institute for Health and Care Research; Weston Brain Institute","keywords":"Scopus; Epilepsy; Prognostic model; Etiology; MEDLINE; Stroke (engine); Ischemic stroke","score_opus":0.03530459040800797,"score_gpt":0.31024345373301426,"score_spread":0.2749388633250063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787297607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9530516,0.004556512,0.0021822182,0.0039465986,0.0005211686,0.00013076057,0.0064928657,0.00021340308,0.028904857],"genre_scores_gemma":[0.98657054,0.001714547,0.0015046739,0.00063353847,0.0006283657,0.000081215774,0.005438615,0.000037050555,0.0033914894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994326,0.00011085161,0.000109580214,0.00005565624,0.00020604687,0.000085224354],"domain_scores_gemma":[0.9967417,0.0011635976,0.0010161877,0.00011814133,0.00052770536,0.0004327602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008359226,0.000889409,0.0012458344,0.0015559893,0.00038720493,0.001564914,0.00029078923,0.0007323693,0.0064283703],"category_scores_gemma":[0.0070041106,0.00013067668,0.0009971282,0.00097515393,0.00035777554,0.0012448006,0.0006913481,0.00072133826,0.0019673477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027432062,0.0001372404,0.91614187,0.00017532283,0.0007209247,0.00026552906,0.000049308303,0.0005160059,0.00061544194,0.00028280332,0.011068313,0.06728423],"study_design_scores_gemma":[0.0002434592,0.00093987834,0.9847484,0.00016133497,0.0006706267,0.0016224384,0.00020180031,0.0026612936,0.0006688654,0.0023194393,0.005692265,0.000070222915],"about_ca_topic_score_codex":0.001885785,"about_ca_topic_score_gemma":0.0049678027,"teacher_disagreement_score":0.0064283703,"about_ca_system_score_codex":0.00042520065,"about_ca_system_score_gemma":0.0006460962,"threshold_uncertainty_score":0.021504998},"labels":[],"label_agreement":null},{"id":"W2788555495","doi":"10.1016/s1474-4422(18)30070-x","title":"Two steps forward for myelin repair in multiple sclerosis","year":2018,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Remyelination; Multiple sclerosis; Alemtuzumab; Medicine; Myelin; Neuroscience; Immunology; Internal medicine; Central nervous system; Psychology; Transplantation","score_opus":0.17628398648425422,"score_gpt":0.34772294697831796,"score_spread":0.17143896049406374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788555495","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016565788,0.003680428,0.00004420913,0.9841188,0.011424766,0.000003813139,0.000022039952,0.0000075723333,0.00053269434],"genre_scores_gemma":[0.0050831325,0.0034040643,0.00031538613,0.8822133,0.10673734,0.000052688094,0.00004144838,0.000020817777,0.0021317624],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9776539,0.012948473,0.0026361407,0.0015351117,0.0038311915,0.0013951828],"domain_scores_gemma":[0.8322565,0.13421081,0.0066398336,0.004645091,0.012888764,0.009359086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027439076,0.0010343253,0.003200601,0.0017270049,0.0046563693,0.0055360286,0.003402821,0.06688877,0.010710539],"category_scores_gemma":[0.12874162,0.00090808683,0.0015140142,0.0014108992,0.008748271,0.010167911,0.0050827996,0.048411887,0.0055479254],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037523842,0.00006967795,0.0011054882,0.00039766668,0.000100130834,0.0008771382,0.0002317251,0.000049621944,0.0001308251,0.006983586,0.96880555,0.020873398],"study_design_scores_gemma":[0.0016919485,0.0002509024,0.0031065538,0.0026345048,0.0002589812,0.0015804195,0.0010524184,0.00041344762,0.0003813514,0.08046087,0.90799373,0.00017492338],"about_ca_topic_score_codex":0.004069017,"about_ca_topic_score_gemma":0.006492648,"teacher_disagreement_score":0.06688877,"about_ca_system_score_codex":0.0052393954,"about_ca_system_score_gemma":0.008696668,"threshold_uncertainty_score":0.14511341},"labels":[],"label_agreement":null},{"id":"W2790038228","doi":"10.1016/s1474-4422(18)30078-4","title":"Accelerated long-term forgetting in asymptomatic APOE ε4 carriers","year":2018,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baycrest Hospital; University of Toronto","funders":"Medical Research Council","keywords":"Apolipoprotein E; Forgetting; Allele; Disease; Genotype; Psychology; Age of onset; Medicine; Gerontology; Internal medicine; Genetics; Biology; Gene","score_opus":0.052583490603488825,"score_gpt":0.3437730681402909,"score_spread":0.2911895775368021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790038228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48725995,0.021144733,0.00065718003,0.44413698,0.01254124,0.000055147466,0.0010135673,0.00026100798,0.032930233],"genre_scores_gemma":[0.8608468,0.007201401,0.00038650108,0.08997379,0.035775386,0.000024625617,0.00026433685,0.00004836277,0.0054786964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995017,0.000120061486,0.000083186846,0.00008010177,0.000107087275,0.000107868414],"domain_scores_gemma":[0.996802,0.0016094716,0.0005036419,0.00020029787,0.0004397353,0.00044483563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000832768,0.00049552484,0.00121057,0.0008031272,0.00092856534,0.0013792181,0.0006740829,0.007773534,0.0024903656],"category_scores_gemma":[0.008959006,0.0003590668,0.00061338185,0.00084318005,0.0006880429,0.0011580697,0.00030895718,0.0040013534,0.0008780851],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038621933,0.00057467236,0.4311355,0.0006204062,0.00037393003,0.2622358,0.0013514375,0.0003140889,0.0026036664,0.002707689,0.1843551,0.109865494],"study_design_scores_gemma":[0.002070766,0.0018118597,0.556108,0.0015748789,0.0010234688,0.33973813,0.0024406696,0.0031074898,0.0011367836,0.021336442,0.06936557,0.00028592738],"about_ca_topic_score_codex":0.0046531283,"about_ca_topic_score_gemma":0.004753025,"teacher_disagreement_score":0.007773534,"about_ca_system_score_codex":0.0007308094,"about_ca_system_score_gemma":0.0006681354,"threshold_uncertainty_score":0.009252071},"labels":[],"label_agreement":null},{"id":"W2790800342","doi":"10.1016/s1474-4422(18)30054-1","title":"Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study","year":2018,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":252,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Economic and Social Research Council; NIHR Maudsley Biomedical Research Centre; Horizon 2020 Framework Programme; Motor Neurone Disease Association; European Commission; EU Joint Programme – Neurodegenerative Disease Research; National Institute for Health and Care Research; Medical Research Council; Sanofi","keywords":"Riluzole; Amyotrophic lateral sclerosis; Medicine; Clinical trial; Retrospective cohort study; Stage (stratigraphy); Survival analysis; Internal medicine; Proportional hazards model; Surgery; Disease","score_opus":0.0915559393461144,"score_gpt":0.32926514168232396,"score_spread":0.23770920233620957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790800342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99658185,0.0020609892,0.00023146834,0.000026429057,0.000007895343,0.000068391375,0.00074816373,0.0000043364525,0.00027046347],"genre_scores_gemma":[0.9979652,0.00034562437,0.00019743435,0.000046362704,0.00001670191,0.00007004887,0.0012749739,0.0000040775703,0.000079627556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964528,0.0014789535,0.0007282486,0.0006538349,0.0005008417,0.00018536889],"domain_scores_gemma":[0.99165523,0.0020537833,0.0041079,0.00095505465,0.0007836498,0.00044432364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036387828,0.00031378664,0.000916974,0.0009916726,0.00029538458,0.00072807365,0.00044909405,0.0005159328,0.00062262674],"category_scores_gemma":[0.0060418155,0.0003028521,0.0012506221,0.0013316396,0.00041995823,0.0005146705,0.00045185475,0.00047015568,0.00017880568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059946673,0.00006315378,0.9884687,0.00011072244,0.00083086826,0.00018785405,0.00009906863,0.0001520801,0.0007241404,0.000025075622,0.00017150416,0.0031721815],"study_design_scores_gemma":[0.0003582947,0.0014209757,0.99528366,0.00002856897,0.0008346784,0.00053712545,0.00008904705,0.0002705791,0.00034665104,0.000030242174,0.00077904045,0.00002099366],"about_ca_topic_score_codex":0.0010036018,"about_ca_topic_score_gemma":0.001556087,"teacher_disagreement_score":0.0036387828,"about_ca_system_score_codex":0.00046679558,"about_ca_system_score_gemma":0.00039053237,"threshold_uncertainty_score":0.019244015},"labels":[],"label_agreement":null},{"id":"W2793526309","doi":"10.1016/s1474-4422(18)30069-3","title":"Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension","year":2018,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":337,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; NeuroRx Research (Canada); University of Ottawa; Montreal Neurological Institute and Hospital","funders":"Actelion Pharmaceuticals; Genentech; Acorda Therapeutics; Celgene; Biogen; Sanofi Genzyme; American Academy of Neurology; Bayer HealthCare; Sanofi; National Institute of Neurological Disorders and Stroke; Teva Pharmaceutical Industries; Novartis Pharma; EMD Serono; Ministry of Education; Novartis; Chugai Pharmaceutical; Roche; Genzyme; Pfizer; Amgen; MedDay Pharmaceuticals; National Multiple Sclerosis Society","keywords":"Natalizumab; Multiple sclerosis; Open label; Medicine; Placebo; Double blind; Disease; Clinical trial; Internal medicine; Pathology; Alternative medicine; Immunology","score_opus":0.11271305273989653,"score_gpt":0.41096368134985845,"score_spread":0.29825062860996193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793526309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798192,0.010300808,0.0008753711,0.0008273036,0.0012863722,0.003047424,0.0012722383,0.0002304386,0.0023409105],"genre_scores_gemma":[0.9829883,0.004809062,0.0020859244,0.001089154,0.0008535891,0.0037298512,0.0012085842,0.00004359704,0.003191939],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992787,0.00032986494,0.000053385706,0.00013116792,0.000069876274,0.00013697808],"domain_scores_gemma":[0.9990357,0.000304828,0.0001737469,0.00009196949,0.000074677664,0.00031902437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001921495,0.0026290657,0.0050853686,0.000659979,0.00067603256,0.0012383655,0.0012333785,0.0027776542,0.0064551756],"category_scores_gemma":[0.0017004595,0.00086162984,0.0034292669,0.00046971024,0.001822084,0.0018616077,0.0004877462,0.004547743,0.0013865173],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9875507,0.0026382955,0.00015684671,0.00050025695,0.0005521349,0.000023428502,0.000030336407,0.0001341741,0.001355846,0.000059903847,0.00033021197,0.0066678803],"study_design_scores_gemma":[0.9662922,0.031833965,0.0007241552,0.000027049502,0.00036208075,0.000017035209,0.000013686936,0.0001620375,0.00024341463,0.00007480033,0.00023801893,0.000011543783],"about_ca_topic_score_codex":0.0012088905,"about_ca_topic_score_gemma":0.0021599045,"teacher_disagreement_score":0.0064551756,"about_ca_system_score_codex":0.0007553135,"about_ca_system_score_gemma":0.0009958469,"threshold_uncertainty_score":0.021594763},"labels":[],"label_agreement":null},{"id":"W2799984449","doi":"10.1016/s1474-4422(18)30127-3","title":"Risk factors for non-motor symptoms in Parkinson's disease","year":2018,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":348,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Apathy; Disease; Medicine; Dementia; Parkinson's disease; Depression (economics); Cognition; Motor symptoms; Excessive daytime sleepiness; Psychiatry; Sleep disorder; Internal medicine","score_opus":0.04575100968918921,"score_gpt":0.3283309805848484,"score_spread":0.28257997089565917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799984449","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008881407,0.99947065,0.000022532942,0.00014407493,0.00007339641,0.0000017257922,0.0000180285,0.0000017590687,0.00017912436],"genre_scores_gemma":[0.0011951672,0.99830085,0.00006406989,0.00012702207,0.00016433299,0.0000038163553,0.000029824492,3.8422453e-7,0.00011455084],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997824,0.00004049394,0.000048055696,0.000035354256,0.000073982796,0.000019751511],"domain_scores_gemma":[0.9993863,0.00038067048,0.00013766625,0.000008861854,0.00006118734,0.000025207639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006043026,0.00087103486,0.001937731,0.0014694849,0.00018851935,0.0008951357,0.0007930317,0.001121075,0.0035889288],"category_scores_gemma":[0.0014749427,0.00027737752,0.0012809846,0.0013543138,0.0003183226,0.0007225609,0.00054438424,0.0016553742,0.0006543825],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016194585,0.00010360363,0.002198991,0.049543295,0.0013420585,0.00026454902,0.00008202806,0.00024980586,0.00036472722,0.0020248743,0.020103775,0.9235603],"study_design_scores_gemma":[0.00029773073,0.0004689882,0.035483833,0.08410493,0.0084665,0.0049007167,0.00037790232,0.0003521829,0.0004996724,0.009588436,0.8553118,0.00014746247],"about_ca_topic_score_codex":0.0036611194,"about_ca_topic_score_gemma":0.006323847,"teacher_disagreement_score":0.0036611194,"about_ca_system_score_codex":0.0004563533,"about_ca_system_score_gemma":0.0011116682,"threshold_uncertainty_score":0.012006104},"labels":[],"label_agreement":null},{"id":"W2802484183","doi":"10.1016/s1474-4422(18)30126-1","title":"Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study","year":2018,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Health Sciences Centre; Occupational Cancer Research Centre; University of Toronto; Sunnybrook Health Science Centre; Western University","funders":"National Institute on Deafness and Other Communication Disorders; National Institute on Aging; UCLH Biomedical Research Centre; School of Public Health, University of California Berkeley; Cancer Institute, University of Pittsburgh; National Institutes of Health; National Institute of Neurological Disorders and Stroke; Arizona Biomedical Research Commission; Associazione Italiana Ricerca Alzheimer; Fondazione Cassa di Risparmio di Firenze; Alzheimer Nederland; National Health and Medical Research Council; Helmholtz Association; Tau Consortium; Stiftung Synapsis - Alzheimer Forschung Schweiz AFS; Vetenskapsrådet; Karolinska Institutet; Hjärnfonden; Else Kröner-Fresenius-Stiftung; Gdański Uniwersytet Medyczny; Eli Lilly and Company; Texas Tech University; Ente Cassa di Risparmio di Firenze; Royal College of Physicians; Alzheimer’s Research UK; Wolfson Foundation; Biogen; Fondazione Telethon; Agence Nationale de la Recherche; Brain Research Trust; National Institute for Health and Care Research; Novo Nordisk Fonden; Helmholtz-Gemeinschaft; FORUM Pharmaceuticals; Centre of Excellence in Cognition and its Disorders, Australian Research Council; Ministero della Salute; Canadian Institutes of Health Research; Alzheimer's Society; Pfizer; EU Joint Programme – Neurodegenerative Disease Research; Stiftelsen för Gamla Tjänarinnor; Bundesministerium für Bildung und Forschung; Arizona Department of Health Services; Denali Therapeutics; GHR Foundation; AbbVie; Medical Research Council; Swedish Brain Power; Fundació la Marató de TV3; NOMIS Stiftung; Sun Health Foundation; Wellcome; Sanofi; Wellcome Trust; Deutsche Forschungsgemeinschaft; Stockholms Läns Landsting; University of Pittsburgh; Roche; TauRx Pharmaceuticals; Mayo Clinic; Merck; McCune Foundation; Bristol-Myers Squibb; Gun och Bertil Stohnes Stiftelse; Grifols; Lundbeckfonden; Genentech; Campbell Foundation; U.S. Department of Veterans Affairs; Consortium canadien en neurodégénérescence associée au vieillissement; Novartis; Celgene; Little Family Foundation; Michael J. Fox Foundation for Parkinson's Research","keywords":"Frontotemporal lobar degeneration; Disease; Genome-wide association study; Genetic association; Medicine; Genetics; Frontotemporal dementia; Association (psychology); Oncology; Biology; Single-nucleotide polymorphism; Gene; Internal medicine; Psychology; Genotype; Dementia","score_opus":0.014201807389074608,"score_gpt":0.2521057737298213,"score_spread":0.23790396634074668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802484183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99460113,0.004152568,0.00037054945,0.00009796238,0.000030476218,0.000009801465,0.0004387933,0.00001941875,0.0002792829],"genre_scores_gemma":[0.9986111,0.0005278285,0.00029472905,0.000053912805,0.000036303165,0.00001007497,0.00028710076,0.000007926063,0.0001709743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990138,0.00025989753,0.000094845745,0.00044964207,0.00010928992,0.00007259202],"domain_scores_gemma":[0.9987796,0.0004983188,0.00034312272,0.00014634377,0.000094720664,0.00013784878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015689348,0.00087126397,0.0011352656,0.0010710685,0.00050035305,0.0008782629,0.00057533506,0.0013660885,0.0018069184],"category_scores_gemma":[0.0018052815,0.00052069494,0.002440137,0.0017983698,0.00031984484,0.00029231608,0.00044044398,0.00074244733,0.00022160035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053128228,0.00011203937,0.96787214,0.00023316138,0.012358345,0.0011681012,0.00020279062,0.00040208644,0.0069872616,0.00008032025,0.0003268715,0.0049439888],"study_design_scores_gemma":[0.00022361467,0.00027160608,0.99106336,0.000027579577,0.006227103,0.0006965527,0.00006946881,0.0006465311,0.0003178869,0.00009127707,0.0003487112,0.000016295806],"about_ca_topic_score_codex":0.0043397066,"about_ca_topic_score_gemma":0.0045769764,"teacher_disagreement_score":0.0043397066,"about_ca_system_score_codex":0.00024091583,"about_ca_system_score_gemma":0.00022159824,"threshold_uncertainty_score":0.008628845},"labels":[],"label_agreement":null},{"id":"W2807364949","doi":"10.1016/s1474-4422(18)30195-9","title":"Restenosis and risk of stroke after stenting or endarterectomy for symptomatic carotid stenosis in the International Carotid Stenting Study (ICSS): secondary analysis of a randomised trial","year":2018,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Cerebrovascular and Carotid Artery Diseases","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Schweizerische Akademie der Medizinischen Wissenschaften; Schweizerische Herzstiftung; Meath Foundation; Irish Institute of Clinical Neuroscience; Brennan and Company; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; University College London; Irish Heart Foundation; Universität Basel; Medical Research Council; Biogen; Daiichi Sankyo Europe; Stroke Association; European Commission; Sanofi; National Institute for Health and Care Research; Novartis; Pfizer; Hartstichting; National Science Foundation","keywords":"Medicine; Restenosis; Stenosis; Carotid stenting; Carotid endarterectomy; Endarterectomy; Stroke (engine); Cardiology; Internal medicine; Surgery; Stent","score_opus":0.024081204271844864,"score_gpt":0.28592166572608313,"score_spread":0.2618404614542383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807364949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95097333,0.021782488,0.001970623,0.001104434,0.0015490308,0.011274195,0.0057250937,0.0002059017,0.005414879],"genre_scores_gemma":[0.96946096,0.0051760077,0.0017345409,0.00077519,0.0016246247,0.0146082565,0.004397964,0.000046873756,0.0021754836],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99235266,0.00498617,0.00090393116,0.0008100797,0.0005237887,0.00042334798],"domain_scores_gemma":[0.9925383,0.0027034418,0.0021956107,0.00076359086,0.00085147924,0.0009475549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009096613,0.0028320167,0.0074143545,0.0011423739,0.00057769817,0.0019247999,0.0011247713,0.002506418,0.006353138],"category_scores_gemma":[0.011256877,0.0008568068,0.009449987,0.0014750937,0.0012101601,0.0011844785,0.000907095,0.002576756,0.0006760087],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9773626,0.0006870097,0.0036245,0.0024406335,0.0107019,0.000052173735,0.000046595767,0.00022639734,0.00039954035,0.00013383213,0.0006375032,0.003687442],"study_design_scores_gemma":[0.93198514,0.028029833,0.015577706,0.00031361086,0.021061873,0.00007953116,0.00004634545,0.0008565696,0.00035655714,0.00064793095,0.0010022821,0.00004267687],"about_ca_topic_score_codex":0.0012670108,"about_ca_topic_score_gemma":0.0017258058,"teacher_disagreement_score":0.009096613,"about_ca_system_score_codex":0.00093941926,"about_ca_system_score_gemma":0.0017671023,"threshold_uncertainty_score":0.04810804},"labels":[],"label_agreement":null},{"id":"W2808975322","doi":"10.1016/s1474-4422(18)30240-0","title":"Myotonic dystrophy type 1: reasons to be OPTIMISTIC","year":2018,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi; Cégep de Jonquière; Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Université de Sherbrooke","funders":"","keywords":"Myotonic dystrophy; Medicine; Muscular dystrophy; Physical therapy; Neurology; Pediatrics; Physical medicine and rehabilitation; Psychiatry; Internal medicine","score_opus":0.08231067657757649,"score_gpt":0.300417522750906,"score_spread":0.2181068461733295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808975322","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015956117,0.0025968796,0.00004354504,0.97573906,0.020150462,0.0000025642064,0.000013805279,0.000012107575,0.0012820044],"genre_scores_gemma":[0.0036989173,0.0031627552,0.00015569979,0.87050724,0.11927443,0.000017482615,0.000024659426,0.00001951056,0.0031393743],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966708,0.0010490285,0.000387636,0.00044811805,0.0009838431,0.00046056978],"domain_scores_gemma":[0.9858635,0.008118598,0.0007767794,0.00038763185,0.0021690968,0.0026842374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00372249,0.0009841247,0.0019297989,0.00085152703,0.0036579238,0.0045609106,0.0019618557,0.061936323,0.0065648714],"category_scores_gemma":[0.03155386,0.0006655117,0.0010985715,0.0006899215,0.0051095462,0.006393959,0.00264135,0.055401698,0.00744035],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069697635,0.000037587975,0.0005168275,0.0000742947,0.000018460794,0.0030468118,0.00011639709,0.000060676957,0.000109882676,0.0032371972,0.9828203,0.009891983],"study_design_scores_gemma":[0.00030131396,0.000106464475,0.00114581,0.0008561611,0.00005210696,0.0062643285,0.0009630408,0.0005369072,0.00017568316,0.02730862,0.96217066,0.0001188471],"about_ca_topic_score_codex":0.002072622,"about_ca_topic_score_gemma":0.0041674054,"teacher_disagreement_score":0.061936323,"about_ca_system_score_codex":0.0036611767,"about_ca_system_score_gemma":0.0030068562,"threshold_uncertainty_score":0.026563764},"labels":[],"label_agreement":null},{"id":"W2861714648","doi":"10.1016/s1474-4422(18)30202-3","title":"Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial","year":2018,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Fingolimod; Polyradiculoneuropathy; Placebo; Expanded Disability Status Scale; Clinical endpoint; Internal medicine; Randomized controlled trial; Physical therapy; Adverse effect; Multiple sclerosis; Pediatrics; Guillain-Barre syndrome; Immunology; Alternative medicine","score_opus":0.04584493217104187,"score_gpt":0.3202035555085758,"score_spread":0.27435862333753397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2861714648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94751567,0.027227422,0.002727169,0.0021600344,0.0030550042,0.008452313,0.0039526774,0.0004802876,0.004429422],"genre_scores_gemma":[0.9580235,0.011529965,0.0047116587,0.0027416123,0.001399942,0.011619688,0.0026438995,0.00008708057,0.0072426274],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991142,0.00039008431,0.00006096626,0.00019641111,0.00007524631,0.00016296771],"domain_scores_gemma":[0.9992532,0.0002226557,0.00019017128,0.00008369735,0.000054608376,0.00019576855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022127093,0.003121198,0.0066675353,0.0004648013,0.00061486854,0.0017568492,0.0015462523,0.0025546607,0.008555835],"category_scores_gemma":[0.0024169292,0.0009106541,0.0028085008,0.00059100863,0.0014768814,0.0018846492,0.00067550957,0.003684214,0.0014174188],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98897725,0.00063516776,0.00013530262,0.0014474182,0.0014102078,0.00003508407,0.000032928965,0.00012413628,0.0009434631,0.00015018586,0.0007146514,0.005394099],"study_design_scores_gemma":[0.9945102,0.004240148,0.00030399836,0.000035268306,0.0004555077,0.000014812143,0.000009211683,0.000083120896,0.000048935646,0.00008198923,0.00020962577,0.0000071418463],"about_ca_topic_score_codex":0.0018445116,"about_ca_topic_score_gemma":0.0031189378,"teacher_disagreement_score":0.008555835,"about_ca_system_score_codex":0.0010386528,"about_ca_system_score_gemma":0.0012604336,"threshold_uncertainty_score":0.02862209},"labels":[],"label_agreement":null},{"id":"W2883808148","doi":"10.1016/s1474-4422(18)30215-1","title":"Rare coding variants in genes encoding GABAA receptors in genetic generalised epilepsies: an exome-based case-control study","year":2018,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Sherbrooke; Université de Montréal","funders":"European Social Fund; Medical Research Council; Epilepsy Society; Desitin Arzneimittel; Fachagentur Nachwachsende Rohstoffe; Technische Universität München; Türkiye Bilimsel ve Teknolojik Araştırma Kurumu; Eisai; Ministry of Science, ICT and Future Planning; Sixth Framework Programme; Hessisches Ministerium für Wissenschaft und Kunst; Nagao Natural Environment Foundation; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Université du Luxembourg; Ministerie van Onderwijs, Cultuur en Wetenschap; Academy of Finland; ZonMw; University College London Hospitals NHS Foundation Trust; Erasmus Universiteit Rotterdam; Science Foundation Ireland; Deutsche Forschungsgemeinschaft; Marie Curie; European Science Foundation; Wellcome Trust; World Health Organization; University College London; Royal Society; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; Deutsche Gesellschaft für Epileptologie; EU Joint Programme – Neurodegenerative Disease Research; Seventh Framework Programme; Ministerio de Ciencia, Innovación y Universidades; Ministerie van Volksgezondheid, Welzijn en Sport; UCB; Erasmus Medisch Centrum; GlaxoSmithKline; European Commission; Danish Cancer Society Research Center","keywords":"GABAA receptor; Exome sequencing; Gene; Genetics; Exome; Coding (social sciences); Biology; Receptor; Computational biology; Mutation; Mathematics","score_opus":0.060064385958468774,"score_gpt":0.331318719255631,"score_spread":0.2712543332971622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883808148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99733895,0.00077144697,0.0007165823,0.000053796903,0.000021541233,0.000053139884,0.0006122891,0.000011650051,0.00042058702],"genre_scores_gemma":[0.9982127,0.00027396274,0.00036256097,0.00007248125,0.000026095391,0.00003415873,0.00066826056,0.0000126751,0.00033707975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793506,0.00035070902,0.0002420108,0.001051934,0.0002472064,0.00017315999],"domain_scores_gemma":[0.9983369,0.000628588,0.0003238849,0.00037065762,0.00018610501,0.0001538256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014114233,0.001158713,0.0011022688,0.0012989573,0.0013735795,0.0012703255,0.0010623139,0.0016405002,0.004242475],"category_scores_gemma":[0.004052167,0.00071158184,0.0013681438,0.0014665248,0.0010456857,0.0006456708,0.0008753893,0.0009007491,0.0005349174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00731833,0.0012199589,0.92159873,0.00037677406,0.004789775,0.028359944,0.002334774,0.0004454902,0.019191898,0.001196558,0.0014500371,0.011717689],"study_design_scores_gemma":[0.00092835113,0.0009286867,0.97417533,0.000074343174,0.0022785093,0.017357765,0.000660704,0.0007658674,0.0006287754,0.0004762214,0.0016576984,0.00006780096],"about_ca_topic_score_codex":0.0053771185,"about_ca_topic_score_gemma":0.005371503,"teacher_disagreement_score":0.0053771185,"about_ca_system_score_codex":0.00045419123,"about_ca_system_score_gemma":0.0002583801,"threshold_uncertainty_score":0.014192522},"labels":[],"label_agreement":null},{"id":"W2887567733","doi":"10.1016/s1474-4422(18)30253-9","title":"Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data","year":2018,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Intracerebral and Subarachnoid Hemorrhage Research","field":"Medicine","cited_by":415,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; University of Calgary; University of Alberta; Ottawa Hospital; Foothills Medical Centre; University of Ottawa","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; Medical Research Council; British Heart Foundation","keywords":"Medicine; Observational study; Intracerebral hemorrhage; Logistic regression; Anticoagulant therapy; Randomized controlled trial; Internal medicine","score_opus":0.09205083249074694,"score_gpt":0.34160497718823724,"score_spread":0.2495541446974903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887567733","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013587015,0.98276156,0.0012211229,0.00023432435,0.00014919613,0.00026692473,0.0014545965,0.000039955117,0.00028533256],"genre_scores_gemma":[0.48536074,0.50431657,0.004309306,0.0010418699,0.0003694212,0.0015784514,0.002627181,0.00007571489,0.00032076932],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9802889,0.010755549,0.005031222,0.0020727168,0.0014404701,0.00041102385],"domain_scores_gemma":[0.93187106,0.054715946,0.008137773,0.0024321154,0.0023987687,0.0004444832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023481412,0.00228894,0.017703233,0.0060663647,0.00052541326,0.0029653893,0.0024250261,0.001924265,0.0022745575],"category_scores_gemma":[0.057350595,0.0015518706,0.039921757,0.008227071,0.00083124614,0.0019920915,0.0016850845,0.0020860615,0.00030638883],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016825856,0.00001416856,0.011690078,0.16145244,0.8187074,0.000090192996,0.000059693237,0.0005138246,0.00010921734,0.0000924539,0.00035737877,0.0052305423],"study_design_scores_gemma":[0.00038268795,0.00012930688,0.0070497436,0.009284817,0.98177034,0.00008256932,0.000032947646,0.00023881611,0.0000700233,0.0001897703,0.0007481853,0.00002084882],"about_ca_topic_score_codex":0.0052662524,"about_ca_topic_score_gemma":0.010485702,"teacher_disagreement_score":0.023481412,"about_ca_system_score_codex":0.0015670321,"about_ca_system_score_gemma":0.0026868593,"threshold_uncertainty_score":0.12418306},"labels":[],"label_agreement":null},{"id":"W2888019585","doi":"10.1016/s1474-4422(18)30314-4","title":"Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data","year":2018,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":393,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Dalhousie University; Toronto Western Hospital; Foothills Medical Centre; St. Michael's Hospital; University of Alberta; University of Calgary","funders":"Faculty of Medicine, Dalhousie University; Health Technology Assessment Programme; Canadian Institutes of Health Research; Medac; Alberta Health Services; Alberta Innovates; Hartstichting; National Stroke Foundation; Agence Nationale de la Recherche; Faculty of Veterinary Medicine, University of Calgary; National Institutes of Health; Royal Australasian College of Physicians; Heart and Stroke Foundation of Canada; National Heart Foundation of Australia; National Institute for Health and Care Research; Medical Research Council; Penumbra; Hotchkiss Brain Institute, University of Calgary; Servier; University of Glasgow; Dalhousie University; Hotchkiss Brain Institute; Stroke Association; Stryker; National Health and Medical Research Council; AstraZeneca; Bracco Imaging","keywords":"Meta-analysis; Medicine; Stroke (engine); Ischaemic stroke; Outcome (game theory); Internal medicine; Patient data; Ischemic stroke; Circulation (fluid dynamics); Cardiology; Ischemia; Computer science; Database","score_opus":0.19803660610346321,"score_gpt":0.34687986729108583,"score_spread":0.14884326118762262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888019585","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31491798,0.67494816,0.0031148696,0.0008729192,0.00069474365,0.0001524305,0.0041292794,0.00013266991,0.0010370153],"genre_scores_gemma":[0.9727955,0.023838507,0.00086532807,0.00042156235,0.00024129119,0.0001536841,0.0013715068,0.000044060343,0.0002684806],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9907085,0.005339096,0.0012934483,0.0016524722,0.0006263114,0.0003801621],"domain_scores_gemma":[0.9835771,0.011185466,0.002873016,0.0013448973,0.0006541215,0.0003654379],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.010945028,0.001803127,0.008521615,0.0022652766,0.0005543816,0.0027637873,0.0017545844,0.0021326838,0.0020705962],"category_scores_gemma":[0.016610539,0.0010429607,0.03357382,0.0037850854,0.0005919027,0.0009863405,0.001142855,0.0018887888,0.0002575844],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010466099,0.000035854657,0.06463842,0.009240969,0.911017,0.00013014044,0.000038901013,0.00071000826,0.00038797606,0.00006602207,0.00036690003,0.0029016945],"study_design_scores_gemma":[0.0010289479,0.00045241296,0.05013763,0.00060157396,0.94580066,0.00010611107,0.000035478817,0.00076629024,0.00018208471,0.00019090432,0.00067498494,0.000022847982],"about_ca_topic_score_codex":0.005088609,"about_ca_topic_score_gemma":0.0057710903,"teacher_disagreement_score":0.9914784,"about_ca_system_score_codex":0.0008570228,"about_ca_system_score_gemma":0.0007474725,"threshold_uncertainty_score":0.0578835},"labels":[],"label_agreement":null},{"id":"W2890874952","doi":"10.1016/s1474-4422(18)30324-7","title":"The hippocampus and behaviour in multiple sclerosis","year":2018,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Multiple sclerosis; Neuroscience; Hippocampus; Neurology; Psychology; Amyotrophic lateral sclerosis; Dementia; Hippocampal sclerosis; Stroke (engine); Medicine; Disease; Psychiatry; Pathology; Temporal lobe","score_opus":0.1110994434323056,"score_gpt":0.3130999897848082,"score_spread":0.20200054635250259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890874952","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013460435,0.006353377,0.000022646003,0.9776244,0.012464935,0.000005225502,0.00008029456,0.000009839541,0.0020932597],"genre_scores_gemma":[0.026510352,0.008617765,0.00016350157,0.8328671,0.12560679,0.00007930267,0.0000950423,0.00002373838,0.006036419],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9972988,0.0014123863,0.00038321526,0.0001999611,0.0004579312,0.0002477663],"domain_scores_gemma":[0.9832561,0.011694256,0.0013509698,0.00051482924,0.0016799435,0.0015039656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003041167,0.000513622,0.0014056005,0.0009008654,0.002155415,0.0019292019,0.001446248,0.024500802,0.0053677442],"category_scores_gemma":[0.03409844,0.0004561389,0.00051584287,0.001017189,0.0026871625,0.0027668036,0.0012276453,0.014928659,0.0030392667],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032531514,0.00006805184,0.005294497,0.00028741476,0.00008360609,0.002294695,0.00028995174,0.000033288066,0.00009715242,0.0019500218,0.9655824,0.023693524],"study_design_scores_gemma":[0.0013693233,0.0003023026,0.025398312,0.0027001067,0.00031900816,0.0062348577,0.0023709931,0.0005507485,0.0003073192,0.02794746,0.9323631,0.00013656743],"about_ca_topic_score_codex":0.009182838,"about_ca_topic_score_gemma":0.0162987,"teacher_disagreement_score":0.024500802,"about_ca_system_score_codex":0.0022981307,"about_ca_system_score_gemma":0.0028771537,"threshold_uncertainty_score":0.01825881},"labels":[],"label_agreement":null},{"id":"W2891574627","doi":"10.1016/s1474-4422(18)30242-4","title":"Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data","year":2018,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":377,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa; Foothills Medical Centre; University of Calgary","funders":"College of Medicine, Drexel University; Canadian Institutes of Health Research; Medac; Bristol-Myers Squibb; Royal Adelaide Hospital; Universiteit Maastricht; Daiichi Sankyo Europe; Servier; Institut National de la Santé et de la Recherche Médicale; University of Glasgow; Alberta Innovates; University of Oxford; National Institute for Health and Care Research; University of Pittsburgh; University of Calgary; Medtronic; CARIM School for Cardiovascular Diseases, Universiteit Maastricht; Pfizer; Newcastle University; Heart and Stroke Foundation of Canada; Drexel University; National Health and Medical Research Council; AstraZeneca; Ottawa Hospital Research Institute; Stryker; Medical Center, University of Pittsburgh; Oxford University Hospitals NHS Foundation Trust; Medical Research Council; Penumbra","keywords":"Meta-analysis; Stroke (engine); Medicine; Internal medicine; Engineering","score_opus":0.1653364864558983,"score_gpt":0.35648474442005346,"score_spread":0.19114825796415516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891574627","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04022445,0.9509776,0.0037005628,0.0005382136,0.0004472159,0.00035592105,0.0028366896,0.00012409805,0.0007951828],"genre_scores_gemma":[0.8117121,0.17609416,0.0053494805,0.0013141002,0.0006279453,0.001274319,0.0029715365,0.00015375948,0.0005026354],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97555566,0.015119559,0.0045626666,0.0027665384,0.0014255743,0.00057006],"domain_scores_gemma":[0.9438711,0.043136887,0.007234743,0.0036895496,0.0016124838,0.0004552713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026243167,0.0029023876,0.01670663,0.00508733,0.0005965974,0.0041557285,0.0024470668,0.0025660282,0.0035649845],"category_scores_gemma":[0.053497814,0.0014464201,0.059529018,0.0069615734,0.0009658704,0.0018848196,0.0015332097,0.0023100192,0.00042408158],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003137433,0.000015138919,0.0075782863,0.029935291,0.9560213,0.000058283775,0.000023810459,0.0005298444,0.00011244289,0.000056603712,0.00023895595,0.002292666],"study_design_scores_gemma":[0.00061591674,0.00016325759,0.0055201,0.0017191707,0.99088764,0.000058948932,0.000012814228,0.00025156233,0.00008456834,0.00020511918,0.00046533532,0.000015564921],"about_ca_topic_score_codex":0.0035086179,"about_ca_topic_score_gemma":0.0044794767,"teacher_disagreement_score":0.026243167,"about_ca_system_score_codex":0.0014565034,"about_ca_system_score_gemma":0.0013040117,"threshold_uncertainty_score":0.13878876},"labels":[],"label_agreement":null},{"id":"W2891668214","doi":"10.1016/s1474-4422(18)30310-7","title":"Strong nocebo effect in amyotrophic lateral sclerosis trials might mask conclusions","year":2018,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Riluzole; Medicine; Amyotrophic lateral sclerosis; Placebo; Rasagiline; Adverse effect; Clinical trial; Neurology; Randomized controlled trial; Physical therapy; Internal medicine; Alternative medicine; Disease; Parkinson's disease; Psychiatry; Pathology","score_opus":0.1439016166949832,"score_gpt":0.3630030759980878,"score_spread":0.2191014593031046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891668214","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012297044,0.006875476,0.00037860675,0.96328837,0.021921651,0.00006309486,0.00033706205,0.000055782963,0.0058502993],"genre_scores_gemma":[0.02546841,0.002313993,0.00085121975,0.89614624,0.07316306,0.00017256066,0.00012157948,0.00008289759,0.001680068],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9365021,0.035921603,0.011356654,0.004858253,0.008976972,0.002384458],"domain_scores_gemma":[0.6751127,0.28177655,0.014119252,0.0060609085,0.014336996,0.008593513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06460758,0.001207793,0.0029651455,0.0017137423,0.0019201693,0.0057140314,0.0036354547,0.02073147,0.016902484],"category_scores_gemma":[0.32912865,0.0010340312,0.0023471005,0.0013457452,0.0056297663,0.0062535265,0.00265768,0.02615665,0.006973438],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058676475,0.000099686506,0.005985696,0.0035793034,0.0020688805,0.0018360333,0.0005324494,0.00036098828,0.0007859511,0.020596523,0.8843368,0.073949985],"study_design_scores_gemma":[0.018921029,0.0014337561,0.010644852,0.0066350764,0.0037289325,0.001965369,0.00059445784,0.0018139892,0.0019488316,0.18408178,0.7679279,0.0003039279],"about_ca_topic_score_codex":0.0021168282,"about_ca_topic_score_gemma":0.0034658127,"teacher_disagreement_score":0.06460758,"about_ca_system_score_codex":0.00413516,"about_ca_system_score_gemma":0.0044894093,"threshold_uncertainty_score":0.34168166},"labels":[],"label_agreement":null},{"id":"W2892232021","doi":"10.1016/s1474-4422(18)30333-8","title":"Myelocortical multiple sclerosis: a new disease subtype?","year":2018,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple sclerosis; White matter; Experimental autoimmune encephalomyelitis; Neuroscience; Medicine; Myelin; Cerebral cortex; Pathological; Pathology; Cortex (anatomy); Disease; Spinal cord; Central nervous system; Psychology; Immunology; Magnetic resonance imaging","score_opus":0.1514102378037913,"score_gpt":0.32204501096039995,"score_spread":0.17063477315660866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892232021","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010708085,0.005621671,0.000086281405,0.9816533,0.00979231,0.000005065727,0.000072417904,0.000011809593,0.0016863131],"genre_scores_gemma":[0.027804192,0.009464195,0.00045356428,0.8078487,0.15070154,0.000044727036,0.00013053087,0.000027051126,0.0035254448],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9944419,0.0022607709,0.001137591,0.0005410928,0.0011002697,0.00051837007],"domain_scores_gemma":[0.97845536,0.013016156,0.0020583975,0.0008602308,0.0032109811,0.0023989102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076420396,0.00061376457,0.002175496,0.001407603,0.0022441468,0.0033392946,0.001982482,0.027045151,0.005934303],"category_scores_gemma":[0.038615968,0.000597207,0.00085821055,0.0015828083,0.003003402,0.0053060176,0.0016894597,0.019909222,0.0040427386],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033172788,0.00006433819,0.011683165,0.00035145006,0.00010618739,0.0072056567,0.0003413927,0.00006615003,0.0004066629,0.006249145,0.93193334,0.041260757],"study_design_scores_gemma":[0.0016337322,0.00020841887,0.015059053,0.003020601,0.00040637542,0.028558386,0.0027390607,0.0009562394,0.0005855886,0.054787826,0.8918622,0.00018244563],"about_ca_topic_score_codex":0.00487126,"about_ca_topic_score_gemma":0.010525624,"teacher_disagreement_score":0.027045151,"about_ca_system_score_codex":0.0026482593,"about_ca_system_score_gemma":0.0035038164,"threshold_uncertainty_score":0.040415466},"labels":[],"label_agreement":null},{"id":"W2894235280","doi":"10.1016/s1474-4422(18)30319-3","title":"Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial","year":2018,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Cardiovascular and Diving-Related Complications","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; Western University; Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Janssen Pharmaceuticals; Janssen Research and Development; Covidien; Bayer Fund; Boston Scientific Corporation; Sanofi; GlaxoSmithKline; Daiichi-Sankyo; Boehringer Ingelheim; Amgen; National Heart, Lung, and Blood Institute; Pfizer; Bristol-Myers Squibb; Bayer","keywords":"Medicine; Rivaroxaban; Patent foramen ovale; Aspirin; Stroke (engine); Subgroup analysis; Internal medicine; Population; Randomized controlled trial; Cardiology; Surgery; Pediatrics; Meta-analysis; Warfarin; Atrial fibrillation; Migraine","score_opus":0.10580791658974105,"score_gpt":0.32157625089973146,"score_spread":0.21576833430999043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894235280","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2836232,0.69501996,0.0040864307,0.0011201518,0.0016085346,0.003367896,0.007836005,0.00020948767,0.00312835],"genre_scores_gemma":[0.9390208,0.048962258,0.0018342461,0.001419937,0.0005968195,0.0032852446,0.0035822918,0.00006676139,0.0012315155],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99458224,0.0025228355,0.00136637,0.0007278055,0.00050633686,0.00029443516],"domain_scores_gemma":[0.9965495,0.0019415163,0.0007709462,0.00034153712,0.0002837116,0.000112794674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006655205,0.0024068833,0.009759906,0.0017692056,0.00044623282,0.0019160315,0.0011247729,0.001762841,0.0040196157],"category_scores_gemma":[0.01150065,0.0006504519,0.037056457,0.001737926,0.00048916583,0.0010301532,0.0009715474,0.0015737683,0.0003398701],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08213695,0.00010737248,0.009428238,0.06688406,0.8265316,0.0003156331,0.0001341383,0.0010541914,0.0011524429,0.0002298942,0.0013902375,0.010635276],"study_design_scores_gemma":[0.03904501,0.0010429323,0.010068936,0.0022236651,0.9446991,0.0001506103,0.000052620693,0.00047195161,0.00030969223,0.0005717533,0.0013207223,0.000042919793],"about_ca_topic_score_codex":0.0036320759,"about_ca_topic_score_gemma":0.008541257,"teacher_disagreement_score":0.009759906,"about_ca_system_score_codex":0.0011692831,"about_ca_system_score_gemma":0.0013004737,"threshold_uncertainty_score":0.035196483},"labels":[],"label_agreement":null},{"id":"W2895944929","doi":"10.1016/s1474-4422(18)30361-2","title":"Response to the growing dementia burden must be broader","year":2018,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Proclamation; Dementia; Stroke (engine); Scopus; Medicine; Atrial fibrillation; Neurology; Incidence (geometry); Disease; MEDLINE; Psychiatry; Internal medicine; Political science; Law","score_opus":0.034779089307811845,"score_gpt":0.2819799052303643,"score_spread":0.24720081592255247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895944929","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000053300413,0.0010439936,0.000031994816,0.9835776,0.014220848,0.0000023840184,0.000010069353,0.000013962405,0.0010458805],"genre_scores_gemma":[0.0011556277,0.0011697384,0.00014032354,0.9380089,0.057310503,0.0000141065475,0.000014951924,0.00001698567,0.002168839],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.990682,0.0023201476,0.0012075312,0.0010735054,0.0031288213,0.0015880285],"domain_scores_gemma":[0.96234715,0.016336054,0.0027966632,0.0012742055,0.0074237576,0.009822161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070951753,0.0013652861,0.0027921067,0.0016192603,0.0064251213,0.010477344,0.0028403928,0.09884025,0.027499236],"category_scores_gemma":[0.060741704,0.0008957014,0.0021103995,0.0010945539,0.008545903,0.011296746,0.0063874703,0.08931266,0.01576418],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036929883,0.0000448758,0.00034721097,0.00013444462,0.000020319854,0.0009360871,0.00016917127,0.00005076058,0.000108977765,0.0034713696,0.98353,0.011149824],"study_design_scores_gemma":[0.00013963302,0.00006245287,0.00076715596,0.00089884165,0.000029209414,0.0010819597,0.00082904333,0.00015132611,0.000078449855,0.017061751,0.9788285,0.00007172723],"about_ca_topic_score_codex":0.003784643,"about_ca_topic_score_gemma":0.007042516,"teacher_disagreement_score":0.09884025,"about_ca_system_score_codex":0.0060911328,"about_ca_system_score_gemma":0.010358078,"threshold_uncertainty_score":0.09199411},"labels":[],"label_agreement":null},{"id":"W2898605065","doi":"10.1016/s1474-4422(18)30336-3","title":"Stroke–heart syndrome: clinical presentation and underlying mechanisms","year":2018,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Takotsubo Cardiomyopathy and Associated Phenomena","field":"Medicine","cited_by":286,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Bundesministerium für Bildung und Forschung; Fondation Leducq; Corona-Stiftung; Daiichi Sankyo Europe; European Commission; Deutsches Zentrum für Herz-Kreislaufforschung; Amgen; Boehringer Ingelheim; Sphingotec GmbH; Covidien; Novartis; Sanofi-Aventis Deutschland; Pfizer; Deutsches Zentrum für Neurodegenerative Erkrankungen; GlaxoSmithKline; Deutsche Forschungsgemeinschaft; Bristol-Myers Squibb; Bayer","keywords":"Medicine; Stroke (engine); Cardiology; Internal medicine; Acute coronary syndrome; Pathophysiology; Myocardial infarction","score_opus":0.1996606920419628,"score_gpt":0.4289614931546535,"score_spread":0.2293008011126907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898605065","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000106829066,0.99912304,0.000058414418,0.00027678872,0.000114401955,0.0000017252529,0.000011874255,0.0000029619691,0.0003039793],"genre_scores_gemma":[0.0011776369,0.9975432,0.000121393045,0.000311992,0.0006636203,0.0000032134571,0.0000292478,8.9949623e-7,0.00014885448],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997104,0.00005323059,0.00006820454,0.000058106736,0.00007721531,0.0000328896],"domain_scores_gemma":[0.9994112,0.00034120367,0.00011599984,0.000012563361,0.000084219064,0.00003478738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057324796,0.0011456078,0.0023454865,0.0022900214,0.00027725723,0.0015286534,0.0010518698,0.0016845169,0.0018422743],"category_scores_gemma":[0.0010945534,0.00030858922,0.000796432,0.0023282862,0.0007465571,0.0015984236,0.00078341225,0.0021162229,0.0007832099],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013341256,0.000081840175,0.0021838758,0.021872027,0.00046769396,0.0031341135,0.00018541994,0.0005954241,0.0011533097,0.003933324,0.048349276,0.91791034],"study_design_scores_gemma":[0.00012483876,0.00016207465,0.011158797,0.023375254,0.001461196,0.04257019,0.0005672192,0.0005104837,0.00039884527,0.012681382,0.9068445,0.00014519108],"about_ca_topic_score_codex":0.001195396,"about_ca_topic_score_gemma":0.0023038327,"teacher_disagreement_score":0.0023454865,"about_ca_system_score_codex":0.00047581823,"about_ca_system_score_gemma":0.0011968303,"threshold_uncertainty_score":0.006163001},"labels":[],"label_agreement":null},{"id":"W2899576798","doi":"10.1016/s1474-4422(18)30398-3","title":"Global burden of motor neuron diseases: mind the gaps","year":2018,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"Science Foundation Ireland","keywords":"Motor neuron; Neuroscience; Business; Psychology; Computer science; Medicine","score_opus":0.039246230920491725,"score_gpt":0.3120785362832986,"score_spread":0.2728323053628069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899576798","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003535512,0.3973934,0.0012772128,0.56133336,0.012201798,0.000037706548,0.012471552,0.00032212652,0.011427348],"genre_scores_gemma":[0.09874258,0.6848951,0.0049751885,0.15355006,0.037066463,0.0002726354,0.015471723,0.00043119187,0.004595151],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9973598,0.00072718057,0.00037799368,0.0005343473,0.00050069747,0.00050001655],"domain_scores_gemma":[0.9910397,0.0029624877,0.0009770027,0.0005032654,0.0021931813,0.0023243844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00580669,0.001883826,0.0030961595,0.0036595927,0.0012021053,0.004829712,0.002752174,0.004925665,0.02530246],"category_scores_gemma":[0.018585969,0.00078499917,0.0017360176,0.004156275,0.0023612024,0.011655784,0.0070962063,0.0056211986,0.00764166],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033288385,0.00007499575,0.011871445,0.008883593,0.000573958,0.00036384727,0.00094196096,0.0009432787,0.00015625777,0.024865314,0.6872134,0.26377913],"study_design_scores_gemma":[0.00011765597,0.00015340022,0.038281217,0.037745543,0.0005920053,0.0007705577,0.0031465283,0.00078812113,0.00017778995,0.08579745,0.8322858,0.00014385517],"about_ca_topic_score_codex":0.026439736,"about_ca_topic_score_gemma":0.019102426,"teacher_disagreement_score":0.026439736,"about_ca_system_score_codex":0.0032805563,"about_ca_system_score_gemma":0.011087965,"threshold_uncertainty_score":0.08464521},"labels":[],"label_agreement":null},{"id":"W2900585653","doi":"10.1016/s1474-4422(18)30387-9","title":"Global, regional, and national burden of meningitis, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016","year":2018,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Bacterial Infections and Vaccines","field":"Immunology and Microbiology","cited_by":383,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Dipartimento di Medicina e Chirurgia, Università degli Studi di Milano-Bicocca; Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences; Health Research Council of New Zealand; Merck Sharp and Dohme; Debre Markos University; Kurdistan University Of Medical Sciences; Pomorski Uniwersytet Medyczny W Szczecinie; Golestan University of Medical Sciences; Medical Research Council; Debre Tabor University; Tartu Ülikool; Technische Universität München; Universitair Medisch Centrum Groningen; Ahvaz Jundishapur University of Medical Sciences; Astellas Pharma; Universiti Kebangsaan Malaysia; York University; Mazandaran University of Medical Sciences; Cochrane South Africa; European Commission; AstraZeneca; Ministério da Educação e Ciência; Islamic Azad University; Ministerio de Educación, Cultura y Deporte; Banaras Hindu University; Universitat de València; Seoul National University; Monash University; Ministério da Educação; Kuwait University; Western Sydney University; Ministry of Education, Science and Technology; Bundesministerium für Bildung und Forschung; Ministerio de Economía y Competitividad; Alborz University of Medical Sciences; Ain Shams University; International Centre for Diarrhoeal Disease Research, Bangladesh; Rijksuniversiteit Groningen; Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja; University of Auckland; Cancer Society of New Zealand; South African Medical Research Council; National Research Foundation; Shahid Beheshti University of Medical Sciences; GlaxoSmithKline; Imperial College London; Meningitis Research Foundation; Alexander von Humboldt-Stiftung; Sanofi Pasteur; Jordan University of Science and Technology; McMaster University; University of Oxford; Maragheh University of Medical Sciences; Hamadan University of Medical Sciences; Novavax; Urmia University of Medical Sciences; Universitetet i Oslo; Johns Hopkins University; UNICEF; Ahmadu Bello University; Wellcome Trust; Urmia University; Ball State University; Alfaisal University; Simmons College; Fundação para a Ciência e a Tecnologia; Pfizer; Università degli Studi di Milano; Università degli Studi di Firenze; Bill and Melinda Gates Foundation; West Virginia University; Tulane University; Maurice Wilkins Centre for Molecular Biodiscovery; Department of Science and Technology, Ministry of Science and Technology, India; Sanofi","keywords":"Medicine; Meningitis; Incidence (geometry); Disease burden; Life expectancy; Case fatality rate; Burden of disease; Cause of death; Pediatrics; Demography; Epidemiology; Disease; Population; Environmental health; Internal medicine","score_opus":0.03163723709474967,"score_gpt":0.2984227735080478,"score_spread":0.2667855364132981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900585653","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024739413,0.9313745,0.0019100237,0.0013564663,0.00028968693,0.0004976972,0.038802058,0.00008487282,0.000945222],"genre_scores_gemma":[0.3580709,0.60284567,0.0072514047,0.0017977617,0.00039910845,0.0025938454,0.026327044,0.000092569484,0.0006217729],"study_design_codex":"meta_analysis","study_design_gemma":"systematic_review","domain_scores_codex":[0.99103934,0.0035445322,0.0026858074,0.001093596,0.0013024176,0.00033435196],"domain_scores_gemma":[0.9918086,0.003563224,0.0023237565,0.0005343188,0.0015882243,0.00018191905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011574945,0.0012549201,0.005369397,0.008743826,0.00045083743,0.0014649176,0.0007957242,0.00094769435,0.0019397129],"category_scores_gemma":[0.027548023,0.0009149789,0.017464114,0.012591367,0.00053050957,0.00086414703,0.0016966576,0.0012185153,0.00031675896],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025265838,0.000046988887,0.2079954,0.29958135,0.35644192,0.00039445466,0.00069753494,0.0023725484,0.0006273203,0.0013987648,0.027189415,0.10072773],"study_design_scores_gemma":[0.0016790926,0.00039529603,0.2558909,0.13710104,0.5604818,0.00096338266,0.00054021855,0.0017458403,0.0004760093,0.0021155735,0.038399763,0.00021114366],"about_ca_topic_score_codex":0.02919077,"about_ca_topic_score_gemma":0.061000817,"teacher_disagreement_score":0.02919077,"about_ca_system_score_codex":0.0021798685,"about_ca_system_score_gemma":0.0067826197,"threshold_uncertainty_score":0.061214864},"labels":[],"label_agreement":null},{"id":"W2901519529","doi":"10.1016/s1474-4422(18)30295-3","title":"Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016","year":2018,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":2768,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Technische Universität München; Universitetet i Oslo; Universitat de València; Deakin University; National University of Singapore; York University; La Trobe University; National Institute for Health and Care Research; Maragheh University of Medical Sciences; Bill and Melinda Gates Foundation; Auckland University of Technology, New Zealand; H. Lundbeck A/S; Ahvaz Jundishapur University of Medical Sciences; Alzheimer's Association","keywords":"Disease; Burden of disease; Medicine; Disease burden; Pathology","score_opus":0.0382370289687563,"score_gpt":0.3161486695046448,"score_spread":0.2779116405358885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901519529","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04931438,0.88555396,0.0020301898,0.0018819508,0.00036577063,0.0006629813,0.058733977,0.00008743908,0.0013695047],"genre_scores_gemma":[0.45735595,0.4948187,0.0070024566,0.0019693377,0.00036968896,0.0025190806,0.035259027,0.000071475,0.0006342647],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9929342,0.0022874842,0.0025196392,0.0008925649,0.0010736346,0.00029251943],"domain_scores_gemma":[0.9908386,0.0032092328,0.0032090691,0.00052728446,0.0019595425,0.00025614898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010254737,0.00094448053,0.0034587346,0.0078049134,0.0004170873,0.001158286,0.0007515749,0.00082108576,0.0015637439],"category_scores_gemma":[0.02516232,0.00080045307,0.011402886,0.010612799,0.0005034073,0.0008320462,0.0017130582,0.0009882881,0.0002570785],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018399432,0.000041654872,0.44751817,0.26289937,0.16018271,0.00036831587,0.001256879,0.0023206994,0.00058321096,0.0018103746,0.0329229,0.08825579],"study_design_scores_gemma":[0.0014182165,0.0004059784,0.54664224,0.17485052,0.22373855,0.0012698635,0.00092194945,0.0018225168,0.00046082286,0.0020752412,0.04619536,0.00019872587],"about_ca_topic_score_codex":0.042208187,"about_ca_topic_score_gemma":0.09382589,"teacher_disagreement_score":0.042208187,"about_ca_system_score_codex":0.0022823776,"about_ca_system_score_gemma":0.0072562792,"threshold_uncertainty_score":0.08392501},"labels":[],"label_agreement":null},{"id":"W2902279932","doi":"10.1016/s1474-4422(18)30444-7","title":"Global burden of traumatic brain and spinal cord injury","year":2018,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":315,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Toronto Western Hospital; University of Toronto; University Health Network","funders":"","keywords":"Traumatic brain injury; Spinal cord; Spinal cord injury; Physical medicine and rehabilitation; Medicine; Psychology; Neuroscience; Psychiatry","score_opus":0.09351210909964776,"score_gpt":0.41072534035769737,"score_spread":0.3172132312580496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902279932","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09632428,0.3478214,0.0037671088,0.059507012,0.00610026,0.00042873953,0.42658922,0.0008540803,0.058607887],"genre_scores_gemma":[0.40394208,0.34319097,0.005561982,0.011708856,0.004337602,0.0008509235,0.22047217,0.0002441096,0.009691345],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9989807,0.0002510512,0.0001444771,0.00018130546,0.00029538973,0.00014708168],"domain_scores_gemma":[0.9988636,0.00009081338,0.00033852848,0.00006974014,0.00048450546,0.00015286407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012863826,0.00066375773,0.000857633,0.0023452456,0.00029480222,0.0008947068,0.00054053863,0.0007413702,0.008979062],"category_scores_gemma":[0.0038997356,0.00025968705,0.0015254776,0.0043623056,0.0005154902,0.0010689206,0.0017481486,0.0011188884,0.0026918817],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046010443,0.000037390153,0.14828315,0.013417186,0.0031860946,0.00035261892,0.0006945806,0.0020266422,0.0007612291,0.008092542,0.5722995,0.250389],"study_design_scores_gemma":[0.00020616026,0.00023977683,0.54741615,0.012849036,0.0017762365,0.0014053754,0.0009562077,0.0010567788,0.0004765688,0.008400427,0.425087,0.00013025982],"about_ca_topic_score_codex":0.042569328,"about_ca_topic_score_gemma":0.0330497,"teacher_disagreement_score":0.042569328,"about_ca_system_score_codex":0.0014031456,"about_ca_system_score_gemma":0.0037638345,"threshold_uncertainty_score":0.084643126},"labels":[],"label_agreement":null},{"id":"W2903325146","doi":"10.1016/s1474-4422(18)30415-0","title":"Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016","year":2018,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":1985,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute on Deafness and Other Communication Disorders; Fuel Cell Technologies Program; Student Research Committee, Tabriz University of Medical Sciences; Faculty of Medicine and Health, University of Sydney; NIHR Imperial Biomedical Research Centre; Collaboration for Leadership in Applied Health Research and Care - Greater Manchester; Lee Kong Chian School of Medicine, Nanyang Technological University; Instituto de Salud Carlos III; National Health and Medical Research Council; Medical Research Council; Manchester Biomedical Research Centre; Research Institute, Nationwide Children's Hospital; University of California, Irvine; National Institutes of Health; University of Health and Allied Sciences; George Institute for Global Health; Laboratório Associado para a Química Verde; Ministry of Health of the Russian Federation; Centro de Investigação em Tecnologias e Serviços de Saúde; Universidade Federal de Sergipe; Frankfurt University of Applied Sciences; Kurdistan University Of Medical Sciences; H. Lundbeck A/S; Lorestan University of Medical Sciences; Hawassa University; Università degli Studi di Messina; Golestan University of Medical Sciences; Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences; Alfaisal University; University of Gondar; Western Sydney University; Tartu Ülikool; Pomorski Uniwersytet Medyczny W Szczecinie; Universidade Federal de Minas Gerais; Wuhan University; Universidade do Porto; Fundação Oswaldo Cruz; National Taiwan University; Department of Science and Technology, Government of Kerala; Universidad de Chile; Debre Tabor University; Università di Bologna; Shahid Beheshti University of Medical Sciences; Universität Bielefeld; Lomonosov Moscow State University; Babol University of Medical Sciences; Universidade de São Paulo; Guilan University of Medical Sciences; Hacettepe Üniversitesi; Universitetet i Oslo; Ahvaz Jundishapur University of Medical Sciences; NIHR Oxford Biomedical Research Centre; Inyuvesi Yakwazulu-Natali; Haramaya University; Curtin University of Technology; Universiti Sains Malaysia; Erasmus Universitair Medisch Centrum Rotterdam; South African Medical Research Council; Bundesministerium für Gesundheit; Politechnika Czestochowska; Chinese Center for Disease Control and Prevention; Tabriz University of Medical Sciences; Tampereen Yliopisto; Seoul National University Hospital; Tsinghua University; Dezful University of Medical Sciences; Fudan University; Guy's and St Thomas' NHS Foundation Trust; Lunds Universitet; Alborz University of Medical Sciences; Northwestern University; Universidad Nacional de Colombia; Universitätsklinikum Heidelberg; Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja; Ministerio de Educación, Cultura y Deporte; Islamic Azad University; Kyung Hee University; National and Kapodistrian University of Athens; Cairo University; Shiraz University of Medical Sciences; Ain Shams University; King Fahd University of Petroleum and Minerals; Ministerio de Economía y Competitividad; Bundesministerium für Bildung und Forschung; University of New South Wales; Ministério da Educação; Public Health Agency; Nanyang Technological University; Kaiser Permanente; Ministry of Health and Medical Education; High Blood Pressure Research Council of Australia; Universiteit Stellenbosch; Public Health England; Australian Catholic University; Brien Holden Vision Institute; Shiraz University; Imperial College London; Sree Chitra Tirunal Institute for Medical Sciences and Technology; King's College London; York University; Loma Linda University; Moscow Institute of Physics and Technology; National Institute of Mental Health and Neurosciences; Maragheh University of Medical Sciences; Addis Ababa University; Università degli Studi di Firenze; Universidad Autónoma Metropolitana; Alexander von Humboldt-Stiftung; Tribhuvan University; Fundação para a Ciência e a Tecnologia; Rede de Química e Tecnologia; Aksum University; Johns Hopkins University; Wellcome Trust; Trường Đại học Duy Tân; National Center for Global Health and Medicine; Tulane University; Applied Molecular Biosciences Unit; Iran University of Medical Sciences; National Institute for Health and Care Research; Korea University; Sanjay Gandhi Postgraduate Institute of Medical Sciences; National Institute on Handicapped Research; Nationwide Children's Hospital; Amgen; Universitat de Barcelona; Public Health Agency of Canada; Universitat de València; Uniwersytet Jagielloński Collegium Medicum; University College London; University of Southampton; Universitas Negeri Semarang; University of Tabriz; European Commission; Ahmadu Bello University; Samara University; Jordan University of Science and Technology; University of Oxford; McMaster University; Jazan University; Uniwersytet Opolski; Generalitat Valenciana; University of Cape Town; University of Ottawa; Arabian Gulf University; Central South University; Virginia Commonwealth University; University of Technology Sydney; Muhimbili University of Health and Allied Sciences; Univerzita Komenského v Bratislave; Universidade Federal de Santa Catarina; University of West Florida; International Centre for Diarrhoeal Disease Research, Bangladesh; Pacific Institute for Research and Evaluation; University of Social Welfare and Rehabilitation Sciences; Deakin University; Helsingin Yliopisto; Ministério da Educação e Ciência; Jackson State University; Harvard University; European Regional Development Fund; Seoul National University; Bill and Melinda Gates Foundation; Georg-August-Universität Göttingen; National University of Singapore; Institute for Physical Activity and Nutrition; Banaras Hindu University; National Institute of Mental Health; Case Western Reserve University; University of Warwick; Ball State University; Karolinska Institutet; Yale University","keywords":"Traumatic brain injury; Spinal cord injury; Medicine; Burden of disease; Incidence (geometry); Injury prevention; Poison control; Disease; Disease burden; Occupational safety and health; Physical therapy; Physical medicine and rehabilitation; Spinal cord; Medical emergency; Psychiatry; Internal medicine; Pathology","score_opus":0.09726924439421014,"score_gpt":0.42544796076878294,"score_spread":0.3281787163745728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903325146","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.051184475,0.8662228,0.0018368328,0.0013005366,0.00036175037,0.00062617863,0.077267125,0.000120430894,0.0010799244],"genre_scores_gemma":[0.47623363,0.4646308,0.007155954,0.0016307251,0.00039388126,0.0027000932,0.046520997,0.00011375456,0.0006201248],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99168956,0.0025803435,0.0029832476,0.0011056471,0.0012709261,0.00037015328],"domain_scores_gemma":[0.99148315,0.0032666812,0.002657987,0.00054828695,0.0018512205,0.00019268814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010025509,0.0013194028,0.0054246713,0.010765884,0.00047056752,0.0013557652,0.0010436748,0.00092921674,0.0019101106],"category_scores_gemma":[0.027065083,0.0010292502,0.019030605,0.018526994,0.00055816385,0.0010059174,0.0021451397,0.0011508304,0.00029337005],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020681643,0.000043374686,0.3173869,0.27716804,0.31698728,0.00032953022,0.000908954,0.002149357,0.0004475688,0.0010305771,0.024071142,0.057409134],"study_design_scores_gemma":[0.0013368864,0.00030903594,0.40552574,0.09480176,0.4628788,0.0009568992,0.0007316245,0.0015222791,0.00037419252,0.0013926638,0.029970774,0.00019937643],"about_ca_topic_score_codex":0.041392487,"about_ca_topic_score_gemma":0.08145439,"teacher_disagreement_score":0.041392487,"about_ca_system_score_codex":0.0022120767,"about_ca_system_score_gemma":0.005738552,"threshold_uncertainty_score":0.08230311},"labels":[],"label_agreement":null},{"id":"W2908553092","doi":"10.1016/s1474-4422(18)30405-8","title":"Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial","year":2019,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of Neurological Disorders and Stroke; School of Public Health, University of California Berkeley; St. Jude Medical; National Institutes of Health; Sunovion; H. Lundbeck A/S; Parkinson Study Group; Kyowa Kirin Pharmaceutical Development; AstraZeneca; International Parkinson and Movement Disorder Society; Acorda Therapeutics; Abbott Laboratories; Śląski Uniwersytet Medyczny; AbbVie; CHDI Foundation; Roche; Novartis; Adamas Pharmaceuticals; ACADIA Pharmaceuticals; Merck; US WorldMeds; National Parkinson Foundation; Pfizer; Michael J. Fox Foundation for Parkinson's Research; American Parkinson Disease Association; Teva Pharmaceutical Industries; Kyowa Hakko Kirin","keywords":"Levodopa; Placebo; Medicine; Parkinson's disease; Clinical endpoint; Inhaler; Inhalation; Physical therapy; Clinical trial; Internal medicine; Anesthesia; Disease; Asthma","score_opus":0.015262376236517433,"score_gpt":0.2623306480630693,"score_spread":0.2470682718265519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908553092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98984677,0.0035565167,0.0004012474,0.00047503304,0.00045441455,0.0021978565,0.00092539884,0.00012421687,0.002018539],"genre_scores_gemma":[0.99177647,0.0017165594,0.0006219095,0.00069856684,0.00042616308,0.0017558268,0.0009003087,0.000023481702,0.002080678],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993586,0.00031145941,0.000048316182,0.00012550887,0.000050415107,0.00010573604],"domain_scores_gemma":[0.99900913,0.00034179565,0.00016413952,0.00006741041,0.000073418516,0.00034413865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013178958,0.001799441,0.0040490367,0.00041529973,0.0006421182,0.0011499998,0.0010404909,0.003084277,0.006330712],"category_scores_gemma":[0.0017995327,0.0007349212,0.0022593387,0.00039368568,0.0015956106,0.0013201358,0.00041679636,0.0029280318,0.0014433304],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98907465,0.0022244935,0.00026360582,0.0003577175,0.00036067358,0.000035448586,0.000030563402,0.00009231002,0.0017328414,0.000038424987,0.0003094242,0.00547986],"study_design_scores_gemma":[0.94299847,0.054484926,0.0016178852,0.00002060844,0.00020294597,0.000027985463,0.0000173187,0.00018317407,0.00017526298,0.000074063246,0.0001829396,0.000014452661],"about_ca_topic_score_codex":0.0013242484,"about_ca_topic_score_gemma":0.0021716799,"teacher_disagreement_score":0.006330712,"about_ca_system_score_codex":0.0007141257,"about_ca_system_score_gemma":0.0009641158,"threshold_uncertainty_score":0.021178305},"labels":[],"label_agreement":null},{"id":"W2908709868","doi":"10.1016/s1474-4422(18)30445-9","title":"Openness, inclusion, and respect in dementia research","year":2019,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Douglas Mental Health University Institute; McGill University; McGill University Health Centre","funders":"","keywords":"Dementia; Scopus; Inclusion (mineral); Informed consent; Harm; Psychology; Public relations; Openness to experience; Medicine; Political science; MEDLINE; Disease; Alternative medicine; Law; Social psychology","score_opus":0.6029333855698348,"score_gpt":0.5912713229968296,"score_spread":0.011662062573005172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908709868","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020111233,0.00092804024,0.000034271077,0.99492633,0.0028688244,0.0000030290375,0.0000055678424,0.0000022008826,0.0010305856],"genre_scores_gemma":[0.0069648135,0.0007127229,0.00016680396,0.9754742,0.014131084,0.000041356983,0.00000547452,0.000010952492,0.002492588],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9528337,0.026879476,0.004558215,0.0028686104,0.007957238,0.0049027842],"domain_scores_gemma":[0.8235704,0.13982092,0.006501762,0.0030351013,0.009576588,0.017495243],"candidate_categories":["open_science"],"consensus_categories":[],"category_scores_codex":[0.043094635,0.0008244676,0.0024617924,0.0013079789,0.016108202,0.015058356,0.0032865237,0.13778222,0.005456125],"category_scores_gemma":[0.15029024,0.0012215176,0.0014103109,0.0014510867,0.025512163,0.017632319,0.008420491,0.10533308,0.0026901672],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012722447,0.00007214521,0.0010536321,0.00024435564,0.00004416752,0.0018309364,0.0036310414,0.00006497432,0.0001743213,0.055608135,0.9233201,0.013828894],"study_design_scores_gemma":[0.0004752968,0.00008612043,0.00200491,0.0021804578,0.0000730634,0.0024487951,0.009702364,0.0006573831,0.0002619802,0.21225533,0.7696191,0.00023523155],"about_ca_topic_score_codex":0.016819946,"about_ca_topic_score_gemma":0.032587033,"teacher_disagreement_score":0.99671346,"about_ca_system_score_codex":0.011378754,"about_ca_system_score_gemma":0.024207182,"threshold_uncertainty_score":0.22790891},"labels":[],"label_agreement":null},{"id":"W2909144970","doi":"10.1016/s1474-4422(18)30371-5","title":"Investigation of frailty as a moderator of the relationship between neuropathology and dementia in Alzheimer's disease: a cross-sectional analysis of data from the Rush Memory and Aging Project","year":2019,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Frailty in Older Adults","field":"Medicine","cited_by":313,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University","funders":"National Institute on Aging; Canadian Institutes of Health Research","keywords":"Dementia; Neuropathology; Medicine; Alzheimer's disease; Cohort; Disease; Cohort study; Gerontology; Cross-sectional study; Clinical Dementia Rating; Psychology; Pathology","score_opus":0.1689694459413566,"score_gpt":0.3658159027975547,"score_spread":0.19684645685619812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909144970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99828714,0.0006972261,0.00009963666,0.00006847379,0.0000135028085,0.000009811518,0.00071573193,0.000003433836,0.00010508545],"genre_scores_gemma":[0.9982765,0.0002647997,0.00020023444,0.00005080984,0.00002336487,0.000026127964,0.00097330095,0.0000054504267,0.0001796265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99671566,0.0019758637,0.00033687783,0.00043359495,0.00025630466,0.00028177953],"domain_scores_gemma":[0.99075377,0.0031490664,0.0028463828,0.0014808357,0.00087138976,0.000898562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009097873,0.00072354794,0.0011234334,0.0012321754,0.0008483014,0.0014555294,0.0011973521,0.001266661,0.0012454926],"category_scores_gemma":[0.013434479,0.00090599025,0.0024900697,0.002379699,0.00063914846,0.0012132047,0.0018065744,0.0015352498,0.00026024622],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004030776,0.000052333642,0.99749315,0.000022724735,0.0010285228,0.000035756686,0.00015309127,0.0000420123,0.00009512572,0.000015418997,0.00007785764,0.00058097835],"study_design_scores_gemma":[0.000018186109,0.00019293795,0.99906176,0.0000094348925,0.00032449275,0.000052437495,0.00014038582,0.00007460814,0.00002424693,0.000015917638,0.00008071965,0.0000048328943],"about_ca_topic_score_codex":0.017416142,"about_ca_topic_score_gemma":0.022416107,"teacher_disagreement_score":0.017416142,"about_ca_system_score_codex":0.00047584184,"about_ca_system_score_gemma":0.0009007985,"threshold_uncertainty_score":0.048114717},"labels":[],"label_agreement":null},{"id":"W2910017905","doi":"10.1016/s1474-4422(18)30460-5","title":"Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders","year":2019,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Multiple Sclerosis Society; European Committee for Treatment and Research in Multiple Sclerosis; National Institute for Health and Care Research; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Neuromyelitis optica; Spinal cord; Medicine; Myelopathy; Pathological; Neuroimaging; Neuroscience; Physical medicine and rehabilitation; Pathology; Psychology; Psychiatry","score_opus":0.24752095201500515,"score_gpt":0.37601433768046916,"score_spread":0.128493385665464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910017905","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004845515,0.99968517,0.0000081321605,0.00006533013,0.00007141708,0.000004213855,0.000020169642,0.0000011854842,0.00009604474],"genre_scores_gemma":[0.0013861513,0.99810046,0.00006593493,0.00022810578,0.00011167676,0.000009162153,0.000024216533,5.6076993e-7,0.000073712596],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984451,0.00041110726,0.0005260479,0.00017794469,0.00035331168,0.00008657582],"domain_scores_gemma":[0.9950755,0.0033294489,0.0011151794,0.00005028519,0.00033597666,0.00009361178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026739915,0.0013390094,0.0063241282,0.00806354,0.0002862708,0.0018489301,0.0013709252,0.001803072,0.00616346],"category_scores_gemma":[0.0063670054,0.0006613623,0.0023192544,0.008280059,0.0009346251,0.001606755,0.0013256288,0.0014156617,0.000565712],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040107954,0.000050966646,0.00071405945,0.5163446,0.0054960866,0.00023324475,0.00015207098,0.00021489194,0.00046856527,0.0011948971,0.017298294,0.4574313],"study_design_scores_gemma":[0.0010042563,0.00050845544,0.01329678,0.5343466,0.04408029,0.0025553862,0.00066206185,0.00016443279,0.00034185572,0.002647799,0.40025115,0.00014093952],"about_ca_topic_score_codex":0.007845887,"about_ca_topic_score_gemma":0.019397669,"teacher_disagreement_score":0.00806354,"about_ca_system_score_codex":0.0016340743,"about_ca_system_score_gemma":0.0030344708,"threshold_uncertainty_score":0.020618796},"labels":[],"label_agreement":null},{"id":"W2911226018","doi":"10.1016/s1474-4422(18)30454-x","title":"Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016","year":2019,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":1003,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences; Instituto de Salud Carlos III; National Health and Medical Research Council; Heller School for Social Policy and Management; Universidade Federal de Sergipe; Universidad Industrial de Santander; Ministério da Educação; Bahir Dar University; Shahid Beheshti University of Medical Sciences; Australian Catholic University; Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja; Universität Bielefeld; Universitair Ziekenhuis Antwerpen; Technische Universität München; Johns Hopkins University; Universitetet i Oslo; Tehran University of Medical Sciences and Health Services; European Commission; Ministério da Educação e Ciência; Imperial College London; Generalitat Valenciana; Western Sydney University; Ministerio de Economía y Competitividad; Alborz University of Medical Sciences; Ain Shams University; University College London; Universitat de València; University of New South Wales; McMaster University; Jordan University of Science and Technology; H. Lundbeck A/S; Institute for Health Metrics and Evaluation; Department of Science and Technology, Ministry of Science and Technology, India; Trường Đại học Duy Tân; Kaiser Permanente; Shanghai Jiao Tong University; Ministerio de Educación, Cultura y Deporte; Islamic Azad University; Maragheh University of Medical Sciences; Universidad de Santander; Ahmadu Bello University; Ahvaz Jundishapur University of Medical Sciences; Saint Paul's Hospital Millennium Medical College; University of Memphis; King Saud University; Brandeis University; Auckland University of Technology, New Zealand; McGill University; Tulane University; Ball State University; National University of Singapore; Alzheimer's Association; Fundação para a Ciência e a Tecnologia; Bill and Melinda Gates Foundation; University of Washington; Karolinska Institutet","keywords":"Burden of disease; Disease burden; Epilepsy; Disease; Medicine; Psychiatry; Internal medicine","score_opus":0.04103339033985737,"score_gpt":0.3400421791483425,"score_spread":0.29900878880848514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911226018","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10724582,0.6667553,0.0024691753,0.00312097,0.0005770577,0.0008496833,0.2158776,0.00014754049,0.0029568367],"genre_scores_gemma":[0.5292594,0.37577364,0.0052222596,0.0017274115,0.00043197355,0.0023165636,0.08424777,0.00009515997,0.000925837],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9959026,0.0012122628,0.0013781096,0.0005435405,0.0006978612,0.0002656591],"domain_scores_gemma":[0.9956281,0.0010493136,0.001604402,0.0002953109,0.0012485788,0.00017417314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006273629,0.00083514873,0.0029237848,0.0062168897,0.00040847808,0.0009479025,0.00067515305,0.00059459807,0.0018067954],"category_scores_gemma":[0.015102714,0.000727548,0.008723371,0.012330884,0.000432196,0.0007340592,0.001454531,0.0008464463,0.00034465993],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017140395,0.00003971873,0.70576954,0.08902487,0.07154122,0.00029278503,0.0008496111,0.0015978036,0.00036709165,0.0012853433,0.05356168,0.07395636],"study_design_scores_gemma":[0.0011475902,0.000213772,0.8065138,0.058003012,0.08645974,0.0009803674,0.00083097117,0.0015753175,0.00027755005,0.0013845605,0.042457495,0.00015588982],"about_ca_topic_score_codex":0.07231566,"about_ca_topic_score_gemma":0.12486455,"teacher_disagreement_score":0.07231566,"about_ca_system_score_codex":0.002020345,"about_ca_system_score_gemma":0.006640682,"threshold_uncertainty_score":0.14378947},"labels":[],"label_agreement":null},{"id":"W2911672308","doi":"10.1016/s1474-4422(19)30040-7","title":"Periprocedural events dominate outcomes of carotid stenting and endarterectomy","year":2019,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Cerebrovascular and Carotid Artery Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Carotid endarterectomy; Stenosis; Carotid stenting; Asymptomatic; Stroke (engine); Endarterectomy; Cardiology; Surgery; Internal medicine","score_opus":0.018064837084229665,"score_gpt":0.2577152636213986,"score_spread":0.23965042653716895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911672308","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06379543,0.032625135,0.00041889743,0.8566393,0.015372044,0.0000142372355,0.0007761763,0.00005986913,0.030298905],"genre_scores_gemma":[0.35742795,0.019579476,0.00032943368,0.47334898,0.14275064,0.00002854456,0.0004298953,0.00011332774,0.0059918277],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99746215,0.00054692564,0.0003600284,0.00034888845,0.0006631163,0.0006188077],"domain_scores_gemma":[0.98078877,0.009584717,0.0032375858,0.0008457817,0.0027578906,0.002785205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028239805,0.00027047633,0.0017088109,0.0009350886,0.0016011486,0.004018562,0.00080199685,0.00944102,0.0079351785],"category_scores_gemma":[0.032500885,0.00037676538,0.0009853579,0.002548212,0.0012857451,0.002114039,0.0008012753,0.009194772,0.0028038465],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005008334,0.00036312977,0.31030914,0.00094630086,0.0011544153,0.0076853978,0.0010490541,0.00042452166,0.00089930824,0.008692309,0.5193733,0.14409485],"study_design_scores_gemma":[0.0020192398,0.0010059366,0.6487143,0.00259829,0.0023757678,0.0143165,0.0050320914,0.0022515585,0.0007739275,0.088096626,0.23249467,0.00032108126],"about_ca_topic_score_codex":0.010793729,"about_ca_topic_score_gemma":0.032296706,"teacher_disagreement_score":0.010793729,"about_ca_system_score_codex":0.0026334366,"about_ca_system_score_gemma":0.00310317,"threshold_uncertainty_score":0.026545763},"labels":[],"label_agreement":null},{"id":"W2913241053","doi":"10.1016/s1474-4422(19)30020-1","title":"Primum non nocere: a call for balance when reporting on CTE","year":2019,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Traumatic Brain Injury Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary; International Collaboration On Repair Discoveries; University of British Columbia","funders":"National Institute of Neurological Disorders and Stroke; National Institute on Aging; National Institute for Health and Care Research","keywords":"Chronic traumatic encephalopathy; Medicine; Traumatic brain injury; Asymptomatic; Chronic fatigue syndrome; Concussion; Scopus; Psychology; MEDLINE; Psychiatry; Pathology; Poison control; Medical emergency; Injury prevention","score_opus":0.15850974870897486,"score_gpt":0.3758718900349021,"score_spread":0.21736214132592727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913241053","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022782761,0.00052782655,0.00005825796,0.9912066,0.007076136,0.000003955293,0.000013272961,0.000008444366,0.00087777496],"genre_scores_gemma":[0.0054866606,0.0007289358,0.00029109797,0.9501085,0.042033087,0.000023656878,0.000016519636,0.00003392672,0.0012774452],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98370695,0.005993241,0.0033471363,0.0015246944,0.0032678063,0.002160274],"domain_scores_gemma":[0.9141476,0.048437063,0.01075459,0.003311271,0.00994969,0.0133997435],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.012564647,0.0007256731,0.0022678832,0.0018116549,0.0068073063,0.0092456965,0.0031922995,0.104882754,0.010107906],"category_scores_gemma":[0.13394582,0.0013882264,0.0015014503,0.0015576873,0.0074731573,0.011246088,0.0036854763,0.07357364,0.006771361],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005777065,0.000020061923,0.00235035,0.00011332571,0.000028646831,0.005823114,0.00063511095,0.0000427212,0.00027921746,0.0032098235,0.9795887,0.007851078],"study_design_scores_gemma":[0.0002458179,0.00010403583,0.0044668936,0.0029624375,0.000097059856,0.019768896,0.005470466,0.0008937038,0.00040105963,0.037412416,0.92784923,0.00032792368],"about_ca_topic_score_codex":0.008336665,"about_ca_topic_score_gemma":0.012138911,"teacher_disagreement_score":0.98743534,"about_ca_system_score_codex":0.0068726474,"about_ca_system_score_gemma":0.009161456,"threshold_uncertainty_score":0.06644899},"labels":[],"label_agreement":null},{"id":"W2914825618","doi":"10.1016/s1474-4422(18)30392-2","title":"Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial","year":2019,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":223,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of British Columbia","funders":"National Institute of Neurological Disorders and Stroke; National Center for Advancing Translational Sciences; University of Texas Health Science Center at San Antonio; Myasthenia Gravis Foundation of America; CSL Behring; University of Kansas; Institute for Clinical and Translational Research, University of Wisconsin, Madison; Muscular Dystrophy Association; Alexion Pharmaceuticals","keywords":"Prednisone; Thymectomy; Myasthenia gravis; Medicine; Edrophonium; Repetitive nerve stimulation; Ocular myasthenia; Adverse effect; Clinical trial; Clinical endpoint; Internal medicine; Surgery; Pediatrics","score_opus":0.008807882992202505,"score_gpt":0.2413963033800569,"score_spread":0.2325884203878544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914825618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96965665,0.02010242,0.0007690079,0.0020660798,0.002773452,0.00094033027,0.0011519301,0.000110233734,0.0024300169],"genre_scores_gemma":[0.9878918,0.0041607283,0.00053344975,0.0013252604,0.001310666,0.00082859595,0.00090184505,0.000019967027,0.003027785],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99830866,0.00092191494,0.00011936036,0.0002794309,0.00007692174,0.00029372965],"domain_scores_gemma":[0.99789315,0.00086980645,0.00042587303,0.00020611243,0.0000881999,0.00051692873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028166801,0.0027750547,0.0065866453,0.00038485922,0.000543828,0.002190095,0.0017335361,0.0035677757,0.007338563],"category_scores_gemma":[0.003851119,0.0010369181,0.006365078,0.0004950249,0.0019245635,0.0027931253,0.0010617812,0.0061879037,0.0013316897],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9945615,0.00041790912,0.00027056978,0.00032813873,0.0011562199,0.000034139335,0.000021254864,0.00017658558,0.0003291762,0.0000557893,0.00019557001,0.0024531928],"study_design_scores_gemma":[0.96913046,0.0261302,0.0018100861,0.00009713769,0.0018025958,0.000035957095,0.00003527898,0.00022575153,0.000095403615,0.000284493,0.00033322448,0.000019427054],"about_ca_topic_score_codex":0.0021558427,"about_ca_topic_score_gemma":0.0030186782,"teacher_disagreement_score":0.007338563,"about_ca_system_score_codex":0.0015398646,"about_ca_system_score_gemma":0.0012563206,"threshold_uncertainty_score":0.024549901},"labels":[],"label_agreement":null},{"id":"W2920989721","doi":"10.1016/s1474-4422(19)30030-4","title":"The global burden of stroke: persistent and disabling","year":2019,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Climate Change and Health Impacts","field":"Environmental Science","cited_by":625,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Stroke (engine); Medicine; Physical medicine and rehabilitation; Engineering","score_opus":0.061680807602133784,"score_gpt":0.2966138084721129,"score_spread":0.2349330008699791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920989721","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033589732,0.56238556,0.0067549134,0.14628397,0.021755174,0.0007498308,0.10499502,0.0017354265,0.1217504],"genre_scores_gemma":[0.16733366,0.665041,0.003879843,0.028377034,0.019641267,0.0006849858,0.087210245,0.00034198587,0.027490033],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99706984,0.000582682,0.00036933628,0.00038904118,0.0011053499,0.0004836977],"domain_scores_gemma":[0.9965539,0.00043891353,0.00088568183,0.00018601782,0.0012624975,0.0006730071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027169385,0.0014896528,0.0022156273,0.0041469764,0.0010672753,0.004997282,0.0011157113,0.001674511,0.019854825],"category_scores_gemma":[0.0064950846,0.00054252404,0.0019734483,0.008301681,0.001230782,0.0031799297,0.0048978236,0.003747775,0.0105049955],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028185642,0.000064412045,0.017169243,0.0062253517,0.0008449296,0.00039068738,0.00042315936,0.00043231976,0.0005331151,0.007101067,0.6876542,0.2788798],"study_design_scores_gemma":[0.00013394374,0.00022359914,0.07088949,0.010509406,0.0007194441,0.0013253081,0.00085276517,0.0004477375,0.00028137024,0.012518315,0.9019968,0.00010184628],"about_ca_topic_score_codex":0.02488069,"about_ca_topic_score_gemma":0.024887217,"teacher_disagreement_score":0.02488069,"about_ca_system_score_codex":0.0028978582,"about_ca_system_score_gemma":0.009168959,"threshold_uncertainty_score":0.06642097},"labels":[],"label_agreement":null},{"id":"W2921008740","doi":"10.1016/s1474-4422(19)30026-2","title":"Safety and efficacy of sonothrombolysis for acute ischaemic stroke: a multicentre, double-blind, phase 3, randomised controlled trial","year":2019,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary","funders":"Daiichi Sankyo Europe; Seventh Framework Programme; Bayer Fund; Shire; Bristol-Myers Squibb; CSL Behring; Bundesministerium für Bildung und Forschung; Biogen; Welch Foundation; Novartis; Merck; Pfizer; National Institutes of Health; Medtronic; Boehringer Ingelheim","keywords":"Medicine; Thrombolysis; Modified Rankin Scale; Randomized controlled trial; Transcranial Doppler; Interim analysis; Odds ratio; Population; Fibrinolytic agent; Stroke (engine); Ultrasound; Tissue plasminogen activator; Physical therapy; Internal medicine; Ischemia; Ischemic stroke; Radiology; Myocardial infarction","score_opus":0.02104800054649133,"score_gpt":0.29183713167470055,"score_spread":0.27078913112820924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921008740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96016103,0.018216854,0.003393554,0.0014875355,0.0023505487,0.009535264,0.0017166521,0.00038097813,0.002757584],"genre_scores_gemma":[0.9684175,0.0070607085,0.0035914439,0.002408015,0.0013207662,0.01109791,0.0012690666,0.00006681458,0.0047676717],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99854445,0.00077123335,0.00012266103,0.00027015104,0.000117959935,0.00017362468],"domain_scores_gemma":[0.9984316,0.00060119794,0.00041247776,0.00015419799,0.00013561906,0.0002648075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026771037,0.0025433274,0.0066377637,0.0005677216,0.0006892055,0.0016556486,0.0011363757,0.0035289493,0.007616433],"category_scores_gemma":[0.0035079347,0.0010416599,0.0035446198,0.0006841029,0.0020364986,0.0014904722,0.00061820855,0.0038425003,0.001274469],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.993149,0.00097631,0.00011555025,0.00075261906,0.0011459577,0.000015700325,0.000025618114,0.00008081237,0.0006899824,0.000052257114,0.00028249604,0.0027138444],"study_design_scores_gemma":[0.9823691,0.01583486,0.0004983605,0.000039798182,0.0006716443,0.000009773093,0.0000111516265,0.00015709801,0.00009137232,0.000107528176,0.00019759379,0.000011781801],"about_ca_topic_score_codex":0.0013728106,"about_ca_topic_score_gemma":0.0020554918,"teacher_disagreement_score":0.007616433,"about_ca_system_score_codex":0.0008525545,"about_ca_system_score_gemma":0.0013225323,"threshold_uncertainty_score":0.025479496},"labels":[],"label_agreement":null},{"id":"W2921259698","doi":"10.1016/s1474-4422(19)30069-9","title":"Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial","year":2019,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Intracerebral and Subarachnoid Hemorrhage Research","field":"Medicine","cited_by":249,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institutes of Health; Canadian Institutes of Health Research; Health Canada; Medical University of South Carolina; National Institute of Neurological Disorders and Stroke; American Heart Association","keywords":"Medicine; Placebo; Population; Modified Rankin Scale; Deferoxamine; Intention-to-treat analysis; Clinical trial; Randomized controlled trial; Intracerebral hemorrhage; Internal medicine; Surgery; Glasgow Coma Scale; Pathology","score_opus":0.029042333603955507,"score_gpt":0.3051081338468827,"score_spread":0.27606580024292715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921259698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98086286,0.010330426,0.000784199,0.0010044138,0.00096470903,0.0025744694,0.0012383306,0.00013648756,0.0021042477],"genre_scores_gemma":[0.98157734,0.006479104,0.0015320427,0.0018066188,0.00081873056,0.0029285303,0.0013797317,0.000025055639,0.00345279],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995776,0.00018446775,0.000026367761,0.000087059554,0.000027960667,0.00009651349],"domain_scores_gemma":[0.9993994,0.0001643962,0.00014011729,0.00004498377,0.000040952138,0.00021011662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011383551,0.0019063734,0.0037618845,0.00035672876,0.00038855695,0.00091214076,0.0008816293,0.0018796953,0.004562879],"category_scores_gemma":[0.001628345,0.0005981455,0.0019235665,0.0003560769,0.0011034801,0.0010572437,0.0003985218,0.002425034,0.00080136704],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9881606,0.0015635438,0.00024470012,0.0006863315,0.0006420077,0.00003383343,0.00004406314,0.000111747184,0.001632169,0.0000784253,0.00049330643,0.0063092443],"study_design_scores_gemma":[0.9768267,0.021818878,0.0006210559,0.000021129666,0.00021999757,0.000016387552,0.000012194697,0.0000771578,0.00010399326,0.000049941686,0.00022503045,0.0000075125477],"about_ca_topic_score_codex":0.001263986,"about_ca_topic_score_gemma":0.0023199706,"teacher_disagreement_score":0.004562879,"about_ca_system_score_codex":0.0006524182,"about_ca_system_score_gemma":0.0008521984,"threshold_uncertainty_score":0.015264392},"labels":[],"label_agreement":null},{"id":"W2939535752","doi":"10.1016/s1474-4422(19)30044-4","title":"Gait impairments in Parkinson's disease","year":2019,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":791,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Wilfrid Laurier University; University of Alberta","funders":"","keywords":"Gait; Physical medicine and rehabilitation; Parkinson's disease; Disease; Medicine; Gait analysis; Psychology; Pathology","score_opus":0.07148719757717771,"score_gpt":0.3449366647397257,"score_spread":0.273449467162548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2939535752","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000029227924,0.99932396,0.000021917756,0.00015066504,0.00015027028,0.0000030348135,0.00001599731,0.0000031947723,0.00030178373],"genre_scores_gemma":[0.00047978034,0.99859554,0.0000671383,0.0003076571,0.00022002553,0.0000066562516,0.000019731586,7.079176e-7,0.0003027845],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996631,0.00006503008,0.000080398284,0.000050552248,0.00010880688,0.000032035812],"domain_scores_gemma":[0.9992499,0.00040750531,0.00017571078,0.000012827566,0.000113670605,0.00004040831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092717167,0.001594671,0.0038451767,0.0040947204,0.00028023502,0.0016281456,0.0011001608,0.0020557812,0.007235147],"category_scores_gemma":[0.0014583437,0.0004817588,0.0010864079,0.0034967975,0.0006744026,0.0014318628,0.0011035484,0.0023407815,0.0019497148],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020678285,0.00007553577,0.00015056474,0.06353988,0.00045021184,0.00014146192,0.000048614464,0.00027194366,0.00040281436,0.0016238322,0.037231192,0.8958572],"study_design_scores_gemma":[0.00040042406,0.00042725174,0.0032396696,0.05237149,0.0025561308,0.0017111745,0.00016722057,0.00024272186,0.00020676847,0.003726958,0.93487716,0.000073207666],"about_ca_topic_score_codex":0.0038243127,"about_ca_topic_score_gemma":0.010728779,"teacher_disagreement_score":0.007235147,"about_ca_system_score_codex":0.0010057089,"about_ca_system_score_gemma":0.0018229149,"threshold_uncertainty_score":0.024203956},"labels":[],"label_agreement":null},{"id":"W2942154415","doi":"10.1016/s1474-4422(19)30068-7","title":"Priorities to reduce the burden of stroke in Latin American countries","year":2019,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":182,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation","funders":"Comisión Nacional de Investigación Científica y Tecnológica; National Health and Medical Research Council; George Institute for Global Health; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Takeda Pharmaceutical Company; Boehringer Ingelheim; World Health Organization","keywords":"Declaration; Latin Americans; Stroke (engine); Medicine; Public health; Economic growth; Political science; Nursing","score_opus":0.10131057520332673,"score_gpt":0.37140056363336,"score_spread":0.2700899884300333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942154415","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000069488815,0.99208915,0.00007359786,0.00656713,0.00056881434,0.000003831921,0.00006618981,0.000008929541,0.0005528725],"genre_scores_gemma":[0.0011509899,0.99652463,0.00018517868,0.001509419,0.00038426768,0.000009078396,0.000050928465,0.0000022315392,0.00018327577],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989716,0.0003532119,0.00016248217,0.000080101825,0.00027545498,0.00015720942],"domain_scores_gemma":[0.997047,0.0013039322,0.00065230875,0.00005320109,0.0006916809,0.0002519039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044934903,0.0013438258,0.002017216,0.0038923114,0.0004667484,0.0034114593,0.0015975656,0.0023710344,0.0072403485],"category_scores_gemma":[0.007481441,0.00034659426,0.0010850825,0.0054439874,0.0010123434,0.002657972,0.0015150467,0.003391946,0.0011439131],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001593727,0.00009528965,0.0009918215,0.048338763,0.00058458897,0.00014669281,0.00014739986,0.0008433289,0.00023305093,0.02165769,0.09191944,0.83488256],"study_design_scores_gemma":[0.00010784598,0.00008031258,0.005108127,0.09139173,0.0008885766,0.00036637555,0.00063489325,0.00030751832,0.0001789689,0.0153470505,0.88554233,0.000046327834],"about_ca_topic_score_codex":0.020738058,"about_ca_topic_score_gemma":0.025183337,"teacher_disagreement_score":0.020738058,"about_ca_system_score_codex":0.0034599327,"about_ca_system_score_gemma":0.017114008,"threshold_uncertainty_score":0.04123473},"labels":[],"label_agreement":null},{"id":"W2944837928","doi":"10.1016/s1474-4422(19)30159-0","title":"First report the findings: genuine balance when reporting CTE","year":2019,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Traumatic Brain Injury Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Balance (ability); Medicine; Psychology; Physical medicine and rehabilitation","score_opus":0.1291830502133909,"score_gpt":0.3506476098179482,"score_spread":0.22146455960455727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944837928","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015471885,0.00072998327,0.00012286649,0.9796595,0.01313135,0.00001490551,0.00007267342,0.000029189277,0.0046923948],"genre_scores_gemma":[0.030579327,0.0014306431,0.0005969652,0.89905167,0.062111232,0.000042909942,0.00006571556,0.00007048309,0.006051038],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966461,0.0008171221,0.0008400427,0.0003692855,0.0006527137,0.0006746702],"domain_scores_gemma":[0.9821117,0.009107929,0.0019496046,0.0007131354,0.003579998,0.0025376752],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0026698413,0.0007397993,0.0011722456,0.0014365866,0.0036274095,0.004165463,0.001632339,0.060386136,0.008432403],"category_scores_gemma":[0.0684182,0.0010639881,0.0010018793,0.0010953153,0.0025259675,0.0038195709,0.0015349612,0.02990219,0.007613885],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008720148,0.000039141727,0.008805303,0.00009258571,0.000043299962,0.06034386,0.00068502064,0.000089894835,0.0004884858,0.0023972471,0.91674346,0.010184609],"study_design_scores_gemma":[0.000320513,0.00021462643,0.010693212,0.0022964664,0.00017021035,0.1687837,0.0069024563,0.001826384,0.0010617011,0.031702798,0.7755803,0.00044771083],"about_ca_topic_score_codex":0.009274609,"about_ca_topic_score_gemma":0.011799969,"teacher_disagreement_score":0.9973301,"about_ca_system_score_codex":0.0033003306,"about_ca_system_score_gemma":0.0037930605,"threshold_uncertainty_score":0.028209269},"labels":[],"label_agreement":null},{"id":"W2945290291","doi":"10.1016/s1474-4422(19)30197-8","title":"Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies","year":2019,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Intracerebral and Subarachnoid Hemorrhage Research","field":"Medicine","cited_by":189,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"European Regional Development Fund; National Medical Research Council; Medical Research Council; Canadian Institutes of Health Research; Manchester Biomedical Research Centre; National Institutes of Health; Chest Heart and Stroke Scotland; Schweizerische Herzstiftung; University College London Hospitals NHS Foundation Trust; Ministry of Health, Labour and Welfare; ZonMw; Health and Medical Research Fund; Agence Nationale de la Recherche; Fondation Leducq; Hartstichting; Center for Translational Molecular Medicine; Imperial College London; Pfizer; Stroke Association; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; National Cerebral and Cardiovascular Center; British Heart Foundation; Instituto de Salud Carlos III; Mrs Gladys Row Fogo Charitable Trust; Wellcome Trust; Japan Agency for Medical Research and Development; Servier; Bayer; National Institute for Health and Care Research; Health Research Board; Bristol-Myers Squibb; Daiichi-Sankyo; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; American Federation for Aging Research","keywords":"Ischaemic stroke; Medicine; Stroke (engine); Internal medicine; Cohort; Cardiology; Cerebral ischaemia; Ischemia","score_opus":0.14733113860297414,"score_gpt":0.3885253906929252,"score_spread":0.24119425208995104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945290291","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34422374,0.61988103,0.00818267,0.00059680745,0.00047475845,0.0020093329,0.023283208,0.00018315915,0.0011652118],"genre_scores_gemma":[0.9229201,0.055245005,0.007151483,0.00043182136,0.0002252243,0.0028683266,0.010753585,0.00007651654,0.00032801554],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9679842,0.014956514,0.0103016505,0.0037787652,0.0023052937,0.00067360146],"domain_scores_gemma":[0.95344645,0.026776211,0.011297614,0.0051586144,0.0027753776,0.00054565695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029444028,0.001942453,0.008980768,0.010498058,0.0005273663,0.0030034918,0.0015043118,0.0018350222,0.0013925929],"category_scores_gemma":[0.061439276,0.0015982342,0.023320492,0.010319875,0.0006172292,0.001474824,0.0026067558,0.0009381674,0.00022987879],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005163827,0.000033023236,0.102487475,0.02444185,0.85862535,0.00021311414,0.00017433743,0.00086037314,0.00048186837,0.00011601123,0.0007594287,0.006643451],"study_design_scores_gemma":[0.0015359565,0.0005033536,0.10682656,0.0033863985,0.88422143,0.00030808686,0.00019267689,0.00054123916,0.00024196917,0.00038867688,0.0017736633,0.00007996932],"about_ca_topic_score_codex":0.0044627218,"about_ca_topic_score_gemma":0.007060137,"teacher_disagreement_score":0.029444028,"about_ca_system_score_codex":0.00097588403,"about_ca_system_score_gemma":0.0015378892,"threshold_uncertainty_score":0.15571672},"labels":[],"label_agreement":null},{"id":"W2946008018","doi":"10.1016/s1474-4422(19)30165-6","title":"The uncertain role for phosphodiesterase inhibitors in stroke prevention","year":2019,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; University of Calgary; Foothills Medical Centre","funders":"National Institute of Neurological Disorders and Stroke; Canadian Institutes of Health Research; Covidien; Boehringer Ingelheim; Medtronic; Heart and Stroke Foundation of Canada; F. Hoffmann-La Roche; Alberta Innovates - Health Solutions","keywords":"Cilostazol; Medicine; Clopidogrel; Pharmacology; Aspirin; Phosphodiesterase; Phosphodiesterase 3; Dipyridamole; Stroke (engine); Internal medicine; Cardiology; Chemistry; Biochemistry; Enzyme","score_opus":0.02473123652386836,"score_gpt":0.28052678669928044,"score_spread":0.25579555017541206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946008018","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018878267,0.0033329716,0.000044535394,0.9745106,0.01922028,0.000003960189,0.000031695552,0.000010398663,0.0026567345],"genre_scores_gemma":[0.004598908,0.004639622,0.00017139217,0.81327987,0.17371397,0.000021462925,0.000033360062,0.000020559715,0.0035208648],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957913,0.0012367538,0.0006359824,0.0004140426,0.0013947191,0.0005270951],"domain_scores_gemma":[0.9792229,0.013411387,0.0013633932,0.00048895995,0.0025801924,0.0029332268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039368616,0.00088454946,0.0023386811,0.0011066619,0.0032641042,0.005103306,0.0016842803,0.06524316,0.010446575],"category_scores_gemma":[0.036837578,0.0008368156,0.0016754079,0.0010460285,0.0037821466,0.004408114,0.0016079633,0.05444329,0.008866963],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001823089,0.000045358895,0.0007340444,0.00016899985,0.00004535526,0.0027586047,0.00009335452,0.000102656195,0.00022180716,0.004509629,0.9737322,0.017405745],"study_design_scores_gemma":[0.00062185404,0.00016653036,0.0019209808,0.0012847905,0.00014386157,0.0038864305,0.0003366069,0.00076418405,0.00027875186,0.02791199,0.96258867,0.00009536767],"about_ca_topic_score_codex":0.0053914646,"about_ca_topic_score_gemma":0.010156241,"teacher_disagreement_score":0.06524316,"about_ca_system_score_codex":0.005123039,"about_ca_system_score_gemma":0.005061962,"threshold_uncertainty_score":0.03717041},"labels":[],"label_agreement":null},{"id":"W2946144894","doi":"10.1016/s1474-4422(19)30158-9","title":"First report the findings: genuine balance when reporting CTE","year":2019,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Traumatic Brain Injury Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"League; Football; Chronic traumatic encephalopathy; Denial; Battle; Concussion; Psychology; History; Law; Political science; Medicine; Psychoanalysis; Poison control","score_opus":0.1291830502133909,"score_gpt":0.3506476098179482,"score_spread":0.22146455960455727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946144894","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015471885,0.00072998327,0.00012286649,0.9796595,0.01313135,0.00001490551,0.00007267342,0.000029189277,0.0046923948],"genre_scores_gemma":[0.030579327,0.0014306431,0.0005969652,0.89905167,0.062111232,0.000042909942,0.00006571556,0.00007048309,0.006051038],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966461,0.0008171221,0.0008400427,0.0003692855,0.0006527137,0.0006746702],"domain_scores_gemma":[0.9821117,0.009107929,0.0019496046,0.0007131354,0.003579998,0.0025376752],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0026698413,0.0007397993,0.0011722456,0.0014365866,0.0036274095,0.004165463,0.001632339,0.060386136,0.008432403],"category_scores_gemma":[0.0684182,0.0010639881,0.0010018793,0.0010953153,0.0025259675,0.0038195709,0.0015349612,0.02990219,0.007613885],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008720148,0.000039141727,0.008805303,0.00009258571,0.000043299962,0.06034386,0.00068502064,0.000089894835,0.0004884858,0.0023972471,0.91674346,0.010184609],"study_design_scores_gemma":[0.000320513,0.00021462643,0.010693212,0.0022964664,0.00017021035,0.1687837,0.0069024563,0.001826384,0.0010617011,0.031702798,0.7755803,0.00044771083],"about_ca_topic_score_codex":0.009274609,"about_ca_topic_score_gemma":0.011799969,"teacher_disagreement_score":0.9973301,"about_ca_system_score_codex":0.0033003306,"about_ca_system_score_gemma":0.0037930605,"threshold_uncertainty_score":0.028209269},"labels":[],"label_agreement":null},{"id":"W2946299736","doi":"10.1016/s1474-4422(19)30160-7","title":"Introducing the International Women in Multiple Sclerosis network","year":2019,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Science, Research, and Medicine","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Merck","keywords":"Mentorship; Public relations; Health care; Medical education; Psychology; Political science; Medicine","score_opus":0.0835080588897186,"score_gpt":0.2955972602981334,"score_spread":0.21208920140841478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946299736","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017990111,0.0010678689,0.000034784938,0.97626877,0.019565444,0.0000064299784,0.000029326153,0.000010759687,0.0028367096],"genre_scores_gemma":[0.0029913937,0.00076203025,0.00008982084,0.9519409,0.035645954,0.0000393866,0.00001632821,0.000022457392,0.00849169],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942334,0.0019045618,0.00044720402,0.0005824789,0.0015285935,0.001303812],"domain_scores_gemma":[0.98150384,0.009413557,0.001050873,0.00046901434,0.001655591,0.0059071197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072577707,0.0010210274,0.0015537544,0.0009653538,0.006753787,0.0076187076,0.0020127324,0.07955182,0.011820148],"category_scores_gemma":[0.032979712,0.000899467,0.0011991537,0.0007236845,0.004986647,0.006734025,0.004453497,0.04864834,0.0062665106],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059504295,0.000028181303,0.00038881498,0.000054436994,0.000011146999,0.0005372674,0.00015734418,0.000023540699,0.000091250055,0.0037164374,0.98928666,0.0056454353],"study_design_scores_gemma":[0.00018908587,0.0000596444,0.0014448477,0.00047677246,0.00003890411,0.00050536514,0.0008829852,0.00021286357,0.00014935715,0.009648991,0.9863259,0.00006536198],"about_ca_topic_score_codex":0.008630328,"about_ca_topic_score_gemma":0.023218999,"teacher_disagreement_score":0.07955182,"about_ca_system_score_codex":0.004947113,"about_ca_system_score_gemma":0.008869318,"threshold_uncertainty_score":0.039542317},"labels":[],"label_agreement":null},{"id":"W2948460590","doi":"10.1016/s1474-4422(19)30195-4","title":"Parkinson's disease in the Western Pacific Region","year":2019,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"National Medical Research Council; International Parkinson and Movement Disorder Society; Animal Health Trust","keywords":"Disease; Parkinson's disease; Ethnic group; Medicine; Disease management; Gerontology; Geography; Political science; Pathology","score_opus":0.10197568259713005,"score_gpt":0.34072565862302207,"score_spread":0.238749976025892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948460590","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000031381496,0.9991499,0.000014487366,0.00018709364,0.00015148908,0.0000028336399,0.000015173466,0.0000026926252,0.00044494658],"genre_scores_gemma":[0.0002152185,0.99918264,0.000043030235,0.00018842593,0.000119645796,0.000003236039,0.000011491042,4.486114e-7,0.000235774],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997943,0.000029828347,0.00004959375,0.000030209325,0.00007531958,0.000020787133],"domain_scores_gemma":[0.99949384,0.00020141937,0.00012907964,0.000009270196,0.0001173646,0.000049098016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080958114,0.0011319445,0.0021093194,0.0028867384,0.00032673407,0.0013296905,0.00078657875,0.0011385444,0.0048998874],"category_scores_gemma":[0.0010091306,0.0003742952,0.00065127347,0.0040981304,0.0005601598,0.0009752589,0.0008911556,0.0016181206,0.0011822286],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009826741,0.00005026706,0.00024178541,0.046951648,0.00025920253,0.00010861941,0.00007232647,0.00020349424,0.00032098056,0.0013259094,0.03986364,0.9105038],"study_design_scores_gemma":[0.00009081201,0.00015343312,0.0038600208,0.03603621,0.0012108858,0.0006996963,0.00020013074,0.00012025062,0.0001254648,0.0017493261,0.95571935,0.000034353197],"about_ca_topic_score_codex":0.0171196,"about_ca_topic_score_gemma":0.040747277,"teacher_disagreement_score":0.0171196,"about_ca_system_score_codex":0.0010674599,"about_ca_system_score_gemma":0.0033759114,"threshold_uncertainty_score":0.034039855},"labels":[],"label_agreement":null},{"id":"W2951652321","doi":"10.1016/s1474-4422(19)30198-x","title":"The pathway towards an effective reduction of stroke burden worldwide: teamwork","year":2019,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; St. Michael's Hospital; University of Toronto","funders":"Heart and Stroke Foundation of Canada; Roche","keywords":"Latin Americans; Scopus; Stroke (engine); Medicine; Excellence; Family medicine; MEDLINE; Political science","score_opus":0.016224677749864202,"score_gpt":0.26536169420238415,"score_spread":0.24913701645251995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951652321","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012534953,0.0023932266,0.00022238184,0.9843323,0.011695021,0.000006908223,0.000012147388,0.000022107432,0.0011906439],"genre_scores_gemma":[0.004276992,0.005122774,0.00087995006,0.91297036,0.07402094,0.000063753156,0.00003540447,0.000034433862,0.0025954382],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9864966,0.004655189,0.0013261114,0.0013141844,0.004277279,0.0019305797],"domain_scores_gemma":[0.95413274,0.018606352,0.0024700933,0.0011624206,0.007404865,0.016223447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008214583,0.0013135856,0.0029035625,0.0014458515,0.0048493105,0.008464027,0.0027865984,0.050076354,0.016299985],"category_scores_gemma":[0.044342943,0.00090128696,0.0025539147,0.00090493896,0.005673754,0.01289685,0.006141869,0.06793017,0.009668216],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006832327,0.00017250537,0.0006275804,0.00026107792,0.00007359569,0.0008723384,0.00028145654,0.00015055918,0.00023005094,0.004534713,0.9670975,0.025630265],"study_design_scores_gemma":[0.0005649179,0.0002964355,0.002470984,0.0030175208,0.0001389425,0.0027338262,0.00250078,0.001146608,0.000254685,0.08206794,0.9045897,0.00021762562],"about_ca_topic_score_codex":0.0053107943,"about_ca_topic_score_gemma":0.008215756,"teacher_disagreement_score":0.050076354,"about_ca_system_score_codex":0.006286151,"about_ca_system_score_gemma":0.015172018,"threshold_uncertainty_score":0.054528892},"labels":[],"label_agreement":null},{"id":"W2953926727","doi":"10.1016/s1474-4422(19)30152-8","title":"Recent developments in drug-induced movement disorders: a mixed picture","year":2019,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Dystonia Coalition; H. Lundbeck A/S; Neurocrine Biosciences; Parkinson's Foundation; AbbVie; Ipsen Biopharmaceuticals; Biogen; International Parkinson and Movement Disorder Society; ACADIA Pharmaceuticals; CHDI Foundation; Canadian Institutes of Health Research; National Science Foundation; Sunovion; Allergan; National Institutes of Health; Medtronic; Teva Pharmaceutical Industries; Università degli Studi di Verona; National Parkinson Foundation; Michael J. Fox Foundation for Parkinson's Research; Boston Scientific Corporation","keywords":"Movement disorders; Medicine; Parkinsonism; Tardive dyskinesia; Drug; Essential tremor; Tics; Psychiatry; Population; Intensive care medicine; Schizophrenia (object-oriented programming); Internal medicine; Disease","score_opus":0.1028258120467406,"score_gpt":0.34882993407719975,"score_spread":0.24600412203045915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953926727","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000032150103,0.99895906,0.000034697736,0.0004022786,0.00020630326,0.0000014252875,0.000013125777,0.0000032745695,0.00034763233],"genre_scores_gemma":[0.00029949698,0.99856395,0.00007747744,0.0004904991,0.00038536818,0.0000022889874,0.000015232284,0.0000010382023,0.00016469955],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996178,0.000081727514,0.00006960072,0.00006693576,0.00012392827,0.000040013827],"domain_scores_gemma":[0.9981206,0.0012892479,0.00022028023,0.000031556105,0.0002420939,0.000096161384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014096482,0.001105125,0.0028368335,0.002977063,0.0003041684,0.002007973,0.0009925957,0.0019053638,0.0069347555],"category_scores_gemma":[0.0019151333,0.0003169523,0.0008792028,0.003710597,0.00074094004,0.0022082415,0.0010172563,0.0024555519,0.002049288],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020357106,0.00005735467,0.00024304462,0.050388027,0.00024190829,0.00022633324,0.00009071612,0.00028563192,0.00084478105,0.004748988,0.04513242,0.89753723],"study_design_scores_gemma":[0.0000697652,0.0001455516,0.0013019214,0.018889088,0.0004896773,0.0012099084,0.00017343431,0.000114454146,0.00017750908,0.0032925094,0.9740984,0.000037724472],"about_ca_topic_score_codex":0.0012789048,"about_ca_topic_score_gemma":0.0040895804,"teacher_disagreement_score":0.0069347555,"about_ca_system_score_codex":0.0008309916,"about_ca_system_score_gemma":0.0015800317,"threshold_uncertainty_score":0.023199081},"labels":[],"label_agreement":null},{"id":"W2954510583","doi":"10.1016/s1474-4422(19)30141-3","title":"Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial","year":2019,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Ipsen; Deutsches Zentrum für Neurodegenerative Erkrankungen; H. Lundbeck A/S; Deutsche Stiftung Neurologie; NOMIS Stiftung; Roche; Deutsche Forschungsgemeinschaft; Deutscher Akademischer Austauschdienst; AbbVie; European Commission; Novartis; ParkinsonFonds Deutschland; Bundesministerium für Bildung und Forschung; Deutsche Parkinson Vereinigung; European Parkinson’s Disease Association; Bischof Dr. Karl Golser Stiftung; Teva Pharmaceutical Industries; Damp Stiftung; UCB; Arthur Arnstein Stiftung; Horizon 2020; Actelion Pharmaceuticals; Biogen; Michael J. Fox Foundation for Parkinson's Research","keywords":"Placebo; Double blind; Medicine; Gallate; Randomized controlled trial; Atrophy; Epigallocatechin gallate; Internal medicine; Pharmacology; Alternative medicine; Pathology; Chemistry; Antioxidant","score_opus":0.025322648121656383,"score_gpt":0.2696299688208813,"score_spread":0.24430732069922492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954510583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9670788,0.019789618,0.0011389962,0.0013186334,0.0017783762,0.004980592,0.0013679267,0.00020535491,0.0023417817],"genre_scores_gemma":[0.97928154,0.0074604168,0.0013023408,0.0015002835,0.0012043201,0.004230621,0.0009657356,0.000038921557,0.004015848],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998917,0.0004956339,0.00010238896,0.00025493203,0.000087718014,0.00014225132],"domain_scores_gemma":[0.9985954,0.00047707462,0.00032039115,0.00012650035,0.00012175274,0.0003589268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002609836,0.0028234825,0.006611646,0.00083318114,0.00079108134,0.0015531398,0.0012973963,0.0044430043,0.008329245],"category_scores_gemma":[0.002986673,0.001289927,0.0038479944,0.00068472483,0.0024492037,0.0018786151,0.0006743255,0.0038433087,0.0014583472],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99398345,0.0012032097,0.0001463846,0.000527079,0.000603956,0.000019683222,0.000018542754,0.000048336227,0.000789118,0.000034098837,0.00014103,0.0024851125],"study_design_scores_gemma":[0.97364455,0.024590451,0.00067650736,0.000034055338,0.0005551098,0.000012169516,0.000010811062,0.00008933385,0.00013261972,0.0000694207,0.00017465749,0.000010160188],"about_ca_topic_score_codex":0.0012117692,"about_ca_topic_score_gemma":0.0014773697,"teacher_disagreement_score":0.008329245,"about_ca_system_score_codex":0.0007743472,"about_ca_system_score_gemma":0.0010593877,"threshold_uncertainty_score":0.027864099},"labels":[],"label_agreement":null},{"id":"W2955874948","doi":"10.1016/s1474-4422(19)30137-1","title":"Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial","year":2019,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"Acorda Therapeutics; Celgene; Biogen","keywords":"Placebo; Multiple sclerosis; Medicine; Phase (matter); Internal medicine; Physical therapy; Alternative medicine; Psychiatry; Chemistry; Pathology","score_opus":0.035426534993532995,"score_gpt":0.2888135071652921,"score_spread":0.2533869721717591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955874948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867137,0.008111265,0.00034935886,0.00069232663,0.0004349513,0.0016491407,0.0006454286,0.0000634178,0.0013403987],"genre_scores_gemma":[0.99060553,0.0032980181,0.00079398433,0.0010439222,0.0004969492,0.0014706907,0.000727877,0.000015796522,0.0015472725],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991763,0.00041229324,0.000064689084,0.00014601705,0.000066832414,0.00013381755],"domain_scores_gemma":[0.9986507,0.0004223871,0.00036765725,0.00009747058,0.00009305899,0.00036868427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019603064,0.0021410824,0.0037992152,0.0004759861,0.00057906756,0.0011260627,0.00081480877,0.0025465132,0.0051294733],"category_scores_gemma":[0.0022613194,0.0008119607,0.0032121588,0.0003762304,0.0012561459,0.0012563057,0.0005976842,0.0033219669,0.00086814846],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98464614,0.0021232187,0.000713333,0.00086162135,0.0013762658,0.00004152864,0.000047912818,0.00012980406,0.0017319517,0.00004821203,0.00036942118,0.007910611],"study_design_scores_gemma":[0.9528021,0.043564375,0.002186865,0.000046801484,0.00072009006,0.000040942858,0.000021614087,0.00012504938,0.00016766507,0.00006446581,0.00024601302,0.000013922908],"about_ca_topic_score_codex":0.000785843,"about_ca_topic_score_gemma":0.0017444688,"teacher_disagreement_score":0.0051294733,"about_ca_system_score_codex":0.0007248803,"about_ca_system_score_gemma":0.0010075773,"threshold_uncertainty_score":0.01715982},"labels":[],"label_agreement":null},{"id":"W2958474879","doi":"10.1016/s1474-4422(19)30243-1","title":"Restoring function in progressive multiple sclerosis","year":2019,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Cerebral Palsy and Movement Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Physical medicine and rehabilitation; Physical therapy; Spinal cord injury; Range of motion; Poliomyelitis; Rehabilitation; Balance (ability); Backpack; Paralysis; Spinal cord; Surgery; Pediatrics","score_opus":0.07476325250101236,"score_gpt":0.2698088400251704,"score_spread":0.19504558752415807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2958474879","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0052947835,0.9923504,0.00003934045,0.0005183991,0.000087440734,0.000052363048,0.00013061587,0.0000063823677,0.0015202061],"genre_scores_gemma":[0.10661442,0.8899149,0.00050243875,0.0014243769,0.0003437898,0.00018222949,0.000295918,0.0000040609257,0.00071791175],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99858814,0.00055049243,0.00042049942,0.000094064424,0.00028192846,0.00006494206],"domain_scores_gemma":[0.9976319,0.0013267713,0.0006587513,0.00005372527,0.00025269768,0.00007617266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020721722,0.00039709744,0.0018844339,0.004019564,0.0004780377,0.00088622235,0.00058693514,0.00082918303,0.0048777456],"category_scores_gemma":[0.006503952,0.00020575419,0.0017024582,0.0025059304,0.0005663586,0.00085030193,0.00087020075,0.00063077675,0.00044054267],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001464117,0.00026509116,0.004872738,0.20886801,0.0029003553,0.0008681161,0.0005602718,0.0002473444,0.0005337068,0.00082678755,0.0068816454,0.7717118],"study_design_scores_gemma":[0.0066667255,0.008823486,0.16941074,0.4927846,0.0253988,0.015337582,0.0030646164,0.000555209,0.0019418233,0.0086743515,0.26717293,0.00016916123],"about_ca_topic_score_codex":0.005677685,"about_ca_topic_score_gemma":0.01956054,"teacher_disagreement_score":0.005677685,"about_ca_system_score_codex":0.0012272882,"about_ca_system_score_gemma":0.002555244,"threshold_uncertainty_score":0.016317666},"labels":[],"label_agreement":null},{"id":"W2961527627","doi":"10.1016/s1474-4422(19)30143-7","title":"Diagnosis, prognosis, and treatment of leukodystrophies","year":2019,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"RNA regulation and disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":174,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hospital for Sick Children","keywords":"Disease; Medicine; Exome sequencing; Leukodystrophy; Genetic diagnosis; Clinical phenotype; Intensive care medicine; Phenotype; Pathology; Biology; Genetics; Gene","score_opus":0.06353283559197256,"score_gpt":0.3256765737329176,"score_spread":0.26214373814094505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2961527627","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000026343147,0.99917406,0.00004896258,0.0004007036,0.00017463349,7.399039e-7,0.000007643829,0.0000027304004,0.00016419996],"genre_scores_gemma":[0.00066749123,0.9980596,0.00010684907,0.00039114302,0.000584496,0.0000026715693,0.000020462225,9.1937557e-7,0.00016650296],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996352,0.00008770043,0.00005600176,0.000059032318,0.00012724985,0.000034802473],"domain_scores_gemma":[0.9991868,0.0004727865,0.00013728325,0.000017500777,0.00012815917,0.000057393787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012901077,0.0011448746,0.00258816,0.0020162775,0.00020850381,0.0011111377,0.0013285746,0.0015932984,0.0014228385],"category_scores_gemma":[0.0021906798,0.00025841434,0.0004526439,0.0017271709,0.0008533498,0.0008192706,0.0006315371,0.0026425677,0.0009988996],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021506936,0.00004709921,0.0003882755,0.0073981914,0.00015798716,0.00030592075,0.000020961108,0.0005709823,0.000500876,0.0039407434,0.054172114,0.9322818],"study_design_scores_gemma":[0.0001379007,0.00016220451,0.003010119,0.009559504,0.00045835145,0.0030106388,0.00007637456,0.0003053142,0.00030845273,0.008612132,0.97430587,0.00005305378],"about_ca_topic_score_codex":0.0016261643,"about_ca_topic_score_gemma":0.0032510262,"teacher_disagreement_score":0.00258816,"about_ca_system_score_codex":0.0011244488,"about_ca_system_score_gemma":0.0011062551,"threshold_uncertainty_score":0.008158445},"labels":[],"label_agreement":null},{"id":"W2964900000","doi":"10.1016/s1474-4422(19)30280-7","title":"Antithrombotics and bleeding risk: paradoxical findings","year":2019,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Calgary","funders":"","keywords":"Medicine","score_opus":0.025362596319350814,"score_gpt":0.2588904235513212,"score_spread":0.23352782723197038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964900000","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015124489,0.93667567,0.0015199764,0.03998476,0.0019163804,0.000050010458,0.0014826077,0.000024535091,0.0032215777],"genre_scores_gemma":[0.46353796,0.46681958,0.0026624661,0.05191252,0.011627057,0.00015192173,0.0014136598,0.00010882153,0.001766],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97682196,0.011164239,0.004492148,0.0032768832,0.00368619,0.0005585988],"domain_scores_gemma":[0.73382723,0.22704887,0.018071886,0.008063889,0.011404874,0.0015832506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03581232,0.0013191163,0.0035573281,0.0039501884,0.0004895943,0.0030647058,0.0021669918,0.003540259,0.010157813],"category_scores_gemma":[0.121297285,0.000860105,0.009195949,0.005999292,0.0015706477,0.0034857094,0.0016925097,0.003584885,0.0009998821],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016482564,0.00015934487,0.15321209,0.12085421,0.30303857,0.0034985372,0.0015169505,0.0012708994,0.0016158021,0.013865381,0.0634733,0.32101232],"study_design_scores_gemma":[0.0063593932,0.0021885738,0.30705926,0.08421251,0.39016446,0.0067507327,0.0024110824,0.002684114,0.0016865281,0.07482949,0.121124156,0.0005297248],"about_ca_topic_score_codex":0.0056914175,"about_ca_topic_score_gemma":0.006145336,"teacher_disagreement_score":0.03581232,"about_ca_system_score_codex":0.0011597489,"about_ca_system_score_gemma":0.0017974534,"threshold_uncertainty_score":0.1893959},"labels":[],"label_agreement":null},{"id":"W2965689998","doi":"10.1016/s1474-4422(19)30231-5","title":"Long-term antithrombotic therapy and risk of intracranial haemorrhage from cerebral cavernous malformations: a population-based cohort study, systematic review, and meta-analysis","year":2019,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Vascular Malformations Diagnosis and Treatment","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Chief Scientist Office, Scottish Government Health and Social Care Directorate; Medical Research Council Canada; Stroke Association; Scottish Government","keywords":"Antithrombotic; Medicine; Intracranial haemorrhage; Cohort; Term (time); Meta-analysis; Cohort study; Pediatrics; Population; Internal medicine; Surgery; Neurosurgery","score_opus":0.08199144843130235,"score_gpt":0.3390013353406911,"score_spread":0.25700988690938875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965689998","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012547958,0.9856331,0.00044317436,0.00016076278,0.00010876032,0.00018950544,0.0006957167,0.00001786197,0.000203143],"genre_scores_gemma":[0.3168883,0.6771802,0.0020713855,0.0009103068,0.00030454117,0.0010337173,0.0012544731,0.00002329852,0.00033379078],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9943116,0.0021083555,0.0018794481,0.00078800437,0.00065236806,0.000260246],"domain_scores_gemma":[0.98372793,0.011448285,0.0028858697,0.00057299534,0.0011442305,0.00022070052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007984376,0.0015476738,0.01129286,0.005391227,0.00061607047,0.002483258,0.0015806314,0.00181509,0.0023953267],"category_scores_gemma":[0.021717723,0.0010776469,0.024612773,0.007559484,0.0006055232,0.0010324799,0.0010459258,0.0011550357,0.00018890569],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019872198,0.000040498166,0.020460097,0.28450835,0.68136036,0.00025244724,0.0001007599,0.0005401151,0.00026686967,0.00012100889,0.00070582854,0.009656526],"study_design_scores_gemma":[0.00040567742,0.00017530328,0.011475858,0.015441887,0.97065735,0.00017131491,0.000046867866,0.00021858227,0.00008155424,0.000149127,0.0011527933,0.00002373943],"about_ca_topic_score_codex":0.0070524807,"about_ca_topic_score_gemma":0.01622292,"teacher_disagreement_score":0.01129286,"about_ca_system_score_codex":0.0015891955,"about_ca_system_score_gemma":0.0025334589,"threshold_uncertainty_score":0.042225897},"labels":[],"label_agreement":null},{"id":"W2968037752","doi":"10.1016/s1474-4422(19)30138-3","title":"MRI in traumatic spinal cord injury: from clinical assessment to neuroimaging biomarkers","year":2019,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Advanced Neuroimaging Techniques and Applications","field":"Medicine","cited_by":208,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Horizon 2020; Canadian Institutes of Health Research; European Research Council; International Foundation for CDKL5 Research; H2020 European Research Council; Eisai; International Foundation for Research in Paraplegia; Siemens; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; F. Hoffmann-La Roche; Singapore Eye Research Institute; University College London Hospitals NHS Foundation Trust; European Commission; Max-Planck-Institut für Kognitions- und Neurowissenschaften; Wings for Life; International Spinal Research Trust; University College London; Staatssekretariat für Bildung, Forschung und Innovation; Craig H. Neilsen Foundation; Wellcome Trust","keywords":"Medicine; Neuroimaging; Magnetic resonance imaging; Spinal cord; Spinal cord injury; Traumatic brain injury; Spinal cord compression; Radiology; Physical medicine and rehabilitation","score_opus":0.3661599137340523,"score_gpt":0.5518174254858047,"score_spread":0.18565751175175238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968037752","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019753425,0.99953115,0.000036659345,0.00016335664,0.00010047913,0.0000013982657,0.0000059719473,0.0000018773171,0.00013924997],"genre_scores_gemma":[0.00032948426,0.9988292,0.00009212039,0.00035325653,0.00027746998,0.0000031467291,0.000012036135,9.083103e-7,0.00010244559],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994154,0.00012676927,0.00012234702,0.00011134364,0.00017940046,0.00004475146],"domain_scores_gemma":[0.9978387,0.0014342383,0.00024465364,0.0000432559,0.00036255666,0.00007656883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017313551,0.0013618312,0.0032196792,0.003882003,0.00024742246,0.0019658464,0.00146283,0.002223864,0.0024871766],"category_scores_gemma":[0.003289785,0.00052976975,0.000920204,0.0031559258,0.0012948348,0.002183034,0.0012166307,0.00278882,0.001360216],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014211347,0.00005137642,0.00034513016,0.034834072,0.00028139568,0.00018091642,0.000053897358,0.00037863656,0.00062471343,0.0032690868,0.0308314,0.9290073],"study_design_scores_gemma":[0.00013242857,0.00025538987,0.0034676222,0.042476207,0.001053005,0.0025871457,0.00022560376,0.00036239933,0.00043702198,0.007007365,0.9419016,0.00009408188],"about_ca_topic_score_codex":0.0025169763,"about_ca_topic_score_gemma":0.0040529617,"teacher_disagreement_score":0.003882003,"about_ca_system_score_codex":0.0011047386,"about_ca_system_score_gemma":0.0022005653,"threshold_uncertainty_score":0.009156346},"labels":[],"label_agreement":null},{"id":"W2969795325","doi":"10.1016/s1474-4422(19)30228-5","title":"Associations between blood pressure across adulthood and late-life brain structure and pathology in the neuroscience substudy of the 1946 British birth cohort (Insight 46): an epidemiological study","year":2019,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":269,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Horizon 2020 Framework Programme; Dementias Platform UK; UK Dementia Research Institute; Avid Radiopharmaceuticals; Medical Research Council; Medical Research Council Canada; Alzheimer’s Research UK; National Institute for Health and Care Research; UCLH Biomedical Research Centre; Nano-Convergence Foundation; Engineering and Physical Sciences Research Council; Brain Research UK; Eli Lilly and Company; Alzheimer's Society; Alzheimer Society; University College London; Wellcome Trust; California State University, Bakersfield; British Heart Foundation; Weston Brain Institute; Mayo Clinic; Wolfson Foundation; Brain Research Trust; Nathan Cummings Foundation","keywords":"Blood pressure; Medicine; Cohort; Cognitive decline; Internal medicine; Dementia; Hyperintensity; Cohort study; Cognition; Cardiology; Psychology; Pathology; Neuroscience; Magnetic resonance imaging; Radiology; Disease","score_opus":0.03149446468084148,"score_gpt":0.3351162142126253,"score_spread":0.3036217495317838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969795325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968208,0.0005790683,0.00009670052,0.000040305164,0.000009088675,0.000026862372,0.001995615,0.000007026493,0.00042461406],"genre_scores_gemma":[0.996636,0.00047942877,0.00017500429,0.00005378047,0.00001775546,0.000048654765,0.0020515106,0.0000052366695,0.00053278066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992262,0.00014651926,0.000082014936,0.00020145113,0.00018247141,0.00016129651],"domain_scores_gemma":[0.99823976,0.00011609415,0.0005874409,0.00030777484,0.00028954854,0.00045939672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009317039,0.0005178124,0.0009209311,0.0013109385,0.0011744055,0.0011828807,0.00080925564,0.0008887533,0.0010555756],"category_scores_gemma":[0.0017252514,0.00070994673,0.0006769868,0.0023080562,0.0005254922,0.0004983957,0.0011103415,0.000989838,0.00046300772],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000348487,0.000071884904,0.9967373,0.00002147142,0.00017403359,0.00015896249,0.00049170235,0.00002728412,0.000728532,0.000024945319,0.00022812015,0.0009872832],"study_design_scores_gemma":[0.000007895106,0.000046078705,0.9995474,0.000005385356,0.000028455217,0.00009893843,0.00008313561,0.000021565802,0.000029989962,0.0000062019362,0.00012177738,0.0000030723515],"about_ca_topic_score_codex":0.14315292,"about_ca_topic_score_gemma":0.17224956,"teacher_disagreement_score":0.14315292,"about_ca_system_score_codex":0.0010514891,"about_ca_system_score_gemma":0.00051808293,"threshold_uncertainty_score":0.28463936},"labels":[],"label_agreement":null},{"id":"W2971487735","doi":"10.1016/s1474-4422(19)30238-8","title":"Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial","year":2019,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":279,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; McGill University; University of Toronto; NeuroRx Research (Canada)","funders":"Javna Agencija za Raziskovalno Dejavnost RS; Celgene","keywords":"Medicine; Internal medicine; Population; Clinical endpoint; Placebo; Multiple sclerosis; Clinical trial; Physical therapy; Pathology; Immunology; Alternative medicine","score_opus":0.1008831938011834,"score_gpt":0.3344472093053279,"score_spread":0.23356401550414452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971487735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902824,0.0061535067,0.00028826346,0.0005803583,0.0003321511,0.00088785554,0.00055018615,0.00006028643,0.00086494134],"genre_scores_gemma":[0.9920203,0.0023198912,0.000801233,0.00082601083,0.00034385966,0.0013737332,0.0006645553,0.000023980849,0.0016263737],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988452,0.0006895239,0.00006974864,0.00015531052,0.00006931398,0.000170903],"domain_scores_gemma":[0.9985935,0.00045602774,0.0003866985,0.00011224457,0.000070758215,0.00038089612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002554465,0.0019185661,0.003996495,0.00042773216,0.0006139468,0.0013722021,0.0010122543,0.002534951,0.005118782],"category_scores_gemma":[0.002387082,0.00070375414,0.0031292855,0.0004983627,0.0015414996,0.0015107724,0.00062224624,0.0038195853,0.0010269319],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9906413,0.0012327264,0.00030313357,0.0002967006,0.00058565056,0.000019882382,0.000039826376,0.000117698204,0.00092989503,0.000035204557,0.00022724537,0.005570866],"study_design_scores_gemma":[0.959164,0.03788142,0.0018326007,0.000031098978,0.00040843454,0.000025550384,0.000025928499,0.00014510108,0.0001561708,0.00009378514,0.00022207272,0.000013801576],"about_ca_topic_score_codex":0.0012516809,"about_ca_topic_score_gemma":0.0019688536,"teacher_disagreement_score":0.005118782,"about_ca_system_score_codex":0.0009743465,"about_ca_system_score_gemma":0.0010712383,"threshold_uncertainty_score":0.017124057},"labels":[],"label_agreement":null},{"id":"W2971577153","doi":"10.1016/s1474-4422(19)30239-x","title":"Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial","year":2019,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":286,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; McGill University; University of Toronto; NeuroRx Research (Canada)","funders":"Schweizerische Multiple Sklerose Gesellschaft; Bayer Schering; Javna Agencija za Raziskovalno Dejavnost RS; Ministerstvo Školství, Mládeže a Tělovýchovy; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Sanofi; European Commission; Bayer; Celgene; Biogen; AbbVie; MedImmune; Merck; Teva Pharmaceutical Industries; Novartis; Roche","keywords":"Medicine; Internal medicine; Population; Clinical endpoint; Placebo; Clinical trial; Physical therapy; Pathology; Alternative medicine","score_opus":0.0951953261825901,"score_gpt":0.33367847965901576,"score_spread":0.23848315347642565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971577153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906529,0.0047357143,0.00038966586,0.00064604275,0.00035968242,0.0011454375,0.0008453416,0.00008378881,0.0011413435],"genre_scores_gemma":[0.99037206,0.0020542687,0.0012022747,0.0010596355,0.00030809257,0.0020001235,0.00093284796,0.000032234268,0.002038351],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988311,0.00069888256,0.00006878226,0.000163916,0.000074489755,0.00016279868],"domain_scores_gemma":[0.9984372,0.0005510219,0.00038432895,0.00014008135,0.000079274,0.0004081258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028024656,0.0016695688,0.00397879,0.0003879459,0.00063453027,0.0013505849,0.00093129155,0.0023336366,0.0068803425],"category_scores_gemma":[0.002345096,0.0007716225,0.00300216,0.00042823522,0.0014459526,0.0014898564,0.0006888434,0.0035615223,0.0011389669],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99026513,0.0011246251,0.0003869051,0.00032319824,0.0005727433,0.0000159323,0.000039496434,0.00015245141,0.00086600456,0.000040467243,0.00033647707,0.0058766007],"study_design_scores_gemma":[0.9698008,0.027505854,0.0017241416,0.00003247982,0.00030441326,0.000021831554,0.000020345638,0.00013915553,0.00013192583,0.000101039106,0.00020669732,0.0000114165905],"about_ca_topic_score_codex":0.001060498,"about_ca_topic_score_gemma":0.00210344,"teacher_disagreement_score":0.0068803425,"about_ca_system_score_codex":0.00089080544,"about_ca_system_score_gemma":0.0011575895,"threshold_uncertainty_score":0.023017049},"labels":[],"label_agreement":null},{"id":"W2971598158","doi":"10.1016/s1474-4422(19)30290-x","title":"Dementia in China: epidemiology, clinical management, and research advances","year":2019,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":861,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Key Scientific Instrument and Equipment Development Projects of China; Public Library Association; Foundation for Innovative Research Groups of the National Natural Science Foundation of China; Capital Medical University; Beijing Municipal Administration of Hospitals; Tianjin Medical University; Peking University; Shanghai Jiao Tong University; Eli Lilly and Company; Guizhou Medical University; Lundbeckfonden; Chinese University of Hong Kong; First Affiliated Hospital, Liaoning Medical University; Department of Neurology, University of Pittsburgh; Innovative Research Group Project of the National Natural Science Foundation of China; Chongqing Medical University; University of South China; Sun Yat-sen University; Harbin Medical University; Chongqing Municipal Human Resources and Social Security Bureau; Beijing Municipal Science and Technology Commission; Shandong University; Guangzhou Municipal Health and Family Planning Commission; Jilin University; AstraZeneca","keywords":"Dementia; Medicine; Epidemiology; China; Government (linguistics); Public health; Health care; Disease; Gerontology; Nursing; Economic growth; Political science; Pathology","score_opus":0.3565858047558982,"score_gpt":0.5651697181433428,"score_spread":0.20858391338744464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971598158","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019955641,0.99924254,0.000017785589,0.0003302461,0.00007846854,0.0000036506556,0.00003819466,0.0000021088895,0.000087390756],"genre_scores_gemma":[0.0013095987,0.9982457,0.00005816465,0.00018594982,0.00013190482,0.000005771622,0.000027453114,3.8826423e-7,0.000034998196],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99925214,0.00013606268,0.00020221224,0.00012879356,0.00020928636,0.0000714788],"domain_scores_gemma":[0.99785256,0.0009832908,0.00057617336,0.000038173075,0.0003999859,0.00014971284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003265698,0.0013427269,0.003888992,0.005231181,0.00040436062,0.0018339552,0.0012136607,0.0012238631,0.0023554505],"category_scores_gemma":[0.004205136,0.00037025227,0.001668497,0.008923917,0.000697911,0.0013683621,0.0011243573,0.0012670634,0.00025518032],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026916183,0.000090104964,0.0057546506,0.10984244,0.0016328207,0.00018305489,0.00017797772,0.0004894336,0.00023610597,0.0019484708,0.019199286,0.8601765],"study_design_scores_gemma":[0.00069043617,0.0010027554,0.14284782,0.22934875,0.023839656,0.0031697971,0.0015595134,0.0015236589,0.00062887,0.00784984,0.5871544,0.0003844885],"about_ca_topic_score_codex":0.02463047,"about_ca_topic_score_gemma":0.043541156,"teacher_disagreement_score":0.02463047,"about_ca_system_score_codex":0.0027931689,"about_ca_system_score_gemma":0.0124103995,"threshold_uncertainty_score":0.048974156},"labels":[],"label_agreement":null},{"id":"W2972934723","doi":"10.1016/s1474-4422(19)30330-8","title":"Regulatory oversights for implantable neurodevices","year":2019,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; BC Children's Hospital; NeuroDevNet; University of British Columbia","funders":"","keywords":"Harm; Medicine; Health care; Patient safety; Medical device; Liability; Christian ministry; Public relations; Medical emergency; Political science; Law","score_opus":0.04376435069353838,"score_gpt":0.280836886577583,"score_spread":0.23707253588404462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972934723","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003534571,0.0016237571,0.0003016926,0.9616798,0.020747934,0.000021593376,0.00008561941,0.00006905414,0.015117129],"genre_scores_gemma":[0.0031702316,0.0005249047,0.0002342018,0.9709892,0.01152724,0.00003896037,0.000034660927,0.000033377877,0.01344729],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9778398,0.0046818214,0.0021797994,0.0026790407,0.008207227,0.0044123707],"domain_scores_gemma":[0.95250493,0.030344186,0.0026735307,0.0015254237,0.0085254805,0.004426476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015798865,0.0015737383,0.0020129152,0.0015123729,0.0083236,0.013051626,0.005405213,0.22867087,0.015726676],"category_scores_gemma":[0.08000393,0.0014462983,0.0039938674,0.0010915404,0.008801753,0.006675679,0.004611706,0.078345,0.009505882],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059988746,0.000031636093,0.0002528534,0.00006650872,0.000018167582,0.0009647268,0.00017830986,0.00008678261,0.00031076622,0.0190242,0.97258323,0.0064228666],"study_design_scores_gemma":[0.00014443896,0.000053412157,0.00051689585,0.0004121452,0.000046683777,0.0007546288,0.00022924866,0.0003672939,0.00036820382,0.022069914,0.9749614,0.000075861724],"about_ca_topic_score_codex":0.022442628,"about_ca_topic_score_gemma":0.03760867,"teacher_disagreement_score":0.22867087,"about_ca_system_score_codex":0.00982298,"about_ca_system_score_gemma":0.027019266,"threshold_uncertainty_score":0.083553374},"labels":[],"label_agreement":null},{"id":"W2973037195","doi":"10.1016/s1474-4422(19)30283-2","title":"Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study","year":2019,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute on Aging; Johnson and Johnson Pharmaceutical Research and Development; Fuel Cell Technologies Program; Fifth Framework Programme; Canadian Institutes of Health Research; Parkinsonfonden; Danone Research Centre for Specialised Nutrition; European Regional Development Fund; European Research Council; GE Healthcare; Fondation Segré; H. Lundbeck A/S; Marcus och Amalia Wallenbergs minnesfond; National Institute of Biomedical Imaging and Bioengineering; Amsterdam Neuroscience; Skånes universitetssjukhus; Pfizer Pharmaceuticals; Innovative Medicines Initiative; AXA Research Fund; Fondation Plan Alzheimer; Servier; American Liver Foundation; Knut och Alice Wallenbergs Stiftelse; Australian Government; Lunds Universitet; Vetenskapsrådet; NIHR Imperial Biomedical Research Centre; Foundation for the National Institutes of Health; Eisai; UCLH Biomedical Research Centre; Fondation pour la Recherche sur la Biodiversite; Hôpitaux Universitaires de Genève; Fondation Vaincre Alzheimer; Bundesministerium für Bildung und Forschung; Alzheimer Nederland; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Institut National de la Santé et de la Recherche Médicale; Boehringer Ingelheim; Seventh Framework Programme; Novartis Pharmaceuticals Corporation; Merck; Association pour la Recherche sur le Cancer; DoD Alzheimer's Disease Neuroimaging Initiative; Alzheimer's Disease Neuroimaging Initiative; Meso Scale Diagnostics; Biogen; Agence Nationale de la Recherche; F. Hoffmann-La Roche; Alzheimer's Association; European Federation of Pharmaceutical Industries and Associations; Takeda Pharmaceutical Company; Hjärnfonden; AstraZeneca; European Commission; AbbVie; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Novartis; Bristol-Myers Squibb; Eli Lilly and Company; Roche; ZonMw; National Institutes of Health; Alzheimer's Drug Discovery Foundation; Nederlandse Brandwonden Stichting; National Science Foundation; Fundação para a Ciência e a Tecnologia; EU Joint Programme – Neurodegenerative Disease Research; Oryzon Genomics; Sweden-America Foundation","keywords":"Dementia; Biomarker; Oncology; Medicine; Cohort; Alzheimer's Disease Neuroimaging Initiative; Internal medicine; Disease; Gerontology","score_opus":0.05165167316379238,"score_gpt":0.332468020614417,"score_spread":0.2808163474506246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973037195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99191916,0.00072268496,0.0033008659,0.0005648629,0.00004793886,0.00007307433,0.002526588,0.000057955094,0.0007869556],"genre_scores_gemma":[0.9954334,0.00033423305,0.0015117675,0.00009872083,0.000027198113,0.00011335185,0.0016604126,0.000014919776,0.0008060514],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9979752,0.0012605742,0.00010036186,0.00036011846,0.00010688936,0.00019689929],"domain_scores_gemma":[0.9834403,0.01195935,0.0015150897,0.0017670036,0.0007351369,0.00058298575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008980106,0.0017166857,0.0017904004,0.0009346401,0.0006925169,0.0022932256,0.002532118,0.0025335432,0.0032953327],"category_scores_gemma":[0.019727733,0.000902144,0.0043219994,0.0012660597,0.00059967645,0.0015370783,0.0015096623,0.0024846534,0.0007478736],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056681335,0.007689221,0.72181666,0.001341419,0.022065615,0.0013046641,0.0025772136,0.13410826,0.0010733911,0.0087787025,0.008804875,0.033758704],"study_design_scores_gemma":[0.005420113,0.007885105,0.40077183,0.0006067799,0.014566641,0.0009219052,0.0015072857,0.54629266,0.0005185848,0.01703614,0.004085534,0.0003874875],"about_ca_topic_score_codex":0.04273356,"about_ca_topic_score_gemma":0.021563385,"teacher_disagreement_score":0.04273356,"about_ca_system_score_codex":0.0017400311,"about_ca_system_score_gemma":0.0014388141,"threshold_uncertainty_score":0.08496964},"labels":[],"label_agreement":null},{"id":"W2983286922","doi":"10.1016/s1474-4422(19)30364-3","title":"New treatment options needed for chronic cluster headache","year":2019,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cluster headache; Sumatriptan; Medicine; Occipital nerve stimulation; Headaches; Chronic Migraine; Dihydroergotamine; Neurology; Migraine; Deep brain stimulation; Anesthesia; Intensive care medicine; Surgery; Internal medicine; Alternative medicine; Psychiatry","score_opus":0.07843010358338122,"score_gpt":0.3330472589486526,"score_spread":0.2546171553652714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983286922","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018448492,0.016045962,0.00004671035,0.96333784,0.017937172,0.000009414235,0.00006134791,0.000009568217,0.002367574],"genre_scores_gemma":[0.003125582,0.012351834,0.000273056,0.8517725,0.12940592,0.00006442927,0.00007611384,0.000016808692,0.002913842],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9917007,0.0033979383,0.0017566095,0.00053193443,0.0017772489,0.00083554926],"domain_scores_gemma":[0.95808184,0.028882436,0.0028473744,0.001104475,0.0046449606,0.0044388743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009439726,0.0009571749,0.0028584837,0.0021007822,0.0030307989,0.005511038,0.00206369,0.044118084,0.016542003],"category_scores_gemma":[0.039712727,0.0008859421,0.0026172851,0.0014663264,0.005332787,0.009984239,0.0031272036,0.034749847,0.005836695],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003700536,0.00006783317,0.00073136616,0.000815614,0.000075732714,0.0021470662,0.00017157874,0.000081708575,0.00018118904,0.005926109,0.94473904,0.04469277],"study_design_scores_gemma":[0.0014757072,0.00014538692,0.0021053927,0.004479399,0.00018068295,0.002556795,0.00078494905,0.00027976316,0.00009296283,0.02505576,0.962725,0.00011812955],"about_ca_topic_score_codex":0.0062847924,"about_ca_topic_score_gemma":0.018783864,"teacher_disagreement_score":0.044118084,"about_ca_system_score_codex":0.0048823557,"about_ca_system_score_gemma":0.0072840317,"threshold_uncertainty_score":0.055338442},"labels":[],"label_agreement":null},{"id":"W2986279507","doi":"10.1016/s1474-4422(19)30354-0","title":"Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study","year":2019,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":186,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Western University; University of Toronto; Sunnybrook Hospital; Occupational Cancer Research Centre; Université Laval","funders":"Medical Research Council; Stockholm läns landsting; Stichting Dioraphte; Hjärnfonden; Vetenskapsrådet; Ministero della Salute; Alzheimer’s Research UK; European Commission; ZonMw; Fondation Thierry Latran; Ionis Pharmaceuticals; Wellcome Trust; Deutsche Forschungsgemeinschaft; Alzheimerfonden; Fundació la Marató de TV3; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; Alzheimer Society; Karolinska Institutet; EU Joint Programme – Neurodegenerative Disease Research; AbbVie","keywords":"Frontotemporal dementia; C9orf72; Medicine; Dementia; Cohort; Oncology; Genetic testing; Frontotemporal lobar degeneration; Internal medicine; Cohort study; Pediatrics; Psychiatry; Disease","score_opus":0.029192319995398074,"score_gpt":0.2940176504076115,"score_spread":0.26482533041221346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986279507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988159,0.00024125961,0.00010881393,0.0000834931,0.000018399776,0.000014699018,0.0005558433,0.0000072127855,0.0001544655],"genre_scores_gemma":[0.9985501,0.00015181353,0.00019047367,0.00008658128,0.000019771449,0.000031696844,0.0005824963,0.0000069536286,0.00038008182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851817,0.00044001336,0.0001120077,0.0005109889,0.00014680636,0.00027211008],"domain_scores_gemma":[0.9972498,0.00037030186,0.00062791194,0.0006526076,0.00047156244,0.00062777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002826114,0.0014397833,0.0012393538,0.0010708694,0.002113738,0.0019327456,0.0015420993,0.0023365773,0.0014877426],"category_scores_gemma":[0.0037622615,0.0016775804,0.0019149885,0.0019851879,0.0010029385,0.0017247801,0.0015930785,0.002178954,0.0004998799],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031752705,0.00043240856,0.9899929,0.00002693065,0.0013750987,0.00074481615,0.00066217966,0.00009436528,0.001511234,0.00007824738,0.00057135936,0.0013351894],"study_design_scores_gemma":[0.00023254742,0.0004104524,0.99725217,0.000015180377,0.00051533425,0.00051818276,0.00045854147,0.00025461472,0.00007838719,0.000066492656,0.0001736911,0.00002443815],"about_ca_topic_score_codex":0.040193725,"about_ca_topic_score_gemma":0.033978328,"teacher_disagreement_score":0.040193725,"about_ca_system_score_codex":0.001455677,"about_ca_system_score_gemma":0.0010430819,"threshold_uncertainty_score":0.07991958},"labels":[],"label_agreement":null},{"id":"W2986932567","doi":"10.1016/s1474-4422(19)30320-5","title":"Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies","year":2019,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":2541,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Division of Human Resource Management; National Institute on Aging; Medical Research Council; School of Public Health, University of California Berkeley; Fédération pour la Recherche sur le Cerveau; Norges Forskningsråd; Agence Nationale de la Recherche; Chung Hua University; Obstetric Anaesthetists' Association; Biogen; London Mathematical Society; Parkinson's UK; Novartis; PSP Association; Adrienne Helis Malvin Medical Research Foundation; GE Healthcare; North Carolina GlaxoSmithKline Foundation; National Institutes of Health; Rosetrees Trust; Association France Parkinson; European Commission; Sanofi; Barts Charity; Boehringer Ingelheim; Michael J. Fox Foundation for Parkinson's Research; Roche; Institut de France; Fondation Roger de Spoelberch; H. Lundbeck A/S; Burroughs Wellcome Fund","keywords":"Genome-wide association study; Disease; LRRK2; Genetic association; Single-nucleotide polymorphism; Mendelian randomization; Genetics; Biology; Meta-analysis; Mendelian inheritance; Heritability; Missing heritability problem; Parkinson's disease; Bioinformatics; Medicine; Genotype; Gene; Genetic variants; Internal medicine","score_opus":0.13242462307934585,"score_gpt":0.3618705636436138,"score_spread":0.22944594056426795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986932567","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001688012,0.99697876,0.00070097856,0.00024977088,0.00006355987,0.000014083719,0.00018841507,0.0000138150435,0.00010250517],"genre_scores_gemma":[0.04643791,0.9490699,0.0027360187,0.0005895154,0.00028286982,0.000058784986,0.00064082706,0.000018357263,0.00016576998],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9964044,0.0017136342,0.0006204881,0.00066800264,0.0004594562,0.00013402842],"domain_scores_gemma":[0.9867867,0.011244625,0.00093941827,0.00044743918,0.00045362665,0.0001281893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009694111,0.0023176023,0.009162616,0.0032271696,0.0002903623,0.0022171407,0.0019123117,0.0018654153,0.002226264],"category_scores_gemma":[0.01430479,0.0007836123,0.014352901,0.004779083,0.00046029646,0.0009870266,0.0014149386,0.001896595,0.00026402078],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033076855,0.000077350414,0.02951329,0.11949179,0.53622526,0.0005267709,0.00015543158,0.0023028362,0.00143371,0.0011008384,0.004270034,0.30159494],"study_design_scores_gemma":[0.00079223013,0.00042879663,0.04722073,0.017425932,0.9034108,0.0010194676,0.0001583267,0.0010786965,0.00065319455,0.0059036515,0.021782145,0.00012616755],"about_ca_topic_score_codex":0.0033620894,"about_ca_topic_score_gemma":0.0073653758,"teacher_disagreement_score":0.009694111,"about_ca_system_score_codex":0.0008981811,"about_ca_system_score_gemma":0.0018774307,"threshold_uncertainty_score":0.05126798},"labels":[],"label_agreement":null},{"id":"W2987888180","doi":"10.1016/s1474-4422(19)30412-0","title":"Core outcomes for subarachnoid haemorrhage","year":2019,"lang":"ceb","type":"letter","venue":"The Lancet Neurology","topic":"Traumatic Brain Injury and Neurovascular Disturbances","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Subarachnoid haemorrhage; Subarachnoid hemorrhage; Medicine; Core (optical fiber); Computer science; Internal medicine; Surgery; Aneurysm; Telecommunications","score_opus":0.1027567357051092,"score_gpt":0.3228525177035942,"score_spread":0.220095781998485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987888180","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031985613,0.006492666,0.000073643525,0.96069807,0.01641304,0.000021921944,0.0006891526,0.00002998398,0.012382994],"genre_scores_gemma":[0.11402464,0.008540335,0.00044588704,0.7055511,0.15913253,0.00026950467,0.0018730173,0.000067190405,0.010095849],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972819,0.00065385585,0.0004027302,0.00016189102,0.00077310554,0.00072643755],"domain_scores_gemma":[0.9852085,0.004356212,0.0015178066,0.00032641037,0.0033920424,0.005199066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018672921,0.00042570598,0.0013242818,0.0013701238,0.002342428,0.0027713042,0.0008035689,0.011963098,0.009596545],"category_scores_gemma":[0.032959934,0.00025920448,0.0007628207,0.0015184091,0.0013221287,0.0018916045,0.0015709448,0.012104417,0.0027473597],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001951376,0.000042057505,0.0056589874,0.00013573753,0.000028805205,0.00095842296,0.00009052328,0.00005875118,0.00008971755,0.0028815742,0.96778286,0.022077441],"study_design_scores_gemma":[0.0018998479,0.00050813385,0.14255294,0.005977256,0.00034971072,0.007448534,0.001755933,0.001690686,0.000505843,0.08462294,0.7522883,0.00039987554],"about_ca_topic_score_codex":0.011808551,"about_ca_topic_score_gemma":0.023635024,"teacher_disagreement_score":0.011963098,"about_ca_system_score_codex":0.005730572,"about_ca_system_score_gemma":0.0071382523,"threshold_uncertainty_score":0.041578412},"labels":[],"label_agreement":null},{"id":"W2992571333","doi":"10.1016/s1474-4422(19)30395-3","title":"Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial","year":2019,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":638,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; Modified Rankin Scale; Randomized controlled trial; Occlusion; Stroke (engine); Adverse effect; Surgery; Intention-to-treat analysis; Internal medicine; Ischemic stroke; Ischemia","score_opus":0.05447406290759358,"score_gpt":0.3370357297031515,"score_spread":0.2825616667955579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992571333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9081724,0.066038296,0.0024739723,0.0034628718,0.005920991,0.005051574,0.002671305,0.00028363595,0.005924871],"genre_scores_gemma":[0.9641899,0.01559675,0.0029781202,0.003021416,0.002866663,0.004925971,0.0016301579,0.00003778155,0.0047533866],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984865,0.0007551561,0.00014398951,0.0002980381,0.00012216187,0.00019415545],"domain_scores_gemma":[0.99799347,0.0010328841,0.00037493304,0.00017710844,0.000117692194,0.00030398797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002540489,0.0019964932,0.007522045,0.000740519,0.0006721584,0.00192146,0.0014280091,0.00454848,0.011519122],"category_scores_gemma":[0.003982183,0.0011770929,0.0047526984,0.0006405639,0.0021437083,0.0025498862,0.0006968719,0.0035248671,0.0014732056],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9916437,0.000980834,0.00015803738,0.0013818435,0.0017712147,0.000026279069,0.000019919951,0.00009587143,0.0002697822,0.00009903553,0.00041428054,0.003139173],"study_design_scores_gemma":[0.9897193,0.007726141,0.00055981666,0.00010308414,0.0012279241,0.00001881817,0.000015410676,0.00015254023,0.000048510137,0.00016748812,0.0002498771,0.0000111799645],"about_ca_topic_score_codex":0.0013422596,"about_ca_topic_score_gemma":0.0023214489,"teacher_disagreement_score":0.011519122,"about_ca_system_score_codex":0.0010257644,"about_ca_system_score_gemma":0.00085438835,"threshold_uncertainty_score":0.038535357},"labels":[],"label_agreement":null},{"id":"W2993046104","doi":"10.1016/s1474-4422(19)30394-1","title":"Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study","year":2019,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":311,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Université Laval; Hôpital de l'Enfant-Jésus; University of Toronto; McGill University Health Centre; Sunnybrook Health Science Centre; Health Sciences Centre; University of British Columbia","funders":"Janssen Pharmaceuticals; National Institute of Neurological Disorders and Stroke; National Institute on Aging; UCLH Biomedical Research Centre; National Health and Medical Research Council; Medical Research Council; GE Healthcare; Alzheimer's Disease Research Center, Emory University; Genentech; Centre Hospitalier Universitaire de Nîmes; Institut de France; Hjärnfonden; Demensfonden; H. Lundbeck A/S; Stockholm läns landsting; Centre Hospitalier Universitaire de Nice; Fédération pour la Recherche sur le Cerveau; Roche; Stockholms Läns Landsting; Biogen; Agence Nationale de la Recherche; Bundesministerium für Bildung und Forschung; Guarantors of Brain; National Institute for Health and Care Research; Association France Parkinson; Stichting Dioraphte; Wellcome Trust; Ontario Ministry of Economic Development and Innovation; Pfizer; EU Joint Programme – Neurodegenerative Disease Research; Astex Pharmaceuticals; Weston Brain Institute; Alzheimerfonden; Karolinska Institutet; ZonMw; National Institutes of Health; Alzheimer's Drug Discovery Foundation; TauRx Pharmaceuticals; UCB; Ministero della Salute; Assistance Publique - Hôpitaux de Paris; AbbVie; Fondation Brain Canada; Vetenskapsrådet; Cytokinetics; National Medical Research Council; Alzheimer Nederland; Instituto de Salud Carlos III; UK Dementia Research Institute; Ontario Brain Institute; Ministero dello Sviluppo Economico; Heart and Stroke Foundation of Canada; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Novartis; Fondation Roger de Spoelberch; Eli Lilly and Company; Amgen; Association for Frontotemporal Degeneration; Alexion Pharmaceuticals; Canadian Institutes of Health Research; Alzheimer's Society","keywords":"C9orf72; Frontotemporal dementia; Age of onset; Dementia; Retrospective cohort study; Medicine; Disease; Cohort; Internal medicine; Oncology; Pediatrics","score_opus":0.024868202057772862,"score_gpt":0.3047817556544416,"score_spread":0.27991355359666875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993046104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99740195,0.00067150337,0.000078891346,0.000068543945,0.00002169274,0.0000077413815,0.0013398009,0.0000061124138,0.00040379],"genre_scores_gemma":[0.9976434,0.00043348625,0.00008795401,0.00006154114,0.000029943314,0.000015800717,0.0013417052,0.0000078756575,0.00037833906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909854,0.00017457735,0.00012340512,0.00033687975,0.00007795439,0.00018866142],"domain_scores_gemma":[0.99661237,0.0004260407,0.001413614,0.0006735992,0.00029054077,0.0005836992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014988119,0.0010632444,0.00086720765,0.0019328698,0.0011321811,0.0020022676,0.0012971758,0.001752049,0.0023692395],"category_scores_gemma":[0.0032183328,0.0014749693,0.0020813122,0.00365007,0.00078408665,0.0019390743,0.0012321391,0.0020670916,0.0005621784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006750952,0.00006249859,0.9972857,0.000014566092,0.00045748387,0.0003338926,0.00021342018,0.000039226077,0.00022699703,0.000029902336,0.00018693274,0.00047432972],"study_design_scores_gemma":[0.000027117483,0.000084264364,0.9986804,0.000010661837,0.00017148751,0.0004572167,0.00029885056,0.00007276024,0.000023901079,0.000030258345,0.00012972967,0.000013327309],"about_ca_topic_score_codex":0.022209192,"about_ca_topic_score_gemma":0.018322334,"teacher_disagreement_score":0.022209192,"about_ca_system_score_codex":0.00077645277,"about_ca_system_score_gemma":0.0006549656,"threshold_uncertainty_score":0.04415983},"labels":[],"label_agreement":null},{"id":"W2996287664","doi":"10.1016/s1474-4422(19)30433-8","title":"Important advances in neuromuscular research in 2019","year":2019,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; University of Toronto","funders":"","keywords":"Myasthenia gravis; Medicine; Placebo; Antibody; Acetylcholine receptor; Neurology; Antagonist; Anesthesia; Internal medicine; Immunology; Receptor; Pathology","score_opus":0.044519179935525066,"score_gpt":0.3633154083129212,"score_spread":0.31879622837739613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996287664","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006857053,0.69224936,0.00054924184,0.18527609,0.10857474,0.000022798085,0.0006719835,0.0001329431,0.011837111],"genre_scores_gemma":[0.017002398,0.61648285,0.0030193273,0.13325347,0.20947789,0.000051336392,0.0014806201,0.000091876595,0.019140175],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968189,0.00086176646,0.00044766607,0.00035564924,0.00090542086,0.00061070523],"domain_scores_gemma":[0.98378223,0.0064764256,0.0013313312,0.00050513615,0.0046587633,0.0032461218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009305352,0.001344092,0.0018368976,0.0029898325,0.00078130537,0.004147577,0.0012715112,0.0076609687,0.016856778],"category_scores_gemma":[0.018763546,0.0005338106,0.0012256497,0.0021010493,0.0020020066,0.0043805228,0.00244168,0.0077248504,0.0076360935],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051481865,0.00012715269,0.0012732008,0.0074539743,0.00021240057,0.00053371023,0.0001172568,0.00026151465,0.0014836869,0.01530947,0.6875604,0.2851524],"study_design_scores_gemma":[0.00012546779,0.00012267932,0.0025930586,0.0028970216,0.00008512389,0.0005191605,0.00013987656,0.00012325853,0.00027981246,0.0053637163,0.9877182,0.000032501823],"about_ca_topic_score_codex":0.0027446758,"about_ca_topic_score_gemma":0.0061365617,"teacher_disagreement_score":0.016856778,"about_ca_system_score_codex":0.0045793904,"about_ca_system_score_gemma":0.007270875,"threshold_uncertainty_score":0.056391597},"labels":[],"label_agreement":null},{"id":"W2998968185","doi":"10.1016/s1474-4422(19)30368-0","title":"The characterisation of subjective cognitive decline","year":2020,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":1369,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"Division of Materials Research; National Institute on Aging; Horizon 2020 Framework Programme; ZonMw; National Natural Science Foundation of China; Schweizerische Akademie der Medizinischen Wissenschaften; Meso Scale Diagnostics; Bundesministerium für Bildung und Forschung; Biogen; Novartis Pharma; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Roche; General Electric; Eli Lilly and Company","keywords":"Cognitive decline; Dementia; Cognition; Disease; Gerontology; Medicine; Epidemiology; Cognitive impairment; Population; Psychology; Clinical psychology; Psychiatry; Pathology; Environmental health","score_opus":0.07552881655128066,"score_gpt":0.39869666605631765,"score_spread":0.32316784950503696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998968185","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007801096,0.99951375,0.000040746287,0.000138848,0.00008815597,0.000004445908,0.00002253963,0.0000012502012,0.0001122968],"genre_scores_gemma":[0.0019639856,0.9971661,0.00015220081,0.0003408771,0.0002264833,0.000017285975,0.00004176005,0.0000012266647,0.0000901306],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9976546,0.0008582453,0.0004986446,0.00028843482,0.0005899045,0.00011016835],"domain_scores_gemma":[0.9926116,0.005295899,0.0011796189,0.00015066561,0.00065305625,0.00010924173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005814116,0.002222768,0.008560549,0.005141667,0.00026390652,0.0032148703,0.0025225135,0.0026754849,0.0034545644],"category_scores_gemma":[0.010741044,0.0005807769,0.0036655627,0.00394865,0.0016924266,0.0027009323,0.0019673402,0.0035120607,0.00079498335],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005351475,0.000051730665,0.0009305887,0.12444869,0.0031382402,0.000098115896,0.0001650057,0.0002815517,0.00030666715,0.004098437,0.010320443,0.8556255],"study_design_scores_gemma":[0.0011249909,0.0013939205,0.027507411,0.27149928,0.02163119,0.003380992,0.001002887,0.0009276255,0.0009792526,0.026175125,0.6439517,0.0004256185],"about_ca_topic_score_codex":0.0053194817,"about_ca_topic_score_gemma":0.0090692025,"teacher_disagreement_score":0.008560549,"about_ca_system_score_codex":0.001858994,"about_ca_system_score_gemma":0.0028287652,"threshold_uncertainty_score":0.030748367},"labels":[],"label_agreement":null},{"id":"W3004592781","doi":"10.1016/s1474-4422(19)30488-0","title":"Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study","year":2020,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":326,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Actelion Pharmaceuticals; Departament de Salut, Generalitat de Catalunya; Instituto de Salud Carlos III; Bayer Schering; TG Therapeutics; Fundación Mutua Madrileña; Generalitat de Catalunya; Teva Pharmaceutical Industries; Novartis Farmacéutica; Bayer; Biogen; Gilead Sciences; Roche; Procter and Gamble; Alexion Pharmaceuticals; National Multiple Sclerosis Society; Merck; Eli Lilly and Company","keywords":"Medicine; Neuromyelitis optica; Acute disseminated encephalomyelitis; Cohort; Myelin oligodendrocyte glycoprotein; Encephalitis; Pediatrics; Optic neuritis; Modified Rankin Scale; Immunology; Multiple sclerosis; Internal medicine; Experimental autoimmune encephalomyelitis","score_opus":0.19798644599821305,"score_gpt":0.36188419751192913,"score_spread":0.16389775151371608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004592781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99714226,0.0012868945,0.00018255372,0.00010201209,0.000018858143,0.000012815462,0.0010572913,0.0000048084066,0.00019248463],"genre_scores_gemma":[0.998102,0.0004485857,0.00023333922,0.00008757718,0.000022739254,0.000031272946,0.00096142216,0.000006016621,0.000107085805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9937344,0.002758886,0.00076334324,0.0014225568,0.000629988,0.00069077045],"domain_scores_gemma":[0.9866447,0.0025768552,0.0069583096,0.0017242581,0.0010167614,0.0010790832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034782887,0.0008875182,0.0014246826,0.0010256241,0.0007751904,0.0014494874,0.0012670506,0.0015193983,0.0012034831],"category_scores_gemma":[0.010449089,0.0011572102,0.002017217,0.0036421625,0.00091236026,0.0012686556,0.0016941468,0.0019232808,0.0002221004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004480493,0.000048606493,0.9971705,0.000058036432,0.00083790655,0.00022620909,0.00017524249,0.000057862737,0.00021054,0.000062762934,0.00019377569,0.00051058794],"study_design_scores_gemma":[0.000058028352,0.0002092567,0.9981857,0.000031467793,0.00030529275,0.0005557387,0.00023941389,0.00011148676,0.000047369715,0.000034781155,0.00021157762,0.000009985371],"about_ca_topic_score_codex":0.013871057,"about_ca_topic_score_gemma":0.010480211,"teacher_disagreement_score":0.013871057,"about_ca_system_score_codex":0.001044465,"about_ca_system_score_gemma":0.0011520265,"threshold_uncertainty_score":0.027580619},"labels":[],"label_agreement":null},{"id":"W3005837745","doi":"10.1016/s1474-4422(20)30033-8","title":"Wearable-based mobility monitoring: the long road ahead","year":2020,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Context-Aware Activity Recognition Systems","field":"Computer Science","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital","funders":"Ipsen; University of Toronto; UCB; Dystonia Medical Research Foundation Canada; Michael J. Fox Foundation for Parkinson's Research; Cummings Foundation; Sunovion; Medtronic; AbbVie Canada; Boston Scientific Corporation; Chiesi Farmaceutici","keywords":"Wearable computer; Wearable technology; Computer science; Clinical trial; Warning system; Tracking (education); Data science; Artificial intelligence; Medicine; Psychology; Embedded system; Telecommunications","score_opus":0.08102115550176789,"score_gpt":0.2829845473969714,"score_spread":0.2019633918952035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005837745","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027386515,0.031622,0.002427819,0.9450152,0.018023072,0.0000114293125,0.00016779754,0.0001260113,0.002332772],"genre_scores_gemma":[0.01032557,0.05258645,0.0064215567,0.75389224,0.17161828,0.00010327741,0.00028189502,0.000083427636,0.0046873232],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99499595,0.0021330393,0.00054869684,0.00060227164,0.0014339531,0.00028610945],"domain_scores_gemma":[0.95199937,0.03480094,0.0014057826,0.0012114051,0.008031904,0.0025506408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070554926,0.0010208928,0.0024016658,0.0011900977,0.0009746603,0.0035441502,0.0025315217,0.02365405,0.008317045],"category_scores_gemma":[0.030865874,0.00055719004,0.001438525,0.00095671084,0.0029087146,0.008479942,0.0017014602,0.025061285,0.008001908],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018945133,0.00006938554,0.001479539,0.0006105168,0.00007800378,0.0005244246,0.000109563334,0.00019188772,0.00061550643,0.006554882,0.8029813,0.18659548],"study_design_scores_gemma":[0.00013245696,0.00018023526,0.002680815,0.0024404884,0.000093365015,0.0021597077,0.00069873274,0.0018650502,0.00035687332,0.03968508,0.949604,0.00010331393],"about_ca_topic_score_codex":0.00333594,"about_ca_topic_score_gemma":0.0073605455,"teacher_disagreement_score":0.02365405,"about_ca_system_score_codex":0.0022340117,"about_ca_system_score_gemma":0.0015729968,"threshold_uncertainty_score":0.03731346},"labels":[],"label_agreement":null},{"id":"W3006790137","doi":"10.1016/s1474-4422(19)30486-7","title":"Health-care disparities for people with multiple sclerosis","year":2020,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Global Health Workforce Issues","field":"Health Professions","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Multiple Sclerosis Society of Canada","funders":"Pfizer UK; Genentech; Eisai; Roche Products; GlaxoSmithKline foundation; Sanofi Genzyme; Five Prime Therapeutics; GW Pharmaceuticals; Ironwood Pharmaceuticals, Incorporated; Biogen; Celgene; EMD Serono; Multiple Sclerosis International Federation; Elan; Novartis; Teva Pharmaceutical Industries; Sanofi; Merck","keywords":"Scopus; Medicine; Multiple sclerosis; Alternative medicine; Family medicine; Resource (disambiguation); MEDLINE; Political science; Psychiatry; Pathology","score_opus":0.09920784599062572,"score_gpt":0.3733095206169387,"score_spread":0.27410167462631296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006790137","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00089734857,0.0009064023,0.000020828222,0.98939264,0.006602731,0.0000050487242,0.00012104892,0.000008196686,0.0020458256],"genre_scores_gemma":[0.008903095,0.0013518218,0.000105517196,0.96608615,0.018638363,0.00004867459,0.00013019165,0.000017709786,0.0047184364],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99482083,0.0014636276,0.0006210014,0.00035331698,0.0011872491,0.0015540286],"domain_scores_gemma":[0.9799468,0.008518285,0.0014619742,0.00038629078,0.002443443,0.0072431597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050338036,0.00060979184,0.0012159992,0.0012569592,0.006623451,0.0041027805,0.0016033105,0.042479087,0.014282385],"category_scores_gemma":[0.030938426,0.0005192482,0.0016680689,0.0011941907,0.0035101336,0.0060653677,0.004810346,0.024936045,0.0036381017],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053110332,0.0000753707,0.0052127587,0.00012519595,0.000024792616,0.00055647496,0.0007578073,0.000029215766,0.000116736635,0.0031884606,0.9751407,0.014719326],"study_design_scores_gemma":[0.00043892462,0.00018404325,0.025528701,0.0027241677,0.00015261448,0.0016068583,0.008246889,0.00045581168,0.00021039136,0.032767747,0.92754483,0.00013894499],"about_ca_topic_score_codex":0.050094683,"about_ca_topic_score_gemma":0.074296586,"teacher_disagreement_score":0.050094683,"about_ca_system_score_codex":0.005417642,"about_ca_system_score_gemma":0.017236954,"threshold_uncertainty_score":0.099606216},"labels":[],"label_agreement":null},{"id":"W3009489683","doi":"10.1016/s1474-4422(20)30034-x","title":"Evidence-based support for autistic people across the lifespan: maximising potential, minimising barriers, and optimising the person–environment fit","year":2020,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Autism Spectrum Disorder Research","field":"Neuroscience","cited_by":233,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Holland Bloorview Kids Rehabilitation Hospital; Centre for Addiction and Mental Health; University of Toronto; Hospital for Sick Children","funders":"Collaboration for Leadership in Applied Health Research and Care - Greater Manchester; Medical Research Council; Canada Research Chairs; National Institute for Health and Care Research; NIHR Bristol Biomedical Research Centre; Centre for Addiction and Mental Health; Department of Psychiatry, University of Toronto; Health Resources and Services Administration; Wellcome Trust; Canadian Institutes of Health Research; Azrieli Foundation; Centre for Addiction and Mental Health Foundation; Fondation Brain Canada; Autism Speaks; European Federation of Pharmaceutical Industries and Associations; Hospital for Sick Children; Ontario Brain Institute; Genome Canada; Simons Foundation Autism Research Initiative; Horizon 2020 Framework Programme; Innovative Medicines Canada","keywords":"Autism; Psychology; Intervention (counseling); Psychological intervention; Cognition; Augmentative and alternative communication; Mental health; Inclusion (mineral); Distress; Applied psychology; Developmental psychology; Psychiatry; Clinical psychology; Social psychology","score_opus":0.18615772903014566,"score_gpt":0.371434915110378,"score_spread":0.18527718608023236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009489683","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024029575,0.9971679,0.00009772291,0.0015075541,0.00025353313,0.000021948214,0.00006178784,0.000006755779,0.0006424279],"genre_scores_gemma":[0.0042634243,0.9937185,0.0006815863,0.00090025144,0.0001617431,0.000040279243,0.0000803726,0.0000028862628,0.00015098129],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975799,0.0010043923,0.0005014345,0.00020355728,0.0005460783,0.00016460457],"domain_scores_gemma":[0.99205774,0.005902068,0.00095262274,0.00009200618,0.0006829684,0.00031261778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058440208,0.0010405539,0.0041769985,0.0027724826,0.0003766551,0.0024627552,0.0025546132,0.0031866627,0.007998063],"category_scores_gemma":[0.01909485,0.00040550207,0.0028828995,0.0020397662,0.000609456,0.0018903572,0.0020138093,0.0025535892,0.0008649037],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043844778,0.000060278984,0.0004949365,0.1938813,0.0033616833,0.00015780184,0.0002169732,0.0003190664,0.00026034153,0.0030383791,0.012089481,0.7856812],"study_design_scores_gemma":[0.00085789186,0.0003572438,0.0067636105,0.67090666,0.012264604,0.0007907394,0.0009587946,0.00018222716,0.00027567055,0.008673325,0.2978866,0.00008271894],"about_ca_topic_score_codex":0.007605146,"about_ca_topic_score_gemma":0.017900605,"teacher_disagreement_score":0.007998063,"about_ca_system_score_codex":0.0020608136,"about_ca_system_score_gemma":0.0066265613,"threshold_uncertainty_score":0.030906558},"labels":[],"label_agreement":null},{"id":"W3010983304","doi":"10.1016/s1474-4422(20)30036-3","title":"Initiation of pharmacological therapy in Parkinson's disease: when, why, and how","year":2020,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":203,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital","funders":"Parkinsonfonden; Scheme for Promotion of Academic and Research Collaboration; H. Lundbeck A/S; Canadian Institutes of Health Research; Parkinson Canada; Edmond J. Safra Philanthropic Foundation; Sunovion; GE Healthcare; Sun Pharma; Fondation Brain Canada; Ontario Brain Institute; Teva Pharmaceutical Industries; CHDI Foundation; Biogen; National Institutes of Health; Medtronic; Acadia University; Bristol-Myers Squibb; Roche; AbbVie Canada; ZonMw; Dystonia Medical Research Foundation; Michael J. Fox Foundation for Parkinson's Research","keywords":"Levodopa; Dyskinesia; Parkinson's disease; Disease; Medicine; Dopaminergic; Dopamine; Quality of life (healthcare); Pharmacotherapy; Psychology; Intensive care medicine; Psychiatry; Internal medicine","score_opus":0.10129969916822404,"score_gpt":0.3505276313403349,"score_spread":0.24922793217211084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010983304","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022184004,0.9989685,0.000026096477,0.0005164191,0.00014140461,0.000001793464,0.000007217672,0.0000026623939,0.00031373062],"genre_scores_gemma":[0.00033850237,0.9987675,0.00009053711,0.0004334866,0.00018535933,0.000004129992,0.000009870987,7.8913206e-7,0.00016987546],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994777,0.00015791749,0.0000806922,0.000075187236,0.0001629294,0.000045697358],"domain_scores_gemma":[0.99856657,0.0009227979,0.00022396931,0.000020699785,0.00018954357,0.00007659575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016267891,0.0009075108,0.002814249,0.001408468,0.00028774567,0.0018219382,0.0013260298,0.002248031,0.005345507],"category_scores_gemma":[0.002106124,0.0003623682,0.001043133,0.001576155,0.0006857697,0.001920173,0.0007013321,0.0038151138,0.002166842],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021358403,0.000058358783,0.00013999411,0.03142562,0.00024582038,0.000094531264,0.00006637622,0.00025397138,0.00044104803,0.005003359,0.03490113,0.9271562],"study_design_scores_gemma":[0.00017279365,0.00019311189,0.0013912395,0.03872819,0.0006787278,0.00071498717,0.00012741903,0.00017486268,0.00018175611,0.0053691533,0.9522292,0.00003859226],"about_ca_topic_score_codex":0.002915298,"about_ca_topic_score_gemma":0.00812946,"teacher_disagreement_score":0.005345507,"about_ca_system_score_codex":0.0013255689,"about_ca_system_score_gemma":0.002063678,"threshold_uncertainty_score":0.017882466},"labels":[],"label_agreement":null},{"id":"W3012517977","doi":"10.1016/s1474-4422(20)30067-3","title":"Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study","year":2020,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":438,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Hôpital Notre-Dame; Université de Montréal","funders":"National Health and Medical Research Council; Sanofi Genzyme; Sveriges Kommuner och Landsting; NIHR Cambridge Biomedical Research Centre; Roche; Multiple Sclerosis Society; Biogen; Novartis; Merck","keywords":"Observational study; Retrospective cohort study; Medicine; Multiple sclerosis; Cohort; Cohort study; Internal medicine; Psychiatry","score_opus":0.3017246710232251,"score_gpt":0.36584941872439863,"score_spread":0.06412474770117355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012517977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99398875,0.003222148,0.00048065552,0.00017210424,0.00007508202,0.0000263006,0.0015958543,0.0000097397,0.00042937603],"genre_scores_gemma":[0.997644,0.0004906699,0.00034565353,0.00010856682,0.000059686678,0.000033116663,0.0010760644,0.000012075238,0.00023008972],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99598795,0.0012057644,0.0006556728,0.0012067525,0.0003437575,0.0006002126],"domain_scores_gemma":[0.9802949,0.0036197442,0.010474207,0.0029836658,0.001048387,0.001579152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004609047,0.0006587122,0.0013197599,0.0008970586,0.00088366494,0.0020384407,0.001184553,0.0016203198,0.002255787],"category_scores_gemma":[0.012741169,0.0011376869,0.0019541448,0.0029124815,0.0005322772,0.0018078533,0.0010768782,0.0023987019,0.00040442613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035163811,0.00012329817,0.99237895,0.000063718566,0.0015171011,0.00019429758,0.0001477563,0.000073407566,0.0004127556,0.0001558782,0.00034466336,0.0010718176],"study_design_scores_gemma":[0.00029118484,0.0006737878,0.9960775,0.000045970533,0.0010421587,0.0005228433,0.0002589249,0.00025823544,0.000096122356,0.00016647717,0.0005372837,0.000029494686],"about_ca_topic_score_codex":0.0075146845,"about_ca_topic_score_gemma":0.0056069517,"teacher_disagreement_score":0.0075146845,"about_ca_system_score_codex":0.00074373407,"about_ca_system_score_gemma":0.0011688966,"threshold_uncertainty_score":0.02437526},"labels":[],"label_agreement":null},{"id":"W3018431352","doi":"10.1016/s1474-4422(20)30071-5","title":"Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts","year":2020,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":1360,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"European Research Council; Fonds de Recherche du Québec - Santé; Montreal Neurological Institute and Hospital; University Hospital Foundation; Wallenberg Centre for Molecular and Translational Medicine; Vetenskapsrådet; Hjärnfonden; GE Healthcare; Knut och Alice Wallenbergs Stiftelse; Lunds Universitet; Canada Foundation for Innovation; Alzheimer Society; Consortium canadien en neurodégénérescence associée au vieillissement; Alzheimer's Drug Discovery Foundation; Canadian Institutes of Health Research; Alzheimerfonden; Weston Brain Institute; Sahlgrenska Universitetssjukhuset; Roche; Marcus och Amalia Wallenbergs minnesfond; Parkinson Research Foundation; Association for Frontotemporal Degeneration","keywords":"Medicine; Biomarker; Cohort; Dementia; Prospective cohort study; Internal medicine; Oncology; Disease; Cohort study; Cognitive decline; Frontotemporal dementia; Alzheimer's disease","score_opus":0.1273085257166265,"score_gpt":0.33754914603741637,"score_spread":0.21024062032078986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3018431352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985116,0.00007217954,0.0008378281,0.000040119787,0.000008335984,0.000016901928,0.0004256595,0.000016204742,0.00007103495],"genre_scores_gemma":[0.996808,0.00005766853,0.0010798628,0.000018092363,0.000007960128,0.00003823566,0.0017231781,0.000015203816,0.0002517734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967996,0.0018987491,0.00015309326,0.0006922908,0.00021841603,0.00023783567],"domain_scores_gemma":[0.9844899,0.0092165,0.0013998393,0.0029764862,0.001259552,0.00065774703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017218383,0.0021550683,0.0012296968,0.0012495784,0.0012354372,0.0022125482,0.002000186,0.001691609,0.0009170509],"category_scores_gemma":[0.01567858,0.0012502314,0.003809755,0.0012992177,0.0010781351,0.0012577699,0.0015473275,0.0026345216,0.00048745458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015519332,0.001368233,0.95769274,0.00006704319,0.0047003506,0.00038645507,0.000934332,0.010113571,0.0011344001,0.00024494517,0.0007942156,0.0070444234],"study_design_scores_gemma":[0.0011290335,0.0026947067,0.8970406,0.00004018552,0.0038482638,0.00066871423,0.00075376785,0.09080357,0.0012723649,0.00088671385,0.00070343335,0.00015865636],"about_ca_topic_score_codex":0.018714081,"about_ca_topic_score_gemma":0.0112739,"teacher_disagreement_score":0.018714081,"about_ca_system_score_codex":0.0011733035,"about_ca_system_score_gemma":0.0011068069,"threshold_uncertainty_score":0.09106058},"labels":[],"label_agreement":null},{"id":"W3018886418","doi":"10.1016/s1474-4422(20)30078-8","title":"Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":490,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Eye Institute; Genentech; Multiple Sclerosis Society of Canada; Japan Blood Products Organization; National Institutes of Health; Guthy-Jackson Charitable Foundation; Patient-Centered Outcomes Research Institute; Bayer Canada; Bayer; Biogen; Teva Pharmaceutical Industries; Otsuka Pharmaceutical; Novartis; National Multiple Sclerosis Society; MedImmune; Chugai Pharmaceutical; Mitsubishi Tanabe Pharma Corporation; Roche","keywords":"Medicine; Placebo; Clinical endpoint; Population; Neuromyelitis optica; Internal medicine; Clinical trial; Intention-to-treat analysis; Pediatrics; Antibody; Immunology; Pathology","score_opus":0.06748685005283493,"score_gpt":0.3488388857934585,"score_spread":0.28135203574062356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3018886418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832987,0.008044655,0.0007405644,0.00090212625,0.0009064814,0.0029223152,0.0014027306,0.0001203699,0.0016620443],"genre_scores_gemma":[0.9870702,0.0025318875,0.0015311874,0.0012778704,0.0006386507,0.0034373873,0.0011721237,0.000031119514,0.0023096032],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987923,0.0005956929,0.000104176564,0.00025367842,0.00010247991,0.00015158021],"domain_scores_gemma":[0.9984206,0.00056521606,0.00036223448,0.00014968096,0.00012392347,0.00037841775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030320727,0.0023013866,0.004499247,0.0005086542,0.0008013391,0.0014823151,0.001166063,0.003641465,0.006460566],"category_scores_gemma":[0.00287756,0.00092689163,0.0034903784,0.0005182109,0.0021087073,0.0016379365,0.00049961073,0.0037130727,0.0014432727],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9915473,0.0012729731,0.00028808028,0.00042299935,0.0007434076,0.000024981193,0.00003925624,0.00010466744,0.0014464763,0.000048571103,0.00031833313,0.0037431428],"study_design_scores_gemma":[0.97293764,0.025381293,0.0008235472,0.000020871094,0.00028596795,0.000017557415,0.000011896755,0.00011522261,0.00013320819,0.00007992784,0.00018303675,0.0000097282655],"about_ca_topic_score_codex":0.0011049876,"about_ca_topic_score_gemma":0.001517367,"teacher_disagreement_score":0.006460566,"about_ca_system_score_codex":0.0010317556,"about_ca_system_score_gemma":0.0014182318,"threshold_uncertainty_score":0.021612763},"labels":[],"label_agreement":null},{"id":"W3028110530","doi":"10.1016/s1474-4422(20)30139-3","title":"Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspective","year":2020,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Neurological Disease Mechanisms and Treatments","field":"Neuroscience","cited_by":181,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Horizon 2020; Horizon 2020 Framework Programme; ZonMw; European Commission; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Roche; Weston Brain Institute; Fundació la Marató de TV3","keywords":"Dementia; Diabetes mellitus; Medicine; Disease; Type 2 diabetes; Cognition; Cognitive decline; Biomarker; Bioinformatics; Vascular dementia; Alzheimer's disease; Intensive care medicine; Neuroscience; Psychiatry; Psychology; Internal medicine; Endocrinology","score_opus":0.37818947868462405,"score_gpt":0.3823874144497137,"score_spread":0.004197935765089644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028110530","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003492925,0.9986583,0.00012233832,0.00074213656,0.00018659311,0.00000191493,0.000013949726,0.0000044409635,0.00023540635],"genre_scores_gemma":[0.0005020027,0.99813336,0.00023589462,0.00053866586,0.00041855252,0.00000533827,0.000017357132,9.774412e-7,0.00014791134],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99968934,0.00008437548,0.000042388318,0.00005868491,0.000092115966,0.00003302065],"domain_scores_gemma":[0.99855167,0.0009469458,0.00016405746,0.00002842302,0.00024979588,0.00005914834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018028481,0.0015590058,0.0034851213,0.0017669619,0.00022317278,0.0019066292,0.0015080414,0.0024797597,0.003000743],"category_scores_gemma":[0.0022194996,0.0003070409,0.0010257341,0.0017218761,0.00082155416,0.0020978893,0.0010196145,0.0034516794,0.0013230407],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020224397,0.00007852571,0.0003810738,0.024674745,0.0005285285,0.00023415514,0.000042962194,0.00045411364,0.0013514324,0.009231591,0.026947614,0.93587303],"study_design_scores_gemma":[0.00015722371,0.00037879223,0.0036453882,0.031028455,0.0016002107,0.0020108938,0.00019437286,0.0005558993,0.00078575575,0.027332455,0.9322112,0.0000994393],"about_ca_topic_score_codex":0.0027512475,"about_ca_topic_score_gemma":0.0053992714,"teacher_disagreement_score":0.0034851213,"about_ca_system_score_codex":0.0011656887,"about_ca_system_score_gemma":0.0022232514,"threshold_uncertainty_score":0.010038435},"labels":[],"label_agreement":null},{"id":"W3029799892","doi":"10.1016/s1474-4422(20)30028-4","title":"Advances in the diagnosis of inherited neuromuscular diseases and implications for therapy development","year":2020,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Children's Hospital of Eastern Ontario","funders":"Horizon 2020; Canadian Institutes of Health Research; Canada Research Chairs; European Regional Development Fund; Canada Foundation for Innovation","keywords":"Massive parallel sequencing; Intensive care medicine; Bioinformatics; Medicine; Neuroscience; Biology; DNA sequencing; Gene; Genetics","score_opus":0.12663666574837187,"score_gpt":0.411642421316362,"score_spread":0.2850057555679901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029799892","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023335606,0.9984993,0.00006780071,0.0006189433,0.00027129648,0.0000018249539,0.000014514413,0.0000049238247,0.00049819506],"genre_scores_gemma":[0.00023560008,0.9985141,0.00013850108,0.00047630916,0.00032829648,0.0000029530952,0.000021604965,0.0000010260244,0.0002816168],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995109,0.000117721844,0.000058764253,0.00006530349,0.000199399,0.000048050897],"domain_scores_gemma":[0.9981305,0.0012459448,0.00016040257,0.000034862947,0.00031583983,0.0001125671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018493738,0.001117855,0.0025443875,0.002543942,0.00027988895,0.0015911569,0.0012835811,0.0020614355,0.006929871],"category_scores_gemma":[0.0024597556,0.0002859977,0.0008512812,0.0025229417,0.00087079586,0.0019447994,0.0010331603,0.0032657601,0.003288919],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012929802,0.000052743624,0.0001514039,0.017507916,0.00014096954,0.00017660274,0.000036548765,0.00035824644,0.0010163687,0.007109412,0.056126796,0.91719365],"study_design_scores_gemma":[0.000048700993,0.00009267879,0.000733429,0.0077374177,0.00017377042,0.00068712264,0.000063402535,0.00008969049,0.00014372768,0.0046291254,0.9855781,0.000022824564],"about_ca_topic_score_codex":0.0019012874,"about_ca_topic_score_gemma":0.004351266,"teacher_disagreement_score":0.006929871,"about_ca_system_score_codex":0.0013254503,"about_ca_system_score_gemma":0.0021302407,"threshold_uncertainty_score":0.02318275},"labels":[],"label_agreement":null},{"id":"W3035840717","doi":"10.1016/s1474-4422(20)30181-2","title":"Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Vascular Malformations Diagnosis and Treatment","field":"Medicine","cited_by":189,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"National Institute of Neurological Disorders and Stroke; ZonMw; European Commission; National Institutes of Health; LivaNova; Bayer; Hartstichting; Boehringer Ingelheim","keywords":"Medicine; Interim analysis; Randomized controlled trial; Interim; Clinical trial; Neurosurgery; Stroke (engine); Surgery; Internal medicine","score_opus":0.05487369495554761,"score_gpt":0.3163977204587913,"score_spread":0.26152402550324366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035840717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95410734,0.02303663,0.002624577,0.0017217394,0.0043707984,0.008965859,0.001713152,0.00026182292,0.003198019],"genre_scores_gemma":[0.9765643,0.0042145005,0.0027990763,0.0013323725,0.0015933407,0.009099103,0.0009685649,0.00003872996,0.0033900475],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9944359,0.0033943825,0.00054419023,0.0008218304,0.0002726606,0.00053091557],"domain_scores_gemma":[0.99472696,0.0025004172,0.0013124516,0.00048416803,0.00033901262,0.00063696486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058564562,0.003544844,0.00902279,0.00070130336,0.0009976403,0.002732223,0.0021997227,0.005915265,0.009268657],"category_scores_gemma":[0.01047814,0.0013473596,0.006714413,0.000734603,0.0024773956,0.0030096923,0.001187017,0.0051239817,0.0015570335],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99507105,0.000663823,0.00014764667,0.0005646077,0.0014337865,0.00001334045,0.000023340943,0.00006003904,0.00019495552,0.000046026507,0.00014908891,0.0016323549],"study_design_scores_gemma":[0.98318833,0.014156675,0.00060460705,0.000088390654,0.0013671672,0.00001241295,0.000015597801,0.0001602717,0.000076661956,0.00015657126,0.00015873717,0.000014534272],"about_ca_topic_score_codex":0.0018083284,"about_ca_topic_score_gemma":0.0022433877,"teacher_disagreement_score":0.009268657,"about_ca_system_score_codex":0.0016497272,"about_ca_system_score_gemma":0.0014418892,"threshold_uncertainty_score":0.031006813},"labels":[],"label_agreement":null},{"id":"W3036438870","doi":"10.1016/s1474-4422(20)30173-3","title":"Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":270,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; McMaster University; Population Health Research Institute; Hamilton Health Sciences","funders":"Eli Lilly and Company","keywords":"Dulaglutide; Type 2 diabetes; Cognitive impairment; Exploratory analysis; Cognition; Psychology; Medicine; Physical therapy; Physical medicine and rehabilitation; Diabetes mellitus; Psychiatry; Computer science; Data science; Endocrinology","score_opus":0.0314851385831056,"score_gpt":0.2928398577921188,"score_spread":0.2613547192090132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036438870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97430533,0.01848923,0.00044848947,0.0011157651,0.00047238855,0.00046516553,0.0017318841,0.00007071179,0.0029010363],"genre_scores_gemma":[0.99191576,0.0030961498,0.000608501,0.00080143556,0.00045356073,0.00033322937,0.0012974053,0.000025804937,0.001468129],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99834526,0.00095951004,0.0001085812,0.00023623875,0.00010790525,0.00024247215],"domain_scores_gemma":[0.9976185,0.0011080473,0.0005500554,0.0003019844,0.00012984843,0.0002915258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032088875,0.0021183183,0.0042468365,0.00029699501,0.00037010264,0.0017083456,0.0009282301,0.001349397,0.0032750226],"category_scores_gemma":[0.0048581,0.00054701295,0.005555349,0.00046330303,0.0009877862,0.0014130567,0.00070323184,0.0033151093,0.00046711025],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96190983,0.00095831853,0.0044602435,0.0015912864,0.015173738,0.000105908286,0.000066701374,0.00060442724,0.0010097984,0.00033562805,0.0012475715,0.012536625],"study_design_scores_gemma":[0.8782309,0.047074735,0.03379834,0.0005531204,0.034380674,0.00016426077,0.000229381,0.001045205,0.0006426747,0.001450124,0.0023202735,0.00011035132],"about_ca_topic_score_codex":0.0023791557,"about_ca_topic_score_gemma":0.004634038,"teacher_disagreement_score":0.0042468365,"about_ca_system_score_codex":0.00095716945,"about_ca_system_score_gemma":0.00090248365,"threshold_uncertainty_score":0.016970456},"labels":[],"label_agreement":null},{"id":"W3036953265","doi":"10.1016/s1474-4422(20)30175-7","title":"Immunotherapy for Parkinson's disease: stay tuned","year":2020,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Substantia nigra; Neurodegeneration; Neuroscience; Dopamine; Parkinson's disease; Lewy body; Neurology; Medicine; Disease; Dementia with Lewy bodies; Dopaminergic; Synucleinopathies; Alpha-synuclein; Dementia; Pathology; Psychology","score_opus":0.0450734169379498,"score_gpt":0.2922685788357068,"score_spread":0.24719516189775698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036953265","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007627485,0.79779696,0.0009047083,0.17568037,0.018484011,0.000017076087,0.00008950593,0.00009912525,0.006165449],"genre_scores_gemma":[0.03630835,0.64899,0.0029783736,0.21877074,0.075784974,0.00012464152,0.0002013665,0.00014513446,0.016696446],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99744946,0.0007220215,0.00024925615,0.00037405276,0.0007170733,0.0004880734],"domain_scores_gemma":[0.99140024,0.004926107,0.00055612583,0.000347797,0.0014111379,0.0013586177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009206412,0.0012640168,0.00272012,0.001360827,0.0012991014,0.006653241,0.0014618678,0.010951517,0.012551673],"category_scores_gemma":[0.009391215,0.00051832374,0.0013559258,0.00090234383,0.004012223,0.01251525,0.0032094778,0.018372616,0.004242292],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013413604,0.00036248367,0.00068805943,0.0032930486,0.00029295043,0.0003931855,0.00030956697,0.0006647511,0.0024403308,0.06281221,0.4557672,0.47163486],"study_design_scores_gemma":[0.0006055116,0.00059265597,0.0009900272,0.0029378147,0.00018029967,0.0005110004,0.00042173034,0.00052572554,0.00037631116,0.07803304,0.914752,0.00007395752],"about_ca_topic_score_codex":0.0014749441,"about_ca_topic_score_gemma":0.0037742516,"teacher_disagreement_score":0.012551673,"about_ca_system_score_codex":0.002750031,"about_ca_system_score_gemma":0.0032737898,"threshold_uncertainty_score":0.04868877},"labels":[],"label_agreement":null},{"id":"W3042397538","doi":"10.1016/s1474-4422(20)30216-7","title":"Huntington's disease in Bangladesh","year":2020,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; University of Oxford; Sunovion; Arcadia Fund; Parkinson Canada; Teva Pharmaceutical Industries; International Parkinson and Movement Disorder Society; CHDI Foundation","keywords":"Chorea; Huntington's disease; Disease; Scopus; Medicine; Population; Incidence (geometry); Meta-analysis; Pediatrics; MEDLINE; Internal medicine; Environmental health; Biology","score_opus":0.04570625464285485,"score_gpt":0.26956341103120723,"score_spread":0.22385715638835238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042397538","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0065100403,0.0025839088,0.000056988156,0.96253467,0.011939093,0.000030233756,0.0003278935,0.0000125917595,0.01600452],"genre_scores_gemma":[0.05671565,0.0050168345,0.00015620061,0.8737063,0.017407766,0.00013902246,0.0002137411,0.000039002625,0.04660555],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.999361,0.00018251307,0.00009060611,0.000059266436,0.000089179026,0.00021739007],"domain_scores_gemma":[0.9980946,0.0006967985,0.00014864048,0.000055632,0.00024136192,0.00076297845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013143722,0.0005122694,0.00068518665,0.00046819614,0.004384667,0.0017677179,0.00081483787,0.02832049,0.009284193],"category_scores_gemma":[0.0065364405,0.00038446722,0.00045059877,0.0006497143,0.0012684731,0.001533498,0.0014164182,0.011475216,0.0029025672],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023044691,0.00004812148,0.013591811,0.00019591862,0.000047445148,0.03838598,0.0013485827,0.00013071884,0.00070559466,0.007341052,0.9247855,0.01318884],"study_design_scores_gemma":[0.00054207776,0.00016404533,0.026380304,0.0016853545,0.00012482269,0.015356095,0.007907924,0.00076111977,0.00034619967,0.019123934,0.92746556,0.0001426439],"about_ca_topic_score_codex":0.06205709,"about_ca_topic_score_gemma":0.09704418,"teacher_disagreement_score":0.06205709,"about_ca_system_score_codex":0.004111378,"about_ca_system_score_gemma":0.0052295933,"threshold_uncertainty_score":0.12339175},"labels":[],"label_agreement":null},{"id":"W3042644388","doi":"10.1016/s1474-4422(20)30225-8","title":"Initiating pharmacotherapy in early Parkinson's disease","year":2020,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital","funders":"Parkinsonfonden; Scheme for Promotion of Academic and Research Collaboration; H. Lundbeck A/S; Dystonia Medical Research Foundation Canada; GE Healthcare; Sun Pharma; Fondation Brain Canada; Ontario Brain Institute; Teva Pharmaceutical Industries; ACADIA Pharmaceuticals; CHDI Foundation; Roche; Biogen; Canadian Institutes of Health Research; Parkinson Canada; Edmond J. Safra Philanthropic Foundation; Sunovion; National Institutes of Health; Medtronic; Bristol-Myers Squibb; AbbVie Canada; ZonMw; Michael J. Fox Foundation for Parkinson's Research","keywords":"Scopus; Disease; Medicine; Parkinson's disease; Psychology; MEDLINE; Internal medicine; Political science","score_opus":0.0490591911957259,"score_gpt":0.30125879078986134,"score_spread":0.25219959959413546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042644388","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038098477,0.0035595996,0.000067513654,0.9751756,0.015409187,0.000010235937,0.000046661982,0.000019953819,0.005330252],"genre_scores_gemma":[0.0043749143,0.0026526581,0.00017193561,0.9210375,0.06566118,0.00003802208,0.000039974988,0.00001879157,0.00600501],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957073,0.0013728046,0.0007013044,0.0003921469,0.0010763064,0.0007500722],"domain_scores_gemma":[0.9821468,0.010467757,0.001314866,0.00039848508,0.0020850003,0.0035872005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034674597,0.00097379886,0.0020611521,0.0012533637,0.0043467446,0.0052354904,0.0019234894,0.09909776,0.009487106],"category_scores_gemma":[0.032773323,0.00082255446,0.0019227472,0.0010991325,0.0035057766,0.004795704,0.0024695694,0.04815483,0.0069783987],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016231254,0.00007011895,0.0009776828,0.00016057813,0.000033678174,0.0036956684,0.00014866609,0.00009312633,0.00025669392,0.0046857106,0.96858805,0.021127587],"study_design_scores_gemma":[0.0008342888,0.00022067064,0.0028225027,0.0016399961,0.000120463345,0.006233988,0.00042925566,0.0008591129,0.0003960561,0.025693212,0.9606358,0.00011462531],"about_ca_topic_score_codex":0.009870838,"about_ca_topic_score_gemma":0.02121892,"teacher_disagreement_score":0.09909776,"about_ca_system_score_codex":0.006322214,"about_ca_system_score_gemma":0.007730891,"threshold_uncertainty_score":0.04587114},"labels":[],"label_agreement":null},{"id":"W3042871336","doi":"10.1016/s1474-4422(20)30214-3","title":"A case of congenital Horner syndrome from the 16th century","year":2020,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Sympathectomy and Hyperhidrosis Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Ptosis; Miosis; Anhidrosis; Medicine; Horner syndrome; Anisocoria; Humanities; Ophthalmology; Psychology; Pupil; Surgery; Art; Neuroscience; Anesthesia","score_opus":0.04388600913215141,"score_gpt":0.2628750707051835,"score_spread":0.2189890615730321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042871336","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25646573,0.044506498,0.0009938035,0.5508601,0.022380698,0.00006447267,0.00037396874,0.000107960586,0.12424675],"genre_scores_gemma":[0.7126494,0.021807458,0.0014184379,0.16696747,0.035046913,0.000055874054,0.00014092475,0.00008277763,0.061830737],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99944144,0.000110364825,0.00005249405,0.00009014117,0.00012808503,0.00017736304],"domain_scores_gemma":[0.99854624,0.000812505,0.0002309834,0.000048059122,0.000101974976,0.00026030958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042473196,0.00052234007,0.0006725105,0.0013309403,0.0030693745,0.0018116549,0.0006635234,0.014002231,0.0024547763],"category_scores_gemma":[0.0054713576,0.00043370447,0.0005151353,0.00095538463,0.0019070939,0.0020449006,0.0013713614,0.0069036162,0.000554924],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052862364,0.000020435666,0.002019929,0.000047744415,0.000014971614,0.9676073,0.0014118096,0.0000907396,0.00040836114,0.0052471054,0.019079521,0.0039991904],"study_design_scores_gemma":[0.00008141035,0.00006207967,0.0033186052,0.0002089002,0.000025900432,0.9214557,0.001328485,0.0003572547,0.00024439566,0.0057156067,0.067169145,0.000032549437],"about_ca_topic_score_codex":0.0071991025,"about_ca_topic_score_gemma":0.014829837,"teacher_disagreement_score":0.014002231,"about_ca_system_score_codex":0.0025963082,"about_ca_system_score_gemma":0.00156641,"threshold_uncertainty_score":0.018837571},"labels":[],"label_agreement":null},{"id":"W3049451695","doi":"10.1016/s1474-4422(20)30269-6","title":"COVID-19 and selective vulnerability to Parkinson's disease","year":2020,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Neurodegeneration; Coronavirus; Virology; Encephalitis; Medicine; Coronaviridae; Coronavirus disease 2019 (COVID-19); Disease; Biology; Immunology; Virus; Internal medicine; Infectious disease (medical specialty)","score_opus":0.0343818008831626,"score_gpt":0.32758520850362655,"score_spread":0.29320340762046393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049451695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9564782,0.03121682,0.00017173197,0.0026851029,0.00021727887,0.00001473532,0.0023835315,0.00002691548,0.0068057254],"genre_scores_gemma":[0.98832256,0.0082249995,0.00015638449,0.00042864797,0.00021020064,0.000011687466,0.0011610569,0.000010726118,0.001473729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998105,0.000037360467,0.000016345288,0.00003842881,0.00003107724,0.00006633713],"domain_scores_gemma":[0.99897313,0.00013691362,0.000501049,0.00007550545,0.000088011206,0.00022546644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037926954,0.00034794371,0.0004961728,0.00042229285,0.0004872648,0.0009042688,0.00031502818,0.00080232974,0.0033162723],"category_scores_gemma":[0.0013297658,0.00015852053,0.00041146175,0.0006716663,0.00056352443,0.00042624425,0.00073645805,0.0010013584,0.00037683055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020040533,0.0005096997,0.8289245,0.0006714018,0.002621392,0.004738182,0.00031631303,0.00063758687,0.042192873,0.0049354513,0.007534569,0.08687749],"study_design_scores_gemma":[0.00017771876,0.00072182453,0.98742074,0.00008630145,0.00038241275,0.0014747967,0.00019756745,0.00013936206,0.001204295,0.0024141702,0.005751214,0.000029685652],"about_ca_topic_score_codex":0.003483239,"about_ca_topic_score_gemma":0.0053152298,"teacher_disagreement_score":0.003483239,"about_ca_system_score_codex":0.00052653055,"about_ca_system_score_gemma":0.00034974088,"threshold_uncertainty_score":0.011094093},"labels":[],"label_agreement":null},{"id":"W3062645889","doi":"10.1016/s1474-4422(20)30265-9","title":"Reappraisal of an ALS trial: unaccounted procedural risk","year":2020,"lang":"nl","type":"letter","venue":"The Lancet Neurology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine","score_opus":0.07098867594139632,"score_gpt":0.3507178103958025,"score_spread":0.27972913445440617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3062645889","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003475966,0.0021495114,0.0002460856,0.9792103,0.015224661,0.000020572745,0.000067303015,0.00003502186,0.0026989507],"genre_scores_gemma":[0.004749611,0.000687671,0.00040594884,0.9374016,0.05462201,0.00007021428,0.000027150423,0.00004669453,0.0019890782],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.95334464,0.02539055,0.0051868935,0.0037188134,0.010046218,0.002312903],"domain_scores_gemma":[0.73780113,0.2160562,0.0108333435,0.007042691,0.01490473,0.013361877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.045614727,0.0011226845,0.0028594816,0.0015287189,0.0040763333,0.0083837705,0.0046297554,0.09684728,0.010844953],"category_scores_gemma":[0.25715733,0.0011054435,0.0031600958,0.0014014515,0.008875284,0.007020283,0.0027275935,0.0653951,0.010763248],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010805887,0.00006843871,0.0009683596,0.0004250516,0.00036494815,0.0017460145,0.00032873332,0.00015743087,0.00041396855,0.016602077,0.9544916,0.023352884],"study_design_scores_gemma":[0.004901398,0.0005387632,0.0023326187,0.0027895793,0.0008846026,0.0021848748,0.00041910048,0.0017948243,0.0011219999,0.09360526,0.8891625,0.00026440504],"about_ca_topic_score_codex":0.0032875375,"about_ca_topic_score_gemma":0.005762254,"teacher_disagreement_score":0.09684728,"about_ca_system_score_codex":0.007230505,"about_ca_system_score_gemma":0.010239499,"threshold_uncertainty_score":0.24123663},"labels":[],"label_agreement":null},{"id":"W3062821267","doi":"10.1016/s1474-4422(20)30233-7","title":"Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia","year":2020,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Trigeminal Neuralgia and Treatments","field":"Medicine","cited_by":475,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Trigeminal neuralgia; Medicine; Neurovascular bundle; Carbamazepine; Neuroimaging; Microvascular decompression; Pathophysiology; Intensive care medicine; Surgery; Pathology; Epilepsy; Psychiatry","score_opus":0.07408984277135275,"score_gpt":0.3721324872777115,"score_spread":0.29804264450635876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3062821267","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000031234733,0.9990294,0.00006568284,0.0003437643,0.0001950256,0.0000023570005,0.0000095758505,0.000003517978,0.00031940165],"genre_scores_gemma":[0.00038004603,0.99855703,0.00016639051,0.00030959453,0.00041346106,0.0000032076248,0.000018204384,9.465413e-7,0.00015110822],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99949956,0.000100069636,0.00008041726,0.00007046098,0.00020915481,0.000040410658],"domain_scores_gemma":[0.99882597,0.00071474584,0.00016848589,0.000023016037,0.00021045617,0.0000572462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001342521,0.00097442756,0.0022003686,0.002441212,0.00025806914,0.0014280357,0.0012822754,0.0013437452,0.004089295],"category_scores_gemma":[0.0020252187,0.00023949497,0.00084437197,0.0020894303,0.000776185,0.0015495718,0.000812796,0.002677874,0.0015645354],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009804562,0.00004411603,0.0001505084,0.02059754,0.00011170305,0.00010368578,0.00003383151,0.0002858022,0.000638086,0.0025233424,0.023365378,0.952048],"study_design_scores_gemma":[0.000078686804,0.00016521775,0.0018354078,0.01689412,0.0004096833,0.0015529351,0.00011187307,0.0002461343,0.0002500084,0.004923892,0.9734871,0.000044997676],"about_ca_topic_score_codex":0.0025042314,"about_ca_topic_score_gemma":0.004748331,"teacher_disagreement_score":0.004089295,"about_ca_system_score_codex":0.0011072387,"about_ca_system_score_gemma":0.0018475086,"threshold_uncertainty_score":0.013680041},"labels":[],"label_agreement":null},{"id":"W3086044293","doi":"10.1016/s1474-4422(20)30273-8","title":"Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study","year":2020,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Prion Diseases and Protein Misfolding","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Public Health Agency of Canada; Ontario Brain Institute; University of Toronto; University Health Network","funders":"National Institute of Neurological Disorders and Stroke; European Regional Development Fund; Instituto de Salud Carlos III; National Health and Medical Research Council; Department of Health and Social Care; Polska Akademia Nauk; Medical Research Council; National Institutes of Health; Robert Koch Institut; European Commission; Institute Pasteur De Lille; Fondation pour la recherche juridique; Associazione Italiana per la Ricerca sul Cancro; Eisai; Wellcome Trust; Alzheimer's Society; Agence Nationale de la Recherche; Agence Française de Sécurité Sanitaire des Produits de Santé; Ministero dell’Istruzione, dell’Università e della Ricerca; Ministry of Health, Labour and Welfare; EU Joint Programme – Neurodegenerative Disease Research; Institut National de la Santé et de la Recherche Médicale; National Institute on Aging; National Institute for Health and Care Research; Department of Health and Aged Care, Australian Government; Quest Diagnostics; Tau Consortium; Fondation de France","keywords":"Genome-wide association study; Single-nucleotide polymorphism; PRNP; Biology; Odds ratio; Genetics; Genetic association; Disease; Heritability; Genotyping; Exome sequencing; SNP; Gene; Genotype; Medicine; Phenotype; Internal medicine","score_opus":0.02173696301547802,"score_gpt":0.26257258035078496,"score_spread":0.24083561733530695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3086044293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99604297,0.0014391767,0.0012097905,0.00023257046,0.000030820498,0.000012991881,0.00045512593,0.00002706447,0.00054938503],"genre_scores_gemma":[0.99830866,0.00037518935,0.0006812792,0.00006399577,0.000037971462,0.000008581956,0.00022912894,0.0000138982,0.0002813916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872476,0.00031976562,0.00014788174,0.00048153882,0.00018334895,0.00014266695],"domain_scores_gemma":[0.9981736,0.00085480703,0.00036717823,0.00020379249,0.00017017273,0.0002304515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021024644,0.0011276321,0.0007378426,0.0019767908,0.0010249511,0.0013384586,0.0010149649,0.0017632088,0.002321808],"category_scores_gemma":[0.0028870294,0.00061924674,0.001512437,0.0024086803,0.00081690896,0.0005617758,0.00082666276,0.001281905,0.0002921957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037616654,0.00035181918,0.94016635,0.00014466334,0.0037525964,0.004663795,0.0006828934,0.00052110426,0.032975722,0.0006682317,0.0007912528,0.011519899],"study_design_scores_gemma":[0.00022089257,0.000303511,0.9897507,0.00002813143,0.0024446466,0.0030364073,0.0003260567,0.0013408428,0.0010387623,0.000535174,0.0009386596,0.000036230387],"about_ca_topic_score_codex":0.0050292797,"about_ca_topic_score_gemma":0.0058841165,"teacher_disagreement_score":0.0050292797,"about_ca_system_score_codex":0.00026567775,"about_ca_system_score_gemma":0.00042337773,"threshold_uncertainty_score":0.011119008},"labels":[],"label_agreement":null},{"id":"W3086247265","doi":"10.1016/s1474-4422(20)30322-7","title":"NeuroCOVID: it's time to join forces globally","year":2020,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; NYU Grossman School of Medicine; Universität Innsbruck; Arvelle Therapeutics; Ministero della Salute; Inselspital, Universitätsspital Bern; York University; Johns Hopkins University; Istituto di Ricerche Farmacologiche Mario Negri - IRCCS; School of Medicine; Center for Clinical and Translational Science, University of Illinois at Chicago; University of Pittsburgh; National Institute on Aging; Medizinische Universität Innsbruck; University of Bern; National Institutes of Health; Ohio State University","keywords":"Medicine; Scopus; Coronavirus disease 2019 (COVID-19); myalgia; Pediatrics; Web of science; Outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); MEDLINE; Disease; Internal medicine; Virology; Infectious disease (medical specialty); Meta-analysis","score_opus":0.022221439183821756,"score_gpt":0.28853771746318446,"score_spread":0.2663162782793627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3086247265","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017843155,0.0018565125,0.000043862066,0.9612114,0.032467686,0.000006522866,0.0000581801,0.000031289725,0.0041461587],"genre_scores_gemma":[0.0021141518,0.0012644914,0.00010133861,0.9535749,0.027528258,0.000024033972,0.00004506675,0.00004297061,0.015304836],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99474144,0.00089905655,0.0003289207,0.00039348222,0.0017511705,0.0018858006],"domain_scores_gemma":[0.9790982,0.004082374,0.0011442302,0.00048960693,0.002694472,0.0124912355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055994936,0.0012602744,0.001411328,0.0010559191,0.007345291,0.010824447,0.0020841763,0.0703938,0.032768235],"category_scores_gemma":[0.024386985,0.00074699754,0.0016910664,0.00082682434,0.0051005343,0.008168069,0.0053853337,0.05310191,0.019496523],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022796024,0.000018221712,0.0002177984,0.000030153376,0.0000070353267,0.0002749787,0.00006473046,0.0000147513265,0.00005696819,0.0017851507,0.9938321,0.0036753118],"study_design_scores_gemma":[0.000058336573,0.00003382701,0.00067498005,0.00021884008,0.000010477641,0.00026073225,0.00063143566,0.000071253315,0.00005104167,0.005081776,0.99286884,0.000038381066],"about_ca_topic_score_codex":0.014774701,"about_ca_topic_score_gemma":0.032076757,"teacher_disagreement_score":0.0703938,"about_ca_system_score_codex":0.005706865,"about_ca_system_score_gemma":0.017225897,"threshold_uncertainty_score":0.10962063},"labels":[],"label_agreement":null},{"id":"W3093950086","doi":"10.1016/s1474-4422(20)30343-4","title":"Interrupting sequence variants and age of onset in Huntington's disease: clinical implications and emerging therapies","year":2020,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; BC Children's Hospital; University of British Columbia; University of Manitoba","funders":"Canadian Institutes of Health Research; Huntington's Disease Society of America","keywords":"Sequence (biology); Disease; Huntington's disease; Medicine; Age of onset; Genetics; Biology; Internal medicine","score_opus":0.21769453727575014,"score_gpt":0.4329402046372093,"score_spread":0.21524566736145914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093950086","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000055000684,0.99940383,0.000034425342,0.00018032361,0.000114771385,0.0000011428632,0.000017070295,0.0000028657255,0.00019051782],"genre_scores_gemma":[0.000612434,0.99854016,0.000105363186,0.00023963439,0.00026762328,0.0000038659223,0.000038900373,8.489471e-7,0.00019131921],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998031,0.00004055453,0.00003356658,0.000040197312,0.00006230188,0.000020154963],"domain_scores_gemma":[0.9994604,0.0003439593,0.00008221931,0.000007842619,0.00007104937,0.000034549117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009061344,0.0011329305,0.0025975,0.0012427523,0.00014167278,0.0010477235,0.001287487,0.0016160997,0.0033226712],"category_scores_gemma":[0.001274631,0.0002369938,0.0007783904,0.0014742545,0.00042484573,0.00086192176,0.00055322587,0.0020016732,0.0012815216],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003705789,0.000050794173,0.0004402513,0.013541369,0.00036040886,0.00022142904,0.00003204453,0.0003327812,0.00054508,0.002002135,0.029886428,0.9522167],"study_design_scores_gemma":[0.00036757553,0.0003498394,0.0060021463,0.017771514,0.0020099008,0.00223352,0.00014432182,0.000345806,0.000335024,0.0069409083,0.96342844,0.000070947885],"about_ca_topic_score_codex":0.0021845035,"about_ca_topic_score_gemma":0.0042321202,"teacher_disagreement_score":0.0033226712,"about_ca_system_score_codex":0.0006391689,"about_ca_system_score_gemma":0.00093068,"threshold_uncertainty_score":0.011115432},"labels":[],"label_agreement":null},{"id":"W3093981954","doi":"10.1016/s1474-4422(20)30312-4","title":"Monogenic variants in dystonia: an exome-wide sequencing study","year":2020,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Hereditary Neurological Disorders","field":"Neuroscience","cited_by":214,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa; Hospital for Sick Children; University of Toronto; SickKids Foundation","funders":"National Eye Institute; National Human Genome Research Institute; National Heart, Lung, and Blood Institute; Else Kröner-Fresenius-Stiftung; Technische Universität München; Bundesministerium für Bildung und Forschung; Eesti Teadusagentuur; Deutsche Forschungsgemeinschaft; Ministerstvo Školství, Mládeže a Tělovýchovy; Simons Foundation Autism Research Initiative; Vedecká Grantová Agentúra MŠVVaŠ SR a SAV; Broad Institute; Univerzita Karlova v Praze","keywords":"Dystonia; Exome sequencing; Medical genetics; Context (archaeology); Movement disorders; Medicine; Exome; Etiology; Genetics; Biology; Mutation; Psychiatry; Pathology; Disease; Gene","score_opus":0.14992170643258612,"score_gpt":0.30427913402324797,"score_spread":0.15435742759066184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093981954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99335384,0.0015441343,0.0005855133,0.0003736353,0.00003474634,0.000027696913,0.002885628,0.00002305887,0.0011717142],"genre_scores_gemma":[0.99637884,0.0005640731,0.00059973734,0.000281136,0.000040188635,0.000016026308,0.0014897638,0.000015091204,0.00061517756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99953437,0.00006509479,0.0000571645,0.00020270616,0.00008072381,0.000060016075],"domain_scores_gemma":[0.9995454,0.00021107445,0.00008935911,0.000035388304,0.000039260744,0.000079486286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046820086,0.0011580107,0.0007128722,0.0009907467,0.0008941989,0.00088095956,0.00062430784,0.0017642061,0.0029239072],"category_scores_gemma":[0.0011931378,0.00031690273,0.00075208175,0.001378537,0.0003718357,0.00031741802,0.00067077903,0.0006602527,0.00042397733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007109108,0.0006134454,0.67681605,0.0006186486,0.005002581,0.10247,0.0020912592,0.0028429532,0.13961305,0.0018702633,0.0084856115,0.052466974],"study_design_scores_gemma":[0.00030628408,0.00035137183,0.9638568,0.00015782731,0.0018692717,0.024482511,0.00038750534,0.0015548442,0.0024364975,0.0008938755,0.003639488,0.00006366124],"about_ca_topic_score_codex":0.005356953,"about_ca_topic_score_gemma":0.010320177,"teacher_disagreement_score":0.005356953,"about_ca_system_score_codex":0.0003825467,"about_ca_system_score_gemma":0.0002979954,"threshold_uncertainty_score":0.010651588},"labels":[],"label_agreement":null},{"id":"W3094186674","doi":"10.1016/s1474-4422(20)30347-1","title":"Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Biotin and Related Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Ottawa Hospital; Montreal Neurological Institute and Hospital; University of Ottawa","funders":"National Institute of Biomedical Imaging and Bioengineering; MedDay Pharmaceuticals; Rosetrees Trust","keywords":"Medicine; Expanded Disability Status Scale; Multiple sclerosis; Placebo; Clinical endpoint; Clinical trial; Physical therapy; Internal medicine; Pediatrics; Surgery; Pathology; Psychiatry","score_opus":0.02683076213583269,"score_gpt":0.26043121205966085,"score_spread":0.23360044992382817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094186674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98483294,0.008119053,0.0006239657,0.0009459512,0.00051224645,0.0015206642,0.0012221368,0.00015089993,0.0020721394],"genre_scores_gemma":[0.98971915,0.0026921828,0.00070784223,0.0012653116,0.00033403526,0.00145481,0.0011615482,0.00002511235,0.002640075],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994873,0.00024820725,0.00002923942,0.000096440184,0.000040534796,0.00009836678],"domain_scores_gemma":[0.9992446,0.00021540762,0.00015630237,0.000054102646,0.000057283138,0.00027236776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014092079,0.0020755215,0.0032100512,0.0003669441,0.0005137025,0.0011766612,0.0009641801,0.0030086022,0.006234927],"category_scores_gemma":[0.001398551,0.00069282786,0.0021878663,0.00043842933,0.0012637917,0.0010707398,0.0004322063,0.0033084766,0.0012752357],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98736936,0.0015917794,0.000315378,0.00045933443,0.0007982492,0.00003268093,0.00002884225,0.00013128217,0.002128422,0.000052767064,0.00047371964,0.006618164],"study_design_scores_gemma":[0.9688354,0.028647853,0.001371307,0.000024960795,0.00032781524,0.000023468965,0.000014029164,0.00013913518,0.00021064036,0.00010687986,0.0002872281,0.000011291213],"about_ca_topic_score_codex":0.0013817272,"about_ca_topic_score_gemma":0.0021753751,"teacher_disagreement_score":0.006234927,"about_ca_system_score_codex":0.000843023,"about_ca_system_score_gemma":0.00081830035,"threshold_uncertainty_score":0.02085787},"labels":[],"label_agreement":null},{"id":"W3095633432","doi":"10.1016/s1474-4422(20)30369-0","title":"Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Intracerebral and Subarachnoid Hemorrhage Research","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research; National Health and Medical Research Council; National Heart Foundation of Australia","keywords":"Medicine; Tranexamic acid; Intracerebral hemorrhage; Glasgow Coma Scale; Placebo; Stroke (engine); Randomized controlled trial; Population; Surgery; Anesthesia","score_opus":0.02640601710580017,"score_gpt":0.2840901390037901,"score_spread":0.25768412189798995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095633432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98119926,0.010377917,0.0007223853,0.0010514905,0.0010649743,0.0022125172,0.001215251,0.00014170667,0.002014415],"genre_scores_gemma":[0.97445935,0.008887228,0.0021503728,0.0020828599,0.0010004207,0.004499114,0.0018469188,0.000037884027,0.005035896],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99950135,0.00023684705,0.00004007496,0.000090706504,0.00003594435,0.00009501447],"domain_scores_gemma":[0.9993191,0.0001951739,0.0001697548,0.000053849704,0.000048259197,0.00021392915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012502219,0.0020670139,0.0040737498,0.0003752604,0.00041441093,0.001096611,0.00090815005,0.0021534641,0.006745009],"category_scores_gemma":[0.0018578334,0.00063130056,0.0021024672,0.00039068973,0.0009203452,0.0012994844,0.00045082974,0.002778773,0.0010185107],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98666126,0.0014774032,0.00024485087,0.00093675696,0.0012019775,0.000053990938,0.000044786662,0.000117797106,0.0015610055,0.000110408946,0.00072075985,0.0068690465],"study_design_scores_gemma":[0.97922254,0.018936835,0.00088044786,0.000030504287,0.00034551776,0.00003275311,0.000015442816,0.00009506664,0.00007496089,0.000072638024,0.00028282037,0.000010408425],"about_ca_topic_score_codex":0.001051725,"about_ca_topic_score_gemma":0.002461008,"teacher_disagreement_score":0.006745009,"about_ca_system_score_codex":0.0005172172,"about_ca_system_score_gemma":0.0008371801,"threshold_uncertainty_score":0.022564292},"labels":[],"label_agreement":null},{"id":"W3096310943","doi":"10.1016/s1474-4422(20)30342-2","title":"Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Ocrelizumab; Post-hoc analysis; Open label; Medicine; Placebo; Term (time); Multiple sclerosis; Post hoc; Oratorio; Randomized controlled trial; Internal medicine; Alternative medicine; Psychiatry","score_opus":0.1371199869251402,"score_gpt":0.35782827517812155,"score_spread":0.22070828825298133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096310943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97250426,0.015739152,0.0010688719,0.0009171049,0.00077745476,0.00074343046,0.006325508,0.00008938679,0.0018348221],"genre_scores_gemma":[0.9851012,0.0020508086,0.000526947,0.0010160599,0.0004948798,0.00090875995,0.0071976883,0.000068618225,0.002634916],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99284416,0.004325278,0.00040048567,0.00092451187,0.0004959876,0.0010094605],"domain_scores_gemma":[0.9882345,0.0064889155,0.0015896525,0.0015685799,0.0008454961,0.0012727908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0139823165,0.0031639978,0.00803435,0.00052414753,0.0012659626,0.0027718802,0.0016442976,0.0033917634,0.0061660837],"category_scores_gemma":[0.013893695,0.00081748597,0.011701107,0.00077707274,0.0011216999,0.0025980598,0.0014481064,0.005741363,0.0008447857],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97889006,0.00040739495,0.0032365934,0.000635475,0.011291619,0.00011281318,0.0000662283,0.0003325327,0.00077583216,0.000057284833,0.00086571136,0.0033284381],"study_design_scores_gemma":[0.71301556,0.058993876,0.12630811,0.00049514114,0.092445895,0.00032113076,0.0003476299,0.0013985102,0.0016518433,0.00089493557,0.0039065364,0.00022089292],"about_ca_topic_score_codex":0.002538007,"about_ca_topic_score_gemma":0.0047367103,"teacher_disagreement_score":0.0139823165,"about_ca_system_score_codex":0.0009831402,"about_ca_system_score_gemma":0.0015653,"threshold_uncertainty_score":0.07394642},"labels":[],"label_agreement":null},{"id":"W3098037544","doi":"10.1016/s1474-4422(20)30358-6","title":"The necessity of diplomacy in brain health","year":2020,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Science, Research, and Medicine","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Fondo de Financiamiento de Centros de Investigación en Áreas Prioritarias; Economic and Social Research Council; Tau Consortium; National Institutes of Health; Adamas Pharmaceuticals; National Institute on Aging; ACADIA Pharmaceuticals; Alzheimer's Drug Discovery Foundation; National Institute of Neurological Disorders and Stroke; National Institute of General Medical Sciences; Alzheimer's Association","keywords":"Diplomacy; Political science; Health care; Public health; Economic growth; Environmental health; Development economics; Medicine; Economics","score_opus":0.0802020945132754,"score_gpt":0.38776700077555876,"score_spread":0.3075649062622834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3098037544","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026067503,0.0008968643,0.000036131085,0.9864442,0.009141091,0.0000050025337,0.000025986152,0.00000671728,0.0031834468],"genre_scores_gemma":[0.0035999536,0.00044554396,0.00008318528,0.9760534,0.015032515,0.000025505688,0.000014609451,0.000014359488,0.0047310386],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9911566,0.0025491246,0.00080530316,0.00094620377,0.0022378345,0.0023048932],"domain_scores_gemma":[0.96853817,0.01792938,0.0014496149,0.00079383265,0.0032851403,0.0080038505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011115224,0.0009851223,0.0019052776,0.0010874942,0.00948351,0.0103184525,0.002514904,0.13465945,0.01102257],"category_scores_gemma":[0.05694236,0.0009473866,0.0013682037,0.0007635083,0.014719391,0.01037146,0.006471214,0.08542231,0.0068074153],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009438136,0.000035332174,0.00050864334,0.00006150398,0.000015595955,0.0008057333,0.00035023416,0.00004249714,0.00019371949,0.029138047,0.9617463,0.007007924],"study_design_scores_gemma":[0.00025688598,0.00006935607,0.0013809482,0.0006582399,0.000027749136,0.0010958947,0.0014760045,0.00035674527,0.00021854464,0.0738019,0.92053795,0.00011991405],"about_ca_topic_score_codex":0.018698625,"about_ca_topic_score_gemma":0.030501949,"teacher_disagreement_score":0.13465945,"about_ca_system_score_codex":0.007952724,"about_ca_system_score_gemma":0.023278695,"threshold_uncertainty_score":0.05878365},"labels":[],"label_agreement":null},{"id":"W3098640872","doi":"10.1016/s1474-4422(20)30364-1","title":"Neuroinflammation in intracerebral haemorrhage: immunotherapies with potential for translation","year":2020,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Intracerebral and Subarachnoid Hemorrhage Research","field":"Medicine","cited_by":316,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research; National Natural Science Foundation of China","keywords":"Neuroinflammation; Medicine; Microglia; Intracerebral hemorrhage; Minocycline; Neurology; Proinflammatory cytokine; Neuroscience; Inflammation; Anesthesia; Immunology; Biology","score_opus":0.07495609564788375,"score_gpt":0.34992268269748383,"score_spread":0.2749665870496001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3098640872","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003784489,0.99908304,0.00004229584,0.00029153808,0.00026755157,0.0000037360476,0.000012990958,0.0000035710455,0.00025739952],"genre_scores_gemma":[0.0004267208,0.99855274,0.00009729256,0.0004349811,0.0002824836,0.000007640212,0.000021254391,0.000001001065,0.00017588482],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996753,0.000085039865,0.00004303947,0.000045050376,0.000103124294,0.000048594608],"domain_scores_gemma":[0.9988978,0.0007399178,0.00010947081,0.000022203556,0.0001695307,0.00006110344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015610638,0.0011919178,0.0032471255,0.001808541,0.0002445448,0.0018670238,0.0012550037,0.0024375697,0.0064643566],"category_scores_gemma":[0.002073202,0.00034685805,0.0011532656,0.00176677,0.0007239328,0.0018078466,0.0009808275,0.0033542933,0.0019484746],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046884597,0.00013632613,0.00012990987,0.057813328,0.00042267024,0.00021844124,0.00007252576,0.00060106727,0.0017276384,0.0055870265,0.051673584,0.8811487],"study_design_scores_gemma":[0.00046990777,0.00048909645,0.0010170749,0.02687249,0.0008575242,0.00079298945,0.00013535016,0.00023980076,0.00032355063,0.0059349225,0.96281374,0.000053691154],"about_ca_topic_score_codex":0.0014937851,"about_ca_topic_score_gemma":0.0034446763,"teacher_disagreement_score":0.0064643566,"about_ca_system_score_codex":0.00083840464,"about_ca_system_score_gemma":0.0018404243,"threshold_uncertainty_score":0.02162546},"labels":[],"label_agreement":null},{"id":"W3106443431","doi":"10.1016/s1474-4422(20)30368-9","title":"Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study","year":2020,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":156,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Agence Nationale de la Recherche; Alnylam Pharmaceuticals","keywords":"Medicine; Transthyretin; Polyneuropathy; Clinical trial; Amyloidosis; Internal medicine; Placebo; Pediatrics; Physical therapy; Pathology; Alternative medicine","score_opus":0.037103833494907805,"score_gpt":0.29327768869214943,"score_spread":0.2561738551972416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3106443431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967912,0.0014477699,0.00023629384,0.00016138339,0.00008212761,0.0001855661,0.000571574,0.000038076327,0.00048603717],"genre_scores_gemma":[0.9955122,0.00090705743,0.00036677415,0.00031385533,0.00023680562,0.00039224548,0.0010688304,0.000018846717,0.0011834592],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9985935,0.00063591305,0.00011163043,0.00024635223,0.00018048473,0.00023210065],"domain_scores_gemma":[0.99669206,0.00090583164,0.0008262696,0.00047663963,0.0002926472,0.00080653245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042597353,0.0020355463,0.0035677468,0.0005463114,0.0005471608,0.0016153281,0.00095879723,0.002245923,0.0023475105],"category_scores_gemma":[0.002959176,0.0005816344,0.003192116,0.0005473877,0.0018404663,0.0025388666,0.00045306972,0.0040675215,0.00092766195],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93055284,0.018946953,0.006496547,0.00032715945,0.0021654721,0.00019433169,0.00017395228,0.00092838943,0.0056327875,0.00008073247,0.0007918962,0.033708923],"study_design_scores_gemma":[0.49609053,0.42980966,0.06427137,0.0000883212,0.0029575971,0.00032416545,0.00017685562,0.0017591969,0.0025991087,0.00048650143,0.0012814832,0.00015520779],"about_ca_topic_score_codex":0.00070957234,"about_ca_topic_score_gemma":0.00073954265,"teacher_disagreement_score":0.0042597353,"about_ca_system_score_codex":0.00089250423,"about_ca_system_score_gemma":0.0008909345,"threshold_uncertainty_score":0.022527874},"labels":[],"label_agreement":null},{"id":"W3113735845","doi":"10.1016/s1474-4422(20)30407-5","title":"Safety and efficacy of riluzole in patients undergoing decompressive surgery for degenerative cervical myelopathy (CSM-Protect): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Cervical and Thoracic Myelopathy","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Saskatchewan; University of Calgary; St. Michael's Hospital; Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; Riluzole; Placebo; Clinical endpoint; Myelopathy; Surgery; Population; Adverse effect; Intention-to-treat analysis; Randomized controlled trial; Anesthesia; Internal medicine; Amyotrophic lateral sclerosis; Spinal cord; Disease","score_opus":0.05286766895403219,"score_gpt":0.3195123663099709,"score_spread":0.26664469735593865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113735845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97798973,0.013553021,0.0007084986,0.0008613912,0.00084900233,0.002817808,0.0011711227,0.00014649823,0.0019029703],"genre_scores_gemma":[0.9835616,0.005904065,0.0013992523,0.001420314,0.00067522546,0.0029381998,0.0011610022,0.000028748398,0.0029115474],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994017,0.00029175406,0.000042536947,0.00011549273,0.000043120814,0.00010541649],"domain_scores_gemma":[0.99914956,0.0002756728,0.000217163,0.000073269206,0.00006378123,0.00022062783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016196426,0.0020619514,0.0042050024,0.00037718887,0.0005128554,0.0011728755,0.0010705309,0.0026808328,0.0058244504],"category_scores_gemma":[0.0020559975,0.00072170375,0.002638712,0.00045059877,0.0015920616,0.0011524733,0.00036119125,0.0033352836,0.0011520145],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9859907,0.001744957,0.0002695935,0.00090043584,0.00080839766,0.000037264283,0.000044271677,0.00012213607,0.002151776,0.00006428224,0.0004921011,0.007373957],"study_design_scores_gemma":[0.9679542,0.03033451,0.00079462846,0.00003134845,0.00029777005,0.000022193284,0.0000122369765,0.00011193672,0.00015019497,0.00005997029,0.0002197984,0.000011143043],"about_ca_topic_score_codex":0.001141483,"about_ca_topic_score_gemma":0.00246486,"teacher_disagreement_score":0.0058244504,"about_ca_system_score_codex":0.0007546196,"about_ca_system_score_gemma":0.0011469394,"threshold_uncertainty_score":0.019484699},"labels":[],"label_agreement":null},{"id":"W3115712647","doi":"10.1016/s1474-4422(20)30431-2","title":"Important advances in stroke research in 2020","year":2020,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Stroke (engine); Medicine; MEDLINE; Data science; Computer science; Political science; Engineering","score_opus":0.07416064239040036,"score_gpt":0.3649405099624521,"score_spread":0.2907798675720517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115712647","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00094146497,0.60046655,0.0010052761,0.33970916,0.048105456,0.000030484269,0.0012315597,0.00020257551,0.00830754],"genre_scores_gemma":[0.024156548,0.67169607,0.007899947,0.19688547,0.08782643,0.00011484828,0.003654085,0.00012996898,0.007636611],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.991083,0.0031940858,0.0013197877,0.00072825217,0.0019272696,0.0017474843],"domain_scores_gemma":[0.957547,0.017381731,0.0027215504,0.0012909044,0.01231809,0.008740734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03031207,0.0020278022,0.00339246,0.004172756,0.0012325135,0.008251806,0.002334623,0.013529087,0.026445486],"category_scores_gemma":[0.03749639,0.00076884223,0.0027927998,0.0039812108,0.003753851,0.01159039,0.0038642795,0.011148492,0.010147621],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089566386,0.00033775638,0.002754602,0.011517408,0.00042972883,0.0003950744,0.00022300152,0.0005240494,0.0017483686,0.0376962,0.6158524,0.3276257],"study_design_scores_gemma":[0.00027791367,0.00033086765,0.006113737,0.00879302,0.00026269586,0.00042593174,0.00071011914,0.00036913858,0.0005149505,0.031049153,0.9510515,0.00010098585],"about_ca_topic_score_codex":0.00612044,"about_ca_topic_score_gemma":0.009466619,"teacher_disagreement_score":0.03031207,"about_ca_system_score_codex":0.006680961,"about_ca_system_score_gemma":0.025269434,"threshold_uncertainty_score":0.16030753},"labels":[],"label_agreement":null},{"id":"W3115760280","doi":"10.1016/s1474-4422(20)30478-6","title":"Surgical decompression in acute spinal cord injury: earlier is better","year":2020,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; International Spinal Research Trust; Rick Hansen Institute; Seventh Framework Programme; Craig H. Neilsen Foundation","keywords":"Medicine; Surgical decompression; Spinal cord injury; Decompression; Surgery; Spinal cord; Neurology; Anesthesia; Spinal decompression; Spinal surgery","score_opus":0.08363682659348307,"score_gpt":0.4068870173064385,"score_spread":0.32325019071295547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115760280","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028454472,0.0028376034,0.00002928293,0.9796538,0.014915841,0.0000038915837,0.00002608134,0.000010967367,0.0022380196],"genre_scores_gemma":[0.004231909,0.0028940705,0.00010366907,0.91265607,0.07657683,0.000017764225,0.000034981018,0.00001927211,0.0034654734],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99646497,0.00097606855,0.0005427397,0.00031115435,0.0010149726,0.0006900964],"domain_scores_gemma":[0.9836488,0.007930537,0.0011196976,0.0003638308,0.0029963776,0.003940766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041983286,0.00084132777,0.0019757375,0.0013779721,0.004284687,0.004546088,0.0018543026,0.059307538,0.0141324485],"category_scores_gemma":[0.03588711,0.0006252632,0.0013426368,0.0013112401,0.0042525535,0.006386248,0.0019261066,0.038841642,0.008098797],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023945468,0.000076490156,0.0010457673,0.00017848484,0.00003079317,0.0014412656,0.000119106146,0.000058802005,0.00023552765,0.0030044299,0.9768261,0.016743794],"study_design_scores_gemma":[0.0011719391,0.00036514498,0.006264369,0.002383921,0.00012942521,0.006123841,0.0012796025,0.0005814675,0.0004267468,0.035123233,0.94594395,0.00020640908],"about_ca_topic_score_codex":0.010079271,"about_ca_topic_score_gemma":0.018787675,"teacher_disagreement_score":0.059307538,"about_ca_system_score_codex":0.0049854503,"about_ca_system_score_gemma":0.008055789,"threshold_uncertainty_score":0.04727775},"labels":[],"label_agreement":null},{"id":"W3117701108","doi":"10.1016/s1474-4422(20)30406-3","title":"The influence of timing of surgical decompression for acute spinal cord injury: a pooled analysis of individual patient data","year":2020,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":374,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research; U.S. Department of Defense","keywords":"Medicine; Spinal cord injury; Decompression; Surgical decompression; Spinal decompression; Spinal cord; Clinical endpoint; Prospective cohort study; Physical therapy; Surgery; Randomized controlled trial","score_opus":0.14272927025392493,"score_gpt":0.44707103326961783,"score_spread":0.30434176301569293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3117701108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7976726,0.16695979,0.019651648,0.001444647,0.0021992594,0.00035021408,0.0089352,0.00026450108,0.0025221677],"genre_scores_gemma":[0.9889209,0.0043054004,0.0028604893,0.00043893198,0.0004347547,0.00015153308,0.0024339552,0.00010063934,0.00035334355],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.92677015,0.053952888,0.008092252,0.0071593313,0.0023842326,0.001641048],"domain_scores_gemma":[0.8931527,0.075731054,0.013276782,0.014700438,0.002218759,0.0009203019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04860875,0.002097066,0.008103735,0.0021287948,0.00040891324,0.0032076675,0.0020605195,0.0030421633,0.0018021555],"category_scores_gemma":[0.09230883,0.0015298511,0.02750845,0.0033359255,0.0007058969,0.002489217,0.0018014549,0.002048598,0.00034689906],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052898638,0.000119838136,0.14215462,0.0040956703,0.7758029,0.0004240543,0.00021776775,0.00442708,0.0012672062,0.00040410942,0.0018234688,0.016364645],"study_design_scores_gemma":[0.00630846,0.0055437926,0.2853957,0.00082231156,0.68631077,0.0007245074,0.00036246242,0.00755985,0.0010006052,0.002566601,0.003154484,0.00025037947],"about_ca_topic_score_codex":0.003234195,"about_ca_topic_score_gemma":0.0035836909,"teacher_disagreement_score":0.04860875,"about_ca_system_score_codex":0.0008762293,"about_ca_system_score_gemma":0.00094580336,"threshold_uncertainty_score":0.25707072},"labels":[],"label_agreement":null},{"id":"W3120366962","doi":"10.1016/s1474-4422(20)30488-9","title":"Optimising prehospital stroke triage in a changing landscape","year":2021,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Stroke (engine); Triage; Endovascular treatment; Scopus; Observational study; Emergency medicine; Acute stroke; Ischemic stroke; MEDLINE; Emergency department; Internal medicine; Surgery; Ischemia; Aneurysm","score_opus":0.029085801788584338,"score_gpt":0.2626923932819537,"score_spread":0.23360659149336938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120366962","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033983836,0.0006885968,0.00009557197,0.9907624,0.0063330885,0.000004214863,0.000017197699,0.000014543046,0.0017445416],"genre_scores_gemma":[0.01412846,0.0033683397,0.0009909888,0.8977184,0.07965913,0.00005248323,0.000051815714,0.000055039945,0.003975322],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949122,0.0016215661,0.0005851646,0.0005040846,0.0011747952,0.0012022345],"domain_scores_gemma":[0.9814571,0.0061583053,0.0012729038,0.00041067073,0.00385281,0.006848169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004249344,0.00073920935,0.001345301,0.0011462234,0.0047352137,0.008909738,0.0020110712,0.0506294,0.012768795],"category_scores_gemma":[0.037203647,0.0006943419,0.0011360256,0.0010681333,0.0040727016,0.0077327015,0.0032330763,0.041635375,0.007922186],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069097376,0.00008759402,0.0016173112,0.00014937534,0.000028565255,0.002175988,0.0003763011,0.00024946692,0.00024639553,0.0027094956,0.9708544,0.021436062],"study_design_scores_gemma":[0.0003999943,0.00020048361,0.006083842,0.0015424499,0.000110441266,0.005206938,0.004752322,0.0018684536,0.0003389601,0.05949981,0.91981065,0.00018571469],"about_ca_topic_score_codex":0.010883703,"about_ca_topic_score_gemma":0.025166074,"teacher_disagreement_score":0.0506294,"about_ca_system_score_codex":0.006504698,"about_ca_system_score_gemma":0.012342492,"threshold_uncertainty_score":0.047195137},"labels":[],"label_agreement":null},{"id":"W3123727478","doi":"10.1016/s1474-4422(20)30486-5","title":"Neuromuscular junctions: mind meeting matter","year":2021,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Muscle activation and electromyography studies","field":"Engineering","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"Medical Research Council; Motor Neurone Disease Association","keywords":"Anatomy; Electromyography; Neuromuscular junction; Neuroscience; Computer science; Medicine; Psychology","score_opus":0.016508803978266224,"score_gpt":0.2159771107878532,"score_spread":0.19946830680958696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3123727478","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001147504,0.20359923,0.0008585499,0.6421795,0.11343429,0.000007590135,0.0001622276,0.00014150188,0.038469613],"genre_scores_gemma":[0.04558751,0.15961698,0.0014434668,0.36654857,0.32353827,0.000042810807,0.00024949864,0.00024024297,0.10273268],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988906,0.0003029508,0.00008798782,0.00021944249,0.0003481984,0.0001508337],"domain_scores_gemma":[0.99595416,0.0015334294,0.0003269986,0.00032246942,0.00064211665,0.0012209406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020357477,0.0007651023,0.0012755236,0.0010176464,0.0018558007,0.0060718474,0.0010906148,0.011098914,0.036666315],"category_scores_gemma":[0.006399256,0.00035923268,0.00054737466,0.0006667029,0.004812917,0.0079532545,0.002441113,0.009837749,0.016534658],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011170939,0.00004199474,0.0007183152,0.00054034125,0.000050294402,0.00038259957,0.00027395764,0.000052689134,0.0007300303,0.03312868,0.8356266,0.12834276],"study_design_scores_gemma":[0.000037563503,0.000046686073,0.0014960037,0.0010192574,0.0000317539,0.0009113511,0.0006014461,0.00005495259,0.00014468169,0.06386422,0.9317669,0.000025155818],"about_ca_topic_score_codex":0.0011429399,"about_ca_topic_score_gemma":0.002736359,"teacher_disagreement_score":0.036666315,"about_ca_system_score_codex":0.0014795377,"about_ca_system_score_gemma":0.001958352,"threshold_uncertainty_score":0.122660995},"labels":[],"label_agreement":null},{"id":"W3124681486","doi":"10.1016/s1474-4422(20)30432-4","title":"Paediatric multiple sclerosis and antibody-associated demyelination: clinical, imaging, and biological considerations for diagnosis and care","year":2021,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University","funders":"","keywords":"Multiple sclerosis; Medicine; Intensive care medicine; Immunology","score_opus":0.35193922202712585,"score_gpt":0.45223468269256006,"score_spread":0.10029546066543421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3124681486","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012888462,0.99957496,0.000016053738,0.0002275589,0.00007966326,0.0000013824763,0.000007065407,0.0000012604995,0.0000791545],"genre_scores_gemma":[0.0002025184,0.999303,0.00008063311,0.00025030994,0.00009905621,0.0000034287489,0.000012883554,4.6433084e-7,0.000047667043],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990717,0.00028126824,0.00020483806,0.00009190878,0.00029043946,0.000059754653],"domain_scores_gemma":[0.99612087,0.0028863924,0.0004269018,0.00004856714,0.00042612493,0.00009110318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027042236,0.0012064397,0.004902569,0.003095328,0.0002736053,0.0018755854,0.0017163663,0.0024234082,0.004247942],"category_scores_gemma":[0.005284812,0.00043529517,0.001392502,0.003924961,0.0008240548,0.0020052458,0.0010999544,0.0027271176,0.0012007258],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020012366,0.000043020034,0.0002829572,0.106811464,0.0007902023,0.00027211208,0.00007716198,0.00038056087,0.00045790218,0.0042081084,0.041683786,0.8447926],"study_design_scores_gemma":[0.0002358386,0.00016190473,0.0026414662,0.15717445,0.0027544403,0.0018846524,0.00026515342,0.00016053145,0.00016440528,0.00488429,0.8296048,0.000068049696],"about_ca_topic_score_codex":0.004482104,"about_ca_topic_score_gemma":0.009944448,"teacher_disagreement_score":0.004902569,"about_ca_system_score_codex":0.0017859617,"about_ca_system_score_gemma":0.0034714327,"threshold_uncertainty_score":0.014301419},"labels":[],"label_agreement":null},{"id":"W3129357302","doi":"10.1016/s1474-4422(21)00029-6","title":"Advanced consent for acute stroke trials","year":2021,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Informed consent; Proxy (statistics); Acute stroke; Medicine; Stroke (engine); Clinical trial; MEDLINE; Alternative medicine; Internal medicine; Emergency department; Psychiatry; Computer science; Pathology; Law; Political science","score_opus":0.7111097790666542,"score_gpt":0.618120120985552,"score_spread":0.09298965808110216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129357302","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005220259,0.0023958327,0.0007905566,0.96853507,0.013515268,0.00022485825,0.00015591987,0.00005649597,0.013804058],"genre_scores_gemma":[0.0038542592,0.00077207235,0.0009846429,0.9726247,0.014642741,0.0005094463,0.000082724306,0.000040731204,0.0064886734],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.8753373,0.07533798,0.016475726,0.006040725,0.017888581,0.00891969],"domain_scores_gemma":[0.62201583,0.31576577,0.011877369,0.015174728,0.015474102,0.019692263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.12181322,0.0018839928,0.0047291345,0.0023550482,0.010269799,0.016501527,0.007899238,0.24894926,0.019483466],"category_scores_gemma":[0.34462595,0.0033753195,0.004180362,0.0026543532,0.01561015,0.012161541,0.009251946,0.11441166,0.016064277],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028167426,0.0000612967,0.00047413356,0.00040000098,0.00008109891,0.0015840621,0.0005474946,0.00011307547,0.00029666527,0.03364975,0.94764346,0.014867446],"study_design_scores_gemma":[0.0018525629,0.00021170243,0.0017230368,0.0028018958,0.00016220476,0.00227149,0.0005613213,0.0011068083,0.0004458239,0.13600898,0.8526562,0.00019796638],"about_ca_topic_score_codex":0.0055994405,"about_ca_topic_score_gemma":0.011998681,"teacher_disagreement_score":0.24894926,"about_ca_system_score_codex":0.008332472,"about_ca_system_score_gemma":0.037471883,"threshold_uncertainty_score":0.6442176},"labels":[],"label_agreement":null},{"id":"W3129403532","doi":"10.1016/s1474-4422(21)00006-5","title":"Treatment of asymptomatic carotid stenosis","year":2021,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Cerebrovascular and Carotid Artery Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Asymptomatic; Medicine; Stenosis; Stroke (engine); Internal medicine; Population; Cardiology; Cohort; Cohort study; Neurology; Radiology","score_opus":0.030678901817351976,"score_gpt":0.26166704644270355,"score_spread":0.23098814462535158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129403532","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012393037,0.01937502,0.0002111687,0.9127537,0.038408794,0.00002173304,0.00008918919,0.000057734058,0.027843345],"genre_scores_gemma":[0.011889619,0.006432726,0.00028455476,0.8506056,0.11410647,0.000050292278,0.000092919334,0.00003190863,0.016505817],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99780947,0.00058429694,0.00021935701,0.00020003812,0.0008149682,0.0003719252],"domain_scores_gemma":[0.9971846,0.0012319838,0.00026541264,0.000110406676,0.0003618742,0.00084572856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015037196,0.00076353416,0.0015410549,0.001365757,0.002559967,0.0024290876,0.0011749358,0.036460098,0.0073696617],"category_scores_gemma":[0.010710135,0.00048023977,0.001609797,0.0007058628,0.0018008566,0.001517898,0.0010861275,0.022237316,0.005293613],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028352474,0.000100979865,0.00091927487,0.00019757535,0.000048005408,0.006874572,0.000088523186,0.00011711693,0.00045749935,0.004269712,0.9444686,0.04217462],"study_design_scores_gemma":[0.0006693482,0.0002933887,0.004358824,0.0010493405,0.00008390125,0.01035662,0.00015503314,0.0004766875,0.00034546893,0.013201446,0.96894306,0.00006694539],"about_ca_topic_score_codex":0.005021688,"about_ca_topic_score_gemma":0.015111945,"teacher_disagreement_score":0.036460098,"about_ca_system_score_codex":0.0029381993,"about_ca_system_score_gemma":0.0027515749,"threshold_uncertainty_score":0.024653971},"labels":[],"label_agreement":null},{"id":"W3130158832","doi":"10.1016/s1474-4422(20)30449-x","title":"Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study","year":2021,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":332,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Weston Brain Institute; Scottish Government","keywords":"Dementia with Lewy bodies; Synucleinopathies; REM sleep behavior disorder; Lumbar puncture; Medicine; Polysomnography; Parkinson's disease; Internal medicine; Rapid eye movement sleep; Biomarker; Dementia; Lumbar; Disease; Cerebrospinal fluid; Oncology; Pathology; Gastroenterology; Alpha-synuclein; Surgery; Ophthalmology; Eye movement; Biology","score_opus":0.028472147307595067,"score_gpt":0.26933038331575526,"score_spread":0.2408582360081602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130158832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987709,0.00040962017,0.00010729582,0.000044815333,0.000017216762,0.000018451205,0.0004129177,0.0000052179894,0.00021343613],"genre_scores_gemma":[0.99883,0.00016546664,0.00009498633,0.000078757854,0.000022271694,0.00002474891,0.00058204215,0.0000046397545,0.0001971057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987878,0.00027633196,0.00015919567,0.00040772633,0.00017039131,0.00019861749],"domain_scores_gemma":[0.99653035,0.00052698294,0.0013881094,0.00039200275,0.00067340984,0.0004890814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013902017,0.0010379006,0.0011577207,0.00115167,0.0013022033,0.0018230417,0.00085077324,0.001834486,0.0009821001],"category_scores_gemma":[0.0044045956,0.0010773891,0.0016269804,0.0017192544,0.0008849874,0.0018894272,0.0008970406,0.0020014474,0.00048132797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006970429,0.00014400436,0.9976671,0.000015176933,0.00021090738,0.00015980285,0.0001334705,0.000022421433,0.0003767257,0.000008826637,0.000077495904,0.00048708424],"study_design_scores_gemma":[0.000059370057,0.0006119505,0.99781704,0.000015698903,0.00021242691,0.00049357093,0.000323395,0.00016741072,0.000099069875,0.000038437323,0.00014433812,0.000017266158],"about_ca_topic_score_codex":0.014992782,"about_ca_topic_score_gemma":0.012524387,"teacher_disagreement_score":0.014992782,"about_ca_system_score_codex":0.001143814,"about_ca_system_score_gemma":0.0009319218,"threshold_uncertainty_score":0.029811025},"labels":[],"label_agreement":null},{"id":"W3132607516","doi":"10.1016/s1474-4422(20)30477-4","title":"Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease","year":2021,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Prion Diseases and Protein Misfolding","field":"Biochemistry, Genetics and Molecular Biology","cited_by":340,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; University of Toronto; University Health Network","funders":"Medical Research Council; MedDay Pharmaceuticals; National Institutes of Health; National Institute on Aging; Institut de Recherches Servier; Ministry of Health, Labour and Welfare; Instituto de Salud Carlos III; National Institute for Health and Care Research; National Institute of Allergy and Infectious Diseases; National Health and Medical Research Council; Japan Agency for Medical Research and Development","keywords":"Medicine; Disease; Biomarker; Prion protein; Clinical trial; Pathology; Biology","score_opus":0.12073006149403474,"score_gpt":0.39405471958615845,"score_spread":0.2733246580921237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132607516","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038352307,0.9972988,0.00020290946,0.0014414702,0.00057879894,0.0000052054406,0.000039814124,0.000013809334,0.00038081352],"genre_scores_gemma":[0.00093384396,0.9935369,0.0008264937,0.002493316,0.0012547078,0.000032039916,0.00018368567,0.0000047773788,0.00073413475],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99932504,0.0001582342,0.00016393622,0.00009894113,0.00019515291,0.000058796824],"domain_scores_gemma":[0.9983564,0.00087705796,0.0002505615,0.00003497108,0.00038394175,0.00009713207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027383545,0.0017269662,0.0036185635,0.0031547935,0.0003402061,0.0018923023,0.0019852237,0.0035745318,0.002661467],"category_scores_gemma":[0.0038137839,0.0005261801,0.0013483512,0.001926145,0.000872543,0.0018464299,0.00095701584,0.004532567,0.001963282],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025824297,0.00006593531,0.00039661184,0.011164276,0.00027052278,0.00034218,0.00004435934,0.0005312291,0.00062597013,0.0058335257,0.14434953,0.83611757],"study_design_scores_gemma":[0.00023109707,0.00015629058,0.0022297548,0.016783612,0.0009224135,0.0016609287,0.00007681898,0.00048300275,0.0003825329,0.010381924,0.9666259,0.0000656728],"about_ca_topic_score_codex":0.003028978,"about_ca_topic_score_gemma":0.0045481944,"teacher_disagreement_score":0.0036185635,"about_ca_system_score_codex":0.0017012835,"about_ca_system_score_gemma":0.0023737338,"threshold_uncertainty_score":0.014481962},"labels":[],"label_agreement":null},{"id":"W3133993978","doi":"10.1016/s1474-4422(20)30483-x","title":"Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trial","year":2021,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":224,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Blood pressure; Stroke (engine); Thrombolysis; Randomized controlled trial; Surgery; Anesthesia; Internal medicine; Myocardial infarction","score_opus":0.016254356893233596,"score_gpt":0.2759883611899233,"score_spread":0.2597340042966897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133993978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98574907,0.00854963,0.0006799929,0.0006863868,0.00071991154,0.0013527472,0.0007372136,0.00007122884,0.0014539984],"genre_scores_gemma":[0.99070376,0.0028153956,0.0009837165,0.0009968035,0.00090444187,0.001716613,0.00072250055,0.000015275176,0.0011414379],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982158,0.0009153618,0.00016165782,0.00035333462,0.0001457479,0.0002080434],"domain_scores_gemma":[0.9977196,0.00092478964,0.0006596781,0.0002042842,0.00010879375,0.0003828817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026957327,0.001824389,0.0045400327,0.0004896165,0.00053931586,0.0014753711,0.0011264527,0.0028803798,0.005086032],"category_scores_gemma":[0.004125073,0.00076572236,0.003067252,0.0006349077,0.0015083345,0.0015380401,0.00073220604,0.0030301763,0.00070335384],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9911505,0.0014545359,0.0005381929,0.00051853945,0.0016829962,0.00001964692,0.0000288136,0.00010149586,0.00039472114,0.000051699193,0.00023967968,0.0038192593],"study_design_scores_gemma":[0.97045183,0.023982625,0.003443813,0.000055739616,0.0014267566,0.000020454132,0.0000147654155,0.00019782527,0.00010178843,0.00012262838,0.0001671346,0.000014566112],"about_ca_topic_score_codex":0.0011718721,"about_ca_topic_score_gemma":0.0013557186,"teacher_disagreement_score":0.005086032,"about_ca_system_score_codex":0.00075888116,"about_ca_system_score_gemma":0.0008079358,"threshold_uncertainty_score":0.017014503},"labels":[],"label_agreement":null},{"id":"W3138463198","doi":"10.1016/s1474-4422(21)00024-7","title":"Development of imaging-based risk scores for prediction of intracranial haemorrhage and ischaemic stroke in patients taking antithrombotic therapy after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies","year":2021,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Intracerebral and Subarachnoid Hemorrhage Research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Horizon 2020; National Medical Research Council; Medical Research Council; Canadian Institutes of Health Research; Bayer Yakuhin; Chest Heart and Stroke Scotland; AstraZeneca Korea; Schweizerische Herzstiftung; Eisai; University College London Hospitals NHS Foundation Trust; Ministry of Health, Labour and Welfare; Hartstichting; Daiichi-Sankyo; ZonMw; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Fondation Leducq; Agence Nationale de la Recherche; Wellcome Trust; University College London; British Heart Foundation; Health Research Board; National Institute for Health and Care Research; NIHR Imperial Biomedical Research Centre; Manchester Biomedical Research Centre; Yuhan; European Regional Development Fund; Boehringer Ingelheim Japan; Sanofi; National Cerebral and Cardiovascular Center; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Instituto de Salud Carlos III; Amgen; Mrs Gladys Row Fogo Charitable Trust; Alzheimer's Society; Alnylam Pharmaceuticals; Daiichi Sankyo Europe; Servier; Bayer; Pfizer; Stroke Association; Biogen; European Commission; AstraZeneca; Bristol-Myers Squibb; Japan Agency for Medical Research and Development; Imperial College London; National Science Foundation","keywords":"Ischaemic stroke; Antithrombotic; Medicine; Stroke (engine); Cardiology; Internal medicine; Brain ischemia; Ischemia","score_opus":0.07445417187508924,"score_gpt":0.33418846878233044,"score_spread":0.2597342969072412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138463198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88740873,0.08589174,0.0156525,0.00051244756,0.00072497764,0.0005048739,0.007785876,0.0001909998,0.0013279018],"genre_scores_gemma":[0.98390573,0.0044487207,0.006015722,0.00017235865,0.00022126223,0.0002648844,0.00468441,0.000060379192,0.00022659618],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9686263,0.020152519,0.004129913,0.0037602405,0.0024967596,0.000834212],"domain_scores_gemma":[0.9458681,0.029264703,0.010831979,0.009093686,0.0041979956,0.00074358407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.043116532,0.003171502,0.00907487,0.0055396156,0.00051537744,0.004894759,0.0023125252,0.0030329723,0.0010544669],"category_scores_gemma":[0.060745336,0.0020665377,0.022318168,0.0048947963,0.00085464725,0.0024444424,0.0029107512,0.0021901794,0.00026959326],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026428329,0.00014040798,0.40908745,0.002460042,0.5374841,0.00017586551,0.00027885646,0.0035313612,0.0010795705,0.00026344138,0.0009754949,0.018095132],"study_design_scores_gemma":[0.007624339,0.0032105052,0.5367991,0.0007452701,0.43651536,0.0004982608,0.000425766,0.009726345,0.0008895484,0.0014710915,0.001751846,0.00034259187],"about_ca_topic_score_codex":0.0036381206,"about_ca_topic_score_gemma":0.0043001985,"teacher_disagreement_score":0.043116532,"about_ca_system_score_codex":0.00077614357,"about_ca_system_score_gemma":0.0008684956,"threshold_uncertainty_score":0.22802472},"labels":[],"label_agreement":null},{"id":"W3142041087","doi":"10.1016/s1474-4422(20)30359-8","title":"Patient-centred management of Parkinson's disease","year":2020,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Healthcare innovation and challenges","field":"Social Sciences","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Direction de l’hospitalisation et de l’offre de Soins; AbbVie Canada; Bayer Vital; Deutsche Parkinson Vereinigung; Daiichi Sankyo Europe; Servier; Agentura Pro Zdravotnický Výzkum České Republiky; Canadian Institutes of Health Research; Centre Hospitalier Universitaire de Toulouse; Ministero dell’Istruzione, dell’Università e della Ricerca; Grantová Agentura České Republiky; Horizon 2020; Physicians' Services Incorporated Foundation; EU Joint Programme – Neurodegenerative Disease Research; H. Lundbeck A/S; Sunovion; Medtronic; Union Chimique Belge; Ottawa Hospital Research Institute; European Commission; Massachusetts Institute of Technology; Fondation Brain Canada; Institut National de la Santé et de la Recherche Médicale; Acorda Therapeutics; GlaxoSmithKline; University of Ottawa; Parkinson Canada; Agence Nationale de la Recherche; Acadia University; Univerzita Karlova v Praze; Ontario Research Foundation; European Institute of Innovation and Technology; Medical Research Council; Universidad San Pablo - CEU; Teva Pharmaceutical Industries; Sanofi; CHDI Foundation; Roche; AstraZeneca; International Parkinson and Movement Disorder Society; Pfizer; Biogen; Universidade de Lisboa; Chiesi Farmaceutici; EVER Neuro Pharma; Michael J. Fox Foundation for Parkinson's Research","keywords":"Excellence; Disease; Health care; Parkinson's disease; Medicine; Disease management; Health professionals; Nursing; Psychology; Political science","score_opus":0.09297318170234417,"score_gpt":0.3201289624422042,"score_spread":0.22715578073986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3142041087","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034351254,0.0024932188,0.000069310685,0.98865277,0.0056441994,0.0000037334598,0.000021268728,0.000009398349,0.002762662],"genre_scores_gemma":[0.017335346,0.0046128873,0.000373389,0.8779101,0.09606577,0.000040718813,0.000063125626,0.000017288456,0.003581404],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99237037,0.0037861194,0.00078731653,0.0003871126,0.0018594498,0.00080967514],"domain_scores_gemma":[0.9658722,0.018051289,0.002162835,0.0007083599,0.0039745336,0.009230793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064332695,0.00047417128,0.0012694891,0.0012407298,0.0024964202,0.0043787365,0.0018634904,0.04059174,0.00761569],"category_scores_gemma":[0.042263616,0.00040039938,0.0013251959,0.00093291997,0.0037191121,0.004396169,0.0028863968,0.025768267,0.0026709079],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008693096,0.00010522801,0.001916423,0.00027053605,0.000047840742,0.0020739879,0.00022513668,0.00017471636,0.00016265549,0.00744645,0.9502989,0.03719128],"study_design_scores_gemma":[0.00063401804,0.0002520805,0.009628818,0.0025177563,0.00010016728,0.008237395,0.0012070831,0.0017014671,0.00037146555,0.058954354,0.9162566,0.00013870226],"about_ca_topic_score_codex":0.0056376834,"about_ca_topic_score_gemma":0.019008782,"teacher_disagreement_score":0.04059174,"about_ca_system_score_codex":0.0054492876,"about_ca_system_score_gemma":0.0111716455,"threshold_uncertainty_score":0.03953749},"labels":[],"label_agreement":null},{"id":"W3153661265","doi":"10.1016/s1474-4422(21)00102-2","title":"A new definition of brain health","year":2021,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Dementia; Mental health; Cognition; Psychology; Vascular dementia; Stroke (engine); Set (abstract data type); Medicine; Disease; Psychiatry; Pathology","score_opus":0.06739538238311957,"score_gpt":0.36269563993027265,"score_spread":0.29530025754715306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153661265","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0090636825,0.099806234,0.18940397,0.49278915,0.041426253,0.00022139215,0.001397751,0.00038830453,0.16550325],"genre_scores_gemma":[0.5065702,0.07440195,0.123824365,0.1722062,0.08744178,0.0025301347,0.002404756,0.0005476005,0.030073047],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.991109,0.0038622795,0.0011442639,0.0013866962,0.0016615584,0.0008362493],"domain_scores_gemma":[0.9900445,0.0039281016,0.0009811104,0.0009835626,0.002614744,0.0014479345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010364023,0.0025626412,0.0025662808,0.009181067,0.0029364817,0.0096280575,0.0038365235,0.007090773,0.008541511],"category_scores_gemma":[0.012443775,0.0005476108,0.0021649625,0.005037435,0.03295167,0.023014415,0.008309171,0.013439365,0.0020081075],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001857175,0.000021451575,0.00050859235,0.00015985416,0.00003324431,0.00007404666,0.00069367554,0.00011929624,0.000109968576,0.9690711,0.018673854,0.010516317],"study_design_scores_gemma":[0.00002631891,0.000043124724,0.00066969334,0.00029596325,0.00002897765,0.0005312301,0.0008803289,0.0004334792,0.00005925856,0.9139594,0.083034724,0.000037461265],"about_ca_topic_score_codex":0.0028112305,"about_ca_topic_score_gemma":0.0021424855,"teacher_disagreement_score":0.010364023,"about_ca_system_score_codex":0.005832007,"about_ca_system_score_gemma":0.0048614736,"threshold_uncertainty_score":0.05481088},"labels":[],"label_agreement":null},{"id":"W3157419554","doi":"10.1016/s1474-4422(17)30299-5","title":"Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015","year":2017,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Neurology and Historical Studies","field":"Neuroscience","cited_by":2280,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; Wageningen University and Research; Health Research Council of New Zealand; Medical Research Council; National Institutes of Health; National Institute on Minority Health and Health Disparities; INCLIVA Instituto de Investigación Sanitaria; University of Peradeniya; University of Oklahoma Health Sciences Center; Hospital for Sick Children; Debre Markos University; Haramaya University; Ministry of Business, Innovation and Employment; Universidad Nacional de Colombia; Universität Bielefeld; Public Health Foundation of India; University of Oxford; University of Toronto; Universitat de València; Brain Research New Zealand; Trường Đại học Duy Tân; Institute for Health Metrics and Evaluation; University of Massachusetts Boston; Wellcome Trust; Universidade de São Paulo; AstraZeneca; Arabian Gulf University; Michigan State University; University of Rochester; Imperial College London; University of Oklahoma; College of Engineering, Michigan State University; University of Washington; Ottawa Hospital Research Institute; Centro de Investigación Biomédica en Red de Salud Mental; Bill and Melinda Gates Foundation; Amgen; National Institute for Health and Care Research; Medical Center, University of Rochester; Massachusetts General Hospital; U.S. Department of Health and Human Services","keywords":"Medicine; Disease; Global health; Disease burden; Burden of disease; Disability-adjusted life year; Environmental health; Public health; Pediatrics; Population","score_opus":0.06657212071504127,"score_gpt":0.33379457703520043,"score_spread":0.2672224563201592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157419554","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.136901,0.6890885,0.0032477845,0.0016218307,0.0004179987,0.0012788472,0.16522212,0.00016384565,0.002058065],"genre_scores_gemma":[0.701648,0.22609031,0.0066147977,0.0015992689,0.00022428932,0.0027028385,0.060540434,0.0000636168,0.000516412],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9947542,0.0015087979,0.0019258687,0.00081493973,0.00073234417,0.00026375768],"domain_scores_gemma":[0.99513596,0.001445494,0.0017465051,0.00031965686,0.0011870137,0.0001654229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075500095,0.00084098754,0.0029357653,0.0074742218,0.00038112784,0.0008783436,0.0006798555,0.0005735201,0.0012377588],"category_scores_gemma":[0.014432326,0.000670186,0.009545374,0.009807122,0.00042164864,0.00063541316,0.0015656846,0.0006592102,0.00017389366],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016729874,0.00004484355,0.6229772,0.13805425,0.12362047,0.0003117355,0.0011218716,0.0025525296,0.0005533332,0.0013863337,0.03831165,0.06939277],"study_design_scores_gemma":[0.00083987595,0.00029136162,0.802857,0.06414793,0.10394708,0.0007117738,0.0006884664,0.0014414823,0.00030905797,0.0008912527,0.02372626,0.00014847612],"about_ca_topic_score_codex":0.07347044,"about_ca_topic_score_gemma":0.12563573,"teacher_disagreement_score":0.07347044,"about_ca_system_score_codex":0.002388227,"about_ca_system_score_gemma":0.006691029,"threshold_uncertainty_score":0.14608562},"labels":[],"label_agreement":null},{"id":"W3163268700","doi":"10.1016/s1474-4422(21)00132-0","title":"Concerns about lamotrigine","year":2021,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Epilepsy Society; Department of Health and Aged Care, Australian Government; ZonMw; National Institute for Health and Care Research","keywords":"Lamotrigine; Medicine; Sudden cardiac death; Epilepsy; QT interval; Internal medicine; Cardiology; Intensive care medicine; Psychiatry","score_opus":0.06226778147332324,"score_gpt":0.3569947421639359,"score_spread":0.29472696069061266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163268700","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002510417,0.026503734,0.00038985765,0.94418395,0.0037034021,0.00000980938,0.00012847476,0.000052336025,0.022517934],"genre_scores_gemma":[0.07092384,0.028401686,0.0011175701,0.87558246,0.014754654,0.000039067076,0.0001616986,0.000095923,0.008923072],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99224275,0.003606574,0.0008960541,0.000433782,0.0022942626,0.00052660104],"domain_scores_gemma":[0.95526075,0.031001441,0.003694195,0.0011310145,0.006453303,0.0024591894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011944514,0.00030922593,0.0006454533,0.00072489,0.0016978557,0.0026774919,0.0015206488,0.009007174,0.016330091],"category_scores_gemma":[0.075300895,0.00025760478,0.0015379515,0.0007360041,0.0035295044,0.0024565146,0.0018944977,0.01530782,0.0034822095],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007823605,0.00008140962,0.0038462705,0.0014230524,0.0003461921,0.0026904342,0.001464746,0.0003591807,0.0013270406,0.03124915,0.6564196,0.30001065],"study_design_scores_gemma":[0.0002571689,0.00024014873,0.0028780808,0.0022042028,0.00021216448,0.0046853665,0.0013867859,0.0001690455,0.00070439256,0.014890937,0.97232383,0.00004796465],"about_ca_topic_score_codex":0.008741375,"about_ca_topic_score_gemma":0.01266582,"teacher_disagreement_score":0.016330091,"about_ca_system_score_codex":0.004523257,"about_ca_system_score_gemma":0.005021231,"threshold_uncertainty_score":0.06316942},"labels":[],"label_agreement":null},{"id":"W3170470841","doi":"10.1016/s1474-4422(21)00159-9","title":"Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial","year":2021,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":668,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Argenx","keywords":"Tolerability; Medicine; Placebo; Myasthenia gravis; Adverse effect; Internal medicine; Physical therapy; Alternative medicine","score_opus":0.014863137273486688,"score_gpt":0.26648226664136565,"score_spread":0.25161912936787895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170470841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98698246,0.007884883,0.00025374806,0.00065994484,0.00037414298,0.0011612161,0.0007848666,0.00008632733,0.0018123672],"genre_scores_gemma":[0.98990154,0.00295352,0.00061537075,0.001476982,0.000585835,0.0015409811,0.0009847382,0.000018228746,0.0019228172],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995388,0.00019381069,0.000028266615,0.00008798591,0.000043834,0.00010734605],"domain_scores_gemma":[0.9992224,0.00023458188,0.00019485282,0.000068048364,0.000044414403,0.00023562356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016258894,0.0020778587,0.0031220352,0.00033504367,0.00042154719,0.0010878351,0.0009056135,0.0021133851,0.0047208155],"category_scores_gemma":[0.0016246577,0.0005531631,0.0021653695,0.00038916603,0.0014089885,0.0011066893,0.0004374664,0.0031441103,0.0008758407],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9758158,0.00301049,0.001221161,0.00074099615,0.0016497619,0.00008419865,0.00008259365,0.00026676615,0.0026441854,0.000099308236,0.00091524125,0.013469441],"study_design_scores_gemma":[0.95094,0.043471586,0.0042753443,0.00003178022,0.00049214606,0.000051154504,0.000025316047,0.00011440099,0.000115541174,0.00011153263,0.00035519828,0.000016032058],"about_ca_topic_score_codex":0.001026883,"about_ca_topic_score_gemma":0.002661,"teacher_disagreement_score":0.0047208155,"about_ca_system_score_codex":0.0007677444,"about_ca_system_score_gemma":0.000666845,"threshold_uncertainty_score":0.015792668},"labels":[],"label_agreement":null},{"id":"W3171747481","doi":"10.1016/s1474-4422(21)00095-8","title":"2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis","year":2021,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":643,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; University of British Columbia","funders":"National Institute of Neurological Disorders and Stroke; Sanofi Genzyme; National Institutes of Health; Eli Lilly and Company; Ono Pharmaceutical; Siemens; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Multiple Sclerosis Society; Schweizerische Multiple Sklerose Gesellschaft; Multiple Sclerosis Society of Canada; European Commission; GlaxoSmithKline España; EMD Serono; UCB; Novartis; Fondazione Italiana Sclerosi Multipla; Roche España; F. Hoffmann-La Roche; Pfizer; Biogen; National Institute for Health and Care Research; Teva Pharmaceutical Industries; Chugai Pharmaceutical; MedDay Pharmaceuticals; Ministero della Salute; UCLH Biomedical Research Centre; Bayer HealthCare; Sanofi; MedImmune; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Consensus conference; Medicine; Internal medicine; Psychiatry","score_opus":0.32800892374507357,"score_gpt":0.36590373030319073,"score_spread":0.03789480655811717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171747481","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007198951,0.9827497,0.00025211324,0.009754738,0.0032743218,0.0002493317,0.0013314422,0.000028430006,0.0022879178],"genre_scores_gemma":[0.0008565186,0.9841839,0.0019440175,0.008760384,0.001167259,0.00056592585,0.0013086869,0.000020725369,0.0011924984],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9905792,0.0031235805,0.0029477181,0.00056898326,0.0023320916,0.0004484731],"domain_scores_gemma":[0.98018324,0.009501306,0.003936316,0.00029995805,0.005422991,0.00065614027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015417725,0.0024463977,0.0063787727,0.013349533,0.0008893382,0.003546106,0.0058581387,0.0068987138,0.011836796],"category_scores_gemma":[0.037851594,0.0014053053,0.0077782283,0.00717889,0.0011595754,0.0027464204,0.0031881144,0.004358544,0.005387697],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005818533,0.00006945381,0.00042563473,0.27917454,0.0025165877,0.00017551826,0.0001454379,0.00029007945,0.00053639174,0.0034672834,0.24387455,0.4687427],"study_design_scores_gemma":[0.00041787126,0.00009766482,0.002182509,0.4379838,0.0053914865,0.00024155893,0.00010418152,0.0000763622,0.00019939685,0.0023495052,0.5508852,0.00007039695],"about_ca_topic_score_codex":0.022694604,"about_ca_topic_score_gemma":0.031282194,"teacher_disagreement_score":0.022694604,"about_ca_system_score_codex":0.0062166685,"about_ca_system_score_gemma":0.02315602,"threshold_uncertainty_score":0.08153772},"labels":[],"label_agreement":null},{"id":"W3182337727","doi":"10.1016/s1474-4422(21)00213-1","title":"Off-label use of aducanumab for cerebral amyloid angiopathy","year":2021,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Intracerebral and Subarachnoid Hemorrhage Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; University of Calgary","funders":"","keywords":"Cerebral amyloid angiopathy; Medicine; Food and drug administration; Superficial siderosis; Intracerebral hemorrhage; Disease; Alzheimer's disease; Intensive care medicine; Pathology; Internal medicine; Pharmacology; Dementia","score_opus":0.08907833845949467,"score_gpt":0.32696566013653566,"score_spread":0.237887321677041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182337727","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37567118,0.50673926,0.0038933863,0.02647081,0.00826986,0.00038521853,0.0019045719,0.00048686896,0.07617888],"genre_scores_gemma":[0.91334313,0.06253584,0.0021519833,0.01027775,0.0034249546,0.0001511599,0.0013258952,0.00006417387,0.006724974],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9993969,0.00025230047,0.000048155922,0.00006645308,0.0001506203,0.000085550055],"domain_scores_gemma":[0.99838626,0.0007261443,0.0002819529,0.000093802926,0.00023151135,0.000280411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011415167,0.00030583228,0.0012195453,0.0003968982,0.00026703664,0.0011800375,0.00053431076,0.0010268389,0.0033859243],"category_scores_gemma":[0.0029223366,0.00013126052,0.0008011914,0.00030773692,0.00055731274,0.00059052743,0.00022318536,0.0021090235,0.0010702809],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014407755,0.00084246515,0.0071916655,0.0019648287,0.0007546255,0.0008635568,0.000097979355,0.00035025805,0.010592549,0.0018499041,0.037589148,0.92349523],"study_design_scores_gemma":[0.029361755,0.039772622,0.16527039,0.0074381824,0.0034683947,0.014158333,0.000645844,0.006176263,0.01799663,0.020828158,0.6945644,0.0003190045],"about_ca_topic_score_codex":0.0009194508,"about_ca_topic_score_gemma":0.002264782,"teacher_disagreement_score":0.0033859243,"about_ca_system_score_codex":0.0011389354,"about_ca_system_score_gemma":0.0006008593,"threshold_uncertainty_score":0.011327088},"labels":[],"label_agreement":null},{"id":"W3185627487","doi":"10.1016/s1474-4422(21)00183-6","title":"Intraparenchymal haemorrhages as a primary outcome measure","year":2021,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Stroke (engine); Blood pressure; Clinical trial; Regimen; Randomized controlled trial; Surgery; Cardiology; Internal medicine","score_opus":0.04908072764284369,"score_gpt":0.2828873160744875,"score_spread":0.23380658843164384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185627487","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00987756,0.015170455,0.00045686396,0.91816247,0.035005268,0.00008693715,0.0016777283,0.000025352349,0.019537304],"genre_scores_gemma":[0.19185741,0.012286112,0.0022932354,0.609758,0.16914347,0.0012314552,0.001412455,0.000077104654,0.0119407065],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9847472,0.00719658,0.0026064496,0.00076769444,0.0034664995,0.0012156297],"domain_scores_gemma":[0.9570491,0.025087371,0.0033971742,0.0010167742,0.008952001,0.004497622],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00991571,0.0005324609,0.0027494635,0.0021196352,0.001452331,0.003395465,0.001195339,0.011243087,0.0041211885],"category_scores_gemma":[0.062495887,0.00034855324,0.0011517862,0.0031404197,0.0012165722,0.0019388858,0.0008779278,0.011562356,0.0024410435],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016039509,0.00044877475,0.03930456,0.0009441913,0.00037125466,0.0017364532,0.00028148643,0.00020300613,0.00035965565,0.0051245573,0.8722373,0.07738482],"study_design_scores_gemma":[0.009026317,0.0028988596,0.17933285,0.015075437,0.0030952895,0.011354571,0.0033575029,0.0072071147,0.002402619,0.10101286,0.66458666,0.0006499364],"about_ca_topic_score_codex":0.004538731,"about_ca_topic_score_gemma":0.012573381,"teacher_disagreement_score":0.9900843,"about_ca_system_score_codex":0.0036377248,"about_ca_system_score_gemma":0.0056978757,"threshold_uncertainty_score":0.052439928},"labels":[],"label_agreement":null},{"id":"W3186052749","doi":"10.1016/s1474-4422(21)00176-9","title":"Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder","year":2021,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":242,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; McGill University; Montreal Neurological Institute and Hospital; Hôpital du Sacré-Cœur de Montréal","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; ParkinsonFonds Deutschland; National Institute on Aging; National Institutes of Health; Agentura Pro Zdravotnický Výzkum České Republiky; Parkinson's UK","keywords":"Synucleinopathies; Dementia with Lewy bodies; Rapid eye movement sleep; Disease; Dementia; Neuroscience; Parkinson's disease; Atrophy; Medicine; REM sleep behavior disorder; Eye movement; Alpha-synuclein; Pathology; Psychology","score_opus":0.0350351471794424,"score_gpt":0.3185176713200386,"score_spread":0.2834825241405962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186052749","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000094840085,0.99942005,0.00005380622,0.00011378954,0.00010779564,0.000003334336,0.000028469776,0.0000038844437,0.00017400777],"genre_scores_gemma":[0.0022171042,0.9966534,0.0002495789,0.0002707415,0.00020922637,0.000012637727,0.00006655623,0.0000012837593,0.00031957173],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99968207,0.00005679038,0.000058015168,0.000049653958,0.00013112127,0.000022335378],"domain_scores_gemma":[0.99922,0.00038780796,0.000203671,0.00001169046,0.00014626692,0.000030543026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009869298,0.0013372673,0.0034777462,0.0023157794,0.00013412477,0.0011710558,0.0008880605,0.0012500242,0.002190266],"category_scores_gemma":[0.0016445544,0.00034065743,0.0011497288,0.0015228239,0.00039998468,0.00078429666,0.0005285356,0.0019564182,0.0010436474],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030403494,0.000051057596,0.00083756854,0.02238616,0.0008092133,0.0001933054,0.000035574805,0.00024507716,0.0009417898,0.0011698245,0.017990505,0.95503587],"study_design_scores_gemma":[0.00073938794,0.0009803888,0.024505671,0.050268553,0.007468415,0.004292499,0.00032364728,0.00094113144,0.0022475375,0.007889588,0.90014166,0.00020172531],"about_ca_topic_score_codex":0.0028122063,"about_ca_topic_score_gemma":0.005872441,"teacher_disagreement_score":0.0034777462,"about_ca_system_score_codex":0.0006572868,"about_ca_system_score_gemma":0.00086910866,"threshold_uncertainty_score":0.0073271394},"labels":[],"label_agreement":null},{"id":"W3191883126","doi":"10.1016/s1474-4422(21)00182-4","title":"Post-viral effects of COVID-19 in the olfactory system and their implications","year":2021,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Olfactory and Sensory Function Studies","field":"Neuroscience","cited_by":187,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières","funders":"Centers for Disease Control and Prevention; National Institutes of Health; Bundesministerium für Bildung und Forschung; University of Toronto; University of Alabama","keywords":"Olfactory bulb; Olfactory system; Olfactory epithelium; Pathology; Neuroimaging; Neuroscience; Olfaction; Biology; Central nervous system; Medicine","score_opus":0.2412151788627014,"score_gpt":0.34444436601559647,"score_spread":0.10322918715289506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3191883126","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000045425484,0.99937373,0.000028511819,0.00017572836,0.00013014018,0.0000010585902,0.000009689231,0.0000016950443,0.00023407835],"genre_scores_gemma":[0.00035212937,0.9990502,0.000062234605,0.00014421443,0.0001956752,0.000002131109,0.000015355039,6.048788e-7,0.00017741167],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998605,0.00002861022,0.000020021842,0.000025564428,0.00004562366,0.000019661396],"domain_scores_gemma":[0.99952805,0.00028449984,0.00005321682,0.000011205476,0.00008999187,0.000033063974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089311035,0.0009606993,0.0017133346,0.0013145824,0.00018358683,0.0013167484,0.00088162086,0.0013440562,0.0030813725],"category_scores_gemma":[0.0010862056,0.000224693,0.0005518253,0.0015030581,0.00068928365,0.0011980726,0.0006823117,0.0019107396,0.0012059779],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002446856,0.0000651701,0.00028259348,0.021958936,0.00019251581,0.0003596211,0.000052349667,0.0004671639,0.0020474694,0.005762562,0.033123232,0.93544376],"study_design_scores_gemma":[0.00006274084,0.00018387995,0.002007157,0.009249346,0.00034262505,0.0016231412,0.00013143626,0.00015561147,0.0006928163,0.00557157,0.9799313,0.000048344307],"about_ca_topic_score_codex":0.0019213138,"about_ca_topic_score_gemma":0.0038823204,"teacher_disagreement_score":0.0030813725,"about_ca_system_score_codex":0.000833946,"about_ca_system_score_gemma":0.0013970009,"threshold_uncertainty_score":0.010308266},"labels":[],"label_agreement":null},{"id":"W3194931521","doi":"10.1016/s1474-4422(21)00237-4","title":"Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial","year":2021,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University; NeuroRx Research (Canada)","funders":"National Institutes of Health; Sanofi","keywords":"Medicine; Multiple sclerosis; Placebo; Cohort; Internal medicine; Interferon beta-1a; Pathology; Immunology","score_opus":0.1181872174142568,"score_gpt":0.3653213659137695,"score_spread":0.2471341484995127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194931521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9575306,0.029344734,0.0009281478,0.0017377048,0.001358832,0.0024838462,0.002477271,0.00020101242,0.0039378717],"genre_scores_gemma":[0.97690886,0.009043441,0.0010577962,0.0023090814,0.0010358864,0.0029174385,0.0025425986,0.00004742407,0.0041374327],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99908113,0.00041095723,0.00007579731,0.00020258177,0.000079427555,0.00015012691],"domain_scores_gemma":[0.9987803,0.00041484323,0.00029453787,0.00009015958,0.00009509545,0.00032502096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002182968,0.0025520278,0.0049331514,0.0005087461,0.00062141917,0.0016441451,0.0010424705,0.0037688657,0.007251218],"category_scores_gemma":[0.0027728386,0.0009340851,0.0029078242,0.000568476,0.0015971723,0.0017022921,0.00039714228,0.0042033494,0.0015743026],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9862255,0.0012371257,0.00028316697,0.0009369792,0.0010714362,0.000033965116,0.000031033604,0.0001388529,0.0016872085,0.00006231962,0.00064984657,0.007642655],"study_design_scores_gemma":[0.9794031,0.01814336,0.0010289388,0.000045458026,0.00056040904,0.000027964028,0.000012368792,0.0001343116,0.00016505475,0.000097697186,0.00036887205,0.000012446332],"about_ca_topic_score_codex":0.0010696988,"about_ca_topic_score_gemma":0.001529056,"teacher_disagreement_score":0.007251218,"about_ca_system_score_codex":0.00093633716,"about_ca_system_score_gemma":0.0009121417,"threshold_uncertainty_score":0.02425778},"labels":[],"label_agreement":null},{"id":"W3195674796","doi":"10.1016/s1474-4422(21)00218-0","title":"Myelin-oligodendrocyte glycoprotein antibody-associated disease","year":2021,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":517,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"UCLH Biomedical Research Centre; Instituto de Salud Carlos III; National Health and Medical Research Council; European Research Council; Seventh Framework Programme; EMD Serono; MedDay Pharmaceuticals; Mitsubishi Tanabe Pharma Corporation; Teijin Pharma; Bayer Schering; Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Ministry of Health, Labour and Welfare; Bundesministerium für Bildung und Forschung; University of Sydney; American Academy of Neurology; TG Therapeutics; Multiple Sclerosis Society; Merck; European Committee for Treatment and Research in Multiple Sclerosis; Sanofi Genzyme; Genzyme; Universität Basel; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Sanofi; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Guthy-Jackson Charitable Foundation; Genentech; National Multiple Sclerosis Society; Biogen Idec; Novartis; Celgene; UCL Institute of Ophthalmology, University College London; Bayer; Biogen; Ministry of Education, Science and Technology; National Institute for Health and Care Research; Teva Pharmaceutical Industries; Agence Nationale de la Recherche; Deutsche Forschungsgemeinschaft; Roche; National Institutes of Health; Rosetrees Trust","keywords":"Neuromyelitis optica; Myelin oligodendrocyte glycoprotein; Multiple sclerosis; Medicine; Optic neuritis; Spectrum disorder; Antibody; Immunology; Disease; Pathological; Pathology; Experimental autoimmune encephalomyelitis; Psychiatry","score_opus":0.14568617235871487,"score_gpt":0.425937900509555,"score_spread":0.2802517281508401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195674796","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000027122373,0.999579,0.000013673943,0.00009031061,0.00013344524,0.000004092332,0.000026888985,0.0000016220649,0.00012386321],"genre_scores_gemma":[0.00056392973,0.998862,0.00007039845,0.00024882553,0.00011339169,0.0000093399,0.000032444193,6.4155626e-7,0.000099070494],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998971,0.0003246979,0.00027572078,0.00011911615,0.00024696815,0.00006256642],"domain_scores_gemma":[0.9973252,0.0018934252,0.00045231124,0.000039495917,0.00022288214,0.00006665791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026848528,0.0013631709,0.005135407,0.0039122603,0.00021867178,0.0015141078,0.0012447828,0.0016377182,0.007368964],"category_scores_gemma":[0.0052853986,0.0004580812,0.0019884536,0.0049022296,0.0005721197,0.0010849735,0.0011326132,0.0014146086,0.0009782917],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054458744,0.00004629474,0.00046033735,0.33885422,0.0047135847,0.00015977696,0.000057643974,0.0001540081,0.0003907328,0.0014129768,0.041302163,0.61190367],"study_design_scores_gemma":[0.0011065825,0.0003504291,0.0070529697,0.3225472,0.032430768,0.0011965893,0.00025450278,0.00013796236,0.00032586546,0.0027820142,0.6317324,0.000082712264],"about_ca_topic_score_codex":0.0053735133,"about_ca_topic_score_gemma":0.013928184,"teacher_disagreement_score":0.007368964,"about_ca_system_score_codex":0.0013611523,"about_ca_system_score_gemma":0.0024432577,"threshold_uncertainty_score":0.024651587},"labels":[],"label_agreement":null},{"id":"W3197233575","doi":"10.1016/s1474-4422(21)00252-0","title":"Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019","year":2021,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":7600,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Human Genome Research Institute; National Research, Development and Innovation Office; Guy's and St Thomas' NHS Foundation Trust; Fundação para a Ciência e a Tecnologia; Japan Society for the Promotion of Science; National Health and Medical Research Council; Daiichi Sankyo Europe; Medical Research Council; Novo Nordisk Pharma; Novartis Pharma; National Institutes of Health; Lilly Deutschland; Fogarty International Center; Idorsia Pharmaceuticals; Jenderal Soedirman University; Italfarmaco; H. Lundbeck A/S; Casen Recordati; Swedish Orphan Biovitrum; Academy of Finland; Servier; Xiamen University; Fondazione Umberto Veronesi; Universiti Kebangsaan Malaysia; Tehran University of Medical Sciences and Health Services; National Institute of Neurological Disorders and Stroke; Universitatea de Medicină şi Farmacie \"Carol Davila\" Bucureşti; University of Oxford; Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii; Kuwait University; Allergan; Neuraxpharm; Novo Nordisk; Precursory Research for Embryonic Science and Technology; King Abdulaziz University; DSM Nutritional Products; Ultragenyx Pharmaceutical; National Research Foundation of Korea; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Ministry of Science and ICT, South Korea; Ministero della Salute; Generalitat de Catalunya; AOSpine; Ain Shams University; Intas Pharmaceuticals; Högskolan Dalarna; Monash University; Deutsche Forschungsgemeinschaft; African Academy of Sciences; Department of Biotechnology, Ministry of Science and Technology, India; National Heart Foundation of Australia; National Research Foundation; Cardiff University; Newcastle University; Novo Nordisk Fonden; Department of Health and Social Care; Bundesministerium für Bildung und Forschung; Esperion Therapeutics; Ministry of Education, Culture, Sports, Science and Technology; British Heart Foundation; The Wellcome Trust DBT India Alliance; University of Queensland; National Institute for Health and Care Research; Wellcome Trust; Johns Hopkins University; Amarin Corporation; Cardinal Health; Australian Academy of Science; Amryt Pharma; American Heart Association; Government of Canada; Kasturba Medical College, Manipal; Karolinska Institutet; Agios Pharmaceuticals; Fresenius Medical Care North America; Istituto Auxologico Italiano; Australian Government; Alzheimer's Association; U.S. Department of Defense; Brigham and Women's Hospital; Global Brain Health Institute; Autoritatea Natională pentru Cercetare Stiintifică; Dipartimento di Medicina e Chirurgia, Università degli Studi di Milano-Bicocca; International Hepato-Pancreato-Biliary Association; Birzeit University; Bill and Melinda Gates Foundation; Pfizer; Università degli Studi di Milano; Iran University of Medical Sciences; Hubei Provincial Department of Education; National Authority for Scientific Research and Innovation; King Saud University; International Society of Travel Medicine; Sanofi; Eisai; National Science and Technology Council; King's College Hospital NHS Foundation Trust; Cilag; Amgen; Fondazione Cariplo; Regeneron Pharmaceuticals; Universitas Airlangga; McMaster University; Korean Diabetes Association; Hamad Medical Corporation; University of Jordan; Harvard University; International Atomic Energy Agency; University of Technology Sydney; Alexion Pharmaceuticals; Bristol-Myers Squibb; Alfaisal University; Teva Pharmaceutical Industries; AstraZeneca; Moderna; Biogen; King's College London; Amicus Therapeutics; Alexander von Humboldt-Stiftung; Astellas Pharma; National Institute for Health Research Applied Research Collaboration West; Student Research Committee, Tabriz University of Medical Sciences; Bayer; Canadian Institutes of Health Research; European Commission; La Trobe University; Cancer Research UK; Eli Lilly and Company; Danone; American Diabetes Association; Japan Science and Technology Agency; European Stroke Organisation; Sociedad Madrileña de Nefrología; National Cerebral and Cardiovascular Center","keywords":"Burden of disease; Stroke (engine); Medicine; Disease; Disease burden; Environmental health; Internal medicine; Engineering","score_opus":0.031070314766542338,"score_gpt":0.3025834401296353,"score_spread":0.27151312536309297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197233575","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.049150467,0.8129981,0.0028455507,0.0021808327,0.00050540816,0.0007152939,0.13001488,0.00016018537,0.001429259],"genre_scores_gemma":[0.4907324,0.42318293,0.007599053,0.0026829334,0.0004070004,0.0031504992,0.07134222,0.00010570714,0.0007973074],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99501437,0.0016246197,0.0014823017,0.0007167963,0.0009421382,0.00021971892],"domain_scores_gemma":[0.99306494,0.002358096,0.0020878357,0.0004895197,0.0017832572,0.00021633097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010109523,0.0009603034,0.0035320024,0.007760811,0.000380406,0.0010199517,0.0007391509,0.00069872494,0.0014313414],"category_scores_gemma":[0.015577994,0.00076028216,0.012836269,0.013442463,0.00040993368,0.00066236884,0.0014910202,0.0009042353,0.0003177998],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024282224,0.000046388763,0.43610978,0.18961099,0.21213293,0.00037874785,0.00084875105,0.0034986637,0.00056106533,0.0016235329,0.057799898,0.094961],"study_design_scores_gemma":[0.0015761012,0.00030101283,0.63217515,0.07658445,0.23588929,0.0007787392,0.00062771497,0.0022478083,0.00033690076,0.0014520348,0.04783378,0.00019706179],"about_ca_topic_score_codex":0.07359947,"about_ca_topic_score_gemma":0.1168956,"teacher_disagreement_score":0.07359947,"about_ca_system_score_codex":0.0022935672,"about_ca_system_score_gemma":0.0077407155,"threshold_uncertainty_score":0.1463421},"labels":[],"label_agreement":null},{"id":"W3199546106","doi":"10.1016/s1474-4422(21)00242-8","title":"Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial","year":2021,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"National Institute for Health and Care Research; OMRON Corporation","keywords":"Medicine; Amyotrophic lateral sclerosis; Clinical endpoint; Placebo; Levosimendan; Adverse effect; Population; Internal medicine; Physical therapy; Riluzole; Clinical trial; Heart failure; Pathology","score_opus":0.08461749481689211,"score_gpt":0.3404554619137068,"score_spread":0.25583796709681467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199546106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.862446,0.06849136,0.001085259,0.035698835,0.0106934095,0.0027042562,0.0047168466,0.0002615634,0.013902522],"genre_scores_gemma":[0.92791635,0.015591545,0.0016120938,0.03419521,0.0052224016,0.0033698557,0.0018807102,0.000047126097,0.010164691],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99920386,0.00049444765,0.0000687893,0.00008319443,0.00006826433,0.00008139591],"domain_scores_gemma":[0.99850106,0.0007985272,0.0002590517,0.00006682834,0.00011954788,0.00025512278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002250062,0.0011627831,0.0030324257,0.00020217703,0.0005328981,0.001055658,0.0006483365,0.004561296,0.0051783565],"category_scores_gemma":[0.0045530396,0.00044878636,0.0016468475,0.00023624527,0.0007835881,0.0010177837,0.000328207,0.0034806,0.0012766296],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94806594,0.0011809524,0.0013248783,0.0025262786,0.0021091558,0.00029900955,0.000107128006,0.00013497252,0.0012700068,0.00026481535,0.010579187,0.032137632],"study_design_scores_gemma":[0.97516465,0.016229918,0.0026017607,0.00023594356,0.0012332378,0.00008668868,0.000053433687,0.00019781075,0.00026511966,0.00041384122,0.003494029,0.000023523526],"about_ca_topic_score_codex":0.000896471,"about_ca_topic_score_gemma":0.0019040412,"teacher_disagreement_score":0.0051783565,"about_ca_system_score_codex":0.00062982045,"about_ca_system_score_gemma":0.0009136617,"threshold_uncertainty_score":0.017323375},"labels":[],"label_agreement":null},{"id":"W3201070133","doi":"10.1016/s1474-4422(21)00219-2","title":"Parkinson's disease outside the brain: targeting the autonomic nervous system","year":2021,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Azrieli Foundation; Israel Science Foundation","keywords":"Autonomic nervous system; Disease; Neuroscience; Medicine; Neurodegeneration; Parkinson's disease; Central nervous system; Pathology; Psychology; Internal medicine; Heart rate","score_opus":0.050137645406834755,"score_gpt":0.3113783835690662,"score_spread":0.2612407381622315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201070133","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000024899326,0.99914694,0.000032989297,0.0001896758,0.00018731107,0.0000020488417,0.000006859851,0.0000030541567,0.00040625158],"genre_scores_gemma":[0.0002779349,0.99884784,0.0000853796,0.00022860231,0.00022445327,0.0000031418851,0.000010828226,7.642474e-7,0.0003210864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997615,0.000048519843,0.000026816293,0.000034770972,0.000100576886,0.000027829275],"domain_scores_gemma":[0.99953735,0.00025923102,0.00006639533,0.000010774266,0.00008304619,0.0000432513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080223836,0.0012554581,0.0026688296,0.0018805079,0.00025865986,0.0015127561,0.0010210722,0.0016684851,0.0055354927],"category_scores_gemma":[0.0008231339,0.0002954457,0.0007787896,0.0017081065,0.0006125062,0.0014712337,0.00075617083,0.003184328,0.002283154],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014553411,0.00008888054,0.000093981274,0.026363483,0.00020829034,0.00016947585,0.0000506048,0.0003917982,0.0014819994,0.004364552,0.04679211,0.9198493],"study_design_scores_gemma":[0.00009795988,0.00019319332,0.0009005457,0.010693323,0.0003417442,0.00090555707,0.000068040805,0.0001350219,0.00022039964,0.0033221247,0.9830945,0.000027510874],"about_ca_topic_score_codex":0.0020317691,"about_ca_topic_score_gemma":0.006213517,"teacher_disagreement_score":0.0055354927,"about_ca_system_score_codex":0.0008060537,"about_ca_system_score_gemma":0.0013782615,"threshold_uncertainty_score":0.01851803},"labels":[],"label_agreement":null},{"id":"W3206255287","doi":"10.1016/s1474-4422(21)00301-x","title":"Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial","year":2021,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; University of Manitoba","funders":"Multiple Sclerosis International Federation; Instituto de Salud Carlos III; Paracelsus Medizinische Privatuniversität; Royan Institute; Multiple Sclerosis Society of Canada; Fondazione Italiana Sclerosi Multipla; French Muscular Dystrophy Association; Multiple Sclerosis Society; Research Manitoba; European Committee for Treatment and Research in Multiple Sclerosis; UK Stem Cell Foundation; Associazione Italiana Sclerosi Multipla; Scleroseforeningen; Bloddonorerne i Danmark; Compagnia di San Paolo; Toyota Foundation","keywords":"Medicine; Tolerability; Clinical endpoint; Multiple sclerosis; Placebo; Expanded Disability Status Scale; Adverse effect; Mesenchymal stem cell; Internal medicine; Clinical trial; Oncology; Surgery; Pathology; Immunology","score_opus":0.2181256498290405,"score_gpt":0.3748098725244554,"score_spread":0.1566842226954149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206255287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848513,0.006702952,0.0010156297,0.0006486815,0.00087078614,0.0035077154,0.00094025716,0.00013819791,0.0013244301],"genre_scores_gemma":[0.98147213,0.0034755524,0.0021147586,0.0010713335,0.00097627455,0.0063392892,0.0009416467,0.000046179517,0.0035629102],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99894375,0.0005313113,0.00007941352,0.000239384,0.000075065844,0.00013114158],"domain_scores_gemma":[0.9986753,0.00046815956,0.0002997487,0.00012076734,0.0001033439,0.00033266097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021366503,0.0032854944,0.0058610914,0.0006367887,0.0006132509,0.0015065452,0.0012150678,0.0033349493,0.00787611],"category_scores_gemma":[0.0029575329,0.0010618208,0.002546334,0.00054048275,0.0021595582,0.0020120295,0.00056121306,0.0040874076,0.0014190517],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9912521,0.0028086032,0.00012944067,0.0003106954,0.00039928925,0.000016676771,0.000031924985,0.000112690715,0.001118745,0.0000551619,0.00019782403,0.0035667375],"study_design_scores_gemma":[0.9447785,0.05369777,0.00057473115,0.000021198488,0.00024552704,0.000012953904,0.000014552176,0.00015935344,0.00017806211,0.00012261602,0.00018216792,0.000012497845],"about_ca_topic_score_codex":0.0006350617,"about_ca_topic_score_gemma":0.0008059888,"teacher_disagreement_score":0.00787611,"about_ca_system_score_codex":0.00071462843,"about_ca_system_score_gemma":0.0007826798,"threshold_uncertainty_score":0.026348174},"labels":[],"label_agreement":null},{"id":"W3208749524","doi":"10.1016/s1474-4422(21)00328-8","title":"Advancing neuropalliative care","year":2021,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Palliative care; Medicine; Scopus; End-of-life care; Population; Family medicine; Quality of life (healthcare); Intensive care unit; Do not resuscitate; Advance care planning; Nursing; MEDLINE; Intensive care medicine","score_opus":0.11608925322825774,"score_gpt":0.3937695756089787,"score_spread":0.27768032238072093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208749524","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008173075,0.002547189,0.000053140986,0.96866465,0.02129414,0.0000073866,0.000010044098,0.000011115726,0.007330572],"genre_scores_gemma":[0.0018755258,0.0017254499,0.0001307288,0.9479638,0.038610034,0.00002350038,0.0000098983655,0.000013339068,0.009647688],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9879737,0.002990827,0.0010817554,0.0011997154,0.0035321675,0.0032217512],"domain_scores_gemma":[0.95677894,0.015496048,0.0019833604,0.0012606778,0.004583885,0.019897226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010972077,0.0014602699,0.0019665726,0.0018285069,0.013297317,0.01682303,0.0032756063,0.14468694,0.031535897],"category_scores_gemma":[0.058354735,0.0011997804,0.0021236127,0.0011761368,0.013304719,0.012625187,0.012879434,0.09063602,0.014299955],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019324123,0.000020244863,0.00014683355,0.00008701542,0.0000106019215,0.0011108642,0.00024090131,0.000037274232,0.000082577186,0.010382341,0.980161,0.0077009345],"study_design_scores_gemma":[0.00008273509,0.000031868454,0.00036521757,0.00075916416,0.000015879668,0.001018158,0.0006079212,0.00013866955,0.00005045961,0.028587215,0.9683051,0.00003766125],"about_ca_topic_score_codex":0.011449018,"about_ca_topic_score_gemma":0.037503522,"teacher_disagreement_score":0.14468694,"about_ca_system_score_codex":0.012163247,"about_ca_system_score_gemma":0.024612498,"threshold_uncertainty_score":0.105498075},"labels":[],"label_agreement":null},{"id":"W3208869977","doi":"10.1016/s1474-4422(21)00333-1","title":"Advancing neuropalliative care","year":2021,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"University of Saskatchewan; International Parkinson and Movement Disorder Society; American Academy of Neurology","keywords":"Computer science","score_opus":0.32904345932259005,"score_gpt":0.41393620307484774,"score_spread":0.0848927437522577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208869977","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007517917,0.002940227,0.00009321676,0.9808075,0.011592941,0.000005994454,0.000023503753,0.000010084034,0.0044513964],"genre_scores_gemma":[0.003424072,0.0035020702,0.0004137461,0.9185889,0.06694407,0.000038940252,0.000030771036,0.00001710063,0.0070403176],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9868413,0.004710702,0.0013336568,0.0012145515,0.0036697972,0.0022299283],"domain_scores_gemma":[0.93557346,0.036807045,0.0026277301,0.0023741443,0.007175075,0.015442476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022330781,0.0009624863,0.0018443598,0.002201157,0.004703863,0.01187499,0.0023903684,0.06730558,0.030538738],"category_scores_gemma":[0.088793896,0.00082958885,0.0017493205,0.0011423293,0.010795596,0.013461422,0.009036107,0.051730383,0.009432675],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037349168,0.000034877517,0.0003446091,0.00011304467,0.00001524186,0.00030806396,0.00009233364,0.000059383798,0.000069252375,0.024872988,0.95554173,0.018511133],"study_design_scores_gemma":[0.00018667706,0.0000405228,0.0010859086,0.0009576774,0.000023499184,0.0003598003,0.0003884448,0.00030828663,0.000059105234,0.07051727,0.9260313,0.000041521052],"about_ca_topic_score_codex":0.010331599,"about_ca_topic_score_gemma":0.029236745,"teacher_disagreement_score":0.06730558,"about_ca_system_score_codex":0.009917841,"about_ca_system_score_gemma":0.018928217,"threshold_uncertainty_score":0.11809784},"labels":[],"label_agreement":null},{"id":"W3211389104","doi":"10.1016/s1474-4422(21)00364-1","title":"Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial","year":2021,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; NeuroRx Research (Canada); McGill University","funders":"Sanofi","keywords":"Teriflunomide; Medicine; Placebo; Multiple sclerosis; Double blind; Phase (matter); Physical therapy; Pediatrics; Internal medicine; Alternative medicine; Psychiatry; Pathology; Fingolimod; Physics","score_opus":0.08451433072359477,"score_gpt":0.33713280273718077,"score_spread":0.252618472013586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211389104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97333956,0.01943847,0.00069517497,0.0008770587,0.0005829886,0.0026853778,0.0009778617,0.00010182994,0.0013017623],"genre_scores_gemma":[0.9770249,0.009989936,0.0024658144,0.0014626532,0.0006653786,0.0052681533,0.0010587969,0.00003393028,0.002030379],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99920255,0.00040321346,0.000079138976,0.00014076372,0.000080176455,0.00009417949],"domain_scores_gemma":[0.99879444,0.00036931835,0.00041385705,0.00008315304,0.00007018528,0.00026907487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002205768,0.0016642126,0.00404155,0.0003989082,0.0004630196,0.0009391467,0.0009108359,0.0025787007,0.0038313693],"category_scores_gemma":[0.0025128208,0.0006695961,0.0024980272,0.0004346013,0.001226007,0.0010995384,0.00038420456,0.0030710336,0.00066511094],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97468364,0.0025984708,0.00077800045,0.0016058125,0.001380419,0.00008851307,0.000078627694,0.00019162761,0.0032125532,0.00011622104,0.00064416655,0.014621834],"study_design_scores_gemma":[0.9600964,0.036295734,0.001973456,0.00007656752,0.000529873,0.000065854365,0.000018995597,0.000117795214,0.00030404088,0.00007285625,0.0004359259,0.000012529081],"about_ca_topic_score_codex":0.0007590182,"about_ca_topic_score_gemma":0.001259603,"teacher_disagreement_score":0.00404155,"about_ca_system_score_codex":0.0007407954,"about_ca_system_score_gemma":0.0010595779,"threshold_uncertainty_score":0.012817144},"labels":[],"label_agreement":null},{"id":"W3217054877","doi":"10.1016/s1474-4422(21)00378-1","title":"Erythropoietin and optic neuritis in the TONE study","year":2021,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Erythropoietin; Optic neuritis; Tone (literature); Medicine; Audiology; Ophthalmology; Internal medicine; Multiple sclerosis; Immunology; Linguistics; Philosophy","score_opus":0.09487648650530811,"score_gpt":0.363467374143586,"score_spread":0.2685908876382779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217054877","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05380436,0.042323172,0.0002471773,0.84765935,0.03308261,0.00012516079,0.002843698,0.000031928743,0.019882604],"genre_scores_gemma":[0.21736082,0.008565765,0.0006128419,0.70929646,0.05525619,0.00046905864,0.0005860106,0.000045771245,0.00780715],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9849377,0.011020085,0.0014522524,0.00053809164,0.0013116298,0.00074015936],"domain_scores_gemma":[0.9656153,0.02396752,0.003772945,0.0015349636,0.001890434,0.0032187863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017245695,0.0005667069,0.0022151098,0.000733813,0.0018680656,0.0023282266,0.0011735646,0.012039677,0.0035571945],"category_scores_gemma":[0.04650742,0.0005730682,0.0011108806,0.0014531652,0.0011640182,0.0013664744,0.0011631004,0.0068564937,0.0011191352],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014778491,0.00039365253,0.12071888,0.0019933823,0.0047883415,0.009458597,0.0012031812,0.00013005415,0.0008938947,0.006084539,0.78942955,0.05012746],"study_design_scores_gemma":[0.032586187,0.0031562485,0.35778543,0.009868437,0.016734283,0.012751856,0.005528596,0.0016884211,0.0012986701,0.027858725,0.53016603,0.00057706673],"about_ca_topic_score_codex":0.009630186,"about_ca_topic_score_gemma":0.024510013,"teacher_disagreement_score":0.017245695,"about_ca_system_score_codex":0.0014210214,"about_ca_system_score_gemma":0.0029333446,"threshold_uncertainty_score":0.09120506},"labels":[],"label_agreement":null},{"id":"W4200042237","doi":"10.1016/s1474-4422(21)00367-7","title":"Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial","year":2021,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":214,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Roche","keywords":"Medicine; Spinal muscular atrophy; Placebo; Clinical endpoint; Physical therapy; Atrophy; Clinical trial; Adverse effect; Internal medicine; Disease; Pathology","score_opus":0.046170689284838515,"score_gpt":0.3368661723032614,"score_spread":0.29069548301842285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200042237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9329186,0.045284934,0.0006886034,0.0072722384,0.003978093,0.0022249024,0.0023170544,0.00028932,0.0050263554],"genre_scores_gemma":[0.96718204,0.009996328,0.0010266345,0.010374576,0.0016706408,0.0020320155,0.0013332524,0.000035271467,0.006349176],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995933,0.00020434098,0.00003268639,0.000076222335,0.000036725625,0.000056741545],"domain_scores_gemma":[0.99910706,0.00039891165,0.0001586033,0.0000447165,0.00007080162,0.00021990048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013794873,0.0012144159,0.0031322513,0.000259448,0.00039718868,0.00083492795,0.0008889121,0.003962611,0.006698322],"category_scores_gemma":[0.0019058372,0.0005166087,0.0018814165,0.00027971316,0.00082442636,0.0008690337,0.00023697755,0.003294055,0.0013335053],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9640241,0.0021635399,0.00048625434,0.0017651767,0.0015199675,0.00017657036,0.00005167504,0.00011635526,0.002708308,0.00009221495,0.0036804317,0.02321532],"study_design_scores_gemma":[0.9637543,0.031950418,0.0018124507,0.00009246879,0.00054470316,0.00007212027,0.00002339873,0.00017842736,0.00025364285,0.00013733993,0.0011638977,0.000016840138],"about_ca_topic_score_codex":0.000799344,"about_ca_topic_score_gemma":0.0017243869,"teacher_disagreement_score":0.006698322,"about_ca_system_score_codex":0.0007542202,"about_ca_system_score_gemma":0.00062145735,"threshold_uncertainty_score":0.022408068},"labels":[],"label_agreement":null},{"id":"W4200203469","doi":"10.1016/s1474-4422(25)00172-3","title":"Correction to Lancet Neurol 2019; 18: 748–59","year":2025,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Cerebrospinal fluid and hydrocephalus","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Merck","keywords":"MEDLINE; Medicine; Computer science; Information retrieval; Political science; Law","score_opus":0.035464431666178464,"score_gpt":0.30431498217019715,"score_spread":0.2688505505040187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200203469","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000054731798,0.0013549157,0.0005805501,0.037397403,0.9541374,0.000026831232,0.002175523,0.00052855426,0.0037440907],"genre_scores_gemma":[0.008352729,0.010046745,0.005951418,0.095629245,0.5848153,0.00051268184,0.006710822,0.0031163744,0.28486463],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9917384,0.0015113112,0.0016321295,0.0010248665,0.0033020808,0.00079122005],"domain_scores_gemma":[0.94824237,0.013228192,0.0036379194,0.003442786,0.029207477,0.0022412422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054089646,0.002703654,0.0023903807,0.005332557,0.0023726772,0.00606048,0.003967588,0.0068075927,0.16219443],"category_scores_gemma":[0.10257673,0.001262152,0.002929147,0.0029310489,0.002679613,0.0032424633,0.0020405827,0.012818461,0.11841026],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005137861,0.0000026372045,0.000029517903,0.00012289724,0.000011156286,0.00007085787,0.000010734463,0.00002620439,0.000028190472,0.0005706005,0.99506253,0.0040133437],"study_design_scores_gemma":[0.00009596159,0.000020399706,0.00048163766,0.0004882168,0.00003709251,0.00033928122,0.00003690832,0.0001336516,0.00015308814,0.0015346155,0.9966427,0.00003639888],"about_ca_topic_score_codex":0.015157939,"about_ca_topic_score_gemma":0.014744419,"teacher_disagreement_score":0.16219443,"about_ca_system_score_codex":0.004511047,"about_ca_system_score_gemma":0.005600312,"threshold_uncertainty_score":0.54259443},"labels":[],"label_agreement":null},{"id":"W4200394195","doi":"10.1016/s1474-4422(21)00459-2","title":"The need for a better global dementia response","year":2021,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Institute for Health and Care Research","keywords":"Dementia; Action plan; Scopus; Action (physics); Public health; Medicine; Resource (disambiguation); Disease; Gerontology; Psychology; Political science; MEDLINE; Nursing; Management; Computer science; Pathology; Law","score_opus":0.04056366479808181,"score_gpt":0.3355213461672357,"score_spread":0.2949576813691539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200394195","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000050562026,0.00074274396,0.000023727911,0.981338,0.016958965,0.0000039759116,0.000015230621,0.000009674379,0.0008570069],"genre_scores_gemma":[0.0006009492,0.0003591075,0.000078841374,0.9708372,0.02623938,0.000020006362,0.0000150853875,0.000011732253,0.0018377099],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97731143,0.00710703,0.002681275,0.0019595649,0.0067862077,0.004154575],"domain_scores_gemma":[0.91804576,0.03518675,0.004729842,0.0020116335,0.013312479,0.026713574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019204983,0.0018905884,0.0040465146,0.0024121075,0.00991806,0.015324535,0.0046487334,0.19904861,0.02407488],"category_scores_gemma":[0.092356116,0.0017081358,0.0032762869,0.0015504822,0.012601444,0.014701223,0.009555789,0.11772486,0.019644508],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049577306,0.000026820453,0.00015509178,0.00008197726,0.000020475816,0.00038495727,0.00011660155,0.000030088515,0.000074563875,0.00342646,0.9911403,0.0044930847],"study_design_scores_gemma":[0.00039844986,0.00009291214,0.0008475477,0.00093554676,0.000057826677,0.0007389137,0.00080619875,0.0002733758,0.00010137755,0.023783222,0.9718473,0.000117292664],"about_ca_topic_score_codex":0.009282386,"about_ca_topic_score_gemma":0.013529863,"teacher_disagreement_score":0.19904861,"about_ca_system_score_codex":0.0102468515,"about_ca_system_score_gemma":0.02224792,"threshold_uncertainty_score":0.10156691},"labels":[],"label_agreement":null},{"id":"W4205430186","doi":"10.1016/s1474-4422(21)00463-4","title":"Advances and ongoing research in the treatment of autoimmune neuromuscular junction disorders","year":2022,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Leids Universitair Medisch Centrum; Ministry of Health, Labour and Welfare; Japan Blood Products Organization; Alexion Pharmaceuticals; Union Chimique Belge; Guthy-Jackson Charitable Foundation; Multiple Sclerosis Society; Chugai Pharmaceutical; Roche; Bayer Schering; National Institute of Neurological Disorders and Stroke; National Institute for Health and Care Research; Novartis","keywords":"Myasthenia gravis; Medicine; Neuromuscular junction; Weakness; Immunotherapy; Clinical trial; Immunology; Intensive care medicine; Vaccination; Immune system; Neuroscience; Internal medicine; Surgery; Psychology","score_opus":0.17601263159619326,"score_gpt":0.4242586232831688,"score_spread":0.24824599168697556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205430186","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002263556,0.99935776,0.000028515497,0.00023153715,0.00017541797,9.484728e-7,0.0000045885163,0.0000022914273,0.00017625054],"genre_scores_gemma":[0.00028761974,0.99883467,0.00007880713,0.0002900296,0.00034669053,0.0000018557059,0.000010092855,7.45606e-7,0.00014951572],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996214,0.000082551574,0.00005191984,0.00005323123,0.0001478173,0.00004302701],"domain_scores_gemma":[0.9988825,0.000737965,0.0001171276,0.000020183374,0.00016887748,0.000073343144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011511062,0.00096365565,0.0025565228,0.0018225063,0.0002729331,0.0014655225,0.0010990775,0.0015896548,0.004508102],"category_scores_gemma":[0.0015698038,0.00023645032,0.00079364626,0.0018652555,0.0007078683,0.0014542013,0.00082145754,0.0032122186,0.0014878624],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015571549,0.000064406115,0.00011933134,0.023050627,0.00015413195,0.00018542283,0.00003789007,0.0003653646,0.00095543254,0.0029307771,0.033591267,0.9383896],"study_design_scores_gemma":[0.0001244981,0.00019765802,0.0009757688,0.012158065,0.00037265892,0.001209039,0.00008471948,0.00015838433,0.00021444263,0.0033034002,0.98117137,0.000030123483],"about_ca_topic_score_codex":0.0015593449,"about_ca_topic_score_gemma":0.0038754886,"teacher_disagreement_score":0.004508102,"about_ca_system_score_codex":0.00083795394,"about_ca_system_score_gemma":0.0013084984,"threshold_uncertainty_score":0.015081108},"labels":[],"label_agreement":null},{"id":"W4210340544","doi":"10.1016/s1474-4422(21)00377-x","title":"Cholinergic system changes in Parkinson's disease: emerging therapeutic approaches","year":2022,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":278,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Douglas Mental Health University Institute; Université du Québec à Montréal; Montreal Neurological Institute and Hospital","funders":"NIHR Newcastle Biomedical Research Centre; National Institutes of Health; Wellcome Trust; Newcastle upon Tyne Hospitals NHS Foundation Trust; Department of Health and Social Care; Parkinson's UK; Parkinson's Foundation; Newcastle University; Farmer Family Foundation; Academy of Medical Sciences; National Institute on Handicapped Research; National Institute of Neurological Disorders and Stroke; National Institute for Health and Care Research; U.S. Department of Veterans Affairs","keywords":"Parkinson's disease; Cholinergic; Cholinergic system; Neuroscience; Disease; Medicine; Psychology; Internal medicine","score_opus":0.10224567664520097,"score_gpt":0.3174941905146112,"score_spread":0.21524851386941024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210340544","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000050855328,0.999175,0.000047815,0.00023193478,0.00013412275,0.000002145936,0.000006163053,0.00000465995,0.0003472947],"genre_scores_gemma":[0.00040589782,0.99886537,0.0001017467,0.00020031606,0.00015410956,0.0000042511583,0.000014343419,8.914873e-7,0.00025304002],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984,0.000030262294,0.000024086741,0.000026014215,0.00006016161,0.000019406047],"domain_scores_gemma":[0.9996593,0.00017794833,0.0000394175,0.000009510613,0.00007900529,0.000034793688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083350384,0.0010452205,0.0017189599,0.0021814995,0.0002727986,0.0010658056,0.0012939742,0.001419683,0.0028595617],"category_scores_gemma":[0.00068562594,0.00027622873,0.00054032716,0.0018581703,0.00062365783,0.0015378966,0.00085755985,0.0023919267,0.0013399598],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013112603,0.00007315327,0.00012364416,0.015167841,0.00008798709,0.00026079884,0.0000534686,0.00039037,0.00089574535,0.0036306242,0.02588869,0.95329654],"study_design_scores_gemma":[0.000068185116,0.00018978967,0.0010227646,0.006821042,0.00019704406,0.0018436987,0.00009408675,0.00018504134,0.00024862305,0.0041295397,0.98517495,0.000025271356],"about_ca_topic_score_codex":0.0010554021,"about_ca_topic_score_gemma":0.0025167477,"teacher_disagreement_score":0.0028595617,"about_ca_system_score_codex":0.0007705964,"about_ca_system_score_gemma":0.0009792844,"threshold_uncertainty_score":0.009566188},"labels":[],"label_agreement":null},{"id":"W4210993281","doi":"10.1016/s1474-4422(03)00305-3","title":"Vascular cognitive impairment","year":2003,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Cerebrovascular and genetic disorders","field":"Medicine","cited_by":1128,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Institute of Neurological Disorders and Stroke; European Commission","keywords":"Dementia; Apathy; Vascular dementia; Cognition; Disease; Stroke (engine); Psychology; Medicine; Dementia with Lewy bodies; Cognitive decline; Psychiatry; Pathology","score_opus":0.05159096613668682,"score_gpt":0.3393628152227229,"score_spread":0.28777184908603604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210993281","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009583794,0.99601644,0.000093581526,0.00041840493,0.0006957111,0.000008980797,0.000043024826,0.000012817618,0.0026150595],"genre_scores_gemma":[0.0012992023,0.99494404,0.00020263935,0.0009306088,0.00060739764,0.000015654177,0.00009070495,0.000002016244,0.0019077305],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999764,0.0000445198,0.00004099807,0.000034060628,0.0000843422,0.000031982938],"domain_scores_gemma":[0.9997073,0.00011058522,0.00006474396,0.000012771622,0.00007587736,0.000028768012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005760792,0.0014951085,0.0031201506,0.0030657446,0.00033337856,0.0009955007,0.0009641709,0.001155187,0.006682411],"category_scores_gemma":[0.0012510099,0.00023662555,0.00063108077,0.003298032,0.00040522616,0.00090509636,0.00087458437,0.0013484822,0.0026139214],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101402235,0.000046586545,0.00016281467,0.011656488,0.00019305701,0.0002484226,0.000022779815,0.0001353474,0.000211116,0.00080408517,0.09590492,0.89051294],"study_design_scores_gemma":[0.00021501938,0.00016699397,0.003186323,0.016332893,0.0011016179,0.0041238545,0.00009447892,0.00012704219,0.00025312963,0.0030650166,0.9713003,0.000033331842],"about_ca_topic_score_codex":0.0048656715,"about_ca_topic_score_gemma":0.012429689,"teacher_disagreement_score":0.006682411,"about_ca_system_score_codex":0.00075551536,"about_ca_system_score_gemma":0.0018480081,"threshold_uncertainty_score":0.02235496},"labels":[],"label_agreement":null},{"id":"W4211032576","doi":"10.1016/s1474-4422(15)00007-1","title":"Gastrointestinal dysfunction in Parkinson's disease","year":2015,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":1009,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"Allos Therapeutics; Canadian Institutes of Health Research; Edmond J. Safra Philanthropic Foundation; Parkinson Society Canada; UCB; Acadia University; Pfizer; Ontario Brain Institute; National Parkinson Foundation; Teva Pharmaceutical Industries; Medtronic; Fondation Brain Canada; W. Garfield Weston Foundation; AbbVie Canada; Michael J. Fox Foundation for Parkinson's Research","keywords":"Gastrointestinal tract; Parkinson's disease; Medicine; Disease; Gastric emptying; Gastrointestinal disease; Swallowing; Gastroenterology; Pathogenesis; Internal medicine; Stomach; Surgery","score_opus":0.07984627035169756,"score_gpt":0.3339109534912149,"score_spread":0.25406468313951736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211032576","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003350562,0.9994294,0.000018091087,0.00012937064,0.00012123857,0.0000024600813,0.000008943498,0.0000020733314,0.00025488288],"genre_scores_gemma":[0.00047771653,0.99880767,0.00006437253,0.0002173211,0.0001927107,0.000003817397,0.000012325059,4.290826e-7,0.00022365921],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975914,0.00004836981,0.000055904216,0.000030795727,0.00008289146,0.000022830942],"domain_scores_gemma":[0.9994404,0.0002826614,0.00015119158,0.000009218656,0.00007929835,0.000037187376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075420114,0.0011323986,0.0027059484,0.002848173,0.0002327836,0.001276364,0.0007860497,0.001594744,0.005594019],"category_scores_gemma":[0.0011000648,0.00039374636,0.00087919645,0.002549566,0.00051645364,0.0013424564,0.0009808906,0.0019262689,0.0013414231],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021991208,0.0000687803,0.00022549911,0.07023363,0.0004922442,0.00028647907,0.00005962267,0.00025816224,0.0006868764,0.001465135,0.037035003,0.88896865],"study_design_scores_gemma":[0.00032564183,0.00032404115,0.0027864755,0.03549178,0.001997849,0.0022609034,0.00015607964,0.00017421809,0.0002416655,0.0026386573,0.953552,0.000050742634],"about_ca_topic_score_codex":0.0018785819,"about_ca_topic_score_gemma":0.0056276335,"teacher_disagreement_score":0.005594019,"about_ca_system_score_codex":0.00062607066,"about_ca_system_score_gemma":0.0012004148,"threshold_uncertainty_score":0.018713832},"labels":[],"label_agreement":null},{"id":"W4211253537","doi":"10.1016/s1474-4422(03)00619-7","title":"Dementia with Lewy bodies","year":2003,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":612,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Vancouver Hospital and Health Sciences Centre","funders":"Forest Laboratories; Eisai; AstraZeneca; Johnson and Johnson; Pfizer","keywords":"Dementia with Lewy bodies; Dementia; Medicine; Pathological; Disease; Lewy body; Psychiatry; Neuroscience; Psychology; Pathology","score_opus":0.07334118428172168,"score_gpt":0.3313540616301439,"score_spread":0.25801287734842226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211253537","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000071052724,0.99817395,0.00006736927,0.00021322152,0.00034878316,0.000006507501,0.00001588182,0.000007481086,0.0010957093],"genre_scores_gemma":[0.0009370077,0.9959778,0.00019336828,0.0006472049,0.0004367563,0.00001413699,0.00004235073,0.0000017489589,0.0017496413],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973434,0.000058738504,0.000056165958,0.000035525158,0.00008735851,0.00002784166],"domain_scores_gemma":[0.9996462,0.0001479846,0.0000917387,0.000013604322,0.00007126048,0.000029162578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007783852,0.0015291331,0.0034888461,0.0041381475,0.0003328317,0.0013430185,0.0009395034,0.0016042511,0.006396619],"category_scores_gemma":[0.0010145725,0.00039258949,0.00060434407,0.002922245,0.0006521542,0.0017170977,0.0010155553,0.0014988976,0.003126297],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015893705,0.000048560418,0.00012422436,0.022325728,0.00014089035,0.0004397817,0.000053690364,0.0001471859,0.00065122155,0.0015704605,0.05736456,0.9169748],"study_design_scores_gemma":[0.00012939223,0.00015454709,0.0009945178,0.009683728,0.00048160492,0.0037693947,0.000091848524,0.00008228264,0.00028949184,0.0019978844,0.98230505,0.00002033401],"about_ca_topic_score_codex":0.0021993625,"about_ca_topic_score_gemma":0.0062449067,"teacher_disagreement_score":0.006396619,"about_ca_system_score_codex":0.00087810477,"about_ca_system_score_gemma":0.0015966349,"threshold_uncertainty_score":0.021398842},"labels":[],"label_agreement":null},{"id":"W4212811433","doi":"10.1016/s1474-4422(22)00041-2","title":"The reality of multiple sclerosis assessment in middle-income countries – Authors' reply","year":2022,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institutes of Health; Universitat de Barcelona; Universitat Autònoma de Barcelona; Medizinischen Hochschule Hannover","keywords":"Multiple sclerosis; Magnetic resonance imaging; Neuroimaging; MEDLINE; Consensus conference; Disease","score_opus":0.13681853339401867,"score_gpt":0.35874038839738054,"score_spread":0.22192185500336187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212811433","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029882122,0.0020886792,0.000047769732,0.966648,0.030595416,0.0000055318997,0.00009256934,0.000009832509,0.00021337568],"genre_scores_gemma":[0.0032990612,0.0018241669,0.00014527218,0.9573963,0.036574073,0.000038922015,0.000049027327,0.000018664874,0.0006544881],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.987955,0.0054183314,0.0023826987,0.0014038522,0.0020383312,0.00080183044],"domain_scores_gemma":[0.8902264,0.07894469,0.0050088842,0.0027916923,0.017140416,0.0058879037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01943396,0.00075998734,0.0020063883,0.0013807669,0.002194827,0.0046154526,0.0027958148,0.032129586,0.005441352],"category_scores_gemma":[0.107601926,0.0008770169,0.0011467099,0.0013220254,0.004814443,0.006966589,0.004272123,0.038019698,0.0027931612],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011379301,0.000023573884,0.001435133,0.0003113396,0.00007781055,0.0004289657,0.0006090715,0.000049610375,0.00008857139,0.0015967432,0.9890999,0.006165485],"study_design_scores_gemma":[0.00048459045,0.000120806566,0.005995812,0.0021111348,0.00021053453,0.0017388515,0.005605729,0.00027746413,0.00042633552,0.009957665,0.97277856,0.0002925654],"about_ca_topic_score_codex":0.0064779404,"about_ca_topic_score_gemma":0.0078008203,"teacher_disagreement_score":0.032129586,"about_ca_system_score_codex":0.002314166,"about_ca_system_score_gemma":0.0064205783,"threshold_uncertainty_score":0.10277784},"labels":[],"label_agreement":null},{"id":"W4213066095","doi":"10.1016/s1474-4422(22)00009-6","title":"Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study","year":2022,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":601,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Disease; Multiple sclerosis; Retrospective cohort study; Amyotrophic lateral sclerosis; Epidemiology; MEDLINE","score_opus":0.09145489506051398,"score_gpt":0.3021662337452696,"score_spread":0.2107113386847556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213066095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976069,0.000098055665,0.0018344518,0.00003129902,0.0000064875117,0.000019664863,0.0003018107,0.000016654867,0.00008464091],"genre_scores_gemma":[0.99824667,0.000053507858,0.0008270902,0.000011911171,0.0000053921526,0.000024368963,0.00070688623,0.000008301091,0.00011590567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964618,0.0024502154,0.00015618642,0.0005187883,0.0002245274,0.0001885048],"domain_scores_gemma":[0.98207444,0.010020482,0.0020250175,0.004434165,0.0010652724,0.00038064248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015006197,0.0013153628,0.0009551352,0.000593647,0.0005704793,0.0012365344,0.0017823398,0.0009303382,0.0008500374],"category_scores_gemma":[0.01540449,0.00093222153,0.0024412086,0.000722459,0.00081506843,0.0007458865,0.0010131462,0.0014390285,0.00034278492],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015738606,0.0010516114,0.9494505,0.00006953989,0.003790839,0.00033118296,0.00072392815,0.017169116,0.0011632392,0.00044346624,0.00088088977,0.009187135],"study_design_scores_gemma":[0.0013333079,0.0054016258,0.81259024,0.00006886806,0.0038949256,0.0009854316,0.00051728886,0.17163847,0.0012869065,0.0008981511,0.0012510902,0.00013367888],"about_ca_topic_score_codex":0.01392148,"about_ca_topic_score_gemma":0.006169887,"teacher_disagreement_score":0.015006197,"about_ca_system_score_codex":0.00079580763,"about_ca_system_score_gemma":0.0010798604,"threshold_uncertainty_score":0.07936132},"labels":[],"label_agreement":null},{"id":"W4214620885","doi":"10.1016/s1474-4422(21)00423-3","title":"Spontaneous intracranial hypotension: searching for the CSF leak","year":2022,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Neurosurgical Procedures and Complications","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Leak; Cerebrospinal fluid; Intracranial Hypotension; Epidural blood patch; Lumbar puncture; Myelography; Orthostatic vital signs; Neuroimaging","score_opus":0.05046167161588383,"score_gpt":0.3009254835190458,"score_spread":0.25046381190316197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214620885","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21017152,0.32358485,0.008028193,0.37942713,0.012813321,0.00023628768,0.00081165787,0.00040122005,0.06452581],"genre_scores_gemma":[0.6462585,0.21359345,0.0073570306,0.060663696,0.06328945,0.00007264859,0.00070745597,0.00017389852,0.0078839185],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99904186,0.00020618111,0.0001539003,0.00013021412,0.0002624284,0.00020535005],"domain_scores_gemma":[0.9957082,0.0019107168,0.00076359126,0.00022060348,0.0008712016,0.000525596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010550438,0.0008785722,0.001076975,0.004357123,0.0011231578,0.0028872464,0.0013782667,0.0060803546,0.004117186],"category_scores_gemma":[0.010354261,0.0004957483,0.00091250765,0.0018321676,0.0025434182,0.005644381,0.00090270897,0.006055739,0.0021529417],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017632975,0.0005749881,0.2303832,0.002897106,0.00039574542,0.21703881,0.0011953339,0.00057723245,0.0040420215,0.01271168,0.12580034,0.40262023],"study_design_scores_gemma":[0.0006034201,0.0013039368,0.10505601,0.01297994,0.0010612186,0.67268354,0.013827323,0.0028799316,0.004240268,0.05821409,0.1267108,0.00043957456],"about_ca_topic_score_codex":0.0027898042,"about_ca_topic_score_gemma":0.0027240575,"teacher_disagreement_score":0.0060803546,"about_ca_system_score_codex":0.0014445281,"about_ca_system_score_gemma":0.0031333491,"threshold_uncertainty_score":0.013773382},"labels":[],"label_agreement":null},{"id":"W4220883272","doi":"10.1016/s1474-4422(22)00045-x","title":"Exercise training in multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Scopus; Multiple sclerosis; Neuroimaging; Atrophy; MEDLINE; Meta-analysis; Disease; Physical exercise; Cognitive training","score_opus":0.2236663054925763,"score_gpt":0.32646338039678474,"score_spread":0.10279707490420845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220883272","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6033817,0.3571366,0.0002149519,0.023038223,0.00268616,0.00020897531,0.0017043856,0.000019992096,0.0116090365],"genre_scores_gemma":[0.9253663,0.0640617,0.00034662944,0.0044064624,0.0023519627,0.00026915016,0.0007619731,0.0000074629356,0.0024284208],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99729806,0.0017196885,0.0002838865,0.00018651143,0.00024175903,0.00027000997],"domain_scores_gemma":[0.9951509,0.0024906544,0.0010694095,0.00027357083,0.00033461937,0.0006806973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044139735,0.00050084904,0.0011346163,0.001078056,0.00046813145,0.0010910638,0.00056736026,0.0019403545,0.0037682625],"category_scores_gemma":[0.011263567,0.00026676638,0.0009034473,0.001985459,0.0005846507,0.00052065647,0.0011205823,0.0014311158,0.0004563818],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058258113,0.007911716,0.3371377,0.022704162,0.025744397,0.0004972079,0.0014300201,0.0009160049,0.0032470005,0.0038098083,0.022748712,0.5155952],"study_design_scores_gemma":[0.004352535,0.0063413107,0.9644199,0.0050867656,0.005403199,0.00013419069,0.0005519539,0.00016376351,0.00023747323,0.0014428751,0.011835214,0.000030822943],"about_ca_topic_score_codex":0.011244232,"about_ca_topic_score_gemma":0.0128665455,"teacher_disagreement_score":0.011244232,"about_ca_system_score_codex":0.0006875589,"about_ca_system_score_gemma":0.0012363289,"threshold_uncertainty_score":0.023343623},"labels":[],"label_agreement":null},{"id":"W4224011623","doi":"10.1016/s1474-4422(22)00129-6","title":"Your After-Visit Summary—May 29, 2042","year":2022,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Psychiatric care and mental health services","field":"Psychology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Psychology","score_opus":0.04097190975861084,"score_gpt":0.34744054486067255,"score_spread":0.3064686351020617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224011623","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015515885,0.006370874,0.0004998799,0.0889785,0.18870084,0.00097251753,0.010646713,0.0028441339,0.6994349],"genre_scores_gemma":[0.0018915958,0.0014579017,0.0001408505,0.028114669,0.017515386,0.00016681394,0.0018050912,0.00027579637,0.9486318],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99939704,0.00006273557,0.000038316404,0.000056888875,0.00025172826,0.00019319126],"domain_scores_gemma":[0.9965683,0.00042147175,0.00014331652,0.00013863081,0.0008309325,0.0018974561],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00092298497,0.0012254735,0.0014808556,0.0016122828,0.0023182419,0.0048531825,0.0018316462,0.010024463,0.5862866],"category_scores_gemma":[0.0053729685,0.0007812846,0.0015262469,0.0010221779,0.0004761769,0.0015070323,0.0020227963,0.0044993088,0.42890158],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054202483,0.00002639689,0.000066660905,0.000028111994,0.0000033175381,0.000038346054,0.0000025162315,0.000009492483,0.000029688956,0.0000376858,0.9957402,0.0039633326],"study_design_scores_gemma":[0.00018470449,0.00008769643,0.0021097464,0.00018256549,0.000018130644,0.00005935949,0.00005263033,0.00007990641,0.00006363559,0.00027446187,0.99686617,0.000021112357],"about_ca_topic_score_codex":0.011505275,"about_ca_topic_score_gemma":0.04616935,"teacher_disagreement_score":0.4137134,"about_ca_system_score_codex":0.0011882122,"about_ca_system_score_gemma":0.0019090554,"threshold_uncertainty_score":0.590112},"labels":[],"label_agreement":null},{"id":"W4224433803","doi":"10.1016/s1474-4422(22)00143-0","title":"Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial","year":2022,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"Biogen","keywords":"Natalizumab; Medicine; Progressive multifocal leukoencephalopathy; Multiple sclerosis; Clinical endpoint; Dosing; Relapsing remitting; Randomized controlled trial; Neurology; Pediatrics; Physical therapy; Internal medicine; Immunology; Psychiatry","score_opus":0.09327933621658352,"score_gpt":0.34297687869190413,"score_spread":0.2496975424753206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224433803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990743,0.0032181754,0.0005061216,0.0007437211,0.0010586765,0.0011921601,0.000663006,0.00012940195,0.0017457115],"genre_scores_gemma":[0.99182934,0.0012929274,0.0010654015,0.00081911485,0.00047219926,0.0014339895,0.0005839299,0.000032005322,0.002471044],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998787,0.0006153579,0.00008236554,0.00025631074,0.00006591801,0.00019296345],"domain_scores_gemma":[0.99821484,0.00075323763,0.00030232978,0.0001697894,0.0000856552,0.00047408638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019385114,0.002186321,0.004451026,0.0004506183,0.00049284805,0.0013286322,0.0015764746,0.0030633686,0.009770821],"category_scores_gemma":[0.0032147893,0.0008467783,0.003234787,0.00039542455,0.0014047935,0.0021713595,0.00050140364,0.0050453255,0.00181419],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.990624,0.002179996,0.00015838518,0.00018482191,0.00045552207,0.000014822253,0.000032615506,0.00015010274,0.00064329087,0.00004170091,0.00020758554,0.0053073196],"study_design_scores_gemma":[0.95212245,0.04524136,0.0013122984,0.000030807467,0.0003185166,0.000019756155,0.000023115706,0.00040818733,0.0001422785,0.0001533056,0.00021120816,0.000016763344],"about_ca_topic_score_codex":0.0017563517,"about_ca_topic_score_gemma":0.0023349614,"teacher_disagreement_score":0.009770821,"about_ca_system_score_codex":0.0010025224,"about_ca_system_score_gemma":0.0009051998,"threshold_uncertainty_score":0.03268659},"labels":[],"label_agreement":null},{"id":"W4229000142","doi":"10.1016/s1474-4422(22)00172-7","title":"Tenecteplase for acute stroke: the thrombolysis puzzle","year":2022,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; University of Calgary","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Tenecteplase; Thrombolysis; Tissue plasminogen activator; Fibrinolytic agent; Stroke (engine); Ischaemic stroke","score_opus":0.02523189622899017,"score_gpt":0.29206472893772617,"score_spread":0.266832832708736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229000142","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016361752,0.69901454,0.0006337413,0.28704888,0.00546439,0.000014945515,0.00022946393,0.000046194804,0.005911689],"genre_scores_gemma":[0.02344807,0.84168476,0.0014352679,0.083736524,0.046637483,0.00007785408,0.00023673804,0.00006460784,0.0026786998],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972011,0.000786419,0.0006402944,0.00028684636,0.0008232488,0.00026213177],"domain_scores_gemma":[0.9871135,0.008230723,0.0015151247,0.00037420474,0.0018949059,0.0008715075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008622551,0.00082429516,0.003756793,0.0014745403,0.00074108166,0.004240401,0.0015579091,0.0051318123,0.0060510715],"category_scores_gemma":[0.016035007,0.00046813858,0.0014990511,0.0015524796,0.0023976625,0.0059687844,0.0013604965,0.012524853,0.0029238267],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011939212,0.0002545269,0.00205822,0.0034546598,0.0006041926,0.0007960743,0.000296021,0.0007503909,0.00076925475,0.027675588,0.34959573,0.61255145],"study_design_scores_gemma":[0.002773365,0.0010109494,0.010883267,0.015210736,0.0010370446,0.0030418583,0.0011042573,0.0014329925,0.00057105353,0.088178076,0.87452734,0.0002290834],"about_ca_topic_score_codex":0.0032768317,"about_ca_topic_score_gemma":0.009027524,"teacher_disagreement_score":0.008622551,"about_ca_system_score_codex":0.0021245647,"about_ca_system_score_gemma":0.0039423816,"threshold_uncertainty_score":0.04560101},"labels":[],"label_agreement":null},{"id":"W4230659217","doi":"10.1016/s1474-4422(11)70215-0","title":"Making EUReMS count for people with multiple sclerosis","year":2011,"lang":"en","type":"editorial","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"General partnership; European commission; Multiple sclerosis; Medicine; Quarter (Canadian coin); Family medicine; Political science; Business; Geography; European union; Finance","score_opus":0.1471674628837841,"score_gpt":0.33990678086503934,"score_spread":0.19273931798125524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230659217","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021642201,0.0074242097,0.00007680873,0.062493257,0.92929107,0.000017724498,0.00006161598,0.000036356447,0.0005773013],"genre_scores_gemma":[0.00046122712,0.0062157097,0.00018777946,0.0873709,0.90010667,0.00006950974,0.000057850644,0.00005453385,0.005475889],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97536623,0.0075821755,0.004622672,0.0019481275,0.00902901,0.0014518069],"domain_scores_gemma":[0.90523505,0.05710598,0.006833639,0.0023882722,0.020671666,0.007765313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03650781,0.006504325,0.008641682,0.0056867236,0.005127211,0.012316444,0.008308821,0.048784815,0.013534455],"category_scores_gemma":[0.09502134,0.0036331841,0.0059045414,0.0033069283,0.004475073,0.009088665,0.0036766117,0.05346676,0.0119201755],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008748841,0.000012165337,0.000032966353,0.00042888135,0.00007873931,0.000051079838,0.000023651253,0.000013428802,0.00002335563,0.00018910819,0.99561274,0.0034464297],"study_design_scores_gemma":[0.00057681673,0.00009842578,0.00080784486,0.002309952,0.0007708803,0.00024723882,0.00018687462,0.00020490916,0.0001336867,0.0016678796,0.9929137,0.00008182148],"about_ca_topic_score_codex":0.005378256,"about_ca_topic_score_gemma":0.013336795,"teacher_disagreement_score":0.048784815,"about_ca_system_score_codex":0.0063680857,"about_ca_system_score_gemma":0.008199213,"threshold_uncertainty_score":0.1930741},"labels":[],"label_agreement":null},{"id":"W4247118366","doi":"10.1016/s1474-4422(18)30451-4","title":"Association between pathological and MRI findings in multiple sclerosis","year":2019,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":251,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Montreal Neurological Institute and Hospital","keywords":"Pathological; Multiple sclerosis; Remyelination; Disease; Pathology; Medicine; Axonal degeneration; Neuroscience; Central nervous system; Psychology; Myelin; Immunology; Internal medicine","score_opus":0.3185663499896594,"score_gpt":0.3868282410566595,"score_spread":0.06826189106700015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247118366","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005543953,0.99971014,0.000014983076,0.000057534464,0.000060198498,0.00000312687,0.000022695493,0.0000013977441,0.000074485026],"genre_scores_gemma":[0.00089466554,0.9986992,0.00008630433,0.00015953077,0.000073096075,0.0000054589154,0.000027017268,7.040495e-7,0.000053934476],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9988544,0.00023945914,0.00043466152,0.00017524838,0.00025043346,0.000045894103],"domain_scores_gemma":[0.9957684,0.003059141,0.00075028854,0.000062925996,0.0002948153,0.00006431272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022812996,0.0010715199,0.0044237683,0.0054157027,0.00024952213,0.0015208885,0.0014124044,0.0014780731,0.0041219145],"category_scores_gemma":[0.0075263223,0.00058069464,0.0019368596,0.006228543,0.00078888476,0.0013500069,0.0012259627,0.0013154887,0.00061280833],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036827495,0.00004313416,0.0014584761,0.5038348,0.0056298235,0.00025395284,0.00011840641,0.00017745394,0.00055587315,0.0010930493,0.014361233,0.47210553],"study_design_scores_gemma":[0.000562905,0.0004906316,0.022899376,0.47477594,0.06217339,0.003151576,0.000631318,0.00018359248,0.00058775034,0.003516828,0.4308411,0.00018564318],"about_ca_topic_score_codex":0.0048472676,"about_ca_topic_score_gemma":0.011221761,"teacher_disagreement_score":0.0054157027,"about_ca_system_score_codex":0.0010152749,"about_ca_system_score_gemma":0.002149617,"threshold_uncertainty_score":0.013789237},"labels":[],"label_agreement":null},{"id":"W4253440928","doi":"10.1016/s1474-4422(09)70010-9","title":"November, 2008","year":2009,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Political science","score_opus":0.02468952989766535,"score_gpt":0.277410376109318,"score_spread":0.25272084621165264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253440928","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013072216,0.0041691298,0.00049402413,0.009872919,0.019477481,0.00020719181,0.0051830094,0.0011098499,0.95817924],"genre_scores_gemma":[0.00080115796,0.000505061,0.000068946494,0.00079028367,0.0003089081,0.000013794547,0.0008958359,0.000036295507,0.9965797],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997254,0.000027287992,0.00001236852,0.000047910464,0.00013228453,0.000054740834],"domain_scores_gemma":[0.9993592,0.00007109302,0.000025526668,0.0000713586,0.00028516803,0.00018769012],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00057974044,0.0008899515,0.000508741,0.0011470496,0.0010173522,0.0032016768,0.0010787259,0.0016706835,0.5752133],"category_scores_gemma":[0.0019642585,0.00028881122,0.0003776367,0.00078335067,0.0003560438,0.0009307625,0.0010077318,0.0015649974,0.49572998],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007717258,0.000027266064,0.00014052438,0.000050012128,0.0000043266023,0.000032478772,0.000010484221,0.000049505943,0.00014520719,0.0008307187,0.96132386,0.037308548],"study_design_scores_gemma":[0.000020044046,0.00001996807,0.0008321864,0.00006463662,0.0000032950823,0.000028103801,0.000019914974,0.00007348657,0.00007766178,0.000315503,0.998541,0.000004320359],"about_ca_topic_score_codex":0.0064101988,"about_ca_topic_score_gemma":0.029597044,"teacher_disagreement_score":0.4247867,"about_ca_system_score_codex":0.0011780894,"about_ca_system_score_gemma":0.0010305247,"threshold_uncertainty_score":0.6059066},"labels":[],"label_agreement":null},{"id":"W4280490056","doi":"10.1016/s1474-4422(21)00464-6","title":"Cell-based and stem-cell-based treatments for spinal cord injury: evidence from clinical trials","year":2022,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":258,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of British Columbia; International Collaboration On Repair Discoveries","funders":"National Institutes of Health; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Canada Foundation for Innovation; U.S. Department of Defense","keywords":"Medicine; Spinal cord injury; Clinical trial; Neurorehabilitation; Stem cell; Transplantation; Autonomic dysreflexia; Spinal cord; Physical medicine and rehabilitation; Surgery; Rehabilitation; Physical therapy; Pathology","score_opus":0.6459092974867382,"score_gpt":0.5944175618135643,"score_spread":0.05149173567317389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280490056","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012125015,0.99951065,0.000030588097,0.00008913387,0.000060165712,0.000010714293,0.00003841267,0.0000020831048,0.00013699668],"genre_scores_gemma":[0.0017727312,0.9976751,0.00012833609,0.00022412285,0.000049681094,0.000015618201,0.00004917211,0.0000012850031,0.00008403925],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9992853,0.00020517652,0.00014426021,0.00010682166,0.00020652676,0.00005189758],"domain_scores_gemma":[0.99749124,0.0020133862,0.00026566678,0.000031138912,0.00014718938,0.000051361818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023436833,0.0012062462,0.0055899224,0.0018362558,0.00021951238,0.0015240466,0.0015144835,0.0017317571,0.0054039136],"category_scores_gemma":[0.0047474974,0.0003146848,0.0035718868,0.0023022133,0.00056000205,0.0008891959,0.000614363,0.001850928,0.00066403864],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00270919,0.00009631617,0.00025350173,0.39181277,0.007440637,0.00011244834,0.00006353271,0.0006508523,0.00095328287,0.0016983816,0.013594343,0.5806148],"study_design_scores_gemma":[0.0077584567,0.0030545276,0.009632603,0.4102489,0.0789353,0.0013868671,0.00046700274,0.00051277137,0.0013775623,0.007216482,0.47924814,0.00016138029],"about_ca_topic_score_codex":0.0033854996,"about_ca_topic_score_gemma":0.008146545,"teacher_disagreement_score":0.0055899224,"about_ca_system_score_codex":0.0009992565,"about_ca_system_score_gemma":0.0018597568,"threshold_uncertainty_score":0.01807785},"labels":[],"label_agreement":null},{"id":"W4282972828","doi":"10.1016/s1474-4422(22)00121-1","title":"Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities","year":2022,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":319,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; UK Dementia Research Institute; Alzheimer’s Research UK; Horizon 2020; Medical Research Council; Cardiff University; Rosetrees Trust; Roche; Wellcome Trust; Alzheimer's Society; CHDI Foundation; European Huntington's Disease Network; Health and Care Research Wales; National Institute for Health and Care Research; Teva Pharmaceutical Industries; Academy of Medical Sciences","keywords":"Huntingtin; Huntington's disease; Disease; Huntingtin Protein; Trinucleotide repeat expansion; Biology; RNA splicing; Bioinformatics; Genetics; Gene; Medicine; RNA; Internal medicine; Allele","score_opus":0.2683770306409242,"score_gpt":0.38317754326950726,"score_spread":0.11480051262858304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282972828","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004647849,0.998814,0.00008718208,0.0004679005,0.00020286435,0.0000019834536,0.000012542103,0.0000053638914,0.00036167758],"genre_scores_gemma":[0.00048596304,0.99820864,0.00022317149,0.0004746559,0.00027790066,0.0000058721475,0.000024703033,0.0000017234587,0.00029741545],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973565,0.00006015217,0.00003261136,0.000043871994,0.000090276546,0.000037418922],"domain_scores_gemma":[0.9989489,0.000701439,0.00008456649,0.000019988043,0.00016739008,0.000077805176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017758515,0.0012709044,0.0030908275,0.0013931573,0.0002757304,0.0016586921,0.0014130217,0.002038986,0.004469233],"category_scores_gemma":[0.0016725321,0.000266058,0.00092100265,0.001378362,0.0008996941,0.0018991387,0.00080661726,0.004247456,0.0017933215],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029423976,0.000111004,0.00015933558,0.015049568,0.00023224595,0.00028113555,0.00005147427,0.0005634545,0.0015217959,0.0070262183,0.04895149,0.9257581],"study_design_scores_gemma":[0.00020951538,0.0002551231,0.0010508719,0.008549618,0.00043362362,0.0009576988,0.00009864504,0.0002639989,0.00034997426,0.00775325,0.98004055,0.000037152688],"about_ca_topic_score_codex":0.001534088,"about_ca_topic_score_gemma":0.005190764,"teacher_disagreement_score":0.004469233,"about_ca_system_score_codex":0.00091723655,"about_ca_system_score_gemma":0.0012988156,"threshold_uncertainty_score":0.01495111},"labels":[],"label_agreement":null},{"id":"W4282979939","doi":"10.1016/s1474-4422(22)00120-x","title":"A biological classification of Huntington's disease: the Integrated Staging System","year":2022,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":301,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Institute of Neurological Disorders and Stroke; Monash University; Wellcome Trust; U.S. Food and Drug Administration; CHDI Foundation","keywords":"Huntington's disease; Disease; Clinical trial; Clinical research; Clinical phenotype; Medicine; Genetic testing; Biomarker; Stage (stratigraphy); Bioinformatics; Pathology; Phenotype; Internal medicine; Biology; Genetics","score_opus":0.1975155839767792,"score_gpt":0.3494666735068053,"score_spread":0.15195108953002612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282979939","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011501827,0.9956748,0.000857072,0.0014138486,0.0010015989,0.000013575327,0.00008367558,0.000017011776,0.00082344026],"genre_scores_gemma":[0.0018147842,0.9918173,0.0024321477,0.0013159394,0.0013390299,0.000032644584,0.00030313415,0.000007999823,0.0009370378],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992761,0.00019549615,0.00015319126,0.00012487531,0.00019343059,0.000056847934],"domain_scores_gemma":[0.9988181,0.00041725946,0.00015167247,0.00003733328,0.00048213868,0.000093480136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003154381,0.0018402438,0.003994139,0.004518715,0.00040674114,0.001980269,0.0028799032,0.0015776947,0.002326734],"category_scores_gemma":[0.0025552146,0.00038036087,0.0012873962,0.0034129736,0.0016888557,0.0027345405,0.0012383072,0.0038400658,0.001724423],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014892375,0.00004067363,0.0009018751,0.011960011,0.00023881177,0.00023217576,0.00010378711,0.0007580706,0.00096710207,0.018526236,0.088165686,0.87795675],"study_design_scores_gemma":[0.00008432566,0.00015896365,0.0042564115,0.0142941065,0.0005896404,0.0028103234,0.0002624702,0.00076338503,0.00029364365,0.018192058,0.95820886,0.00008571341],"about_ca_topic_score_codex":0.0054459497,"about_ca_topic_score_gemma":0.0068848697,"teacher_disagreement_score":0.0054459497,"about_ca_system_score_codex":0.002431061,"about_ca_system_score_gemma":0.003453499,"threshold_uncertainty_score":0.017638683},"labels":[],"label_agreement":null},{"id":"W4285384859","doi":"10.1016/s1474-4422(22)00169-7","title":"Diagnosis and treatment of orthostatic hypotension","year":2022,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Cardiovascular Syncope and Autonomic Disorders","field":"Medicine","cited_by":200,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"National Institute of Neurological Disorders and Stroke; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; U.S. Food and Drug Administration; International Collaboration on Repair Discoveries; H. Lundbeck A/S; Union Chimique Belge; GlaxoSmithKline; Zogenix; Craig H. Neilsen Foundation; National Heart, Lung, and Blood Institute; Pfizer; Heart and Stroke Foundation of Canada; National Institutes of Health; Medtronic; Dysautonomia Foundation; Biogen; Epilepsiefonds; ZonMw; Michael J. Fox Foundation for Parkinson's Research","keywords":"Orthostatic vital signs; Medicine; Blood pressure; Supine position; Anesthesia; Midodrine; Presyncope; Asymptomatic; Pure autonomic failure; Internal medicine; Heart rate","score_opus":0.11316604777950094,"score_gpt":0.33266834529984185,"score_spread":0.2195022975203409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285384859","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002270415,0.9993687,0.00003953546,0.00012503752,0.00023268699,0.0000027811059,0.0000088442885,0.0000032077442,0.00019655691],"genre_scores_gemma":[0.00041029992,0.998372,0.00010287265,0.00040755403,0.00046196042,0.000005898581,0.000023350487,0.0000013953834,0.00021464968],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99952555,0.00008931773,0.00009729981,0.000080894024,0.00016285003,0.000044005566],"domain_scores_gemma":[0.9991991,0.00043695647,0.00017312802,0.000018143877,0.00012594035,0.00004689041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001121872,0.001474798,0.0038786158,0.0028252434,0.00023914587,0.0015291236,0.0014892451,0.0019446061,0.0048999577],"category_scores_gemma":[0.002048981,0.0004625533,0.0015238537,0.00165085,0.0006088977,0.0012862129,0.0007597882,0.0035524215,0.0020862373],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021922344,0.000083630104,0.00012517783,0.03953606,0.00044720835,0.00016268154,0.000033300577,0.00029861878,0.0005704332,0.0015053786,0.04299145,0.9140268],"study_design_scores_gemma":[0.0005739683,0.0005038939,0.0023089165,0.03703713,0.0021890518,0.002027687,0.00010088179,0.00030164394,0.0003812409,0.0034875937,0.9510152,0.00007279998],"about_ca_topic_score_codex":0.0019754188,"about_ca_topic_score_gemma":0.004265127,"teacher_disagreement_score":0.0048999577,"about_ca_system_score_codex":0.00074875756,"about_ca_system_score_gemma":0.0012423487,"threshold_uncertainty_score":0.016391933},"labels":[],"label_agreement":null},{"id":"W4285384968","doi":"10.1016/s1474-4422(22)00208-3","title":"The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy study","year":2022,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Intracerebral and Subarachnoid Hemorrhage Research","field":"Medicine","cited_by":659,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; University of Calgary","funders":"Daiichi Sankyo Europe; Medical Research Council; Canadian Institutes of Health Research; Avid Radiopharmaceuticals; University of California, Irvine; UK Dementia Research Institute; Novo Nordisk; Magyar Tudományos Akadémia; Bodossaki Foundation; Roche; Deutsche Forschungsgemeinschaft; Alexion Pharmaceuticals; Apellis Pharmaceuticals; University of Glasgow; National Institutes of Health; Rosetrees Trust; National Institute on Aging; National Institute for Health and Care Research; National Institute of Neurological Disorders and Stroke; British Heart Foundation; North Carolina Stroke Association; Ministère des Affaires Sociales et de la Santé; Boston Scientific Corporation; Alzheimer's Association; Alnylam Pharmaceuticals; Pfizer; Biogen; Alzheimer's Society; Wellcome Trust; AstraZeneca; Stiftung zur Erforschung der Vaskulären Demenz; Innovációs és Technológiai Minisztérium; Bristol-Myers Squibb; Deutsches Zentrum für Neurodegenerative Erkrankungen; Alzheimer’s Research UK; Voyager Therapeutics; Fondation Brain Canada; Amgen","keywords":"Cerebral amyloid angiopathy; Neuropathology; Medicine; Retrospective cohort study; Cohort; Cohort study; Radiology; Pathology; Disease; Dementia","score_opus":0.02580301682288553,"score_gpt":0.3206894992939322,"score_spread":0.29488648247104665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285384968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99554765,0.0014462203,0.0005195724,0.00010794442,0.000023037312,0.00006488836,0.0012955178,0.000018770634,0.0009764049],"genre_scores_gemma":[0.9959099,0.00032791778,0.0004497399,0.000078806006,0.00003299022,0.00007317442,0.0028128147,0.000017871589,0.00029671585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964671,0.000935097,0.00067202206,0.0006748145,0.000955315,0.00029567507],"domain_scores_gemma":[0.9919933,0.0020517725,0.002750741,0.0009137226,0.001680957,0.00060952065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004013138,0.00083721324,0.0009995206,0.003726101,0.0006529506,0.0014118307,0.0013546873,0.0014352616,0.0010638286],"category_scores_gemma":[0.011837945,0.00073126046,0.0006757054,0.00231225,0.00078313047,0.0016778174,0.0012993192,0.0008559324,0.0007343468],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057224155,0.00006532605,0.99470526,0.000033622,0.00038459722,0.00018670154,0.00016706953,0.00014507737,0.00058434444,0.00006642386,0.0005186255,0.0025707295],"study_design_scores_gemma":[0.00008921034,0.00024754173,0.9969909,0.000028533388,0.00025006186,0.0009989209,0.0001610562,0.0006177561,0.00015440177,0.00008823679,0.0003554409,0.00001781821],"about_ca_topic_score_codex":0.0071679717,"about_ca_topic_score_gemma":0.00868997,"teacher_disagreement_score":0.0071679717,"about_ca_system_score_codex":0.0008931971,"about_ca_system_score_gemma":0.00051971513,"threshold_uncertainty_score":0.021223724},"labels":[],"label_agreement":null},{"id":"W4285384998","doi":"10.1016/s1474-4422(22)00262-9","title":"Improving prognostication after severe brain injury","year":2022,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Traumatic Brain Injury Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine","score_opus":0.05866550646163989,"score_gpt":0.32680961864003405,"score_spread":0.2681441121783942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285384998","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00040885853,0.0011447561,0.000039646126,0.9862207,0.010370148,0.000008232824,0.00008199692,0.000012506548,0.0017132208],"genre_scores_gemma":[0.007868924,0.0023455832,0.00022481529,0.92233324,0.06377238,0.00005599698,0.00013050294,0.000020599,0.0032479719],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948507,0.0021745195,0.0008280256,0.0003769049,0.0010307411,0.00073907716],"domain_scores_gemma":[0.9759093,0.013436115,0.0013883103,0.00078714854,0.0045815776,0.0038975938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068361554,0.000952931,0.00193669,0.0016799314,0.0037397363,0.0038674858,0.0019328153,0.040035155,0.006079412],"category_scores_gemma":[0.07429284,0.0007130506,0.0011861919,0.0017094201,0.002877181,0.004595024,0.0024097322,0.030572461,0.006374198],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013103531,0.00004716583,0.0032425646,0.000078706296,0.00003266761,0.0006145243,0.00012176026,0.000058887726,0.00007501102,0.0014371617,0.97121507,0.022945305],"study_design_scores_gemma":[0.001321726,0.00041283737,0.026018675,0.0027708132,0.00032811283,0.0029370007,0.0016047092,0.0016761216,0.0004470678,0.06479575,0.8974197,0.0002675268],"about_ca_topic_score_codex":0.016611163,"about_ca_topic_score_gemma":0.027562479,"teacher_disagreement_score":0.040035155,"about_ca_system_score_codex":0.0045525017,"about_ca_system_score_gemma":0.009670614,"threshold_uncertainty_score":0.036153495},"labels":[],"label_agreement":null},{"id":"W4285603539","doi":"10.1016/s1474-4422(22)00125-9","title":"Emerging therapies for Duchenne muscular dystrophy","year":2022,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":112,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"American Academy of Neurology; Muscular Dystrophy UK; Fonds de Recherche du Québec - Santé; Life Sciences, University of California, Los Angeles; National Health and Medical Research Council; McGill University","keywords":"Duchenne muscular dystrophy; Clinical trial; Dystrophin; Exon skipping; Muscular dystrophy; Medicine; Bioinformatics; Disease; Adverse effect; Internal medicine; Exon; Biology; Gene; Genetics; Alternative splicing","score_opus":0.049598782072430576,"score_gpt":0.32496529377347994,"score_spread":0.27536651170104937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285603539","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000028901084,0.9982508,0.000092564296,0.0004454412,0.00057796936,0.0000029316634,0.0000126936075,0.000007424274,0.0005811817],"genre_scores_gemma":[0.00034109643,0.9974343,0.00018888483,0.00067985046,0.0005856054,0.00000779542,0.000027950358,0.0000021202447,0.0007322725],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997465,0.000051838266,0.000029963228,0.00003742433,0.00010025504,0.000034052664],"domain_scores_gemma":[0.99953544,0.00025818494,0.000050015835,0.0000113634305,0.00009156152,0.000053526783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010216691,0.0013697004,0.002332812,0.001742223,0.00030208187,0.0014188247,0.0012243353,0.0018288367,0.00540098],"category_scores_gemma":[0.0011289396,0.00029477832,0.0006517647,0.0013485671,0.0007471143,0.0013989559,0.0010038879,0.0042451895,0.0027245397],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021698765,0.00007592079,0.0000746757,0.01126515,0.00012429363,0.0002493707,0.000030864332,0.0004720104,0.0011706895,0.004875736,0.09728891,0.88415545],"study_design_scores_gemma":[0.00011190482,0.00011574026,0.00037499485,0.0038837593,0.00014559396,0.00060553616,0.000034140045,0.000101109916,0.00016748687,0.0028124696,0.9916299,0.000017318862],"about_ca_topic_score_codex":0.0012759945,"about_ca_topic_score_gemma":0.0038267316,"teacher_disagreement_score":0.00540098,"about_ca_system_score_codex":0.0008931001,"about_ca_system_score_gemma":0.0009697631,"threshold_uncertainty_score":0.018068075},"labels":[],"label_agreement":null},{"id":"W4286615938","doi":"10.1016/s1474-4422(22)00295-2","title":"Brain health for all on World Brain Day 2022","year":2022,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Montreal Neurological Institute and Hospital; University of Toronto; McGill University; Baycrest Hospital; McGill University Health Centre","funders":"","keywords":"Psychology; Neuroscience","score_opus":0.044643263285291515,"score_gpt":0.30418354544673964,"score_spread":0.25954028216144814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286615938","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028371028,0.0019694732,0.00008224104,0.95034695,0.04150212,0.00002110417,0.000120861456,0.000042910677,0.005630554],"genre_scores_gemma":[0.0018851138,0.0014502174,0.00017066322,0.92358756,0.054692533,0.00006474458,0.00006170505,0.000028282382,0.018059172],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980406,0.0003275808,0.00018694796,0.00022577429,0.00072713033,0.00049191044],"domain_scores_gemma":[0.9945011,0.0020043324,0.0003361611,0.00016160888,0.000980493,0.0020163148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002808203,0.001190386,0.0018508575,0.0009575462,0.00531347,0.004793829,0.0015525601,0.056499973,0.017502349],"category_scores_gemma":[0.01741092,0.0007775623,0.0014384524,0.00078898465,0.0030798728,0.0034778703,0.0026418085,0.040232603,0.013635746],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005558609,0.000041100164,0.0002887237,0.000049797123,0.000010369663,0.00041364096,0.00004918961,0.000019252057,0.00008744769,0.0015146325,0.99049765,0.006972557],"study_design_scores_gemma":[0.000168498,0.00007356725,0.0011398753,0.00035988205,0.00003686912,0.00044610281,0.00035290394,0.0002007234,0.000102178536,0.008222375,0.9888442,0.00005272668],"about_ca_topic_score_codex":0.0153528005,"about_ca_topic_score_gemma":0.03239995,"teacher_disagreement_score":0.056499973,"about_ca_system_score_codex":0.0035227586,"about_ca_system_score_gemma":0.0072818045,"threshold_uncertainty_score":0.058551133},"labels":[],"label_agreement":null},{"id":"W4291398401","doi":"10.1016/s1474-4422(22)00213-7","title":"Advances in the genetics and neuropathology of tuberous sclerosis complex: edging closer to targeted therapy","year":2022,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Tuberous Sclerosis Complex Research","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Seventh Framework Programme; ZonMw; BC Children's Hospital","keywords":"Tuberous sclerosis; TSC1; TSC2; Neuropathology; Epileptogenesis; Epilepsy; Autism; Vigabatrin; Medicine; Neuroscience; Everolimus; Megalencephaly; Disease; PI3K/AKT/mTOR pathway; Bioinformatics; Psychology; Biology; Pathology; Psychiatry; Genetics; Oncology; Anticonvulsant","score_opus":0.28996690849821694,"score_gpt":0.40634701580977806,"score_spread":0.11638010731156112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291398401","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021114576,0.9981439,0.0000594536,0.0009612195,0.00045306282,0.0000013488072,0.000008510486,0.000005061514,0.00034635648],"genre_scores_gemma":[0.00029560222,0.99762017,0.00012082017,0.00094740593,0.00069039257,0.0000029333314,0.00001720969,0.0000013915522,0.00030397656],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995301,0.00013012391,0.000048516893,0.000059877697,0.00018380153,0.000047569963],"domain_scores_gemma":[0.99846846,0.0009627079,0.0001257801,0.000039107475,0.00028931617,0.000114539595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016941604,0.0010446233,0.002554008,0.002168023,0.0003257242,0.0016312606,0.0013465001,0.0024509216,0.005441489],"category_scores_gemma":[0.00239098,0.00024447788,0.00082119764,0.0019332322,0.0008924783,0.0022393728,0.0010311906,0.0044622794,0.0021552509],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017752178,0.0000783704,0.00015720869,0.017687483,0.00021010682,0.00022930057,0.000055887147,0.00050122244,0.001163562,0.010108686,0.11683784,0.85279286],"study_design_scores_gemma":[0.00006169622,0.00008264066,0.0005215206,0.00705859,0.00016036835,0.0005148999,0.00007347129,0.00010656938,0.000108679356,0.006146697,0.98514163,0.00002316814],"about_ca_topic_score_codex":0.0020645692,"about_ca_topic_score_gemma":0.0047909636,"teacher_disagreement_score":0.005441489,"about_ca_system_score_codex":0.0012638603,"about_ca_system_score_gemma":0.0019488336,"threshold_uncertainty_score":0.018203616},"labels":[],"label_agreement":null},{"id":"W4295746362","doi":"10.1016/s1474-4422(22)00302-7","title":"Risk of subsequent disabling or fatal stroke in patients with transient ischaemic attack or minor ischaemic stroke: an international, prospective cohort study","year":2022,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Kowa Company; Boston Scientific Corporation; Boehringer Ingelheim; Sanofi; Janssen Pharmaceuticals; Bayer; AstraZeneca; Amgen; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Stroke (engine); Modified Rankin Scale; Proportional hazards model; Ischaemic stroke; Hazard ratio; Prospective cohort study; Minor stroke; Observational study; Internal medicine; Cohort study; Cohort; Pediatrics; Physical therapy; Confidence interval; Atrial fibrillation; Ischemia; Ischemic stroke","score_opus":0.0263512349511377,"score_gpt":0.29091002862911347,"score_spread":0.26455879367797575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295746362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99732167,0.00043280952,0.0001454827,0.00010683475,0.000041214043,0.000024063658,0.0012781497,0.000010110768,0.0006397779],"genre_scores_gemma":[0.9973099,0.00033638862,0.00015374593,0.00011415722,0.00006410856,0.000040126226,0.0014891159,0.000010910168,0.00048165777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990175,0.00023288888,0.000099866666,0.0003149217,0.00009323284,0.00024151366],"domain_scores_gemma":[0.9971624,0.00041520264,0.0007703173,0.0007065388,0.00021993299,0.0007256409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016803697,0.001186775,0.0011944028,0.0010268757,0.0013450134,0.0023742747,0.0013775633,0.0020145003,0.0028142515],"category_scores_gemma":[0.003473347,0.001704634,0.00271587,0.002224757,0.0006816643,0.0017879708,0.0011929617,0.0037169782,0.00069047144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029402548,0.00031139873,0.99360985,0.000024534482,0.0010024962,0.0002426948,0.00019753467,0.00006797706,0.00041805665,0.00006243776,0.0003851697,0.0007375744],"study_design_scores_gemma":[0.00024217984,0.0003329268,0.997781,0.0000119359,0.00047967068,0.00034501738,0.00029242123,0.00020379141,0.000039359427,0.00005888333,0.00018793868,0.000024965297],"about_ca_topic_score_codex":0.013790098,"about_ca_topic_score_gemma":0.012314565,"teacher_disagreement_score":0.013790098,"about_ca_system_score_codex":0.00056073006,"about_ca_system_score_gemma":0.000759181,"threshold_uncertainty_score":0.027419686},"labels":[],"label_agreement":null},{"id":"W4296902573","doi":"10.1016/s1474-4422(22)00187-9","title":"Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment","year":2022,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Neurological Disorders and Stroke; National Eye Institute; NIHR Cambridge Biomedical Research Centre; National Institutes of Health; Moorfields Eye Hospital NHS Foundation Trust; National Institute for Health and Care Research; Research to Prevent Blindness","keywords":"Optic neuritis; Medicine; Myelin oligodendrocyte glycoprotein; Multiple sclerosis; Optic nerve; Optic neuropathy; Neuromyelitis optica; Visual acuity; Ophthalmology; Immunology; Experimental autoimmune encephalomyelitis","score_opus":0.13319424611832342,"score_gpt":0.383575422481007,"score_spread":0.2503811763626836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296902573","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011663545,0.99968994,0.000014066506,0.00012489974,0.000088800276,0.000001299666,0.000006225043,0.0000014381123,0.00006170674],"genre_scores_gemma":[0.00015879032,0.9993812,0.000051582258,0.00019219697,0.00015921415,0.0000024771434,0.000009652677,4.5064917e-7,0.000044440996],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991202,0.00022001287,0.00017185301,0.00012400972,0.00029922032,0.00006474667],"domain_scores_gemma":[0.99737895,0.0017565179,0.00038079402,0.00004772987,0.00034328425,0.00009277921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002570428,0.001512893,0.005236645,0.0037677274,0.00030983592,0.0020713056,0.001730751,0.002415211,0.0049087633],"category_scores_gemma":[0.0037583476,0.00045750014,0.0014496075,0.004584321,0.000892773,0.0019104342,0.0011625433,0.0026746462,0.0011606197],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025132808,0.00006570581,0.00023341834,0.085411936,0.00064977084,0.00011839042,0.000049929462,0.00032556173,0.00054187403,0.0022998368,0.037079144,0.8729731],"study_design_scores_gemma":[0.00039041523,0.00032065838,0.0033087567,0.075466275,0.0032501111,0.0013589363,0.00023167102,0.00025633862,0.00029487547,0.005104611,0.9099187,0.00009859643],"about_ca_topic_score_codex":0.003483027,"about_ca_topic_score_gemma":0.0066127516,"teacher_disagreement_score":0.005236645,"about_ca_system_score_codex":0.00130676,"about_ca_system_score_gemma":0.0029187582,"threshold_uncertainty_score":0.016421497},"labels":[],"label_agreement":null},{"id":"W4297231406","doi":"10.1016/s1474-4422(22)00200-9","title":"Diagnosis and classification of optic neuritis","year":2022,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":293,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary","funders":"Chugai Pharmaceutical; National Institute of Neurological Disorders and Stroke; IXICO; National Institute of Mental Health; Sanofi Genzyme; Daewoong Pharmaceutical Company; Sanofi; Multiple Sclerosis International Federation; National Institute on Aging; CSL Behring; Ministry of Education, Science and Technology; Celltrion; Eisai; Handok; Teva Pharmaceutical Industries; National Research Foundation of Korea; National Multiple Sclerosis Society; Vrije Universiteit Amsterdam; National Research Foundation; University College London; Multiple Sclerosis Society; European Committee for Treatment and Research in Multiple Sclerosis; Fondation Charcot; Biogen; Celgene; Bundesministerium für Bildung und Forschung; U.S. Department of State; Deutsche Forschungsgemeinschaft; Alexion Pharmaceuticals","keywords":"Optic neuritis; Medicine; Myelin oligodendrocyte glycoprotein; Multiple sclerosis; Neuromyelitis optica; Optic nerve; Ophthalmology; Immunology","score_opus":0.3028653037930656,"score_gpt":0.42055223291395416,"score_spread":0.11768692912088857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297231406","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000851919,0.99933976,0.000046385754,0.000129174,0.00017758057,0.00001373858,0.000056838435,0.0000024212393,0.00014884735],"genre_scores_gemma":[0.0022465545,0.996666,0.00034862413,0.00029563118,0.00019245528,0.000019325633,0.00012849098,0.0000017061798,0.000101093116],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971123,0.0007143785,0.0009810632,0.00035794658,0.0007095729,0.00012460384],"domain_scores_gemma":[0.9954181,0.002644819,0.001167093,0.00008583633,0.00059938536,0.000084908585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041605486,0.0015773815,0.0064271493,0.008992276,0.00032834624,0.002198465,0.00252158,0.0016476397,0.0044911276],"category_scores_gemma":[0.010062125,0.0006263434,0.0042912406,0.006175708,0.0014444359,0.0019125637,0.0012392954,0.0019011961,0.00074213225],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042962152,0.000044246914,0.001709411,0.32606807,0.004486812,0.00011879239,0.0001253216,0.0003764508,0.0003547839,0.002490848,0.023034954,0.64076066],"study_design_scores_gemma":[0.0015473884,0.00061634,0.020835893,0.51763624,0.042316593,0.0028101164,0.00072872883,0.00072275725,0.0005694473,0.007948469,0.40403938,0.0002285504],"about_ca_topic_score_codex":0.01422183,"about_ca_topic_score_gemma":0.021008411,"teacher_disagreement_score":0.01422183,"about_ca_system_score_codex":0.0026121556,"about_ca_system_score_gemma":0.0041663097,"threshold_uncertainty_score":0.028278053},"labels":[],"label_agreement":null},{"id":"W4297983178","doi":"10.1016/s1474-4422(22)00309-x","title":"Traumatic brain injury: progress and challenges in prevention, clinical care, and research","year":2022,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Traumatic Brain Injury and Neurovascular Disturbances","field":"Medicine","cited_by":1353,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"School of Medicine, University of California, San Diego; Department of Radiology and Biomedical Imaging, University of California, San Francisco; National Institute of Neurological Disorders and Stroke; Faculty of Medicine and Health, University of Sydney; UCLH Biomedical Research Centre; Canadian Institutes of Health Research; National Institutes of Health; Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medicine; Universiteit Antwerpen; Sorbonne Université; Turun Yliopistollinen Keskussairaala; Monash University; Università degli Studi di Messina; Massachusetts General Hospital; University of Cape Town; Leids Universitair Medisch Centrum; Karolinska Institutet; Turun Yliopisto; School of Medicine, Indiana University; University of Pittsburgh; KU Leuven; Graduate School of Public Health, University of Pittsburgh; Eisai; Örebro Universitet; ZNS - Hannelore Kohl Stiftung; University of Washington; Curtin University of Technology; Perelman School of Medicine, University of Pennsylvania; University of Glasgow; Universiteit Leiden; University of Exeter; Curtin Health Innovation Research Institute, Curtin University; Academy of Medical Sciences; One Mind; ACADIA Pharmaceuticals; Jazz Pharmaceuticals; Brain Injury Research Center; University of California, San Diego; Helsingin Yliopisto; Université Laval; University of Stirling; University of Pennsylvania; U.S. Department of Veterans Affairs; GlaxoSmithKline; Imperial College London; NIHR Cambridge Biomedical Research Centre; Integra LifeSciences; University of Ottawa; Auckland University of Technology, New Zealand; Renji Hospital; University of Cincinnati; Universitätsklinikum Heidelberg; Centre Hospitalier Universitaire de Québec; University College Cork; Università degli Studi di Genova; European Commission; National Institute for Health and Care Research; Assistance publique-Hôpitaux de Paris; U.S. Department of Defense","keywords":"Traumatic brain injury; Medicine; Public health; Societal impact of nanotechnology; Health care; Global health; Psychiatry; Medical emergency; Political science; Nursing","score_opus":0.5044423020968787,"score_gpt":0.510413394638093,"score_spread":0.005971092541214307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297983178","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016403093,0.9990765,0.000031385982,0.0005358564,0.00016003165,0.0000015447322,0.0000093350845,0.0000032780479,0.0001655902],"genre_scores_gemma":[0.00017983433,0.9992342,0.000076897646,0.00025120642,0.00017859522,0.0000026117575,0.000009214592,6.022776e-7,0.000066845845],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991862,0.00021721736,0.000118969234,0.000098385644,0.0003057996,0.000073383366],"domain_scores_gemma":[0.9963098,0.0025041655,0.00034358999,0.00006541633,0.00059331936,0.0001836593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027754926,0.0012711352,0.0039434712,0.0031907323,0.00048688176,0.0027835828,0.0015608424,0.0023624124,0.0055003334],"category_scores_gemma":[0.004286046,0.00039033024,0.0009527285,0.0054249903,0.001108831,0.0028413786,0.0015285653,0.0034120379,0.0018149767],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010338107,0.00006713919,0.00022425987,0.048322473,0.0002380618,0.000101839265,0.00009601345,0.00038465604,0.00036916134,0.0053969445,0.050921507,0.89377457],"study_design_scores_gemma":[0.000052151972,0.0001052056,0.0015510437,0.04065682,0.000536045,0.00056540477,0.00029972347,0.00016172661,0.00010234873,0.0070932494,0.948828,0.0000483398],"about_ca_topic_score_codex":0.0042082323,"about_ca_topic_score_gemma":0.009401552,"teacher_disagreement_score":0.0055003334,"about_ca_system_score_codex":0.0017372948,"about_ca_system_score_gemma":0.0056811073,"threshold_uncertainty_score":0.01840049},"labels":[],"label_agreement":null},{"id":"W4303473149","doi":"10.1016/s1474-4422(22)00184-3","title":"Ageing and multiple sclerosis","year":2022,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":238,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"National Institute of Neurological Disorders and Stroke; Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Medical Research Council; Fondazione per la Ricerca Biomedica; Ohio State University; National Institutes of Health; Multiple Sclerosis Society; Fondazione Cariplo; National Eye Institute; Wellcome Trust; Conrad N. Hilton Foundation","keywords":"Multiple sclerosis; Remyelination; Ageing; Medicine; Disease; Neuroprotection; Immune system; Neuroscience; Central nervous system; Immunology; Psychology; Pathology; Myelin; Internal medicine","score_opus":0.3495520240052712,"score_gpt":0.3891217182035496,"score_spread":0.03956969419827844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4303473149","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000027541266,0.9994236,0.000008797555,0.00017981698,0.00018704266,0.0000037698892,0.000016510794,0.0000013386497,0.00015148333],"genre_scores_gemma":[0.000667329,0.9983072,0.000042117423,0.0005595855,0.00020593933,0.000011507215,0.000020517076,6.758743e-7,0.00018505583],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985014,0.0005438442,0.00039590022,0.00013736452,0.0003309271,0.00009058785],"domain_scores_gemma":[0.99677247,0.0020230392,0.0007547442,0.00006351303,0.0002603865,0.0001258669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036092696,0.0015920654,0.004967104,0.006921521,0.00038975375,0.002464288,0.0009182815,0.0027089317,0.012902339],"category_scores_gemma":[0.00681992,0.0006693511,0.0019721198,0.00724805,0.00083164236,0.0023965645,0.0021547044,0.0022015173,0.0017853923],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005256017,0.000059820635,0.00037850626,0.31575692,0.0031627573,0.00021437553,0.00022391221,0.00017738152,0.00041452018,0.0021665746,0.044797212,0.63212246],"study_design_scores_gemma":[0.0008094459,0.00039484396,0.0052643553,0.28887004,0.014475505,0.0013591492,0.00045952536,0.00009383359,0.00020306962,0.0035941612,0.68440425,0.00007182412],"about_ca_topic_score_codex":0.0055440567,"about_ca_topic_score_gemma":0.014391877,"teacher_disagreement_score":0.012902339,"about_ca_system_score_codex":0.0017211337,"about_ca_system_score_gemma":0.0042562867,"threshold_uncertainty_score":0.043162644},"labels":[],"label_agreement":null},{"id":"W4306722846","doi":"10.1016/s1474-4422(22)00396-9","title":"Delineating the epileptogenic zone: spikes versus oscillations","year":2022,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University","funders":"National Health and Medical Research Council; Canadian Institutes of Health Research; Monash University; Epilepsy Foundation of Victoria; Sir Edward 'Weary' Dunlop Medical Research Foundation; Norman Beischer Medical Research Foundation; University of Melbourne","keywords":"Epilepsy; Epilepsy surgery; Electroencephalography; Scopus; Scalp; Magnetoencephalography; Neuroscience; Ictal; Stereoelectroencephalography; Temporal lobe; Medicine; Psychology; Surgery; MEDLINE; Chemistry","score_opus":0.08479247272832988,"score_gpt":0.33858696809883476,"score_spread":0.2537944953705049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306722846","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003134078,0.002387843,0.0001592853,0.9846442,0.010925444,0.000004993915,0.000027389056,0.000014287511,0.0015231635],"genre_scores_gemma":[0.0071717133,0.0029045313,0.0004713236,0.8713434,0.11554467,0.000027271471,0.00002492125,0.000026945783,0.00248531],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976052,0.0008649008,0.00041886896,0.00031073004,0.00055341667,0.00024682956],"domain_scores_gemma":[0.98766965,0.008871004,0.0006680908,0.00027100404,0.0014961021,0.00102419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033998534,0.00075461244,0.0018097466,0.0009898042,0.00221676,0.0037848244,0.0016551749,0.048270397,0.003887088],"category_scores_gemma":[0.030230071,0.0006813513,0.0010757897,0.00077982404,0.0040364536,0.0050794347,0.0012469906,0.046563827,0.0048001898],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021746608,0.000045123812,0.001334355,0.00016682738,0.00003818256,0.0059329527,0.00026229542,0.00009937,0.00036456194,0.00682123,0.9545428,0.030174905],"study_design_scores_gemma":[0.0006649441,0.00014313463,0.0027857302,0.001429772,0.00011790699,0.01832999,0.0013516543,0.0016308511,0.0006595172,0.09371335,0.8790277,0.00014545913],"about_ca_topic_score_codex":0.005243267,"about_ca_topic_score_gemma":0.008937376,"teacher_disagreement_score":0.048270397,"about_ca_system_score_codex":0.0032460466,"about_ca_system_score_gemma":0.0024618134,"threshold_uncertainty_score":0.023551881},"labels":[],"label_agreement":null},{"id":"W4307571138","doi":"10.1016/s1474-4422(22)00338-6","title":"Intracerebral haemorrhage expansion: definitions, predictors, and prevention","year":2022,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Intracerebral and Subarachnoid Hemorrhage Research","field":"Medicine","cited_by":199,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"British Heart Foundation","keywords":"Medicine; Antithrombotic; Clinical trial; Intensive care medicine; Angiography; Radiology; Internal medicine","score_opus":0.17961539702650808,"score_gpt":0.367683523869698,"score_spread":0.1880681268431899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307571138","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003741325,0.99965453,0.00001903746,0.0001561893,0.000059217673,0.00000248191,0.000020062074,0.0000012402895,0.000049841416],"genre_scores_gemma":[0.00058353244,0.99906176,0.000059918177,0.00010899653,0.00012814277,0.000005673006,0.000023799957,4.7551072e-7,0.00002772178],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99913293,0.00019415536,0.0002238727,0.00014817121,0.00023982307,0.000060928454],"domain_scores_gemma":[0.99680066,0.0020593784,0.0006221377,0.000050781095,0.00036246493,0.00010459907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002578719,0.0016037219,0.005297948,0.0040209084,0.00027201322,0.002231061,0.0017788046,0.0017273114,0.0032513891],"category_scores_gemma":[0.0063970196,0.00056016375,0.0024933338,0.0048933937,0.00094853545,0.0016210882,0.0010646184,0.0026944627,0.00062286033],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000363972,0.00008190928,0.0022147864,0.11677905,0.0021598958,0.000120863966,0.00008859943,0.0006273465,0.00017147315,0.004175234,0.025402607,0.8478142],"study_design_scores_gemma":[0.0008246797,0.0005599121,0.027895814,0.34094983,0.018566867,0.0030703307,0.00069434394,0.0011824075,0.0004589193,0.016145162,0.58941084,0.00024076628],"about_ca_topic_score_codex":0.007746108,"about_ca_topic_score_gemma":0.012233777,"teacher_disagreement_score":0.007746108,"about_ca_system_score_codex":0.0018605448,"about_ca_system_score_gemma":0.005216398,"threshold_uncertainty_score":0.015402019},"labels":[],"label_agreement":null},{"id":"W4307647128","doi":"10.1016/s1474-4422(22)00438-0","title":"Remote ischaemic conditioning for stroke prevention","year":2022,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Cardiac Ischemia and Reperfusion","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Ischaemic stroke; Stroke (engine); Ischemia; Subarachnoid hemorrhage; Internal medicine; Blood pressure; Cardiology","score_opus":0.03163754649872402,"score_gpt":0.30020845688347864,"score_spread":0.2685709103847546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307647128","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036058077,0.0029127435,0.00009088397,0.96285284,0.025871301,0.000019617284,0.00005450935,0.000019211982,0.0078184055],"genre_scores_gemma":[0.0038560557,0.0023253716,0.00013484393,0.8884323,0.09462945,0.000047743928,0.000039984443,0.000019597246,0.010514679],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99783164,0.0005634252,0.0002588316,0.00024483257,0.000683555,0.00041765795],"domain_scores_gemma":[0.9942222,0.0031442933,0.0003752448,0.00018222354,0.0007659481,0.0013100515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023221006,0.0010680635,0.0017413874,0.0009360706,0.004539787,0.004975868,0.0015776167,0.08400171,0.013171033],"category_scores_gemma":[0.018453907,0.0007189127,0.0017902078,0.00090258504,0.0032010162,0.0030073726,0.0019339361,0.05818506,0.009149974],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093615046,0.00004868895,0.00045691995,0.00007807729,0.000028449595,0.0018959182,0.000086544846,0.00007590474,0.00019993886,0.004728186,0.97813,0.014177655],"study_design_scores_gemma":[0.0005850178,0.00012758932,0.0019928608,0.0009721027,0.00010448214,0.0027330264,0.00030590393,0.000801176,0.0002922833,0.027683256,0.9643209,0.00008133097],"about_ca_topic_score_codex":0.008205928,"about_ca_topic_score_gemma":0.018273197,"teacher_disagreement_score":0.08400171,"about_ca_system_score_codex":0.0038651514,"about_ca_system_score_gemma":0.005453504,"threshold_uncertainty_score":0.04406154},"labels":[],"label_agreement":null},{"id":"W4309374247","doi":"10.1016/s1474-4422(22)00289-7","title":"Multiple sclerosis progression: time for a new mechanism-driven framework","year":2022,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":615,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Manitoba; Hotchkiss Brain Institute; McGill University; Montreal Neurological Institute and Hospital","funders":"University College London Hospitals NHS Foundation Trust; Deutsche Forschungsgemeinschaft; National Institutes of Health; European Committee for Treatment and Research in Multiple Sclerosis; Multiple Sclerosis Society; National Institute of Neurological Disorders and Stroke; UCLH Biomedical Research Centre; Università degli Studi di Napoli Federico II; National Institute for Health and Care Research; National Multiple Sclerosis Society","keywords":"Mechanism (biology); Multiple sclerosis; Computer science; Medicine; Neuroscience; Psychology; Epistemology; Immunology; Philosophy","score_opus":0.2652376272862743,"score_gpt":0.4103880129017697,"score_spread":0.14515038561549537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309374247","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002679063,0.996739,0.0002525254,0.0023523439,0.00042650016,0.0000046681575,0.000018225803,0.000006330798,0.00017369728],"genre_scores_gemma":[0.0014054353,0.99283504,0.0008158667,0.0035951908,0.0010585254,0.000028067987,0.000031073203,0.0000047727613,0.0002260021],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964857,0.0016510009,0.00052392896,0.0004644472,0.00070413016,0.00017065727],"domain_scores_gemma":[0.97712314,0.019586414,0.0012110085,0.00036681883,0.0014350242,0.00027748547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013957882,0.002183698,0.009378231,0.0030540468,0.0006051997,0.0054003936,0.003332175,0.005326245,0.0069630807],"category_scores_gemma":[0.015865518,0.0006981203,0.0032558416,0.0026697677,0.0030477946,0.008664764,0.0025493975,0.009203316,0.0016681674],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005994208,0.000100029836,0.0005476237,0.1429594,0.0035253696,0.00032650185,0.00034374523,0.0012594739,0.00066546694,0.07899893,0.05386765,0.7168063],"study_design_scores_gemma":[0.0004079706,0.00032784455,0.0016390196,0.13919213,0.005097834,0.0009031711,0.00055623177,0.0008365291,0.0002974632,0.1031165,0.74747354,0.00015176686],"about_ca_topic_score_codex":0.0034631898,"about_ca_topic_score_gemma":0.0066071316,"teacher_disagreement_score":0.013957882,"about_ca_system_score_codex":0.0042358795,"about_ca_system_score_gemma":0.007863828,"threshold_uncertainty_score":0.07381725},"labels":[],"label_agreement":null},{"id":"W4309486150","doi":"10.1016/s1474-4422(22)00435-5","title":"Revisiting levodopa for advanced Parkinson's disease","year":2022,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Levodopa; Parkinson's disease; Medicine; Disease; Physical medicine and rehabilitation; Neuroscience; Psychology; Internal medicine","score_opus":0.04539767896701396,"score_gpt":0.29858553848227365,"score_spread":0.2531878595152597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309486150","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034456525,0.0060910657,0.000074914955,0.9556383,0.033573225,0.000008837579,0.000037889567,0.000022259092,0.0042090546],"genre_scores_gemma":[0.00378343,0.0027973482,0.00012073403,0.88933605,0.09917634,0.00001880548,0.000026224916,0.00002346705,0.0047177104],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961421,0.0009926313,0.00064399355,0.00041121256,0.0011281767,0.00068202964],"domain_scores_gemma":[0.98783886,0.0072735194,0.00064720656,0.00033864303,0.0016802443,0.0022216379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036885203,0.0011598709,0.0021547864,0.0014357378,0.0043982794,0.005160722,0.00213284,0.08515074,0.0076394146],"category_scores_gemma":[0.025509987,0.0008768979,0.0022841142,0.001191856,0.0043599308,0.0046293796,0.0021738934,0.05278544,0.007150276],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012208454,0.000037682465,0.0004970039,0.00013807711,0.000040140443,0.004494158,0.00013849029,0.000091795766,0.00026121968,0.003325818,0.9760416,0.014811929],"study_design_scores_gemma":[0.00041462824,0.0001364985,0.0012923017,0.00091133174,0.00010937587,0.00483766,0.00036199664,0.00050996256,0.00026023175,0.013610139,0.97747403,0.00008185126],"about_ca_topic_score_codex":0.010284932,"about_ca_topic_score_gemma":0.023670506,"teacher_disagreement_score":0.08515074,"about_ca_system_score_codex":0.0069616428,"about_ca_system_score_gemma":0.006083323,"threshold_uncertainty_score":0.050510526},"labels":[],"label_agreement":null},{"id":"W4309487094","doi":"10.1016/s1474-4422(22)00446-x","title":"Ublituximab: a new anti-CD20 agent for multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Ocrelizumab; Ofatumumab; Teriflunomide; Medicine; Multiple sclerosis; Web of science; Daclizumab; Rituximab; Dermatology; Internal medicine; Fingolimod; Monoclonal antibody; Immunology; Antibody; Lymphoma; Meta-analysis","score_opus":0.21835925808922874,"score_gpt":0.34189910527511397,"score_spread":0.12353984718588523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309487094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70844364,0.24036387,0.0013992811,0.014141791,0.0032926274,0.0008468651,0.0019269,0.00023719466,0.029347884],"genre_scores_gemma":[0.9292685,0.04423506,0.0031241234,0.0055247964,0.0005164756,0.00037086176,0.0016726272,0.000029169367,0.015258425],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993449,0.0003003215,0.000050578536,0.00006459254,0.00015339916,0.000086118176],"domain_scores_gemma":[0.99937135,0.00020198444,0.00013056053,0.000029365294,0.00008172171,0.00018508267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023224873,0.00035092636,0.00061880215,0.00053752225,0.0002664169,0.00085809367,0.00037104535,0.00085192436,0.0036071301],"category_scores_gemma":[0.0016271601,0.00016703061,0.0005121876,0.00038277585,0.00031920115,0.000944795,0.00043436643,0.0012980119,0.0004030506],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11240241,0.0026185259,0.009574699,0.0048795184,0.0025546765,0.00036682258,0.00018272351,0.0011668787,0.01914978,0.0030947959,0.028522424,0.81548685],"study_design_scores_gemma":[0.24382229,0.112963066,0.17938794,0.003793611,0.01264439,0.0022941171,0.0005865747,0.0033860696,0.024226213,0.0036132252,0.41300988,0.00027267903],"about_ca_topic_score_codex":0.0026249052,"about_ca_topic_score_gemma":0.008716298,"teacher_disagreement_score":0.0036071301,"about_ca_system_score_codex":0.0012581521,"about_ca_system_score_gemma":0.0009801857,"threshold_uncertainty_score":0.01228261},"labels":[],"label_agreement":null},{"id":"W4311425737","doi":"10.1016/s1474-4422(22)00488-4","title":"Clinical trials in stroke in 2022: new answers and questions","year":2022,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Foothills Medical Centre","funders":"","keywords":"Stroke (engine); Clinical trial; Medicine; Clinical neurology; MEDLINE; Physical medicine and rehabilitation; Neuroscience; Psychology; Internal medicine; Political science; Engineering","score_opus":0.11143155650954549,"score_gpt":0.40651321661823164,"score_spread":0.29508166010868614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311425737","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046677663,0.24426912,0.00049875857,0.7311995,0.02054106,0.000042269363,0.0006256973,0.000051731164,0.00230515],"genre_scores_gemma":[0.02029814,0.14789426,0.004276925,0.68706703,0.1369853,0.0005344984,0.0010944669,0.0002092641,0.0016401628],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.87906224,0.07716407,0.018289307,0.0065037166,0.014388268,0.004592287],"domain_scores_gemma":[0.42719916,0.49069524,0.024542868,0.007813703,0.031038933,0.018710019],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.2250662,0.0023360914,0.012000173,0.003343727,0.0038208808,0.024449645,0.0077697104,0.04916742,0.026701756],"category_scores_gemma":[0.36629248,0.0023508754,0.005582442,0.006193304,0.015230094,0.046490636,0.007482479,0.03376991,0.007833736],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004405536,0.0005330437,0.004565628,0.016590511,0.0025163095,0.00033577246,0.00086105516,0.0010205886,0.00040460427,0.07421713,0.7027035,0.19184634],"study_design_scores_gemma":[0.006614595,0.00085082534,0.009043697,0.03849912,0.0019686534,0.00035099042,0.0026054804,0.0015055784,0.00029004994,0.26013386,0.67763215,0.00050490274],"about_ca_topic_score_codex":0.010723628,"about_ca_topic_score_gemma":0.016859222,"teacher_disagreement_score":0.2250662,"about_ca_system_score_codex":0.013956,"about_ca_system_score_gemma":0.029612022,"threshold_uncertainty_score":0.9556313},"labels":[],"label_agreement":null},{"id":"W4312095442","doi":"10.1016/s1474-4422(22)00408-2","title":"Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study","year":2022,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Down syndrome and intellectual disability research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Child Health and Human Development; NIHR Cambridge Biomedical Research Centre; Instituto de Salud Carlos III; Fonds de Recherche du Québec - Santé; National Institutes of Health; UK Dementia Research Institute; Fleni; Deutsches Zentrum für Neurodegenerative Erkrankungen; Eisai; University of Oxford; Department of Health and Social Care; Korea Health Industry Development Institute; National Institute on Aging; National Institute for Health and Care Research; Canadian Institutes of Health Research; Foundation for Barnes-Jewish Hospital; Japan Agency for Medical Research and Development; GHR Foundation; Fondation Brain Canada; U.S. Department of Defense; Eli Lilly and Company; BrightFocus Foundation; Hope Center for Neurological Disorders; Alzheimer's Association; Biogen; Autism Speaks; University College London Hospitals NHS Foundation Trust","keywords":"PSEN1; Down syndrome; Alzheimer's disease; Medicine; Presenilin; Apolipoprotein E; Pittsburgh compound B; Amyloid (mycology); Amyloid precursor protein; Disease; Biomarker; Dementia; Internal medicine; Pathology; Oncology; Genetics; Biology; Psychiatry","score_opus":0.10096722055200749,"score_gpt":0.3962231031738922,"score_spread":0.29525588262188474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312095442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99944943,0.00019165859,0.000044082524,0.000013666617,0.0000064770825,0.0000043311866,0.00015770833,0.0000014926413,0.00013120858],"genre_scores_gemma":[0.9994006,0.00011850903,0.000046299258,0.000031510994,0.000009390821,0.00000709206,0.00026172545,0.0000019780127,0.000123002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891174,0.00045232754,0.00012191181,0.00029605662,0.00010779385,0.00011019226],"domain_scores_gemma":[0.99772626,0.00051370444,0.00077392854,0.00028176088,0.00026264554,0.00044177263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019523165,0.00067275955,0.0006820773,0.0010473337,0.00062190497,0.0011978779,0.00055122754,0.0012326116,0.0009742898],"category_scores_gemma":[0.003775609,0.00084431045,0.0007885792,0.001424351,0.0006090994,0.0011731118,0.00064305257,0.000879532,0.00031785405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007310087,0.00008097284,0.9978199,0.000011584159,0.00036847117,0.00008983268,0.00017483729,0.000018588033,0.00036496692,0.000012971812,0.000033928616,0.00029286437],"study_design_scores_gemma":[0.000021120783,0.00028556734,0.9991041,0.000003144238,0.000093527764,0.00014864047,0.00021268427,0.00003939959,0.000030961302,0.000014263124,0.000042360756,0.0000040764503],"about_ca_topic_score_codex":0.0077598793,"about_ca_topic_score_gemma":0.0066236868,"teacher_disagreement_score":0.0077598793,"about_ca_system_score_codex":0.00039977138,"about_ca_system_score_gemma":0.00025653077,"threshold_uncertainty_score":0.015429378},"labels":[],"label_agreement":null},{"id":"W4317708826","doi":"10.1016/s1474-4422(22)00524-5","title":"Adrian I Espiritu","year":2023,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Classical Studies and Legal History","field":"Arts and Humanities","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"Philosophy; Archaeology; Art; History","score_opus":0.09032452500957687,"score_gpt":0.2539682313019277,"score_spread":0.1636437062923508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317708826","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006058814,0.10228648,0.0007634621,0.40441918,0.39954978,0.000028577711,0.0002563634,0.00019711195,0.09189314],"genre_scores_gemma":[0.02005033,0.06328787,0.0009582971,0.30646235,0.2038246,0.000110236586,0.00026213753,0.0003763106,0.4046678],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984131,0.00046607325,0.000097314594,0.00032282228,0.000525483,0.00017514355],"domain_scores_gemma":[0.9964418,0.0014784576,0.000274759,0.00031278163,0.0009208616,0.00057139323],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024095373,0.0008439694,0.00078579696,0.0016561301,0.0016494439,0.0037111223,0.0011279248,0.0042640273,0.046240035],"category_scores_gemma":[0.015473995,0.0002995104,0.000415067,0.0006700858,0.0020379391,0.0026221953,0.0030551897,0.0057493523,0.02596074],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028375534,0.000007371408,0.00007260645,0.00014726083,0.0000071470813,0.00015055788,0.00008876708,0.000021297112,0.000048309717,0.01425105,0.9560247,0.029152509],"study_design_scores_gemma":[0.000007276111,0.0000053097083,0.000110532455,0.0002510527,0.0000046197183,0.00036629144,0.00008188733,0.000021394368,0.000051154577,0.0046146573,0.9944798,0.000005978788],"about_ca_topic_score_codex":0.0013173317,"about_ca_topic_score_gemma":0.001200364,"teacher_disagreement_score":0.95375997,"about_ca_system_score_codex":0.001259831,"about_ca_system_score_gemma":0.0014490375,"threshold_uncertainty_score":0.1546883},"labels":[],"label_agreement":null},{"id":"W4319870667","doi":"10.1016/s1474-4422(22)00483-5","title":"Endovascular thrombectomy for basilar artery occlusion: translating research findings into clinical practice","year":2023,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Basilar artery; Occlusion; Clinical Practice; Radiology; Cardiology; Physical therapy","score_opus":0.32414872334705536,"score_gpt":0.5170486627469176,"score_spread":0.19289993939986227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319870667","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002360974,0.99940264,0.00002385358,0.0002458573,0.00016389064,0.000002870268,0.00001103245,0.0000025808538,0.00012366739],"genre_scores_gemma":[0.00036824428,0.99893206,0.00008044912,0.0003727044,0.00016996633,0.0000050216822,0.000015900067,0.0000010116645,0.000054725046],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989567,0.00029088694,0.00019751723,0.0001532903,0.0003259075,0.000075593394],"domain_scores_gemma":[0.99602425,0.0027642238,0.0005183249,0.00006100511,0.00050053175,0.0001316757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032023767,0.0013323887,0.0050967294,0.0035785118,0.00031913086,0.0025390573,0.001967945,0.0025319264,0.0052129105],"category_scores_gemma":[0.006198131,0.00046303243,0.0019794605,0.003385361,0.0007913788,0.0019219778,0.0012119395,0.0028278385,0.0015210797],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022720941,0.000049997136,0.00021594737,0.14109108,0.0013352981,0.00012578188,0.00005560143,0.0002645618,0.0005273272,0.0021465442,0.033788938,0.8201717],"study_design_scores_gemma":[0.00071036397,0.00042196704,0.003496274,0.2017488,0.008884183,0.0010896564,0.00028237107,0.00028352853,0.0003993161,0.0063387034,0.7762337,0.00011109894],"about_ca_topic_score_codex":0.0027596871,"about_ca_topic_score_gemma":0.0059756064,"teacher_disagreement_score":0.0052129105,"about_ca_system_score_codex":0.0014283287,"about_ca_system_score_gemma":0.0032577405,"threshold_uncertainty_score":0.017438889},"labels":[],"label_agreement":null},{"id":"W4320888637","doi":"10.1016/s1474-4422(23)00033-9","title":"Treatment of asymptomatic carotid stenosis in SPACE-2","year":2023,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Cerebrovascular and Carotid Artery Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Asymptomatic; Stenosis; Medicine; Cardiology; Internal medicine; Radiology","score_opus":0.033659890882554236,"score_gpt":0.27249264547553625,"score_spread":0.23883275459298203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320888637","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008305312,0.015427798,0.0006176262,0.8839013,0.04501545,0.0000473342,0.0001847377,0.00009542132,0.046404917],"genre_scores_gemma":[0.068295725,0.0067068185,0.0007400835,0.73970443,0.14797837,0.00007831461,0.00023354641,0.00006764501,0.036195014],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99910957,0.00020327284,0.00009600628,0.00007057839,0.00022925831,0.0002913335],"domain_scores_gemma":[0.99875855,0.0005017297,0.0001176394,0.000051357278,0.00017017341,0.0004006384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084122515,0.00056247046,0.00092255767,0.00085053244,0.001969595,0.0018103067,0.00093249383,0.0307354,0.0066978713],"category_scores_gemma":[0.005897363,0.0003623658,0.001482851,0.00061683636,0.0012576764,0.00129319,0.0008834015,0.014695974,0.0030958473],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006163394,0.00025335947,0.0056609535,0.00032718308,0.00007596994,0.07165921,0.00029919948,0.00039567036,0.0014427372,0.008657616,0.86275417,0.047857597],"study_design_scores_gemma":[0.00085909537,0.0006789053,0.011238743,0.0011189308,0.000114401504,0.06312058,0.00045225662,0.0015712373,0.0010495108,0.017714206,0.9019714,0.00011065209],"about_ca_topic_score_codex":0.0040503386,"about_ca_topic_score_gemma":0.0110968575,"teacher_disagreement_score":0.0307354,"about_ca_system_score_codex":0.0020111038,"about_ca_system_score_gemma":0.0023576466,"threshold_uncertainty_score":0.022406578},"labels":[],"label_agreement":null},{"id":"W4323656930","doi":"10.1016/s1474-4422(22)00519-1","title":"Thrombolysis for acute ischaemic stroke: current status and future perspectives","year":2023,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":336,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Thrombolysis; Penumbra; Tenecteplase; Medicine; Tissue plasminogen activator; Stroke (engine); Intensive care medicine; Fibrinolytic agent; Ischemia; Cardiology; Internal medicine; Myocardial infarction","score_opus":0.06429154657565571,"score_gpt":0.38613510006518564,"score_spread":0.3218435534895299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323656930","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016801885,0.9993395,0.000021139222,0.00027533708,0.00019296895,0.0000019881268,0.000009257741,0.0000028815616,0.00014009271],"genre_scores_gemma":[0.00019372469,0.9991085,0.00006243465,0.00032618496,0.00021968971,0.0000034073098,0.000010276426,7.5047217e-7,0.000074974756],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993813,0.00014703027,0.00012378204,0.000092390714,0.00018903238,0.00006645286],"domain_scores_gemma":[0.9978192,0.001317601,0.00035562,0.000032367756,0.00034693346,0.00012824254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024170843,0.0013887006,0.0047480855,0.002502668,0.00030419714,0.0027377063,0.0015254675,0.0024918623,0.006964538],"category_scores_gemma":[0.003446895,0.0004836436,0.0014466611,0.003574525,0.0007727241,0.0023625866,0.0011659857,0.0032468275,0.002381325],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033946414,0.00006886097,0.00018025778,0.07117293,0.000516921,0.000103887854,0.000055969052,0.0003155782,0.0004038139,0.0024406258,0.05079856,0.8736031],"study_design_scores_gemma":[0.0004921904,0.00032736803,0.0018197324,0.062464215,0.0026009374,0.0006453991,0.000185147,0.0003020697,0.0001633834,0.0042440863,0.926687,0.000068406865],"about_ca_topic_score_codex":0.002390025,"about_ca_topic_score_gemma":0.006624496,"teacher_disagreement_score":0.006964538,"about_ca_system_score_codex":0.0012445813,"about_ca_system_score_gemma":0.0029994468,"threshold_uncertainty_score":0.02329868},"labels":[],"label_agreement":null},{"id":"W4324392923","doi":"10.1016/s1474-4422(23)00067-4","title":"Effect of atherosclerosis on 5-year risk of major vascular events in patients with transient ischaemic attack or minor ischaemic stroke: an international prospective cohort study","year":2023,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Cerebrovascular and Carotid Artery Diseases","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Sanofi-Aventis Deutschland; Sanofi K.K.; AstraZeneca France; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Cardiology; Stroke (engine); Population; Vascular disease; Prospective cohort study; Stenosis; Ischaemic stroke; Cohort; Ischemia","score_opus":0.01094372557833469,"score_gpt":0.2681837718657373,"score_spread":0.2572400462874026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324392923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965475,0.0010308818,0.00013666363,0.00010580104,0.000053031927,0.000014622622,0.0013127056,0.000016661568,0.0007821128],"genre_scores_gemma":[0.9972415,0.00042736577,0.00014354689,0.000073838346,0.000069051326,0.000020584066,0.0014910956,0.000014382182,0.00051869114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982508,0.00053181185,0.00017543216,0.00054416264,0.00013810227,0.0003596906],"domain_scores_gemma":[0.9950537,0.00088946836,0.0014461515,0.0012304765,0.00037769953,0.001002514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002731759,0.0015999669,0.0015784693,0.0014606786,0.0012230806,0.002616669,0.0016223622,0.002765115,0.002412012],"category_scores_gemma":[0.004506215,0.0018872117,0.004459004,0.002666919,0.0008008063,0.0015806224,0.0014105263,0.00354246,0.0005940523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004188315,0.0002854184,0.9913356,0.000033689557,0.0021548334,0.00024648735,0.00014201335,0.00009918441,0.00050867285,0.00005425986,0.00020573706,0.000745747],"study_design_scores_gemma":[0.00008249575,0.00026937,0.99862933,0.000007875401,0.00048467188,0.00012992151,0.00009761771,0.00013752133,0.000027466309,0.000031865304,0.00008521062,0.000016703654],"about_ca_topic_score_codex":0.017743103,"about_ca_topic_score_gemma":0.014247584,"teacher_disagreement_score":0.017743103,"about_ca_system_score_codex":0.0006020459,"about_ca_system_score_gemma":0.0007327216,"threshold_uncertainty_score":0.03527969},"labels":[],"label_agreement":null},{"id":"W4324393042","doi":"10.1016/s1474-4422(22)00426-4","title":"Family planning considerations in people with multiple sclerosis","year":2023,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Sanofi Genzyme; Bayer HealthCare; European Committee for Treatment and Research in Multiple Sclerosis; Hexal AG; Teva Pharmaceutical Industries; Biogen; Celgene; Barts Charity; Sanofi","keywords":"Multiple sclerosis; Pregnancy; Discontinuation; Medicine; Breastfeeding; Disease; In utero; Pediatrics; Intensive care medicine; Fetus; Psychiatry; Internal medicine","score_opus":0.29587736864059866,"score_gpt":0.38452892364377733,"score_spread":0.08865155500317867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324393042","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004507793,0.9992531,0.000010850827,0.00031836002,0.000111275775,0.0000018823912,0.000012091715,0.0000013318523,0.00024591034],"genre_scores_gemma":[0.0010736452,0.99807125,0.00006233773,0.00048024856,0.0001527626,0.000005884715,0.0000128853335,6.342945e-7,0.00014039599],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99949455,0.00019911506,0.000090454516,0.000043248172,0.00013459814,0.000038005546],"domain_scores_gemma":[0.99795675,0.001507517,0.00033389364,0.000017951443,0.000116062125,0.00006776374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013946713,0.00074029854,0.0020121892,0.0023461014,0.00030154956,0.00103241,0.00059854926,0.0015859131,0.007919361],"category_scores_gemma":[0.00429729,0.00033435252,0.001052933,0.0024454412,0.00040575108,0.00081562286,0.0008845086,0.0018485738,0.00054735487],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023793642,0.000040812705,0.0004005377,0.09724548,0.00087895175,0.00023451532,0.00014777767,0.00025668903,0.00014394982,0.0015427788,0.030685252,0.8681854],"study_design_scores_gemma":[0.0005264143,0.00030637832,0.0049074627,0.22323887,0.0060434043,0.0020642292,0.00052354805,0.00017123632,0.00016462436,0.0029607418,0.7590332,0.000059909868],"about_ca_topic_score_codex":0.0073955683,"about_ca_topic_score_gemma":0.022199152,"teacher_disagreement_score":0.007919361,"about_ca_system_score_codex":0.0010946076,"about_ca_system_score_gemma":0.002410012,"threshold_uncertainty_score":0.026492953},"labels":[],"label_agreement":null},{"id":"W4324394716","doi":"10.1016/s1474-4422(23)00072-8","title":"The International Stroke Recovery and Rehabilitation Alliance","year":2023,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Stroke Rehabilitation and Recovery","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; University of Calgary; University of Ottawa","funders":"National Health and Medical Research Council; Medical Research Council; Ipsen","keywords":"Scopus; Rehabilitation; Stroke (engine); Alliance; International Classification of Functioning, Disability and Health; Medicine; Quality of life (healthcare); Global health; Occupational therapy; MEDLINE; Gerontology; Physical therapy; Physical medicine and rehabilitation; Public health; Nursing; Political science","score_opus":0.025378958442404228,"score_gpt":0.2866655821640614,"score_spread":0.2612866237216572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324394716","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018040986,0.0014360242,0.000054619595,0.9554452,0.03527718,0.000025912148,0.00007892791,0.000022268245,0.007479521],"genre_scores_gemma":[0.0014775139,0.00086524634,0.00006451534,0.94838935,0.032592926,0.0000799619,0.000046604237,0.000028441014,0.016455414],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99265796,0.0012471646,0.0007546389,0.00087129994,0.0024295081,0.0020394244],"domain_scores_gemma":[0.98151994,0.00885919,0.0011514444,0.0004959088,0.0024020374,0.0055714636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055913753,0.001996957,0.0029711837,0.0017764593,0.012031041,0.012013569,0.0031644683,0.17102574,0.018773578],"category_scores_gemma":[0.04923154,0.0019147331,0.0027227183,0.0015381625,0.004954799,0.0067479387,0.0049529723,0.096815504,0.017265327],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030352156,0.00002023589,0.00018363196,0.000031505042,0.000014313955,0.0004764157,0.00007664175,0.000020965817,0.000047619946,0.0020177742,0.9938585,0.0032220026],"study_design_scores_gemma":[0.00022506021,0.00006046781,0.0014343744,0.0007668729,0.000073140596,0.0007481784,0.00057693984,0.0003432603,0.00015042238,0.012852506,0.98267174,0.000096972006],"about_ca_topic_score_codex":0.018100815,"about_ca_topic_score_gemma":0.038920872,"teacher_disagreement_score":0.17102574,"about_ca_system_score_codex":0.0075962762,"about_ca_system_score_gemma":0.018833283,"threshold_uncertainty_score":0.062803924},"labels":[],"label_agreement":null},{"id":"W4324395202","doi":"10.1016/s1474-4422(23)00076-5","title":"Admission systolic blood pressure and effect of endovascular treatment in patients with ischaemic stroke: an individual patient data meta-analysis","year":2023,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Sapheon; Medtronic","keywords":"Medicine; Modified Rankin Scale; Thrombolysis; Blood pressure; Internal medicine; Stroke (engine); Cardiology; Randomized controlled trial; Stent; Endovascular treatment; Surgery; Ischemic stroke; Aneurysm; Ischemia; Myocardial infarction","score_opus":0.10474120260353326,"score_gpt":0.34099524969967115,"score_spread":0.2362540470961379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324395202","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026911488,0.9683819,0.0017333836,0.00043725024,0.00064718345,0.000159468,0.0010163749,0.00011559478,0.00059745077],"genre_scores_gemma":[0.5576992,0.43204376,0.003538392,0.0023323584,0.00083275425,0.0004412956,0.001700017,0.00013319461,0.0012790458],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9956619,0.0023997414,0.0008017388,0.0005823725,0.0002950068,0.00025924796],"domain_scores_gemma":[0.9917862,0.0062893014,0.0008890003,0.00051794783,0.0003463222,0.00017127735],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0071481713,0.0028393758,0.014429939,0.0015264387,0.00041346723,0.0025224497,0.002092655,0.0025305995,0.0048898053],"category_scores_gemma":[0.016144622,0.0017028895,0.03846329,0.0023062187,0.000578362,0.0013675517,0.0014272702,0.003604509,0.00057650736],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008141614,0.000034022738,0.0030147107,0.048925944,0.93204147,0.000089038,0.000041722877,0.0004748266,0.00023746118,0.000093125935,0.0006802562,0.00622578],"study_design_scores_gemma":[0.002232553,0.0002132381,0.0029867224,0.0017687747,0.9916381,0.000036343434,0.000020303776,0.00017090524,0.00004795042,0.00017349383,0.0006920118,0.000019586918],"about_ca_topic_score_codex":0.0070266556,"about_ca_topic_score_gemma":0.014442686,"teacher_disagreement_score":0.9855701,"about_ca_system_score_codex":0.0013718128,"about_ca_system_score_gemma":0.0014407487,"threshold_uncertainty_score":0.03780365},"labels":[],"label_agreement":null},{"id":"W4365456202","doi":"10.1016/s1474-4422(23)00121-7","title":"Vera Bril: what if?","year":2023,"lang":"de","type":"article","venue":"The Lancet Neurology","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Government of Ontario; Mayo Clinic","keywords":"Myasthenia gravis; Placebo; Medicine; Bridge (graph theory); Clinical trial; Family medicine; Internal medicine; Physical therapy; Alternative medicine; Pathology","score_opus":0.039889119579370705,"score_gpt":0.2931219988935759,"score_spread":0.2532328793142052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365456202","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004065584,0.16565415,0.00009509527,0.7725237,0.05122319,0.000008945407,0.00012385374,0.000059678692,0.00990477],"genre_scores_gemma":[0.011081166,0.14250688,0.00045602847,0.65060896,0.17248401,0.00005884772,0.00017343397,0.0001170982,0.022513611],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99731284,0.0009576932,0.00028130936,0.00024242107,0.00073021377,0.00047547146],"domain_scores_gemma":[0.9885693,0.0052297353,0.0010636443,0.00046580457,0.002048147,0.0026232775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044160923,0.0008769187,0.002153756,0.0014679199,0.001929618,0.005769886,0.001665544,0.018336562,0.023667859],"category_scores_gemma":[0.019121023,0.0004848049,0.0011320728,0.00095645426,0.004096862,0.0067706523,0.0018396027,0.017029889,0.01441334],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024454918,0.000056992205,0.00060506596,0.00081604946,0.00007814979,0.0007336636,0.0001128155,0.000033844106,0.00016671907,0.006507774,0.8844207,0.106223755],"study_design_scores_gemma":[0.000289516,0.000103551145,0.001134642,0.0035877049,0.000112269045,0.0012272549,0.00062326953,0.000065238055,0.00007528637,0.014053374,0.97866994,0.000057904082],"about_ca_topic_score_codex":0.006047588,"about_ca_topic_score_gemma":0.011547722,"teacher_disagreement_score":0.023667859,"about_ca_system_score_codex":0.0021238825,"about_ca_system_score_gemma":0.0037596496,"threshold_uncertainty_score":0.0791769},"labels":[],"label_agreement":null},{"id":"W4365456974","doi":"10.1016/s1474-4422(23)00080-7","title":"Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study","year":2023,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":250,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"UCB Pharma; NIHR Sheffield Biomedical Research Centre; National Institute for Health and Care Research","keywords":"Myasthenia gravis; Placebo; Medicine; Double blind; Phase (matter); Anesthesia; Internal medicine; Alternative medicine; Physics; Pathology","score_opus":0.027218538536803883,"score_gpt":0.2993150519911387,"score_spread":0.27209651345433483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365456974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98593014,0.008694817,0.00054092123,0.00057059096,0.0004173476,0.0017476742,0.00059890276,0.00010714168,0.0013924959],"genre_scores_gemma":[0.9915201,0.003057863,0.00071187376,0.0009497586,0.00035023337,0.0011625809,0.00058584736,0.000017137867,0.0016446408],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99952483,0.00022240271,0.000032502652,0.00007904779,0.000048990092,0.000092220434],"domain_scores_gemma":[0.9992924,0.00025040036,0.00016578117,0.00004822782,0.00003882316,0.00020427517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012874888,0.0011920081,0.002891464,0.0003567915,0.00035825593,0.00094756664,0.000715272,0.0020139157,0.0036886008],"category_scores_gemma":[0.0015001027,0.00061724277,0.0020802796,0.00035283162,0.0010495805,0.0009052451,0.00029883554,0.00305234,0.00067879894],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97362196,0.0027717764,0.00071869214,0.0008068376,0.000982569,0.00007605083,0.00006083479,0.0001818273,0.0047564986,0.00007419762,0.0004959855,0.015452718],"study_design_scores_gemma":[0.9422947,0.053386837,0.0029697537,0.00002413354,0.00040644457,0.000041214313,0.000017388822,0.00016138703,0.00026212493,0.00007617409,0.00034677197,0.000012992278],"about_ca_topic_score_codex":0.0007957921,"about_ca_topic_score_gemma":0.001501128,"teacher_disagreement_score":0.0036886008,"about_ca_system_score_codex":0.000600967,"about_ca_system_score_gemma":0.0005937175,"threshold_uncertainty_score":0.012339592},"labels":[],"label_agreement":null},{"id":"W4365457148","doi":"10.1016/s1474-4422(23)00077-7","title":"Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study","year":2023,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":260,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"UCB Pharma; National Institute of Neurological Disorders and Stroke","keywords":"Myasthenia gravis; Placebo; Medicine; Double blind; Phase (matter); Physical medicine and rehabilitation; Anesthesia; Physical therapy; Internal medicine; Alternative medicine; Physics; Pathology","score_opus":0.031035434631971257,"score_gpt":0.29350922155553044,"score_spread":0.26247378692355916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365457148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902294,0.005074949,0.00045450393,0.00056525803,0.00030717513,0.0013655281,0.00058788015,0.00009315597,0.0013222272],"genre_scores_gemma":[0.99207544,0.0019710457,0.0008071536,0.0010719093,0.00033078072,0.0014965119,0.00060189737,0.00002251023,0.0016228331],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993469,0.00033403205,0.00003961971,0.00010354741,0.00005033808,0.00012545787],"domain_scores_gemma":[0.9990459,0.00030525174,0.00020648084,0.000090806054,0.000053523123,0.00029799298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001685643,0.001508295,0.0032297168,0.00039693943,0.00045122395,0.0011440443,0.0009067074,0.0026559315,0.004261289],"category_scores_gemma":[0.0016318875,0.00073375116,0.0023383775,0.0003715809,0.0015674022,0.0012197805,0.00034967723,0.0031607703,0.0010862066],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97578454,0.0038231276,0.0006502854,0.0004645224,0.00069374713,0.000056090288,0.00006094916,0.00020685664,0.0044083544,0.000067512075,0.00041650125,0.013367437],"study_design_scores_gemma":[0.9348607,0.061206426,0.0028242234,0.000018988354,0.00027379536,0.000033612476,0.000015465226,0.0001719288,0.00020890105,0.00007756536,0.00029317258,0.000015142473],"about_ca_topic_score_codex":0.00082596554,"about_ca_topic_score_gemma":0.0014351323,"teacher_disagreement_score":0.004261289,"about_ca_system_score_codex":0.00067805994,"about_ca_system_score_gemma":0.00079877867,"threshold_uncertainty_score":0.0142554045},"labels":[],"label_agreement":null},{"id":"W4365786879","doi":"10.1016/s1474-4422(11)70149-1","title":"Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring","year":2011,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":266,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University Hospital","funders":"EMD Serono; Biogen Idec; Bayer Schering; Genesis Pharma; Novartis; Teva Pharmaceutical Industries; Biogen; Bayer; Pfizer","keywords":"Natalizumab; Multiple sclerosis; Selection (genetic algorithm); Medicine; Computer science; Intensive care medicine; Artificial intelligence; Immunology","score_opus":0.267705996502269,"score_gpt":0.35536813352001656,"score_spread":0.08766213701774755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365786879","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028089425,0.3794989,0.06659423,0.41472748,0.030269064,0.005703465,0.015874749,0.0022342098,0.057008494],"genre_scores_gemma":[0.16239934,0.1982625,0.3654095,0.19860747,0.022668647,0.013948478,0.022890009,0.00075617287,0.015057879],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9669106,0.015642064,0.009984011,0.0008477328,0.0059991903,0.0006164451],"domain_scores_gemma":[0.91865116,0.037156735,0.013973632,0.0030352892,0.02481761,0.0023656082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.036976766,0.0016525665,0.004947824,0.0039536045,0.001037998,0.0027413745,0.002859642,0.0052241883,0.003796825],"category_scores_gemma":[0.0816791,0.0006998916,0.0033107277,0.0042093075,0.00067378615,0.0023346716,0.0012746146,0.0059467326,0.0027398134],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002802075,0.00044819235,0.017254787,0.0038122428,0.0010137522,0.0003195355,0.00021465545,0.0009289153,0.0007154113,0.001308176,0.40141383,0.5697685],"study_design_scores_gemma":[0.014020454,0.0015500464,0.12567085,0.033519454,0.012201657,0.002699094,0.0005713965,0.0073343483,0.0032546031,0.008664734,0.7901251,0.00038820202],"about_ca_topic_score_codex":0.0071936175,"about_ca_topic_score_gemma":0.012284518,"teacher_disagreement_score":0.036976766,"about_ca_system_score_codex":0.0023923705,"about_ca_system_score_gemma":0.0052438937,"threshold_uncertainty_score":0.1955542},"labels":[],"label_agreement":null},{"id":"W4377018269","doi":"10.1016/s1474-4422(23)00150-3","title":"Aspiring to restore arm and hand function after stroke","year":2023,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Stroke Rehabilitation and Recovery","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Institutes of Health; National Health and Medical Research Council; National Heart Foundation of Australia","keywords":"Physical medicine and rehabilitation; Stroke (engine); Medicine; Engineering; Mechanical engineering","score_opus":0.03402514128510466,"score_gpt":0.2794003012410739,"score_spread":0.24537515995596926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377018269","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018495779,0.0056843855,0.0001425711,0.947166,0.02955313,0.000036783385,0.00009643872,0.00004767493,0.015423413],"genre_scores_gemma":[0.016685542,0.004327351,0.0002130274,0.88216746,0.081347406,0.00007210154,0.00007691583,0.00003840321,0.015071802],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984983,0.0004572964,0.0002679773,0.00012434,0.0003889843,0.00026315954],"domain_scores_gemma":[0.99670404,0.0020571542,0.0002377725,0.000110957306,0.0003915894,0.00049843226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017992493,0.0006792992,0.0015240178,0.00079254364,0.0030698369,0.0024468307,0.0011370741,0.042139377,0.0060346117],"category_scores_gemma":[0.016317626,0.0005185933,0.0014317244,0.0007615762,0.0016963101,0.0017237057,0.0009273651,0.02380507,0.0053689866],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032523958,0.00013697897,0.0009195807,0.00018153325,0.0000638923,0.0046674293,0.00017302937,0.00008277556,0.00032629212,0.003251211,0.9523877,0.037484337],"study_design_scores_gemma":[0.0013514269,0.00046399827,0.005613523,0.00088788214,0.00021168421,0.0072534177,0.00052220596,0.0010868813,0.0006381467,0.020463552,0.96139896,0.000108375796],"about_ca_topic_score_codex":0.007716744,"about_ca_topic_score_gemma":0.018825928,"teacher_disagreement_score":0.042139377,"about_ca_system_score_codex":0.0033258307,"about_ca_system_score_gemma":0.0031685971,"threshold_uncertainty_score":0.024130762},"labels":[],"label_agreement":null},{"id":"W4377018328","doi":"10.1016/s1474-4422(23)00164-3","title":"The Brain Research Africa Initiative (BRAIN)","year":2023,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Government (linguistics); Commission; Economic shortage; Economic growth; Brain research; Political science; Medicine; Psychology; Law","score_opus":0.15238377473445405,"score_gpt":0.36603190533673613,"score_spread":0.21364813060228208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377018328","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032001812,0.0014490715,0.00006353934,0.9630265,0.027722161,0.000025419919,0.00012526712,0.000020068233,0.007247911],"genre_scores_gemma":[0.001981303,0.0006758057,0.00008027033,0.95819587,0.018111546,0.00006860675,0.000035761957,0.000025784888,0.020824995],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958663,0.0007615339,0.00032481313,0.000493056,0.0011016828,0.0014526716],"domain_scores_gemma":[0.98954177,0.0048212726,0.0006580421,0.00022350356,0.0011495134,0.0036058524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004185552,0.0016263578,0.0018455698,0.00097102684,0.00816572,0.009825776,0.0025588716,0.1422956,0.015875297],"category_scores_gemma":[0.02517691,0.0013256137,0.001789683,0.0009337132,0.003518864,0.0051743053,0.003983157,0.062927686,0.009876469],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005848126,0.000019187257,0.00023620106,0.000038776405,0.00001209185,0.00083326304,0.00009003498,0.000024975097,0.00010647899,0.004244384,0.9914869,0.0028492387],"study_design_scores_gemma":[0.00022272654,0.000057054458,0.0013551818,0.00047865903,0.000053192372,0.00060580316,0.0005637363,0.0003177048,0.00026557004,0.015082949,0.9809194,0.0000780025],"about_ca_topic_score_codex":0.023145994,"about_ca_topic_score_gemma":0.050194275,"teacher_disagreement_score":0.1422956,"about_ca_system_score_codex":0.0057070325,"about_ca_system_score_gemma":0.015941435,"threshold_uncertainty_score":0.053108215},"labels":[],"label_agreement":null},{"id":"W4377695484","doi":"10.1016/s1474-4422(23)00114-x","title":"Progression of cerebral amyloid angiopathy: a pathophysiological framework","year":2023,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Intracerebral and Subarachnoid Hemorrhage Research","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; University of Calgary","funders":"National Institute on Aging; Dutch CAA Foundation","keywords":"Cerebral amyloid angiopathy; Angiopathy; Perivascular space; Pathology; Medicine; Amyloid (mycology); Subclinical infection; Pathophysiology; Disease; Neuroscience; Dementia; Biology; Endocrinology","score_opus":0.13858194382486635,"score_gpt":0.4232526733791576,"score_spread":0.2846707295542913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377695484","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000026449072,0.9995247,0.000025329244,0.00021463391,0.000087371845,0.0000011761641,0.000006037863,0.0000014851242,0.00011280585],"genre_scores_gemma":[0.00036989537,0.9991178,0.000059015383,0.00015983358,0.00021006021,0.0000025877869,0.000008213561,3.2149418e-7,0.00007223913],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996289,0.000087360626,0.00007255433,0.00006673235,0.00010608254,0.000038384034],"domain_scores_gemma":[0.99912006,0.0005105159,0.00015145984,0.000017010316,0.00015925651,0.00004163597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014231293,0.0013709663,0.0033381649,0.0028077918,0.00032240915,0.0023172991,0.0015740794,0.0021672186,0.0025052547],"category_scores_gemma":[0.0016122113,0.00035904266,0.00089588616,0.0027692702,0.0011019527,0.002251963,0.00094789715,0.0026797443,0.00092419586],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023830254,0.00009619593,0.0006081011,0.05572101,0.00045402034,0.00063014857,0.00015152057,0.0006421526,0.0013332176,0.010586989,0.037121363,0.89241695],"study_design_scores_gemma":[0.00015982051,0.00028279074,0.0032732692,0.041473202,0.001288415,0.0037102427,0.00035042982,0.0004597244,0.00038761165,0.014788999,0.93374383,0.00008163144],"about_ca_topic_score_codex":0.002427064,"about_ca_topic_score_gemma":0.0037988436,"teacher_disagreement_score":0.0033381649,"about_ca_system_score_codex":0.0011814074,"about_ca_system_score_gemma":0.0023979521,"threshold_uncertainty_score":0.008571744},"labels":[],"label_agreement":null},{"id":"W4377695790","doi":"10.1016/s1474-4422(23)00131-x","title":"Neuroimaging standards for research into small vessel disease—advances since 2013","year":2023,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Cerebrovascular and Carotid Artery Diseases","field":"Medicine","cited_by":973,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute; University of Toronto; Sunnybrook Health Science Centre; University of British Columbia; Hotchkiss Brain Institute; Foothills Medical Centre; University of Calgary","funders":"Daiichi Sankyo Europe; Medical Research Council; Canadian Institutes of Health Research; Bayer Korea; Sanofi Genzyme; Directorate for Biological Sciences; National Institutes of Health; Dementias Platform UK; UK Dementia Research Institute; European Stroke Organisation; European Academy of Neurology; Alberta Innovates; EVER Neuro Pharma; AstraZeneca Korea; Novo Nordisk; Eisai; Fondation Leducq; Agence Nationale de la Recherche; British Heart Foundation; Sanofi; Government of Canada; Bayer Vital; Bristol-Myers Squibb; Nestlé Health Science; Consortium canadien en neurodégénérescence associée au vieillissement; Amicus Therapeutics; Canadian Cardiovascular Society; Alzheimer Society; Alzheimer's Society; Biotechnology and Biological Sciences Research Council; Wellcome Trust; Research Councils UK; Yuhan; McMaster University; Alexion Pharmaceuticals; Pfizer; Biogen; Alnylam Pharmaceuticals; Heart and Stroke Foundation of Canada; UK Research and Innovation; Eli Lilly and Company; AstraZeneca; Siemens Healthineers; Amgen; Weston Brain Institute; American Heart Association","keywords":"Neuroimaging; Cognition; Disease; Medicine; Neuroscience; Cognitive decline; Stroke (engine); Neurodegeneration; Magnetic resonance imaging; Psychology; Pathology; Radiology; Dementia","score_opus":0.19642661224351549,"score_gpt":0.4604967340291935,"score_spread":0.264070121785678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377695790","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016585807,0.9979371,0.000079234596,0.001186136,0.00053629966,0.0000029819694,0.000021635004,0.0000069844004,0.00021316095],"genre_scores_gemma":[0.0003327383,0.99683195,0.0003459276,0.0014449124,0.0008751935,0.000009550334,0.00005499025,0.0000034578395,0.000101381665],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99782735,0.000464326,0.0005146131,0.00033661717,0.00071892765,0.0001381376],"domain_scores_gemma":[0.98682564,0.008314256,0.0014230893,0.0002521361,0.0026700492,0.0005148714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00726527,0.0018314805,0.0044915304,0.004526633,0.00048304125,0.0033368072,0.0023145291,0.0035070162,0.003831393],"category_scores_gemma":[0.015000411,0.00064743776,0.0015259644,0.00445741,0.001955614,0.0041699335,0.0022374813,0.005122577,0.0018243489],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019305942,0.00004041092,0.00028913657,0.04182077,0.00038049987,0.00008592104,0.00005671424,0.00027079775,0.00044567746,0.006332222,0.08315205,0.86693275],"study_design_scores_gemma":[0.00011786979,0.000112833986,0.0016276536,0.048090465,0.00091819983,0.000530888,0.00012407135,0.00018750658,0.00021444395,0.00891376,0.9390906,0.00007180343],"about_ca_topic_score_codex":0.0042453613,"about_ca_topic_score_gemma":0.007235836,"teacher_disagreement_score":0.00726527,"about_ca_system_score_codex":0.0032701122,"about_ca_system_score_gemma":0.007709916,"threshold_uncertainty_score":0.038422883},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W4381547226","doi":"10.1016/s1474-4422(23)00200-4","title":"Discontinuing disease-modifying multiple sclerosis therapies","year":2023,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Biogen; Roche","keywords":"Multiple sclerosis; Medicine; Observational study; Discontinuation; Disease; Malignancy; Intensive care medicine; Drug; Internal medicine; Pediatrics; Immunology; Psychiatry","score_opus":0.18851413202055178,"score_gpt":0.34402648021813065,"score_spread":0.15551234819757886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381547226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7123734,0.23404002,0.0017245616,0.012016503,0.004124259,0.0010451614,0.008342661,0.00014935622,0.026184103],"genre_scores_gemma":[0.96494806,0.018568568,0.0010373584,0.006058933,0.0016401118,0.00067983824,0.003079725,0.00002356777,0.0039638923],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9868738,0.008284948,0.0017061236,0.00081177196,0.0016779851,0.0006454148],"domain_scores_gemma":[0.9638262,0.021800796,0.0075022196,0.0036852423,0.0020333186,0.0011522726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012137155,0.0005053915,0.002484156,0.00065948075,0.00079925533,0.0016062083,0.0010671167,0.0022604375,0.0038974206],"category_scores_gemma":[0.032773905,0.00028992165,0.0022548586,0.0014528241,0.00049953145,0.0011170922,0.00044861613,0.003079438,0.0007666715],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12442625,0.003226255,0.17178033,0.011709425,0.021182133,0.000409871,0.001689718,0.00077008555,0.005104444,0.0039820834,0.02383377,0.6318856],"study_design_scores_gemma":[0.03502923,0.027539387,0.7498633,0.0049640937,0.020733315,0.0007272094,0.00095205853,0.0008471321,0.0034665305,0.00526681,0.1504891,0.00012167419],"about_ca_topic_score_codex":0.004047397,"about_ca_topic_score_gemma":0.006227761,"teacher_disagreement_score":0.012137155,"about_ca_system_score_codex":0.0011432149,"about_ca_system_score_gemma":0.0020610618,"threshold_uncertainty_score":0.06418818},"labels":[],"label_agreement":null},{"id":"W4381549900","doi":"10.1016/s1474-4422(23)00129-1","title":"Palliative care to support the needs of adults with neurological disease","year":2023,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute on Aging; National Institutes of Health","keywords":"Palliative care; Psychosocial; Medicine; Dementia; Disease; Curative care; Nursing; Psychological intervention; Quality of life (healthcare); Health care; Ambulatory care; Family medicine; Psychiatry","score_opus":0.2788598509594322,"score_gpt":0.46097254677671456,"score_spread":0.18211269581728234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381549900","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000034715235,0.9986388,0.000026872533,0.0006000541,0.00020057074,0.000003719405,0.000007912846,0.0000016772924,0.00048562844],"genre_scores_gemma":[0.00046782847,0.998566,0.00008856958,0.000595842,0.00014403558,0.0000051376637,0.000010243183,5.171324e-7,0.00012188298],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99955934,0.00014719523,0.000065750784,0.000036375848,0.00014852382,0.000042799096],"domain_scores_gemma":[0.99795353,0.0014824909,0.0002417113,0.00001842217,0.00020559326,0.000098188386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013699522,0.0008330874,0.0017036955,0.0017122738,0.0004146008,0.0015338172,0.0009319587,0.0019428548,0.0050445814],"category_scores_gemma":[0.0033363583,0.00023709258,0.00078238384,0.001942879,0.0005869595,0.0015300717,0.0014927712,0.0028806974,0.00088481914],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068243746,0.00003879729,0.00013465669,0.06619211,0.00021956717,0.000116768926,0.00015394049,0.00027947692,0.00030482022,0.0050169895,0.036324512,0.8911502],"study_design_scores_gemma":[0.00007287249,0.0000924928,0.0010754457,0.11459967,0.0004491739,0.0008466238,0.0003587933,0.00010422458,0.00009408016,0.0039888527,0.8782913,0.000026290274],"about_ca_topic_score_codex":0.0028283335,"about_ca_topic_score_gemma":0.010592629,"teacher_disagreement_score":0.0050445814,"about_ca_system_score_codex":0.0011717918,"about_ca_system_score_gemma":0.0030418755,"threshold_uncertainty_score":0.016875803},"labels":[],"label_agreement":null},{"id":"W4385063933","doi":"10.1016/s1474-4422(23)00217-x","title":"Lessons and future directions for GBA1-targeting therapies","year":2023,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Glucocerebrosidase; Synucleinopathies; Parkinson's disease; LRRK2; Parkinsonism; Disease; Scopus; Medicine; Internal medicine; Bioinformatics; Alpha-synuclein; MEDLINE; Biology; Biochemistry","score_opus":0.06570343640683732,"score_gpt":0.34535366225135206,"score_spread":0.2796502258445147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385063933","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014369462,0.022295065,0.00019848492,0.95644164,0.018465249,0.000006190584,0.00004190331,0.000035006182,0.0023728525],"genre_scores_gemma":[0.0038891535,0.02257887,0.0007587768,0.85080105,0.1170847,0.00004555842,0.000057283723,0.000035594945,0.0047490806],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954514,0.0015728995,0.00048725502,0.0004919358,0.0013538523,0.0006427297],"domain_scores_gemma":[0.98106134,0.012335531,0.00076280435,0.00047256198,0.0026065789,0.0027611996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0080871135,0.0011989886,0.0026685074,0.0012248817,0.0025180564,0.006239754,0.0024463127,0.045006905,0.014302698],"category_scores_gemma":[0.024907451,0.0005765307,0.0020959775,0.0008160337,0.0073108156,0.009480262,0.002877181,0.0437295,0.008726728],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018441603,0.00009045815,0.0002749382,0.0002860803,0.000040010615,0.0015686571,0.00010374381,0.00027634957,0.00030043442,0.018287703,0.93792886,0.040658385],"study_design_scores_gemma":[0.0003955139,0.00010993576,0.00027695182,0.0008258652,0.000045027755,0.0012836709,0.0003365252,0.00046762484,0.00012447972,0.07418811,0.9218889,0.0000574722],"about_ca_topic_score_codex":0.0023535318,"about_ca_topic_score_gemma":0.0064767436,"teacher_disagreement_score":0.045006905,"about_ca_system_score_codex":0.0050470065,"about_ca_system_score_gemma":0.005473296,"threshold_uncertainty_score":0.04784727},"labels":[],"label_agreement":null},{"id":"W4385064082","doi":"10.1016/s1474-4422(23)00239-9","title":"Peru initiates the IMPACT project","year":2023,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Legal, Health, Environmental and COVID-19 Challenges","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Fogarty International Center; National Institute of Mental Health; National Heart, Lung, and Blood Institute; Fondo Nacional de Desarrollo Científico, Tecnológico y de Innovación Tecnológica; Biotechnology and Biological Sciences Research Council; Medical Research Council; University of North Carolina at Chapel Hill; Alliance for Health Policy and Systems Research; World Diabetes Foundation; Pontificia Universidad Católica del Perú; Inter-American Institute for Global Change Research; Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica; National Science Foundation; Grand Challenges Canada; National Institute for Health and Care Research; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; International Development Research Centre; Bloomberg Philanthropies; Wellcome Trust; Engineering and Physical Sciences Research Council; UK Research and Innovation; Alzheimer's Association","keywords":"Dementia; Context (archaeology); Medicine; Health care; Pandemic; Global health; Gerontology; Disease; Economic growth; Public health; Nursing; Coronavirus disease 2019 (COVID-19); Geography; Pathology","score_opus":0.11688282311943653,"score_gpt":0.36952496473258845,"score_spread":0.2526421416131519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385064082","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002384834,0.002730066,0.0008354929,0.7239163,0.017625034,0.00022253404,0.0008179273,0.00032216593,0.25114572],"genre_scores_gemma":[0.027393578,0.0022315218,0.0011510373,0.34025893,0.008736107,0.00049583055,0.00086395914,0.00039417052,0.6184749],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960836,0.0010086229,0.000094963405,0.00030644124,0.001443182,0.0010631285],"domain_scores_gemma":[0.98891395,0.0018178425,0.0003812173,0.0007232026,0.0025353509,0.0056284335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005483993,0.0006472835,0.00064142223,0.00091875193,0.006433602,0.0063419524,0.0014725162,0.015859526,0.08403601],"category_scores_gemma":[0.018282648,0.00046651863,0.00065456686,0.0007238404,0.002299619,0.0038423615,0.009535564,0.012507702,0.02880601],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037190337,0.000037178743,0.0008161087,0.000050800692,0.000009596711,0.0004624455,0.00022174322,0.000021951844,0.00011011444,0.011200792,0.97551167,0.011520486],"study_design_scores_gemma":[0.000016290038,0.000014130912,0.00077461,0.000042437012,0.0000044069866,0.00008971389,0.00034596678,0.000026124444,0.000047671638,0.0020343603,0.99659735,0.000007010455],"about_ca_topic_score_codex":0.012265405,"about_ca_topic_score_gemma":0.03636373,"teacher_disagreement_score":0.08403601,"about_ca_system_score_codex":0.0028337152,"about_ca_system_score_gemma":0.016175363,"threshold_uncertainty_score":0.28112847},"labels":[],"label_agreement":null},{"id":"W4385064130","doi":"10.1016/s1474-4422(23)00195-3","title":"Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019","year":2023,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Bacterial Infections and Vaccines","field":"Immunology and Microbiology","cited_by":193,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Data Research UK; European Social Fund; Division of Human Resource Development; Faculty of Medicine and Health, University of Sydney; Sistema Nacional de Investigadores; Russian Academy of Sciences; Fundação para a Ciência e a Tecnologia; National Health and Medical Research Council; Maryland Population Research Center, University of Maryland; Samsung; Directorate for Biological Sciences; National Institutes of Health; Uniwersytet Opolski; Humanitas Research Hospital; Pirogov Russian National Research Medical University; Universitas Sam Ratulangi; NIH Clinical Center; Moscow Institute of Physics and Technology; Jahrom University of Medical Sciences; Imam Abdulrahman Bin Faisal University; Lingnan University; Kurdistan University Of Medical Sciences; Al-Farabi Kazakh National University; University of Nizwa; Lorestan University of Medical Sciences; Alborz University of Medical Sciences; Kwame Nkrumah University of Science and Technology; Gonabad University of Medical Sciences; University of Zanjan; Khulna University; Dire Dawa University; Zanjan University of Medical Sciences; Tarbiat Modares University; Alfaisal University; University of Gondar; Madda Walabu University; Shahid Bahonar University of Kerman; Fakultet Medicinskih Nauka, Univerziteta U Kragujevcu; Universitatea de Medicină şi Farmacie \"Carol Davila\" Bucureşti; Universidade Federal de Minas Gerais; Urmia University; University of Cape Town; Secretaría Nacional de Ciencia, Tecnología e Innovación; Yarmouk University; Universidade de Lisboa; Shahrekord University of Medical Sciences; Universitetet i Oslo; Masarykova Univerzita; Universitair Medisch Centrum Groningen; Leids Universitair Medisch Centrum; Nankai University; Shahrekord University; Indian Council of Medical Research; Westfälische Wilhelms-Universität Münster; King Fahad Medical City; Haramaya University; Inyuvesi Yakwazulu-Natali; Federation University Australia; Abdul Wali Khan University Mardan; Universiti Kebangsaan Malaysia; Golestan University of Medical Sciences; Cardiff University; Università di Catania; Università degli Studi di Firenze; Sultan Qaboos University; Rajiv Gandhi University of Health Sciences; National Cheng Kung University; King Abdulaziz University; Urmia University of Medical Sciences; Universitas Padjadjaran; University of the Western Cape; Tulane University; Sungkyunkwan University; Gachon University; University of Exeter; Kyung Hee University; Universidad de Concepción; Yonsei University; Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja; King Saud University; Centro Interdisciplinar de Investigação Marinha e Ambiental; Ain Shams University; Wollega University; Universiteit Stellenbosch; Public Health England; Ministerstvo Školství, Mládeže a Tělovýchovy; Tabriz University of Medical Sciences; Universitas Indonesia; University of Technology Sydney; University of Pretoria; University of New South Wales; Rijksuniversiteit Groningen; Cleveland Clinic; University College Cork; Amity University; Debre Tabor University; Shahid Beheshti University of Medical Sciences; Prince Sattam bin Abdulaziz University; Cancer Institute NSW; University of Leeds; McMaster University; University of Oxford; Isfahan University of Medical Sciences; Syddansk Universitet; Manipal Academy of Higher Education; Meningitis Research Foundation; Hormozgan University of Medical Sciences; Kasturba Medical College, Manipal; Northwell Health; Case Western Reserve University; University of Sydney; University of Wollongong; Asian Institute of Medicine, Science and Technology; Nemzeti Kutatási Fejlesztési és Innovációs Hivatal; University of Engineering and Technology, Lahore; Monash University; South Eastern Sydney Local Health District; Iran University of Medical Sciences; Rajarata University of Sri Lanka; Shaqra University; Lebanese American University; Süleyman Demirel Üniversitesi; Anglia Ruskin University; Taibah University; International Medical University; Wellcome Trust; Ministero della Salute; Arizona State University; National Institute for Health and Care Research; University of Patras; University of Karachi; Charles Sturt University; Universidade do Porto; Australian Government; Student Research Committee, Tabriz University of Medical Sciences; Bahir Dar University; Sheffield Hallam University; Mazandaran University of Medical Sciences; National Heart, Lung, and Blood Institute; Centre Hospitalier Universitaire Vaudois; Universiteit Leiden; Universiti Tun Hussein Onn Malaysia; James Cook University; Rajshahi University; Saveetha Institute of Medical and Technical Sciences; University of Tabriz; European Commission; Helsingin Yliopisto; Dilla University; Universität Basel; Universidade da Beira Interior; University of Central Punjab; Ahvaz Jundishapur University of Medical Sciences; Massachusetts General Hospital; Hawassa University; Kuwait University; Universidade de São Paulo; Academy of Scientific Research and Technology; Baqiyatallah University of Medical Sciences; University of Minnesota; Technische Universität München; Indiana University Health; Cleveland Clinic Foundation; Universidad de Antioquia; New Mexico State University; University of South Carolina; Islamic Azad University; U.S. Department of Veterans Affairs; Rice University; Vanderbilt University; National University of Singapore; Universitatea din București; La Trobe University; Curtin University of Technology; Bill and Melinda Gates Foundation","keywords":"Burden of disease; Medicine; Disease; Meningitis; Disease burden; Intensive care medicine; Global health; Environmental health; Pediatrics; Public health; Internal medicine; Pathology","score_opus":0.0883311845201253,"score_gpt":0.35306490319834405,"score_spread":0.26473371867821877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385064130","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.040355068,0.8932428,0.0021690358,0.0013124452,0.00027969485,0.0007141812,0.060803376,0.0000923398,0.00103107],"genre_scores_gemma":[0.43889213,0.51980287,0.0064787497,0.0016621074,0.00023415084,0.0032983127,0.028905893,0.00007498528,0.00065080373],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9932162,0.0022123235,0.002236447,0.00089829124,0.0011462156,0.00029049217],"domain_scores_gemma":[0.9893133,0.0046576294,0.003063668,0.00052835775,0.0021978584,0.000239164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011401784,0.0011450382,0.0041277832,0.011736224,0.00038780094,0.0012041642,0.00095532136,0.00093770673,0.001691428],"category_scores_gemma":[0.025360513,0.0008809482,0.018168075,0.015470843,0.0005564078,0.0009668017,0.0020638313,0.0009917232,0.0002787226],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017847413,0.000044365304,0.2858499,0.3902893,0.21627128,0.0004967326,0.0014265822,0.0035467679,0.0005462941,0.0016410092,0.02355037,0.07455272],"study_design_scores_gemma":[0.0010447849,0.00043838526,0.42789802,0.1867871,0.3349132,0.0010774011,0.0013166427,0.0023373757,0.00042903,0.0016043457,0.041941743,0.00021194224],"about_ca_topic_score_codex":0.060253847,"about_ca_topic_score_gemma":0.092100434,"teacher_disagreement_score":0.060253847,"about_ca_system_score_codex":0.003040449,"about_ca_system_score_gemma":0.009088004,"threshold_uncertainty_score":0.11980629},"labels":[],"label_agreement":null},{"id":"W4385064560","doi":"10.1016/s1474-4422(23)00148-5","title":"Differential diagnosis of suspected multiple sclerosis: an updated consensus approach","year":2023,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Chugai Pharmaceutical; MedDay Pharmaceuticals; IXICO; EMD Serono; Fondation Charcot; Eisai; Deutsche Forschungsgemeinschaft; Multiple Sclerosis Society of Canada; Genentech; Horizon Therapeutics; Fondazione Italiana Sclerosi Multipla; Celgene; Ministry of Education, Culture, Sports, Science and Technology; Mylan; TG Therapeutics; Multiple Sclerosis Society; European Committee for Treatment and Research in Multiple Sclerosis; Biogen; Prothena; Greenwich Biosciences; Alexion Pharmaceuticals; Ohio State University; Bundesministerium für Bildung und Forschung; Teva Pharmaceutical Industries; European Commission; Eli Lilly and Company; U.S. Department of Defense; Multiple Sclerosis International Federation; Sanofi; Emory University; Patient-Centered Outcomes Research Institute; Bristol-Myers Squibb","keywords":"Multiple sclerosis; Medicine; Differential diagnosis; Medical diagnosis; Neurology; Intensive care medicine; Clinical trial; Disease; Pediatrics; Pathology; Psychiatry","score_opus":0.31018732219816986,"score_gpt":0.38806233150762,"score_spread":0.07787500930945013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385064560","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012427053,0.99464524,0.0006285523,0.0028439693,0.00106028,0.00006683177,0.00012676603,0.000014717539,0.000489271],"genre_scores_gemma":[0.0025682256,0.9889787,0.0029001639,0.0038553472,0.0009336518,0.000114780414,0.0003618744,0.000008353117,0.00027891202],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.992121,0.0017188465,0.0034837911,0.00075057737,0.0017142204,0.00021168655],"domain_scores_gemma":[0.9832629,0.008422002,0.0024890976,0.000315746,0.005120809,0.00038944022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013741124,0.002023915,0.009676328,0.014370174,0.0007505378,0.0043592374,0.0052883327,0.0049960725,0.0032962598],"category_scores_gemma":[0.023926366,0.0011409569,0.0054849028,0.0066579035,0.0012955194,0.005103163,0.002846191,0.004074301,0.0014794081],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003423226,0.00006392544,0.0012211996,0.1832242,0.003806493,0.00040300394,0.0002508522,0.00050408416,0.00071679626,0.0035337862,0.057395607,0.74853766],"study_design_scores_gemma":[0.0008356648,0.00023432262,0.0062616165,0.47112688,0.019312577,0.0032059106,0.0007163505,0.0008642163,0.00051024667,0.0071615623,0.48954847,0.00022219922],"about_ca_topic_score_codex":0.0053550685,"about_ca_topic_score_gemma":0.010964975,"teacher_disagreement_score":0.014370174,"about_ca_system_score_codex":0.0038577742,"about_ca_system_score_gemma":0.00843502,"threshold_uncertainty_score":0.07267088},"labels":[],"label_agreement":null},{"id":"W4385871824","doi":"10.1016/s1474-4422(23)00272-7","title":"Prehospital triage in acute stroke: which questions to ask?","year":2023,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Medical Research Council; National Institutes of Health; National Health and Medical Research Council; Nederlandse Organisatie voor Wetenschappelijk Onderzoek","keywords":"Triage; Medicine; Stroke (engine); Emergency medicine; Neurology; Medical emergency; Emergency medical services; Acute stroke; Emergency department; Nursing","score_opus":0.02771708085370404,"score_gpt":0.2967118164417204,"score_spread":0.26899473558801634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385871824","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000114979455,0.0011444656,0.00003307018,0.9900013,0.0072167167,0.000005096947,0.00002096099,0.000008521457,0.001454789],"genre_scores_gemma":[0.0029980245,0.0024827265,0.00026417425,0.9234118,0.0680728,0.00003726788,0.000051918578,0.00002689568,0.002654354],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99300414,0.002266826,0.0013498808,0.0006278223,0.0015231057,0.0012282929],"domain_scores_gemma":[0.96876,0.01123413,0.0025536215,0.0007011372,0.0075609377,0.009190238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058637564,0.00092904986,0.002500254,0.0018331078,0.005762612,0.008388481,0.0029705367,0.09507173,0.015199251],"category_scores_gemma":[0.0554718,0.0013351426,0.0019454911,0.0020139634,0.004656995,0.008713592,0.00270595,0.06730393,0.0134947905],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056200133,0.000040580013,0.0010227688,0.00010701876,0.000022543978,0.0009388175,0.00014136652,0.0000610931,0.00007026062,0.0012014635,0.986555,0.009782811],"study_design_scores_gemma":[0.0007091539,0.00014716075,0.0058983467,0.0039350577,0.00014917017,0.004764382,0.0033333334,0.0012096257,0.00017904295,0.024025707,0.9553788,0.00027026792],"about_ca_topic_score_codex":0.019574659,"about_ca_topic_score_gemma":0.03720343,"teacher_disagreement_score":0.09507173,"about_ca_system_score_codex":0.008070538,"about_ca_system_score_gemma":0.01472144,"threshold_uncertainty_score":0.05855614},"labels":[],"label_agreement":null},{"id":"W4385889024","doi":"10.1016/s1474-4422(23)00246-6","title":"Evaluation of the feasibility, diagnostic yield, and clinical utility of rapid genome sequencing in infantile epilepsy (Gene-STEPS): an international, multicentre, pilot cohort study","year":2023,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; Medical Research Council; National Institute for Health and Care Research; Wellcome Trust","keywords":"Medicine; Epilepsy; Pediatrics; Cohort; Subspecialty; Population; Family medicine; Psychiatry; Internal medicine","score_opus":0.11884142375273556,"score_gpt":0.37321251976502684,"score_spread":0.2543710960122913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385889024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99838495,0.000054590437,0.00045713547,0.00003709596,0.000005054096,0.00016028198,0.00065369793,0.00000969757,0.00023752023],"genre_scores_gemma":[0.9963826,0.00006584693,0.0016662929,0.00006469095,0.000018274675,0.00032003687,0.0013664832,0.00001792805,0.000097915625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99621934,0.0018622387,0.00027728573,0.00074953376,0.00051306427,0.0003786127],"domain_scores_gemma":[0.9883951,0.0043327883,0.0024134985,0.002203074,0.0014589633,0.0011965929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010739184,0.0009583904,0.0005105148,0.000912462,0.0005634774,0.0009469336,0.0010564146,0.00075764884,0.0009696374],"category_scores_gemma":[0.018984135,0.0003833051,0.0006916539,0.0007586718,0.00075682765,0.000711612,0.0013010361,0.0006982813,0.00026029337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032977904,0.00029554282,0.9893085,0.000047891725,0.00019683226,0.00034662784,0.00063592853,0.00016717576,0.0012121912,0.00007140509,0.00039774942,0.004022319],"study_design_scores_gemma":[0.0006990547,0.004868193,0.9889143,0.000035454974,0.00035131408,0.0017352955,0.00050676067,0.00097263535,0.0009437063,0.00006937373,0.00087050715,0.000033410295],"about_ca_topic_score_codex":0.0045652166,"about_ca_topic_score_gemma":0.0047670053,"teacher_disagreement_score":0.010739184,"about_ca_system_score_codex":0.0007743159,"about_ca_system_score_gemma":0.001057559,"threshold_uncertainty_score":0.05679488},"labels":[],"label_agreement":null},{"id":"W4386906375","doi":"10.1016/s1474-4422(23)00280-6","title":"Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trial","year":2023,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Multiple Sclerosis Trust; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Scleroseforeningen; National Multiple Sclerosis Society","keywords":"Physical medicine and rehabilitation; Cognition; Physical therapy; Aerobic exercise; Rehabilitation; Cognitive impairment; Multiple sclerosis; Medicine; Cognitive rehabilitation therapy; Randomized controlled trial; Psychology; Psychiatry; Internal medicine","score_opus":0.07327297752255707,"score_gpt":0.3391771258711482,"score_spread":0.2659041483485911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386906375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9572886,0.017162247,0.0012062609,0.0011847597,0.0028096812,0.01452019,0.0015703872,0.00024727732,0.0040106787],"genre_scores_gemma":[0.9610342,0.0064324695,0.0024955191,0.0018287841,0.0016463076,0.020572957,0.0008422084,0.000030351828,0.0051172506],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982541,0.0007990096,0.00021901632,0.00031926917,0.00013700608,0.00027160984],"domain_scores_gemma":[0.9986405,0.0005328367,0.00028322788,0.00012219387,0.00010664701,0.000314609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029222714,0.002778513,0.005907201,0.0009243873,0.0010478132,0.0017937945,0.0015728395,0.004860251,0.009799512],"category_scores_gemma":[0.004343873,0.0010510214,0.003803972,0.0008376094,0.0019726746,0.0015977512,0.0009882654,0.003252145,0.0011794616],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9927933,0.0016815724,0.000109373286,0.00088159024,0.0008248731,0.000015364989,0.000031005737,0.000050796938,0.00028426794,0.000056487108,0.000189299,0.003082007],"study_design_scores_gemma":[0.9894321,0.009434975,0.00038961027,0.00005338949,0.00041410822,0.0000056567933,0.00001027523,0.000045029512,0.000037479393,0.00005614445,0.000115150855,0.000005973568],"about_ca_topic_score_codex":0.0041787582,"about_ca_topic_score_gemma":0.0047495365,"teacher_disagreement_score":0.009799512,"about_ca_system_score_codex":0.0012945518,"about_ca_system_score_gemma":0.0017630055,"threshold_uncertainty_score":0.032782614},"labels":[],"label_agreement":null},{"id":"W4386906450","doi":"10.1016/s1474-4422(23)00209-0","title":"Prevention of perioperative stroke in patients undergoing non-cardiac surgery","year":2023,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Hotchkiss Brain Institute; Impact; McMaster University; Population Health Research Institute","funders":"Physicians' Services Incorporated Foundation","keywords":"Medicine; Perioperative; Atrial fibrillation; Delirium; Stroke (engine); Incidence (geometry); Cardiac surgery; Complication; Embolism; Intensive care medicine; Internal medicine; Cardiology; Anesthesia","score_opus":0.07831511852882014,"score_gpt":0.34655413625382403,"score_spread":0.2682390177250039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386906450","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016710752,0.9993723,0.000035608435,0.00011825245,0.00011006846,0.000004182561,0.000024403656,0.000003366364,0.00016476012],"genre_scores_gemma":[0.0020205486,0.9974765,0.000098307726,0.00015989288,0.00014676893,0.000006885987,0.000025175788,8.7691984e-7,0.00006499969],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9996413,0.00007319036,0.0000992616,0.000063571606,0.00009102357,0.000031661802],"domain_scores_gemma":[0.9990227,0.0006176888,0.00019728988,0.000014583978,0.000109135704,0.000038613947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082299433,0.0010223449,0.0035692877,0.0016312313,0.00019056298,0.0009535749,0.0010962386,0.0012917023,0.0036805575],"category_scores_gemma":[0.0028384526,0.00033770743,0.002279247,0.0014096313,0.00024786755,0.00055617053,0.00044669755,0.0017225975,0.0005786805],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006770624,0.0001353305,0.0012555806,0.15542062,0.0047000404,0.00014543509,0.000054964967,0.00035552465,0.0003736153,0.0010664128,0.014497832,0.82131755],"study_design_scores_gemma":[0.0034723775,0.0034256822,0.039735477,0.3684411,0.08029724,0.0032691003,0.00054877077,0.0012117656,0.0014318831,0.0075378097,0.4903904,0.0002384388],"about_ca_topic_score_codex":0.004002228,"about_ca_topic_score_gemma":0.0072195525,"teacher_disagreement_score":0.004002228,"about_ca_system_score_codex":0.0005123724,"about_ca_system_score_gemma":0.0012925689,"threshold_uncertainty_score":0.01231271},"labels":[],"label_agreement":null},{"id":"W4387445706","doi":"10.1016/s1474-4422(23)00277-6","title":"Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization–Lancet Neurology Commission","year":2023,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":668,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; Hacettepe Üniversitesi; Health Research Council of New Zealand; Tartu Ülikool; African Academy of Sciences; Medical Research Council; Uniwersytet Opolski; Brain Research New Zealand; Universität Innsbruck; National Taiwan University Hospital; Royal Hobart Hospital Research Foundation; National Institute on Aging; University College Dublin; Université de Bourgogne; Chang Gung Medical Foundation; School of Medicine, Johns Hopkins University; National and Kapodistrian University of Athens; University of Washington; Bill and Melinda Gates Foundation; National Heart Foundation of Australia; Chang Gung University; Pusan National University; Al-Farabi Kazakh National University; Chungnam National University Hospital; Fogarty International Center; National Institutes of Health; Chungnam National University; Yale University; University of Glasgow; University of Southern California; King's College London; Medizinische Universität Innsbruck; National Institute of Neurological Disorders and Stroke; Universiti Kebangsaan Malaysia; Inselspital, Universitätsspital Bern; National Health and Medical Research Council; Arabian Gulf University; Universidad El Bosque; Auckland University of Technology, New Zealand; Alzheimer's Association; Global Brain Health Institute; Stroke Foundation; Irving Medical Center, Columbia University; University of Bern; Hamilton Health Sciences; National Taiwan University; Royal Society; National Human Genome Research Institute; Rigshospitalet; Johns Hopkins University","keywords":"Stroke (engine); Medicine; Health care; Psychological intervention; Environmental health; Economic growth; Nursing","score_opus":0.07279366266780601,"score_gpt":0.3527026851244482,"score_spread":0.2799090224566422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387445706","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000045708184,0.96147656,0.00021531316,0.031005813,0.0059765964,0.000026484538,0.00005830025,0.000022320857,0.0011728343],"genre_scores_gemma":[0.0016728624,0.9581268,0.0011115943,0.033992052,0.0038459175,0.00008977175,0.000097315366,0.000018256282,0.0010453884],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955029,0.0020282648,0.0005149496,0.0002630164,0.0013568195,0.00033410656],"domain_scores_gemma":[0.9870459,0.00860649,0.0009045978,0.00025266656,0.0023659114,0.0008243946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012375908,0.0020949815,0.0050082877,0.0026336962,0.00072976126,0.003907926,0.0025628118,0.008070454,0.008472174],"category_scores_gemma":[0.019684298,0.0007413208,0.0028040812,0.0029096387,0.0018205618,0.005242563,0.0028684882,0.010856066,0.0026956673],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032899683,0.00012244038,0.00011429724,0.048060857,0.0010399356,0.00012757687,0.00020566577,0.00069305504,0.00037316454,0.026291711,0.4138769,0.50876546],"study_design_scores_gemma":[0.00036044436,0.00010095689,0.00048767516,0.061313067,0.0007860442,0.00013442914,0.00018809999,0.00016999287,0.00008002091,0.01821346,0.91811746,0.000048350386],"about_ca_topic_score_codex":0.008276446,"about_ca_topic_score_gemma":0.016515044,"teacher_disagreement_score":0.012375908,"about_ca_system_score_codex":0.0042877113,"about_ca_system_score_gemma":0.018198876,"threshold_uncertainty_score":0.06545085},"labels":[],"label_agreement":null},{"id":"W4387568171","doi":"10.1016/s1474-4422(23)00315-0","title":"Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials","year":2023,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Wilfrid Laurier University; University of Ottawa; Okanagan University College; University of British Columbia, Okanagan Campus; University of British Columbia; Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"National Institute on Minority Health and Health Disparities; University of Edinburgh; National Institute of Nursing Research; National Institute of Neurological Disorders and Stroke; Medical Research Council; Novo Nordisk Fonden; Chest Heart and Stroke Scotland; National Heart, Lung, and Blood Institute; Heart and Stroke Foundation of Canada; Hartstichting; National Institute of Biomedical Imaging and Bioengineering; British Heart Foundation","keywords":"Atrial fibrillation; Medicine; Meta-analysis; Prospective cohort study; Internal medicine; Cardiology","score_opus":0.3859829479190023,"score_gpt":0.43291885263183266,"score_spread":0.04693590471283038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387568171","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018150313,0.9673712,0.006606735,0.0005267346,0.0010106849,0.002937958,0.0022955271,0.00021364939,0.0008871988],"genre_scores_gemma":[0.4978257,0.452921,0.025094608,0.0028812871,0.00086183194,0.013874229,0.004748718,0.00026061546,0.0015319996],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.95769966,0.02846369,0.007596429,0.002891085,0.0027189502,0.0006301509],"domain_scores_gemma":[0.96580327,0.024183985,0.005931447,0.002193492,0.001512705,0.00037515396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.043564983,0.0037825024,0.023542484,0.0074945465,0.0006231492,0.005526282,0.0024445166,0.0032196674,0.0039431737],"category_scores_gemma":[0.07900503,0.0021874416,0.061520822,0.0069928435,0.0009955752,0.0026488071,0.0023272708,0.003222881,0.00046167738],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043277554,0.000019603558,0.0014771177,0.07945479,0.91075045,0.000052831267,0.000037798993,0.00047874544,0.00007580175,0.00013575601,0.00030327728,0.0028859861],"study_design_scores_gemma":[0.0028769523,0.00023702998,0.0012467717,0.0062000193,0.9878564,0.000062623374,0.000020159809,0.00030232925,0.000077393146,0.00041239042,0.00068405725,0.000023803745],"about_ca_topic_score_codex":0.004812481,"about_ca_topic_score_gemma":0.0066453107,"teacher_disagreement_score":0.043564983,"about_ca_system_score_codex":0.0026548859,"about_ca_system_score_gemma":0.0029735551,"threshold_uncertainty_score":0.23039645},"labels":[],"label_agreement":null},{"id":"W4387569176","doi":"10.1016/s1474-4422(23)00326-5","title":"Towards a new classification of atrial fibrillation detected after a stroke or a transient ischaemic attack","year":2023,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; BC Innovation Council; Montreal Heart Institute; University of British Columbia; Université de Montréal; Robarts Clinical Trials; Lawson Health Research Institute; Western University","funders":"University of British Columbia; London Health Sciences Foundation","keywords":"Atrial fibrillation; Medicine; Stroke (engine); Cardiology; Internal medicine","score_opus":0.2860347193761095,"score_gpt":0.42279695952496843,"score_spread":0.1367622401488589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387569176","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015007851,0.9969785,0.00027931924,0.0011278488,0.0010056744,0.000015622394,0.00006628531,0.000007890295,0.0003688308],"genre_scores_gemma":[0.0039078444,0.98943615,0.0017461968,0.002791993,0.0015075541,0.000047018042,0.00021843963,0.000006955237,0.00033775464],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972451,0.00076308113,0.00085822196,0.00035330778,0.0006499847,0.00013030884],"domain_scores_gemma":[0.99431914,0.0030875134,0.0011855067,0.000091776885,0.0011332786,0.00018274237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057630297,0.0017873471,0.0070709228,0.0061990004,0.00041103386,0.0029654459,0.0022227543,0.002391093,0.0029244353],"category_scores_gemma":[0.009636173,0.0006781252,0.003930121,0.003314399,0.0012959877,0.0029920435,0.0015225019,0.005231037,0.0010828973],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004314679,0.000066785295,0.0018562453,0.1261874,0.004362587,0.00012610783,0.00021213092,0.00041654918,0.0004705621,0.008765564,0.046306662,0.8107979],"study_design_scores_gemma":[0.001466481,0.0006740652,0.013461061,0.30472633,0.029236376,0.0017541384,0.00091297005,0.0012394072,0.0003821096,0.019347502,0.62653375,0.0002658367],"about_ca_topic_score_codex":0.007499017,"about_ca_topic_score_gemma":0.013958007,"teacher_disagreement_score":0.007499017,"about_ca_system_score_codex":0.002865857,"about_ca_system_score_gemma":0.00482024,"threshold_uncertainty_score":0.03047812},"labels":[],"label_agreement":null},{"id":"W4387761620","doi":"10.1016/s1474-4422(23)00374-5","title":"α-synuclein seed amplification in Parkinson‘s disease","year":2023,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute; University of Toronto; University Health Network; Ottawa Hospital; Toronto Western Hospital; University of Ottawa","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Parkinson Canada; Weston Brain Institute; Ontario Brain Institute; Michael J. Fox Foundation for Parkinson's Research","keywords":"Parkinson's disease; Disease; Medicine; Alpha-synuclein; Pathology","score_opus":0.05045288915826302,"score_gpt":0.2872705145484891,"score_spread":0.2368176253902261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387761620","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001536808,0.0050881994,0.00013743764,0.9676407,0.020367632,0.0000122233,0.000066172055,0.000031031173,0.0051197796],"genre_scores_gemma":[0.026191661,0.0048214328,0.00033910756,0.818976,0.13976182,0.00004720489,0.0000509691,0.00004580642,0.009766065],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988814,0.00030089243,0.00018346497,0.00016745733,0.00030268406,0.00016408425],"domain_scores_gemma":[0.99467707,0.0035193686,0.00039926954,0.00016616704,0.00064603647,0.0005921725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014376664,0.00079436245,0.0014048711,0.0009020173,0.002698253,0.002060853,0.0011359266,0.04678993,0.0042508836],"category_scores_gemma":[0.014721059,0.0006556854,0.0011787624,0.00073829695,0.0025484702,0.0024081157,0.0010485032,0.022674968,0.0034912657],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021372402,0.00004618277,0.0014240403,0.00014616108,0.00006372919,0.022797236,0.00019612325,0.00012437862,0.0006430554,0.00484892,0.94521827,0.024278121],"study_design_scores_gemma":[0.0013416803,0.000375796,0.0060096662,0.0011764588,0.00036540243,0.053550567,0.0007204938,0.002602008,0.0015645971,0.060425572,0.87169665,0.00017112786],"about_ca_topic_score_codex":0.004586885,"about_ca_topic_score_gemma":0.0059820795,"teacher_disagreement_score":0.04678993,"about_ca_system_score_codex":0.0034618438,"about_ca_system_score_gemma":0.0021573922,"threshold_uncertainty_score":0.025117517},"labels":[],"label_agreement":null},{"id":"W4387761701","doi":"10.1016/s1474-4422(23)00287-9","title":"Global, regional, and national burden of spinal cord injury, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019","year":2023,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":333,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Stanford Cardiovascular Institute, School of Medicine, Stanford University; National Heart, Lung, and Blood Institute; University of California, Irvine; Universidade Federal de Minas Gerais; Rajshahi University; King Abdullah International Medical Research Center; Wenzhou Medical University; Rajarata University of Sri Lanka; University of Thessaly; Division of Human Resource Development; Syddansk Universitet; Bahir Dar University; Weill Cornell Medical College; Dire Dawa University; Guilan University of Medical Sciences; North-West University; Helsingin Yliopisto; Süleyman Demirel Üniversitesi; Mazandaran University of Medical Sciences; King Abdulaziz University; Dilla University; Islamic Azad University; Birjand University of Medical Sciences; Fundación Valle del Lili; McMaster University; Jordan University of Science and Technology; University of Oxford; Wuhan University; University of Tabriz; Ain Shams University; Menofia University; Shahrekord University; Yale University; University of Queensland; Imperial College London; Manipal Academy of Higher Education; Isfahan University of Medical Sciences; Trường Đại học Duy Tân; Kasturba Medical College, Manipal; King Saud University; Institute for Health Metrics and Evaluation; Public Health England; National Institutes of Health; School of Medicine, Case Western Reserve University; Flinders University; National University of Singapore; Shahrekord University of Medical Sciences; Case Western Reserve University; Tabriz University of Medical Sciences; Bill and Melinda Gates Foundation","keywords":"Burden of disease; Spinal cord injury; Medicine; Disease; Disease burden; Physical medicine and rehabilitation; Spinal cord; Psychiatry; Internal medicine","score_opus":0.09678081033336514,"score_gpt":0.42813742239377817,"score_spread":0.331356612060413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387761701","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023872044,0.9505149,0.0020388826,0.0013370872,0.00029484363,0.0003694484,0.02084456,0.00008748439,0.00064066896],"genre_scores_gemma":[0.50194436,0.46756092,0.00752056,0.0025781423,0.00047524556,0.0022718864,0.01710847,0.00008257994,0.00045779167],"study_design_codex":"meta_analysis","study_design_gemma":"systematic_review","domain_scores_codex":[0.98994815,0.004549761,0.0025262435,0.0013152122,0.0013065786,0.0003539419],"domain_scores_gemma":[0.9904738,0.004764102,0.0023308499,0.00058743055,0.0016661129,0.00017760899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015191758,0.0014097301,0.0056533027,0.007017303,0.0004382626,0.0014857344,0.0009697695,0.0011755779,0.001654811],"category_scores_gemma":[0.025002353,0.0009628747,0.022915162,0.009335745,0.0005189236,0.00086941046,0.0016960665,0.001288269,0.00024549794],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021968794,0.000029363195,0.11909784,0.18822342,0.63678825,0.00020479772,0.0003381764,0.0025850113,0.00042229745,0.00085202977,0.0108417375,0.038420174],"study_design_scores_gemma":[0.0012074688,0.00030495285,0.123642705,0.05051404,0.8077982,0.00039596643,0.00020757694,0.0014437417,0.00024314258,0.0010391861,0.013092458,0.000110627596],"about_ca_topic_score_codex":0.031116107,"about_ca_topic_score_gemma":0.06018874,"teacher_disagreement_score":0.031116107,"about_ca_system_score_codex":0.0020960195,"about_ca_system_score_gemma":0.0048919865,"threshold_uncertainty_score":0.08034271},"labels":[],"label_agreement":null},{"id":"W4387761730","doi":"10.1016/s1474-4422(23)00372-1","title":"α-synuclein seed amplification in Parkinson‘s disease","year":2023,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"Centers for Disease Control and Prevention; National Institutes of Health; Argenx; Patient-Centered Outcomes Research Institute; Muscular Dystrophy Association; UCB Pharma; Alexion Pharmaceuticals; Myasthenia Gravis Foundation of America","keywords":"Disease; Parkinson's disease; REM sleep behavior disorder; Medicine; Population; Psychiatry; Gerontology; Pathology; Environmental health","score_opus":0.05045288915826302,"score_gpt":0.2872705145484891,"score_spread":0.2368176253902261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387761730","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001536808,0.0050881994,0.00013743764,0.9676407,0.020367632,0.0000122233,0.000066172055,0.000031031173,0.0051197796],"genre_scores_gemma":[0.026191661,0.0048214328,0.00033910756,0.818976,0.13976182,0.00004720489,0.0000509691,0.00004580642,0.009766065],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988814,0.00030089243,0.00018346497,0.00016745733,0.00030268406,0.00016408425],"domain_scores_gemma":[0.99467707,0.0035193686,0.00039926954,0.00016616704,0.00064603647,0.0005921725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014376664,0.00079436245,0.0014048711,0.0009020173,0.002698253,0.002060853,0.0011359266,0.04678993,0.0042508836],"category_scores_gemma":[0.014721059,0.0006556854,0.0011787624,0.00073829695,0.0025484702,0.0024081157,0.0010485032,0.022674968,0.0034912657],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021372402,0.00004618277,0.0014240403,0.00014616108,0.00006372919,0.022797236,0.00019612325,0.00012437862,0.0006430554,0.00484892,0.94521827,0.024278121],"study_design_scores_gemma":[0.0013416803,0.000375796,0.0060096662,0.0011764588,0.00036540243,0.053550567,0.0007204938,0.002602008,0.0015645971,0.060425572,0.87169665,0.00017112786],"about_ca_topic_score_codex":0.004586885,"about_ca_topic_score_gemma":0.0059820795,"teacher_disagreement_score":0.04678993,"about_ca_system_score_codex":0.0034618438,"about_ca_system_score_gemma":0.0021573922,"threshold_uncertainty_score":0.025117517},"labels":[],"label_agreement":null},{"id":"W4387761810","doi":"10.1016/s1474-4422(23)00366-6","title":"Global burden of spinal cord injury: future directions","year":2023,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; Vancouver Coastal Health Research Institute; Vancouver Coastal Health; NOSM University; International Collaboration On Repair Discoveries; University of British Columbia","funders":"","keywords":"Medicine; Epidemiology; Incidence (geometry); Spinal cord injury; Global health; Burden of disease; Health care; Poison control; Injury prevention; Occupational safety and health; Environmental health; Spinal cord; Public health; Population; Psychiatry; Pathology","score_opus":0.07425606252050347,"score_gpt":0.4036834220301432,"score_spread":0.3294273595096397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387761810","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009328761,0.0037435822,0.00004360784,0.9722921,0.022500314,0.0000034741527,0.0000857773,0.000022215003,0.001215577],"genre_scores_gemma":[0.0016057118,0.0049222275,0.00017470359,0.89872104,0.09064372,0.000028224542,0.00008966397,0.00002071492,0.0037940927],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954336,0.001399496,0.00055256416,0.0004367544,0.0014187082,0.0007586828],"domain_scores_gemma":[0.98177576,0.009619548,0.0010929392,0.0003995223,0.003356011,0.0037562319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057248184,0.0011986484,0.002709138,0.0012840807,0.0036022542,0.006820653,0.0024121075,0.06270794,0.022560494],"category_scores_gemma":[0.029202763,0.00072642,0.0026039951,0.0012510874,0.0045728376,0.007875179,0.003445274,0.03428716,0.0136672],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006428146,0.000024419674,0.0003709808,0.00016642951,0.000018270208,0.00036448348,0.00005604745,0.00004456321,0.0000779102,0.0020685513,0.9862985,0.01044545],"study_design_scores_gemma":[0.00027049863,0.00008052982,0.0018657411,0.0012114631,0.00008185541,0.00074464345,0.000777013,0.00032662982,0.000075767304,0.024504278,0.9699673,0.000094174946],"about_ca_topic_score_codex":0.013045576,"about_ca_topic_score_gemma":0.025910337,"teacher_disagreement_score":0.06270794,"about_ca_system_score_codex":0.0052498616,"about_ca_system_score_gemma":0.013415028,"threshold_uncertainty_score":0.075472414},"labels":[],"label_agreement":null},{"id":"W4388687049","doi":"10.1016/s1474-4422(23)00370-8","title":"Classic ketogenic diet versus further antiseizure medicine in infants with drug-resistant epilepsy (KIWE): a UK, multicentre, open-label, randomised clinical trial","year":2023,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Diet and metabolism studies","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"NIHR Great Ormond Street Hospital Biomedical Research Centre; Hospital for Sick Children; Great Ormond Street Institute of Child Health; Great Ormond Street Hospital for Children; University College London; University of Cambridge; Cambridge University Hospitals; University Hospitals of Leicester NHS Trust; Efficacy and Mechanism Evaluation Programme; National Institute for Health and Care Research; University of Oxford; Alder Hey Children's NHS Foundation Trust","keywords":"Ketogenic diet; Medicine; Epilepsy; Pediatrics; Drug Resistant Epilepsy; Clinical trial; Adverse effect; Randomized controlled trial; Internal medicine; Psychiatry","score_opus":0.12488970824044734,"score_gpt":0.39468642642217133,"score_spread":0.269796718181724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388687049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814399,0.007648094,0.0004661607,0.0008461177,0.0005938079,0.0065337215,0.0008800149,0.000113865826,0.0014783238],"genre_scores_gemma":[0.972029,0.0046127466,0.0029415148,0.0009823352,0.000474961,0.014701117,0.0007005976,0.000025907457,0.003531823],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979631,0.0013652386,0.00016028089,0.00021314557,0.0001086635,0.00018969405],"domain_scores_gemma":[0.99751055,0.0008830401,0.0007326411,0.0001664098,0.00017604357,0.00053142663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003322736,0.0018664944,0.003944144,0.00058855943,0.00046312925,0.0011042667,0.001263167,0.0029998801,0.0072876737],"category_scores_gemma":[0.0059773996,0.0007531734,0.0015161767,0.00061443093,0.0013106944,0.001620444,0.0007891611,0.0022274759,0.0008659476],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9838706,0.0036309059,0.00029069278,0.0015422463,0.00044958733,0.00005585976,0.0000768301,0.0001477015,0.0009321732,0.00006535302,0.00042691838,0.008511056],"study_design_scores_gemma":[0.9373417,0.060234237,0.0011547748,0.00010062173,0.00029825862,0.000037086702,0.000032626464,0.00019194116,0.00013921918,0.00006866526,0.00038873314,0.000012180915],"about_ca_topic_score_codex":0.0013020979,"about_ca_topic_score_gemma":0.0028473767,"teacher_disagreement_score":0.0072876737,"about_ca_system_score_codex":0.001108914,"about_ca_system_score_gemma":0.0013001425,"threshold_uncertainty_score":0.02437973},"labels":[],"label_agreement":null},{"id":"W4388687053","doi":"10.1016/s1474-4422(23)00313-7","title":"Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trial","year":2023,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Cellular transport and secretion","field":"Biochemistry, Genetics and Molecular Biology","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Astellas Pharma US; Astellas Pharma; Washington University School of Medicine in St. Louis; Institut National de la Santé et de la Recherche Médicale; University of Washington; Cincinnati Children's Hospital Medical Center","keywords":"Medicine; Dosing; Clinical trial; Adverse effect; Internal medicine; Pediatrics","score_opus":0.04870708411124729,"score_gpt":0.31033400657414617,"score_spread":0.26162692246289887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388687053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934769,0.0024406442,0.00030779306,0.00038033564,0.00009264134,0.0011050422,0.0007234424,0.000058069916,0.0014152015],"genre_scores_gemma":[0.9919594,0.0013203413,0.0010618285,0.0006750702,0.00010796159,0.0020287065,0.0009801801,0.000020050655,0.001846533],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994351,0.00029679257,0.000027989949,0.00009386351,0.00007118695,0.00007508451],"domain_scores_gemma":[0.99921584,0.0001652145,0.00022435296,0.000066876055,0.00006453317,0.00026319802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020204873,0.0009095259,0.001368787,0.0003053833,0.00033789276,0.0008337414,0.0006000924,0.0012631358,0.003376869],"category_scores_gemma":[0.0009968422,0.00027088332,0.00095518254,0.00024495178,0.0008870943,0.0007709761,0.00036862583,0.0019850782,0.0005862444],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87070906,0.03153622,0.005052062,0.0011934162,0.0015923814,0.000110404115,0.0002461433,0.0012489184,0.019900598,0.00037259137,0.0024302904,0.065607905],"study_design_scores_gemma":[0.58367753,0.39742827,0.010764015,0.00012029087,0.00066407333,0.00019848353,0.0000807312,0.001474766,0.0026023956,0.00025779742,0.0027015703,0.000030037345],"about_ca_topic_score_codex":0.0004988793,"about_ca_topic_score_gemma":0.0012610633,"teacher_disagreement_score":0.003376869,"about_ca_system_score_codex":0.0008659794,"about_ca_system_score_gemma":0.0009827488,"threshold_uncertainty_score":0.011296749},"labels":[],"label_agreement":null},{"id":"W4388714921","doi":"10.1016/s1474-4422(23)00418-0","title":"Prevention of dementia with holistic brain health","year":2023,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Dementia; Life expectancy; Medicine; Scopus; Disease; Population; Stroke (engine); Population ageing; Gerontology; Summit; Family medicine; Pediatrics; MEDLINE; Political science; Environmental health; Internal medicine","score_opus":0.09041881436053889,"score_gpt":0.3831788730027587,"score_spread":0.2927600586422198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388714921","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021038206,0.0014973799,0.000052600884,0.9823449,0.013595899,0.000010192674,0.000045102974,0.000015747251,0.0022277734],"genre_scores_gemma":[0.0022628054,0.0015064637,0.00020401356,0.9429054,0.049351852,0.00004506256,0.000030781794,0.00001161998,0.0036820737],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959384,0.0012855628,0.0006425096,0.00034356365,0.0012092349,0.0005807254],"domain_scores_gemma":[0.98610735,0.0076120486,0.000776104,0.00035825558,0.002343515,0.0028027196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045320317,0.0011765485,0.0022023565,0.0012120208,0.0046030963,0.0039032153,0.0018788045,0.07678432,0.010386785],"category_scores_gemma":[0.03331177,0.0007981917,0.0020008208,0.0009740749,0.002908918,0.004765567,0.0021454254,0.04743546,0.007056839],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012902965,0.000113067836,0.00084961037,0.00017057647,0.000042211297,0.0013385395,0.00011388934,0.00006040748,0.00017898982,0.0041819545,0.9741743,0.018647345],"study_design_scores_gemma":[0.0009723925,0.00030514516,0.003434809,0.0016759546,0.00017961788,0.0028336705,0.0006411367,0.0009691429,0.0003103954,0.02747994,0.96106434,0.00013331098],"about_ca_topic_score_codex":0.014297159,"about_ca_topic_score_gemma":0.026686003,"teacher_disagreement_score":0.07678432,"about_ca_system_score_codex":0.0039329203,"about_ca_system_score_gemma":0.00783315,"threshold_uncertainty_score":0.034747303},"labels":[],"label_agreement":null},{"id":"W4389472243","doi":"10.1016/s1474-4422(23)00409-x","title":"Corticosteroids versus clobazam for treatment of children with epileptic encephalopathy with spike-wave activation in sleep (RESCUE ESES): a multicentre randomised controlled trial","year":2023,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"Stichting Epilepsie Instellingen Nederland; Radboud Universitair Medisch Centrum; Albert-Ludwigs-Universität Freiburg; Great Ormond Street Hospital for Children; Radboud Universiteit","keywords":"Clobazam; Medicine; Spike-and-wave; Epilepsy; Randomized controlled trial; Sleep (system call); Encephalopathy; Pediatrics; Anesthesia; Psychiatry; Internal medicine","score_opus":0.04660200789255939,"score_gpt":0.31021021546835076,"score_spread":0.2636082075757914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389472243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9625063,0.026385743,0.0006947411,0.0017060308,0.0021538339,0.003840871,0.0011050041,0.00010027281,0.0015073598],"genre_scores_gemma":[0.98028976,0.010245022,0.001123023,0.0015225761,0.00067896163,0.0031645824,0.00060362334,0.00001714934,0.0023553495],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991008,0.00041705885,0.00009522018,0.00017130937,0.000063817184,0.00015188797],"domain_scores_gemma":[0.998806,0.00038380595,0.0003059749,0.0000853127,0.000089294634,0.00032952623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014304393,0.0020939112,0.005531454,0.00048357103,0.00052922947,0.0013525982,0.0010682294,0.0030060501,0.006629735],"category_scores_gemma":[0.0023900478,0.0008098762,0.0035210855,0.00059766334,0.0016825243,0.0011630922,0.00064146344,0.003070987,0.0008983348],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.989902,0.00094975805,0.0002971812,0.001364204,0.0017667216,0.000054214528,0.000036179365,0.00011170779,0.00064513885,0.00007482003,0.0003320982,0.00446589],"study_design_scores_gemma":[0.98314744,0.014603846,0.0006762784,0.00009556064,0.00095830404,0.000021672062,0.000028618964,0.00008225313,0.000060261118,0.000066167864,0.0002498464,0.000009802062],"about_ca_topic_score_codex":0.0044886232,"about_ca_topic_score_gemma":0.008703816,"teacher_disagreement_score":0.006629735,"about_ca_system_score_codex":0.0012541303,"about_ca_system_score_gemma":0.0015212643,"threshold_uncertainty_score":0.02217865},"labels":[],"label_agreement":null},{"id":"W4389657620","doi":"10.1016/s1474-4422(23)00403-9","title":"Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial","year":2023,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton; Impact; McMaster University; Population Health Research Institute","funders":"European Stroke Organisation; Janssen Research and Development; HLS Therapeutics; Ipsen; Janssen Pharmaceuticals; Göteborgs Universitet; Deutsches Zentrum für Neurodegenerative Erkrankungen; Daiichi Sankyo Europe; Sanofi; Deutsches Zentrum für Herz-Kreislaufforschung; Sahlgrenska Universitetssjukhuset; American Stroke Association; Alexion Pharmaceuticals; Amgen; National Heart, Lung, and Blood Institute; Pfizer; Inventiva Pharma; Bristol-Myers Squibb; AstraZeneca; Novo Nordisk; American Heart Association","keywords":"Medicine; Placebo; Stroke (engine); Aspirin; Population; Clopidogrel; Risk factor; Clinical endpoint; Internal medicine; Randomized controlled trial; Anesthesia; Pathology","score_opus":0.06879306530208357,"score_gpt":0.35347818787607,"score_spread":0.2846851225739864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389657620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792421,0.010505592,0.001351852,0.0011749109,0.00086873886,0.002468673,0.001190737,0.000277484,0.0029198513],"genre_scores_gemma":[0.98325884,0.005249245,0.0019110456,0.0019621917,0.0006667196,0.0023980264,0.0014460101,0.00004217142,0.0030658166],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99937314,0.00029847032,0.000040394723,0.00011782276,0.00005179934,0.0001183349],"domain_scores_gemma":[0.999186,0.000283237,0.00015903193,0.00008377892,0.000060063056,0.00022796115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002234204,0.0025313294,0.0043067,0.0004754734,0.0005380587,0.001587702,0.0011207226,0.0025839612,0.007061792],"category_scores_gemma":[0.0019726164,0.00087440765,0.0025368372,0.00041763714,0.0016097778,0.0015793963,0.00047264644,0.004414313,0.001265666],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9797044,0.0039470936,0.00029325427,0.0007556138,0.0013063371,0.00003212692,0.00003613278,0.00018113229,0.0017582894,0.0001354024,0.0007110476,0.011139162],"study_design_scores_gemma":[0.96667147,0.03144783,0.0006253155,0.000026367406,0.00039402608,0.000023432498,0.000011748736,0.00018641607,0.00022007934,0.00014573643,0.00023502873,0.000012544665],"about_ca_topic_score_codex":0.0006369053,"about_ca_topic_score_gemma":0.0012516488,"teacher_disagreement_score":0.007061792,"about_ca_system_score_codex":0.00069911894,"about_ca_system_score_gemma":0.0009460805,"threshold_uncertainty_score":0.023624003},"labels":[],"label_agreement":null},{"id":"W4389701772","doi":"10.1016/s1474-4422(23)00377-0","title":"Blood–brain barrier dysfunction in multiple sclerosis: causes, consequences, and potential effects of therapies","year":2023,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Barrier Structure and Function Studies","field":"Neuroscience","cited_by":130,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Multiple sclerosis; Blood–brain barrier; Medicine; Neuroscience; Intensive care medicine; Psychology; Immunology; Central nervous system","score_opus":0.09878283544503473,"score_gpt":0.29301948381710713,"score_spread":0.19423664837207238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389701772","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020653046,0.9996258,0.000022909615,0.00015251442,0.00006659406,0.0000011778917,0.0000060852417,0.0000017897285,0.00010236922],"genre_scores_gemma":[0.00018237709,0.999511,0.00004739983,0.00009610615,0.00009871993,0.0000022092854,0.0000067914116,3.42628e-7,0.000055013505],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971443,0.00006270387,0.000045104764,0.000045746598,0.00010769112,0.00002429542],"domain_scores_gemma":[0.99912316,0.00051179685,0.00013191933,0.000018039895,0.00016280095,0.000052261483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001334134,0.0013788339,0.003534064,0.0023926867,0.00027646692,0.0015025509,0.0014780873,0.0018322363,0.0028009522],"category_scores_gemma":[0.001728938,0.00033080997,0.0008534514,0.0029865014,0.00077732967,0.0014690568,0.00091025076,0.0026503343,0.0013778723],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020478513,0.000082140716,0.00019986986,0.035451118,0.00032720453,0.00016539323,0.00004448184,0.00038982098,0.0010011804,0.0032209528,0.028659405,0.93025374],"study_design_scores_gemma":[0.0001722991,0.00027799964,0.0027151613,0.029107936,0.0012538804,0.0017180595,0.00016226743,0.0002638056,0.00054107717,0.006453839,0.95726305,0.00007072186],"about_ca_topic_score_codex":0.0021597163,"about_ca_topic_score_gemma":0.0045517343,"teacher_disagreement_score":0.003534064,"about_ca_system_score_codex":0.0009820051,"about_ca_system_score_gemma":0.0018532278,"threshold_uncertainty_score":0.009370089},"labels":[],"label_agreement":null},{"id":"W4391090353","doi":"10.1016/s1474-4422(23)00405-2","title":"A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research","year":2024,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":563,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute on Aging; Parkinson Canada; Cure Parkinson's Trust; Parkinson's UK; Lewy Body Dementia Association; Michael J. Fox Foundation for Parkinson's Research","keywords":"Disease; Neuroscience; Medicine; Computer science; Psychology; Pathology","score_opus":0.3489519676435442,"score_gpt":0.4452597496736825,"score_spread":0.09630778203013829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391090353","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000031052896,0.99747366,0.00028770402,0.0012762705,0.00045671235,0.000006747682,0.000020847016,0.000008864198,0.00043812828],"genre_scores_gemma":[0.00047922783,0.99667823,0.00076481525,0.0011815066,0.00047417867,0.000015269196,0.00004700876,0.0000025948932,0.00035712466],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99900997,0.0002871875,0.000176205,0.00013442786,0.00031992007,0.00007231273],"domain_scores_gemma":[0.9979487,0.0012210481,0.00021264852,0.00005680177,0.0004569837,0.000103898754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00404905,0.0019488874,0.0044963923,0.004440609,0.00049049774,0.0030565334,0.002284309,0.0026769992,0.0028698838],"category_scores_gemma":[0.002900196,0.00047440775,0.0012791606,0.0038614757,0.002118004,0.0036500078,0.0017573051,0.0054527675,0.0019005121],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013317197,0.000066951194,0.00023880391,0.03352488,0.00029650706,0.00017460574,0.0001653391,0.0005928382,0.0013698154,0.030955529,0.07007827,0.8624033],"study_design_scores_gemma":[0.000050497878,0.00012082324,0.0007901329,0.01858388,0.000334312,0.0006127251,0.0002001457,0.00022667545,0.00019676068,0.01824095,0.9605983,0.000044752465],"about_ca_topic_score_codex":0.0034914513,"about_ca_topic_score_gemma":0.006292388,"teacher_disagreement_score":0.0044963923,"about_ca_system_score_codex":0.0027717615,"about_ca_system_score_gemma":0.004413324,"threshold_uncertainty_score":0.021413684},"labels":[],"label_agreement":null},{"id":"W4391090585","doi":"10.1016/s1474-4422(23)00404-0","title":"A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria","year":2024,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":498,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; McGill University; Toronto Western Hospital; Montreal Neurological Institute and Hospital","funders":"Fonds de Recherche du Québec - Santé; Canada Foundation for Innovation; Parkinsonfonden; Volkswagen Foundation; National Institutes of Health; Damp Stiftung; R. Howard Webster Foundation; Bundesministerium für Bildung und Forschung; European Parkinson’s Disease Association; Garfield Weston Foundation; Deutsche Forschungsgemeinschaft; Michael J. Fox Foundation for Parkinson's Research; Parkinson Society Canada; Fondation Brain Canada; Niedersächsisches Ministerium für Wissenschaft und Kultur; Mayo Clinic; W. Garfield Weston Foundation; Canadian Institutes of Health Research; Innovative Medicines Initiative; Parkinson Canada; Edmond J. Safra Philanthropic Foundation; Weston Brain Institute; Horizon 2020; Ontario Brain Institute","keywords":"Disease; Neurodegeneration; Medicine; Neuroimaging; Parkinson's disease; Bioinformatics; Pathology; Biology; Psychiatry","score_opus":0.27843804011143114,"score_gpt":0.4518668732840056,"score_spread":0.17342883317257446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391090585","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015917773,0.9947514,0.0005128333,0.002554483,0.0008968532,0.000042868953,0.00011575909,0.000011655195,0.0009549443],"genre_scores_gemma":[0.0028620907,0.9891557,0.002677321,0.0027127208,0.0010683032,0.00008995925,0.0004942194,0.000006357836,0.00093337777],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984871,0.00029356344,0.00044790388,0.00020608371,0.0004621049,0.00010324001],"domain_scores_gemma":[0.99791354,0.0008482276,0.00033767088,0.000045433357,0.0007199373,0.00013509713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045649717,0.0018509773,0.00454951,0.005272944,0.0005420318,0.0020609892,0.0030435969,0.0021777756,0.00243774],"category_scores_gemma":[0.0040003066,0.0004624576,0.0020435746,0.0035281128,0.0018358573,0.0021831568,0.0017016011,0.004332518,0.0014745551],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021477933,0.00008079443,0.0011519751,0.029075291,0.00037931162,0.00024839726,0.00014852236,0.00047811994,0.00091381813,0.017933695,0.08213579,0.8672394],"study_design_scores_gemma":[0.0002661318,0.00025677306,0.006873471,0.040552866,0.0012554779,0.0027731466,0.00031954216,0.00074185187,0.00038654558,0.0160227,0.9304407,0.000110858375],"about_ca_topic_score_codex":0.008537588,"about_ca_topic_score_gemma":0.013429714,"teacher_disagreement_score":0.008537588,"about_ca_system_score_codex":0.0033017963,"about_ca_system_score_gemma":0.0065449458,"threshold_uncertainty_score":0.024142146},"labels":[],"label_agreement":null},{"id":"W4391090596","doi":"10.1016/s1474-4422(23)00460-x","title":"Platelet glycoprotein VI inhibition: a promising therapeutic avenue in acute ischaemic stroke","year":2024,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Ischaemic stroke; Platelet; Medicine; Platelet membrane glycoprotein; Stroke (engine); Pharmacology; Internal medicine; Cardiology; Ischemia; Engineering","score_opus":0.026461192166563736,"score_gpt":0.27374953994579354,"score_spread":0.2472883477792298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391090596","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003969293,0.01752303,0.00016989112,0.94998586,0.024013428,0.000013218603,0.00006021914,0.000036175945,0.0078013204],"genre_scores_gemma":[0.008408507,0.023847146,0.00048655426,0.7375355,0.22062998,0.00005383824,0.00008646872,0.000032154287,0.008919895],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982728,0.0005028765,0.00018888466,0.00017148715,0.00062599266,0.00023802051],"domain_scores_gemma":[0.99675316,0.001795375,0.00026813697,0.00008301745,0.0004639261,0.00063640974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016435143,0.000970294,0.002350703,0.0009870322,0.0018232239,0.0041722665,0.0012354844,0.032868348,0.007849848],"category_scores_gemma":[0.0101299,0.0005244173,0.0014222242,0.0008450324,0.0026112327,0.0034112209,0.0010878096,0.030795451,0.0078049246],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022365108,0.00007417404,0.00042849552,0.00025080764,0.000048628466,0.002894885,0.00006327546,0.0001614876,0.00031259988,0.005421161,0.9528715,0.037249386],"study_design_scores_gemma":[0.0009370384,0.00026652846,0.001322876,0.0010774106,0.000104431696,0.0039407206,0.00023221744,0.0007187106,0.00025650547,0.027770437,0.9633095,0.00006361265],"about_ca_topic_score_codex":0.0017838563,"about_ca_topic_score_gemma":0.0052049565,"teacher_disagreement_score":0.032868348,"about_ca_system_score_codex":0.0026605674,"about_ca_system_score_gemma":0.0023639314,"threshold_uncertainty_score":0.026260316},"labels":[],"label_agreement":null},{"id":"W4391090633","doi":"10.1016/s1474-4422(23)00505-7","title":"WHO considers multiple sclerosis treatments essential","year":2024,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact; Queen's University","funders":"Multiple Sclerosis International Federation; Biogen; Mylan; University of Exeter; Sanofi; Bristol-Myers Squibb","keywords":"Medicine; Multiple sclerosis; Ocrelizumab; Glatiramer acetate; Cladribine; Rituximab; Alternative medicine; Family medicine; Alemtuzumab; Teriflunomide; Fingolimod; Pathology; Psychiatry; Internal medicine; Lymphoma; Transplantation","score_opus":0.4708904504937731,"score_gpt":0.39906779415307875,"score_spread":0.07182265634069435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391090633","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000630113,0.0034152227,0.00006353301,0.9825502,0.010649406,0.000006140358,0.00003793664,0.000009787022,0.003204724],"genre_scores_gemma":[0.0017651607,0.002909306,0.00026311932,0.9356684,0.05512085,0.00004028905,0.000039381663,0.000023518602,0.004169991],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98242503,0.0057230988,0.002375552,0.0012010764,0.006148702,0.0021264753],"domain_scores_gemma":[0.92330426,0.043634996,0.0043279384,0.0021968451,0.013155615,0.013380377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018412685,0.0009580545,0.003926535,0.0027329428,0.0052509326,0.010080998,0.002383934,0.07376505,0.012817811],"category_scores_gemma":[0.07633937,0.0011574207,0.0020781285,0.002147085,0.00769276,0.010414711,0.004423625,0.05773331,0.008820317],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057747333,0.000044087188,0.00033093974,0.00013909246,0.000033112174,0.00025976228,0.00007871513,0.000050791004,0.00008220147,0.0077532683,0.9722044,0.018966014],"study_design_scores_gemma":[0.00030660362,0.000033162138,0.0008940838,0.001504474,0.00007039707,0.00037640595,0.0003173043,0.00029569556,0.00007986129,0.03870548,0.9573336,0.000083083796],"about_ca_topic_score_codex":0.01601584,"about_ca_topic_score_gemma":0.0330321,"teacher_disagreement_score":0.07376505,"about_ca_system_score_codex":0.0077791302,"about_ca_system_score_gemma":0.019619243,"threshold_uncertainty_score":0.097376704},"labels":[],"label_agreement":null},{"id":"W4391123303","doi":"10.1016/s1474-4422(23)00414-3","title":"Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis","year":2024,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Douglas Mental Health University Institute","funders":"National Institute of Neurological Disorders and Stroke; National Institute on Deafness and Other Communication Disorders; National Institute on Aging; NIHR Cambridge Biomedical Research Centre; National Health and Medical Research Council; Economic and Social Research Council; Medical Research Council; Fonds de Recherche du Québec - Santé; Avid Radiopharmaceuticals; National Institutes of Health; GIESKES-STRIJBIS FONDS; Alzheimer's Society; Italfarmaco; Fondation pour la Recherche sur Alzheimer; Genentech; Marcus och Amalia Wallenbergs minnesfond; Celgene; Skånes universitetssjukhus; Stichting Dioraphte; National Natural Science Foundation of China; UK Dementia Research Institute; Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica; Knut och Alice Wallenbergs Stiftelse; Australian Government; Lunds Universitet; Vetenskapsrådet; Eisai; Wolfson Foundation; Brain Research Trust; Eli Lilly and Company; Hersenstichting; Bristol-Myers Squibb; Teva Pharmaceutical Industries; Department of Health and Social Care; University College London; British Heart Foundation; Parkinsonfonden; Ministero della Salute; Mater Foundation; Pfizer; EU Joint Programme – Neurodegenerative Disease Research; ZonMw; Weston Brain Institute; Reta Lila Weston Institute of Neurological Studies, UCL Queen Square Institute of Neurology,University College London; Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Fondazione Italiana Sclerosi Multipla; Alzheimer Nederland; Biogen; Novo Nordisk; University of Pennsylvania; Alexion Pharmaceuticals; National Institute for Health and Care Research; Alzheimer's Association; Roche Nederland; Sanofi","keywords":"Biomarker; Atrophy; Meta-analysis; Cohort; Medicine; Cohort study; Posterior cortical atrophy; Pathology; Oncology; Biology; Disease; Dementia","score_opus":0.5311008510600352,"score_gpt":0.5185259060859717,"score_spread":0.012574944974063529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391123303","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15124187,0.82376504,0.012282861,0.0009466473,0.0005675463,0.0015364357,0.007933501,0.0002412895,0.0014848323],"genre_scores_gemma":[0.8968073,0.08370722,0.008997465,0.0011498262,0.00026048362,0.004193635,0.004119133,0.0001202503,0.00064468465],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9807233,0.010435085,0.0035138282,0.0034002573,0.0012006975,0.0007268891],"domain_scores_gemma":[0.9649555,0.025044678,0.004412704,0.0031257428,0.00199791,0.00046345405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030522684,0.0028839689,0.011158632,0.0052241683,0.0009704248,0.0035316667,0.0031782147,0.002677803,0.003563867],"category_scores_gemma":[0.04459959,0.0012713319,0.0379859,0.009226393,0.0010321381,0.0015418219,0.0020782582,0.002122648,0.00035752833],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049610133,0.000054197328,0.044362906,0.038238723,0.90494835,0.00028448817,0.00016991048,0.00097531703,0.00036271184,0.00017544015,0.0008464946,0.0046205027],"study_design_scores_gemma":[0.00095153006,0.00020283581,0.020879345,0.0028000849,0.97351044,0.00013631486,0.000064165615,0.00039487786,0.000108148764,0.00023501513,0.00069109746,0.000026132398],"about_ca_topic_score_codex":0.00707098,"about_ca_topic_score_gemma":0.010249139,"teacher_disagreement_score":0.030522684,"about_ca_system_score_codex":0.0014850787,"about_ca_system_score_gemma":0.0021451255,"threshold_uncertainty_score":0.16142136},"labels":[],"label_agreement":null},{"id":"W4391166174","doi":"10.1016/s1474-4422(23)00454-4","title":"Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study","year":2024,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"iCo Therapeutics (Canada); University of British Columbia","funders":"Wellcome Trust; Active Biotech; European Huntington's Disease Network; Teva Pharmaceutical Industries","keywords":"Huntington's disease; Medicine; Placebo; Clinical endpoint; Internal medicine; Adverse effect; Physical therapy; Clinical trial; Disease; Pathology","score_opus":0.04614417203517779,"score_gpt":0.3386271924069397,"score_spread":0.29248302037176194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391166174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98845077,0.004638456,0.0008013229,0.00053930865,0.00047291178,0.0026604675,0.00096168934,0.0001313509,0.0013438024],"genre_scores_gemma":[0.98725265,0.00215571,0.0015586191,0.0014548899,0.0006297292,0.0031480063,0.001181289,0.00003889913,0.002580069],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991559,0.00044345067,0.000045388737,0.0001634999,0.00006560989,0.00012611975],"domain_scores_gemma":[0.99894994,0.00029565545,0.00021230374,0.00010139883,0.000090147114,0.00035053346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025666626,0.0022841732,0.0034631686,0.0005389407,0.0005570645,0.0012240116,0.0013006484,0.0033223222,0.005197853],"category_scores_gemma":[0.001960326,0.00091800507,0.001755866,0.00034301422,0.0018892357,0.0016891845,0.00048020086,0.0028755357,0.0010536329],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97867054,0.0061476524,0.00041755545,0.00042862454,0.00061633554,0.000040699702,0.000051272567,0.00014874547,0.004661776,0.00006603323,0.0005372154,0.008213522],"study_design_scores_gemma":[0.93485665,0.06276647,0.0013794297,0.000016045391,0.00022082358,0.000020244912,0.000012633929,0.00011759456,0.00024909043,0.00006479478,0.000282968,0.000013337256],"about_ca_topic_score_codex":0.0008163362,"about_ca_topic_score_gemma":0.0016057771,"teacher_disagreement_score":0.005197853,"about_ca_system_score_codex":0.00086907507,"about_ca_system_score_gemma":0.0010013402,"threshold_uncertainty_score":0.017388523},"labels":[],"label_agreement":null},{"id":"W4391166271","doi":"10.1016/s1474-4422(24)00001-2","title":"Laquinimod, Huntington's disease, and disease modification","year":2024,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Huntingtin; Huntington's disease; Microglia; Neuroinflammation; Disease; Exon; Medicine; Mutation; Huntingtin Protein; Leukoencephalopathy; Neuroscience; Biology; Gene; Inflammation; Genetics; Immunology; Pathology","score_opus":0.05286272735153576,"score_gpt":0.3013742496650739,"score_spread":0.24851152231353818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391166271","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22719853,0.68929064,0.0016905537,0.054091647,0.0034139624,0.000058058697,0.0024094135,0.0003061517,0.021540942],"genre_scores_gemma":[0.7864138,0.1829808,0.0024332805,0.013022624,0.0047427104,0.00008704606,0.0012411252,0.000045707606,0.009032909],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.999699,0.00009731605,0.00003421892,0.00005821801,0.00007389779,0.00003738353],"domain_scores_gemma":[0.9992568,0.00029095463,0.00025963548,0.00004409471,0.000056759836,0.000091713904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010105944,0.00034883912,0.00070679514,0.00035197524,0.00017573468,0.00077695795,0.00053590443,0.0013979618,0.0026270049],"category_scores_gemma":[0.0017855868,0.00009115706,0.00041651097,0.00042753198,0.00050571,0.00035283348,0.00024253721,0.00077903084,0.00025054484],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012338051,0.000672413,0.059299253,0.002641704,0.004525955,0.002637822,0.00032805486,0.0017564227,0.021025166,0.028863264,0.08438,0.7815319],"study_design_scores_gemma":[0.010320528,0.007766084,0.37824488,0.0027137385,0.006888116,0.008775403,0.00044579536,0.0027656858,0.0067255376,0.105363086,0.46969336,0.00029773818],"about_ca_topic_score_codex":0.003141399,"about_ca_topic_score_gemma":0.0048853103,"teacher_disagreement_score":0.003141399,"about_ca_system_score_codex":0.0007006573,"about_ca_system_score_gemma":0.0004746228,"threshold_uncertainty_score":0.008788228},"labels":[],"label_agreement":null},{"id":"W4391837820","doi":"10.1016/s1474-4422(24)00023-1","title":"Monitoring patients with severe traumatic brain injury","year":2024,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Traumatic Brain Injury and Neurovascular Disturbances","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health","keywords":"Traumatic brain injury; Medicine; Psychiatry","score_opus":0.035535218895864674,"score_gpt":0.27738952065194933,"score_spread":0.24185430175608466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391837820","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016418632,0.0060975924,0.00036792774,0.9481403,0.012420501,0.000036884558,0.00009652725,0.00007293364,0.016348697],"genre_scores_gemma":[0.14054294,0.0057873954,0.001078818,0.7708338,0.07566462,0.00007875601,0.00011221458,0.000043258904,0.0058582965],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988005,0.0003579578,0.00025753365,0.00012595544,0.0001993717,0.00025866175],"domain_scores_gemma":[0.99361694,0.0025989152,0.00083060766,0.00019834137,0.00097301067,0.0017821433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011599085,0.0005887086,0.00097041146,0.00083354244,0.0021606414,0.0020575419,0.0012367052,0.022692386,0.0033451777],"category_scores_gemma":[0.017384069,0.0004837642,0.00073575863,0.0008197669,0.0013719538,0.0019757252,0.00080537994,0.013658589,0.0017562112],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000656279,0.0002531833,0.06924667,0.00041167668,0.00016429505,0.0992278,0.0014272018,0.0006649145,0.0024300453,0.0023548626,0.7265106,0.096652485],"study_design_scores_gemma":[0.0013840015,0.0017065543,0.13504077,0.0036071741,0.0005964765,0.19419478,0.0066226483,0.0052801766,0.0022521438,0.033955883,0.6149678,0.00039158884],"about_ca_topic_score_codex":0.008233326,"about_ca_topic_score_gemma":0.013752698,"teacher_disagreement_score":0.022692386,"about_ca_system_score_codex":0.00252914,"about_ca_system_score_gemma":0.002439024,"threshold_uncertainty_score":0.018350303},"labels":[],"label_agreement":null},{"id":"W4391870195","doi":"10.1016/s1474-4422(24)00027-9","title":"Clinical trials for progressive multiple sclerosis: progress, new lessons learned, and remaining challenges","year":2024,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Multiple sclerosis; Clinical trial; Remyelination; Medicine; Disease; Intensive care medicine; Expanded Disability Status Scale; Pathology; Psychiatry; Internal medicine","score_opus":0.7178297648655821,"score_gpt":0.5358146476112376,"score_spread":0.1820151172543445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391870195","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009973627,0.7166119,0.0017331904,0.2713,0.007531354,0.000117466,0.00031296434,0.00010756139,0.0012882483],"genre_scores_gemma":[0.035465453,0.72787535,0.019268265,0.15324149,0.06039324,0.0010415672,0.0010282224,0.0002817774,0.0014045223],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.844991,0.10324789,0.021673968,0.007217406,0.01797161,0.004898115],"domain_scores_gemma":[0.28784943,0.60951656,0.01852352,0.015164898,0.050832465,0.018113183],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.40286604,0.0027887232,0.015119206,0.003939007,0.0027526517,0.019141871,0.009322432,0.017778374,0.013121394],"category_scores_gemma":[0.35983938,0.0017120049,0.006420213,0.0055752993,0.017902331,0.039869413,0.009361434,0.025256181,0.0035936078],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009030588,0.00087483856,0.0054391604,0.04637681,0.004096805,0.00035754903,0.0018832252,0.0017387179,0.0011715636,0.05748629,0.23575512,0.6357893],"study_design_scores_gemma":[0.010745922,0.004604171,0.01377544,0.10742364,0.004300981,0.00081384124,0.005713624,0.0026197461,0.00067344774,0.23473682,0.61393404,0.0006583607],"about_ca_topic_score_codex":0.0081028035,"about_ca_topic_score_gemma":0.015179016,"teacher_disagreement_score":0.40286604,"about_ca_system_score_codex":0.009487452,"about_ca_system_score_gemma":0.027798124,"threshold_uncertainty_score":0.7363725},"labels":[],"label_agreement":null},{"id":"W4392791500","doi":"10.1016/s1474-4422(24)00038-3","title":"Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021","year":2024,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":1711,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Europe; National Institute on Deafness and Other Communication Disorders; National Institute of Mental Health; National Heart, Lung, and Blood Institute; Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia; Faculty of Medicine and Health, University of Sydney; Instituto de Salud Carlos III; Russian Academy of Sciences; Medical Research Council; Research Institute, Nationwide Children's Hospital; Duke Global Health Institute, Duke University; Directorate for Biological Sciences; Babcock University; University of Veterinary and Animal Sciences; Adigrat University; King Faisal University; Université de Versailles Saint-Quentin-en-Yvelines; KfW Entwicklungsbank; University of Nicosia; Alfaisal University; Western Sydney University; Berlin Institute of Health; Mahatma Gandhi University; Universidade Federal de Sergipe; Universitas Syiah Kuala; Universitas Mataram; Jahrom University of Medical Sciences; University of Nizwa; Aja University of Medical Sciences; Razi Vaccine and Serum Research Institute; Lorestan University of Medical Sciences; Gonabad University of Medical Sciences; St. Olavs Hospital Universitetssykehuset i Trondheim; Universitas Hasanuddin; Masarykova Univerzita; University of Thessaly; Hawassa University; Karl-Franzens-Universität Graz; University of Social Welfare and Rehabilitation Sciences; George Institute for Global Health; University of Peradeniya; Central University of Kerala; Guru Angad Dev Veterinary and Animal Sciences University; Dire Dawa University; Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta; Nanjing University; National Nutrition and Food Technology Research Institute; Tokyo Medical and Dental University; Addis Ababa University; Ilam University; Tartu Ülikool; European Academy of Neurology; University of Tabriz; European Stroke Organisation; Shaqra University; University of the Philippines; China Medical University; Urmia University; Tarbiat Modares University; Yasuj University of Medical Sciences; Trakya Üniversitesi; Nazarbayev University; Wuhan University; African Population and Health Research Center; Technische Universität Berlin; University of Johannesburg; University of Tsukuba; Syddansk Universitet; University of Zanjan; Università degli Studi dell'Aquila; Management and Science University; Oulun Yliopisto; Zanjan University of Medical Sciences; University of Gondar; United Arab Emirates University; Bahir Dar University; Golestan University of Medical Sciences; Universitatea de Medicină şi Farmacie \"Carol Davila\" Bucureşti; Shahid Beheshti University of Medical Sciences; Baqiyatallah University of Medical Sciences; Universitat de Barcelona; Göteborgs Universitet; Universidade de Coimbra; International Trachoma Initiative; University of Jordan; Kerman Neuroscience Research Center, Kerman University of Medical Sciences; Guilan University of Medical Sciences; Tamilnadu State Council For Science And Technology; Deakin University; University of Electronic Science and Technology of China; Universitetet i Oslo; Nationwide Children's Hospital; Universidad de Costa Rica; Deutsches Zentrum für Neurodegenerative Erkrankungen; Keele University; Leids Universitair Medisch Centrum; Jazan University; Griffith University; Ahvaz Jundishapur University of Medical Sciences; Mazandaran University of Medical Sciences; Shahrekord University; Hamadan University of Medical Sciences; Jenderal Soedirman University; Prince Sattam bin Abdulaziz University; Thomas Jefferson University; Abdul Wali Khan University Mardan; Alborz University of Medical Sciences; University of Peshawar; Yarmouk University; University of Technology Sydney; South Eastern Sydney Local Health District; Tehran University of Medical Sciences and Health Services; Tabriz University of Medical Sciences; Shiraz University of Medical Sciences; Ajman University; Universidad Autónoma Metropolitana; University of Wollongong; King Abdulaziz University; Karolinska Institutet; Jordan University of Science and Technology; European and Developing Countries Clinical Trials Partnership; Universiti Malaya; Sabzevar University of Medical Sciences; Isfahan University of Medical Sciences; Shandong University; Ilam University of Medical Sciences; Universidade de São Paulo; Queen's University; Pirogov Russian National Research Medical University; Uniwersytet Łódzki; University of Florida Health; Baker Heart and Diabetes Institute; Delhi Technological University; Université de Bordeaux; Dongguk University; Università di Catania; Universidad ICESI; Università di Bologna; Asia University; Taibah University; National and Kapodistrian University of Athens; Paracelsus Medizinische Privatuniversität; University of Canberra; Cancer Institute NSW; Cairo University; School of Medicine, Indiana University; University of Ottawa; King Faisal Specialist Hospital and Research Centre; Imperial College London; Public Health England; University of Central Punjab; James Cook University; University of Patras; Universiti Sains Malaysia; University of South Australia; University of New South Wales; Kermanshah University of Medical Sciences; RMIT University; Cleveland Clinic; Universiteit Leiden; Sunnybrook Research Institute; Institut National de la Santé et de la Recherche Médicale; University of Pennsylvania; Tsinghua University; Deutsche Forschungsgemeinschaft; Amity University; Johns Hopkins University; University of Warwick; Southern Cross University; Bauman Moscow State Technical University; Public Health Foundation of India; Chung Shan Medical University; Westfälische Wilhelms-Universität Münster; Indian Council of Medical Research; University of Pretoria; Bundesministerium für Gesundheit; South African Medical Research Council; King Abdullah University of Science and Technology; Capital Medical University; Student Research Committee, Tabriz University of Medical Sciences; La Trobe University; Dilla University; Australian Catholic University; Queensland Brain Institute; Sydney Medical School; Newcastle University; University of Oxford; Shiraz University; University of Southampton; COMSATS Institute of Information Technology; University of Queensland; National Institute for Health and Care Research; University of Colombo; Universidade Federal do Rio Grande do Sul; Arabian Gulf University; Arak University of Medical Sciences; Neyshabur University of Medical Sciences; Shanghai Jiao Tong University; Kasturba Medical College, Manipal; Jamia Millia Islamia; Northwell Health; Lawson Health Research Institute; Karpagam Academy of Higher Education; University of Kufa; Ahmadu Bello University; KU Leuven; Università Cattolica del Sacro Cuore; Islamic Azad University, Shahrekord; Université Mohammed VI Polytechnique; Universidad de Antioquia; Musculoskeletal Research Center, Washington University in St. Louis; Hamad Medical Corporation; Xiamen University; Children's Hospital of Philadelphia; Krishna Institute Of Medical Sciences Deemed To Be University; Università degli Studi di Siena; Shahrekord University of Medical Sciences; Imam Abdulrahman Bin Faisal University; Augusta University; University College London; Universiti Kebangsaan Malaysia; University at Buffalo; Coventry University; London School of Economics and Political Science; Academy of Military Medical Sciences; Madda Walabu University; Kerman University of Medical Sciences; Trường Đại học Duy Tân; Wellcome Trust; Universitas Ahmad Dahlan; Islamic Azad University; University of Essex; Dezful University of Medical Sciences; Högskolan Dalarna; Sheffield Hallam University; Gastrointestinal and Liver Diseases Research Center; Vanderbilt University; Institut für Arbeitsmarkt- und Berufsforschung; New Mexico State University; Universidad de Colima; Kurdistan University Of Medical Sciences; Brody School of Medicine; National Science Foundation; Houston Methodist Research Institute; Iran University of Medical Sciences; Nankai University; Universiteit Utrecht; Université de Limoges; Flinders University; Norges Teknisk-Naturvitenskapelige Universitet; Mekelle University; Cooperative Research Centre for Contamination Assessment and Remediation of the Environment; Université de Bourgogne; Qazvin University of Medical Sciences; University of South Carolina; University of Glasgow; National Institute of Mental Health and Neurosciences; Taipei Medical University; University College Cork; Loma Linda University; Harvard Business School; Universidad Peruana Cayetano Heredia; Ministero della Salute; Universitas Airlangga; Houston Methodist Hospital; National Institutes of Health; Wollega University; National University of Singapore; Kuwait University; Centre International de Recherche sur le Cancer; University of Health and Allied Sciences; Universidade de Lisboa; Nanjing University of Science and Technology; Ottawa Hospital Research Institute; Amgen; University of Waterloo; Salahaddin University-Erbil; Norwegian Institute of Public Health; Rafsanjan University of Medical Sciences; United Nations Population Fund; Auckland University of Technology, New Zealand; New York University Shanghai; University of Connecticut; Universität Basel; East Carolina University; Univerzita Karlova v Praze; Universidade da Beira Interior; Universitas Padjadjaran; Mashhad University of Medical Sciences; Massachusetts General Hospital; International Centre for Diarrhoeal Disease Research, Bangladesh; St. Baldrick's Foundation; Khalifa University of Science, Technology and Research; Monash University; Vanderbilt University Medical Center; Washington University in St. Louis; Macquarie University; Arizona State University; Florida Department of Health; American Stroke Association; Qatar University; Asian Institute of Medicine, Science and Technology; Jimma University; Zahedan University of Medical Sciences; Warwick Medical School; Deutsches Krebsforschungszentrum; Harvard University; Case Western Reserve University; University of South Florida; Loughborough University; Alexander von Humboldt-Stiftung; Università degli Studi di Milano; Urmia University of Medical Sciences; Háskólinn í Reykjavík; Pfizer; Federation University Australia; Bill and Melinda Gates Foundation; Aarhus Universitet; Medizinische Universität Graz; GAVI Alliance; Universidad de Concepción; Haramaya University; Division of Mathematical Sciences; Aksum University; Conquer Cancer Foundation; Universidad Nacional de Colombia; Institute for Advanced Studies in Basic Sciences; Northwestern University","keywords":"Burden of disease; Disease; Medicine; Environmental health; Pathology","score_opus":0.021706423475754223,"score_gpt":0.3233096114456594,"score_spread":0.30160318796990515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392791500","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20810579,0.4825896,0.0040055625,0.0025911366,0.0006250237,0.00090011524,0.2982253,0.00021797874,0.00273961],"genre_scores_gemma":[0.729224,0.15525486,0.005883142,0.0018575845,0.000339389,0.0025079758,0.104050145,0.00008019643,0.0008026881],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971527,0.0008875606,0.000713948,0.0005162686,0.00047690043,0.00025263577],"domain_scores_gemma":[0.9961987,0.0008664426,0.0013322679,0.00024447247,0.0011425279,0.000215527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005281181,0.0010034479,0.0024572287,0.0057022073,0.00039327968,0.0009760458,0.00078947435,0.0007009048,0.0014269922],"category_scores_gemma":[0.009207795,0.0007122722,0.009366564,0.00954353,0.0003884827,0.00066862337,0.0016478922,0.0009012007,0.00028249453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011859383,0.0000386418,0.816426,0.04469638,0.06094282,0.00026097437,0.00062544463,0.0034424297,0.00036250745,0.0009998204,0.03631562,0.034703523],"study_design_scores_gemma":[0.00061606796,0.00019343251,0.90658545,0.023219476,0.04308106,0.00056896586,0.00076639355,0.002435019,0.00024129238,0.00084824435,0.021332284,0.00011233409],"about_ca_topic_score_codex":0.10258599,"about_ca_topic_score_gemma":0.13841124,"teacher_disagreement_score":0.10258599,"about_ca_system_score_codex":0.0020081804,"about_ca_system_score_gemma":0.005199231,"threshold_uncertainty_score":0.20397776},"labels":[],"label_agreement":null},{"id":"W4392900167","doi":"10.1016/s1474-4422(24)00037-1","title":"Secondary stroke prevention in people with atrial fibrillation: treatments and trials","year":2024,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Inselspital, Universitätsspital Bern","keywords":"Atrial fibrillation; Medicine; Stroke (engine); Cardiology; Internal medicine; Subclinical infection; Clinical trial; Randomized controlled trial; Intensive care medicine","score_opus":0.16446187474786628,"score_gpt":0.41971722693092517,"score_spread":0.2552553521830589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392900167","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007466612,0.9990613,0.000053353324,0.0001798406,0.0001651061,0.000048030655,0.00003946552,0.0000072131124,0.0003709977],"genre_scores_gemma":[0.0011234722,0.9977264,0.000220858,0.00043656092,0.00012975997,0.00010952184,0.000059890608,0.000003049617,0.00019050429],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9985697,0.0005860797,0.00031286248,0.00010691123,0.00035810488,0.00006638465],"domain_scores_gemma":[0.9951615,0.003384539,0.00083651947,0.00008536193,0.00038135226,0.00015071206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038492063,0.0012556363,0.0044490406,0.0026172367,0.00024391958,0.0016436693,0.0013894266,0.0019307947,0.007298355],"category_scores_gemma":[0.009605682,0.00041402908,0.0029494646,0.0029776434,0.0004691276,0.0010160368,0.0007770971,0.0016951027,0.00094843376],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075066194,0.00008672968,0.00018892087,0.33820888,0.0024666784,0.00007698472,0.00008203738,0.00027179942,0.00032852558,0.0020723555,0.03515649,0.62030995],"study_design_scores_gemma":[0.002413305,0.0007672335,0.0024466908,0.48385358,0.01355393,0.0006277967,0.00017300347,0.00030723237,0.00041924018,0.0055263997,0.48985624,0.000055294837],"about_ca_topic_score_codex":0.0015204317,"about_ca_topic_score_gemma":0.0026910421,"teacher_disagreement_score":0.007298355,"about_ca_system_score_codex":0.0009799859,"about_ca_system_score_gemma":0.0022145123,"threshold_uncertainty_score":0.024415433},"labels":[],"label_agreement":null},{"id":"W4392906461","doi":"10.1016/s1474-4422(24)00088-7","title":"Detection of atrial fibrillation in patients after stroke – Authors' reply","year":2024,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute; BC Innovation Council; University of British Columbia; Lawson Health Research Institute; Western University","funders":"Schulich School of Medicine and Dentistry; Robarts Research Institute; Institut de Cardiologie de Montréal; Schulich School of Medicine and Dentistry, Western University; Université de Montréal; Lawson Health Research Institute","keywords":"Atrial fibrillation; Medicine; Stroke (engine); Cardiology; Internal medicine; Physical medicine and rehabilitation; Engineering","score_opus":0.03741750231584929,"score_gpt":0.29716311777106247,"score_spread":0.2597456154552132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392906461","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032280784,0.00092185294,0.000040536215,0.9623539,0.03556947,0.0000090710955,0.00013127612,0.00001858625,0.00063243526],"genre_scores_gemma":[0.002667369,0.00063637696,0.00008364383,0.9355739,0.05935334,0.0000413535,0.00006163123,0.000016258857,0.0015660404],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939114,0.0017261329,0.0013607218,0.0008282637,0.0014599214,0.00071363826],"domain_scores_gemma":[0.9631204,0.021735102,0.0028344619,0.0010823495,0.007181821,0.0040458427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049191136,0.0010692904,0.0028048467,0.0019845502,0.003128335,0.0047129733,0.0023125107,0.06722559,0.006663138],"category_scores_gemma":[0.05786643,0.0013527155,0.0017115559,0.001301509,0.0027601165,0.0041043432,0.0022853143,0.047686007,0.007042283],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101173166,0.000034063316,0.0028463192,0.00010504295,0.00006132262,0.0009015041,0.00015830048,0.000037960388,0.00009179929,0.0005067253,0.9900309,0.0051248646],"study_design_scores_gemma":[0.0010598139,0.00030231092,0.014958856,0.0021527251,0.0004925487,0.00482816,0.0019364688,0.0012585614,0.00064175547,0.010598534,0.9613137,0.00045659146],"about_ca_topic_score_codex":0.007825184,"about_ca_topic_score_gemma":0.007913545,"teacher_disagreement_score":0.06722559,"about_ca_system_score_codex":0.0028937827,"about_ca_system_score_gemma":0.0043155337,"threshold_uncertainty_score":0.026015043},"labels":[],"label_agreement":null},{"id":"W4392906644","doi":"10.1016/s1474-4422(24)00036-x","title":"Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","year":2024,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":120,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Holland Bloorview Kids Rehabilitation Hospital; Alberta Children's Hospital; Children's & Women's Health Centre of British Columbia; University of Calgary","funders":"Italfarmaco","keywords":"Duchenne muscular dystrophy; Medicine; Muscular dystrophy; Placebo; Dystrophin; Physical therapy; Pediatrics; Internal medicine; Alternative medicine; Pathology","score_opus":0.015321144511670604,"score_gpt":0.28214595699246814,"score_spread":0.26682481248079754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392906644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98496664,0.009269508,0.00041962217,0.00077754696,0.0004719541,0.0014816312,0.0010621641,0.00012728009,0.0014236931],"genre_scores_gemma":[0.98864335,0.0033696739,0.00084618956,0.0010598458,0.00028552715,0.00195879,0.0010246402,0.000029000765,0.0027829786],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99946624,0.00026933235,0.000029203246,0.00010583076,0.00004051748,0.00008892097],"domain_scores_gemma":[0.99930537,0.00022260383,0.00015291868,0.000042323492,0.000044052722,0.00023271597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001425203,0.001680245,0.0036206895,0.00036870682,0.0004773426,0.0009549815,0.000982502,0.002885395,0.0059928205],"category_scores_gemma":[0.0014230988,0.00060470303,0.0024017126,0.0003080278,0.0013602239,0.0009599536,0.00043157084,0.002974846,0.0008929605],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98052245,0.0023505036,0.0006071491,0.00095047173,0.001024933,0.00007166645,0.00007136642,0.00021979198,0.0024455558,0.00009626133,0.00075989455,0.010879965],"study_design_scores_gemma":[0.9552829,0.04199296,0.0016130932,0.00005055207,0.00031267272,0.00003194948,0.000029201068,0.00012078542,0.00016914014,0.00008541567,0.00030003328,0.00001124988],"about_ca_topic_score_codex":0.0015100382,"about_ca_topic_score_gemma":0.0031504626,"teacher_disagreement_score":0.0059928205,"about_ca_system_score_codex":0.0009991993,"about_ca_system_score_gemma":0.00084106164,"threshold_uncertainty_score":0.020048022},"labels":[],"label_agreement":null},{"id":"W4394695501","doi":"10.1016/s1474-4422(24)00121-2","title":"RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses","year":2024,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan; Saskatchewan Health; Montreal Neurological Institute and Hospital; McGill University; Saskatchewan Health Authority; University of British Columbia","funders":"Medical Research Council; Canadian Institutes of Health Research; Wellcome Trust; Canada Excellence Research Chairs, Government of Canada; National Institute of Neurological Disorders and Stroke; National Institute for Health and Care Research; National Institutes of Health; Cancer Research UK; Aligning Science Across Parkinson’s; Merck KGaA; Department of Health and Social Care; Michael J. Fox Foundation for Parkinson's Research; Mayo Foundation for Medical Education and Research; GlaxoSmithKline","keywords":"LRRK2; Proband; Disease; Neurogenetics; Rab; Genome-wide association study; Medicine; Genetics; Exome sequencing; Parkinson's disease; Genetic association; Genotyping; Exome; Biology; Single-nucleotide polymorphism; Genotype; Internal medicine; GTPase; Mutation; Gene","score_opus":0.04058787193801303,"score_gpt":0.3131351227711136,"score_spread":0.27254725083310055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394695501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99496585,0.0015496005,0.0010055077,0.00012524544,0.000010506802,0.000050530423,0.0009414667,0.00002727186,0.0013239629],"genre_scores_gemma":[0.9965983,0.00041136757,0.0014188065,0.00003284771,0.000014643435,0.000036754653,0.0010420297,0.000009221734,0.00043616092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906045,0.0004169919,0.000089157045,0.00019998314,0.00013490008,0.00009845839],"domain_scores_gemma":[0.9992156,0.00034326845,0.00012864817,0.00006471749,0.00015052175,0.00009713605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017720973,0.0007605372,0.00045863696,0.0033499028,0.00076409825,0.00043349058,0.0005758563,0.0006971499,0.003817291],"category_scores_gemma":[0.0018923357,0.00024035372,0.00086549553,0.0025047984,0.00032168732,0.0002034072,0.0006945844,0.00037539724,0.0005463275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006426076,0.00074951275,0.8734564,0.00042492177,0.0026912675,0.013757801,0.0012209694,0.0026138746,0.0497709,0.0012962824,0.0018456457,0.04574641],"study_design_scores_gemma":[0.00037049633,0.0009506431,0.96206605,0.00007290185,0.0013837144,0.018533932,0.0004332053,0.0037574214,0.0040622978,0.0009658852,0.0073562395,0.000047216254],"about_ca_topic_score_codex":0.006354589,"about_ca_topic_score_gemma":0.0043195905,"teacher_disagreement_score":0.006354589,"about_ca_system_score_codex":0.0004010866,"about_ca_system_score_gemma":0.00036165782,"threshold_uncertainty_score":0.012770116},"labels":[],"label_agreement":null},{"id":"W4394800579","doi":"10.1016/s1474-4422(24)00089-9","title":"Factors affecting brain maturation trajectories in early childhood","year":2024,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Neonatal and fetal brain pathology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Hospital for Sick Children; University of British Columbia","funders":"University of British Columbia","keywords":"Brain development; Quality of life (healthcare); Early childhood; Medicine; Promotion (chess); Psychology; Developmental psychology; Gerontology; Physical medicine and rehabilitation; Neuroscience; Nursing","score_opus":0.024028622519729634,"score_gpt":0.2722280275079838,"score_spread":0.24819940498825416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394800579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99308664,0.002792514,0.0001554319,0.0008574606,0.000023769653,0.0000062091462,0.00094876083,0.000014489801,0.0021147237],"genre_scores_gemma":[0.99682295,0.001835236,0.00016393034,0.00004692009,0.000015170153,0.000009238214,0.00046644817,0.000012697688,0.00062734814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995695,0.000076258184,0.000027203661,0.000083299106,0.00007099792,0.00017277268],"domain_scores_gemma":[0.9977621,0.00052733853,0.0009625972,0.00008736928,0.00031495726,0.00034563825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067691546,0.0002694175,0.00029740419,0.00090746797,0.0005555083,0.0015278006,0.00047244757,0.00051042164,0.0024437844],"category_scores_gemma":[0.0068238904,0.00019073405,0.0003051644,0.0015746999,0.0005039556,0.00069276616,0.00071680907,0.0007370657,0.00034974856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036110138,0.00005304823,0.9731101,0.00007860128,0.000097476695,0.00066620944,0.0015263435,0.00048121854,0.001170733,0.0012704019,0.0010406481,0.020144068],"study_design_scores_gemma":[0.00000121324,0.000032482247,0.997656,0.000039956365,0.000014369771,0.0002372142,0.0006689008,0.00006256014,0.00020511683,0.00032933493,0.0007484421,0.0000044783046],"about_ca_topic_score_codex":0.040209178,"about_ca_topic_score_gemma":0.043215174,"teacher_disagreement_score":0.040209178,"about_ca_system_score_codex":0.0010552774,"about_ca_system_score_gemma":0.0015101626,"threshold_uncertainty_score":0.07995027},"labels":[],"label_agreement":null},{"id":"W4394800582","doi":"10.1016/s1474-4422(24)00133-9","title":"Dementia prevention: from idealism to realism","year":2024,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Dementia; Idealism; Medicine; Stroke (engine); Disease; Realism; Gerontology; Internal medicine","score_opus":0.050921359853041234,"score_gpt":0.3505936350448056,"score_spread":0.29967227519176437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394800582","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007267839,0.0010174523,0.000026632142,0.9922192,0.0053953887,0.0000026866796,0.00000970599,0.0000038772255,0.0012523424],"genre_scores_gemma":[0.0017765451,0.0006631428,0.000094925206,0.9759946,0.019191012,0.000022429187,0.0000059558297,0.000009571037,0.0022419416],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9851088,0.0061542904,0.0013297419,0.0015011461,0.004153191,0.0017528706],"domain_scores_gemma":[0.9486495,0.03536432,0.0020327554,0.0012097344,0.005672004,0.0070715803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016948495,0.0013450781,0.0027236016,0.0016155567,0.010201314,0.01242262,0.003947611,0.14400424,0.009385233],"category_scores_gemma":[0.07966538,0.0013042488,0.0017722254,0.001302537,0.01518057,0.012979804,0.0055473624,0.11656341,0.0052791527],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058551184,0.0000403604,0.00022543018,0.00008875508,0.000024672569,0.00046799824,0.00044614516,0.000039616614,0.000060561215,0.02331058,0.9688738,0.006363513],"study_design_scores_gemma":[0.0004323761,0.000072204675,0.00077149057,0.0013630695,0.00005877918,0.00078959577,0.0018641152,0.0005826808,0.00012087926,0.12054828,0.8732761,0.000120352546],"about_ca_topic_score_codex":0.018483965,"about_ca_topic_score_gemma":0.026404686,"teacher_disagreement_score":0.14400424,"about_ca_system_score_codex":0.009537862,"about_ca_system_score_gemma":0.015743522,"threshold_uncertainty_score":0.089633286},"labels":[],"label_agreement":null},{"id":"W4394800606","doi":"10.1016/s1474-4422(24)00073-5","title":"Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial","year":2024,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Children's Hospital of Eastern Ontario; University of Ottawa; Montreal Neurological Institute and Hospital","funders":"","keywords":"Facioscapulohumeral muscular dystrophy; Medicine; Tolerability; Clinical endpoint; Placebo; Muscular dystrophy; Internal medicine; Physical therapy; Clinical trial; Surrogate endpoint; Muscle biopsy; Adverse effect; Biopsy; Pathology","score_opus":0.019641097763679075,"score_gpt":0.29850602104886403,"score_spread":0.278864923285185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394800606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9725094,0.015666304,0.0009612319,0.0015943028,0.0013329585,0.0023400174,0.0017302701,0.00031534128,0.003550248],"genre_scores_gemma":[0.9774431,0.00636449,0.0014274126,0.0023494184,0.0010915973,0.003539981,0.0017379529,0.000055459066,0.0059906994],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99933845,0.00031673367,0.00003589095,0.00012446719,0.00005081386,0.00013363929],"domain_scores_gemma":[0.9993068,0.00021173748,0.00015581054,0.000050745028,0.000051909738,0.00022295301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017902931,0.0026137538,0.004441876,0.000517805,0.0005138877,0.0013568741,0.0012473523,0.0030294908,0.009437083],"category_scores_gemma":[0.0017648796,0.00086549966,0.002366322,0.0003733873,0.0017097968,0.0015486033,0.00049268856,0.0037729554,0.0017628614],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.985558,0.0017513017,0.00021882994,0.00064368197,0.0007064415,0.000029195862,0.000023126246,0.00016925712,0.0015689167,0.00008392157,0.00073965424,0.008507666],"study_design_scores_gemma":[0.97722626,0.021085666,0.0007358997,0.000031785694,0.0002319488,0.000015970556,0.000012533282,0.00012447975,0.0001393921,0.000092242175,0.0002933934,0.00001035205],"about_ca_topic_score_codex":0.0010667543,"about_ca_topic_score_gemma":0.0015250711,"teacher_disagreement_score":0.009437083,"about_ca_system_score_codex":0.0009062764,"about_ca_system_score_gemma":0.0007476321,"threshold_uncertainty_score":0.031570196},"labels":[],"label_agreement":null},{"id":"W4394800620","doi":"10.1016/s1474-4422(24)00084-x","title":"Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study","year":2024,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Down syndrome and intellectual disability research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Advancing Translational Sciences; National Institute of Mental Health; Instituto de Salud Carlos III; Avid Radiopharmaceuticals; National Institutes of Health; Grifols; Deutsches Zentrum für Neurodegenerative Erkrankungen; National Institute of Child Health and Human Development; GHR Foundation; Fondation Brain Canada; Ministry of Health and Welfare; Eisai; University of Oxford; Korea Health Industry Development Institute; National Institute on Aging; National Institute for Health and Care Research; U.S. Department of Defense; Eli Lilly and Company; Alzheimer's Association; Biogen; Canadian Institutes of Health Research; Autism Speaks; NIHR Cambridge Biomedical Research Centre","keywords":"Cross-sectional study; Alzheimer's disease; Disease; Medicine; Down syndrome; Internal medicine; Pathology; Psychiatry","score_opus":0.09807487610417275,"score_gpt":0.4099793309425782,"score_spread":0.31190445483840545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394800620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990765,0.00029026502,0.00014208541,0.000014769678,0.000007948405,0.000025557245,0.00031958977,0.0000019540678,0.00012135825],"genre_scores_gemma":[0.99896824,0.00013686383,0.00017862978,0.00004348116,0.000010834945,0.000047418747,0.0005260556,0.00000223509,0.000086336564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843436,0.0005158731,0.00024322752,0.00051139324,0.00016101137,0.00013408494],"domain_scores_gemma":[0.9971386,0.0006650969,0.001033499,0.00032311413,0.00042456755,0.00041514364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002661424,0.0005608425,0.0007050571,0.0011975636,0.00071041816,0.0008870021,0.0005239068,0.0010503877,0.0009741431],"category_scores_gemma":[0.004996492,0.00063145737,0.0012142846,0.0011818914,0.00048373724,0.00091749657,0.00088888116,0.00066978217,0.000239835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047570397,0.000075547585,0.99790573,0.00003014861,0.00039126852,0.000075526405,0.00027073163,0.0000283001,0.00019972057,0.000022076661,0.00005258357,0.00047260989],"study_design_scores_gemma":[0.000049260994,0.00042601052,0.99838006,0.000013859617,0.00021045492,0.00019799788,0.00039804718,0.00012150473,0.000047414243,0.000035964815,0.00011205363,0.000007469989],"about_ca_topic_score_codex":0.006405936,"about_ca_topic_score_gemma":0.0074677584,"teacher_disagreement_score":0.006405936,"about_ca_system_score_codex":0.0004029726,"about_ca_system_score_gemma":0.00027941546,"threshold_uncertainty_score":0.0140751},"labels":[],"label_agreement":null},{"id":"W4394800621","doi":"10.1016/s1474-4422(24)00083-8","title":"MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study","year":2024,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; University of Toronto; Western University; Ontario Brain Institute; University of British Columbia; McGill University; Toronto Rehabilitation Institute; Douglas Mental Health University Institute; Occupational Cancer Research Centre; Health Sciences Centre; University Health Network; Sunnybrook Health Science Centre","funders":"State of Florida; National Institute on Deafness and Other Communication Disorders; National Institute on Aging; Faculty of Medicine and Health, University of Sydney; Nederlands Herseninstituut; NIHR Oxford Biomedical Research Centre; Schulich School of Medicine and Dentistry; National Health and Medical Research Council; Medical Research Council; Alzheimer's Disease Research Center, University of Pittsburgh; NIHR Cambridge Biomedical Research Centre; Tau Consortium; Directorate for Biological Sciences; Rossy Foundation; Drake Foundation; Schulich School of Medicine and Dentistry, Western University; National Institutes of Health; Nationale Genossenschaft für die Lagerung radioaktiver Abfälle; Goizueta Business School, Emory University; Institute of Psychiatry, Psychology and Neuroscience, King’s College London; Victorian Brain Bank; UK Dementia Research Institute; Yulgilbar Foundation; Irving Medical Center, Columbia University; Centre hospitalier universitaire Sainte-Justine; Sorbonne Université; Universiteit Antwerpen; Centre Hospitalier Universitaire de Rennes; Centre Hospitalier Régional Universitaire de Montpellier; National Institute of Neurological Disorders and Stroke; Arizona Biomedical Research Commission; Deutsches Zentrum für Neurodegenerative Erkrankungen; Memphis Research Consortium; Banco Bilbao Vizcaya Argentaria; Chung Hua University; Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta; Università degli Studi di Firenze; Karolinska Institutet; University of California, San Francisco; U.S. Department of Health and Human Services; Mayo Clinic; Universiteit Gent; Newcastle upon Tyne Hospitals NHS Foundation Trust; Aligning Science Across Parkinson’s; University of Toronto; CurePSP; Edmond J. Safra Philanthropic Foundation; New York State Department of Health; Newcastle University; Fonds de Recherche du Québec - Santé; School of Medicine, Emory University; Universitair Ziekenhuis Gent; King's College London; University of Cambridge; Parkinson's UK; Department of Health and Social Care; Alzheimer Society; National Institute for Health and Care Research; Nederlandse Hersenbank; NIHR Newcastle Biomedical Research Centre; Evelyn Trust; Alzheimer’s Research UK; Lewy Body Dementia Association; Canadian Institutes of Health Research; Alzheimer's Society; FightMND; PSP Association; Mayo Foundation for Medical Education and Research; Northwestern University; Sunnybrook Research Institute; Wellcome Trust; Klinisch Chemisch Laboratorium; Arizona Department of Health Services; King's College Hospital NHS Foundation Trust; Rainwater Charitable Foundation; Fondation Brain Canada; London Health Sciences Centre; McGill University; Demensförbundet; Parkinson’s Victoria; Michael J. Fox Foundation for Parkinson's Research; Emory University; Cambridge University Hospitals; PCB Solutions; University of Pennsylvania; Canada First Research Excellence Fund; Little Family Foundation; National Institute on Handicapped Research; Fundación BBVA; Universidade do Minho; Brain Research UK; U.S. Department of Defense","keywords":"Progressive supranuclear palsy; Corticobasal degeneration; Haplotype; Tauopathy; Tau protein; Frontotemporal dementia; Disease; Medicine; Dementia; Pick's disease; Genetics; Alzheimer's disease; Pathology; Biology; Genotype; Neurodegeneration; Gene","score_opus":0.027150916931590954,"score_gpt":0.3250310894294317,"score_spread":0.29788017249784077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394800621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984786,0.00017807203,0.0001397341,0.000057229896,0.000009162723,0.000018153596,0.00054875325,0.000005098403,0.0005652987],"genre_scores_gemma":[0.9988539,0.00006161299,0.00022861875,0.000033523524,0.000028057058,0.000023247145,0.0005637464,0.000005393833,0.00020180093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931586,0.00018225613,0.000065277985,0.00020229013,0.0001340791,0.00010013476],"domain_scores_gemma":[0.99854565,0.00028304008,0.00045157352,0.00014482987,0.00018892784,0.0003859317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011205475,0.00081824075,0.0005798858,0.001243001,0.0011561216,0.0011119075,0.00057432946,0.0009868499,0.0022527238],"category_scores_gemma":[0.0025380151,0.00038758563,0.0005069335,0.0018240025,0.00040470844,0.0003777636,0.000789688,0.0006819993,0.00027824525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011430971,0.00012025506,0.99420196,0.000019808704,0.0003557631,0.0008122758,0.00029394924,0.00013070031,0.0012715561,0.00008858904,0.00044651123,0.0011156496],"study_design_scores_gemma":[0.00016245623,0.00017551758,0.9964259,0.000017199682,0.00030869583,0.001339125,0.00020476803,0.0005497344,0.0002059965,0.00009807325,0.0004947895,0.000017683355],"about_ca_topic_score_codex":0.009050293,"about_ca_topic_score_gemma":0.008866417,"teacher_disagreement_score":0.009050293,"about_ca_system_score_codex":0.00034754307,"about_ca_system_score_gemma":0.00038745874,"threshold_uncertainty_score":0.017995179},"labels":[],"label_agreement":null},{"id":"W4396915254","doi":"10.1016/s1474-4422(24)00122-4","title":"Haemorrhagic stroke and brain vascular malformations in women: risk factors and clinical features","year":2024,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Intracerebral and Subarachnoid Hemorrhage Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Leids Universitair Medisch Centrum; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; ZonMw","keywords":"Medicine; Pregnancy; Stroke (engine); Eclampsia; Arteriovenous malformation; Subarachnoid haemorrhage; Pediatrics; Subarachnoid hemorrhage; Intensive care medicine; Aneurysm; Surgery","score_opus":0.027100889914798736,"score_gpt":0.3282623116594957,"score_spread":0.30116142174469696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396915254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866029,0.0068462742,0.00017805093,0.0013699785,0.00008661057,0.000017946924,0.0010660234,0.0000149658135,0.0038172288],"genre_scores_gemma":[0.9945537,0.0032816073,0.00018021732,0.0002383165,0.00029564902,0.00001679148,0.00064726494,0.000006926624,0.0007795746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997441,0.00006156242,0.000028989292,0.000051036604,0.00004192675,0.000072371186],"domain_scores_gemma":[0.9992262,0.00021918549,0.00026245456,0.000049536466,0.000051931893,0.0001906959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033418872,0.0004243932,0.00071914296,0.0011645494,0.00042586567,0.0010435038,0.0004313218,0.0010777956,0.0036523219],"category_scores_gemma":[0.002505431,0.00046382178,0.0006323984,0.0028287491,0.00047630494,0.0014118972,0.00046012976,0.00087404327,0.000564187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028737122,0.00004737261,0.99447626,0.000024181905,0.000082235296,0.0009175043,0.00015240352,0.000025276766,0.0003927363,0.000097707416,0.00029679408,0.0031999517],"study_design_scores_gemma":[0.000015832842,0.00009174385,0.9965154,0.000023367511,0.00005070748,0.0020785357,0.00045922265,0.00007007075,0.000034956294,0.0003178847,0.0003267659,0.000015449017],"about_ca_topic_score_codex":0.0032212208,"about_ca_topic_score_gemma":0.0035629172,"teacher_disagreement_score":0.0036523219,"about_ca_system_score_codex":0.00024487192,"about_ca_system_score_gemma":0.00048616945,"threshold_uncertainty_score":0.0122182965},"labels":[],"label_agreement":null},{"id":"W4398147758","doi":"10.1016/s1474-4422(24)00223-0","title":"Amyotrophic lateral sclerosis: a lesson in translation","year":2024,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"","keywords":"Amyotrophic lateral sclerosis; SOD1; Medicine; Riluzole; Frontotemporal dementia; Clinical trial; C9orf72; Neuroscience; Physical medicine and rehabilitation; Disease; Dementia; Oncology; Internal medicine; Psychology","score_opus":0.12052447291214426,"score_gpt":0.3391764895561311,"score_spread":0.21865201664398687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398147758","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014129272,0.09198916,0.00050537,0.7611792,0.13948488,0.000009748761,0.0001405872,0.00006950438,0.0064802323],"genre_scores_gemma":[0.0073218057,0.114902794,0.001782157,0.5812688,0.28275684,0.0000733565,0.00021657058,0.00024315805,0.0114346],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99189067,0.002790465,0.0014058021,0.00095870026,0.0023615183,0.0005928565],"domain_scores_gemma":[0.94360745,0.033942055,0.0015178156,0.0035159125,0.013783639,0.0036331317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018864805,0.0015756493,0.0024712062,0.002317114,0.0019460984,0.0072778687,0.0028778664,0.017907446,0.016510429],"category_scores_gemma":[0.06550447,0.0007220598,0.0014419265,0.0016007021,0.011846554,0.014996846,0.004712884,0.033843115,0.01269108],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001234634,0.000044978,0.00017947893,0.0013278435,0.000040643263,0.00028267739,0.0006525784,0.00012070704,0.00017329396,0.034211405,0.90962106,0.05322185],"study_design_scores_gemma":[0.00017974566,0.000051529583,0.00049464725,0.0024791707,0.000038925216,0.00033244485,0.00072610384,0.000090518086,0.000092834394,0.052914992,0.94253194,0.00006726104],"about_ca_topic_score_codex":0.010628526,"about_ca_topic_score_gemma":0.01008802,"teacher_disagreement_score":0.018864805,"about_ca_system_score_codex":0.0051583066,"about_ca_system_score_gemma":0.008970372,"threshold_uncertainty_score":0.099767864},"labels":[],"label_agreement":null},{"id":"W4398147835","doi":"10.1016/s1474-4422(24)00134-0","title":"Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial","year":2024,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Health Sciences Centre; Western University; Sunnybrook Health Science Centre; Montreal Neurological Institute and Hospital","funders":"","keywords":"Amyotrophic lateral sclerosis; Medicine; Placebo; Double blind; Physical therapy; Clinical trial; Physical medicine and rehabilitation; Internal medicine; Alternative medicine; Pathology; Disease","score_opus":0.045541862834641476,"score_gpt":0.3116773344806093,"score_spread":0.26613547164596785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398147835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869644,0.007026311,0.00036642098,0.0008104417,0.0005021265,0.0012563935,0.0009717035,0.00015097074,0.0019512888],"genre_scores_gemma":[0.98934364,0.0027132442,0.0007573105,0.001390688,0.00045297973,0.0016699169,0.0010240979,0.00002794273,0.0026202283],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99943584,0.0002664455,0.000032643766,0.00010635508,0.00004450858,0.00011409603],"domain_scores_gemma":[0.9992084,0.00023776125,0.00017228814,0.000056570705,0.000048587062,0.00027650633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017416312,0.0018914245,0.0032934444,0.0003591772,0.00051967625,0.0012166348,0.0012373622,0.0023201637,0.0054125395],"category_scores_gemma":[0.001505246,0.00065541425,0.002200826,0.00033949982,0.0012269673,0.0011750925,0.00041581693,0.0034684206,0.0012001873],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98089117,0.0024896034,0.00065412314,0.00063816196,0.0009887804,0.000057752262,0.00006091658,0.0001616656,0.0023351612,0.00008073084,0.0008486504,0.010793295],"study_design_scores_gemma":[0.9652905,0.031064969,0.0024236555,0.000028907854,0.00038885992,0.00003180374,0.000023459954,0.00017740493,0.00014686963,0.00008061849,0.0003276145,0.000015407968],"about_ca_topic_score_codex":0.0013963671,"about_ca_topic_score_gemma":0.0031399361,"teacher_disagreement_score":0.0054125395,"about_ca_system_score_codex":0.0007308219,"about_ca_system_score_gemma":0.0010340101,"threshold_uncertainty_score":0.018106759},"labels":[],"label_agreement":null},{"id":"W4399610274","doi":"10.1016/s1474-4422(24)00206-0","title":"Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trial","year":2024,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Health and Medical Research Council; Boehringer Ingelheim","keywords":"Tenecteplase; Thrombolysis; Medicine; Stroke (engine); Ischaemic stroke; Randomized controlled trial; Cardiology; Tissue plasminogen activator; Internal medicine; Perfusion scanning; Anesthesia; Perfusion; Ischemia; Myocardial infarction","score_opus":0.020680896476744808,"score_gpt":0.29737218790768805,"score_spread":0.27669129143094323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399610274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98596907,0.0028281086,0.0009003418,0.0006180675,0.00041770155,0.0072390493,0.0006185882,0.00006365724,0.0013454368],"genre_scores_gemma":[0.98617953,0.0011184957,0.0015579683,0.0009407744,0.00035922712,0.008263973,0.00048124118,0.000013768967,0.0010849219],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978542,0.0013994182,0.00020392204,0.00023626379,0.00009403464,0.00021216614],"domain_scores_gemma":[0.9979882,0.0006616611,0.0006250233,0.00016388626,0.00012737612,0.00043377443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048330207,0.0016345233,0.0029804332,0.00038754707,0.00039349383,0.00109987,0.0008751158,0.0018355716,0.005041191],"category_scores_gemma":[0.0044679474,0.0005069195,0.0024588376,0.00046845447,0.0011871413,0.0010693423,0.00050329167,0.0018369316,0.00060186203],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9911459,0.0019546004,0.00047725113,0.0004507623,0.00063954643,0.000024889934,0.00003345482,0.00012832423,0.0012105093,0.00006168018,0.00017543505,0.0036976098],"study_design_scores_gemma":[0.96414256,0.03377463,0.0010450566,0.000022262255,0.00043427825,0.000020476313,0.000011490269,0.00014999782,0.00015557048,0.000111820824,0.00012424873,0.0000075776306],"about_ca_topic_score_codex":0.00039107725,"about_ca_topic_score_gemma":0.0009775166,"teacher_disagreement_score":0.005041191,"about_ca_system_score_codex":0.0006183812,"about_ca_system_score_gemma":0.0011227337,"threshold_uncertainty_score":0.025559783},"labels":[],"label_agreement":null},{"id":"W4399615205","doi":"10.1016/s1474-4422(24)00167-4","title":"Neurological disorders caused by novel non-coding repeat expansions: clinical features and differential diagnosis","year":2024,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Medical Research Council; Canadian Institutes of Health Research; Fondazione Cariplo","keywords":"Differential diagnosis; Medicine; Clinical neurology; Coding (social sciences); Physical medicine and rehabilitation; Neuroscience; Pathology; Psychology; Mathematics; Statistics","score_opus":0.05921271414879134,"score_gpt":0.3312657438543549,"score_spread":0.27205302970556355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399615205","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9594203,0.016473869,0.003273061,0.002354764,0.0002053706,0.00006492894,0.0005391427,0.00013535851,0.017533123],"genre_scores_gemma":[0.9923233,0.0037850535,0.0019121338,0.00049682683,0.0004894515,0.000014911195,0.00027052686,0.000021479984,0.0006862149],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9997837,0.000024938967,0.000033701286,0.00005519544,0.000048886603,0.00005356561],"domain_scores_gemma":[0.99934965,0.00032092928,0.00016719171,0.000030015186,0.00005603202,0.00007624192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027617556,0.0010397077,0.0006700781,0.00095704454,0.0003551658,0.0006196735,0.0005989653,0.0018978484,0.0017382783],"category_scores_gemma":[0.0016387212,0.00025170943,0.0003647194,0.00088486215,0.00079233036,0.00071175006,0.00042865015,0.00076328067,0.00061610836],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005390135,0.00013142897,0.102864094,0.00019635765,0.00008637145,0.8370724,0.00035578094,0.0007195202,0.021747584,0.0017320182,0.0036992142,0.030856268],"study_design_scores_gemma":[0.000041582087,0.00009503214,0.066623956,0.0000710838,0.00008220183,0.9260403,0.0002563268,0.0007736628,0.0017832349,0.0023549176,0.0018525104,0.000025248197],"about_ca_topic_score_codex":0.000674239,"about_ca_topic_score_gemma":0.00078374794,"teacher_disagreement_score":0.0018978484,"about_ca_system_score_codex":0.00026985272,"about_ca_system_score_gemma":0.00032143315,"threshold_uncertainty_score":0.0058151484},"labels":[],"label_agreement":null},{"id":"W4399616927","doi":"10.1016/s1474-4422(24)00212-6","title":"Concerns with the new biological research criteria for synucleinopathy – Authors' reply","year":2024,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital; Toronto Western Hospital","funders":"","keywords":"MEDLINE; Data science; Medicine; Psychology; Computer science; Biology","score_opus":0.17504854452259241,"score_gpt":0.3999181929545974,"score_spread":0.224869648432005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399616927","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001631283,0.0011094754,0.000041444684,0.97195315,0.026048386,0.000005603806,0.000030935724,0.000012516183,0.0006353549],"genre_scores_gemma":[0.001429235,0.0004217297,0.00007555106,0.9564351,0.040068604,0.000019824001,0.000013551917,0.000013512478,0.0015228651],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924217,0.0021006998,0.0011284676,0.0011672421,0.0022302351,0.00095168484],"domain_scores_gemma":[0.968997,0.0192716,0.0019733687,0.0009158049,0.00526386,0.0035784498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008079709,0.0010608633,0.0030661633,0.0013976443,0.0045009404,0.006059047,0.0031528987,0.11011934,0.005513503],"category_scores_gemma":[0.04837901,0.0015193375,0.0021149071,0.0010279587,0.00630133,0.006114033,0.0032004414,0.086962864,0.0060581705],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060631708,0.000021319423,0.00042581878,0.000060213875,0.0000313473,0.0009986379,0.000197755,0.000035569858,0.000114932096,0.0018431176,0.9927555,0.0034552114],"study_design_scores_gemma":[0.0002506043,0.000091509006,0.0012971987,0.0004881628,0.00010110044,0.0021612868,0.00086358184,0.00034329804,0.00027793145,0.013648483,0.98029,0.00018694454],"about_ca_topic_score_codex":0.004488821,"about_ca_topic_score_gemma":0.00679227,"teacher_disagreement_score":0.11011934,"about_ca_system_score_codex":0.0038580014,"about_ca_system_score_gemma":0.005117824,"threshold_uncertainty_score":0.042730093},"labels":[],"label_agreement":null},{"id":"W4400721014","doi":"10.1016/s1474-4422(24)00274-6","title":"Clinical versus biomarker-based diagnosis of neurocognitive disorders","year":2024,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network","funders":"Parkinsonfonden; National Institute on Aging; Deutsche Forschungsgemeinschaft; Canadian Institutes of Health Research; Parkinson Canada; Fondation Brain Canada; National Institutes of Health; Alzheimer's Association","keywords":"Neurocognitive; Biomarker; Medicine; Psychiatry; Cognition; Biology","score_opus":0.0955460231696886,"score_gpt":0.4031418260545736,"score_spread":0.307595802884885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400721014","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007955714,0.002085106,0.0000978103,0.97925687,0.01473095,0.000011195729,0.000117730546,0.000015247592,0.0028894632],"genre_scores_gemma":[0.011730965,0.0016724318,0.0003694765,0.8809531,0.102972396,0.000037682035,0.000076352175,0.000023125758,0.0021645722],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9910847,0.003867022,0.0016004242,0.0008584347,0.0018504236,0.00073902187],"domain_scores_gemma":[0.96056306,0.028262349,0.0016924401,0.000771238,0.0056956755,0.0030153217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011229588,0.00075319025,0.0025096268,0.0018754364,0.0028456456,0.0041578664,0.0021127558,0.053572387,0.006575257],"category_scores_gemma":[0.07164663,0.0008127232,0.0014834957,0.0015935214,0.0034399813,0.0035530967,0.0011881659,0.02874401,0.0053431243],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007737291,0.000121852085,0.007782122,0.00022440495,0.0001269588,0.002555991,0.00018225143,0.00013229303,0.00039495516,0.0067326627,0.94784284,0.03313002],"study_design_scores_gemma":[0.004048016,0.00067653647,0.028351178,0.0041290247,0.00072421005,0.0121266,0.0019054917,0.005444502,0.0013885393,0.09416881,0.8466435,0.0003935352],"about_ca_topic_score_codex":0.010202455,"about_ca_topic_score_gemma":0.016440187,"teacher_disagreement_score":0.053572387,"about_ca_system_score_codex":0.0044127624,"about_ca_system_score_gemma":0.004500958,"threshold_uncertainty_score":0.05938846},"labels":[],"label_agreement":null},{"id":"W4400721146","doi":"10.1016/s1474-4422(24)00209-6","title":"Detecting awareness after acute brain injury","year":2024,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Traumatic Brain Injury Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Medical emergency; Traumatic brain injury; Emergency medicine; Psychiatry","score_opus":0.17657616511560875,"score_gpt":0.45800052835976074,"score_spread":0.281424363244152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400721146","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004381828,0.99934036,0.000017746988,0.00018019148,0.00019454677,0.000007185388,0.000022697055,0.000002620933,0.00019074441],"genre_scores_gemma":[0.001008029,0.9980046,0.00006652049,0.00053205993,0.0002140479,0.00001428438,0.000028598977,0.0000011238589,0.00013072611],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99916303,0.00022896337,0.00020838843,0.000121989026,0.00021363582,0.00006385628],"domain_scores_gemma":[0.99548197,0.003290629,0.0006736997,0.00005096385,0.00039498316,0.00010783523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018567533,0.0015272908,0.004586319,0.0041943137,0.00028523552,0.0014908988,0.0012382759,0.002398484,0.0069520106],"category_scores_gemma":[0.010185394,0.000570676,0.0023028487,0.0025660978,0.0007689272,0.0016791614,0.0012136034,0.0023419466,0.0011922158],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003484018,0.000046235768,0.0003842099,0.19862387,0.0012822677,0.00011341248,0.00007810874,0.00011423551,0.00018731327,0.00052965956,0.02569855,0.77259374],"study_design_scores_gemma":[0.0010857033,0.0009880041,0.011335291,0.49988535,0.01942025,0.00227903,0.0005514732,0.00019684453,0.00065582746,0.00342458,0.4600272,0.00015055102],"about_ca_topic_score_codex":0.008296666,"about_ca_topic_score_gemma":0.015563552,"teacher_disagreement_score":0.008296666,"about_ca_system_score_codex":0.0015220331,"about_ca_system_score_gemma":0.0034822444,"threshold_uncertainty_score":0.023256838},"labels":[],"label_agreement":null},{"id":"W4400901227","doi":"10.1016/s1474-4422(24)00216-3","title":"Safety, tolerability, and pharmacokinetics of antisense oligonucleotide BIIB078 in adults with C9orf72-associated amyotrophic lateral sclerosis: a phase 1, randomised, double blinded, placebo-controlled, multiple ascending dose study","year":2024,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; University of Calgary; Montreal Neurological Institute and Hospital","funders":"Biogen","keywords":"Amyotrophic lateral sclerosis; Tolerability; Pharmacokinetics; Placebo; Medicine; C9orf72; Internal medicine; Pharmacology; Adverse effect; Pathology; Disease","score_opus":0.051970871787159964,"score_gpt":0.3354768177880474,"score_spread":0.2835059460008874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400901227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947547,0.0027347312,0.0003209686,0.00021755093,0.00014900455,0.00058303494,0.00043202273,0.00006947222,0.0007384218],"genre_scores_gemma":[0.99288684,0.0018816978,0.00075088453,0.0007531088,0.00026989018,0.0010766023,0.0006680477,0.000024651908,0.0016883065],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996203,0.00016047205,0.00002570495,0.00008597464,0.000042157782,0.00006531325],"domain_scores_gemma":[0.99945205,0.00012045578,0.00013126538,0.00003436278,0.000051024716,0.00021079807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009543648,0.0018509985,0.002542471,0.0003315203,0.00037081412,0.0007730088,0.00057177874,0.00189859,0.002734729],"category_scores_gemma":[0.0011218153,0.0007496632,0.0010720126,0.00029265712,0.00081032666,0.0011022724,0.00024218873,0.002532025,0.0008012334],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9474184,0.008584331,0.0012941122,0.00044437387,0.0009150168,0.000077699326,0.00009642523,0.00036891972,0.01841821,0.00006328403,0.00074850983,0.021570671],"study_design_scores_gemma":[0.7116744,0.27326494,0.010489927,0.0000417112,0.0009729609,0.00008861458,0.00005869961,0.0007115246,0.0015813875,0.00015900715,0.000910131,0.000046719408],"about_ca_topic_score_codex":0.00081918354,"about_ca_topic_score_gemma":0.0012432075,"teacher_disagreement_score":0.002734729,"about_ca_system_score_codex":0.00053847424,"about_ca_system_score_gemma":0.0006416411,"threshold_uncertainty_score":0.009148538},"labels":[],"label_agreement":null},{"id":"W4401057297","doi":"10.1016/s1474-4422(24)00278-3","title":"Endovascular thrombectomy for acute ischaemic stroke with established large infarct (TENSION): 12-month outcomes of a multicentre, open-label, randomised trial","year":2024,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"European Commission","keywords":"Medicine; Ischaemic stroke; Stroke (engine); Open label; Acute stroke; Endovascular treatment; Randomized controlled trial; Internal medicine; Cardiology; Surgery; Tissue plasminogen activator; Ischemia; Aneurysm","score_opus":0.034472132029581846,"score_gpt":0.3220161830991929,"score_spread":0.28754405106961106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401057297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9710684,0.010121142,0.0014471116,0.001018701,0.0010171559,0.009406397,0.003230555,0.0001238109,0.0025667588],"genre_scores_gemma":[0.96497136,0.003564634,0.003043727,0.0015244592,0.0015586527,0.019123115,0.0038378465,0.00003451714,0.0023416174],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99366075,0.0043519433,0.0006279634,0.0007000202,0.00030658665,0.00035288482],"domain_scores_gemma":[0.99468094,0.001260317,0.0018575907,0.00064706197,0.0004981512,0.0010559561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007825801,0.0021916777,0.003684387,0.0007614455,0.0007259429,0.0019518203,0.0010138053,0.0034665172,0.0062089697],"category_scores_gemma":[0.01033749,0.0006651443,0.0032054926,0.00091161556,0.0011130271,0.0023452353,0.0014157095,0.0022628284,0.0008463532],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99116385,0.0012802376,0.0010271602,0.00062557857,0.0015966743,0.000027241536,0.000032759286,0.00010170168,0.00048111557,0.000069600406,0.00037250307,0.0032216096],"study_design_scores_gemma":[0.968501,0.02557175,0.0036918065,0.00007100172,0.0012693236,0.000047024114,0.000020641899,0.0001696486,0.00008639495,0.00012392536,0.0004307852,0.000016865495],"about_ca_topic_score_codex":0.0007227507,"about_ca_topic_score_gemma":0.0011733242,"teacher_disagreement_score":0.007825801,"about_ca_system_score_codex":0.0008496427,"about_ca_system_score_gemma":0.00097333605,"threshold_uncertainty_score":0.04138732},"labels":[],"label_agreement":null},{"id":"W4401558826","doi":"10.1016/s1474-4422(24)00316-8","title":"Pragmatic outcomes for stroke research","year":2024,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Stroke (engine); Medicine; Physical medicine and rehabilitation; Psychology; Engineering","score_opus":0.09733558514523016,"score_gpt":0.38604256570571327,"score_spread":0.2887069805604831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401558826","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000913028,0.0030428797,0.00014394734,0.9829988,0.010492035,0.000021878424,0.00007607319,0.000013888721,0.003119093],"genre_scores_gemma":[0.0033647304,0.0016165999,0.0006836441,0.94799215,0.044062193,0.0002620477,0.00007570639,0.00003632304,0.0019065867],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.7688686,0.15427673,0.020608611,0.008189852,0.038876124,0.009180062],"domain_scores_gemma":[0.47685516,0.41884306,0.013229456,0.017994368,0.029369239,0.04370872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.15762767,0.002291543,0.0065736095,0.004271488,0.0094793225,0.021602178,0.0069303014,0.12681682,0.030115962],"category_scores_gemma":[0.47928888,0.002637276,0.0047659897,0.0036376973,0.024760831,0.025825903,0.022370782,0.08835873,0.010160106],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018013323,0.00004424018,0.0004286215,0.00040067913,0.00012475655,0.00028233213,0.00022285504,0.000060067174,0.00004087882,0.03876597,0.94301426,0.016435247],"study_design_scores_gemma":[0.0019319113,0.00012719214,0.0017265143,0.004860644,0.0002553535,0.0005380446,0.00083743787,0.0005525074,0.00012643747,0.40141398,0.5874419,0.00018812016],"about_ca_topic_score_codex":0.008220347,"about_ca_topic_score_gemma":0.015320943,"teacher_disagreement_score":0.15762767,"about_ca_system_score_codex":0.017658949,"about_ca_system_score_gemma":0.045338172,"threshold_uncertainty_score":0.8336248},"labels":[],"label_agreement":null},{"id":"W4401805747","doi":"10.1016/s1474-4422(24)00364-8","title":"The Yaoundé Declaration","year":2024,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Global Peace and Security Dynamics","field":"Social Sciences","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Declaration; Political science; Law","score_opus":0.04717381111692802,"score_gpt":0.31306443765973785,"score_spread":0.2658906265428098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401805747","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016349452,0.012489284,0.0005790295,0.81078666,0.05706296,0.000089955305,0.0007454073,0.00009170852,0.116520084],"genre_scores_gemma":[0.02223009,0.004500996,0.001146848,0.7091905,0.016572658,0.0004952687,0.0003489399,0.00014785463,0.24536686],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918435,0.0022835121,0.00056955987,0.00062321237,0.0021871512,0.0024929885],"domain_scores_gemma":[0.99429387,0.0022473137,0.00073165144,0.0004867957,0.00131372,0.0009265605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009389826,0.0010038285,0.001524973,0.001121709,0.004835918,0.008498954,0.001999223,0.036181223,0.018745495],"category_scores_gemma":[0.034868922,0.0008838704,0.0011258788,0.001223616,0.004885385,0.0035212024,0.006964475,0.03079438,0.009788464],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001202702,0.000030473604,0.0003918131,0.00020557575,0.000044119453,0.0009622061,0.0005436472,0.000115752875,0.00023148686,0.12090231,0.8630818,0.013370539],"study_design_scores_gemma":[0.0000473557,0.000012266937,0.0005317126,0.0004665194,0.000017810182,0.00024312049,0.00016874385,0.000062090185,0.00013282323,0.01811325,0.98018277,0.000021499045],"about_ca_topic_score_codex":0.009201955,"about_ca_topic_score_gemma":0.013506896,"teacher_disagreement_score":0.036181223,"about_ca_system_score_codex":0.0069599156,"about_ca_system_score_gemma":0.01860802,"threshold_uncertainty_score":0.06270987},"labels":[],"label_agreement":null},{"id":"W4402497563","doi":"10.1016/s1474-4422(24)00291-6","title":"Frailty for neurologists: perspectives on how frailty influences care planning","year":2024,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Frailty in Older Adults","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Dalhousie University","keywords":"Gerontology; Psychology; Medicine","score_opus":0.18268218875449305,"score_gpt":0.4232887373552949,"score_spread":0.24060654860080183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402497563","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006806856,0.99164903,0.00003852511,0.00741112,0.00043481428,0.0000015056271,0.000020306245,0.0000022858146,0.00037428952],"genre_scores_gemma":[0.0018435096,0.99263614,0.00018626644,0.004058389,0.001073281,0.000011002341,0.000031166506,0.0000018167866,0.00015844028],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99786526,0.0010287463,0.0003164879,0.00018461086,0.00040070858,0.00020408152],"domain_scores_gemma":[0.9835466,0.012907956,0.0011009239,0.000147587,0.0016567395,0.0006402223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007486262,0.0009805546,0.0037076701,0.00231386,0.0007163665,0.0041738264,0.0017516445,0.0047918437,0.006193301],"category_scores_gemma":[0.02146093,0.0004218887,0.0018625241,0.00318216,0.0010454934,0.003203575,0.002296312,0.005484978,0.0009932583],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024804007,0.000094777526,0.001620501,0.06053945,0.0015071972,0.00032696797,0.0007832285,0.00080014014,0.00015056219,0.013393706,0.12595694,0.79457855],"study_design_scores_gemma":[0.00022994947,0.00018826297,0.006945353,0.2253734,0.002274627,0.00090808416,0.0015256307,0.00029132696,0.00007532562,0.01736297,0.7446937,0.00013152201],"about_ca_topic_score_codex":0.019526856,"about_ca_topic_score_gemma":0.052966885,"teacher_disagreement_score":0.019526856,"about_ca_system_score_codex":0.0043859645,"about_ca_system_score_gemma":0.010755828,"threshold_uncertainty_score":0.03959167},"labels":[],"label_agreement":null},{"id":"W4402497576","doi":"10.1016/s1474-4422(24)00355-7","title":"Looking beyond the neurological diagnosis: considering frailty","year":2024,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Frailty in Older Adults","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Research (Canada)","funders":"","keywords":"Medicine; Computer science; Psychology","score_opus":0.055353812983606594,"score_gpt":0.31151605627027285,"score_spread":0.25616224328666626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402497576","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01045006,0.32914877,0.0019883201,0.63114405,0.015620825,0.00002340588,0.00035779047,0.000037207177,0.011229595],"genre_scores_gemma":[0.2284424,0.34720933,0.0039060728,0.30197442,0.11440992,0.00008501368,0.0005104276,0.00007051526,0.0033919143],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970624,0.001301143,0.0003948615,0.00030221124,0.0005892336,0.00035027272],"domain_scores_gemma":[0.97913617,0.013275191,0.0017329897,0.00043327102,0.0026626529,0.0027597882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067775147,0.0009356047,0.0029967215,0.0023885008,0.0018686897,0.005460303,0.0015435192,0.008555126,0.005189245],"category_scores_gemma":[0.041217025,0.00054677366,0.0016683787,0.0012298445,0.003129983,0.010904699,0.003267516,0.018130241,0.0007308202],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010759459,0.00041711415,0.061142046,0.008521789,0.0025573291,0.0064224857,0.003522166,0.0023434195,0.0010379179,0.04706307,0.39482054,0.47107622],"study_design_scores_gemma":[0.00065116887,0.0009928732,0.09444072,0.056983814,0.0035002471,0.008823548,0.012028077,0.0032064647,0.00036889836,0.489123,0.32927272,0.0006085402],"about_ca_topic_score_codex":0.017123083,"about_ca_topic_score_gemma":0.034294955,"teacher_disagreement_score":0.017123083,"about_ca_system_score_codex":0.0033655392,"about_ca_system_score_gemma":0.008031866,"threshold_uncertainty_score":0.035843313},"labels":[],"label_agreement":null},{"id":"W4402630414","doi":"10.1016/s1474-4422(24)00328-4","title":"Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials","year":2024,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"Merck KGaA; Merck","keywords":"Multiple sclerosis; Medicine; Physical therapy; Phase (matter); Double blind; Physical medicine and rehabilitation; Internal medicine; Alternative medicine; Placebo; Psychiatry; Pathology; Physics","score_opus":0.12333061164448297,"score_gpt":0.3887133599125956,"score_spread":0.2653827482681126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402630414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9694503,0.023062864,0.0007586835,0.00087968545,0.00041570998,0.0017376153,0.0011856873,0.00011404202,0.0023953412],"genre_scores_gemma":[0.9831081,0.0064872224,0.0015732623,0.0018314357,0.00046408628,0.00251055,0.001755372,0.00003316713,0.0022367667],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998844,0.0006518761,0.00008497312,0.00015655652,0.000102206075,0.00016031256],"domain_scores_gemma":[0.9984048,0.00054455164,0.00046193285,0.00011778698,0.00011576892,0.00035513946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036173244,0.0016775707,0.0032703234,0.0004924963,0.0004990517,0.0012001336,0.00092732447,0.0025314374,0.0038296757],"category_scores_gemma":[0.0026305579,0.00060764374,0.0032009159,0.00049251533,0.0013414972,0.0013844301,0.00044543683,0.003140327,0.0007320421],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9519999,0.002757407,0.0010880491,0.0013418923,0.0025776792,0.000065078195,0.00010332933,0.00038896836,0.003998604,0.00016609933,0.0012504729,0.034262475],"study_design_scores_gemma":[0.94063425,0.053320356,0.0032954887,0.000087939006,0.00073214195,0.000084695785,0.000026964735,0.00019057043,0.00039624536,0.00022760186,0.0009799766,0.000023781457],"about_ca_topic_score_codex":0.00074569846,"about_ca_topic_score_gemma":0.0019455124,"teacher_disagreement_score":0.0038296757,"about_ca_system_score_codex":0.0008585995,"about_ca_system_score_gemma":0.0009038717,"threshold_uncertainty_score":0.019130528},"labels":[],"label_agreement":null},{"id":"W4402643250","doi":"10.1016/s1474-4422(24)00256-4","title":"Differential diagnosis of suspected multiple sclerosis: global health considerations","year":2024,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Multiple sclerosis; Differential diagnosis; Medicine; Differential (mechanical device); Pathology; Psychiatry; Engineering","score_opus":0.2485999333305211,"score_gpt":0.4290205653791422,"score_spread":0.18042063204862108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402643250","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000050551735,0.9982992,0.000058087608,0.0010802109,0.0002543828,0.0000037002342,0.000023475088,0.0000027938027,0.00022767825],"genre_scores_gemma":[0.0017081292,0.995654,0.00027583347,0.0015668763,0.0006132749,0.000009512675,0.000060436756,0.0000018625082,0.00011006147],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99789196,0.0007408905,0.00054860814,0.00023882312,0.00049706706,0.00008255379],"domain_scores_gemma":[0.98967385,0.007681661,0.0010660317,0.000120181954,0.0012928334,0.00016542032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046855276,0.001054908,0.0060481383,0.0052284547,0.00039171902,0.0025793444,0.0023611025,0.0031073922,0.004527168],"category_scores_gemma":[0.013551373,0.0005230251,0.0019491712,0.0036461393,0.0011305478,0.002996572,0.0012331747,0.0028703886,0.0011694228],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024687886,0.00003853491,0.0012553468,0.1175283,0.0017411419,0.0005262772,0.00014435379,0.00026868153,0.00041694115,0.0029890197,0.050635003,0.8242095],"study_design_scores_gemma":[0.0004470383,0.00019013738,0.008938183,0.33542126,0.008255506,0.005082018,0.0010345618,0.00049415993,0.00033214918,0.01105759,0.6286016,0.00014572054],"about_ca_topic_score_codex":0.004765687,"about_ca_topic_score_gemma":0.011291933,"teacher_disagreement_score":0.0060481383,"about_ca_system_score_codex":0.0013346914,"about_ca_system_score_gemma":0.0030693978,"threshold_uncertainty_score":0.024779677},"labels":[],"label_agreement":null},{"id":"W4402643366","doi":"10.1016/s1474-4422(24)00369-7","title":"Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021","year":2024,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":1221,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cilag; Precursory Research for Embryonic Science and Technology; Japan Science and Technology Agency; Novartis Pharma; Allergan; National Institutes of Health; European Stroke Organisation; Esperion Therapeutics; National Science and Technology Council; DSM Nutritional Products; Intas Pharmaceuticals; Lilly Deutschland; National Research, Development and Innovation Office; National Health and Medical Research Council; Neuraxpharm; Novo Nordisk Pharma; Ministry of Science and ICT, South Korea; Medical Research Council; African Academy of Sciences; Servier; Istituto Auxologico Italiano; University of Jordan; Novo Nordisk; Eisai; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Ministero della Salute; Generalitat de Catalunya; Ministry of Education, Culture, Sports, Science and Technology; Amryt Pharma; Australian Academy of Science; Johns Hopkins University; Amarin Corporation; Cardinal Health; Daiichi Sankyo Europe; Agios Pharmaceuticals; Regeneron Pharmaceuticals; Fondazione Cariplo; Fresenius Medical Care North America; Deutsche Forschungsgemeinschaft; Alzheimer's Association; Global Brain Health Institute; Idorsia Pharmaceuticals; H. Lundbeck A/S; International Hepato-Pancreato-Biliary Association; Government of Canada; Ultragenyx Pharmaceutical; Canadian Institutes of Health Research; Italfarmaco; Korean Diabetes Association; European Commission; AstraZeneca; International Atomic Energy Agency; Alexion Pharmaceuticals; National Research Foundation of Korea; Biogen; King Saud University; Bristol-Myers Squibb; Teva Pharmaceutical Industries; American Heart Association; Moderna; Bill and Melinda Gates Foundation; Pfizer; Amicus Therapeutics; Casen Recordati; Alexander von Humboldt-Stiftung; Japan Society for the Promotion of Science; Swedish Orphan Biovitrum; Astellas Pharma; Bayer; Cardiff University; U.S. Department of Defense; Eli Lilly and Company; AOSpine; Danone; American Diabetes Association; Sociedad Madrileña de Nefrología; National Research Foundation; Amgen; International Society of Travel Medicine; National Cerebral and Cardiovascular Center; Sanofi","keywords":"Burden of disease; Stroke (engine); Disease; Medicine; Environmental health; Internal medicine; Engineering","score_opus":0.03265310704893108,"score_gpt":0.309195719158222,"score_spread":0.27654261210929093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402643366","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11415831,0.7543515,0.0068777483,0.0031509085,0.0005583545,0.0010116947,0.118031375,0.00026933188,0.0015908488],"genre_scores_gemma":[0.6398968,0.28344753,0.012324969,0.0018522613,0.00034808714,0.0030770495,0.058240037,0.000113834176,0.00069945416],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99553204,0.0018607632,0.00093470205,0.0006526588,0.0008040444,0.00021578696],"domain_scores_gemma":[0.9929248,0.0025750084,0.0020451036,0.00051216746,0.0017138881,0.00022895828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012011361,0.0010643632,0.0035843858,0.007328573,0.00038732486,0.0010264467,0.00080888177,0.00083107315,0.0011915512],"category_scores_gemma":[0.016001187,0.00092738186,0.012326256,0.011032071,0.00044547292,0.0006416998,0.0014339287,0.00091261853,0.00027161284],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025421341,0.00005950759,0.57961106,0.112183645,0.16237013,0.0003967258,0.00091252365,0.00850792,0.0005384568,0.0016463669,0.040617652,0.09061392],"study_design_scores_gemma":[0.0014901984,0.0003949196,0.72765285,0.054312643,0.17424409,0.0007891739,0.00067963154,0.006047227,0.000352524,0.0017217709,0.032135673,0.00017936011],"about_ca_topic_score_codex":0.07649399,"about_ca_topic_score_gemma":0.11478833,"teacher_disagreement_score":0.07649399,"about_ca_system_score_codex":0.0022283164,"about_ca_system_score_gemma":0.0074196835,"threshold_uncertainty_score":0.15209746},"labels":[],"label_agreement":null},{"id":"W4402643398","doi":"10.1016/s1474-4422(24)00288-6","title":"Differential diagnosis of suspected multiple sclerosis: considerations in people from minority ethnic and racial backgrounds in North America, northern Europe, and Australasia","year":2024,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Michael's Hospital","funders":"","keywords":"Ethnic group; Multiple sclerosis; Differential (mechanical device); Geography; Medicine; Political science; Psychiatry; Engineering; Law","score_opus":0.15215242773144125,"score_gpt":0.3590320944813354,"score_spread":0.20687966674989414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402643398","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019141453,0.9991062,0.000041530184,0.00035412906,0.000115216826,0.0000063426087,0.000027198912,0.0000018397957,0.0001560804],"genre_scores_gemma":[0.0032891866,0.99557626,0.0002702638,0.0005844271,0.00015840602,0.000011521135,0.000053413085,9.804018e-7,0.000055569537],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989506,0.00032277495,0.00033281712,0.000102723585,0.00024708512,0.000043959204],"domain_scores_gemma":[0.9956637,0.003085778,0.0006352305,0.00003328541,0.0004943813,0.00008769504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002372431,0.0006476102,0.0036724515,0.0032180042,0.00029375713,0.0014393191,0.0015447139,0.0016509718,0.002593788],"category_scores_gemma":[0.008162481,0.0003257329,0.0016394382,0.0026847546,0.0005144368,0.0016159528,0.00075177185,0.0013666546,0.0004144785],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039299327,0.00004512572,0.0044930573,0.18187597,0.0021779316,0.0006710264,0.0002831642,0.0001849366,0.00051091856,0.0010936216,0.021979501,0.7862918],"study_design_scores_gemma":[0.0006399205,0.00040513495,0.041645724,0.5285509,0.017649818,0.008568123,0.0024084763,0.00045355118,0.00041885005,0.0042351056,0.39484435,0.0001801693],"about_ca_topic_score_codex":0.006993698,"about_ca_topic_score_gemma":0.019808529,"teacher_disagreement_score":0.006993698,"about_ca_system_score_codex":0.0007861958,"about_ca_system_score_gemma":0.0022793543,"threshold_uncertainty_score":0.013906002},"labels":[],"label_agreement":null},{"id":"W4404555965","doi":"10.1016/s1474-4422(24)00431-9","title":"Effects of climate change on the brain: an environmental neurology perspective","year":2024,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Perspective (graphical); Climate change; Neurology; Environmental change; Environmental ethics; Psychology; Neuroscience; Environmental science; Ecology; Computer science; Philosophy; Biology; Artificial intelligence","score_opus":0.026861759633702166,"score_gpt":0.26491867604889746,"score_spread":0.2380569164151953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404555965","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023345272,0.011572497,0.000057944733,0.96295047,0.02342254,0.0000025259426,0.000034650973,0.000014124657,0.0017117998],"genre_scores_gemma":[0.005314732,0.014463653,0.00015940289,0.7138593,0.2627769,0.000017771734,0.000024008905,0.000016189126,0.0033680133],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988073,0.0003245438,0.00011932674,0.00019015007,0.00038091006,0.00017776749],"domain_scores_gemma":[0.993397,0.0041034035,0.00035958158,0.00017130375,0.0011094066,0.00085930957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002440418,0.00090625003,0.0022573383,0.00088636886,0.0024484035,0.0035001824,0.0017858273,0.03674524,0.008087282],"category_scores_gemma":[0.011787014,0.00039237735,0.0011359444,0.0007077027,0.0033622188,0.0047459695,0.0018828365,0.032491658,0.0041165217],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012761171,0.00007256618,0.00085357454,0.00027679454,0.00007014739,0.0024018842,0.0001411562,0.00013330425,0.00033365306,0.0057618427,0.96102506,0.02880232],"study_design_scores_gemma":[0.0002511036,0.00010076616,0.0024672225,0.0009200822,0.00010960357,0.0027777376,0.0007084919,0.0004163355,0.00023221294,0.04663487,0.9452936,0.00008804434],"about_ca_topic_score_codex":0.006695508,"about_ca_topic_score_gemma":0.011418565,"teacher_disagreement_score":0.03674524,"about_ca_system_score_codex":0.0029492837,"about_ca_system_score_gemma":0.0031364216,"threshold_uncertainty_score":0.027054667},"labels":[],"label_agreement":null},{"id":"W4405534589","doi":"10.1016/s1474-4422(24)00497-6","title":"Infectious diseases research in 2024: insights into dementia","year":2024,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute of Allergy and Infectious Diseases; National Institute of Neurological Disorders and Stroke; Canada Excellence Research Chairs, Government of Canada","keywords":"Dementia; Medicine; Psychology; Pathology; Disease","score_opus":0.037509547513215384,"score_gpt":0.37721827657456847,"score_spread":0.3397087290613531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405534589","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003426223,0.52528965,0.000451733,0.40522456,0.044988044,0.000031411793,0.003970885,0.00013389863,0.016483529],"genre_scores_gemma":[0.079019524,0.6032247,0.0041590855,0.20363247,0.08966747,0.00018582538,0.0046567507,0.00013553385,0.015318633],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9925781,0.0035393396,0.00096898916,0.00034763335,0.0013904187,0.0011755693],"domain_scores_gemma":[0.9684778,0.009919755,0.005429707,0.0010178962,0.0054305717,0.009724304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01402237,0.0014014569,0.0020541942,0.0047149356,0.0014593439,0.00867861,0.0011486334,0.008608915,0.029758498],"category_scores_gemma":[0.030184435,0.0005724863,0.0026082501,0.004566222,0.0019754386,0.0070290007,0.0053736307,0.0076606353,0.004900932],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009518227,0.00033911687,0.015827129,0.006516536,0.0008511449,0.0004925109,0.00042489741,0.00034746915,0.0006763603,0.035026632,0.6679443,0.27060205],"study_design_scores_gemma":[0.000458932,0.0006073949,0.051069506,0.015691454,0.0007046684,0.0005414486,0.0015878184,0.00041886815,0.0003478014,0.03669378,0.89168334,0.00019489472],"about_ca_topic_score_codex":0.013194847,"about_ca_topic_score_gemma":0.02643069,"teacher_disagreement_score":0.029758498,"about_ca_system_score_codex":0.005110586,"about_ca_system_score_gemma":0.014194522,"threshold_uncertainty_score":0.099552035},"labels":[],"label_agreement":null},{"id":"W4405535312","doi":"10.1016/s1474-4422(24)00482-4","title":"Progress and future directions in spinal cord injury trials","year":2024,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Spinal cord injury; Spinal cord; Medicine; Physical medicine and rehabilitation; Neuroscience; Psychology","score_opus":0.11541561459361127,"score_gpt":0.4618278023219634,"score_spread":0.34641218772835214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405535312","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010875929,0.8109255,0.002477498,0.17490357,0.0064872117,0.00022805361,0.00060546596,0.00014635979,0.0031388027],"genre_scores_gemma":[0.036237422,0.7549358,0.021798287,0.15250362,0.027806826,0.0017910118,0.0020967466,0.00025417155,0.0025761907],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.91270304,0.063814186,0.009694094,0.0038306033,0.0066307336,0.0033273543],"domain_scores_gemma":[0.60629666,0.32929128,0.01475997,0.0074832584,0.02935318,0.012815667],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.21727988,0.0023776668,0.016241256,0.003346679,0.002101212,0.016262883,0.006849092,0.015554428,0.028643904],"category_scores_gemma":[0.22428608,0.001519012,0.008111217,0.0056580435,0.008535832,0.027982192,0.004614217,0.020597855,0.0061285202],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019551322,0.0013969679,0.005478405,0.07359963,0.004512322,0.0004292056,0.0010391205,0.0029215917,0.0019747026,0.07256375,0.17304029,0.6434927],"study_design_scores_gemma":[0.023332808,0.00875206,0.008306131,0.12534048,0.0072389073,0.0008333365,0.002550231,0.0036793929,0.0009942536,0.22147593,0.5970525,0.0004440081],"about_ca_topic_score_codex":0.0067539434,"about_ca_topic_score_gemma":0.010173893,"teacher_disagreement_score":0.21727988,"about_ca_system_score_codex":0.008042248,"about_ca_system_score_gemma":0.026166588,"threshold_uncertainty_score":0.96523327},"labels":[],"label_agreement":null},{"id":"W4405535345","doi":"10.1016/s1474-4422(24)00447-2","title":"Safety and efficacy of intrathecal antibodies to Nogo-A in patients with acute cervical spinal cord injury: a randomised, double-blind, multicentre, placebo-controlled, phase 2b trial","year":2024,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Collaboration On Repair Discoveries","funders":"Eidgenössische Technische Hochschule Zürich; Bundesministerium für Bildung und Forschung; Universität Zürich; Deutsche Forschungsgemeinschaft; H2020 European Research Council; Wings for Life","keywords":"Medicine; Placebo; Double blind; Spinal cord injury; Randomized controlled trial; Anesthesia; Intrathecal; Spinal cord; Surgery; Alternative medicine; Pathology","score_opus":0.04676489466065083,"score_gpt":0.4001762883629379,"score_spread":0.3534113937022871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405535345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97709596,0.007909071,0.00059999473,0.0011558873,0.00078186713,0.009350445,0.001267424,0.00013276606,0.0017065166],"genre_scores_gemma":[0.97196895,0.0044153947,0.0016991795,0.0017671434,0.0008432588,0.015233585,0.0012747457,0.00002716884,0.002770515],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99861944,0.00074007217,0.00010925927,0.0002626481,0.000088576264,0.00018002714],"domain_scores_gemma":[0.9986992,0.00034584658,0.0003363112,0.00010694477,0.00013636233,0.0003753909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002688126,0.0024627645,0.0042419173,0.0006494326,0.000672782,0.0015877692,0.00122701,0.0038213439,0.006207381],"category_scores_gemma":[0.0032471796,0.0009915857,0.0020359948,0.000565287,0.0015765437,0.0014321895,0.0005190433,0.0026287246,0.0013729583],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98764193,0.0034630296,0.00035413547,0.0006998618,0.0003652862,0.000027490289,0.00004014913,0.00010985279,0.0013306685,0.000038582188,0.0003394839,0.0055894675],"study_design_scores_gemma":[0.97268325,0.026161805,0.00061116245,0.000022918319,0.00012335248,0.000011047078,0.000007714994,0.00008063318,0.00008192523,0.000034297904,0.0001753279,0.0000065733575],"about_ca_topic_score_codex":0.0010053713,"about_ca_topic_score_gemma":0.0018055093,"teacher_disagreement_score":0.006207381,"about_ca_system_score_codex":0.0010386246,"about_ca_system_score_gemma":0.0017709151,"threshold_uncertainty_score":0.020765722},"labels":[],"label_agreement":null},{"id":"W4405535445","doi":"10.1016/s1474-4422(24)00479-4","title":"Amyotrophic lateral sclerosis caused by SOD1 variants: from genetic discovery to disease prevention","year":2024,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Amyotrophic lateral sclerosis; SOD1; Disease; Medicine; Genetics; Neuroscience; Biology; Pathology","score_opus":0.049355441589908185,"score_gpt":0.3083702974779759,"score_spread":0.2590148558880677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405535445","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018209333,0.64504683,0.0035657126,0.30747473,0.012943109,0.000042504704,0.0006967561,0.00033547677,0.011685464],"genre_scores_gemma":[0.22872715,0.6056971,0.0057399697,0.102352135,0.04996292,0.0001273831,0.00091249513,0.00013006298,0.006350829],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981504,0.00060677313,0.00020438372,0.00031941902,0.0005462289,0.00017270222],"domain_scores_gemma":[0.9930387,0.0041253497,0.00083660474,0.0003024926,0.0009382235,0.0007585441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043895887,0.0010501166,0.0024046265,0.0018342703,0.0006408942,0.0030082304,0.0011876395,0.005368312,0.0025918249],"category_scores_gemma":[0.012238566,0.0005675853,0.0010877921,0.0011205475,0.0015772721,0.002001541,0.0014291892,0.004409366,0.0011881788],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023273672,0.00065752334,0.03522715,0.0044226153,0.0032237314,0.0024867689,0.00050137215,0.0010574176,0.005685814,0.036163222,0.23731087,0.6709361],"study_design_scores_gemma":[0.0060909935,0.0023043565,0.08671929,0.02210905,0.0072007608,0.0068711713,0.0016579228,0.0039692135,0.0051053683,0.2850361,0.5725398,0.00039603465],"about_ca_topic_score_codex":0.00221132,"about_ca_topic_score_gemma":0.002669694,"teacher_disagreement_score":0.005368312,"about_ca_system_score_codex":0.0015025008,"about_ca_system_score_gemma":0.0024544215,"threshold_uncertainty_score":0.023214638},"labels":[],"label_agreement":null},{"id":"W4406716183","doi":"10.1016/s1474-4422(24)00456-3","title":"Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trial","year":2025,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Neuroendocrine regulation and behavior","field":"Psychology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre; Health Sciences Centre; Sunnybrook Health Science Centre; Centre hospitalier universitaire de Québec; McGill University; University of British Columbia; Université Laval; University of Toronto; University Health Network; St Joseph's Health Care","funders":"Weston Family Foundation; Weston Brain Institute; Canadian Institutes of Health Research; Clinical Trials Fund, Canadian Institutes of Health Research","keywords":"Apathy; Crossover study; Oxytocin; Medicine; Placebo; Double blind; Frontotemporal dementia; Physical medicine and rehabilitation; Physical therapy; Dementia; Internal medicine; Psychiatry; Alternative medicine; Cognition","score_opus":0.0544603218960251,"score_gpt":0.3719175854420453,"score_spread":0.31745726354602016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406716183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814928,0.010591239,0.00090551673,0.0008629985,0.0010357453,0.002810573,0.0007303819,0.00012881118,0.0014418961],"genre_scores_gemma":[0.9817916,0.0055957576,0.002170168,0.0013864882,0.0007723957,0.004201241,0.0006322081,0.00003310001,0.0034170118],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993973,0.00028563506,0.000041897023,0.00011297016,0.00005175294,0.000110497276],"domain_scores_gemma":[0.99917054,0.0003085749,0.00018223152,0.00007524546,0.000051731527,0.00021176798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018366982,0.0018700092,0.0043275533,0.0003919971,0.0005654015,0.0011945382,0.0011490417,0.003031244,0.0069354456],"category_scores_gemma":[0.002510852,0.00077519857,0.002284473,0.0003740357,0.0016380348,0.0015920526,0.00061399187,0.0027542058,0.00083165383],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98744655,0.0016759051,0.00022277184,0.0007123262,0.00062972365,0.000033760778,0.00005688594,0.00007547455,0.0010254578,0.000077275654,0.0003969376,0.007646836],"study_design_scores_gemma":[0.9867199,0.012266559,0.0004681839,0.000027692206,0.00016570021,0.000011723528,0.000014298389,0.000062329804,0.00004813173,0.000059985054,0.00014897872,0.000006544813],"about_ca_topic_score_codex":0.0017549804,"about_ca_topic_score_gemma":0.0029053146,"teacher_disagreement_score":0.0069354456,"about_ca_system_score_codex":0.00088187284,"about_ca_system_score_gemma":0.0009426191,"threshold_uncertainty_score":0.023201406},"labels":[],"label_agreement":null},{"id":"W4406716256","doi":"10.1016/s1474-4422(24)00524-6","title":"Anticoagulation for patients with device-detected atrial fibrillation and a history of stroke","year":2025,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"Western University","keywords":"Atrial fibrillation; Stroke (engine); Cardiology; Medicine; Internal medicine; Engineering","score_opus":0.04327883706068564,"score_gpt":0.2986976388698754,"score_spread":0.25541880180918974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406716256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66429234,0.19078057,0.00072886416,0.06951887,0.0074577914,0.00014229963,0.0046151867,0.00008605233,0.06237795],"genre_scores_gemma":[0.9260975,0.0472843,0.0006810797,0.0100758085,0.011158175,0.000082163795,0.0025549512,0.000016371458,0.0020496843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930406,0.00017706015,0.00014683143,0.00009957897,0.00015044623,0.00012197901],"domain_scores_gemma":[0.9961957,0.001373423,0.0013497015,0.0001169965,0.00021794964,0.0007463711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007810348,0.00026633436,0.00084776967,0.00090314896,0.00039512405,0.0011841147,0.00042876028,0.0019827113,0.0043600877],"category_scores_gemma":[0.0098387245,0.0002350009,0.0012994083,0.0014210681,0.00034267007,0.0009405848,0.00046635838,0.0023546552,0.0004920559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002898108,0.0005810894,0.8168136,0.0020235723,0.0022069057,0.002005639,0.00033814687,0.0002611792,0.0005352981,0.0015612934,0.03217923,0.13859586],"study_design_scores_gemma":[0.0013778147,0.0010568828,0.967963,0.0019776546,0.0021658286,0.004860432,0.0005866883,0.0005465869,0.00014776851,0.005296528,0.01392907,0.00009181459],"about_ca_topic_score_codex":0.0028912893,"about_ca_topic_score_gemma":0.00609057,"teacher_disagreement_score":0.0043600877,"about_ca_system_score_codex":0.0005210206,"about_ca_system_score_gemma":0.000989058,"threshold_uncertainty_score":0.014585912},"labels":[],"label_agreement":null},{"id":"W4406716278","doi":"10.1016/s1474-4422(24)00498-8","title":"Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study","year":2025,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Placebo; Myasthenia gravis; Medicine; Double blind; Phase (matter); Internal medicine; Alternative medicine; Physics","score_opus":0.02076521010656574,"score_gpt":0.30523110668830233,"score_spread":0.2844658965817366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406716278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9722263,0.020915302,0.0006528852,0.00077158096,0.00058162695,0.0016446617,0.00090530695,0.0001342751,0.0021681106],"genre_scores_gemma":[0.9889193,0.0042852536,0.00081590965,0.0016046928,0.00050876685,0.0013520345,0.0008405199,0.000017401508,0.0016561516],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995041,0.00022362698,0.00003624744,0.00008798823,0.000050241775,0.00009772577],"domain_scores_gemma":[0.9991178,0.0002738824,0.0002080339,0.000053677366,0.00005415912,0.0002924056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016803601,0.0012900708,0.0029562959,0.0002663486,0.0003366895,0.0011035386,0.0007721077,0.0025407895,0.003688915],"category_scores_gemma":[0.0017226305,0.00059130276,0.0020771804,0.000286792,0.0011496828,0.0011230637,0.00032494168,0.002959543,0.0009184674],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9606271,0.002741341,0.0009839165,0.0014024574,0.0011000724,0.000119220516,0.00008864001,0.00030818814,0.004656854,0.00010651398,0.0010308027,0.026834905],"study_design_scores_gemma":[0.9090679,0.08448409,0.004123334,0.000076866476,0.0005417532,0.000108941116,0.000028624352,0.00027387167,0.00034781557,0.00015609842,0.00076998724,0.000020687385],"about_ca_topic_score_codex":0.00053187937,"about_ca_topic_score_gemma":0.0008757635,"teacher_disagreement_score":0.003688915,"about_ca_system_score_codex":0.00053019915,"about_ca_system_score_gemma":0.00064676034,"threshold_uncertainty_score":0.012340605},"labels":[],"label_agreement":null},{"id":"W4406716329","doi":"10.1016/s1474-4422(24)00475-7","title":"Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trial","year":2025,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; University of Ottawa; University of Calgary; University of British Columbia; University of Toronto; Population Health Research Institute","funders":"Canadian Institutes of Health Research; Hamilton Health Sciences; Medtronic; Heart and Stroke Foundation of Canada; Bristol-Myers Squibb Foundation","keywords":"Atrial fibrillation; Medicine; Aspirin; Stroke (engine); Apixaban; Subclinical infection; Subgroup analysis; Cardiology; Internal medicine; Randomized controlled trial; Ischaemic stroke; Meta-analysis; Warfarin; Rivaroxaban","score_opus":0.07440965477632437,"score_gpt":0.3541185238956161,"score_spread":0.2797088691192917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406716329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8004439,0.17222333,0.004441324,0.002924108,0.005993672,0.0033849638,0.00513677,0.00044019325,0.0050117224],"genre_scores_gemma":[0.9722134,0.016427886,0.0016819393,0.0017178013,0.0014794857,0.0022242735,0.0017626673,0.000083055485,0.0024095264],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99518675,0.0027877723,0.00077266863,0.00060871994,0.0002698897,0.00037416376],"domain_scores_gemma":[0.99637705,0.0019891376,0.00074777385,0.00045114124,0.00018124937,0.00025357286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053168107,0.003560451,0.013204711,0.0010083704,0.00049871055,0.0026764318,0.0016522399,0.0031214177,0.006817049],"category_scores_gemma":[0.012155486,0.0013237529,0.016848855,0.0010988143,0.00094973773,0.0018922475,0.0013433332,0.0052527483,0.00065857626],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9114956,0.00018548367,0.0016550295,0.005624506,0.07315435,0.000110664136,0.00007914204,0.00045197384,0.000638008,0.00021259705,0.00091717375,0.0054753474],"study_design_scores_gemma":[0.86856675,0.00567275,0.007127627,0.0006142146,0.11421199,0.00010897039,0.00012291955,0.0011785185,0.00021966721,0.0011452152,0.00094325,0.00008811077],"about_ca_topic_score_codex":0.0030604969,"about_ca_topic_score_gemma":0.0054122033,"teacher_disagreement_score":0.013204711,"about_ca_system_score_codex":0.0010553669,"about_ca_system_score_gemma":0.0010955767,"threshold_uncertainty_score":0.028118312},"labels":[],"label_agreement":null},{"id":"W4407468362","doi":"10.1016/s1474-4422(24)00515-5","title":"Safety and efficacy of nerinetide in patients with acute ischaemic stroke enrolled in the early window: a post-hoc meta-analysis of individual patient data from three randomised trials","year":2025,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NoNO (Canada); Health Sciences Centre; Sunnybrook Health Science Centre; Foothills Medical Centre; University of Calgary; University of British Columbia; University of Toronto; University Health Network","funders":"","keywords":"Ischaemic stroke; Post-hoc analysis; Medicine; Stroke (engine); Meta-analysis; Post hoc; Window (computing); Clinical trial; Patient data; Physical therapy; Internal medicine; Emergency medicine; Computer science; World Wide Web; Database; Engineering; Ischemia","score_opus":0.09916635292498673,"score_gpt":0.3418296991754197,"score_spread":0.242663346250433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407468362","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06809096,0.9273435,0.0016370035,0.0003533566,0.00063080934,0.00033810886,0.00068696094,0.000083337734,0.0008360541],"genre_scores_gemma":[0.6517582,0.34090593,0.0028025273,0.001358915,0.00045112026,0.00046723397,0.0010972269,0.00008313644,0.0010758034],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9963309,0.0021065061,0.0007126613,0.00043349847,0.000246701,0.00016979266],"domain_scores_gemma":[0.9951042,0.0036178818,0.0006862129,0.0002645101,0.00020802779,0.0001191012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007642839,0.0022451645,0.01373108,0.0011629979,0.0003221615,0.0023191727,0.0012202621,0.001545487,0.0027611258],"category_scores_gemma":[0.010421717,0.0010350588,0.024426987,0.0016152706,0.00054643035,0.0013405897,0.0009488342,0.0032841128,0.00031829983],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.062388834,0.00009571566,0.0029449593,0.069456086,0.8417126,0.000112668706,0.00008505336,0.000891861,0.0007503661,0.00015093412,0.0006606062,0.020750286],"study_design_scores_gemma":[0.01775177,0.0019845369,0.0056561837,0.0027090092,0.9689034,0.00008444382,0.00007019076,0.0003765194,0.0002792069,0.00041574577,0.0017213771,0.000047605226],"about_ca_topic_score_codex":0.0021224057,"about_ca_topic_score_gemma":0.005142984,"teacher_disagreement_score":0.01373108,"about_ca_system_score_codex":0.0010574682,"about_ca_system_score_gemma":0.00094643206,"threshold_uncertainty_score":0.04041964},"labels":[],"label_agreement":null},{"id":"W4407731750","doi":"10.1016/s1474-4422(25)00035-3","title":"Direct oral anticoagulants for cerebral venous thrombosis","year":2025,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Cerebral Venous Sinus Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Venous thrombosis; Medicine; Thrombosis; Cardiology; Internal medicine","score_opus":0.054770610211278575,"score_gpt":0.3341791984930001,"score_spread":0.27940858828172155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407731750","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022206875,0.8690477,0.00012607913,0.08185368,0.021749854,0.000016506012,0.00030787295,0.000024846277,0.024652824],"genre_scores_gemma":[0.034237757,0.81404877,0.000496428,0.031717375,0.10405315,0.000058251437,0.00039971288,0.000022815462,0.014965832],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989801,0.00030689803,0.00015131505,0.00006699048,0.00037103437,0.00012351129],"domain_scores_gemma":[0.99588,0.0022992615,0.00075365364,0.000102634855,0.00049944327,0.00046499673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015047044,0.00049419556,0.0014174985,0.0016068958,0.00042323992,0.0017521665,0.00051731634,0.003917534,0.017308017],"category_scores_gemma":[0.006863303,0.00023386297,0.00081266544,0.0017131381,0.00078223285,0.001150294,0.0005229999,0.00355675,0.0035792803],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011673304,0.00013998877,0.0030776318,0.0049190577,0.0005858421,0.0010411772,0.00007634422,0.00011531361,0.0006263188,0.009593421,0.45689985,0.5217577],"study_design_scores_gemma":[0.002848465,0.00066402304,0.01750733,0.0071950695,0.0010786868,0.0045378106,0.00026930112,0.00019508915,0.00032489176,0.019124994,0.9462018,0.000052503277],"about_ca_topic_score_codex":0.0023465224,"about_ca_topic_score_gemma":0.0075231064,"teacher_disagreement_score":0.017308017,"about_ca_system_score_codex":0.0009134632,"about_ca_system_score_gemma":0.002070353,"threshold_uncertainty_score":0.057901144},"labels":[],"label_agreement":null},{"id":"W4407731842","doi":"10.1016/s1474-4422(24)00432-0","title":"An ethical framework to assess covert consciousness","year":2025,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Deception detection and forensic psychology","field":"Psychology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"H2020 European Research Council; Fondazione Regionale per la Ricerca Biomedica; Fonds De La Recherche Scientifique - FNRS; National Institutes of Health; H. Lundbeck A/S; Canadian Institute for Advanced Research; Neurocritical Care Society; Common Fund; Lundbeckfonden; National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; Novo Nordisk; Regione Lombardia; University of Pennsylvania","keywords":"Covert; Consciousness; Psychology; Sociology; Political science; Philosophy; Linguistics; Neuroscience","score_opus":0.0627294747283055,"score_gpt":0.41954480017458845,"score_spread":0.3568153254462829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407731842","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022646494,0.0043262513,0.4378296,0.18317093,0.0027231395,0.0010480377,0.00025757076,0.00013891057,0.34785905],"genre_scores_gemma":[0.8223696,0.0009998465,0.14511304,0.017414464,0.0013682218,0.0019074446,0.00010415312,0.0000673959,0.01065583],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9493585,0.03256872,0.003023593,0.0023577148,0.010382972,0.0023083824],"domain_scores_gemma":[0.9266649,0.041970592,0.006317099,0.006753927,0.015546251,0.0027472395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.051002152,0.0011285088,0.00093971065,0.0054144314,0.004775315,0.008977504,0.0025355888,0.009027751,0.004066617],"category_scores_gemma":[0.11525648,0.0005992993,0.0011918254,0.0013240189,0.04139946,0.008543725,0.0064556184,0.0105960425,0.0009230416],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010471658,0.000027399517,0.001035479,0.000025374124,0.000009427895,0.00010434042,0.0010762211,0.0001500752,0.00007771393,0.9870863,0.0022984217,0.008098759],"study_design_scores_gemma":[0.000014816871,0.000027977081,0.0010342117,0.00018238374,0.000014196333,0.00049079984,0.0010706582,0.0010804122,0.0002427169,0.98438406,0.011436786,0.000021095502],"about_ca_topic_score_codex":0.0026897998,"about_ca_topic_score_gemma":0.0028609408,"teacher_disagreement_score":0.051002152,"about_ca_system_score_codex":0.0062880307,"about_ca_system_score_gemma":0.011243554,"threshold_uncertainty_score":0.26972842},"labels":[],"label_agreement":null},{"id":"W4408598434","doi":"10.1016/s1474-4422(25)00006-7","title":"Multiple sclerosis and COVID-19: interactions and unresolved issues","year":2025,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Multiple sclerosis; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Virology; Coronavirus Infections; Betacoronavirus; Neuroscience; Medicine; Biology; Immunology; Pathology; Infectious disease (medical specialty); Outbreak; Disease","score_opus":0.10245334872510307,"score_gpt":0.399596184910284,"score_spread":0.2971428361851809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408598434","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000030751686,0.99918085,0.000014407801,0.00045172827,0.00014840021,0.0000012424347,0.00001563706,0.0000019064667,0.00015522142],"genre_scores_gemma":[0.00067893654,0.99800223,0.00008543424,0.00064159767,0.00039773018,0.0000053941753,0.000024741206,0.0000011104673,0.00016294103],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99925655,0.00023152695,0.00012468104,0.00009013154,0.00022499914,0.00007199804],"domain_scores_gemma":[0.9968412,0.0020802259,0.0004540772,0.00004583263,0.000439486,0.00013920553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026061942,0.00093310483,0.004104548,0.0017117783,0.00036456485,0.0022770055,0.0013629852,0.0026556235,0.00809525],"category_scores_gemma":[0.0041459524,0.00039036953,0.0018813146,0.002766934,0.0007323449,0.0021592602,0.001170728,0.0034073764,0.0016068125],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048611194,0.00008127767,0.00048508664,0.051939283,0.0011589212,0.00017975716,0.00009101843,0.00043885026,0.00045833184,0.0057808533,0.053437207,0.88546324],"study_design_scores_gemma":[0.00028718013,0.00032518766,0.0032395497,0.041277755,0.0023458684,0.0007647952,0.00025864592,0.00024996296,0.00019378892,0.0058213905,0.9451656,0.00007027437],"about_ca_topic_score_codex":0.003339893,"about_ca_topic_score_gemma":0.009840718,"teacher_disagreement_score":0.00809525,"about_ca_system_score_codex":0.0012663684,"about_ca_system_score_gemma":0.0031627691,"threshold_uncertainty_score":0.02708137},"labels":[],"label_agreement":null},{"id":"W4408598466","doi":"10.1016/s1474-4422(25)00024-9","title":"Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial","year":2025,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre; University of British Columbia; McGill University","funders":"National Institutes of Health; F. Hoffmann-La Roche; National Institute on Aging; Eli Lilly and Company; GHR Foundation; Alzheimer's Association; Foundation for the National Institutes of Health","keywords":"Placebo; Double blind; Open label; Medicine; Term (time); Psychiatry; Internal medicine; Psychology; Randomized controlled trial; Physics; Alternative medicine; Pathology","score_opus":0.09254967723950812,"score_gpt":0.3965164070112476,"score_spread":0.30396672977173944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408598466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98794323,0.0077783517,0.00044028356,0.00055422226,0.00036843208,0.00059118116,0.0007909154,0.00009005366,0.0014434401],"genre_scores_gemma":[0.9926744,0.0022318563,0.00063403195,0.00074346835,0.0002539182,0.00081207644,0.0009683362,0.000019239316,0.0016626789],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99919564,0.0004441004,0.000039345337,0.00012571574,0.000060291186,0.00013499685],"domain_scores_gemma":[0.9991549,0.00024070319,0.00018147305,0.00009397063,0.00006625786,0.0002626802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022526113,0.0016162104,0.0029771817,0.00029010055,0.00038189505,0.001025443,0.0009568134,0.0020171306,0.0036770098],"category_scores_gemma":[0.0017131272,0.00041607246,0.0021735674,0.00028037827,0.0012827965,0.0014487396,0.00037849892,0.0033368245,0.0009025661],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9694436,0.0033093914,0.00058903435,0.00041485223,0.00090801594,0.000041774725,0.00005179781,0.00022649333,0.0033809082,0.000080898666,0.00069293834,0.020860346],"study_design_scores_gemma":[0.90200454,0.09020294,0.0051025352,0.00005779344,0.00057321053,0.00007398798,0.00003166641,0.00036019666,0.0005697734,0.00024064166,0.0007535939,0.000029140823],"about_ca_topic_score_codex":0.000712463,"about_ca_topic_score_gemma":0.0014343078,"teacher_disagreement_score":0.0036770098,"about_ca_system_score_codex":0.0007440946,"about_ca_system_score_gemma":0.0007682666,"threshold_uncertainty_score":0.012300849},"labels":[],"label_agreement":null},{"id":"W4409490318","doi":"10.1016/s1474-4422(25)00103-6","title":"CGRP blockade and cluster headache: another step forward","year":2025,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Cluster headache; Blockade; Calcitonin gene-related peptide; Cluster (spacecraft); Medicine; Computer science; Internal medicine; Migraine; Computer network; Receptor","score_opus":0.02463699265385246,"score_gpt":0.3041562444962759,"score_spread":0.27951925184242343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409490318","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035613803,0.70881045,0.0010704829,0.25918788,0.020846404,0.000075639065,0.0004074812,0.00008216401,0.0059581012],"genre_scores_gemma":[0.041505117,0.64612406,0.0072039654,0.19985205,0.09916987,0.00020709672,0.0006457608,0.0000984025,0.005193681],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99440044,0.0023859553,0.0008681945,0.00064852595,0.001319911,0.00037686116],"domain_scores_gemma":[0.9238274,0.061267603,0.0030428644,0.0024994472,0.006455932,0.0029067048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023155704,0.0017184312,0.008669471,0.0021336502,0.0014382984,0.009395488,0.0034436896,0.012238075,0.021596115],"category_scores_gemma":[0.030002683,0.0009280085,0.0050642127,0.0026250153,0.0027891186,0.013533861,0.0030555483,0.015050332,0.0037188581],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014276142,0.0014870233,0.020030307,0.033944014,0.015851527,0.0013263924,0.0011747538,0.000620797,0.0035555698,0.031011797,0.3052914,0.57143027],"study_design_scores_gemma":[0.016211968,0.005121038,0.06725785,0.05894596,0.017784618,0.0020910953,0.005277294,0.0010864711,0.0006198128,0.0908182,0.7339982,0.00078757614],"about_ca_topic_score_codex":0.0065634404,"about_ca_topic_score_gemma":0.015333401,"teacher_disagreement_score":0.023155704,"about_ca_system_score_codex":0.0017676338,"about_ca_system_score_gemma":0.006018225,"threshold_uncertainty_score":0.122460544},"labels":[],"label_agreement":null},{"id":"W4409497248","doi":"10.1016/s1474-4422(25)00068-7","title":"Pharmacotherapy and non-invasive neuromodulation for neuropathic pain: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Pain Management and Treatment","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Fraser Institute; Fraser Health","funders":"Daiichi Sankyo Europe; Advanced Scientific Computing Research; Faculty of Medicine Siriraj Hospital, Mahidol University; Biotechnology and Biological Sciences Research Council; HORIZON EUROPE Framework Programme; Berlin Institute of Health; Desitin Arzneimittel; H. Lundbeck A/S; Teijin Pharma; Hospital for Special Surgery; Otsuka Pharmaceutical; Novo Nordisk; Angelini Pharma; National Institutes of Health; Deutsche Forschungsgemeinschaft; Deutsche Gesetzliche Unfallversicherung; Japan Society for the Promotion of Science; Queen's University; Versus Arthritis; Bundesministerium für Wirtschaft und Technologie; Bundesministerium für Bildung und Forschung; Alnylam Pharmaceuticals; AstraZeneca; European Commission; University of Oxford; Medical Research Council; Physicians' Services Incorporated Foundation; Wellcome Trust; Nippon Zoki Pharmaceutical; Canadian Institutes of Health Research; Diabetes UK; Directorate for Biological Sciences; Imperial College London; Taiju Life Social Welfare Foundation; CSL Behring; Universidade de São Paulo; Aarhus Universitet; Royal British Legion; Boston Scientific Corporation; Alexion Pharmaceuticals; Teva Pharmaceutical Industries; Boston Scientific Japan; Pfizer; Biogen; Lundbeckfonden; Eli Lilly and Company; U.S. Department of Defense; Sanofi; Medtronic Japan; Amgen; UK Research and Innovation; Stowers Institute for Medical Research","keywords":"Neuromodulation; Neuropathic pain; Pharmacotherapy; Medicine; Meta-analysis; Anesthesia; Internal medicine; Central nervous system","score_opus":0.1162045571169581,"score_gpt":0.38075226009101726,"score_spread":0.26454770297405916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409497248","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034767424,0.99452883,0.00061196357,0.0001961383,0.00012251895,0.00038007903,0.00044609865,0.000026202426,0.00021149722],"genre_scores_gemma":[0.14013422,0.8512555,0.003491067,0.0009965127,0.0003266804,0.0025243592,0.00090545387,0.00003365061,0.00033254636],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98492926,0.00800715,0.0037949176,0.0012112501,0.0016377551,0.00041969368],"domain_scores_gemma":[0.9730339,0.02022354,0.0040102135,0.0008409721,0.0016273763,0.00026404913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017935654,0.0031484207,0.023007346,0.0077642603,0.00065076567,0.0032551915,0.0025660158,0.0023297234,0.0043035564],"category_scores_gemma":[0.036447197,0.0014212548,0.04170499,0.009878125,0.00081967853,0.002064909,0.0015861243,0.001790963,0.00033791465],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013664848,0.000033840533,0.0030945572,0.37684923,0.60721976,0.00009458382,0.000060604696,0.00045424642,0.00008845127,0.000120620425,0.00063052966,0.009987148],"study_design_scores_gemma":[0.0008273646,0.00019612501,0.003470602,0.03110901,0.96240556,0.000093333896,0.000038599457,0.0002671582,0.00007842185,0.00021388254,0.0012743018,0.000025708052],"about_ca_topic_score_codex":0.0064677624,"about_ca_topic_score_gemma":0.012479358,"teacher_disagreement_score":0.023007346,"about_ca_system_score_codex":0.0030947542,"about_ca_system_score_gemma":0.0039713094,"threshold_uncertainty_score":0.09485394},"labels":[],"label_agreement":null},{"id":"W4409497257","doi":"10.1016/s1474-4422(25)00107-3","title":"Optimised medical therapy alone versus optimised medical therapy plus revascularisation for asymptomatic or low-to-intermediate risk symptomatic carotid stenosis (ECST-2): 2-year interim results of a multicentre randomised trial","year":2025,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Cerebrovascular and Carotid Artery Diseases","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"UCLH Biomedical Research Centre; Research for Patient Benefit Programme; ZonMw; University College London; University College London Hospitals NHS Foundation Trust; Stroke Association; National Institute for Health and Care Research; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Medicine; Interim; Asymptomatic; Stenosis; Interim analysis; Randomized controlled trial; Medical therapy; Internal medicine; Surgery","score_opus":0.03097718313561519,"score_gpt":0.32048920405689485,"score_spread":0.28951202092127964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409497257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98738396,0.0035463858,0.0010391873,0.00087880506,0.000667817,0.00386031,0.0009440426,0.0000756137,0.0016038975],"genre_scores_gemma":[0.9858618,0.0012608093,0.0024311545,0.00090330106,0.0007614886,0.0058147316,0.0012059439,0.000021239372,0.0017396298],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99638736,0.0023667917,0.00022915976,0.0004400387,0.00020073171,0.0003759745],"domain_scores_gemma":[0.9966738,0.0012687821,0.00079576904,0.0003740042,0.00019606875,0.0006914879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074366955,0.002550409,0.004508891,0.0005632489,0.0003838443,0.0015874457,0.0011760079,0.0030295958,0.00631216],"category_scores_gemma":[0.00644627,0.0007542601,0.00517419,0.0004679992,0.0014427766,0.0016509002,0.0010113525,0.0027366425,0.0008036512],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9935175,0.0017159599,0.0002719514,0.00022023424,0.00085505075,0.000016000507,0.000023058776,0.00030437106,0.0003222916,0.000053067284,0.00013672555,0.0025639674],"study_design_scores_gemma":[0.95837826,0.038852815,0.0010638348,0.00003038265,0.0008294166,0.000015186058,0.000009508777,0.00041329346,0.00011547839,0.00013576206,0.00014498692,0.0000110169285],"about_ca_topic_score_codex":0.00078182825,"about_ca_topic_score_gemma":0.0010454431,"teacher_disagreement_score":0.0074366955,"about_ca_system_score_codex":0.001074379,"about_ca_system_score_gemma":0.0013362349,"threshold_uncertainty_score":0.03932947},"labels":[],"label_agreement":null},{"id":"W4410514047","doi":"10.1016/s1474-4422(25)00154-1","title":"A new characterisation of acute traumatic brain injury: the NIH-NINDS TBI Classification and Nomenclature Initiative","year":2025,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Traumatic Brain Injury and Neurovascular Disturbances","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; HORIZON EUROPE Framework Programme; Vetenskapsrådet; WorkSafeBC; CSL Behring; UK Research and Innovation; Integra LifeSciences; Patient-Centered Outcomes Research Institute; GlaxoSmithKline; National Institute of Neurological Disorders and Stroke; ZNS - Hannelore Kohl Stiftung; National Institute for Health and Care Research; Dexcom; Massachusetts General Hospital; Abbott Laboratories; National Institutes of Health; U.S. Department of Health and Human Services; European Commission; U.S. Department of Defense","keywords":"Traumatic brain injury; Glasgow Coma Scale; Pillar; Medicine; Presentation (obstetrics); Glasgow Outcome Scale; Intensive care medicine; Psychiatry; Surgery; Engineering","score_opus":0.10018504908685226,"score_gpt":0.3667295373734923,"score_spread":0.26654448828664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410514047","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000060091268,0.9983406,0.0001798621,0.0006690802,0.00041333758,0.000014012959,0.00009483889,0.0000053334343,0.0002227742],"genre_scores_gemma":[0.0006235969,0.9974826,0.00063874404,0.0006283997,0.00025270853,0.000022845918,0.00021588094,0.00000330796,0.00013184384],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985097,0.000318944,0.0005005752,0.00021218386,0.000361576,0.00009697444],"domain_scores_gemma":[0.9968958,0.0012157786,0.0006041111,0.000057470188,0.0010878679,0.00013901507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052111894,0.0017442269,0.005292046,0.006320393,0.0004609909,0.002465444,0.0025645092,0.0015761354,0.0024069885],"category_scores_gemma":[0.005830901,0.0005005384,0.002127036,0.0063036,0.0013790276,0.0025935832,0.0016203461,0.003778268,0.001305212],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016672906,0.000047104262,0.0006956439,0.045964886,0.000364999,0.000064943524,0.00011029223,0.0003649938,0.00047744473,0.005689835,0.053125408,0.89292777],"study_design_scores_gemma":[0.00017591224,0.00022982963,0.006079507,0.06042456,0.0015418344,0.0008262154,0.0004024456,0.00034983226,0.00027082203,0.004621273,0.9249571,0.000120632634],"about_ca_topic_score_codex":0.0134952795,"about_ca_topic_score_gemma":0.016706215,"teacher_disagreement_score":0.0134952795,"about_ca_system_score_codex":0.0032222974,"about_ca_system_score_gemma":0.010161952,"threshold_uncertainty_score":0.027559757},"labels":[],"label_agreement":null},{"id":"W4410514059","doi":"10.1016/s1474-4422(25)00111-5","title":"Extended CT angiography versus standard CT angiography for the detection of cardioaortic thrombus in patients with ischaemic stroke and transient ischaemic attack (DAYLIGHT): a prospective, randomised, open-label, blinded end-point trial","year":2025,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; London Health Sciences Centre; Western University","funders":"Schulich School of Medicine and Dentistry, Western University; London Health Sciences Centre; Western University; Cotton Incorporated","keywords":"Ischaemic stroke; Medicine; Thrombus; Stroke (engine); Angiography; Radiology; Clinical endpoint; Open label; Prospective cohort study; Cardiology; Randomized controlled trial; Internal medicine; Ischemia","score_opus":0.050562735477567615,"score_gpt":0.3350790927906468,"score_spread":0.28451635731307917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410514059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849148,0.006665041,0.0010483906,0.00093386223,0.0011811972,0.0019019856,0.001087857,0.00011097997,0.0021558641],"genre_scores_gemma":[0.98493725,0.0028706307,0.002057064,0.0017874112,0.0012033769,0.0031281374,0.0010371527,0.00003179845,0.0029472183],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99878865,0.0006273049,0.00009342943,0.00025668665,0.00007163838,0.00016226909],"domain_scores_gemma":[0.9977375,0.000909098,0.0004954696,0.00021103212,0.000118810334,0.00052806403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020068455,0.0021814457,0.0045351908,0.0003995051,0.00053171156,0.0018938729,0.0011778908,0.0030826353,0.0061655575],"category_scores_gemma":[0.0036044265,0.0007745915,0.0027449618,0.00046365891,0.0017213017,0.001838471,0.0009312557,0.003881426,0.0011534765],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99313074,0.0010324304,0.00031547088,0.00029484558,0.000615241,0.000018727473,0.00002812075,0.000096749885,0.0005066004,0.00005310028,0.00026755646,0.0036404128],"study_design_scores_gemma":[0.976304,0.021006193,0.0012596683,0.000049192116,0.000543218,0.000023715858,0.000019325002,0.00025623487,0.00011370841,0.00018383987,0.00022229145,0.000018745657],"about_ca_topic_score_codex":0.0011513047,"about_ca_topic_score_gemma":0.0018228751,"teacher_disagreement_score":0.0061655575,"about_ca_system_score_codex":0.00082584633,"about_ca_system_score_gemma":0.0007921966,"threshold_uncertainty_score":0.02062589},"labels":[],"label_agreement":null},{"id":"W4411361655","doi":"10.1016/s1474-4422(25)00157-7","title":"Diagnostic and prognostic value of α-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort study","year":2025,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"NHLBI Division of Intramural Research; National Institute of Allergy and Infectious Diseases; Avid Radiopharmaceuticals; Allergan; Genentech; NIHR Cambridge Biomedical Research Centre; Sun Pharma; Medical Research Council; Teva Pharmaceutical Industries; Verily Life Sciences; Department of Health and Social Care; Parkinson's UK; Voyager Therapeutics; Neurocrine Biosciences; Jazz Pharmaceuticals; Pfizer; Biogen; PSP Association; Celgene; Servier; CurePSP; National Institute for Health and Care Research; Division of Intramural Research, National Institute of Allergy and Infectious Diseases; UK Research and Innovation; Eli Lilly and Company; Bristol-Myers Squibb; Rosetrees Trust; Sanofi; H. Lundbeck A/S; Van Andel Research Institute; Michael J. Fox Foundation for Parkinson's Research","keywords":"Parkinson's disease; Cohort; Disease; Medicine; Cohort study; Oncology; Internal medicine","score_opus":0.024235086750184525,"score_gpt":0.28565854878256125,"score_spread":0.2614234620323767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411361655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992487,0.00016729906,0.00013375758,0.000024697447,0.000005842313,0.000014535257,0.00027848379,0.0000028695792,0.00012375393],"genre_scores_gemma":[0.9992471,0.00006734844,0.00017573325,0.000018081595,0.000008932499,0.000021743857,0.00037594515,0.0000021610258,0.00008306277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987582,0.0004200916,0.00010488317,0.00039117373,0.00015950916,0.00016611909],"domain_scores_gemma":[0.9965683,0.000732653,0.0010977634,0.0005578383,0.0005220643,0.0005214321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033278104,0.0004379882,0.00045747156,0.00071426964,0.0006507793,0.0008412204,0.00050044816,0.0007265436,0.00074381096],"category_scores_gemma":[0.0056072124,0.00033000292,0.0006426978,0.0006828757,0.0003621945,0.0006893977,0.00065181596,0.0007742945,0.00016677883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068755297,0.000062716514,0.9977385,0.000004899779,0.00012017703,0.00008155139,0.000086311076,0.00003896122,0.00027002956,0.000015052652,0.000062703475,0.0008315961],"study_design_scores_gemma":[0.000043666136,0.0005413214,0.9983791,0.0000069244875,0.00011341613,0.0002600137,0.00009863222,0.0002940943,0.00008742514,0.000037410122,0.00012931421,0.000008598569],"about_ca_topic_score_codex":0.0038442523,"about_ca_topic_score_gemma":0.003782188,"teacher_disagreement_score":0.0038442523,"about_ca_system_score_codex":0.0003778974,"about_ca_system_score_gemma":0.0004319044,"threshold_uncertainty_score":0.017599404},"labels":[],"label_agreement":null},{"id":"W4411361836","doi":"10.1016/s1474-4422(25)00175-9","title":"Friedreich's ataxia—a rare multisystem disease","year":2025,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Medizinische Fakultät, RWTH Aachen University; Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg; RWTH Aachen University","keywords":"Ataxia; Medicine; Disease; Physical medicine and rehabilitation; Pediatrics; Pathology; Psychiatry","score_opus":0.09786984225415413,"score_gpt":0.3532553373447138,"score_spread":0.2553854950905597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411361836","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010735943,0.9974778,0.00008274231,0.00036354837,0.0002166653,0.0000028903876,0.00001941428,0.000013518458,0.0017161178],"genre_scores_gemma":[0.00080972794,0.9976509,0.000121899095,0.00023411558,0.00017995412,0.0000036910137,0.000053853262,0.0000017068336,0.00094411545],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99987245,0.00001789297,0.0000148209265,0.000018854458,0.000058239217,0.000017669692],"domain_scores_gemma":[0.9998398,0.00005891104,0.000026090236,0.000005724359,0.000042694533,0.000026732596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037986843,0.00075188396,0.0011687245,0.0017959542,0.00025908585,0.0008465903,0.00079836283,0.0008523234,0.0033187272],"category_scores_gemma":[0.0004035808,0.00014153452,0.0002965276,0.0014798491,0.0003786067,0.0007146486,0.0007049254,0.0013209803,0.003238082],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005396447,0.00003263847,0.0001540835,0.00783787,0.00007685245,0.00034906092,0.000033524982,0.00015012249,0.0011259859,0.0031648339,0.06334185,0.9236793],"study_design_scores_gemma":[0.000013988527,0.000031166535,0.0005103435,0.0022080536,0.000052101223,0.0020827078,0.000026376812,0.000032970354,0.00019787063,0.0013151518,0.9935207,0.000008573553],"about_ca_topic_score_codex":0.0013427646,"about_ca_topic_score_gemma":0.002979497,"teacher_disagreement_score":0.0033187272,"about_ca_system_score_codex":0.0006392987,"about_ca_system_score_gemma":0.0009871301,"threshold_uncertainty_score":0.011102259},"labels":[],"label_agreement":null},{"id":"W4412520511","doi":"10.1016/s1474-4422(25)00201-7","title":"Safety and effectiveness of the Walk ‘n Watch structured, progressive exercise protocol delivered by physical therapists for inpatient stroke rehabilitation in Canada: a phase 3, multisite, pragmatic, stepped-wedge, cluster-randomised controlled trial","year":2025,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Stroke Rehabilitation and Recovery","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; Bruyère; BC Centre for Disease Control; University of Saskatchewan; Glenrose Rehabilitation Hospital; University of Calgary; Université de Sherbrooke; Western University; University of Toronto; University Health Network; Vancouver Coastal Health; GF Strong Rehabilitation Centre; Centre for Interdisciplinary Research in Rehabilitation; Parkwood Institute; Lawson Health Research Institute","funders":"Fonds de Recherche du Québec - Santé; Canada Research Chairs; Michael Smith Health Research BC; Heart and Stroke Foundation of Canada; University of Calgary; Glenrose Rehabilitation Hospital; Canadian Institutes of Health Research; Sunnybrook Research Institute; Fondation Brain Canada","keywords":"Medicine; Physical therapy; Cluster randomised controlled trial; Rehabilitation; Randomized controlled trial; Stroke (engine); Walk-in; Clinical trial; Intention-to-treat analysis; Physical medicine and rehabilitation; Surgery; Alternative medicine","score_opus":0.005269261967364783,"score_gpt":0.295302740730576,"score_spread":0.2900334787632112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412520511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747372,0.0033426369,0.0011375971,0.001017988,0.00071308494,0.013594411,0.0019139097,0.00018061552,0.003362514],"genre_scores_gemma":[0.9810909,0.0012514621,0.0026993533,0.0007888791,0.00022790473,0.010872819,0.0008628729,0.000026964508,0.002178702],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99536115,0.0023728227,0.00034063266,0.0006577087,0.0006216576,0.0006460121],"domain_scores_gemma":[0.99646324,0.0010997994,0.00091011636,0.00025208003,0.00039367774,0.00088103634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004352318,0.0024274625,0.0041088075,0.0006634273,0.0014215587,0.0018667332,0.001895118,0.002909431,0.0073268036],"category_scores_gemma":[0.009401716,0.0010377127,0.0036324644,0.0009604339,0.002659387,0.0013609651,0.0009689047,0.0034816072,0.00062086654],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98187214,0.003997824,0.0005526075,0.001135459,0.0019408546,0.00002192857,0.00015179854,0.00033107254,0.00037435952,0.00015059195,0.00081238925,0.008658926],"study_design_scores_gemma":[0.97845435,0.017016165,0.0026214037,0.0001032123,0.00085231394,0.000008073617,0.000050535764,0.00046045257,0.00007621785,0.00013368731,0.00019472826,0.000028977052],"about_ca_topic_score_codex":0.1397385,"about_ca_topic_score_gemma":0.1890676,"teacher_disagreement_score":0.8602615,"about_ca_system_score_codex":0.009732546,"about_ca_system_score_gemma":0.016303724,"threshold_uncertainty_score":0.27785027},"labels":[],"label_agreement":null},{"id":"W4412520970","doi":"10.1016/s1474-4422(25)00198-x","title":"Acute-onset axonal neuropathy following infection in children with biallelic RCC1 variants: a case series","year":2025,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Hereditary Neurological Disorders","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"Medical Research Council; Manchester Biomedical Research Centre; Department of Health and Social Care; National Institute for Health and Care Research; Heart of England NHS Foundation Trust; Cancer Research UK; LifeArc; Research Trainees Coordinating Centre; University of Manchester; Wellcome Trust","keywords":"Missense mutation; Exome sequencing; Medicine; Phenotype; Exome; Pathology; Biology; Genetics; Gene","score_opus":0.021564009943141317,"score_gpt":0.26586161634917516,"score_spread":0.24429760640603385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412520970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973821,0.0006616055,0.0005360546,0.0001464814,0.000025820415,0.00005590997,0.00010211997,0.00002624184,0.0010637605],"genre_scores_gemma":[0.9988129,0.00033898428,0.000424201,0.00008537507,0.00004975787,0.000013554405,0.00007121683,0.000009085395,0.0001949127],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99898523,0.00008743401,0.00014842903,0.0003359244,0.00016663005,0.00027645618],"domain_scores_gemma":[0.9981401,0.0005152798,0.00056859636,0.00012337448,0.00014171783,0.00051092065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040933344,0.0016729445,0.000880563,0.001439801,0.0021673753,0.0010717956,0.00085135305,0.0018794172,0.002091389],"category_scores_gemma":[0.0020892005,0.00093725795,0.00070211885,0.0014898628,0.0014122468,0.0009503546,0.001357687,0.0012870553,0.00043204235],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096736854,0.00008164882,0.1652187,0.00008657826,0.00005253962,0.8277161,0.0010621177,0.00010607729,0.0018231795,0.00013286511,0.00040952992,0.0032138291],"study_design_scores_gemma":[0.000012370939,0.00011986811,0.04892178,0.000022004466,0.000030050336,0.94966483,0.00048983685,0.00009901873,0.00028772774,0.000040659612,0.00029696146,0.000014842862],"about_ca_topic_score_codex":0.004848487,"about_ca_topic_score_gemma":0.0066700936,"teacher_disagreement_score":0.004848487,"about_ca_system_score_codex":0.0010450698,"about_ca_system_score_gemma":0.0007801006,"threshold_uncertainty_score":0.009640515},"labels":[],"label_agreement":null},{"id":"W4412521105","doi":"10.1016/s1474-4422(25)00236-4","title":"Updates to the ILAE seizure classification","year":2025,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Psychology; Medicine; Computer science","score_opus":0.04864545620924898,"score_gpt":0.3554075505303054,"score_spread":0.30676209432105644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412521105","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00565703,0.13478872,0.013340912,0.49317554,0.22866988,0.0002548334,0.0128955,0.00163501,0.10958261],"genre_scores_gemma":[0.058572147,0.22711386,0.049232766,0.23435906,0.27539665,0.00091612805,0.046960637,0.0021404517,0.105308324],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943507,0.0011027559,0.0014942749,0.0004303204,0.002031244,0.0005907811],"domain_scores_gemma":[0.9556353,0.007371218,0.0029520153,0.001753111,0.029381864,0.0029064815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009725834,0.0010935606,0.0015710315,0.007351043,0.00094395597,0.0056767915,0.0025287035,0.0032356603,0.015401902],"category_scores_gemma":[0.04596142,0.00042690462,0.0018854055,0.0041647786,0.0014657017,0.0049416767,0.0020865868,0.007368911,0.013485342],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000110034016,0.00003469034,0.001770844,0.00040741975,0.00003780393,0.000088428395,0.000080881306,0.00021366077,0.00020232314,0.0038994101,0.7576086,0.23554589],"study_design_scores_gemma":[0.000059481237,0.00003723448,0.003812227,0.0015578081,0.000056789933,0.00044691985,0.00012750382,0.0001885625,0.00014242908,0.003295198,0.9902378,0.000037967773],"about_ca_topic_score_codex":0.019104404,"about_ca_topic_score_gemma":0.028605321,"teacher_disagreement_score":0.019104404,"about_ca_system_score_codex":0.003696706,"about_ca_system_score_gemma":0.006535193,"threshold_uncertainty_score":0.05152446},"labels":[],"label_agreement":null},{"id":"W4412521255","doi":"10.1016/s1474-4422(25)00241-8","title":"Over a decade of MR-guided focused ultrasound","year":2025,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute; Toronto Western Hospital","funders":"University Health Network Foundation","keywords":"Ultrasound; Medical physics; Medicine; Radiology","score_opus":0.03687892878586512,"score_gpt":0.3198798382536295,"score_spread":0.28300090946776435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412521255","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022564415,0.79202086,0.020098656,0.09159097,0.015814226,0.00013757279,0.0008215195,0.00060037425,0.05635146],"genre_scores_gemma":[0.1749948,0.6349033,0.026518473,0.10226182,0.029573707,0.00025246167,0.0016597114,0.0004985668,0.02933714],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975496,0.0008333323,0.00026010562,0.0005284136,0.0006610326,0.0001675687],"domain_scores_gemma":[0.9772864,0.01165503,0.0016552005,0.0013726376,0.00672739,0.0013032558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007414873,0.00084789813,0.0006583184,0.0030587923,0.0004884504,0.002290598,0.001122484,0.0022768432,0.0068866564],"category_scores_gemma":[0.02369195,0.00039755707,0.00059774483,0.0020065724,0.0028811456,0.0024531588,0.0019664622,0.0036701404,0.002899224],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039273308,0.00018343522,0.0054067895,0.0027131294,0.00017480156,0.00072037266,0.0009697067,0.00097105734,0.0032463858,0.017835999,0.08599196,0.8813936],"study_design_scores_gemma":[0.00007501115,0.0003787891,0.009293371,0.0050771856,0.00016569752,0.003990172,0.0006471908,0.000598713,0.0018566304,0.0056800214,0.9721637,0.00007349256],"about_ca_topic_score_codex":0.006763627,"about_ca_topic_score_gemma":0.007917188,"teacher_disagreement_score":0.007414873,"about_ca_system_score_codex":0.003035462,"about_ca_system_score_gemma":0.0030795317,"threshold_uncertainty_score":0.039214075},"labels":[],"label_agreement":null},{"id":"W4412523022","doi":"10.1016/s1474-4422(25)00174-7","title":"Safety and efficacy of fenebrutinib in relapsing multiple sclerosis (FENopta): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial and open-label extension study","year":2025,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Roche","keywords":"Medicine; Clinical endpoint; Placebo; Internal medicine; Population; Expanded Disability Status Scale; Adverse effect; Clinical trial; Multiple sclerosis; Clinically isolated syndrome; Phases of clinical research; Surrogate endpoint; Physical therapy; Pathology; Immunology","score_opus":0.16614358490683614,"score_gpt":0.4016988338568246,"score_spread":0.23555524894998844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412523022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98606443,0.0069629904,0.00046061634,0.0006545158,0.00040449496,0.0020527416,0.0014725307,0.00008373177,0.0018439129],"genre_scores_gemma":[0.9858996,0.0025376754,0.0014704638,0.0014691813,0.00052420504,0.003725212,0.0017088843,0.000033704957,0.0026309714],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990491,0.00046497124,0.00005616998,0.00017760751,0.00009072999,0.00016130622],"domain_scores_gemma":[0.9987205,0.000299466,0.0002969879,0.00012563703,0.00011989696,0.00043742036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030612808,0.0022755803,0.0042299824,0.00048784178,0.00073194376,0.0012499284,0.0011329537,0.0029099374,0.00589839],"category_scores_gemma":[0.0024093506,0.00081244874,0.0025589569,0.00039970453,0.0013196114,0.0017099817,0.0005518313,0.0034161329,0.0012255575],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98228216,0.0037802581,0.00064705353,0.0004952367,0.0010339381,0.000042563424,0.000046253565,0.00013391112,0.0023559618,0.00007015354,0.000682042,0.008430517],"study_design_scores_gemma":[0.95849127,0.036447372,0.0035916895,0.000028125325,0.00046852147,0.000046594683,0.000015573423,0.00014541003,0.00022598225,0.00008697796,0.0004349305,0.000017626498],"about_ca_topic_score_codex":0.0009860562,"about_ca_topic_score_gemma":0.001834313,"teacher_disagreement_score":0.00589839,"about_ca_system_score_codex":0.0008402874,"about_ca_system_score_gemma":0.0012315664,"threshold_uncertainty_score":0.019732058},"labels":[],"label_agreement":null},{"id":"W4413150167","doi":"10.1016/s1474-4422(25)00286-8","title":"The Bern Declaration on Brain Health: a decalogue to launch an international alliance","year":2025,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute","funders":"","keywords":"Alliance; Declaration; Political science; Ancient history; History; Law","score_opus":0.053626910372596,"score_gpt":0.3229990977132536,"score_spread":0.2693721873406576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413150167","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007373812,0.001984961,0.000044815966,0.9740974,0.021821916,0.0000039166257,0.000021378739,0.000007400395,0.001944456],"genre_scores_gemma":[0.0015545925,0.0010090383,0.00011513584,0.9602875,0.03117529,0.000025366046,0.000017129774,0.000022018487,0.0057939338],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9910507,0.0026418515,0.0007313896,0.00076982076,0.002556788,0.0022493245],"domain_scores_gemma":[0.98043936,0.008620886,0.0010531069,0.0005889748,0.00253629,0.0067614573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011540278,0.0016727216,0.0023098488,0.0011266855,0.007997148,0.01095982,0.0028502797,0.10985249,0.008647447],"category_scores_gemma":[0.036571205,0.0010125109,0.002116365,0.00088697334,0.011051905,0.009092102,0.006349069,0.108614795,0.0084058205],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003935991,0.000027905993,0.00014981977,0.00004992742,0.000017474653,0.000537848,0.00018675733,0.000032915963,0.000093846145,0.00830769,0.98683757,0.0037187806],"study_design_scores_gemma":[0.00009171518,0.000027742624,0.00046059667,0.0004196619,0.00002690031,0.00033989598,0.0005663732,0.0001155471,0.00009127279,0.017501036,0.98029447,0.000064790285],"about_ca_topic_score_codex":0.015171405,"about_ca_topic_score_gemma":0.027613886,"teacher_disagreement_score":0.10985249,"about_ca_system_score_codex":0.0075094113,"about_ca_system_score_gemma":0.020123862,"threshold_uncertainty_score":0.06103158},"labels":[],"label_agreement":null},{"id":"W4413150283","doi":"10.1016/s1474-4422(25)00227-3","title":"Blood phosphorylated tau for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"UCLH Biomedical Research Centre; Fonds de Recherche du Québec - Santé; Horizon 2020 Framework Programme; Olav Thon Stiftelsen; National Institutes of Health; Faculty of Medicine, McGill University; Instituto Serrapilheira; Kirsten og Freddy Johansens Fond; Instituto Nacional de Ciência e Tecnologia para Excitotoxicidade e Neuroproteção; University College London; EU Joint Programme – Neurodegenerative Disease Research; UK Dementia Research Institute; Vetenskapsrådet; National Academy of Neuropsychology; Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul; Cure Alzheimer's Fund; Consortium canadien en neurodégénérescence associée au vieillissement; Alzheimer's Association; Conselho Nacional de Desenvolvimento Científico e Tecnológico; University of Pittsburgh; Familjen Erling-Perssons Stiftelse; Canadian Institutes of Health Research; Alzheimerfonden; Weston Brain Institute; Alzheimer's Drug Discovery Foundation","keywords":"Meta-analysis; Disease; Medicine; Alzheimer's disease; Neuroscience; Psychology; Internal medicine","score_opus":0.12161754026764802,"score_gpt":0.40700595459423206,"score_spread":0.285388414326584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413150283","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053795185,0.9927617,0.0005345188,0.00019341375,0.00013693002,0.00033940445,0.00043786614,0.000026387874,0.00019024091],"genre_scores_gemma":[0.20254362,0.789641,0.0032829696,0.00090225803,0.00043485741,0.0019646497,0.00089565886,0.00003378468,0.00030111254],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98615617,0.007753523,0.0031211004,0.001372939,0.0011870805,0.00040917442],"domain_scores_gemma":[0.96653473,0.026351633,0.003924305,0.00076736877,0.0020606143,0.00036145354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018403258,0.0032240576,0.023274032,0.007052737,0.000826571,0.0032598828,0.0028321096,0.0028271812,0.0034551125],"category_scores_gemma":[0.041245885,0.0017415315,0.044754557,0.0074634226,0.0008988561,0.0018202541,0.0015532441,0.0020622793,0.00031414223],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002887964,0.000027930133,0.005458732,0.27359936,0.70789015,0.00012016617,0.00006130474,0.00056602096,0.00014493536,0.00009300646,0.00050158275,0.008648904],"study_design_scores_gemma":[0.0007439554,0.0001486693,0.0029757267,0.014295998,0.9807803,0.00006506481,0.000022789982,0.00020569142,0.000063247935,0.00010202945,0.0005808495,0.000015701087],"about_ca_topic_score_codex":0.01020129,"about_ca_topic_score_gemma":0.017485702,"teacher_disagreement_score":0.023274032,"about_ca_system_score_codex":0.0033801766,"about_ca_system_score_gemma":0.004108333,"threshold_uncertainty_score":0.097326934},"labels":[],"label_agreement":null},{"id":"W4414272694","doi":"10.1016/s1474-4422(25)00270-4","title":"Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria","year":2025,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":299,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Nova Scotia Health Authority; Ottawa Hospital; University of Toronto; Dalhousie University; University of Ottawa; St. Michael's Hospital","funders":"National Institute of Neurological Disorders and Stroke; Chugai Pharmaceutical; Novartis Pharma; Instituto de Salud Carlos III; Pfizer Foundation; EMD Serono; National Institutes of Health; MedDay Pharmaceuticals; National Health and Medical Research Council; Neuraxpharm; Ipsen; University College London Hospitals NHS Foundation Trust; Shionogi; Janssen Pharmaceuticals; Sanofi Genzyme; Novo Nordisk; Samsung; Eisai; University of Toronto; Ministero della Salute; IXICO; BMA Foundation for Medical Research; Dalhousie University; Fondazione Cariplo; ZonMw; University of Sydney; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Ministry of Education, Culture, Sports, Science and Technology; Multiple Sclerosis International Federation; Public Health Agency; Multiple Sclerosis Australia; Idorsia Pharmaceuticals; H. Lundbeck A/S; Rosetrees Trust; Fondation pour la Recherche Médicale; Bayer HealthCare; University College London; Schweizerische Multiple Sklerose Gesellschaft; Multiple Sclerosis Society; Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques; Prothena; Argenx; Fondation Charcot; Celltrion; CVS Health; Mylan; Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada; Race to Erase MS; Deutsche Forschungsgemeinschaft; Arthritis Society; Medical Research Council; Patient-Centered Outcomes Research Institute; Hope Foundation; Kiniksa Pharmaceuticals; Alexion Pharmaceuticals; Myelin Repair Foundation; Amgen; Public Health Agency of Canada; Genentech; AstraZeneca; European Commission; American Academy of Neurology; Fondation Brain Canada; European Committee for Treatment and Research in Multiple Sclerosis; University of Pennsylvania; Bristol-Myers Squibb; Teva Pharmaceutical Industries; Crohn's and Colitis Canada; BioCryst; Fondazione Italiana Sclerosi Multipla; Celgene; Moderna; Pfizer; Biogen; Allergan; F. Hoffmann-La Roche; Sanofi; TG Therapeutics; Eli Lilly and Company; Regione Toscana; Petre Foundation; U.S. Department of Defense; Horizon Therapeutics; Amicus Therapeutics; Multiple Sclerosis Scientific Research Foundation; National Multiple Sclerosis Society; U.S. Department of Health and Human Services; GlaxoSmithKline; National Research Foundation; National Institute for Health and Care Research; CSL Behring; Royal Australasian College of Physicians; National Science Foundation","keywords":"Multiple sclerosis; McDonald criteria; Clinically isolated syndrome; Clinical Practice; Disease","score_opus":0.22084498077835243,"score_gpt":0.41215687542773727,"score_spread":0.19131189464938483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414272694","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047847854,0.9975414,0.00009546715,0.001087857,0.0009103846,0.000028494225,0.00010822798,0.0000062939425,0.0001739708],"genre_scores_gemma":[0.0010590095,0.9948726,0.0009400198,0.0018505191,0.00080213795,0.000067693305,0.00023787898,0.0000056987956,0.00016435383],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99169594,0.0023247881,0.0032385697,0.0005526392,0.0019775422,0.00021043992],"domain_scores_gemma":[0.98433197,0.009379311,0.0026317516,0.000271006,0.0030745678,0.00031135447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016346145,0.0024256422,0.008348516,0.013155993,0.00054421276,0.003055576,0.0034018995,0.0026979488,0.00460543],"category_scores_gemma":[0.023554308,0.000981667,0.0064170263,0.0072986856,0.0017476568,0.002824573,0.0023051833,0.0034790537,0.0011220418],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008225562,0.000060294416,0.0009006317,0.27323574,0.0049896506,0.00019556194,0.00016740435,0.0003495207,0.00042798696,0.003932247,0.09017708,0.6247414],"study_design_scores_gemma":[0.0014808181,0.00039045015,0.0077914177,0.34089652,0.022827733,0.0018920817,0.00028763135,0.00032832279,0.00029272103,0.0052759834,0.6183596,0.00017663166],"about_ca_topic_score_codex":0.011985167,"about_ca_topic_score_gemma":0.024425708,"teacher_disagreement_score":0.016346145,"about_ca_system_score_codex":0.0037216449,"about_ca_system_score_gemma":0.009285399,"threshold_uncertainty_score":0.086447716},"labels":[],"label_agreement":null},{"id":"W4414272711","doi":"10.1016/s1474-4422(25)00312-6","title":"Sleep biomarkers for sudden unexpected death in epilepsy","year":2025,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Epilepsy; Sudden death; Incidence (geometry); Sleep (system call); Pathophysiology; Cause of death; Disease; Electroencephalography","score_opus":0.03851450891523223,"score_gpt":0.34329852578390674,"score_spread":0.3047840168686745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414272711","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4095992,0.48745018,0.0030550938,0.050069228,0.011817726,0.00016373696,0.009979256,0.00026192033,0.027603712],"genre_scores_gemma":[0.8993369,0.07137886,0.0029162462,0.009868746,0.008699285,0.000103094026,0.0041795745,0.000032315165,0.0034849495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996141,0.00012221973,0.00008721516,0.000051134317,0.000079938916,0.000045360863],"domain_scores_gemma":[0.99694747,0.0011550088,0.0010175663,0.0001094901,0.00050359155,0.00026690075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012682563,0.00057122123,0.00084474747,0.0010626642,0.00021917358,0.0012374092,0.00042661413,0.0011329185,0.0030495059],"category_scores_gemma":[0.0054092137,0.00015033386,0.00096807367,0.0007716321,0.00030062036,0.00076388894,0.0005867905,0.0013451307,0.0005755553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041858177,0.00028642666,0.65495074,0.0024183078,0.0047751344,0.0010996151,0.00014933592,0.00086541334,0.0025295718,0.0031208678,0.051905617,0.27371305],"study_design_scores_gemma":[0.00080297195,0.0016437683,0.9338739,0.0026757652,0.0029592796,0.0017795098,0.0005178491,0.0032156804,0.0011747269,0.018819368,0.03238437,0.0001527867],"about_ca_topic_score_codex":0.00217805,"about_ca_topic_score_gemma":0.005783481,"teacher_disagreement_score":0.0030495059,"about_ca_system_score_codex":0.0004190293,"about_ca_system_score_gemma":0.00065198896,"threshold_uncertainty_score":0.010201573},"labels":[],"label_agreement":null},{"id":"W4414273413","doi":"10.1016/s1474-4422(25)00321-7","title":"Refining risk stratification in cerebral amyloid angiopathy: the role of the Edinburgh criteria","year":2025,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Intracerebral and Subarachnoid Hemorrhage Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Risk stratification; Risk assessment; Amyloid (mycology); Diabetes mellitus; Refining (metallurgy)","score_opus":0.01838883290112124,"score_gpt":0.30046660091742927,"score_spread":0.282077768016308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414273413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85588443,0.052257825,0.021541921,0.042588133,0.002314029,0.00019716253,0.0014891361,0.00017551592,0.023551818],"genre_scores_gemma":[0.97217757,0.0077682454,0.015024522,0.001748052,0.0011399307,0.00004342815,0.0005992182,0.000046789308,0.0014522034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947767,0.002534059,0.00080748484,0.00039460117,0.0012001259,0.00028706354],"domain_scores_gemma":[0.9836647,0.008588463,0.0026586272,0.0011398575,0.0029521673,0.0009961623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012703561,0.0008936955,0.0012437932,0.002362853,0.0005206431,0.0021379385,0.0013884122,0.0010883352,0.001382613],"category_scores_gemma":[0.038474128,0.00026082873,0.0005322174,0.0014222324,0.00090746494,0.002869611,0.0018846043,0.002103467,0.0003803685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025285343,0.00016288081,0.629529,0.0003904566,0.00094798964,0.00092431606,0.00075063424,0.0016896682,0.0015555474,0.00786494,0.018625228,0.33503094],"study_design_scores_gemma":[0.0012589942,0.0010789684,0.8872345,0.0013268039,0.0013622708,0.004508763,0.001763471,0.010267106,0.0015184524,0.05153624,0.037763495,0.0003809103],"about_ca_topic_score_codex":0.0057471725,"about_ca_topic_score_gemma":0.0068368716,"teacher_disagreement_score":0.012703561,"about_ca_system_score_codex":0.00069487473,"about_ca_system_score_gemma":0.0012464433,"threshold_uncertainty_score":0.06718367},"labels":[],"label_agreement":null},{"id":"W4414273415","doi":"10.1016/s1474-4422(25)00304-7","title":"2024 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI for the diagnosis of multiple sclerosis","year":2025,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto; University of Calgary; International Collaboration On Repair Discoveries; St. Michael's Hospital","funders":"Instituto de Salud Carlos III; EMD Serono; AstraZeneca; Genentech; Multiple Sclerosis Society; Schweizerische Multiple Sklerose Gesellschaft; Janssen Pharmaceuticals; Sanofi Genzyme; Novo Nordisk; MedDay Pharmaceuticals; Ministero della Salute; Celgene; Amsterdam Neuroscience; Rosetrees Trust; Idorsia Pharmaceuticals; ZonMw; National Institute for Health and Care Research; National Research Foundation; Shionogi; Alexion Pharmaceuticals; Myelin Repair Foundation; Wellcome Trust; Kiniksa Pharmaceuticals; Atara Biotherapeutics; National Institutes of Health; International Collaboration on Repair Discoveries; Mylan; Sanofi; TG Therapeutics; European Committee for Treatment and Research in Multiple Sclerosis; Eurostars; Patient-Centered Outcomes Research Institute; Medical Research Council; National Health and Medical Research Council; Neuraxpharm; Craig H. Neilsen Foundation; Bristol-Myers Squibb; Teva Pharmaceutical Industries; Fondazione Italiana Sclerosi Multipla; Natural Sciences and Engineering Research Council of Canada; Pfizer; Biogen; Eli Lilly and Company; U.S. Department of Defense; Multiple Sclerosis International Federation; CSL Behring; Samsung; Allergan; Multiple Sclerosis Society of Canada; Race to Erase MS; U.S. Department of Health and Human Services","keywords":"Multiple sclerosis; Magnetic resonance imaging; Clinical Practice; McDonald criteria; Spinal cord; Medical imaging","score_opus":0.48056161174560574,"score_gpt":0.4234462015130648,"score_spread":0.057115410232540964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414273415","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007718913,0.9816311,0.00043243033,0.0095315175,0.0036276297,0.00028458334,0.0012259725,0.000037969894,0.0031515334],"genre_scores_gemma":[0.00084418635,0.9830308,0.0026531199,0.008587267,0.0011224666,0.00050467835,0.0014108026,0.000025213085,0.0018213604],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99015033,0.0030361982,0.0029425905,0.00057444663,0.002832297,0.00046415834],"domain_scores_gemma":[0.98001194,0.0097935675,0.0033463256,0.00035591057,0.0058582053,0.0006340512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01851138,0.0024204312,0.0064346474,0.016206482,0.0009609309,0.0039684623,0.006704997,0.0068018246,0.013245882],"category_scores_gemma":[0.036077987,0.0013139178,0.00895846,0.0075443704,0.0014947712,0.0030052399,0.003497298,0.0042437688,0.006656996],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005296121,0.000071427094,0.00043501475,0.25125858,0.0025798744,0.00026904617,0.00016663459,0.00031689793,0.0007423104,0.005871585,0.23525059,0.5025084],"study_design_scores_gemma":[0.00032497136,0.000092973736,0.0018842345,0.30763772,0.0050279447,0.00032182373,0.000110636196,0.00007592871,0.0002524824,0.0032903731,0.6809109,0.00007006798],"about_ca_topic_score_codex":0.0220206,"about_ca_topic_score_gemma":0.027999545,"teacher_disagreement_score":0.0220206,"about_ca_system_score_codex":0.0060042446,"about_ca_system_score_gemma":0.02360115,"threshold_uncertainty_score":0.09789872},"labels":[],"label_agreement":null},{"id":"W4415215835","doi":"10.1016/s1474-4422(25)00308-4","title":"Intravenous alteplase versus oral aspirin for acute central retinal artery occlusion within 4·5 h of severe vision loss (THEIA): a multicentre, double-dummy, patient-blinded and assessor-blinded, randomised, controlled, phase 3 trial","year":2025,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Retinal and Optic Conditions","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Direction de l’hospitalisation et de l’offre de Soins; Ministère des Solidarités et de la Santé; Boehringer Ingelheim France; Boehringer Ingelheim","keywords":"Central retinal artery occlusion; Aspirin; Occlusion; Central retinal artery; Vision disorder; Retinal; Eye disease","score_opus":0.0375417818587189,"score_gpt":0.36071778427671564,"score_spread":0.3231760024179967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415215835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9611159,0.017245641,0.0016022737,0.0012315235,0.0012948029,0.013011053,0.0018737533,0.00017307524,0.002451994],"genre_scores_gemma":[0.9766839,0.004144893,0.0022964198,0.00134088,0.00073964,0.012485967,0.00090634724,0.000028164271,0.0013737675],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974057,0.0016191412,0.00024530853,0.00035183536,0.00013758827,0.0002403902],"domain_scores_gemma":[0.9971794,0.00094526436,0.0009981254,0.00023820282,0.00023531835,0.00040362735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050199684,0.0019366533,0.0049844827,0.0005054956,0.0005916796,0.0016207811,0.0011350277,0.0023649863,0.004657037],"category_scores_gemma":[0.0053496133,0.00073379034,0.005037306,0.0005579995,0.0010150293,0.0010733645,0.0005907352,0.0028019368,0.0007236997],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9895739,0.001479123,0.0003707882,0.0012803726,0.0018789218,0.000018805826,0.000043669097,0.00013691443,0.00084840035,0.00005955984,0.00025589325,0.0040534874],"study_design_scores_gemma":[0.9633103,0.03335161,0.0010301745,0.00007938586,0.001534011,0.000014952965,0.000013622583,0.00014700946,0.00012342869,0.00008154809,0.00030385252,0.00001023433],"about_ca_topic_score_codex":0.00094210915,"about_ca_topic_score_gemma":0.0017283314,"teacher_disagreement_score":0.0050199684,"about_ca_system_score_codex":0.0010135749,"about_ca_system_score_gemma":0.0013087197,"threshold_uncertainty_score":0.026548445},"labels":[],"label_agreement":null},{"id":"W4416276297","doi":"10.1016/s1474-4422(25)00350-3","title":"Lifetime and 10-year absolute risk of cognitive impairment in relation to amyloid PET severity: a retrospective, longitudinal cohort study","year":2025,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute on Aging; National Institutes of Health; GHR Foundation; Alexander Family Foundation","keywords":"Cognitive impairment; Cohort; Cohort study; Absolute risk reduction; Amyloid (mycology); Dementia; Longitudinal study; Cognition","score_opus":0.013353816647461781,"score_gpt":0.3103538440556378,"score_spread":0.29700002740817605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416276297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99825865,0.00038996126,0.00013602947,0.000043618835,0.000016545991,0.0000057174498,0.0008910287,0.000008390508,0.00024997562],"genre_scores_gemma":[0.99843866,0.00020502615,0.00012846908,0.000032072858,0.000020083071,0.00001046809,0.000767771,0.0000060945113,0.00039135208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992036,0.00018965636,0.00007678933,0.00032447817,0.000073346026,0.00013204449],"domain_scores_gemma":[0.99719393,0.00037116482,0.0008536689,0.0007583903,0.0003343044,0.000488584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017635629,0.00074513163,0.00067693874,0.00080011634,0.00088151795,0.0013405483,0.0008678537,0.0013130497,0.001691573],"category_scores_gemma":[0.0032948784,0.0013635202,0.0014973882,0.0014622658,0.0005546638,0.0010863438,0.00072453887,0.0018875478,0.00049377274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016003562,0.00011143438,0.995902,0.000011777367,0.000661225,0.00015914085,0.00015192454,0.000075804826,0.00048155105,0.0000418892,0.00017581602,0.00062699185],"study_design_scores_gemma":[0.00004572648,0.00019605207,0.9986469,0.0000054548,0.00020041289,0.00029844066,0.00015292683,0.00022308665,0.00004111627,0.00004673257,0.00013167398,0.00001137495],"about_ca_topic_score_codex":0.016525464,"about_ca_topic_score_gemma":0.013582688,"teacher_disagreement_score":0.016525464,"about_ca_system_score_codex":0.00047873583,"about_ca_system_score_gemma":0.0005409254,"threshold_uncertainty_score":0.03285855},"labels":[],"label_agreement":null},{"id":"W4416276298","doi":"10.1016/s1474-4422(25)00323-0","title":"The evolving therapeutic landscape of dementia with Lewy bodies","year":2025,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network","funders":"NIHR Cambridge Biomedical Research Centre; Dementias Platform UK; NIHR Newcastle Biomedical Research Centre; National Institute for Health and Care Research; Manchester Biomedical Research Centre; Lewy Body Society","keywords":"Dementia with Lewy bodies; Dementia; Disease; Clinical trial; Lewy body; Neuropathology","score_opus":0.01983781715529768,"score_gpt":0.3083523891218573,"score_spread":0.2885145719665596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416276298","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003184351,0.66405064,0.00079723494,0.31546995,0.0037317416,0.00001155484,0.00008371265,0.00005688045,0.012613933],"genre_scores_gemma":[0.073697425,0.75910085,0.0029616961,0.12626383,0.034680415,0.000071082904,0.000124437,0.00006371509,0.0030364683],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961169,0.0016888027,0.0004278922,0.0003661953,0.0010154084,0.00038491737],"domain_scores_gemma":[0.98628145,0.008374077,0.0013134449,0.0003680534,0.0022965278,0.0013663685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012301539,0.00067108654,0.0022192146,0.00233071,0.0014460785,0.008870898,0.0018995525,0.0071703135,0.006298605],"category_scores_gemma":[0.014256708,0.0003501908,0.0009450764,0.0016103297,0.007155522,0.01015871,0.0032212639,0.009148285,0.001857616],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094530423,0.00034911424,0.002070339,0.0058381474,0.00024531747,0.0013501188,0.0012919871,0.0009788305,0.0018577249,0.15013722,0.12908284,0.70585304],"study_design_scores_gemma":[0.00039119276,0.0007682775,0.004230103,0.010241425,0.0001892011,0.0028730715,0.0033794346,0.0008913246,0.00061650644,0.19987011,0.77639705,0.0001524013],"about_ca_topic_score_codex":0.001993704,"about_ca_topic_score_gemma":0.0071126586,"teacher_disagreement_score":0.012301539,"about_ca_system_score_codex":0.0046521346,"about_ca_system_score_gemma":0.0065285335,"threshold_uncertainty_score":0.065057516},"labels":[],"label_agreement":null},{"id":"W4416412120","doi":"10.1016/s1474-4422(25)00402-8","title":"Global, regional, and national burden of headache disorders, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023","year":2025,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Université de Montréal; University of New Brunswick; McMaster University; University of Toronto","funders":"Bill and Melinda Gates Foundation","keywords":"Burden of disease; Disease burden; Disease; MEDLINE; Double burden; Epidemiology","score_opus":0.08308929373608914,"score_gpt":0.392420882073459,"score_spread":0.30933158833736984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416412120","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017212182,0.9479919,0.0037840228,0.0023571413,0.0004908316,0.0006347779,0.026762731,0.00013404906,0.0006323487],"genre_scores_gemma":[0.45355088,0.4974248,0.015999028,0.0033266651,0.00065293023,0.0049719494,0.023367433,0.00015323191,0.00055298756],"study_design_codex":"meta_analysis","study_design_gemma":"systematic_review","domain_scores_codex":[0.9829402,0.009000974,0.003380913,0.0019012995,0.0022847971,0.0004918616],"domain_scores_gemma":[0.9838847,0.009052787,0.0031755741,0.001052698,0.0025278777,0.00030626365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024124168,0.00185307,0.007865156,0.008891847,0.0005560141,0.0018014652,0.0012071105,0.0015511358,0.0021953136],"category_scores_gemma":[0.04078441,0.0012989022,0.03333439,0.014123855,0.00067441445,0.0009644685,0.0021882108,0.0018074543,0.0003384279],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020537379,0.000029908395,0.0837781,0.17939086,0.6746997,0.0003335754,0.00041392053,0.0029523831,0.00047761333,0.0012447084,0.01678293,0.03784247],"study_design_scores_gemma":[0.0014788909,0.0002353813,0.08146763,0.047276393,0.85090435,0.0004137197,0.00022387443,0.0016052813,0.00024463836,0.0015962704,0.014433283,0.00012030094],"about_ca_topic_score_codex":0.035603512,"about_ca_topic_score_gemma":0.0515048,"teacher_disagreement_score":0.035603512,"about_ca_system_score_codex":0.0028209116,"about_ca_system_score_gemma":0.007883066,"threshold_uncertainty_score":0.12758225},"labels":[],"label_agreement":null},{"id":"W4417210396","doi":"10.1016/s1474-4422(25)00432-6","title":"Exploring immunomodulation with azathioprine in Parkinson's disease","year":2025,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Neuroinflammation; Microglia; Neurodegeneration; Disease; Substantia nigra; Azathioprine; Immune system; Central nervous system","score_opus":0.057416337214366814,"score_gpt":0.2773893815183859,"score_spread":0.21997304430401907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417210396","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023262396,0.94335127,0.00045713855,0.021153895,0.002026277,0.0000436136,0.000096218275,0.000034343495,0.009574842],"genre_scores_gemma":[0.19103253,0.77635,0.001945172,0.01410538,0.009801005,0.00012852099,0.0001333718,0.000015879694,0.0064880196],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997398,0.00009857581,0.000024405228,0.000024787474,0.00005582525,0.000056583685],"domain_scores_gemma":[0.999546,0.0002455603,0.00007088314,0.000016457476,0.00006553781,0.00005550157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001196023,0.00029801755,0.0007959058,0.0003507787,0.00024282363,0.0012715184,0.00042332488,0.001197335,0.00350242],"category_scores_gemma":[0.00080189144,0.000103877195,0.0005943247,0.0003023363,0.0006146614,0.0011109568,0.00048759396,0.0019806488,0.00063952105],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004015859,0.0006284979,0.0024690183,0.0063189813,0.0005365957,0.0007505665,0.00033375708,0.00056262163,0.015961444,0.015659897,0.027910966,0.9248518],"study_design_scores_gemma":[0.0054335464,0.012994726,0.016928285,0.0061290204,0.0019187286,0.0027080842,0.0008440988,0.0010919316,0.011370535,0.036333717,0.9041574,0.00008991364],"about_ca_topic_score_codex":0.00048539496,"about_ca_topic_score_gemma":0.0021280847,"teacher_disagreement_score":0.00350242,"about_ca_system_score_codex":0.0006790361,"about_ca_system_score_gemma":0.00078046456,"threshold_uncertainty_score":0.011716783},"labels":[],"label_agreement":null}]}